Citrus Sinensis ID: 012053
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 472 | 2.2.26 [Sep-21-2011] | |||||||
| Q7X996 | 443 | CBL-interacting protein k | yes | no | 0.904 | 0.963 | 0.735 | 0.0 | |
| Q5W736 | 457 | CBL-interacting protein k | no | no | 0.951 | 0.982 | 0.691 | 0.0 | |
| Q9C562 | 479 | CBL-interacting serine/th | yes | no | 0.921 | 0.908 | 0.679 | 0.0 | |
| Q9LWM4 | 461 | CBL-interacting protein k | no | no | 0.923 | 0.945 | 0.681 | 1e-177 | |
| Q10LQ2 | 451 | CBL-interacting protein k | no | no | 0.927 | 0.971 | 0.662 | 1e-172 | |
| Q9FJ54 | 439 | CBL-interacting serine/th | no | no | 0.911 | 0.979 | 0.654 | 1e-169 | |
| Q9LYQ8 | 456 | CBL-interacting serine/th | no | no | 0.940 | 0.973 | 0.655 | 1e-167 | |
| P92937 | 421 | CBL-interacting serine/th | no | no | 0.891 | 1.0 | 0.660 | 1e-165 | |
| Q2QYM3 | 439 | CBL-interacting protein k | no | no | 0.904 | 0.972 | 0.640 | 1e-165 | |
| Q0JI49 | 502 | CBL-interacting protein k | no | no | 0.983 | 0.924 | 0.616 | 1e-164 |
| >sp|Q7X996|CIPK2_ORYSJ CBL-interacting protein kinase 2 OS=Oryza sativa subsp. japonica GN=CIPK2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 656 bits (1692), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/435 (73%), Positives = 371/435 (85%), Gaps = 8/435 (1%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
E +G++LM++YE+G+LLGQGTFAKV++ARN +T SVAIK+IDKEKVLK G++DQIKREI
Sbjct: 3 EQRGNMLMKKYEMGKLLGQGTFAKVYHARNTETSESVAIKMIDKEKVLKGGLMDQIKREI 62
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISA 121
SVM+LVRHPN+V+LYEVMA+KTKIYFV+E+VKGGELF KV +G+LKEDAARKYFQQLI A
Sbjct: 63 SVMKLVRHPNIVQLYEVMATKTKIYFVLEHVKGGELFNKVQRGRLKEDAARKYFQQLICA 122
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
VD+CHSRGV HRDLKPENLLLDE+ NLKVSDFGLSALA+ K QDGLLHTTCGTPAYVAPE
Sbjct: 123 VDFCHSRGVYHRDLKPENLLLDENSNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPE 182
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRR 241
VINRRGYDG+KADIWSCGVIL+VLLAGYLPFHD NLM+MY+KIGKAEFK P+WF +VRR
Sbjct: 183 VINRRGYDGAKADIWSCGVILFVLLAGYLPFHDKNLMDMYKKIGKAEFKCPSWFNTDVRR 242
Query: 242 LLSKILDPNPNTRISMTKIMENSWFRKGL-VKPSISETEEKEWAPVDADAVFSPSGSTST 300
LL +ILDPNP+TRISM KIMEN WFRKGL K + K+ PVD F S T
Sbjct: 243 LLLRILDPNPSTRISMDKIMENPWFRKGLDAKLLRYNLQPKDAIPVDMSTDFDSFNSAPT 302
Query: 301 VAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKLEGIA 360
+ + KP NLNAFDIIS S G DLSG+FEE +K KE +FTS STIISK+E IA
Sbjct: 303 LEK------KPSNLNAFDIISLSTGLDLSGMFEESDK-KESKFTSTSTASTIISKIEDIA 355
Query: 361 KLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKVM 420
K LRLK+ KKDGGLLK+EGSK GRKGV+G+DAEIFE+TP FHLVE+KK++GDTLEY+KV+
Sbjct: 356 KGLRLKLTKKDGGLLKMEGSKPGRKGVMGIDAEIFEVTPNFHLVELKKTNGDTLEYRKVL 415
Query: 421 NQEIRPALKDIVWTW 435
NQE+RPALKDIVW W
Sbjct: 416 NQEMRPALKDIVWAW 430
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5W736|CIPKI_ORYSJ CBL-interacting protein kinase 18 OS=Oryza sativa subsp. japonica GN=CIPK18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 634 bits (1636), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 314/454 (69%), Positives = 381/454 (83%), Gaps = 5/454 (1%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
+E G+IL++RYE+G+LLGQGTFAKV++ RN+ T SVAIK+IDK+K+ KVG++DQIKRE
Sbjct: 4 LEKNGNILLRRYEIGKLLGQGTFAKVYHGRNIVTSQSVAIKVIDKDKIFKVGLMDQIKRE 63
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVM+LVRHPN+V+LYEVMA+K+KIYFV+EYVKGGELF KVAKG+LKEDAARKYFQQL+S
Sbjct: 64 ISVMKLVRHPNIVQLYEVMATKSKIYFVLEYVKGGELFNKVAKGRLKEDAARKYFQQLVS 123
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVD+CHSRGV HRDLKPENLL+DE+GNLK++DFGLSALAES+ QDGLLHTTCGTPAYVAP
Sbjct: 124 AVDFCHSRGVYHRDLKPENLLVDENGNLKITDFGLSALAESRRQDGLLHTTCGTPAYVAP 183
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVI+R+GYDG K D WSCGVIL+VL+AGYLPF DSNLMEMYRKIGKAEFK P WF+ +VR
Sbjct: 184 EVISRKGYDGVKVDTWSCGVILFVLMAGYLPFQDSNLMEMYRKIGKAEFKCPAWFSSDVR 243
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSI---SETEEKEWAPVDADAVFSPSGS 297
+L+S+ILDPNP +R+ +TKIME WF+KGL I ET E A D + VFS GS
Sbjct: 244 KLVSRILDPNPRSRMPITKIMETYWFKKGLDSKLILKNVETNEPVTALADVNVVFSSMGS 303
Query: 298 TST-VAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKL 356
+S+ E K + K NLNAFDIIS S GFDLSGLFEE +K+KE RFTS++ S IISKL
Sbjct: 304 SSSKKTEEKQDAGKLTNLNAFDIISLSEGFDLSGLFEETDKKKEARFTSSQSASAIISKL 363
Query: 357 EGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEY 416
E +A +L VKKK+GG+LK+EG+ EGRKGVL +DAEIFE+TP FHLVE+KK++GDTLEY
Sbjct: 364 EDVASCSKLTVKKKEGGVLKMEGASEGRKGVLAIDAEIFEVTPSFHLVEIKKNNGDTLEY 423
Query: 417 QKVMNQEIRPALKDIVWTWQGE-QRQQCQEQVAP 449
Q + ++++PALKDIVW WQGE Q QQ ++ P
Sbjct: 424 QHLWKEDMKPALKDIVWAWQGERQDQQPEDHGQP 457
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C562|CIPKA_ARATH CBL-interacting serine/threonine-protein kinase 10 OS=Arabidopsis thaliana GN=CIPK10 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 634 bits (1635), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 309/455 (67%), Positives = 370/455 (81%), Gaps = 20/455 (4%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
MENK S+L +Y++GRLLGQGTFAKV+Y R++ T SVAIK+IDKEKV+KVG+I+QIKRE
Sbjct: 1 MENKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMR+ RHPNVVELYEVMA+KT+IYFVMEY KGGELF KVAKGKL++D A KYF QLI+
Sbjct: 61 ISVMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLIN 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVD+CHSR V HRD+KPENLLLD++ NLKVSDFGLSALA+ K QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINR+GYDG+KADIWSCGV+L+VLLAGYLPFHDSNLMEMYRKIGKA+FK P+WFAPEVR
Sbjct: 181 EVINRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVR 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGL----------------VKPSISETEEKEWA 284
RLL K+LDPNP TRI++ +I E+SWFRKGL V+ + T E
Sbjct: 241 RLLCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNENGAG 300
Query: 285 PVDADAVFSPSGSTSTVAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFT 344
P + A PS + V E +N +P NLNAFD+I+ SAGFDL+GLF + KR E RFT
Sbjct: 301 PSENGA--GPSENGDRVTE-ENHTDEPTNLNAFDLIALSAGFDLAGLFGDDNKR-ESRFT 356
Query: 345 SNKPVSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLV 404
S KP S IISKLE +A+ L+L ++K++ GL K+E KEGRKG+L MDAEIF++TP FHLV
Sbjct: 357 SQKPASVIISKLEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLV 416
Query: 405 EVKKSSGDTLEYQKVMNQEIRPALKDIVWTWQGEQ 439
EVKKS+GDTLEYQK++ +++RPAL DIVW WQGE+
Sbjct: 417 EVKKSNGDTLEYQKLVAEDLRPALSDIVWVWQGEK 451
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LWM4|CIPK5_ORYSJ CBL-interacting protein kinase 5 OS=Oryza sativa subsp. japonica GN=CIPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 622 bits (1603), Expect = e-177, Method: Compositional matrix adjust.
Identities = 302/443 (68%), Positives = 364/443 (82%), Gaps = 7/443 (1%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
ME K SILM RYELGR+LGQGTFAKV++ARNL + SVAIK+IDKEKVL+VGMIDQIKRE
Sbjct: 1 MEKKASILMNRYELGRMLGQGTFAKVYHARNLASNQSVAIKVIDKEKVLRVGMIDQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
IS+MRLVRHPN+V+L+EVMASK+KIYF MEYV+GGELF +VA+G+LKEDAARKYFQQLI
Sbjct: 61 ISIMRLVRHPNIVQLHEVMASKSKIYFAMEYVRGGELFSRVARGRLKEDAARKYFQQLIG 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVD+CHSRGV HRDLKPENLL+DE+GNLKVSDFGLSA E + QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLVDENGNLKVSDFGLSAFKECQKQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
E+IN+RGYDG+KADIWSCGVIL+VLLAGYLPFHDSNLMEMYRKI K + KFP WF +VR
Sbjct: 181 EIINKRGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMEMYRKISKGDVKFPQWFTTDVR 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPV-DADAVFSPS--GS 297
RLLS++LDPNPN RI++ K++E+ WF+KG KP++ ++ E + D FS +
Sbjct: 241 RLLSRLLDPNPNIRITVEKLVEHPWFKKGY-KPAVMLSQPNESNNLKDVHTAFSADHKDN 299
Query: 298 TSTVAESKNELAKPCNLNAFDIISFSAGFDLSGLFE-EREKRKEVRFTSNKPVSTIISKL 356
E + L KP +LNAFDIIS S GFDLSGLFE ++E++ + RF + KP S I+SKL
Sbjct: 300 EGKAKEPASSL-KPVSLNAFDIISLSKGFDLSGLFENDKEQKADSRFMTQKPASAIVSKL 358
Query: 357 EGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEY 416
E IA+ KVKK+D GL+K++GSKEGRKG L +DAEIFE+TP F +VEVKKS+GDTLEY
Sbjct: 359 EQIAETESFKVKKQD-GLVKLQGSKEGRKGQLAIDAEIFEVTPSFFVVEVKKSAGDTLEY 417
Query: 417 QKVMNQEIRPALKDIVWTWQGEQ 439
+K N+ +RP+L+DI W Q E
Sbjct: 418 EKFCNKGLRPSLRDICWDGQSEH 440
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10LQ2|CIPKA_ORYSJ CBL-interacting protein kinase 10 OS=Oryza sativa subsp. japonica GN=CIPK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 605 bits (1561), Expect = e-172, Method: Compositional matrix adjust.
Identities = 295/445 (66%), Positives = 364/445 (81%), Gaps = 7/445 (1%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
+E KG+ILM+RYE+G+LLGQG+FAKV++ RN+K SVAIK+IDKEK+LK ++DQI+RE
Sbjct: 2 VEQKGNILMKRYEIGKLLGQGSFAKVYHGRNIKNSQSVAIKVIDKEKILKCELMDQIRRE 61
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVM LVRHP +V+LYEVMA+KTKIYF++EYVKGGELF KV +G+LKE+ ARKYFQQLIS
Sbjct: 62 ISVMNLVRHPCIVQLYEVMATKTKIYFILEYVKGGELFNKVRRGRLKEEVARKYFQQLIS 121
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
A+D+CHSRGV HRDLKPENLLLDE+ NLK+SDFGLSALAE K QDGLLHTTCGTPAYVAP
Sbjct: 122 AIDFCHSRGVYHRDLKPENLLLDENRNLKISDFGLSALAECKRQDGLLHTTCGTPAYVAP 181
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINR+GYDG+KAD+W+CGVILYVLLAGYLPF D N++ MY+KI KAEFK+P+WF+ ++R
Sbjct: 182 EVINRKGYDGAKADVWACGVILYVLLAGYLPFQDKNVINMYKKICKAEFKWPSWFSSDIR 241
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKG----LVKPSISETEEKEWAPVDADAVFSPSG 296
+LL +ILDPNP TRIS+++IME+ WFR G L+ +I + + VD D+ F
Sbjct: 242 KLLRRILDPNPATRISVSEIMEDPWFRVGLNSDLLNKTIPTDKVDKVVHVDMDSTF--GN 299
Query: 297 STSTVAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKL 356
++ + E K E +LNAFDIIS S+GFDLS +FE+ ++E +FTS +TI KL
Sbjct: 300 LSNNINEGKQEAENLTSLNAFDIISLSSGFDLSAMFEDENSKEESKFTSTNTATTITKKL 359
Query: 357 EGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEY 416
E +AK LRLK KK+GGLLK+EGSK GRKGV+ ++AEIF+ITP FHLVE K +GDTLEY
Sbjct: 360 EDVAKNLRLKFLKKNGGLLKMEGSKPGRKGVMSINAEIFQITPDFHLVEFTKINGDTLEY 419
Query: 417 QKVMNQEIRPALKDIVWTWQGEQRQ 441
QKV QE+RPALKDIVW WQGEQ Q
Sbjct: 420 QKV-KQEMRPALKDIVWAWQGEQPQ 443
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FJ54|CIPKK_ARATH CBL-interacting serine/threonine-protein kinase 20 OS=Arabidopsis thaliana GN=CIPK20 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 594 bits (1532), Expect = e-169, Method: Compositional matrix adjust.
Identities = 296/452 (65%), Positives = 354/452 (78%), Gaps = 22/452 (4%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
M+ G +LM++YELGRLLGQGTFAKV++ARN+KTG SVAIK+IDK+KV KVG+IDQIKRE
Sbjct: 1 MDKNGIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMRLVRHP+VV L+EVMASKTKIYF MEYVKGGELF KV+KGKLKE+ ARKYFQQLI
Sbjct: 61 ISVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIG 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
A+DYCHSRGV HRDLKPENLLLDE+G+LK+SDFGLSAL ESK QDGLLHTTCGTPAYVAP
Sbjct: 121 AIDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVI ++GYDG+KAD+WSCGV+LYVLLAG+LPFH+ NL+EMYRKI K EFK PNWF PEV+
Sbjct: 181 EVIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVK 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVK---PSISETEEKEWAPVDADAVFSPSGS 297
+LLS+ILDPNPN+RI + KIMENSWF+KG K P E+ + + D A FS
Sbjct: 241 KLLSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFS---- 296
Query: 298 TSTVAESKNELAKPCNLNAFDII-SFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKL 356
KP + NAFD+I S S GFDLSGLF E+E+R E +FT+ K I+SK
Sbjct: 297 -----------VKPMSYNAFDLISSLSQGFDLSGLF-EKEERSESKFTTKKDAKEIVSKF 344
Query: 357 EGIAKLL-RLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLE 415
E IA R + K D G +K+E +EGRKG L +D EIFE+T FH+VE KKS GDT+E
Sbjct: 345 EEIATSSERFNLTKSDVG-VKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTME 403
Query: 416 YQKVMNQEIRPALKDIVWTWQGEQRQQCQEQV 447
Y++ ++E+RP+LKDIVW WQG E++
Sbjct: 404 YKQFCDRELRPSLKDIVWKWQGNNNNSNNEKI 435
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner (By similarity). Required for the abscisic acid-mediated (ABA) signaling pathway involved in seed germination and growth elongation inhibition. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYQ8|CIPK2_ARATH CBL-interacting serine/threonine-protein kinase 2 OS=Arabidopsis thaliana GN=CIPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 587 bits (1513), Expect = e-167, Method: Compositional matrix adjust.
Identities = 291/444 (65%), Positives = 357/444 (80%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
MENK S+L +RYE+GRLLGQGTFAKV++ R+ T SVAIK+IDK+KV++VG+ QIKRE
Sbjct: 1 MENKPSVLTERYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMR+ +HPNVVELYEVMA+K++IYFV+EY KGGELF KVAKGKLKED A KYF QLIS
Sbjct: 61 ISVMRIAKHPNVVELYEVMATKSRIYFVIEYCKGGELFNKVAKGKLKEDVAWKYFYQLIS 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVD+CHSRGV HRD+KPENLLLD++ NLKVSDFGLSALA+ K QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINR+GY+G+KADIWSCGV+L+VLLAGYLPFHD+NLMEMYRKIGKA+FK P+WFAPEV+
Sbjct: 181 EVINRKGYEGTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVK 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGSTST 300
RLL K+LDPN TRI++ KI E+SWFRKGL + ++ +A GS
Sbjct: 241 RLLCKMLDPNHETRITIAKIKESSWFRKGLHLKQKKMEKMEKQQVREATNPMEAGGSGQN 300
Query: 301 VAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKLEGIA 360
+E + LNAFDII+ S GF L+GLF + ++E RF S KP S IISKL +A
Sbjct: 301 ENGENHEPPRLATLNAFDIIALSTGFGLAGLFGDVYDKRESRFASQKPASEIISKLVEVA 360
Query: 361 KLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKVM 420
K L+LK++K+ GL K+E KEG+ G+L MDAEIF++TP FHLVEVKK +GDT+EYQK++
Sbjct: 361 KCLKLKIRKQGAGLFKLERVKEGKNGILTMDAEIFQVTPTFHLVEVKKCNGDTMEYQKLV 420
Query: 421 NQEIRPALKDIVWTWQGEQRQQCQ 444
+++RPAL DIVW WQGE+ ++ Q
Sbjct: 421 EEDLRPALADIVWVWQGEKEKEEQ 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P92937|CIPKF_ARATH CBL-interacting serine/threonine-protein kinase 15 OS=Arabidopsis thaliana GN=CIPK15 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 582 bits (1499), Expect = e-165, Method: Compositional matrix adjust.
Identities = 288/436 (66%), Positives = 350/436 (80%), Gaps = 15/436 (3%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
ME KGS+LM RYE+G+ LGQGTFAKV++AR+LKTG SVAIK+IDKE++LKVGM +QIKRE
Sbjct: 1 MEKKGSVLMLRYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
IS MRL+RHPN+VEL+EVMA+K+KIYFVME+VKGGELF KV+ GKL+ED ARKYFQQL+
Sbjct: 61 ISAMRLLRHPNIVELHEVMATKSKIYFVMEHVKGGELFNKVSTGKLREDVARKYFQQLVR 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVD+CHSRGVCHRDLKPENLLLDEHGNLK+SDFGLSAL++S+ QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVI+R GYDG KAD+WSCGVIL+VLLAGYLPF DSNLME+Y+KIGKAE KFPNW AP +
Sbjct: 181 EVISRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAK 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGSTST 300
RLL +ILDPNPNTR+S KIM++SWFRKGL + +E VDA+A G+ S
Sbjct: 241 RLLKRILDPNPNTRVSTEKIMKSSWFRKGL--QEEVKESVEEETEVDAEA----EGNASA 294
Query: 301 VAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKLEGIA 360
E K + NLNAF+IIS S GFDLSGLFE+ E+++E+RFTSN+ S I KL I
Sbjct: 295 EKEKK----RCINLNAFEIISLSTGFDLSGLFEKGEEKEEMRFTSNREASEITEKLVEIG 350
Query: 361 KLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKVM 420
K L++KV+KK+ +++ S E ++AE+FEI P +H+V +KKS GDT EY++VM
Sbjct: 351 KDLKMKVRKKEHE-WRVKMSAEATV----VEAEVFEIAPSYHMVVLKKSGGDTAEYKRVM 405
Query: 421 NQEIRPALKDIVWTWQ 436
+ IRPAL D V W
Sbjct: 406 KESIRPALIDFVLAWH 421
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QYM3|CIPKE_ORYSJ CBL-interacting protein kinase 14 OS=Oryza sativa subsp. japonica GN=CIPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 580 bits (1495), Expect = e-165, Method: Compositional matrix adjust.
Identities = 289/451 (64%), Positives = 357/451 (79%), Gaps = 24/451 (5%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
ME++G ILM+RYELGRLLG+GTF KVHYARNL++ SVAIK++DK++VLKVG+ +QI+RE
Sbjct: 1 MESRGKILMERYELGRLLGKGTFGKVHYARNLESNQSVAIKMMDKQQVLKVGLSEQIRRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLI 119
I+ MRLV H N+V+L+EVMA++ KIYFVMEYVKGGELF KVAK GKL E A KYFQQLI
Sbjct: 61 ITTMRLVAHKNIVQLHEVMATRNKIYFVMEYVKGGELFEKVAKRGKLTEVVAHKYFQQLI 120
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
SAVDYCHSRGV HRDLKPENLLLDE+ NLKVSDFGLSAL+ESK QDGLLHTTCGTPAYVA
Sbjct: 121 SAVDYCHSRGVYHRDLKPENLLLDENENLKVSDFGLSALSESKRQDGLLHTTCGTPAYVA 180
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEV 239
PEVI++ GYDG+K+DIWSCGVIL+VL+AGYLPF NLMEMYRKI EF+ P WF+ ++
Sbjct: 181 PEVISKIGYDGAKSDIWSCGVILFVLVAGYLPFQGPNLMEMYRKIQHGEFRCPGWFSRKL 240
Query: 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG------LVKPSISETEEKEWAPVDADAVFS 293
++LL KI+DPNP+TRIS+ KI E++WFRKG L + +++E K A V
Sbjct: 241 QKLLYKIMDPNPSTRISIQKIKESTWFRKGPEENRILKERTLNENTTKNVALVLG----- 295
Query: 294 PSGSTSTVAESKN--ELAKP---CNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKP 348
V KN E KP NLNAF+IISFS GFDLSG+F +E R E RFTS+K
Sbjct: 296 -------VRRKKNAHEDVKPMSVTNLNAFEIISFSKGFDLSGMFIVKEWRNEARFTSDKS 348
Query: 349 VSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKK 408
STIISKLE +AK L L+V+KKD G++K++G KEGR GVL D EIFE+T +H++E+K+
Sbjct: 349 ASTIISKLEDVAKALNLRVRKKDNGVVKMQGRKEGRNGVLQFDIEIFEVTTSYHIIEMKQ 408
Query: 409 SSGDTLEYQKVMNQEIRPALKDIVWTWQGEQ 439
+SGD+LEY++++ + IRPALKDIV W G++
Sbjct: 409 TSGDSLEYRQLLEEGIRPALKDIVLAWHGDE 439
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0JI49|CIPKB_ORYSJ CBL-interacting protein kinase 11 OS=Oryza sativa subsp. japonica GN=CIPK11 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 578 bits (1489), Expect = e-164, Method: Compositional matrix adjust.
Identities = 298/483 (61%), Positives = 382/483 (79%), Gaps = 19/483 (3%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
M + SILM RYE+G+ LGQGTFAKV+YARNL TG +VAIK+I+K+KV+KVG+++QIKRE
Sbjct: 1 MMDGRSILMGRYEVGKQLGQGTFAKVYYARNLTTGQAVAIKMINKDKVMKVGLMEQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLI 119
IS+MRLV+HPNV++L+EVMASK+KIYFV+EY KGGELF K+AK GKL ED+AR+YF QLI
Sbjct: 61 ISIMRLVKHPNVLQLFEVMASKSKIYFVLEYAKGGELFNKIAKEGKLSEDSARRYFHQLI 120
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
+AVDYCHSRGV HRDLKPENLLLDE+ NLKVSDFGLSALAESK QDGLLHTTCGTPAYVA
Sbjct: 121 NAVDYCHSRGVYHRDLKPENLLLDENENLKVSDFGLSALAESKRQDGLLHTTCGTPAYVA 180
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEV 239
PEV++R+GYDG+KAD+WSCGVIL+VL+AGYLPFHD NL+EMYRKI +A+F+ P +F+ E+
Sbjct: 181 PEVLSRKGYDGAKADVWSCGVILFVLVAGYLPFHDPNLIEMYRKICRADFRCPRYFSAEL 240
Query: 240 RRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVD--ADAVFSPSGS 297
+ L+ KILD +P+TRIS+ +I ++W+R KP + E A + + V + SGS
Sbjct: 241 KDLIHKILDSDPSTRISIPRIKRSTWYR----KPVEINAKNSEAATTNSISSGVATTSGS 296
Query: 298 T--STVAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISK 355
ST E++ L+ P NLNAFDIIS S GF+LSG FE+ +E RFT+ +PV+T++ K
Sbjct: 297 AECSTSEENQGSLSLP-NLNAFDIISLSTGFNLSGFFEDTHGHQEERFTTRQPVTTVLGK 355
Query: 356 LEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLE 415
L+ +AK L+LKVKKKD G+L++ KEG+KG L +DAEIFE+TP F LVE+KK++GDT+E
Sbjct: 356 LKELAKRLKLKVKKKDNGVLRLAAPKEGKKGFLELDAEIFEVTPSFLLVELKKTNGDTME 415
Query: 416 YQKVMNQEIRPALKDIVWTWQGEQRQQCQ------EQVAPLPEQQELPPCDAHP-LPIAP 468
Y+K++ ++IRPALKDIVW WQG++ Q +Q +PLP ELP P LP
Sbjct: 416 YRKLVKEDIRPALKDIVWVWQGDEHLNSQSILQGEQQQSPLPP--ELPQDQLQPSLPQQE 473
Query: 469 PQD 471
QD
Sbjct: 474 KQD 476
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 472 | ||||||
| 224139330 | 447 | predicted protein [Populus trichocarpa] | 0.940 | 0.993 | 0.838 | 0.0 | |
| 116265960 | 470 | CBL-interacting protein kinase 22 [Popul | 0.925 | 0.929 | 0.842 | 0.0 | |
| 356496299 | 467 | PREDICTED: CBL-interacting protein kinas | 0.963 | 0.974 | 0.801 | 0.0 | |
| 225439641 | 462 | PREDICTED: CBL-interacting protein kinas | 0.919 | 0.939 | 0.844 | 0.0 | |
| 356568210 | 462 | PREDICTED: CBL-interacting protein kinas | 0.970 | 0.991 | 0.781 | 0.0 | |
| 356532175 | 460 | PREDICTED: CBL-interacting protein kinas | 0.963 | 0.989 | 0.782 | 0.0 | |
| 224993586 | 470 | CBL-interacting protein kinase 22 [Popul | 0.925 | 0.929 | 0.828 | 0.0 | |
| 449464412 | 470 | PREDICTED: CBL-interacting protein kinas | 0.949 | 0.953 | 0.796 | 0.0 | |
| 449521513 | 470 | PREDICTED: CBL-interacting protein kinas | 0.949 | 0.953 | 0.794 | 0.0 | |
| 164471600 | 453 | serine-threonine kinase [Persea american | 0.932 | 0.971 | 0.778 | 0.0 |
| >gi|224139330|ref|XP_002323059.1| predicted protein [Populus trichocarpa] gi|222867689|gb|EEF04820.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 772 bits (1994), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/446 (83%), Positives = 408/446 (91%), Gaps = 2/446 (0%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
MENKG++LMQ+YE+GRLLGQGTFAKVH+AR+LKTGMSVAIK+IDKEKV KVGM+DQIKRE
Sbjct: 1 MENKGNVLMQKYEIGRLLGQGTFAKVHHARDLKTGMSVAIKMIDKEKVFKVGMMDQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMRL+RHPNVVELYEVMA+KTKIYFVMEYVKGGELF KVAKGKLKED ARKYFQQLIS
Sbjct: 61 ISVMRLIRHPNVVELYEVMATKTKIYFVMEYVKGGELFNKVAKGKLKEDVARKYFQQLIS 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVDYCHSRGV HRDLKPENLLLDE+ NLKVSDFGLSALAESK QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDYCHSRGVSHRDLKPENLLLDENENLKVSDFGLSALAESKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINR+GYDG+KADIWSCGVILYVLLAGYLPF D NLMEMYRKI K EFK PNWFAPEVR
Sbjct: 181 EVINRKGYDGAKADIWSCGVILYVLLAGYLPFRDPNLMEMYRKIAKGEFKCPNWFAPEVR 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGL-VKPSISETEEKEWAPVDADAVFSPSGSTS 299
+LLSKILDPNPNTRISM KIMENSW RK L +P + E E KE AP+D++AVF + +
Sbjct: 241 KLLSKILDPNPNTRISMAKIMENSWVRKDLQSRPCVLEAEVKEPAPLDSEAVFGINEISC 300
Query: 300 TVAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKLEGI 359
E K E+AKPCNLNAFDIISFSAGFDLSGLFEE+E++KEVRFTSNKP STIISKLE I
Sbjct: 301 AAVEPKQEVAKPCNLNAFDIISFSAGFDLSGLFEEKEQKKEVRFTSNKPASTIISKLEDI 360
Query: 360 AKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKV 419
AK LRLK+KK DGGLLKIEGSKEGRKGV+G+DAEIFEITPFFHLVE+KKSSGDT+EYQKV
Sbjct: 361 AKRLRLKIKKNDGGLLKIEGSKEGRKGVMGIDAEIFEITPFFHLVEMKKSSGDTVEYQKV 420
Query: 420 MNQEIRPALKDIVWTWQGE-QRQQCQ 444
+ Q+IRPALKDIVW+WQGE QR+Q Q
Sbjct: 421 VKQDIRPALKDIVWSWQGEQQREQLQ 446
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116265960|gb|ABJ91228.1| CBL-interacting protein kinase 22 [Populus trichocarpa] gi|118487767|gb|ABK95707.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1979), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/438 (84%), Positives = 402/438 (91%), Gaps = 1/438 (0%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
MENKG++LMQ+YE+GRLLGQGTFAKVH+AR+LKTGMSVAIK+IDKEKV KVGM+DQIKRE
Sbjct: 1 MENKGNVLMQKYEIGRLLGQGTFAKVHHARDLKTGMSVAIKMIDKEKVFKVGMMDQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMRL+RHPNVVELYEVMA+KTKIYFVMEYVKGGELF KVAKGKLKED ARKYFQQLIS
Sbjct: 61 ISVMRLIRHPNVVELYEVMATKTKIYFVMEYVKGGELFNKVAKGKLKEDVARKYFQQLIS 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVDYCHSRGV HRDLKPENLLLDE+ NLKVSDFGLSALAESK QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDYCHSRGVSHRDLKPENLLLDENENLKVSDFGLSALAESKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINR+GYDG+KADIWSCGVILYVLLAGYLPF D NLMEMYRKI K EFK PNWFAPEVR
Sbjct: 181 EVINRKGYDGAKADIWSCGVILYVLLAGYLPFRDPNLMEMYRKIAKGEFKCPNWFAPEVR 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGL-VKPSISETEEKEWAPVDADAVFSPSGSTS 299
+LLSKILDPNPNTRISM KIMENSW RK L +P + E E KE AP+D++AVF + +
Sbjct: 241 KLLSKILDPNPNTRISMAKIMENSWVRKDLQSRPCVLEAEVKEPAPLDSEAVFGINEISC 300
Query: 300 TVAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKLEGI 359
E K E+AKPCNLNAFDIISFSAGFDLSGLFEE+E++KEVRFTSNKP STIISKLE I
Sbjct: 301 AAVEPKQEVAKPCNLNAFDIISFSAGFDLSGLFEEKEQKKEVRFTSNKPASTIISKLEDI 360
Query: 360 AKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKV 419
AK LRLK+KK DGGLLKIEGSKEGRKGV+G+DAEIFEITPFFHLVE+KKSSGDT+EYQKV
Sbjct: 361 AKRLRLKIKKNDGGLLKIEGSKEGRKGVMGIDAEIFEITPFFHLVEMKKSSGDTVEYQKV 420
Query: 420 MNQEIRPALKDIVWTWQG 437
+ Q+IRPALKDIVW+WQG
Sbjct: 421 VKQDIRPALKDIVWSWQG 438
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356496299|ref|XP_003517006.1| PREDICTED: CBL-interacting protein kinase 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 760 bits (1962), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/458 (80%), Positives = 409/458 (89%), Gaps = 3/458 (0%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
ME KG +LMQRYELGRLLGQGTFAKV++ARN+ TGMSVAIKIIDKEK+LKVGMIDQIKRE
Sbjct: 1 MEQKGGVLMQRYELGRLLGQGTFAKVYHARNIITGMSVAIKIIDKEKILKVGMIDQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMRL+RHP+VVELYEVMASKTKIYFVMEYVKGGELF KV+KGKLK+D AR+YFQQLIS
Sbjct: 61 ISVMRLIRHPHVVELYEVMASKTKIYFVMEYVKGGELFNKVSKGKLKQDDARRYFQQLIS 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVDYCHSRGVCHRDLKPENLLLDE+GNLKV+DFGLSALAE+KHQDGLLHTTCGTPAYVAP
Sbjct: 121 AVDYCHSRGVCHRDLKPENLLLDENGNLKVTDFGLSALAETKHQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINRRGYDG+KADIWSCGVILYVLLAG+LPF DSNLMEMYRKIG+ EFKFPNWFAP+VR
Sbjct: 181 EVINRRGYDGAKADIWSCGVILYVLLAGFLPFRDSNLMEMYRKIGRGEFKFPNWFAPDVR 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGSTST 300
RLLSKILDPNP TRISM KIME+SWF+KGL KP+I++ E++E AP+DAD VF +
Sbjct: 241 RLLSKILDPNPKTRISMAKIMESSWFKKGLEKPTITQNEDEELAPLDADGVFGACENGDP 300
Query: 301 VAESKNELAKPC-NLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKLEGI 359
+ +KN +KPC NLNAFDIIS+S+GFDLSGLFEE +++KE RFTS+KP S IISKLE I
Sbjct: 301 IEPAKN--SKPCNNLNAFDIISYSSGFDLSGLFEETDRKKEERFTSDKPASIIISKLEEI 358
Query: 360 AKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKV 419
+ LRLKVKKKDGGL K+EGSKEGRKG LG+DAEIFEITP FHLVE+KKSSGDTLEYQK+
Sbjct: 359 CRRLRLKVKKKDGGLFKLEGSKEGRKGPLGIDAEIFEITPVFHLVELKKSSGDTLEYQKL 418
Query: 420 MNQEIRPALKDIVWTWQGEQRQQCQEQVAPLPEQQELP 457
+ QE+RPALKDIVW WQGEQ Q Q V EQ P
Sbjct: 419 LKQEVRPALKDIVWNWQGEQPQPLQHGVVQKEEQPSYP 456
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439641|ref|XP_002269189.1| PREDICTED: CBL-interacting protein kinase 18 isoform 1 [Vitis vinifera] gi|147843535|emb|CAN81218.1| hypothetical protein VITISV_040419 [Vitis vinifera] gi|229609815|gb|ACQ83523.1| CBL-interacting protein kinase 07 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1954), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/437 (84%), Positives = 399/437 (91%), Gaps = 3/437 (0%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
MEN GSILMQRYELG+LLGQGTFAKVH+ARNLKTG SVAIKIIDKEK+LKVGM+DQIKRE
Sbjct: 1 MENNGSILMQRYELGKLLGQGTFAKVHHARNLKTGTSVAIKIIDKEKILKVGMVDQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMRLVRHPNVVELYEVMASKTKIYFVMEY KGGELF KVAKGKLKED ARKYFQQLIS
Sbjct: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYAKGGELFNKVAKGKLKEDVARKYFQQLIS 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVD+CHSRGV HRDLKPENLLLDE+GNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLLDENGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINR+GYDG+KADIWSCGV+L+VLLAGYLPFHDSNLME+YRKIGKAE++FPNWF EVR
Sbjct: 181 EVINRKGYDGAKADIWSCGVVLFVLLAGYLPFHDSNLMELYRKIGKAEYRFPNWFPSEVR 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKP--SISETEEKEWAPVDADAVFSPSGST 298
RLLSKILDPNP TRIS+TKIMENSWF+KGL P I+ET EKE A ++ +AVF + S
Sbjct: 241 RLLSKILDPNPKTRISITKIMENSWFQKGL-DPVLRITETGEKEPADLEVEAVFGSNESA 299
Query: 299 STVAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKLEG 358
ST AE+K ELA NLNAFDIISFSAGFDLSGLFEE +++KEVRFTS +P S IISKLE
Sbjct: 300 STTAEAKQELATLSNLNAFDIISFSAGFDLSGLFEENKQKKEVRFTSRQPASAIISKLED 359
Query: 359 IAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQK 418
IAK L LKVKKKDGGLLK+EGSKEGRKGVL +DAEIFE+TP FHLVEVKKSSGDTLEYQK
Sbjct: 360 IAKRLMLKVKKKDGGLLKMEGSKEGRKGVLSIDAEIFEVTPSFHLVEVKKSSGDTLEYQK 419
Query: 419 VMNQEIRPALKDIVWTW 435
++ QEIRPALKDIVW W
Sbjct: 420 IVKQEIRPALKDIVWAW 436
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568210|ref|XP_003552306.1| PREDICTED: CBL-interacting protein kinase 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1922), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/458 (78%), Positives = 399/458 (87%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
ME KGS+LMQRYELGRLLGQGTFAKV++ARNL TGMSVAIK+IDKE++LKVGMIDQIKRE
Sbjct: 1 MEQKGSVLMQRYELGRLLGQGTFAKVYHARNLITGMSVAIKVIDKERILKVGMIDQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMRL+RHP+VVELYEVMASKTKIYFVME+ KGGELF KV KG+LK D ARKYFQQLIS
Sbjct: 61 ISVMRLIRHPHVVELYEVMASKTKIYFVMEHAKGGELFNKVVKGRLKVDVARKYFQQLIS 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVDYCHSRGVCHRDLKPENLLLDE+ NLKVSDFGLSALAESK QDGLLHTTCGTPAYV+P
Sbjct: 121 AVDYCHSRGVCHRDLKPENLLLDENENLKVSDFGLSALAESKCQDGLLHTTCGTPAYVSP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINR+GYDG KADIWSCGVILYVLLAG+LPFHDSNLMEMYRKIG+ EFKFP W AP+VR
Sbjct: 181 EVINRKGYDGMKADIWSCGVILYVLLAGHLPFHDSNLMEMYRKIGRGEFKFPKWLAPDVR 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGSTST 300
RLLS+ILDPNP RISM KIME+SWF+KGL KP+I+ TE +E P+DAD +F S +
Sbjct: 241 RLLSRILDPNPKARISMAKIMESSWFKKGLEKPAITVTENEELVPLDADGIFEVSENGGP 300
Query: 301 VAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKLEGIA 360
+A+ K E AKPCNLNAFDIISFS GFDLSGLFE+ RKE RF S KP S IISKLE +
Sbjct: 301 IAKPKQEQAKPCNLNAFDIISFSTGFDLSGLFEDTVLRKETRFMSKKPASIIISKLEEVC 360
Query: 361 KLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKVM 420
K LRLKVKKKDGGLLK+EGSKEGRKG LG+DAEIFEITP FH+VE++K +GDT+EYQK+
Sbjct: 361 KQLRLKVKKKDGGLLKLEGSKEGRKGTLGVDAEIFEITPHFHMVELRKCNGDTMEYQKLF 420
Query: 421 NQEIRPALKDIVWTWQGEQRQQCQEQVAPLPEQQELPP 458
Q+IRP+LKDIVWTWQGEQ Q QE+ Q+E P
Sbjct: 421 KQDIRPSLKDIVWTWQGEQPHQDQERQQHEVVQEEHQP 458
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532175|ref|XP_003534649.1| PREDICTED: CBL-interacting protein kinase 18-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 742 bits (1915), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/455 (78%), Positives = 398/455 (87%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
ME KGS+LMQRYELGRLLGQGTFAKV++ARNL TGMSVAIK++DKEK+LKVGMIDQIKRE
Sbjct: 1 MEQKGSVLMQRYELGRLLGQGTFAKVYHARNLITGMSVAIKVVDKEKILKVGMIDQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMRL+RHP+VVELYEVMASKTKIYFVME+ KGGELF KV KG+LK D ARKYFQQLIS
Sbjct: 61 ISVMRLIRHPHVVELYEVMASKTKIYFVMEHAKGGELFNKVVKGRLKVDVARKYFQQLIS 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVDYCHSRGVCHRDLKPENLLLDE+ NLKVSDFGLSALAESK QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDYCHSRGVCHRDLKPENLLLDENENLKVSDFGLSALAESKCQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINR+GYDG KADIWSCGVILYVLLAG+LPF D+NLMEMYRKIG+ EFKFP WFAP+VR
Sbjct: 181 EVINRKGYDGIKADIWSCGVILYVLLAGHLPFQDTNLMEMYRKIGRGEFKFPKWFAPDVR 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGSTST 300
R LS+ILDPNP RISM KIME+SWF+KGL KP+I+ TE +E AP+DAD +F +
Sbjct: 241 RFLSRILDPNPKARISMAKIMESSWFKKGLEKPAITVTENEELAPLDADGIFEACENDGP 300
Query: 301 VAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKLEGIA 360
+AE K E AKPCNLNAFDIISFS GFDLSGLFE+ +KE RF S KP S I+ KLE I
Sbjct: 301 IAEPKQEQAKPCNLNAFDIISFSTGFDLSGLFEDTFLKKETRFMSKKPASIIVLKLEEIC 360
Query: 361 KLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKVM 420
K L LKVKKKDGGLLK+EGSKEGRKG LG+DAEIFEITP FH+VE++KS+GDT+EYQK+
Sbjct: 361 KRLCLKVKKKDGGLLKLEGSKEGRKGTLGVDAEIFEITPHFHMVELRKSNGDTMEYQKLF 420
Query: 421 NQEIRPALKDIVWTWQGEQRQQCQEQVAPLPEQQE 455
Q+IRPALKDIVWTWQGE+ QQ QEQ + E+ +
Sbjct: 421 KQDIRPALKDIVWTWQGEKPQQEQEQHEVVQEEHQ 455
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224993586|gb|ACN76472.1| CBL-interacting protein kinase 22 [Populus euphratica] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1903), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/438 (82%), Positives = 399/438 (91%), Gaps = 1/438 (0%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
MENKG++LM +YE+GRLLG+GTFAKVH+AR+LKTGMSVAIK+IDKEKV KVGM+DQIKRE
Sbjct: 1 MENKGNVLMHKYEIGRLLGRGTFAKVHHARDLKTGMSVAIKMIDKEKVFKVGMMDQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMRL+RHPNVVELYEVMA+KTKIYFVMEYVKGGELF KVAKGKLKE ARKYFQQLIS
Sbjct: 61 ISVMRLIRHPNVVELYEVMATKTKIYFVMEYVKGGELFNKVAKGKLKEHVARKYFQQLIS 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVDYCHSRGV HRDLKPENLLLDE+ NLKVSDFGLSAL+ESK QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDYCHSRGVSHRDLKPENLLLDENENLKVSDFGLSALSESKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINR+GYDG+KADIWSCGVILYVLLAGYLPF D NLMEMYRKI K EFK PNWFAPEVR
Sbjct: 181 EVINRKGYDGAKADIWSCGVILYVLLAGYLPFRDPNLMEMYRKIAKGEFKCPNWFAPEVR 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGL-VKPSISETEEKEWAPVDADAVFSPSGSTS 299
+LLSKILDPNPNTRIS+ KIMENSW RK L +P + E KE AP+D++AVF + +
Sbjct: 241 KLLSKILDPNPNTRISIAKIMENSWVRKDLQSRPCVLAAEVKEPAPLDSEAVFGINEISC 300
Query: 300 TVAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKLEGI 359
E K E+AKPCNLNAFDIISFSAGFDLSGLFEE+E++KEVRFTSNKP STIISKLE I
Sbjct: 301 AAVEPKQEVAKPCNLNAFDIISFSAGFDLSGLFEEKEQKKEVRFTSNKPASTIISKLEDI 360
Query: 360 AKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKV 419
AK LRLK+KKKDGG LKIEGSKEGRKGV+G+DAEIFEITPFFHLVE+KKSSGDT+EYQKV
Sbjct: 361 AKRLRLKIKKKDGGFLKIEGSKEGRKGVMGIDAEIFEITPFFHLVEMKKSSGDTVEYQKV 420
Query: 420 MNQEIRPALKDIVWTWQG 437
+ Q+IRPALKDIVW+WQG
Sbjct: 421 VKQDIRPALKDIVWSWQG 438
|
Source: Populus euphratica Species: Populus euphratica Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449464412|ref|XP_004149923.1| PREDICTED: CBL-interacting protein kinase 2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1862), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/452 (79%), Positives = 401/452 (88%), Gaps = 4/452 (0%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
MENKG+ILM+RYELGRLLGQGTFAKV+YAR++K+G+SVAIKIIDKEK+LKVGMIDQIKRE
Sbjct: 1 MENKGAILMERYELGRLLGQGTFAKVYYARDIKSGLSVAIKIIDKEKILKVGMIDQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMRL++HPNVVELYEVMASKTKIYFVMEYVKGGELF KV+KGKLKE ARKYF QLIS
Sbjct: 61 ISVMRLIKHPNVVELYEVMASKTKIYFVMEYVKGGELFNKVSKGKLKESVARKYFWQLIS 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINRRGYDG KADIWSCGVILYVLLAGYLPFHD NLMEMY+KIGK EFKFPNWFAPEVR
Sbjct: 181 EVINRRGYDGCKADIWSCGVILYVLLAGYLPFHDPNLMEMYKKIGKGEFKFPNWFAPEVR 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGL-VKPSISETEE-KEWAPVDADAVF-SPSGS 297
+LLSKILDPNPNTRIS+ KIM +SW R+ L VKP ++ EE E P+D DAVF S +
Sbjct: 241 KLLSKILDPNPNTRISIAKIMGSSWLRRELNVKPQVNTAEEVNEGDPLDLDAVFVSTAED 300
Query: 298 TSTVAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKLE 357
++V + K E+ KP NLNAFDIIS S+GFDLSGLFEE + +KEVRFTSNKP S IISKL+
Sbjct: 301 RNSVKDQKPEMEKPLNLNAFDIISLSSGFDLSGLFEEADLKKEVRFTSNKPASVIISKLQ 360
Query: 358 GIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQ 417
IAK L+LK+KKKD GLLKIEG KEGRKG + +DAEIFE+TP FH+VE+KKS+GDTLEY+
Sbjct: 361 DIAKCLKLKIKKKDRGLLKIEGCKEGRKGAVCIDAEIFEVTPSFHIVEMKKSNGDTLEYR 420
Query: 418 KVMNQEIRPALKDIVWTWQGEQRQQCQEQVAP 449
K+M IRPALKD+VWTWQGE QQ + Q+ P
Sbjct: 421 KIMKDNIRPALKDVVWTWQGEHEQQ-RRQLLP 451
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449521513|ref|XP_004167774.1| PREDICTED: CBL-interacting protein kinase 2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 720 bits (1858), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/452 (79%), Positives = 401/452 (88%), Gaps = 4/452 (0%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
MENKG+ILM+RYELGRLLGQGTFAKV+YAR++K+G+SVAIKIIDKEK+LKVGMIDQIKRE
Sbjct: 1 MENKGAILMERYELGRLLGQGTFAKVYYARDIKSGLSVAIKIIDKEKILKVGMIDQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMRL++HPNVVELYEVMASKTKIYFVMEYVKGGELF KV+KGKLKE ARKYF QLIS
Sbjct: 61 ISVMRLIKHPNVVELYEVMASKTKIYFVMEYVKGGELFNKVSKGKLKESVARKYFWQLIS 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINRRGYDG KADIWSCGVILYVLLAGYLPFHD NLMEMY+KIGK EFKFPNWFAPEVR
Sbjct: 181 EVINRRGYDGCKADIWSCGVILYVLLAGYLPFHDPNLMEMYKKIGKGEFKFPNWFAPEVR 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGL-VKPSISETEE-KEWAPVDADAVF-SPSGS 297
+LLSKILDPNPNTRIS+ KIM +SW R+ L VKP ++ EE E P+D DAVF S +
Sbjct: 241 KLLSKILDPNPNTRISIAKIMGSSWLRRELNVKPQVNTAEEVNEGDPLDLDAVFVSTAED 300
Query: 298 TSTVAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKLE 357
++V + K E+ KP NLNAFDIIS S+GFDLSGLFEE + +KEVRFTSNKP S IISKL+
Sbjct: 301 RNSVKDQKPEMEKPLNLNAFDIISLSSGFDLSGLFEEADLKKEVRFTSNKPASVIISKLQ 360
Query: 358 GIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQ 417
IAK L+LK+KKKD GLLKIEG KEGRKG + +DAEIFE+TP FH+VE+KKS+GDTLEY+
Sbjct: 361 DIAKCLKLKIKKKDRGLLKIEGCKEGRKGAVCIDAEIFEVTPSFHIVEMKKSNGDTLEYR 420
Query: 418 KVMNQEIRPALKDIVWTWQGEQRQQCQEQVAP 449
K+M I+PALKD+VWTWQGE QQ + Q+ P
Sbjct: 421 KIMKDNIKPALKDVVWTWQGEHEQQ-RRQLLP 451
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|164471600|gb|ABY58264.1| serine-threonine kinase [Persea americana] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/443 (77%), Positives = 390/443 (88%), Gaps = 3/443 (0%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
M+NKG ILMQR+ELGRLLGQGTFAKV++ARNLK+ SVAIK+IDKEKVLKVGMIDQIKRE
Sbjct: 1 MDNKGGILMQRFELGRLLGQGTFAKVYHARNLKSSQSVAIKVIDKEKVLKVGMIDQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
I+ MRL HPNVV+LYEVMA+KTKIYFV+EYVKGGELF KVAKGKLKED ARKYFQQL+S
Sbjct: 61 IATMRLASHPNVVQLYEVMATKTKIYFVLEYVKGGELFNKVAKGKLKEDVARKYFQQLVS 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVD+CHSRGV HRDLKPENLL+DE+ NLKV+DFGLSALAESK QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDLKPENLLVDENENLKVTDFGLSALAESKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVI+R+GYDG+KADIWSCGVIL+VLLAGYLPFHDSNLME+YRK+GKAE+K PNWF PEVR
Sbjct: 181 EVISRKGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMELYRKVGKAEYKCPNWFPPEVR 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGL-VKPSISETEEKEWAPVDADAVFSPSGSTS 299
RLL++ILDPNPNTRIS+ KI +NSWF++G K + ET+ KE AP+D DA F + S +
Sbjct: 241 RLLARILDPNPNTRISIAKIKDNSWFKRGFEAKFAKGETKSKELAPLDTDAAF--ASSDA 298
Query: 300 TVAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSNKPVSTIISKLEGI 359
VA K EL KP +LNAFDIIS SAGFDLSGLFE+ RKE RF S +P STIISKLE I
Sbjct: 299 GVAARKPELVKPQHLNAFDIISLSAGFDLSGLFEDTNCRKEARFASKQPASTIISKLEDI 358
Query: 360 AKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKV 419
AK LRLKVKKKD G+LK+EGSKEGRKGVL +DAEIF + P FHLVEVKKSSGDTLEYQK+
Sbjct: 359 AKRLRLKVKKKDEGILKLEGSKEGRKGVLSIDAEIFVVNPSFHLVEVKKSSGDTLEYQKL 418
Query: 420 MNQEIRPALKDIVWTWQGEQRQQ 442
NQ++RPAL DIVW WQG+Q+QQ
Sbjct: 419 WNQDMRPALTDIVWAWQGDQQQQ 441
|
Source: Persea americana Species: Persea americana Genus: Persea Family: Lauraceae Order: Laurales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 472 | ||||||
| TAIR|locus:2161273 | 479 | SIP1 "SOS3-interacting protein | 0.919 | 0.906 | 0.662 | 1.9e-154 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.919 | 0.951 | 0.646 | 2.7e-148 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.894 | 0.961 | 0.646 | 5.5e-148 | |
| TAIR|locus:2181047 | 421 | CIPK15 "CBL-interacting protei | 0.889 | 0.997 | 0.645 | 3.2e-145 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.883 | 0.945 | 0.602 | 1.6e-132 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.898 | 0.868 | 0.581 | 1e-130 | |
| TAIR|locus:2124072 | 489 | CIPK12 "CBL-interacting protei | 0.896 | 0.865 | 0.587 | 1.5e-129 | |
| TAIR|locus:2183720 | 445 | CIPK5 "CBL-interacting protein | 0.911 | 0.966 | 0.566 | 1.2e-127 | |
| TAIR|locus:2152370 | 483 | CIPK19 "CBL-interacting protei | 0.902 | 0.881 | 0.568 | 2.6e-127 | |
| UNIPROTKB|Q84XC0 | 516 | Q84XC0 "Calcineurin B-like-int | 0.559 | 0.511 | 0.690 | 6.3e-127 |
| TAIR|locus:2161273 SIP1 "SOS3-interacting protein 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1506 (535.2 bits), Expect = 1.9e-154, P = 1.9e-154
Identities = 297/448 (66%), Positives = 353/448 (78%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
MENK S+L +Y++GRLLGQGTFAKV+Y R++ T SVAIK+IDKEKV+KVG+I+QIKRE
Sbjct: 1 MENKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMR+ RHPNVVELYEVMA+KT+IYFVMEY KGGELF KVAKGKL++D A KYF QLI+
Sbjct: 61 ISVMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLIN 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVD+CHSR V HRD+KPENLLLD++ NLKVSDFGLSALA+ K QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINR+GYDG+KADIWSCGV+L+VLLAGYLPFHDSNLMEMYRKIGKA+FK P+WFAPEVR
Sbjct: 181 EVINRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVR 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGL-VKPSISETEEKEWAPVDADAVFS------ 293
RLL K+LDPNP TRI++ +I E+SWFRKGL +K E KE V+A +
Sbjct: 241 RLLCKMLDPNPETRITIARIRESSWFRKGLHMKQKKMEKRVKEINSVEAGTAGTNENGAG 300
Query: 294 PSGSTSTVAES------KNELAKPCNLNAFDIISFSAGFDLSGLFXXXXXXXXVRFTSNK 347
PS + + +E+ +N +P NLNAFD+I+ SAGFDL+GLF RFTS K
Sbjct: 301 PSENGAGPSENGDRVTEENHTDEPTNLNAFDLIALSAGFDLAGLFGDDNKRES-RFTSQK 359
Query: 348 PVSTIISKLEGIAXXXXXXXXXXXXXXXXIEGSKEGRKGVLGMDAEIFEITPFFHLVEVK 407
P S IISKLE +A +E KEGRKG+L MDAEIF++TP FHLVEVK
Sbjct: 360 PASVIISKLEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHLVEVK 419
Query: 408 KSSGDTLEYQKVMNQEIRPALKDIVWTW 435
KS+GDTLEYQK++ +++RPAL DIVW W
Sbjct: 420 KSNGDTLEYQKLVAEDLRPALSDIVWVW 447
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1448 (514.8 bits), Expect = 2.7e-148, P = 2.7e-148
Identities = 282/436 (64%), Positives = 337/436 (77%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
MENK S+L +RYE+GRLLGQGTFAKV++ R+ T SVAIK+IDK+KV++VG+ QIKRE
Sbjct: 1 MENKPSVLTERYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMR+ +HPNVVELYEVMA+K++IYFV+EY KGGELF KVAKGKLKED A KYF QLIS
Sbjct: 61 ISVMRIAKHPNVVELYEVMATKSRIYFVIEYCKGGELFNKVAKGKLKEDVAWKYFYQLIS 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVD+CHSRGV HRD+KPENLLLD++ NLKVSDFGLSALA+ K QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVINR+GY+G+KADIWSCGV+L+VLLAGYLPFHD+NLMEMYRKIGKA+FK P+WFAPEV+
Sbjct: 181 EVINRKGYEGTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVK 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGL-VKPSISETEEKEWAPVDADAVFSPSGSTS 299
RLL K+LDPN TRI++ KI E+SWFRKGL +K E EK+ +A GS
Sbjct: 241 RLLCKMLDPNHETRITIAKIKESSWFRKGLHLKQKKMEKMEKQQVR-EATNPMEAGGSGQ 299
Query: 300 TVAESKNELAKPCNLNAFDIISFSAGFDLSGLFXXXXXXXXVRFTSNKPVSTIISKLEGI 359
+E + LNAFDII+ S GF L+GLF RF S KP S IISKL +
Sbjct: 300 NENGENHEPPRLATLNAFDIIALSTGFGLAGLFGDVYDKRESRFASQKPASEIISKLVEV 359
Query: 360 AXXXXXXXXXXXXXXXXIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKV 419
A +E KEG+ G+L MDAEIF++TP FHLVEVKK +GDT+EYQK+
Sbjct: 360 AKCLKLKIRKQGAGLFKLERVKEGKNGILTMDAEIFQVTPTFHLVEVKKCNGDTMEYQKL 419
Query: 420 MNQEIRPALKDIVWTW 435
+ +++RPAL DIVW W
Sbjct: 420 VEEDLRPALADIVWVW 435
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1445 (513.7 bits), Expect = 5.5e-148, P = 5.5e-148
Identities = 282/436 (64%), Positives = 337/436 (77%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
M+ G +LM++YELGRLLGQGTFAKV++ARN+KTG SVAIK+IDK+KV KVG+IDQIKRE
Sbjct: 1 MDKNGIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
ISVMRLVRHP+VV L+EVMASKTKIYF MEYVKGGELF KV+KGKLKE+ ARKYFQQLI
Sbjct: 61 ISVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIG 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
A+DYCHSRGV HRDLKPENLLLDE+G+LK+SDFGLSAL ESK QDGLLHTTCGTPAYVAP
Sbjct: 121 AIDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVI ++GYDG+KAD+WSCGV+LYVLLAG+LPFH+ NL+EMYRKI K EFK PNWF PEV+
Sbjct: 181 EVIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVK 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGSTST 300
+LLS+ILDPNPN+RI + KIMENSWF+KG K ++ E D++ S + +
Sbjct: 241 KLLSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESH----QIDSLISDVHAAFS 296
Query: 301 VAESKNELAKPCNLNAFDIIS-FSAGFDLSGLFXXXXXXXXVRFTSNKPVSTIISKLEGI 359
V KP + NAFD+IS S GFDLSGLF +FT+ K I+SK E I
Sbjct: 297 V--------KPMSYNAFDLISSLSQGFDLSGLFEKEERSES-KFTTKKDAKEIVSKFEEI 347
Query: 360 AXXXXXXXXXXXXXXXXIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKV 419
A +E +EGRKG L +D EIFE+T FH+VE KKS GDT+EY++
Sbjct: 348 ATSSERFNLTKSDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQF 407
Query: 420 MNQEIRPALKDIVWTW 435
++E+RP+LKDIVW W
Sbjct: 408 CDRELRPSLKDIVWKW 423
|
|
| TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1419 (504.6 bits), Expect = 3.2e-145, P = 3.2e-145
Identities = 281/435 (64%), Positives = 336/435 (77%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
ME KGS+LM RYE+G+ LGQGTFAKV++AR+LKTG SVAIK+IDKE++LKVGM +QIKRE
Sbjct: 1 MEKKGSVLMLRYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKRE 60
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
IS MRL+RHPN+VEL+EVMA+K+KIYFVME+VKGGELF KV+ GKL+ED ARKYFQQL+
Sbjct: 61 ISAMRLLRHPNIVELHEVMATKSKIYFVMEHVKGGELFNKVSTGKLREDVARKYFQQLVR 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVD+CHSRGVCHRDLKPENLLLDEHGNLK+SDFGLSAL++S+ QDGLLHTTCGTPAYVAP
Sbjct: 121 AVDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAP 180
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVI+R GYDG KAD+WSCGVIL+VLLAGYLPF DSNLME+Y+KIGKAE KFPNW AP +
Sbjct: 181 EVISRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAK 240
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGSTST 300
RLL +ILDPNPNTR+S KIM++SWFRKGL + + E+ E+E VDA+A G+ S
Sbjct: 241 RLLKRILDPNPNTRVSTEKIMKSSWFRKGL-QEEVKESVEEE-TEVDAEA----EGNASA 294
Query: 301 VAESKNELAKPCNLNAFDIISFSAGFDLSGLFXXXXXXXXVRFTSNKPVSTIISKLEGIA 360
E K + NLNAF+IIS S GFDLSGLF +RFTSN+ S I KL I
Sbjct: 295 EKEKKRCI----NLNAFEIISLSTGFDLSGLFEKGEEKEEMRFTSNREASEITEKLVEIG 350
Query: 361 XXXXXXXXXXXXXXXXIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKVM 420
++ S E ++AE+FEI P +H+V +KKS GDT EY++VM
Sbjct: 351 KDLKMKVRKKEHEWR-VKMSAEATV----VEAEVFEIAPSYHMVVLKKSGGDTAEYKRVM 405
Query: 421 NQEIRPALKDIVWTW 435
+ IRPAL D V W
Sbjct: 406 KESIRPALIDFVLAW 420
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1299 (462.3 bits), Expect = 1.6e-132, P = 1.6e-132
Identities = 259/430 (60%), Positives = 315/430 (73%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL 66
+L RYELGRLLG GTFAKV++ARN++TG SVA+K++ KEKV+KVGM+DQIKREISVMR+
Sbjct: 19 LLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRM 78
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCH 126
V+HPN+VEL+EVMASK+KIYF ME V+GGELF KVAKG+L+ED AR YFQQLISAVD+CH
Sbjct: 79 VKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYFQQLISAVDFCH 138
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR 186
SRGV HRDLKPENLLLDE GNLKV+DFGLSA E QDGLLHTTCGTPAYVAPEVI ++
Sbjct: 139 SRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKK 198
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246
GYDG+KAD+WSCGVIL+VLLAGYLPF D NL+ MYRKI + +FK P W + + RRL++K+
Sbjct: 199 GYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKL 258
Query: 247 LDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGSTSTVAESKN 306
LDPNPNTRI++ K+M++ WF+K + S E PV A + V +SK
Sbjct: 259 LDPNPNTRITIEKVMDSPWFKKQATR---SRNE-----PVAATITTTEEDVDFLVHKSKE 310
Query: 307 ELAKPCNLNAFDIISFSAGFDLSGLFXXXXXXXX--VRFTSNKPVSTIISKLEGIAXXXX 364
E LNAF II+ S GFDLS LF +RF +++P S++IS LE A
Sbjct: 311 ETE---TLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAARVGN 367
Query: 365 XXXXXXXXXXXXIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKVMNQEI 424
IEG + GRKG L ++AEIF + P F +VEVKK GDTLEY + +
Sbjct: 368 KFDVRKSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCSTAL 427
Query: 425 RPALKDIVWT 434
RPALKDI WT
Sbjct: 428 RPALKDIFWT 437
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1282 (456.3 bits), Expect = 1.0e-130, P = 1.0e-130
Identities = 250/430 (58%), Positives = 319/430 (74%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL 66
+L +YE+GRLLG+GTF KV+Y + + TG SVAIKII+K++V + GM++QIKREIS+MRL
Sbjct: 38 VLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQIKREISIMRL 97
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCH 126
VRHPN+VEL EVMA+KTKI+F+MEYVKGGELF K+ KGKLKED+ARKYFQQLISAVD+CH
Sbjct: 98 VRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIVKGKLKEDSARKYFQQLISAVDFCH 157
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR 186
SRGV HRDLKPENLL+DE+G+LKVSDFGLSAL E QDGLLHT CGTPAYVAPEV+ ++
Sbjct: 158 SRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAYVAPEVLRKK 217
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246
GYDG+K DIWSCG+ILYVLLAG+LPF D NLM+MYRKI K+EF++P WF+PE +RL+SK+
Sbjct: 218 GYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSPESKRLISKL 277
Query: 247 LDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGSTSTVAESKN 306
L +PN RIS+ IM WFRK + P + +E E V+ + +P+ +T+T A +
Sbjct: 278 LVVDPNKRISIPAIMRTPWFRKNINSPIEFKIDELEIQNVEDE---TPT-TTATTATTTT 333
Query: 307 ELAKPCNLNAFDIIS-FSAGFDLSGLFXXXXXXXXVRFTSNKPVSTIISKLEGIAXXXXX 365
P NAF+ IS S+GFDLS LF + FTS S I+ KLEGI
Sbjct: 334 TPVSPKFFNAFEFISSMSSGFDLSSLFESKRKLRSM-FTSRWSASEIMGKLEGIGKEMNM 392
Query: 366 XXXXXXXXXXXIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKVMNQEIR 425
+ G EGRKG + + AE+FE+ P +VE+ KS+GDTLEY ++ + +R
Sbjct: 393 KVKRTKDFKVKLFGKTEGRKGQIAVTAEVFEVAPEVAVVELCKSAGDTLEYNRLYEEHVR 452
Query: 426 PALKDIVWTW 435
PAL++IVW+W
Sbjct: 453 PALEEIVWSW 462
|
|
| TAIR|locus:2124072 CIPK12 "CBL-interacting protein kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1271 (452.5 bits), Expect = 1.5e-129, P = 1.5e-129
Identities = 258/439 (58%), Positives = 319/439 (72%)
Query: 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR 65
++++ RYE+G+LLG GTFAKV+ ARN+KT SVAIK+IDKEKVLK G+I IKREIS++R
Sbjct: 20 ALILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREISILR 79
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYC 125
VRHPN+V+L+EVMA+K KIYFVMEYV+GGELF KVAKG+LKE+ ARKYFQQLISAV +C
Sbjct: 80 RVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLISAVTFC 139
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
H+RGV HRDLKPENLLLDE+GNLKVSDFGLSA+++ QDGL HT CGTPAYVAPEV+ R
Sbjct: 140 HARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLAR 199
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245
+GYD +K DIWSCGVIL+VL+AGYLPFHD N+M MY+KI + EF+ P WF+ E+ RLLSK
Sbjct: 200 KGYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRLLSK 259
Query: 246 ILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGST---STVA 302
+L+ NP R + +IMENSWF+KG ++K VD D + S S + S +
Sbjct: 260 LLETNPEKRFTFPEIMENSWFKKGFKHIKFYVEDDKLCNVVDDDELESDSVESDRDSAAS 319
Query: 303 ESKNE----------LAKPCNLNAFDIISFSAGFDLSGLFXXXXXXXXVRFTSNKPVSTI 352
ES+ E L +P +LNAFDIISFS GFDLSGLF RF S PVS I
Sbjct: 320 ESEIEYLEPRRRVGGLPRPASLNAFDIISFSQGFDLSGLFDDDGEGS--RFVSGAPVSKI 377
Query: 353 ISKLEGIAXXXXXXXXXXXXXXXXIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGD 412
ISKLE IA +EGS++G KG L + AEIFE+TP +VEVKK GD
Sbjct: 378 ISKLEEIAKVVSFTVRKKDCRVS-LEGSRQGVKGPLTIAAEIFELTPSLVVVEVKKKGGD 436
Query: 413 TLEYQKVMNQEIRPALKDI 431
EY+ N E++P L+++
Sbjct: 437 KTEYEDFCNNELKPKLQNL 455
|
|
| TAIR|locus:2183720 CIPK5 "CBL-interacting protein kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1253 (446.1 bits), Expect = 1.2e-127, P = 1.2e-127
Identities = 248/438 (56%), Positives = 313/438 (71%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK-VGMIDQIKR 59
ME + +L +YE+GRLLG+GTFAKV+Y + + G VAIK+I+K++V+K GM++QIKR
Sbjct: 1 MEEERRVLFGKYEMGRLLGKGTFAKVYYGKEIIGGECVAIKVINKDQVMKRPGMMEQIKR 60
Query: 60 EISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLI 119
EIS+M+LVRHPN+VEL EVMA+KTKI+FVME+VKGGELF K++KGKL EDAAR+YFQQLI
Sbjct: 61 EISIMKLVRHPNIVELKEVMATKTKIFFVMEFVKGGELFCKISKGKLHEDAARRYFQQLI 120
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
SAVDYCHSRGV HRDLKPENLLLDE+G+LK+SDFGLSAL E QDGLLHT CGTPAYVA
Sbjct: 121 SAVDYCHSRGVSHRDLKPENLLLDENGDLKISDFGLSALPEQILQDGLLHTQCGTPAYVA 180
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEV 239
PEV+ ++GYDG+KADIWSCGV+LYVLLAG LPF D NLM MYRKI +A+F+FP WF+PE
Sbjct: 181 PEVLKKKGYDGAKADIWSCGVVLYVLLAGCLPFQDENLMNMYRKIFRADFEFPPWFSPEA 240
Query: 240 RRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPV-DADAVFSPSGST 298
RRL+SK+L +P+ RIS+ IM W RK P + +E P+ + +
Sbjct: 241 RRLISKLLVVDPDRRISIPAIMRTPWLRKNFTPPLAFKIDE----PICSQSSKNNEEEEE 296
Query: 299 STVAESKNELAKPCNLNAFDIIS-FSAGFDLSGLFXXXXXXXXVRFTSNKPVSTIISKLE 357
E++ E P NAF+ IS S+GFDLS LF V FTS + ++ K+E
Sbjct: 297 DGDCENQTEPISPKFFNAFEFISSMSSGFDLSSLFESKRKVQSV-FTSRSSATEVMEKIE 355
Query: 358 GIAXXXXXXXXXXXXXXXXIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQ 417
+ +EG EGRKG L M AE+FE+ P +VE KS+GDTLEY
Sbjct: 356 TVTKEMNMKVKRTKDFKVKMEGKTEGRKGRLSMTAEVFEVAPEISVVEFCKSAGDTLEYD 415
Query: 418 KVMNQEIRPALKDIVWTW 435
++ +E+RPAL DIVW+W
Sbjct: 416 RLYEEEVRPALNDIVWSW 433
|
|
| TAIR|locus:2152370 CIPK19 "CBL-interacting protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1250 (445.1 bits), Expect = 2.6e-127, P = 2.6e-127
Identities = 253/445 (56%), Positives = 321/445 (72%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
N ++++ +YE+GRLLG GTFAKV+ ARN ++G SVAIK+IDKEKVLK G+I IKREIS
Sbjct: 19 NHQALILGKYEMGRLLGHGTFAKVYLARNAQSGESVAIKVIDKEKVLKSGLIAHIKREIS 78
Query: 63 VMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAV 122
++R VRHPN+V+L+EVMA+K+KIYFVMEYVKGGELF KVAKG+LKE+ ARKYFQQLISAV
Sbjct: 79 ILRRVRHPNIVQLFEVMATKSKIYFVMEYVKGGELFNKVAKGRLKEEMARKYFQQLISAV 138
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV 182
+CH RGV HRDLKPENLLLDE+GNLKVSDFGLSA+++ QDGL HT CGTPAYVAPEV
Sbjct: 139 SFCHFRGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV 198
Query: 183 INRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242
+ R+GYDG+K DIWSCGVIL+VL+AG+LPFHD N+M MY+KI + +F+ P WF E+ RL
Sbjct: 199 LARKGYDGAKVDIWSCGVILFVLMAGFLPFHDRNVMAMYKKIYRGDFRCPRWFPVEINRL 258
Query: 243 LSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPV-DAD---AVFSPSGST 298
L ++L+ P R +M IME SWF+KG ++ + V D D ++ S SG +
Sbjct: 259 LIRMLETKPERRFTMPDIMETSWFKKGFKHIKFYVEDDHQLCNVADDDEIESIESVSGRS 318
Query: 299 STVAESKN-----------ELAKPCNLNAFDIISFSAGFDLSGLFXXXXXXXXVRFTSNK 347
STV+E ++ + +P +LNAFD+ISFS GFDLSGLF RF S
Sbjct: 319 STVSEPEDFESFDGRRRGGSMPRPASLNAFDLISFSPGFDLSGLFEDDGEGS--RFVSGA 376
Query: 348 PVSTIISKLEGIAXXXXXXXXXXXXXXXXIEGSKEGR-KGVLGMDAEIFEITPFFHLVEV 406
PV IISKLE IA +EGS+EG KG L + AEIFE+TP +VEV
Sbjct: 377 PVGQIISKLEEIARIVSFTVRKKDCKVS-LEGSREGSMKGPLSIAAEIFELTPALVVVEV 435
Query: 407 KKSSGDTLEYQKVMNQEIRPALKDI 431
KK GD +EY + N+E++P L+++
Sbjct: 436 KKKGGDKMEYDEFCNKELKPKLQNL 460
|
|
| UNIPROTKB|Q84XC0 Q84XC0 "Calcineurin B-like-interacting protein kinase" [Pisum sativum (taxid:3888)] | Back alignment and assigned GO terms |
|---|
Score = 1018 (363.4 bits), Expect = 6.3e-127, Sum P(2) = 6.3e-127
Identities = 183/265 (69%), Positives = 231/265 (87%)
Query: 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR 65
++L+ R+ELG+LLG GTFAKVH A+N+KTG +VAIKII K+K+LK G++ IKREIS++R
Sbjct: 20 NLLLGRFELGKLLGHGTFAKVHLAKNIKTGEAVAIKIISKDKILKSGLVSHIKREISILR 79
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYC 125
VRHPN+V+L+EVMA+KTKIYFVMEYV+GGELF KVAKG+LKE+ ARKYFQQLI AV++C
Sbjct: 80 RVRHPNIVQLFEVMATKTKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLICAVEFC 139
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
H+RGV HRD+KPENLLLDE+GNLKVSDFGLSA+++ QDGL HT CGTPAYVAPEV++R
Sbjct: 140 HARGVFHRDIKPENLLLDENGNLKVSDFGLSAVSDEIKQDGLFHTFCGTPAYVAPEVLSR 199
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAEFKFPNWFAPEVRRLLS 244
+GYDG K DIWSCGV+L+VL+AGYLPFHD +N+M MY+KI K +F+ P WF+PE+ LL+
Sbjct: 200 KGYDGGKVDIWSCGVVLFVLMAGYLPFHDPNNVMVMYKKIYKGDFRCPRWFSPELVNLLT 259
Query: 245 KILDPNPNTRISMTKIMENSWFRKG 269
++LD P TRIS+ +IMEN WF+ G
Sbjct: 260 RLLDTKPQTRISIPEIMENRWFKIG 284
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9C562 | CIPKA_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6791 | 0.9216 | 0.9081 | yes | no |
| Q7X996 | CIPK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7356 | 0.9046 | 0.9638 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 472 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-108 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-95 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-82 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-82 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-72 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-69 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-69 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-66 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-64 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-63 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-60 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-56 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-56 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-55 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-54 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-53 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-53 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-52 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 2e-52 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-52 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-52 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-51 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-50 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-49 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-49 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-49 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-49 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-48 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-48 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-47 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-47 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-46 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-46 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-46 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-45 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-45 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-45 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-45 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-45 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-44 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-43 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-43 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-43 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-42 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-42 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-42 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-42 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-42 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-42 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-42 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-42 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-41 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-41 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-41 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-41 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-41 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-41 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-41 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-40 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-40 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-40 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-40 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-39 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-39 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-39 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-38 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-38 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-38 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-38 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-38 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-38 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-38 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-38 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-37 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-37 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-37 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-37 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-37 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-37 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-37 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-36 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-36 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-36 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-36 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-35 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-35 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-35 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-35 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-35 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-34 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-34 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-34 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-34 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-34 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-33 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-33 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-33 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-33 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-33 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-33 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-33 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-33 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-33 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-32 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-32 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-32 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-32 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-32 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-32 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-31 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-31 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-31 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-31 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-31 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-31 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-31 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-31 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-30 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-30 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-30 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-30 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-30 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-30 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-29 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-29 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-29 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-29 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-28 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-28 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-28 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-28 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-27 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-27 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-27 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-27 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-27 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-27 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-26 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-26 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-26 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 4e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-26 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-25 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-25 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-25 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-24 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-24 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-23 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-23 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-23 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-23 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-23 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-23 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-23 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-23 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-23 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-22 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-22 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-22 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-22 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-22 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-21 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-21 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-21 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-21 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-20 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-20 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-20 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-20 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-15 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 7e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-04 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 8e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.002 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 321 bits (825), Expect = e-108
Identities = 117/260 (45%), Positives = 172/260 (66%), Gaps = 11/260 (4%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
YE+ LG+G+F KV+ AR+ KTG VAIK+I K+K+ K ++I REI +++ ++HPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPN 58
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHSRGV 130
+V LY+V + K+Y VMEY +GG+LF +G+L ED AR Y +Q++SA++Y HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDG 190
HRDLKPEN+LLDE G++K++DFGL+ L T GTP Y+APEV+ +GY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 191 SKADIWSCGVILYVLLAGYLPF-HDSNLMEMYRKIGKAEFKFPNWFA---PEVRRLLSKI 246
DIWS GVILY LL G PF D L+E+++KIGK + FP PE + L+ K+
Sbjct: 176 -AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 247 LDPNPNTRISMTKIMENSWF 266
L +P R++ + +++ +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 287 bits (738), Expect = 2e-95
Identities = 102/263 (38%), Positives = 150/263 (57%), Gaps = 11/263 (4%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
YEL R LG G+F V+ A++ TG VA+KI+ K +REI ++R + HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKS-KKDQTARREIRILRRLSHPN 59
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHSRGV 130
+V L + K +Y VMEY +GG+LF G L ED A+K Q++ ++Y HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDG 190
HRDLKPEN+LLDE+G +K++DFGL+ L T GTP Y+APEV+ G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 191 SKADIWSCGVILYVLLAGYLPF---HDSNLMEMYRKIGKAEFKFPNWF----APEVRRLL 243
K D+WS GVILY LL G PF + + +++ R+I +F + E + L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 244 SKILDPNPNTRISMTKIMENSWF 266
K L+ +P+ R + +I+++ WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 255 bits (654), Expect = 3e-82
Identities = 99/264 (37%), Positives = 158/264 (59%), Gaps = 12/264 (4%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+E + LG G+F +V R+ +G A+KI+ K K++K+ ++ + E +++ +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR 128
P +V LY + +Y VMEYV GGELF + K G+ E AR Y Q++ A++Y HS
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY 188
+ +RDLKPENLLLD G +K++DFG + K G +T CGTP Y+APE+I +GY
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFA-----KRVKGRTYTLCGTPEYLAPEIILSKGY 175
Query: 189 DGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248
+ D W+ G+++Y +LAGY PF D N +++Y KI + + +FP++F+P+ + L+ +L
Sbjct: 176 GKA-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234
Query: 249 PNPNTRISMTK-----IMENSWFR 267
+ R+ K I + WF
Sbjct: 235 VDLTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 8e-82
Identities = 97/253 (38%), Positives = 156/253 (61%), Gaps = 7/253 (2%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG+G+F KV R TG A+K++ K+K++K ++ E +++ + HP +V+L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLK 136
++ K+Y V+EY GGELF ++K G+ E+ AR Y +++ A++Y HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 137 PENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIW 196
PEN+LLD G++K++DFGL+ E + +T CGTP Y+APEV+ +GY + D W
Sbjct: 121 PENILLDADGHIKLTDFGLA--KELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA-VDWW 177
Query: 197 SCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRI- 255
S GV+LY +L G PF+ + E+Y KI K +FP + +PE R L+S +L +P R+
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
Query: 256 --SMTKIMENSWF 266
+I + +F
Sbjct: 238 SGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 1e-72
Identities = 100/249 (40%), Positives = 142/249 (57%), Gaps = 38/249 (15%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG+G F V+ AR+ KTG VAIKII KE +++++ REI +++ + HPN+V+LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDL 135
V + +Y VMEY +GG L + + GKL ED + Q++ ++Y HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 136 KPENLLLDE-HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKAD 194
KPEN+LLD +G +K++DFGLS L LL T GTPAY+APEV+ +GY K+D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 195 IWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254
IWS GVILY L PE++ L+ K+L +P R
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205
Query: 255 ISMTKIMEN 263
S +I+E+
Sbjct: 206 PSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 1e-69
Identities = 90/272 (33%), Positives = 152/272 (55%), Gaps = 21/272 (7%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHP 70
++ G+++G+G+F+ V A+ +T AIKI+DK +++K + +K E V+ RL HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRG 129
+++LY + +YFV+EY GEL + K G L E R Y +++ A++Y HS+G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSAL-------AESKHQDGLLHTT----------- 171
+ HRDLKPEN+LLD+ ++K++DFG + + +K + +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF 231
GT YV+PE++N G +D+W+ G I+Y +L G PF SN ++KI K E+ F
Sbjct: 183 VGTAEYVSPELLN-EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 232 PNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263
P F P+ + L+ K+L +P R+ + + +
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 221 bits (567), Expect = 1e-69
Identities = 91/265 (34%), Positives = 147/265 (55%), Gaps = 22/265 (8%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIID------KEKVLKVGMIDQIKREISVM 64
+YE+ + +G+G+F KV+ R G +K ID KE+ + E+ ++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-------EDALNEVKIL 53
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK-----LKEDAARKYFQQLI 119
+ + HPN+++ YE K K+ VMEY GG+L K+ K K E+ +F QL
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
A+ Y HSR + HRD+KP+N+ L +G +K+ DFG+S + S L T GTP Y++
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--VDLAKTVVGTPYYLS 171
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FPNWFAPE 238
PE+ + Y+ K+DIWS G +LY L PF NL+E+ KI K ++ P+ ++ E
Sbjct: 172 PELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE 230
Query: 239 VRRLLSKILDPNPNTRISMTKIMEN 263
+R L+S +L +P R S+ +I+++
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 2e-66
Identities = 94/261 (36%), Positives = 146/261 (55%), Gaps = 13/261 (4%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+ +G + +V A+ TG AIK+I K +++ +DQ+ E ++ + P VV+LY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLK 136
K +Y VMEY+ GG+L + G L ED AR Y +++ A++Y HS G+ HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 137 PENLLLDEHGNLKVSDFGLSALAESKHQDGLL------HTTCGTPAYVAPEVINRRGYDG 190
P+N+L+D +G+LK++DFGLS + + Q L GTP Y+APEVI +G+
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179
Query: 191 SKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWF--APEVRRLLSKILD 248
D WS G ILY L G PFH E+++ I + ++P + E L+SK+L
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 249 PNPNTRI---SMTKIMENSWF 266
P+P R+ S+ +I + +F
Sbjct: 240 PDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 3e-64
Identities = 83/262 (31%), Positives = 135/262 (51%), Gaps = 8/262 (3%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
+ G LLG+G+F V+ A + TG +A+K ++ + + + ++REI ++ ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHP 59
Query: 71 NVVELY--EVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS 127
N+V Y E K + +EYV GG L + K GKL E RKY +Q++ + Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
G+ HRD+K N+L+D G +K++DFG + + GTP ++APEVI
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAEFK--FPNWFAPEVRRLLS 244
Y G ADIWS G + + G P+ + N M KIG + P + E + L
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 245 KILDPNPNTRISMTKIMENSWF 266
K L +P R + +++++ +
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 9e-63
Identities = 97/252 (38%), Positives = 146/252 (57%), Gaps = 7/252 (2%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+ +E+G LG G+F +V A++ TG AIK + K ++LK+ + + +E S++ +
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS 127
HP +V + + ++YF++E+V GGELF + K G+ D A+ Y +L+ A +Y HS
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
+ + +RDLKPENLLLD G++KV+DFG +K T CGTP Y+APEVI +G
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGF-----AKKVPDRTFTLCGTPEYLAPEVIQSKG 191
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247
+ G D W+ GV+LY +AGY PF D +Y KI KFPNWF R L+ +L
Sbjct: 192 H-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLL 250
Query: 248 DPNPNTRISMTK 259
+ R+ K
Sbjct: 251 QTDHTKRLGTLK 262
|
Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 1e-60
Identities = 96/259 (37%), Positives = 142/259 (54%), Gaps = 14/259 (5%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG G F +V + + A+K + K +++ G + I E ++ HP +V+LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 78 VMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLK 136
K IY +MEY GGEL+ + +G E AR Y ++ A +Y H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 137 PENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIW 196
PENLLLD +G +K+ DFG + +S + T CGTP YVAPE+I +GYD S D W
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKT---WTFCGTPEYVAPEIILNKGYDFS-VDYW 176
Query: 197 SCGVILYVLLAGYLPFHDSNL--MEMYRKI--GKAEFKFPNWFAPEVRRLLSKILDPNPN 252
S G++LY LL G PF + + ME+Y I G + +FPN+ + L+ ++L NP
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236
Query: 253 TRISMTK-----IMENSWF 266
R+ K I ++ WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 2e-56
Identities = 79/261 (30%), Positives = 145/261 (55%), Gaps = 10/261 (3%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+EL R++G+G F KV + T A+K ++K+K ++ G + + E +++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 72 VVELYEVMASKTKIYFVMEYVKGGEL-FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGV 130
+V L+ + +Y V++ + GG+L + K K E+ + + +++ A++Y HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDG 190
HRD+KP+N+LLDE G++ ++DF ++ D L +T GTP Y+APEV+ R+GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATK---VTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 191 SKADIWSCGVILYVLLAGYLPF--HDSNLMEMYR-KIGKAEFKFPNWFAPEVRRLLSKIL 247
D WS GV Y L G P+ H + + R K A+ +P ++ E ++K+L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 248 DPNPNTRIS--MTKIMENSWF 266
+ +P R+ + + + +F
Sbjct: 238 ERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 2e-56
Identities = 84/265 (31%), Positives = 141/265 (53%), Gaps = 12/265 (4%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
E + +G GTF +VH R+ + A+K++ +V+++ + E V++ V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCHSR 128
P ++ L+ + +Y +MEYV GGELF + G+ Y +++ A++Y HS+
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY 188
+ +RDLKPEN+LLD+ G++K++DFG +K T CGTP Y+APEVI +G+
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGF-----AKKLRDRTWTLCGTPEYLAPEVIQSKGH 175
Query: 189 DGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248
D W+ G+++Y +L GY PF D N +Y KI + +FP + L+ K+L
Sbjct: 176 -NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234
Query: 249 PNPNTRISMTK-----IMENSWFRK 268
+ R+ K + + WF+
Sbjct: 235 VDRTRRLGNMKNGADDVKNHRWFKS 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 2e-55
Identities = 85/257 (33%), Positives = 134/257 (52%), Gaps = 14/257 (5%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+E+ +G+G F +V+ AR+ +TG VAIK+I E K ++I EI +++ +HPN
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK---KEKIINEIQILKKCKHPN 58
Query: 72 VVELYEVMASKTKIYFVMEYVKGG---ELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
+V+ Y K +++ VME+ GG +L K L E ++L+ ++Y HS
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY 188
G+ HRD+K N+LL G +K+ DFGLSA +T GTP ++APEVIN + Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPEVINGKPY 174
Query: 189 DGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245
D KADIWS G+ L G P+ + + G + P ++ E + L K
Sbjct: 175 DY-KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233
Query: 246 ILDPNPNTRISMTKIME 262
L NP R + ++++
Sbjct: 234 CLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 4e-54
Identities = 96/281 (34%), Positives = 144/281 (51%), Gaps = 28/281 (9%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP- 70
Y + R LG+G+F +V+ AR+ K VA+K++ K+ K +++ REI ++ + HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFG----KVAKGKLKEDAARKYFQQLISAVDYCH 126
N+V+LY+ + +Y VMEYV GG L KG L E A Q++SA++Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 127 SRGVCHRDLKPENLLLDEHGN-LKVSDFGLSALA----ESKHQDGLLHTTCGTPAYVAPE 181
S+G+ HRD+KPEN+LLD G +K+ DFGL+ L + L T+ GTP Y+APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 182 VI--NRRGYDGSKADIWSCGVILYVLLAGYLPFH----DSNLMEMYRKIGKAEFK----- 230
V+ Y S +DIWS G+ LY LL G PF S + + I +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 231 ----FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267
P + LL K+L +P R+S + + +
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 2e-53
Identities = 87/271 (32%), Positives = 143/271 (52%), Gaps = 29/271 (10%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIID------KEKVLKVGMIDQIKREISVMR 65
YE+ +G+G+F V R G + K ID KEK Q+ E++++R
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-------QQLVSEVNILR 54
Query: 66 LVRHPNVVELY--EVMASKTKIYFVMEYVKGGELFGKVAKGK-----LKEDAARKYFQQL 118
++HPN+V Y + S +Y VMEY +GG+L + K K ++E+ + QL
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 119 ISAVDYCHSRG-----VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173
+ A+ CH+R V HRDLKP N+ LD + N+K+ DFGL+ + T G
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVG 172
Query: 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFP 232
TP Y++PE +N YD K+DIWS G ++Y L A PF N +++ KI + +F + P
Sbjct: 173 TPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIP 231
Query: 233 NWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263
++ E+ ++ +L+ +P+ R S ++++
Sbjct: 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 6e-53
Identities = 84/260 (32%), Positives = 142/260 (54%), Gaps = 10/260 (3%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
Y+LG L+G+G F V+ NL+TG VAIK I EK +K + I +EI +++ ++HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSR 128
N+V+ + + +Y ++EY + G L ++ K G E Y Q++ + Y H +
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSL-RQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
GV HRD+K N+L + G +K++DFG++ L + D + GTP ++APEVI G
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD---ASVVGTPYWMAPEVIEMSG 175
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLME-MYRKIGKAEFKFPNWFAPEVRRLLSKI 246
+ +DIWS G + LL G P++D N M ++R + P +PE++ L +
Sbjct: 176 AS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC 234
Query: 247 LDPNPNTRISMTKIMENSWF 266
+PN R + +++++ W
Sbjct: 235 FQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 2e-52
Identities = 95/258 (36%), Positives = 145/258 (56%), Gaps = 9/258 (3%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
+LLG+GTF KV R TG A+KI+ KE ++ + E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRD 134
+ ++ FVMEY GGELF +++ ED AR Y +++SA+ Y HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKAD 194
LK ENL+LD+ G++K++DFGL E + T CGTP Y+APEV+ Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 195 IWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254
W GV++Y ++ G LPF++ + +++ I E +FP +PE + LL+ +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 255 I-----SMTKIMENSWFR 267
+ +IME+ +F
Sbjct: 238 LGGGPEDAKEIMEHRFFA 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 2e-52
Identities = 67/116 (57%), Positives = 81/116 (69%), Gaps = 1/116 (0%)
Query: 315 NAFDIISFSAGFDLSGLFEE-REKRKEVRFTSNKPVSTIISKLEGIAKLLRLKVKKKDGG 373
NAFD+IS S+G DLSGLFEE E ++E RFTS KP II KLE AK L +V+KK G
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKEG 60
Query: 374 LLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKVMNQEIRPALK 429
+K+EG K GRKG L + E+FE+TP +VEVKKS+GDTLEY K +RP LK
Sbjct: 61 GVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 179 bits (454), Expect = 3e-52
Identities = 93/257 (36%), Positives = 148/257 (57%), Gaps = 9/257 (3%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
+LLG+GTF KV R TG A+KI+ KE ++ + E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAKGKL-KEDAARKYFQQLISAVDYCHSRGVCHRD 134
+ ++ FVMEY GGELF +++ ++ E+ AR Y +++SA++Y HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKAD 194
+K ENL+LD+ G++K++DFGL E + T CGTP Y+APEV+ Y G D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 195 IWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254
W GV++Y ++ G LPF++ + ++ I E +FP +PE + LL+ +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 255 I-----SMTKIMENSWF 266
+ ++ME+ +F
Sbjct: 238 LGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 4e-52
Identities = 88/265 (33%), Positives = 139/265 (52%), Gaps = 12/265 (4%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
R++ G +G GTF KV+ A NL TG +A+K I + I +I E+ V+ L++HP
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHP 59
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRG 129
N+V+ Y V + K+Y MEY GG L + G+ L E R Y QL+ + Y HS G
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD---GLLHTTCGTPAYVAPEVINRR 186
+ HRD+KP N+ LD +G +K+ DFG A+ + + + GTPAY+APEVI
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFG-CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 187 GYDG--SKADIWSCGVILYVLLAGYLPFH--DSNLMEMYRKIGKAEFKFP--NWFAPEVR 240
G ADIWS G ++ + G P+ D+ M+ + P +PE +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238
Query: 241 RLLSKILDPNPNTRISMTKIMENSW 265
L + L+ +P R + ++++++ +
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-51
Identities = 93/244 (38%), Positives = 150/244 (61%), Gaps = 8/244 (3%)
Query: 16 RLLGQGTFAKVHYARNLK---TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV 72
++LGQG+F KV R + G A+K++ K+ LKV + K E ++ V HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 73 VELYEVMASKTKIYFVMEYVKGGELFGKVAKGKL-KEDAARKYFQQLISAVDYCHSRGVC 131
V+L+ ++ K+Y ++++++GG+LF +++K + E+ + Y +L A+D+ HS G+
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 132 HRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGS 191
+RDLKPEN+LLDE G++K++DFGLS ES + ++ CGT Y+APEV+NRRG+ S
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNP 251
AD WS GV+++ +L G LPF + E I KA+ P + +PE + LL + NP
Sbjct: 179 -ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237
Query: 252 NTRI 255
R+
Sbjct: 238 ANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 9e-50
Identities = 95/257 (36%), Positives = 149/257 (57%), Gaps = 9/257 (3%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
+LLG+GTF KV R +G A+KI+ KE ++ + E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAKGKL-KEDAARKYFQQLISAVDYCHSRGVCHRD 134
+K ++ FVMEYV GGELF +++ ++ ED R Y +++SA+DY HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKAD 194
LK ENL+LD+ G++K++DFGL E + T CGTP Y+APEV+ Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 195 IWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254
W GV++Y ++ G LPF++ + +++ I + KFP + + + LLS +L +PN R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 255 I-----SMTKIMENSWF 266
+ +IM +S+F
Sbjct: 238 LGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 1e-49
Identities = 85/259 (32%), Positives = 134/259 (51%), Gaps = 20/259 (7%)
Query: 20 QGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH-PNVVELYEV 78
+G F V+ A+ TG AIK++ K ++ + +K E ++M + P V +LY
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 79 MASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKP 137
SK +Y VMEY+ GG+ + G L ED A++Y +++ V+ H RG+ HRD+KP
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKP 125
Query: 138 ENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA-DIW 196
ENLL+D+ G+LK++DFGLS + GTP Y+APE I G K D W
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETIL--GVGDDKMSDWW 177
Query: 197 SCGVILYVLLAGYLPFHDSNLMEMY-----RKIGKAEFKFPNWFAPEVRRLLSKILDPNP 251
S G +++ L GY PFH ++ R+I E + +PE L++++L +P
Sbjct: 178 SLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVK-EFCSPEAVDLINRLLCMDP 236
Query: 252 NTRISMTKIME---NSWFR 267
R+ E + +F+
Sbjct: 237 AKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 3e-49
Identities = 95/306 (31%), Positives = 144/306 (47%), Gaps = 75/306 (24%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIK----REISVMR 65
YE LG+GT+ V+ AR+ KTG VA+K I D E+ + I REIS+++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-------EGIPSTALREISLLK 53
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYV----KGGELFGKVAKGKLKEDAARKYFQQLISA 121
++HPN+V+L +V+ ++ K+Y V EY K + G L + + QL+
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKK---YLDKRPGPLSPNLIKSIMYQLLRG 110
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA----- 176
+ YCHS + HRDLKP+N+L++ G LK++DFGL+ G P
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-------------RAFGIPLRTYTH 157
Query: 177 ------YVAPEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSN---LMEMYRKIG 225
Y APE++ + Y + DIWS G I ++ G F DS L ++++ +G
Sbjct: 158 EVVTLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILG 216
Query: 226 ----------------KAEF-KFP--------NWFAPEVRRLLSKILDPNPNTRISMTKI 260
K F KFP PE LLSK+L NP RIS +
Sbjct: 217 TPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA 276
Query: 261 MENSWF 266
+++ +F
Sbjct: 277 LKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 4e-49
Identities = 89/291 (30%), Positives = 142/291 (48%), Gaps = 35/291 (12%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
+E+ +++G+G F +V R+ TG A+K++ K ++K I ++ E ++ P
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHSRG 129
+V+LY + +Y VMEY+ GG+L + K E+ AR Y +L+ A+D H G
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL--------------------- 168
HRD+KP+N+L+D G++K++DFGL
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 169 ------HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR 222
++T GTP Y+APEV+ Y D WS GVILY +L G+ PF+ L E Y
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETYN 240
Query: 223 KI--GKAEFKFP--NWFAPEVRRLLSKILDPNPNTRI-SMTKIMENSWFRK 268
KI K +FP +PE L+ ++L P R+ S +I + +F+
Sbjct: 241 KIINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 5e-49
Identities = 90/240 (37%), Positives = 134/240 (55%), Gaps = 6/240 (2%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+G+G+F KV R T A+K I K ++ + E +V+ V P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLK 136
S K+Y V+ ++ GGELF + + G+ AR Y +L+ A++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 137 PENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA-DI 195
PEN+LLD G++ + DFGL L D +T CGTP Y+APE++ GY +KA D
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGY--TKAVDW 176
Query: 196 WSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRI 255
W+ GV+LY +L G PF+D N+ EMYRKI + +FP+ F + + LL +L +P R+
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRL 236
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 3e-48
Identities = 95/258 (36%), Positives = 149/258 (57%), Gaps = 10/258 (3%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
+LLG+GTF KV + TG A+KI+ KE ++ + E V++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAKGKL-KEDAARKYFQQLISAVDYCHS-RGVCHR 133
+ ++ FVMEY GGELF +++ ++ ED AR Y +++SA+DY HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
DLK ENL+LD+ G++K++DFGL E + T CGTP Y+APEV+ Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253
D W GV++Y ++ G LPF++ + +++ I E +FP +PE + LLS +L +P
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237
Query: 254 RI-----SMTKIMENSWF 266
R+ +IM++ +F
Sbjct: 238 RLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 9e-48
Identities = 83/247 (33%), Positives = 145/247 (58%), Gaps = 15/247 (6%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVE 74
++LG+G+F KV A T A+K++ K+ +L+ ++ E V+ L +HP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 75 LYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHR 133
L+ +K +++FVMEYV GG+L + + G+ E AR Y +++ + + H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH-----TTCGTPAYVAPEVINRRGY 188
DLK +N+LLD G++K++DFG+ ++G+L T CGTP Y+APE+++ + Y
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMC-------KEGILGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 189 DGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248
+ D W+ GV+LY +LAG PF + E+++ I + E ++P W + E + +L L
Sbjct: 174 GPA-VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLT 232
Query: 249 PNPNTRI 255
NP R+
Sbjct: 233 KNPEKRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 1e-47
Identities = 82/260 (31%), Positives = 131/260 (50%), Gaps = 15/260 (5%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+GQG + +V A+ TG VA+K + K + K+ + + E ++ + +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 78 VMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLK 136
+Y MEYV GG+ + G L ED AR Y ++ AVD H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 137 PENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIW 196
PEN L+D G++K++DFGLS + ++ G+P Y+APEV+ +GYD + D W
Sbjct: 129 PENFLIDASGHIKLTDFGLSKGIVTY-----ANSVVGSPDYMAPEVLRGKGYDFT-VDYW 182
Query: 197 SCGVILYVLLAGYLPFHDSNLMEMYRKIG--KAEFKFPNWFAP------EVRRLLSKILD 248
S G +LY L G+ PF S E + + K + P + P E L++K+++
Sbjct: 183 SLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLIN 242
Query: 249 PNPNTRISMTKIMENSWFRK 268
S+ I + +F++
Sbjct: 243 DPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 2e-47
Identities = 90/245 (36%), Positives = 143/245 (58%), Gaps = 8/245 (3%)
Query: 16 RLLGQGTFAKVHYARNLK---TGMSVAIKIIDKEKVLKVGM-IDQIKREISVMRLVRHPN 71
++LG+G + KV R + TG A+K++ K +++ K E +++ V+HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGV 130
+V+L + K+Y ++EY+ GGELF + + G ED A Y ++ A+++ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDG 190
+RDLKPEN+LLD G++K++DFGL ES H+ + HT CGT Y+APE++ R G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 191 SKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPN 250
D WS G ++Y +L G PF N + KI K + P + PE R LL K+L N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 251 PNTRI 255
P++R+
Sbjct: 239 PSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 4e-46
Identities = 86/242 (35%), Positives = 135/242 (55%), Gaps = 5/242 (2%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVVE 74
+++G+G+F KV A++ G A+K++ K+ +LK I E +V+ + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 75 LYEVMASKTKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHR 133
L+ + K+YFV++YV GGELF + + + E AR Y ++ SA+ Y HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
DLKPEN+LLD G++ ++DFGL E T CGTP Y+APEV+ ++ YD +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT-V 177
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253
D W G +LY +L G PF+ + EMY I + + R LL +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 254 RI 255
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 6e-46
Identities = 90/255 (35%), Positives = 147/255 (57%), Gaps = 6/255 (2%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVE 74
++LG+G+F KV A T AIK + K+ VL+ ++ E V+ L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 75 LYEVMASKTKIYFVMEYVKGGEL-FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHR 133
L+ +K ++FVMEY+ GG+L F + G+ E AR Y ++I + + H +G+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
DLK +N+LLD+ G++K++DFG+ E+ + +G T CGTP Y+APE++ + Y+ S
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYNES-V 177
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253
D WS GV+LY +L G PFH + E++ I FP W + E + LSK+ + +P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237
Query: 254 RISMT-KIMENSWFR 267
R+ + I ++ +FR
Sbjct: 238 RLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 6e-46
Identities = 82/242 (33%), Positives = 136/242 (56%), Gaps = 5/242 (2%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVE 74
R+LG+G+F KV AR ++G A+K++ K+ +L+ ++ E ++ L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 75 LYEVMASKTKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHR 133
LY + +++FVME+V GG+L + K + E AR Y ++ SA+ + H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
DLK +N+LLD G+ K++DFG+ E T CGTP Y+APE++ Y G
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMC--KEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253
D W+ GV+LY +L G+ PF N +++ I E +P W + + +L + NP
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 254 RI 255
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 83/274 (30%), Positives = 141/274 (51%), Gaps = 7/274 (2%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ + L +G+G+F +V+ A + +T VAIK+ID E+ I+ I++EI + R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQCRS 58
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
P + + Y +K++ +MEY GG + GKL E ++++ ++Y H G
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD 189
HRD+K N+LL E G++K++DFG+S + +T GTP ++APEVI + GYD
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 190 GSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF--PNWFAPEVRRLLSKIL 247
KADIWS G+ L G P D + M + I K N F+ + +S L
Sbjct: 177 -EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235
Query: 248 DPNPNTRISMTKIMENSWFRKGLVKPSISETEEK 281
+ +P R S +++++ + +K ++ E+
Sbjct: 236 NKDPKERPSAKELLKHKFIKKAKKTSYLTLLIER 269
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 87/258 (33%), Positives = 142/258 (55%), Gaps = 18/258 (6%)
Query: 12 YELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVL-KVGMIDQIKREISVMRLV 67
+EL R+LG G + KV R + G A+K++ K ++ K + + E V+ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 68 RH-PNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYC 125
R P +V L+ + TK++ +++YV GGELF + + E R Y +++ A+D+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA--LAESKHQDGLLHTTCGTPAYVAPEVI 183
H G+ +RD+K EN+LLD G++ ++DFGLS LAE + + ++ CGT Y+APEVI
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER---AYSFCGTIEYMAPEVI 178
Query: 184 NR--RGYDGSKADIWSCGVILYVLLAGYLPF----HDSNLMEMYRKIGKAEFKFPNWFAP 237
G+D D WS GV+ + LL G PF ++ E+ R+I K++ FP +
Sbjct: 179 RGGSGGHD-KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237
Query: 238 EVRRLLSKILDPNPNTRI 255
E R + K+L+ +P R+
Sbjct: 238 EARDFIQKLLEKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 4e-45
Identities = 90/294 (30%), Positives = 149/294 (50%), Gaps = 37/294 (12%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ ++ +LLG+G +V R TG A+K++DK++++K + ++ E ++ + H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFG--KVAKGK-LKEDAARKYFQQLISAVDYCH 126
P + LY ++T + VM+Y GGELF + GK L E+ AR Y +++ A++Y H
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLS---------------ALAESKHQDGLLHTT 171
G+ +RDLKPEN+LL E G++ +SDF LS + + + T
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 172 ------------CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME 219
GT Y+APEVI+ G+ + D W+ G++LY +L G PF SN E
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDE 239
Query: 220 MYRKIGKAEFKFPN--WFAPEVRRLLSKILDPNPNTRI----SMTKIMENSWFR 267
+ I K E FP + R L+ K+L +P+ R+ +I ++ +FR
Sbjct: 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 87/272 (31%), Positives = 137/272 (50%), Gaps = 24/272 (8%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
YEL ++G G A V+ A L VAIK ID EK +D++++E+ M HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPN 60
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFG----KVAKGKLKEDAARKYFQQLISAVDYCHS 127
VV+ Y +++ VM Y+ GG L +G L E ++++ ++Y HS
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAES-KHQDGLLHTTCGTPAYVAPEVIN- 184
G HRD+K N+LL E G++K++DFG+SA LA+ + T GTP ++APEV+
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 185 RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI----------GKAEFKFPNW 234
GYD KADIWS G+ L G P+ M++ G K+
Sbjct: 181 VHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239
Query: 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266
F R+++S L +P+ R + +++++ +F
Sbjct: 240 F----RKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 7e-45
Identities = 83/266 (31%), Positives = 131/266 (49%), Gaps = 18/266 (6%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKII---DKEKVLKVGMIDQIKREISVMRLVRH 69
E ++LGQG+ V+ R+ TG A+K I E+ K Q+ RE+ +R
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-----QLLRELKTLRSCES 58
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS- 127
P VV+ Y + +I V+EY+ GG L + K GK+ E +Q++ +DY H+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
R + HRD+KP NLL++ G +K++DFG+S + E+ +T GT Y++PE I
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT--LDQCNTFVGTVTYMSPERIQGE- 175
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKI--GKAEFKFPNWFAPEVRRL 242
ADIWS G+ L G PF E+ + I G F+PE R
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235
Query: 243 LSKILDPNPNTRISMTKIMENSWFRK 268
+S L +P R S +++++ + +K
Sbjct: 236 ISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 5e-44
Identities = 72/265 (27%), Positives = 130/265 (49%), Gaps = 22/265 (8%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKR-----EISVMR 65
+++ + LG+G++ V+ + L A+K +D +G + Q +R EI ++
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD------LGSMSQKEREDAVNEIRILA 54
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK-----LKEDAARKYFQQLIS 120
V HPN++ E K+ VMEY G+L ++K K + E + F QL+
Sbjct: 55 SVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
+ H + + HRDLK N+LL + +K+ D G+S + + + T GTP Y+AP
Sbjct: 115 GLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAP 170
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEV 239
EV R Y K+DIWS G +LY + PF ++ ++ K+ + ++ P ++ ++
Sbjct: 171 EVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDL 229
Query: 240 RRLLSKILDPNPNTRISMTKIMENS 264
+ + +L P R + KI+ +
Sbjct: 230 QNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 2e-43
Identities = 92/291 (31%), Positives = 137/291 (47%), Gaps = 40/291 (13%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
YE +G+GT+ +V+ ARN KTG VA+K I E K G REI +++ +RHPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE-KEGFPITAIREIKLLQKLRHPN 59
Query: 72 VVELYEVMASKTK--IYFVMEYVKGGELFG--KVAKGKLKEDAARKYFQQLISAVDYCHS 127
+V L E++ SK K IY V EY+ +L G + K E + Y +QL+ + Y HS
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI-NRR 186
G+ HRD+K N+L++ G LK++DFGL+ ++ + T Y PE++
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGAT 177
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------- 227
Y G + D+WS G IL L G F S +E KI +
Sbjct: 178 RY-GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236
Query: 228 EFK------------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266
K F + P LL K+L +P RIS + +++ +F
Sbjct: 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 4e-43
Identities = 87/277 (31%), Positives = 148/277 (53%), Gaps = 23/277 (8%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+E +L+ G + V+ R+ +T A+K I+K+ ++ I Q+ E ++ +P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRG 129
VV ++ +K + VMEYV+GG+ + K G L D AR YF + + A++Y H+ G
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDC-ATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALA-------------ESKHQDGLLHTTCGTPA 176
+ HRDLKP+NLL+ G++K++DFGLS + E ++ L CGTP
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP---N 233
Y+APEVI R+GY G D W+ G+ILY L G +PF E++ ++ + ++P
Sbjct: 182 YIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240
Query: 234 WFAPEVRRLLSKILDPNPNTRI---SMTKIMENSWFR 267
+ + L+S++L NP R+ ++ ++ +F
Sbjct: 241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 4e-43
Identities = 87/245 (35%), Positives = 137/245 (55%), Gaps = 5/245 (2%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVVE 74
+++G+G+F KV AR+ A+K++ K+ +LK I E +V+ + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 75 LYEVMASKTKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHR 133
L+ + K+YFV++Y+ GGELF + + + E AR Y ++ SA+ Y HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
DLKPEN+LLD G++ ++DFGL E+ +G T CGTP Y+APEV++++ YD +
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLC--KENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT-V 177
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253
D W G +LY +L G PF+ N EMY I + R LL +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 254 RISMT 258
R+
Sbjct: 238 RLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 77/261 (29%), Positives = 136/261 (52%), Gaps = 7/261 (2%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRLVRH 69
+ G+LLGQG F +V+ ++ TG +A+K + D + ++ ++ EI +++ ++H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCHSR 128
+V+ Y + + MEY+ GG + ++ A G L E RKY +Q++ V+Y HS
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH-QDGLLHTTCGTPAYVAPEVINRRG 187
+ HRD+K N+L D GN+K+ DFG S ++ + + GTP +++PEVI+ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK--AEFKFPNWFAPEVRRLLSK 245
Y G KAD+WS G + +L P+ + M KI + P+ +P+ R L +
Sbjct: 184 Y-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242
Query: 246 ILDPNPNTRISMTKIMENSWF 266
N R S +++ + +
Sbjct: 243 TFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 2e-42
Identities = 86/256 (33%), Positives = 142/256 (55%), Gaps = 10/256 (3%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
+YE R++G+G F VH R V IK I E++ K + E V++L+ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER-LAAQNECQVLKLLSHP 59
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK---LKEDAARKYFQQLISAVDYCHS 127
N++E YE + VMEY GG L + K L ED +F Q++ A+ + H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 128 RGVCHRDLKPENLLLDEHGN-LKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR 186
+ + HRDLK +N+LLD+H +K+ DFG+S + SK + +T GTP Y++PE+ +
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGK 176
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FPNWFAPEVRRLLSK 245
Y+ K+DIW+ G +LY L + F +NL + KI F + ++P++R+L+
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235
Query: 246 ILDPNPNTRISMTKIM 261
+L+ +P+ R +++IM
Sbjct: 236 MLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 83/262 (31%), Positives = 139/262 (53%), Gaps = 12/262 (4%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVE 74
++LG+G+F KV A T AIK++ K+ +L+ +D E ++ L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 75 LYEVMASKTKIYFVMEYVKGGELFGKVAKG-KLKEDAARKYFQQLISAVDYCHSRGVCHR 133
L+ +K +++FVMEYV GG+L ++ + K E +R Y ++ A+ + H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
DLK +N+LLD G+ K++DFG+ E T CGTP Y+APE++ Y S
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMC--KEGILNGVTTTTFCGTPDYIAPEILQELEYGPS-V 177
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253
D W+ GV++Y ++AG PF N +++ I + +P W + E +L + NPN
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 254 RISMT-------KIMENSWFRK 268
R+ I ++ +F++
Sbjct: 238 RLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 3e-42
Identities = 82/248 (33%), Positives = 140/248 (56%), Gaps = 9/248 (3%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQI--KREISVMRLVRH-PNVVE 74
+G+GTF +V+ R T A+K++ K++++ + +R I V L+ P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 75 LYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHR 133
L + + +Y V +Y+ GGELF + K G+ ED A+ Y +L+ A+++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV-INRRGYDGSK 192
DLKPEN+LLD G++ + DFGLS + + +T CGT Y+APEV ++ +GY
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 193 ADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-NWFAPEVRRLLSKILDPNP 251
D WS GV+++ + G+ PF+ + +MYR I + +FP N + E R+ + +L+ NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 252 NTRISMTK 259
R+ +
Sbjct: 238 QHRLGAHR 245
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 4e-42
Identities = 87/262 (33%), Positives = 140/262 (53%), Gaps = 22/262 (8%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIID--KEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
LG G F KV+ A++ +TG+ A KII E+ L+ M+ EI ++ +HPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV-----EIDILSECKHPNIVGL 67
Query: 76 YEVMASKTKIYFVMEYVKGGEL---FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCH 132
YE + K++ ++E+ GG L ++ +G L E R +Q++ A+++ HS V H
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVIN-----RRG 187
RDLK N+LL G++K++DFG+SA +K T GTP ++APEV+
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAK--NKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRRLLS 244
YD KADIWS G+ L L P H+ N M + KI K+E P+ ++ L
Sbjct: 185 YD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLK 243
Query: 245 KILDPNPNTRISMTKIMENSWF 266
L +P+ R + +++++ +
Sbjct: 244 SCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 6e-42
Identities = 76/244 (31%), Positives = 129/244 (52%), Gaps = 12/244 (4%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+G+G +V+ A + TG VAIK + K K + I EI +M+ +HPN+V+ Y+
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK----ELIINEILIMKDCKHPNIVDYYD 82
Query: 78 VMASKTKIYFVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDL 135
+++ VMEY+ GG L + ++ E ++++ ++Y HS+ V HRD+
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDI 142
Query: 136 KPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADI 195
K +N+LL + G++K++DFG +A + ++ GTP ++APEVI R+ Y K DI
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYG-PKVDI 199
Query: 196 WSCGVILYVLLAGYLP-FHDSNLMEMY--RKIGKAEFKFPNWFAPEVRRLLSKILDPNPN 252
WS G++ + G P + L ++ G K P ++PE + L+K L +P
Sbjct: 200 WSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPE 259
Query: 253 TRIS 256
R S
Sbjct: 260 KRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 6e-42
Identities = 84/242 (34%), Positives = 135/242 (55%), Gaps = 5/242 (2%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVVE 74
+++G+G+F KV A+ G A+K++ K+ +LK + I E +V+ + ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 75 LYEVMASKTKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHR 133
L+ + K+YFV++YV GGELF + + + E AR Y ++ SA+ Y HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
DLKPEN+LLD G++ ++DFGL E + T CGTP Y+APEV+ + YD +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT-V 177
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253
D W G +LY +L G PF+ ++ +MY I + P LL +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 254 RI 255
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 8e-42
Identities = 94/304 (30%), Positives = 139/304 (45%), Gaps = 65/304 (21%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRLVR 68
RYE G+ LG+GT+A V+ AR+ +TG VAIK I + K K G+ REI +++ ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK---LKEDAARKYFQQLISAVDYC 125
HPN++ L +V K+ I V E++ +L KV K K L + Y + ++Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFM-ETDL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV-APEVIN 184
HS + HRDLKP NLL+ G LK++DFGL+ + G+P +V+
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQVVT 165
Query: 185 R-----------RGYDGSKADIWSCGVILYVLLAG--YLP-----------FH------D 214
R R Y G D+WS G I LL +LP F +
Sbjct: 166 RWYRAPELLFGARHY-GVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE 224
Query: 215 SNLMEMYRKIGKAEFK----------FPNWFAPEVR-RLLSKILDPNPNTRISMTKIMEN 263
N + EFK FP A + LL ++L NPN RI+ + +E+
Sbjct: 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPA--ASDDALDLLQRLLTLNPNKRITARQALEH 282
Query: 264 SWFR 267
+F
Sbjct: 283 PYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 98/299 (32%), Positives = 154/299 (51%), Gaps = 12/299 (4%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVE 74
++LG+G+F KV A T AIK + K+ VL ++ E V+ L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 75 LYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHR 133
LY +K ++FVMEY+ GG+L + K A Y ++I + + HS+G+ +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
DLK +N+LLD G++K++DFG+ E+ D T CGTP Y+APE++ + Y +
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSV 177
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253
D WS GV+LY +L G PFH + E+++ I +P W E + +L K+ P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237
Query: 254 RISMT-KIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGSTSTVAESKNELAKP 311
R+ + I ++ +FR + S EE+E P V S + ++ E NE KP
Sbjct: 238 RLGVKGDIRQHPFFR----EIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNE--KP 290
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 85/301 (28%), Positives = 131/301 (43%), Gaps = 51/301 (16%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
+ +G G F +V R + T A+K + K VL +K E ++ + VV+L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 76 YEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRD 134
Y K +YFVM+Y+ GG++ + G +ED AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 135 LKPENLLLDEHGNLKVSDFGLSA------------------------------------- 157
+KP+N+L+D G++K++DFGL
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 158 ----LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH 213
+ +HQ L H+ GTP Y+APEV+ R GY D WS GVILY +L G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFL 245
Query: 214 DSNLMEMYRKI--GKAEFKFPNW--FAPEVRRLLSKILDPNPNTRI---SMTKIMENSWF 266
E K+ + P+ + E L+ + L R+ +I + +F
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFF 304
Query: 267 R 267
+
Sbjct: 305 K 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-41
Identities = 83/286 (29%), Positives = 134/286 (46%), Gaps = 34/286 (11%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
Y+ +G+GT+ V+ AR+ TG VAIK I K + G+ REI +++ + HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59
Query: 72 VVELYEVMASKTKIYFVMEYVKGG-ELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGV 130
+++L +V K +Y V E++ K + L E + Y QL+ + +CHS G+
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDG 190
HRDLKPENLL++ G LK++DFGL+ S T Y APE++
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 191 SKADIWSCGVILYVLLAGYLPF-HDSNLMEMYRKIG------------------KAEFKF 231
+ DIWS G I LL+ F S + ++++ +F F
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 232 PNW-----------FAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266
P +P+ LLS++L +P+ RI+ + + + +F
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 4e-41
Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 13/260 (5%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+++ LG+G++ V+ A + +TG VAIK++ E + +I +EIS+++ P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDSPY 59
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFG--KVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
+V+ Y T ++ VMEY G + K+ L E+ Q + ++Y HS
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD 189
HRD+K N+LL+E G K++DFG+S +T GTP ++APEVI GY+
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 190 GSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK---AEFKFPNWFAPEVRRLLSKI 246
+KADIWS G+ + G P+ D + M I P ++PE + K
Sbjct: 178 -NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236
Query: 247 LDPNPNTRISMTKIMENSWF 266
L +P R S +++++ +
Sbjct: 237 LVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 4e-41
Identities = 75/257 (29%), Positives = 131/257 (50%), Gaps = 8/257 (3%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIK--IIDKEKVLKVGMIDQIKREISVMRLVR 68
R+ G LLG G+F V+ NL G A+K + + + Q+++EI+++ ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS 127
HPN+V+ + +Y +E V GG L + K G E R Y +Q++ ++Y H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
R HRD+K N+L+D +G +K++DFG++ + + G+P ++APEVI ++G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMA--KQVVEFSFAK-SFKGSPYWMAPEVIAQQG 177
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG--KAEFKFPNWFAPEVRRLLSK 245
G ADIWS G + + G P+ + KIG K P+ + E + + K
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 246 ILDPNPNTRISMTKIME 262
L +P+ R + +++E
Sbjct: 238 CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 4e-41
Identities = 85/259 (32%), Positives = 138/259 (53%), Gaps = 15/259 (5%)
Query: 16 RLLGQGTFAKVHYARNLKTG--MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVV 73
R LG G+F +V A K VAIK +K K++K +D + E ++ + HP V
Sbjct: 36 RTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 74 ELYEVMASKTKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCH 132
LY ++ +Y V+E+V GGE F + + K D Y Q++ +Y S + +
Sbjct: 95 NLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSK 192
RDLKPENLLLD+ G +K++DFG + + +++ +T CGTP Y+APE++ G+ G
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGH-GKA 208
Query: 193 ADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPN 252
AD W+ G+ +Y +L G PF+ + + +Y+KI + FP + + L+ K+L +
Sbjct: 209 ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLT 268
Query: 253 TRISMTK-----IMENSWF 266
R K + E+ WF
Sbjct: 269 KRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 6e-41
Identities = 90/300 (30%), Positives = 148/300 (49%), Gaps = 46/300 (15%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+E +++G+G F +V + TG A+K + K ++L+ + ++ E ++ +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHSRGV 130
VV+LY + +Y +MEY+ GG++ + K E+ R Y + I A+D H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGL----------------------------------S 156
HRD+KP+NLLLD G++K+SDFGL
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 157 ALAES--KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD 214
AE+ +++ L ++T GTP Y+APEV + GY + D WS GVI+Y +L GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 215 SNLMEMYRKI--GKAEFKFPN--WFAPEVRRLLSKILDPNPNTRI---SMTKIMENSWFR 267
N E YRKI K +FP+ +PE + L+ ++ R+ + +I + +F+
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 83/290 (28%), Positives = 137/290 (47%), Gaps = 39/290 (13%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
RY++ +G+G V A++ +TG +VA+K + ++ G+ +Q REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHP 59
Query: 71 NVVELYEVMASKTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
VV+L +V + VMEY+ E+ + L E + Y + L+ V Y H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT-TCGTPAYVAPEVI-NRR 186
G+ HRDLKP NLL+ G LK++DFGL+ L ++ L++ T Y APE++ R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSE--EEPRLYSHQVATRWYRAPELLYGAR 176
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLME----MYRKIGKAEFK------------ 230
YD D+W+ G I LL G F N +E ++R +G +
Sbjct: 177 KYDPG-VDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 231 ---FPN-----W--FAPEVRR----LLSKILDPNPNTRISMTKIMENSWF 266
FP P+ LL +L +P+ R+S + + + +F
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 100/318 (31%), Positives = 170/318 (53%), Gaps = 35/318 (11%)
Query: 12 YELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEK-VLKVGMIDQIKREISVMRLV 67
+EL ++LG G + KV R + TG A+K++ K V K ++ + E +V+ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 68 RH-PNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYC 125
R P +V L+ ++ K++ +++YV GGE+F + + ED R Y ++I A+++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA--LAESKHQDGLLHTTCGTPAYVAPEVI 183
H G+ +RD+K EN+LLD G++ ++DFGLS L+E K + ++ CGT Y+APE+I
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT---YSFCGTIEYMAPEII 178
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPF----HDSNLMEMYRKIGKAEFKFPNWFAPEV 239
+G G D WS G++++ LL G PF + E+ R+I K + FP++ PE
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 240 RRLLSKILDPNPNTRISM----TKIMENSWFRKGL-------------VKPSI-SETEEK 281
+ LL K+L +P R+ ++ F KGL +PSI +E +
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVG 298
Query: 282 EWAP--VDADAVFSPSGS 297
+A + + V+SP+G+
Sbjct: 299 NFAEEFTNLEPVYSPAGT 316
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 84/265 (31%), Positives = 141/265 (53%), Gaps = 22/265 (8%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKR-----EISVMRL 66
+++ + +G+G F+ V+ A L G VA+K KV M+D R EI +++
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALK-----KVQIFEMMDAKARQDCLKEIDLLKQ 58
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGEL---FGKVAKGK--LKEDAARKYFQQLISA 121
+ HPNV++ ++ V+E G+L K K + E KYF QL SA
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+++ HS+ + HRD+KP N+ + G +K+ D GL SK H+ GTP Y++PE
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPE 176
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS--NLMEMYRKIGKAEFK-FPN-WFAP 237
I+ GY+ K+DIWS G +LY + A PF+ NL + +KI K ++ P ++
Sbjct: 177 RIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235
Query: 238 EVRRLLSKILDPNPNTRISMTKIME 262
E+R L+S+ ++P+P R ++ +++
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 2e-40
Identities = 85/242 (35%), Positives = 135/242 (55%), Gaps = 5/242 (2%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVVE 74
+++G+G+F KV A+ G A+K++ K+ VL I E +V+ + V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 75 LYEVMASKTKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHR 133
L+ + K+YFV+++V GGELF + + + E AR Y ++ SA+ Y HS + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
DLKPEN+LLD G++ ++DFGL E Q T CGTP Y+APEVI ++ YD +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT-V 177
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253
D W G +LY +L G PF+ ++ EMY I + +L ++L+ +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237
Query: 254 RI 255
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 4e-40
Identities = 72/259 (27%), Positives = 127/259 (49%), Gaps = 14/259 (5%)
Query: 13 ELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
LG+ LG+G F +V+ + K + VA+K + ++ + I++ RE +MR +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKLD 59
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCH 126
HPNVV+L V + +Y VMEY++GG+L + + + KL + Q+ ++Y
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVINR 185
S+ HRDL N L+ E+ +K+SDFGLS P ++APE +
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKE 177
Query: 186 RGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLL 243
+ SK+D+WS GV+L+ + G P+ + E+ + P PE+ L+
Sbjct: 178 GKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLM 236
Query: 244 SKILDPNPNTRISMTKIME 262
+ +P R + ++++E
Sbjct: 237 LQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-39
Identities = 88/269 (32%), Positives = 137/269 (50%), Gaps = 30/269 (11%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII---DKEKVLKVGMIDQIKREISVMRL 66
+ YEL + +G GT+ V+ AR++ TG VAIK+I + + I++EIS+++
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD------FEIIQQEISMLKE 56
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDY 124
RHPN+V + + K++ VMEY GG L +V +G L E ++ + + Y
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 125 CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE---SKHQDGLLHTTCGTPAYVAPE 181
H G HRD+K N+LL E G++K++DFG+SA +K + + GTP ++APE
Sbjct: 117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK-----SFIGTPYWMAPE 171
Query: 182 VIN---RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP------ 232
V + GYDG K DIW+ G+ L P D + M I K+ F P
Sbjct: 172 VAAVERKGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKE 230
Query: 233 NWFAPEVRRLLSKILDPNPNTRISMTKIM 261
W +P + K L +P R + TK++
Sbjct: 231 KW-SPVFHDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 76/263 (28%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIID------KEKVLKVGMIDQIKREISVMRLVR 68
G L+G G+F V+ N +G +A+K ++ K K M+D + REI++++ ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS 127
H N+V+ + +EYV GG + + G +E R + +Q++ ++Y H+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT----CGTPAYVAPEVI 183
RG+ HRD+K N+L+D G +K+SDFG+S E+ + G+ ++APEV+
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG-KAEFKFPNWFAPEVRRL 242
+ Y KADIWS G ++ +L G PF D ++ KIG A + P+ + E
Sbjct: 185 KQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDF 243
Query: 243 LSKILDPNPNTRISMTKIMENSW 265
L K + + N R + +++++ +
Sbjct: 244 LEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 79/206 (38%), Positives = 106/206 (51%), Gaps = 15/206 (7%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIK----IIDKEKVLKVGMIDQIKREISVMR 65
+YE+ ++G+G + V RN TG VAIK D E V K + RE+ V+R
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL-----REVKVLR 55
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQLISAVD 123
+RH N+V L E K ++Y V EYV+ EL G L DA R Y QL+ A+
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG-LPPDAVRSYIWQLLQAIA 114
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS-ALAESKHQDGLLHTTCGTPAYVAPEV 182
YCHS + HRD+KPEN+L+ E G LK+ DFG + AL L T Y APE+
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPEL 172
Query: 183 INRRGYDGSKADIWSCGVILYVLLAG 208
+ G D+W+ G I+ LL G
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 80/270 (29%), Positives = 143/270 (52%), Gaps = 23/270 (8%)
Query: 10 QRYELGRL--LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE-----IS 62
R L +G+G+ V A + TG VA+K +D K Q +RE +
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--------QQRRELLFNEVV 68
Query: 63 VMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAV 122
+MR +HPN+VE+Y +++ VME+++GG L V ++ E+ ++ A+
Sbjct: 69 IMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKAL 128
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPE 181
+ H++GV HRD+K +++LL G +K+SDFG A +++ + L GTP ++APE
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPE 185
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLP-FHDSNL--MEMYRKIGKAEFKFPNWFAPE 238
VI+R Y G++ DIWS G+++ ++ G P F++ L M+ R + K + +P
Sbjct: 186 VISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPR 244
Query: 239 VRRLLSKILDPNPNTRISMTKIMENSWFRK 268
+R L ++L +P R + +++ + + K
Sbjct: 245 LRSFLDRMLVRDPAQRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 97/317 (30%), Positives = 162/317 (51%), Gaps = 12/317 (3%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVE 74
++LG+G+F KV A G A+K + K+ VL ++ E V+ L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 75 LYEVMASKTKIYFVMEYVKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHR 133
LY +K ++FVME++ GG+L + KG+ A Y +++ + + HS+G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
DLK +N++LD G++K++DFG+ E+ D T CGTP Y+APE++ Y S
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFS-V 177
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253
D WS GV+LY +L G PFH + E++ I +P W E + +L K+ + +P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 254 RISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGSTSTVAESKNELAK--P 311
R+ + + F K + + + E++E P V SPS ++ E +E +
Sbjct: 238 RLGVVGNIRGHPFFKTI---NWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLSY 294
Query: 312 CNLNAFDIISFSA--GF 326
+ N D + SA GF
Sbjct: 295 SDKNLIDSMDQSAFAGF 311
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 89/287 (31%), Positives = 135/287 (47%), Gaps = 48/287 (16%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKII----DKEKVLKVGMIDQIKREISVMRLVRHPNVV 73
+G+GT+ V+ AR+ TG VA+K I + E V + REIS+++ + HPN+V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-----REISLLKELNHPNIV 61
Query: 74 ELYEVMASKTKIYFVMEYV----KGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
L +V+ S+ K+Y V E++ K + L + Y QL+ + YCHS
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLK--KYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD 189
V HRDLKP+NLL+D G LK++DFGL A A H T Y APE++
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGL-ARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQY 177
Query: 190 GSKADIWSCGVILYVLLAGYLPFH-DSNLMEMYRKIGKA----------------EFK-- 230
+ DIWS G I ++ F DS + +++R I + ++K
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR-IFRTLGTPDEDVWPGVTSLPDYKPT 236
Query: 231 FPNW-----------FAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266
FP W + LLSK+L +P RIS +++ +F
Sbjct: 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 81/269 (30%), Positives = 135/269 (50%), Gaps = 15/269 (5%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+++ L+G+G F +V R TG A+K++ K +L + + E ++ + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRG 129
+ +L K +Y VMEY GG+L + + + ED A+ Y +L+ A+ H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPEVI----- 183
HRD+KPEN+L+D G++K++DFG +A L +K + L GTP Y+APEV+
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL--PVGTPDYIAPEVLTTMNG 180
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI--GKAEFKFPN--WFAPEV 239
+ +G G + D WS GVI Y ++ G PFH+ + Y I + KFP + +
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240
Query: 240 RRLLSKILDPNPNTRISMTKIMENSWFRK 268
L+ +L R+ + + +F K
Sbjct: 241 LDLIQSLL-CGQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 74/243 (30%), Positives = 129/243 (53%), Gaps = 15/243 (6%)
Query: 15 GRLLGQGTFAKVHYARNLKTGMSVAIK-------IIDKEKVLKVGMIDQIKREISVMRLV 67
G L+G+GT+ +V+ A N+ TG +A+K I + + M+ ++ EI ++ +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYC 125
H N+V+ ++ + +EYV GG + G + G+ +E R + +Q++ + Y
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVIN- 184
HS+G+ HRDLK +NLL+D G K+SDFG+S ++ + + + G+ ++APEVI+
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 185 -RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLL 243
+GY K DIWS G ++ + AG P+ D + K+G P P+V L
Sbjct: 185 YSQGYSA-KVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP--IPPDVSMNL 241
Query: 244 SKI 246
S +
Sbjct: 242 SPV 244
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-38
Identities = 74/258 (28%), Positives = 141/258 (54%), Gaps = 8/258 (3%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
+Y + +G+G+F K ++ + G IK I+ K + ++ ++E++V+ ++HP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK---LKEDAARKYFQQLISAVDYCHS 127
N+V+ E +Y VM+Y +GG+L+ K+ + ED +F Q+ A+ + H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
R + HRD+K +N+ L + G +K+ DFG++ + S + L T GTP Y++PE+ R
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP 177
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSKI 246
Y+ +K+DIW+ G +LY + F N+ + KI + + + ++ ++R L+S++
Sbjct: 178 YN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236
Query: 247 LDPNPNTRISMTKIMENS 264
NP R S+ I+E +
Sbjct: 237 FKRNPRDRPSVNSILEKN 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 4e-38
Identities = 88/295 (29%), Positives = 136/295 (46%), Gaps = 52/295 (17%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDK-----EKVLKVGMIDQIKREI-SVMR 65
Y++ + LG GTF V+ ARN +TG VAIK + K E+ + + RE+ S+ +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-------REVKSLRK 53
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQLISAVD 123
L HPN+V+L EV ++YFV EY++G +L E R Q++ +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT-CGTPAYVAPEV 182
+ H G HRDLKPENLL+ +K++DFGL+ S+ +T T Y APE+
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEI 169
Query: 183 INRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI------------------ 224
+ R S DIW+ G I+ L F S+ ++ KI
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229
Query: 225 -GKAEFKFPNWFAP------------EVRRLLSKILDPNPNTRISMTKIMENSWF 266
K F+FP FAP E L+ +L +P R + ++ +++ +F
Sbjct: 230 ASKLGFRFPQ-FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 7e-38
Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 15/260 (5%)
Query: 13 ELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
LG+ LG+G F +V+ + VA+K + ++ + I++ RE +MR +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLD 59
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGK-LKEDAARKYFQQLISAVDYC 125
HPN+V+L V + + VMEY+ GG+L + + + K L + Q+ ++Y
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVIN 184
S+ HRDL N L+ E+ +K+SDFGLS + P ++APE +
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLK 177
Query: 185 RRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRL 242
+ SK+D+WS GV+L+ + G P+ + E+ + K P PE+ +L
Sbjct: 178 EGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKL 236
Query: 243 LSKILDPNPNTRISMTKIME 262
+ + +P R + ++++E
Sbjct: 237 MLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 8e-38
Identities = 81/261 (31%), Positives = 127/261 (48%), Gaps = 17/261 (6%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQI---KREISVMRLVRHPNVVE 74
LG+G F KV A KTG AIK + K ++ ++ + KR RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 75 LYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRD 134
L+ ++ + FVMEY GG+L + E A Y ++ + Y H + +RD
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRD 126
Query: 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT---CGTPAYVAPEVINRRGYDGS 191
LK +NLLLD G +K++DFGL K G T CGTP ++APEV+ Y +
Sbjct: 127 LKLDNLLLDTEGFVKIADFGL-----CKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA 181
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNP 251
D W GV++Y +L G PF + E++ I E ++P + + E ++ ++L NP
Sbjct: 182 -VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNP 240
Query: 252 NTRISMTK-----IMENSWFR 267
R+ + + + +FR
Sbjct: 241 ERRLGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 1e-37
Identities = 81/258 (31%), Positives = 143/258 (55%), Gaps = 11/258 (4%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
RYE+ + +G+G+F K++ A+ IK ID K + V + K+E+ ++ ++HP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHP 59
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK---LKEDAARKYFQQLISAVDYCHS 127
N+V + +++ VMEY GG+L ++ + + ED +F Q+ + + H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 128 RGVCHRDLKPENLLLDEHGNL-KVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR 186
R + HRD+K +N+ L ++G + K+ DFG++ + L +T GTP Y++PE+ R
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNR 177
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK--FPNWFAPEVRRLLS 244
Y+ +K DIWS G +LY L PF +NL ++ KI + F PN F+ ++R L+S
Sbjct: 178 PYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPN-FSRDLRSLIS 235
Query: 245 KILDPNPNTRISMTKIME 262
++ +P R S+T I++
Sbjct: 236 QLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 84/259 (32%), Positives = 141/259 (54%), Gaps = 10/259 (3%)
Query: 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVEL 75
+LG+G+F KV A T AIKI+ K+ V++ ++ E V+ L + P + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRD 134
+ + ++YFVMEYV GG+L + + GK KE A Y ++ + + H RG+ +RD
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKAD 194
LK +N++LD G++K++DFG+ E T CGTP Y+APE+I + Y G D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMC--KEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 195 IWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254
W+ GV+LY +LAG PF + E+++ I + +P + E + ++ +P+ R
Sbjct: 184 WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKR 243
Query: 255 ISM-----TKIMENSWFRK 268
+ I E+++FR+
Sbjct: 244 LGCGPEGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 84/258 (32%), Positives = 140/258 (54%), Gaps = 10/258 (3%)
Query: 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN-VVEL 75
+LG+G+F KV A T AIKI+ K+ +++ ++ E V+ L P + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRD 134
+ + ++YFVMEYV GG+L + + GK KE A Y ++ + + HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKAD 194
LK +N++LD G++K++DFG+ E+ T CGTP Y+APE+I + Y S D
Sbjct: 127 LKLDNVMLDAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKS-VD 183
Query: 195 IWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254
W+ GV+LY +LAG PF + E+++ I + +P + E + +L +P R
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243
Query: 255 ISMT-----KIMENSWFR 267
+ I E+++FR
Sbjct: 244 LGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 80/231 (34%), Positives = 129/231 (55%), Gaps = 10/231 (4%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ YE+ +++G+G F +V R+ T A+K++ K +++K E +M
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
P VV+L+ +Y VMEY+ GG+L ++ + E AR Y +++ A+D HS G
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH--TTCGTPAYVAPEVINRR- 186
HRD+KP+N+LLD+ G+LK++DFG +++G++ T GTP Y++PEV+ +
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 187 --GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI--GKAEFKFPN 233
GY G + D WS GV LY +L G PF+ +L+ Y KI K FP+
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 77/230 (33%), Positives = 129/230 (56%), Gaps = 10/230 (4%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ Y++ +++G+G F +V R+ + A+K++ K +++K E +M
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
P VV+L+ +Y VMEY+ GG+L ++ + E A+ Y +++ A+D HS G
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH--TTCGTPAYVAPEVINRR- 186
+ HRD+KP+N+LLD+HG+LK++DFG + + G++ T GTP Y++PEV+ +
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD---ETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 187 --GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI--GKAEFKFP 232
GY G + D WS GV L+ +L G PF+ +L+ Y KI K FP
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP 269
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 75/228 (32%), Positives = 126/228 (55%), Gaps = 10/228 (4%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+++ +++G+G F +V R+ + A+K++ K +++K E +M
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVC 131
+V+L+ +Y VMEY+ GG+L ++ + E AR Y +++ A+D HS G
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 132 HRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH--TTCGTPAYVAPEVINRRGYD 189
HRD+KP+N+LLD+ G+LK++DFG ++ +G++ T GTP Y++PEV+ +G D
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDA---NGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 190 ---GSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI--GKAEFKFP 232
G + D WS GV LY +L G PF+ +L+ Y KI K FP
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP 269
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 7e-37
Identities = 87/282 (30%), Positives = 140/282 (49%), Gaps = 41/282 (14%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR-LVRH 69
+EL ++G+GT+ KV+ AR+ KTG VAIKI+D + ++IK E +++R H
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSNH 62
Query: 70 PNVVELYEVMASKT------KIYFVMEYVKGG---ELFGKV-AKGK-LKEDAARKYFQQL 118
PN+ Y K +++ VME GG +L + KGK LKE+ ++
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
+ + Y H V HRD+K +N+LL ++ +K+ DFG+S A+ G +T GTP ++
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS--AQLDSTLGRRNTFIGTPYWM 180
Query: 179 APEVIN-----RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN 233
APEVI YD +++D+WS G+ L G P D + M +A FK P
Sbjct: 181 APEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPM-------RALFKIPR 232
Query: 234 WFAPEVRR----------LLSKILDPNPNTRISMTKIMENSW 265
P ++ +S+ L N R M +++E+ +
Sbjct: 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 86/283 (30%), Positives = 147/283 (51%), Gaps = 24/283 (8%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
L QR EL +G+G + V+ +++ TG VA+KII+ + + I+RE++++ +
Sbjct: 2 LYQRLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQL 56
Query: 68 RH---PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDY 124
R PN+ + Y +++ +MEY +GG + + G + E ++++ A+ Y
Sbjct: 57 RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKY 116
Query: 125 CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL---AESKHQDGLLHTTCGTPAYVAPE 181
H GV HRD+K N+L+ GN+K+ DFG++AL SK T GTP ++APE
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS-----TFVGTPYWMAPE 171
Query: 182 VINR-RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWFA 236
VI + YD +KADIWS G+ +Y + G P+ D + I K+ K P N ++
Sbjct: 172 VITEGKYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYS 228
Query: 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETE 279
+R ++ LD P R+S +++++ W + P E
Sbjct: 229 KLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKE 271
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 2e-36
Identities = 69/259 (26%), Positives = 118/259 (45%), Gaps = 13/259 (5%)
Query: 13 ELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
ELG+ LG+G F +V+ T VA+K + + + ++ E S+M+ +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE--REEFLEEASIMKKLS 59
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCH 126
HPN+V L V +Y V EY+ GG+L F + KL + Q+ ++Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVINR 185
S+ HRDL N L+ E+ +K+SDFGLS P ++APE +
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-RKRGGGKLPIKWMAPESLKD 178
Query: 186 RGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLL 243
+ SK+D+WS GV+L+ + G P+ + E+ + P E+ L+
Sbjct: 179 GKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELM 237
Query: 244 SKILDPNPNTRISMTKIME 262
+ +P R + ++++E
Sbjct: 238 LQCWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 80/251 (31%), Positives = 139/251 (55%), Gaps = 14/251 (5%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVE 74
R++G+G++AKV KT A+K+I KE V ID ++ E V HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 75 LYEVMASKTKIYFVMEYVKGGEL-FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHR 133
L+ ++++++FV+E+V GG+L F + KL E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
DLK +N+LLD G++K++D+G+ E T CGTP Y+APE++ Y S
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMC--KEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS-V 177
Query: 194 DIWSCGVILYVLLAGYLPFH--------DSNLME-MYRKIGKAEFKFPNWFAPEVRRLLS 244
D W+ GV+++ ++AG PF D N + +++ I + + + P + + +L
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 245 KILDPNPNTRI 255
L+ +P R+
Sbjct: 238 GFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-36
Identities = 84/259 (32%), Positives = 144/259 (55%), Gaps = 12/259 (4%)
Query: 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVEL 75
+LG+G+F KV A T AIKI+ K+ V++ ++ E V+ L + P + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRD 134
+ + ++YFVMEYV GG+L ++ + G+ KE A Y ++ + + HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT-CGTPAYVAPEVINRRGYDGSKA 193
LK +N++LD G++K++DFG + + DG+ T CGTP Y+APE+I + Y G
Sbjct: 127 LKLDNVMLDSEGHIKIADFG---MCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSV 182
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253
D W+ GV+LY +LAG PF + E+++ I + +P + E + ++ +P
Sbjct: 183 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 242
Query: 254 RISM-----TKIMENSWFR 267
R+ I E+++FR
Sbjct: 243 RLGCGPEGERDIKEHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 79/263 (30%), Positives = 130/263 (49%), Gaps = 16/263 (6%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG+G F +V + TG A K +DK+++ K E ++ V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 78 VMASKTKIYFVMEYVKGGEL---FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRD 134
+K + VM + GG+L V + E A Y Q+I +++ H R + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKAD 194
LKPEN+LLD+HGN+++SD GL+ + + + GTP Y+APEV+ YD S D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYDFS-VD 176
Query: 195 IWSCGVILYVLLAGYLPFHDSNLM----EMYRKIGKAEFKFPNWFAPEVRRLLSKILDPN 250
++ G LY ++AG PF E+ R+ + ++P+ F+PE + L +L +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 251 PNTRI-----SMTKIMENSWFRK 268
P R+ S ++ E+ F+
Sbjct: 237 PEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 84/252 (33%), Positives = 143/252 (56%), Gaps = 16/252 (6%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVVE 74
R++G+G++AKV R KT A+K++ KE V ID ++ E V + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 75 LYEVMASKTKIYFVMEYVKGGEL-FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHR 133
L+ ++++++FV+EYV GG+L F + KL E+ AR Y ++ A++Y H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD-GSK 192
DLK +N+LLD G++K++D+G+ E T CGTP Y+APE++ RG D G
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEIL--RGEDYGFS 176
Query: 193 ADIWSCGVILYVLLAGYLPFH--------DSNLME-MYRKIGKAEFKFPNWFAPEVRRLL 243
D W+ GV+++ ++AG PF D N + +++ I + + + P + + +L
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236
Query: 244 SKILDPNPNTRI 255
L+ +P R+
Sbjct: 237 KSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 88/289 (30%), Positives = 144/289 (49%), Gaps = 52/289 (17%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
LG+GT+A V+ RN TG VA+K I D E+ G REIS+M+ ++H N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRL 63
Query: 76 YEVMASKTKIYFVMEYVKGG-----ELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGV 130
++V+ ++ K+ V EY+ + G +G L + + + QL+ + +CH V
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLS---ALAESKHQDGLLHTTCGTPAYVAPEVI-NRR 186
HRDLKP+NLL+++ G LK++DFGL+ + + + ++ T Y AP+V+ R
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-----TLWYRAPDVLLGSR 176
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSN----LMEMYRKIG--------------KAE 228
Y S DIWS G I+ ++ G F +N L++++R +G + +
Sbjct: 177 TYSTS-IDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235
Query: 229 FKFPNW-----------FAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266
FP + P LL ++L NP RIS +++ WF
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-35
Identities = 68/257 (26%), Positives = 124/257 (48%), Gaps = 8/257 (3%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+E+ +G+G+F V A+K ID K + ++ E V+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSSY 60
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK---LKEDAARKYFQQLISAVDYCHSR 128
++ YE K K+ VMEY + G+L + + L ED ++F Q++ + + HS+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY 188
+ HRD+K NL LD + N+K+ D G++ L +T GTP Y++PE+ + Y
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCEDKPY 178
Query: 189 DGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FPNWFAPEVRRLLSKIL 247
+ K+D+W+ GV+LY G PF +N + KI + F ++ ++ +L+ + L
Sbjct: 179 N-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237
Query: 248 DPNPNTRISMTKIMENS 264
+ R +++ N
Sbjct: 238 TKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-35
Identities = 79/258 (30%), Positives = 137/258 (53%), Gaps = 9/258 (3%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
+Y + R++G+G+F + +++ + A+K I K ++ ++E ++ ++HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVA--KGKL-KEDAARKYFQQLISAVDYCHS 127
N+V E + +Y VMEY GG+L K+ +GKL ED ++F Q+ V + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
+ V HRD+K +N+ L ++G +K+ DFG + L T GTP YV PE+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPPEIWENMP 176
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FPNWFAPEVRRLLSKI 246
Y+ +K+DIWS G ILY L PF ++ + K+ + +K P+ ++ E+R L+ ++
Sbjct: 177 YN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 247 LDPNPNTRISMTKIMENS 264
NP +R S T I+
Sbjct: 236 FKRNPRSRPSATTILSRG 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-35
Identities = 73/257 (28%), Positives = 132/257 (51%), Gaps = 8/257 (3%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
Y R+LG+G F + R + V K ++ ++ + D + EI ++ L++HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN-EIVILSLLQHP 59
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK---LKEDAARKYFQQLISAVDYCHS 127
N++ Y + MEY GG L+ K+ + K +E+ Y Q++SAV Y H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
G+ HRD+K N+ L + G +K+ DFG+S + S++ + T GTP Y++PE+
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVK 177
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FPNWFAPEVRRLLSKI 246
Y+ K+DIW+ G +LY LL F +N + + KI + + + ++ E+ L+ +
Sbjct: 178 YN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236
Query: 247 LDPNPNTRISMTKIMEN 263
L +P R + ++++
Sbjct: 237 LQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-34
Identities = 80/261 (30%), Positives = 141/261 (54%), Gaps = 12/261 (4%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+ + + + +G+G F++V+ A L G+ VA+K + ++ +EI +++ +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK-----LKEDAARKYFQQLISAVD 123
HPNV++ Y ++ V+E G+L + K + E KYF QL SA++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
+ HSR V HRD+KP N+ + G +K+ D GL SK H+ GTP Y++PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERI 178
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDS--NLMEMYRKIGKAEF-KFP-NWFAPEV 239
+ GY+ K+DIWS G +LY + A PF+ NL + +KI + ++ P + ++ E+
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237
Query: 240 RRLLSKILDPNPNTRISMTKI 260
R+L++ ++P+P R +T +
Sbjct: 238 RQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 3e-34
Identities = 102/355 (28%), Positives = 149/355 (41%), Gaps = 65/355 (18%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
+ LG G F +V AR + T A+K + K+ VL + +K E ++ + VV L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRD 134
Y K +YFVM+Y+ GG++ + + G ED AR Y +L AV+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 135 LKPENLLLDEHGNLKVSDFGLSA------------------------------------- 157
+KP+N+L+D G++K++DFGL
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 158 --------LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGY 209
A +HQ L H+ GTP Y+APEV+ R GY D WS GVILY +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 210 LPFHDSNLMEMYRKIGK--AEFKFPNW--FAPEVRRLLSKI-------LDPNPNTRISMT 258
PF +E K+ P +PE L+ K+ L N I
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAH 305
Query: 259 KIMENSWFRKGLVK------PSISE-TEEKEWAPVDADAVFSPSGSTSTVAESKN 306
+ F L + P I+ T+ + PVD D ++S V ++ N
Sbjct: 306 PFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDTLN 360
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-34
Identities = 83/267 (31%), Positives = 140/267 (52%), Gaps = 17/267 (6%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+GQG V+ A ++ TG VAIK ++ ++ K +I EI VMR +HPN+V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI---INEILVMRENKHPNIVNYLD 83
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKP 137
+++ VMEY+ GG L V + + E ++ + A+++ HS V HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKS 143
Query: 138 ENLLLDEHGNLKVSDFGLSAL---AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKAD 194
+N+LL G++K++DFG A +SK T GTP ++APEV+ R+ Y G K D
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQSKRS-----TMVGTPYWMAPEVVTRKAY-GPKVD 197
Query: 195 IWSCGVILYVLLAGYLPFHDSNLMEMYRKI---GKAEFKFPNWFAPEVRRLLSKILDPNP 251
IWS G++ ++ G P+ + N + I G E + P + R L++ L+ +
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 257
Query: 252 NTRISMTKIMENSWFRKGLVKPSISET 278
R S +++++ + + + KP S T
Sbjct: 258 EKRGSAKELLQHPFLK--IAKPLSSLT 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 6e-34
Identities = 84/305 (27%), Positives = 137/305 (44%), Gaps = 55/305 (18%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
+++G+G F +V + TG A+K + K ++ K + +K E V+ P VV L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAKGKL-KEDAARKYFQQLISAVDYCHSRGVCHRD 134
Y +Y +ME++ GG+L + K ED R Y + + A++ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDG---------------------------- 166
+KP+N+L+D G++K+SDFGLS +H
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 167 -----------------LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGY 209
+ ++T GTP Y+APE+ ++GY G + D WS G I++ L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 210 LPFHDSNLMEMYRKI--GKAEFKFPN--WFAPEVRRLLSKILDPNPNTRI---SMTKIME 262
PF N E YRKI + FP+ + E L+ +++ N R+ +I
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304
Query: 263 NSWFR 267
+ +FR
Sbjct: 305 HPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 8e-34
Identities = 81/267 (30%), Positives = 145/267 (54%), Gaps = 18/267 (6%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVVE 74
R++G+G++AKV R K A+K++ KE V ID ++ E V + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 75 LYEVMASKTKIYFVMEYVKGGEL-FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHR 133
L+ + ++++ V+EYV GG+L F + KL E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
DLK +N+LLD G++K++D+G+ E T CGTP Y+APE++ Y G
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMC--KEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 194 DIWSCGVILYVLLAGYLPFH------DSNLME-MYRKIGKAEFKFPNWFAPEVRRLLSKI 246
D W+ GV+++ ++AG PF D N + +++ I + + P + + + +L
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 247 LDPNPNTRI------SMTKIMENSWFR 267
L+ +P R+ + I +++FR
Sbjct: 238 LNKDPKERLGCQPQTGFSDIKSHTFFR 264
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 88/282 (31%), Positives = 136/282 (48%), Gaps = 38/282 (13%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
+G+GT+ V+ ARN TG VA+K I D E G+ REIS+++ + HPN+V+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKL 64
Query: 76 YEVMASKTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHR 133
+V+ ++ K+Y V E++ + + + Y QL+ + +CHS V HR
Sbjct: 65 LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
DLKP+NLL++ G +K++DFGL A A H T Y APE++ Y +
Sbjct: 125 DLKPQNLLINTEGAIKLADFGL-ARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAV 182
Query: 194 DIWSCGVILYVLLAGYLPF-HDS---NLMEMYRKIGK------------AEFK--FPNW- 234
DIWS G I ++ F DS L ++R +G ++K FP W
Sbjct: 183 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWA 242
Query: 235 ----------FAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266
+ R LLS++L +PN RIS + + +F
Sbjct: 243 RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 19/262 (7%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG G V + TG +A+K I E + + QI RE+ ++ P +V Y
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 78 VMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHS-RGVCHRD 134
+ I MEY+ GG L K +G++ E K ++ + Y H + HRD
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRD 126
Query: 135 LKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA 193
+KP N+L++ G +K+ DFG+S L S + T GT +Y+APE I Y K+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-----TFVGTSSYMAPERIQGNDY-SVKS 180
Query: 194 DIWSCGVILYVLLAGYLPFHDSN-----LMEMYRKIGKAEF-KFPN-WFAPEVRRLLSKI 246
DIWS G+ L L G P+ N + E+ + I + P+ F+P+ + ++
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLC 240
Query: 247 LDPNPNTRISMTKIMENSWFRK 268
L +P R S +++E+ + +K
Sbjct: 241 LIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 84/267 (31%), Positives = 129/267 (48%), Gaps = 47/267 (17%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+E +++G+G F +V + TG A+KI+ K +L+ + I+ E ++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCHSRGV 130
VV+++ K +Y +ME++ GG++ + K L E+A + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGL---------------------------------SA 157
HRD+KP+NLLLD G++K+SDFGL A
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 158 LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL 217
K++ L ++T GTP Y+APEV + GY+ D WS GVI+Y +L GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 218 MEMYRKIGKAEFKFPNW-----FAPEV 239
E YRK+ NW F PEV
Sbjct: 242 QETYRKV-------MNWKETLVFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 86/266 (32%), Positives = 140/266 (52%), Gaps = 26/266 (9%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIID--KEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
LG G F KV+ A+N +TG A K+I+ E+ L+ M+ EI ++ HP +V+L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-----EIEILATCNHPYIVKL 74
Query: 76 YEVMASKTKIYFVMEYVKGGELFG---KVAKGKLKEDAARKYFQQLISAVDYCHSRGVCH 132
K++ ++E+ GG + ++ +G L E + +Q++ A+ Y HS + H
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSA--LAESKHQDGLLHTTCGTPAYVAPEVI-----NR 185
RDLK N+LL G++K++DFG+SA + + +D + GTP ++APEV+
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCETMKD 189
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRRL 242
YD KADIWS G+ L + P H+ N M + KI K+E P+ ++ E R
Sbjct: 190 TPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248
Query: 243 LSKILDPNPNTRISMTKIMENSWFRK 268
L LD +P TR S +++E+ +
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-33
Identities = 79/255 (30%), Positives = 137/255 (53%), Gaps = 12/255 (4%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+ +++ + +G+G F++V+ A L VA+K + +++ +EI +++ +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGEL-----FGKVAKGKLKEDAARKYFQQLISAVD 123
HPNV++ + ++ V+E G+L + K K + E KYF QL SAV+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
+ HSR V HRD+KP N+ + G +K+ D GL SK H+ GTP Y++PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERI 178
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDS--NLMEMYRKIGKAEF-KFPN-WFAPEV 239
+ GY+ K+DIWS G +LY + A PF+ NL + +KI + ++ P ++ ++
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 240 RRLLSKILDPNPNTR 254
R L+S + P+P+ R
Sbjct: 238 RELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 83/311 (26%), Positives = 133/311 (42%), Gaps = 70/311 (22%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQ-------IKREISV 63
RYEL + +G G + V A + +TG VAIK K+ + I REI +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--------KISNVFDDLIDAKRILREIKL 52
Query: 64 MRLVRHPNVVELYEVMASKTK-----IYFVMEYVKGGELFGKV--AKGKLKEDAARKYFQ 116
+R +RH N++ L +++ + +Y V E +L KV + L +D + +
Sbjct: 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METDL-HKVIKSPQPLTDDHIQYFLY 110
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
Q++ + Y HS V HRDLKP N+L++ + +LK+ DFGL+ + + T
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT-----E 165
Query: 177 YV------APEVI-NRRGYDGSKADIWSCGVILYVLLAG--YLPFHDS----NL------ 217
YV APE++ + Y + DIWS G I LL P D NL
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224
Query: 218 ---MEMYRKIGKAEFK-----------------FPNWFAPEVRRLLSKILDPNPNTRISM 257
E + I + + FP +PE LL K+L +P RI+
Sbjct: 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITA 283
Query: 258 TKIMENSWFRK 268
+ + + + +
Sbjct: 284 DEALAHPYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 79/259 (30%), Positives = 148/259 (57%), Gaps = 20/259 (7%)
Query: 12 YELGRLLGQGTFAKVHYARNLK---TGMSVAIKIIDKEKVL-KVGMIDQIKREISVMRLV 67
+EL ++LG G + KV R + +G A+K++ K ++ K + + E V+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 68 RH-PNVVELYEVMASKTKIYFVMEYVKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYC 125
R P +V L+ + TK++ +++Y+ GGELF ++ + + KE + Y +++ A+++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL--LHTTCGTPAYVAPEVI 183
H G+ +RD+K EN+LLD +G++ ++DFGLS + H+D + ++ CGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLS---KEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 184 NRRGYDG---SKADIWSCGVILYVLLAGYLPF----HDSNLMEMYRKIGKAEFKFPNWFA 236
RG DG D WS GV++Y LL G PF ++ E+ R+I K+E +P +
Sbjct: 179 --RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 236
Query: 237 PEVRRLLSKILDPNPNTRI 255
+ ++ ++L +P R+
Sbjct: 237 ALAKDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 67/263 (25%), Positives = 114/263 (43%), Gaps = 24/263 (9%)
Query: 16 RLLGQGTFAKVHYAR---NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV 72
+ LG+G F +V+ + VA+K + ++ + +E VM+ + HPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNV 58
Query: 73 VELYEVMASKTKIYFVMEYVKGGEL----------FGKVAKGKLKEDAARKYFQQLISAV 122
V L V + +Y V+EY++GG+L F K L + Q+ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV---A 179
+Y S+ HRDL N L+ E +K+SDFGLS D G + A
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD---DDYYRKKTGGKLPIRWMA 175
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEF-KFPNWFAP 237
PE + + SK+D+WS GV+L+ + G P+ + E+ + K P +
Sbjct: 176 PESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234
Query: 238 EVRRLLSKILDPNPNTRISMTKI 260
E+ L+ +P R + +++
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 77/266 (28%), Positives = 136/266 (51%), Gaps = 21/266 (7%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMS-VAIKIID-------KEKVLKVGMIDQIKREISV 63
Y + LG G F V+ R G + +A+K I+ K+K + I I E+++
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 64 MR-LVRHPNVVELYEVMASKTKIYFVMEYVKG---GELFG--KVAKGKLKEDAARKYFQQ 117
++ +RHPN+V Y+ ++Y VM+ ++G GE F K K + E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 118 LISAVDYCH-SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
++ A+ Y H + + HRDL P N++L E + ++DFGL A+ K + L + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL---AKQKQPESKLTSVVGTIL 178
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN--W 234
Y PE++ Y G KAD+W+ G ILY + PF+ +N++ + KI +A ++
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 235 FAPEVRRLLSKILDPNPNTRISMTKI 260
++ +V +++ L P+ R + ++
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 9e-33
Identities = 81/269 (30%), Positives = 127/269 (47%), Gaps = 47/269 (17%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ +E +++G+G F +V + TG A+KI+ K +L+ + I+ E ++
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCHSR 128
VV+++ K +Y +ME++ GG++ + K L E+ + Y + + A+D H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD----------------------- 165
G HRD+KP+NLLLD G++K+SDFGL + H+
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 166 ----------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS 215
L +T GTP Y+APEV + GY+ D WS GVI+Y +L GY PF
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 216 NLMEMYRKIGKAEFKFPNW-----FAPEV 239
E Y+K+ NW F PEV
Sbjct: 240 TPQETYKKV-------MNWKETLIFPPEV 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 80/233 (34%), Positives = 132/233 (56%), Gaps = 17/233 (7%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+E+ +++G+G F +V + TG A+KI++K ++LK + E V LV
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV--LVNGDR 60
Query: 72 --VVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHS 127
+ L+ + +Y VM+Y GG+L ++K +L ED AR Y +++ A+D H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT--CGTPAYVAPEVI-- 183
G HRD+KP+N+LLD++G+++++DFG S L DG + + GTP Y++PE++
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLA--DGTVQSNVAVGTPDYISPEILQA 177
Query: 184 --NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI--GKAEFKFP 232
+ +G G + D WS GV +Y +L G PF+ +L+E Y KI K F+FP
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 91/282 (32%), Positives = 143/282 (50%), Gaps = 37/282 (13%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+G+GT+ V+ RN KTG VA+K I E + G+ REIS+++ ++HPN+V L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLE-SEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 78 VMASKTKIYFVMEYVKGG--ELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHRD 134
V+ ++++Y + E++ + + KG+ + + + Y Q++ + +CHSR V HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKAD 194
LKP+NLL+D G +K++DFGL A A H T Y APEV+ + D
Sbjct: 127 LKPQNLLIDNKGVIKLADFGL-ARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTPVD 184
Query: 195 IWSCGVILYVLLAGYLP-FH-DS---NLMEMYRKIGKA------------EFK--FPNWF 235
IWS G I + +A P FH DS L ++R +G ++K FP W
Sbjct: 185 IWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWK 243
Query: 236 APEVRR-----------LLSKILDPNPNTRISMTKIMENSWF 266
+R LL K+L +P RIS K + + +F
Sbjct: 244 KGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 4e-32
Identities = 83/272 (30%), Positives = 143/272 (52%), Gaps = 11/272 (4%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
++Y +GQG V+ A ++ TG VAIK ++ ++ K +I EI VMR ++
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI---INEILVMRENKN 75
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
PN+V + +++ VMEY+ GG L V + + E ++ + A+D+ HS
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD 189
V HRD+K +N+LL G++K++DFG A+ + T GTP ++APEV+ R+ Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 190 GSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI---GKAEFKFPNWFAPEVRRLLSKI 246
G K DIWS G++ ++ G P+ + N + I G E + P + R L++
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252
Query: 247 LDPNPNTRISMTKIMENSWFRKGLVKPSISET 278
L+ + + R S +++++ + + L KP S T
Sbjct: 253 LEMDVDRRGSAKELLQHPFLK--LAKPLSSLT 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 83/288 (28%), Positives = 125/288 (43%), Gaps = 65/288 (22%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
+ LG G F +V A + T A+K + K+ VL + +K E ++ + VV+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRD 134
Y K +YFVM+Y+ GG++ + + E AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 135 LKPENLLLDEHGNLKVSDFGLSA------------------------------------- 157
+KP+N+L+D G++K++DFGL
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 158 --------LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGY 209
A +HQ L H+ GTP Y+APEV+ R+GY D WS GVIL+ +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 210 LPFHDSNLMEMYRKIGKAEFKFPNW-----------FAPEVRRLLSKI 246
PF E + K NW +PE L++K+
Sbjct: 246 PPFLAPTPTE-------TQLKVINWENTLHIPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 76/232 (32%), Positives = 131/232 (56%), Gaps = 13/232 (5%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+E+ +++G+G F +V + T A+KI++K ++LK + E +V+
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRG 129
+ L+ + +Y VM+Y GG+L ++K +L ED AR Y +++ A+ H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT--CGTPAYVAPEVI---- 183
HRD+KP+N+LLD +G+++++DFG S L +QDG + ++ GTP Y++PE++
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCL--KMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPN 233
+ G G + D WS GV +Y +L G PF+ +L+E Y KI E F+FP+
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPS 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 74/233 (31%), Positives = 131/233 (56%), Gaps = 13/233 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ +E+ +++G+G F +V + A+KI++K ++LK + E V+ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHS 127
+ L+ + +Y VM+Y GG+L ++K +L ED AR Y +++ A+D H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT--CGTPAYVAPEVI-- 183
HRD+KP+N+L+D +G+++++DFG S L +DG + ++ GTP Y++PE++
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 184 --NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI--GKAEFKFP 232
+ +G G + D WS GV +Y +L G PF+ +L+E Y KI K F+FP
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 9e-32
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIK---IIDKEKVLKVGMIDQIKREISVMRLVR 68
YE +G+G + V+ AR+L TG VA+K + E+ + + + REI++++ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL----REIALLKQLE 56
Query: 69 ---HPNVVELYEV-----MASKTKIYFVMEYVKG--GELFGKVAKGKLKEDAARKYFQQL 118
HPN+V L +V + K+ V E+V K K L + + +QL
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
+ VD+ HS + HRDLKP+N+L+ G +K++DFGL+ + + L + T Y
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF---EMALTSVVVTLWYR 173
Query: 179 APEVINRRGYDGSKADIWSCGVILYVL 205
APEV+ + Y + D+WS G I L
Sbjct: 174 APEVLLQSSY-ATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-31
Identities = 75/218 (34%), Positives = 119/218 (54%), Gaps = 9/218 (4%)
Query: 15 GRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRLVRHPNV 72
G+LLGQG F +V+ ++ TG +A K + D E + ++ EI +++ ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 73 VELYEVM---ASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCHSR 128
V+ Y + A KT F MEY+ GG + ++ A G L E RKY +Q++ + Y HS
Sbjct: 67 VQYYGCLRDRAEKTLTIF-MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL-LHTTCGTPAYVAPEVINRRG 187
+ HRD+K N+L D GN+K+ DFG S ++ G + + GTP +++PEVI+ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG 225
Y G KAD+WS G + +L P+ + M KI
Sbjct: 186 Y-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-31
Identities = 75/244 (30%), Positives = 128/244 (52%), Gaps = 9/244 (3%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRLVRH 69
+ LG+LLG+G F +V+ + TG +A+K + D + ++ ++ EI +++ +RH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 70 PNVVELYEVMASKT--KIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCH 126
+V+ Y + K+ +EY+ GG + ++ A G L E+ R+Y +Q++ V Y H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL-LHTTCGTPAYVAPEVINR 185
S + HRD+K N+L D GN+K+ DFG S ++ G + + GTP +++PEVI+
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK--FPNWFAPEVRRLL 243
GY G KAD+WS + +L P+ + M KI K P+ + R L
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL 242
Query: 244 SKIL 247
+I
Sbjct: 243 KQIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 83/272 (30%), Positives = 143/272 (52%), Gaps = 11/272 (4%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
++Y +GQG V A ++ TG VAIK I+ +K K +I EI VM+ +++
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI---INEILVMKELKN 75
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
PN+V + +++ VMEY+ GG L V + + E ++ + A+++ H+
Sbjct: 76 PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD 189
V HRD+K +N+LL G++K++DFG A+ + T GTP ++APEV+ R+ Y
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 190 GSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI---GKAEFKFPNWFAPEVRRLLSKI 246
G K DIWS G++ ++ G P+ + N + I G E + P +P R L++
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252
Query: 247 LDPNPNTRISMTKIMENSWFRKGLVKPSISET 278
L+ + R S +++++ + + L KP S T
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK--LAKPLSSLT 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 83/292 (28%), Positives = 137/292 (46%), Gaps = 59/292 (20%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK--REISVMRLVR-HPNVVE 74
+G+GTF++V A++ KTG AIK + K ++Q+ REI +R + HPN++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 75 LYEVMASKT--KIYFVME--------YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDY 124
L EV+ + ++ V E +KG K L E + Y QL+ ++D+
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELIKG-------RKRPLPEKRVKSYMYQLLKSLDH 115
Query: 125 CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT-CGTPAYVAPEVI 183
H G+ HRD+KPEN+L+ + LK++DFG SK +T T Y APE +
Sbjct: 116 MHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP----YTEYISTRWYRAPECL 170
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPF------------HD------SNLMEMYRKIG 225
GY G K DIW+ G + + +L+ + F HD + +++ +RK
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230
Query: 226 KAEFKFPN----WFA-------PEVRRLLSKILDPNPNTRISMTKIMENSWF 266
+ FP+ E LL K+L +P+ RI+ + + + +F
Sbjct: 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 78/252 (30%), Positives = 139/252 (55%), Gaps = 9/252 (3%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+G+G+ V AR +G VA+K++D K + ++ E+ +MR +H NVVE+Y+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN---EVVIMRDYQHQNVVEMYK 85
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKP 137
+++ +ME+++GG L V++ +L E+ + ++ A+ Y HS+GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 138 ENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWS 197
+++LL G +K+SDFG A+ + GTP ++APEVI+R Y G++ DIWS
Sbjct: 146 DSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWS 202
Query: 198 CGVILYVLLAGYLP-FHDSNLMEMYRKIGKAEFKFPNW--FAPEVRRLLSKILDPNPNTR 254
G+++ ++ G P F DS + M R K N +P +R L ++L P R
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER 262
Query: 255 ISMTKIMENSWF 266
+ +++++ +
Sbjct: 263 ATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 82/261 (31%), Positives = 137/261 (52%), Gaps = 12/261 (4%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+G+G+F +V + +T VAIKIID E+ I+ I++EI+V+ P V + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKP 137
TK++ +MEY+ GG + G E ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKA 129
Query: 138 ENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIW 196
N+LL E G++K++DFG++ L +++ + +T GTP ++APEVI + YD SKADIW
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKR---NTFVGTPFWMAPEVIQQSAYD-SKADIW 185
Query: 197 SCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNW---FAPEVRRLLSKILDPNPNT 253
S G+ L G P D + M + I K P F+ + + L+ +P+
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNPPTLTGEFSKPFKEFIDACLNKDPSF 243
Query: 254 RISMTKIMENSWFRKGLVKPS 274
R + +++++ + K K S
Sbjct: 244 RPTAKELLKHKFIVKNAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 78/263 (29%), Positives = 141/263 (53%), Gaps = 16/263 (6%)
Query: 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV-LKVGMIDQIKREI--SVMRLVRHPNVV 73
++G+G F +V+ R TG A+K +DK+++ +K G + I S++ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 74 ELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCH 132
+ + K+ F+++ + GG+L +++ G E R Y ++I +++ H+R V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSK 192
RDLKP N+LLDEHG++++SD GL+ K H + GT Y+APEV+ + S
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSS 176
Query: 193 ADIWSCGVILYVLLAGYLPFHD---SNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDP 249
AD +S G +L+ LL G+ PF + E+ R + P+ F+PE++ LL +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236
Query: 250 NPNTRI-----SMTKIMENSWFR 267
+ + R+ ++ E+ +F+
Sbjct: 237 DVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 75/270 (27%), Positives = 135/270 (50%), Gaps = 23/270 (8%)
Query: 15 GRLLGQGTFAKVHYARNLKTGMSVAIKII--------DKEKVLKVGMIDQIKREISVMRL 66
G+ LG G F+ + AR++KTG +A+K + ++E+V ++ +++EI +M
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEV-----VEALRKEIRLMAR 59
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYC 125
+ HP+++ + + +E++ GG + ++K G KE Y +QL+ + Y
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYL 119
Query: 126 HSRGVCHRDLKPENLLLDEHGN-LKVSDFGLSA-LAESKHQDGLLH-TTCGTPAYVAPEV 182
H + HRD+K NLL+D G L+++DFG +A LA G GT A++APEV
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 183 INRRGYDGSKADIWSCGVILYVLLAGYLPFHD---SNLMEMYRKIGKAEF--KFPNWFAP 237
+ Y G D+WS G ++ + P++ SN + + KI A P +P
Sbjct: 180 LRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 238 EVRRLLSKILDPNPNTRISMTKIMENSWFR 267
+R + + L+ P R +++++ FR
Sbjct: 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-31
Identities = 82/270 (30%), Positives = 136/270 (50%), Gaps = 24/270 (8%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKR----EISVMR 65
++Y + R+LG G V A+ + G A+K++D E GM + K E+ +
Sbjct: 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDME-----GMSEADKNRAQAEVCCLL 86
Query: 66 LVRHPNVVELYEVMASKTK--------IYFVMEYVKGGELFGKV-----AKGKLKEDAAR 112
++V+ +E A K I V++Y G+L ++ +E A
Sbjct: 87 NCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG 146
Query: 113 KYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC 172
F Q++ AV + HS+ + HRD+K N+LL +G +K+ DFG S + + D + T C
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-F 231
GTP YVAPE+ R+ Y KAD++S GV+LY LL PF N+ E+ K +
Sbjct: 207 GTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265
Query: 232 PNWFAPEVRRLLSKILDPNPNTRISMTKIM 261
P +PE++ +++ +L +P R S +K++
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 84/270 (31%), Positives = 143/270 (52%), Gaps = 24/270 (8%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIID--KEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
LG G F KV+ A+N +TG+ A K+ID E+ L+ M+ EI ++ HPN+V+L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV-----EIDILASCDHPNIVKL 67
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAKGK--LKEDAARKYFQQLISAVDYCHSRGVCHR 133
+ + ++ ++E+ GG + + + + L E R +Q + A++Y H + HR
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHR 127
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAES--KHQDGLLHTTCGTPAYVAPEVI-----NRR 186
DLK N+L G++K++DFG+SA + +D + GTP ++APEV+ R
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKDR 183
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRRLL 243
YD KAD+WS G+ L + P H+ N M + KI K+E P+ ++ E + L
Sbjct: 184 PYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242
Query: 244 SKILDPNPNTRISMTKIMENSWFRKGLVKP 273
K L+ N + R + T+++++ + KP
Sbjct: 243 KKCLEKNVDARWTTTQLLQHPFVTVNSNKP 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 82/275 (29%), Positives = 142/275 (51%), Gaps = 17/275 (6%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
++Y +GQG V+ A ++ TG VAI+ ++ ++ K +I EI VMR ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKN 76
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
PN+V + +++ VMEY+ GG L V + + E ++ + A+++ HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSAL---AESKHQDGLLHTTCGTPAYVAPEVINRR 186
V HRD+K +N+LL G++K++DFG A +SK GTP ++APEV+ R+
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-----MVGTPYWMAPEVVTRK 191
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI---GKAEFKFPNWFAPEVRRLL 243
Y G K DIWS G++ ++ G P+ + N + I G E + P + R L
Sbjct: 192 AY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250
Query: 244 SKILDPNPNTRISMTKIMENSWFRKGLVKPSISET 278
++ LD + R S +++++ + + + KP S T
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLK--IAKPLSSLT 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 76/244 (31%), Positives = 126/244 (51%), Gaps = 9/244 (3%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRLVRH 69
+ LG+LLGQG F +V+ + TG +A+K + D E ++ ++ EI +++ + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 70 PNVVELYEVM--ASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCH 126
+V+ Y + + + ME++ GG + ++ + G L E+ RKY +Q++ V Y H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL-LHTTCGTPAYVAPEVINR 185
S + HRD+K N+L D GN+K+ DFG S ++ G + + GTP +++PEVI+
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK--AEFKFPNWFAPEVRRLL 243
GY G KADIWS G + +L P+ + M KI P + R L
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 244 SKIL 247
+I
Sbjct: 243 KRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 83/264 (31%), Positives = 143/264 (54%), Gaps = 18/264 (6%)
Query: 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV-LKVGMIDQIKREI--SVMRLVRHPNVV 73
++G+G F +V+ R TG A+K +DK+++ +K G + I S++ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 74 ELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCH 132
+ + K+ F+++ + GG+L +++ G E R Y ++I +++ H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR-RGYDGS 191
RDLKP N+LLDEHG++++SD GL+ K H + GT Y+APEV+ + YD S
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYD-S 175
Query: 192 KADIWSCGVILYVLLAGYLPFH---DSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248
AD +S G +L+ LL G+ PF + E+ R + P+ F+PE+R LL +L
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235
Query: 249 PNPNTRI-----SMTKIMENSWFR 267
+ N R+ ++ E+ +FR
Sbjct: 236 RDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-30
Identities = 79/259 (30%), Positives = 136/259 (52%), Gaps = 8/259 (3%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+G+G+F +V + +T VAIKIID E+ I+ I++EI+V+ P V + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKP 137
TK++ +MEY+ GG + G L E ++++ +DY HS HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKA 129
Query: 138 ENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIW 196
N+LL EHG +K++DFG++ L +++ + GTP ++APEVI + YD SKADIW
Sbjct: 130 ANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF---VGTPFWMAPEVIKQSAYD-SKADIW 185
Query: 197 SCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRI 255
S G+ L G P + + M++ I K ++ ++ + L+ P+ R
Sbjct: 186 SLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245
Query: 256 SMTKIMENSWFRKGLVKPS 274
+ +++++ + + K S
Sbjct: 246 TAKELLKHKFIVRFAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 76/263 (28%), Positives = 132/263 (50%), Gaps = 12/263 (4%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV--LKVGMIDQIKREISVMRLVR 68
RY L + LG+G+F V+ ++ K +K++ + V L Q +E ++ +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGKV-----AKGKLKEDAARKYFQQLISAVD 123
HP +V+ + + + EY +G +L K+ L E+ ++F QL+ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
Y H R + HRDLK +N+ L ++ LK+ DFG+S L L T GTP Y++PE +
Sbjct: 121 YMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEAL 177
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRL 242
+GYD SK+DIWS G ILY + F N + + +I + P ++ ++ +
Sbjct: 178 KHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236
Query: 243 LSKILDPNPNTRISMTKIMENSW 265
+ +L+ +P+ R S +I+ N +
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 8e-30
Identities = 84/290 (28%), Positives = 132/290 (45%), Gaps = 43/290 (14%)
Query: 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVV 73
L R+ G+GT+ V+ AR+ +G VA+K + + + G+ REI+++ +RHPN+V
Sbjct: 12 LNRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIV 69
Query: 74 ELYEVMASK--TKIYFVMEYVKG--GELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
EL EV+ K I+ VMEY + L + E + QL+ + Y H
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF 128
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI-NRRGY 188
+ HRDLK NLLL + G LK++DFGL+ + T Y APE++ Y
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYG--LPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 189 DGSKADIWSCGVILYVLLAG--YLP----FHDSNLM------------------EMYRKI 224
+ D+W+ G IL LLA LP +L+ + K
Sbjct: 187 TTA-IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245
Query: 225 -------GKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267
+ KFP W + RLL+ +L +P R + + +E+S+F+
Sbjct: 246 TLPKQPYNNLKHKFP-WLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 87/299 (29%), Positives = 135/299 (45%), Gaps = 51/299 (17%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKI----IDKEKVLKVGMIDQIKREISVMRLV 67
YE +G+GT+ KV+ AR+ TG VA+K +D+E + + REIS+++++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL-----REISLLQML 57
Query: 68 RH-PNVVELYEVMASKTK-----IYFVMEYV-----KGGELFGKVAKGKLKEDAARKYFQ 116
+V L +V + K +Y V EY+ K + G+ L + +
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLDEHGN-LKVSDFGLSALAESKHQDGLLHTTCGTP 175
QL+ V +CH GV HRDLKP+NLL+D+ LK++D GL A S H T
Sbjct: 118 QLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIV-TL 175
Query: 176 AYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPF-HDS---NLMEMYRKIG------ 225
Y APEV+ + + DIWS G I + F DS L+ +++ +G
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235
Query: 226 -------KAEFKFPNW-----------FAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266
+ +FP W +PE LL K+L +P RIS + + +F
Sbjct: 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 73/209 (34%), Positives = 113/209 (54%), Gaps = 21/209 (10%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKII---DKEKVLKVGMIDQIKREISVMRLVRH 69
E +G G V+ + TG A+K+I ++ V + QI REI ++R V H
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR-----QICREIEILRDVNH 131
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFG-KVAKGKLKEDAARKYFQQLISAVDYCHSR 128
PNVV+ +++ +I ++E++ GG L G +A + D AR Q++S + Y H R
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRR 187
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLS-ALAESKHQDGLLHTTCGTPAYVAPEVI---- 183
+ HRD+KP NLL++ N+K++DFG+S LA++ +++ GT AY++PE I
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINTDL 244
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPF 212
N YDG DIWS GV + G PF
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 87/291 (29%), Positives = 131/291 (45%), Gaps = 56/291 (19%)
Query: 20 QGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVM 79
+GT+ V+ AR+ KTG VA+K + EK + I + REI+++ ++HPN+V + EV+
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL-REINILLKLQHPNIVTVKEVV 73
Query: 80 ASKT--KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ--------QLISAVDYCHSRG 129
KIY VMEYV+ +L K L E + + Q QL+S V + H
Sbjct: 74 VGSNLDKIYMVMEYVEH-DL-----KS-LMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW 126
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG--TPAYVAPEVINRRG 187
+ HRDLK NLLL+ G LK+ DFGL+ ++ L T T Y APE++
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFGLA----REYGSPLKPYTQLVVTLWYRAPELLLGAK 182
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA----------EF-------- 229
+ D+WS G I LL F + ++ KI K F
Sbjct: 183 EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242
Query: 230 -------------KFPNWFAPEVR-RLLSKILDPNPNTRISMTKIMENSWF 266
KFP + LL+++L +P RIS +++ +F
Sbjct: 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 73/210 (34%), Positives = 117/210 (55%), Gaps = 7/210 (3%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+G+G+F +V+ + +T VAIKIID E+ I+ I++EI+V+ P + Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYITRYYG 69
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKP 137
TK++ +MEY+ GG + G L+E ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKA 129
Query: 138 ENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIW 196
N+LL E G++K++DFG++ L +++ + +T GTP ++APEVI + YD KADIW
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKR---NTFVGTPFWMAPEVIKQSAYD-FKADIW 185
Query: 197 SCGVILYVLLAGYLPFHDSNLMEMYRKIGK 226
S G+ L G P D + M + I K
Sbjct: 186 SLGITAIELAKGEPPNSDLHPMRVLFLIPK 215
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 84/298 (28%), Positives = 141/298 (47%), Gaps = 53/298 (17%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII----DKEKVLKVGMIDQIKREISVMR 65
++YE L+G+G++ V ++ +TG VAIK D + V K+ M REI +++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-----REIRMLK 55
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKG---GELFGKVAKGKLKEDAARKYFQQLISAV 122
+RH N+V L EV K ++Y V E+V +L + L E RKY Q++ +
Sbjct: 56 QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVRKYLFQILRGI 113
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT-CGTPAYVAPE 181
++CHS + HRD+KPEN+L+ + G +K+ DFG A + G ++T T Y APE
Sbjct: 114 EFCHSHNIIHRDIKPENILVSQSGVVKLCDFG---FARTLAAPGEVYTDYVATRWYRAPE 170
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAG--YLPFHDSNLMEMYRKIGK------------- 226
++ G DIW+ G ++ +L G P DS++ ++Y I
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYHIIKCLGNLIPRHQEIFQ 229
Query: 227 ------------------AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266
E +FP + V L + L +P+ R S ++++ + +F
Sbjct: 230 KNPLFAGMRLPEVKEIEPLEKRFPKL-SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 82/304 (26%), Positives = 132/304 (43%), Gaps = 68/304 (22%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKII----DKEKVLKVGMIDQIKREISVMRL 66
+YE +G+GT+ V A+N +T VA+K + D E V + REI +++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----REICLLKE 55
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGG-ELFGKVAKGKLKEDAARKYFQQLISAVDYC 125
++H N+V LY+V+ S K+ V EY + + G + + + + QL+ + +C
Sbjct: 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA--------- 176
HS V HRDLKP+NLL++++G LK++DFGL+ G P
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLA-------------RAFGIPVRCYSAEVVT 162
Query: 177 --YVAPEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFH-----DSNLMEMYRKIGK-- 226
Y P+V+ + Y S D+WS G I L P D L ++R +G
Sbjct: 163 LWYRPPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 221
Query: 227 ----------AEFKF--------------PNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
++K P R LL +L NP RIS + ++
Sbjct: 222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLN-STGRDLLQNLLVCNPVQRISAEEALQ 280
Query: 263 NSWF 266
+ +F
Sbjct: 281 HPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 91/294 (30%), Positives = 144/294 (48%), Gaps = 41/294 (13%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
M +YE +G+GT+ V+ AR+ T ++A+K I E+ + G+ REIS+++ ++
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQ 59
Query: 69 HPNVVELYEVMASKTKIYFVMEYV-----KGGELFGKVAKGKLKEDAARKYFQQLISAVD 123
H N+V L +V+ S+ ++Y V EY+ K + AK + Y Q++ +
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAK---NPRLIKTYLYQILRGIA 116
Query: 124 YCHSRGVCHRDLKPENLLLDEHGN-LKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV 182
YCHS V HRDLKP+NLL+D N LK++DFGL A A H T Y APE+
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGL-ARAFGIPVRTFTHEVV-TLWYRAPEI 174
Query: 183 INRRGYDGSKADIWSCGVILYVLLAGYLPF-HDSNLMEMY---RKIGK------------ 226
+ + + DIWS G I ++ F DS + E++ R +G
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234
Query: 227 AEFK--FPNW-----------FAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267
++K FP W P LLSK+L +P+ RI+ +E+ +F+
Sbjct: 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-28
Identities = 73/255 (28%), Positives = 135/255 (52%), Gaps = 13/255 (5%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+G+G+ V A TG VA+K +D K + ++ E+ +MR H NVV++Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN---EVVIMRDYHHENVVDMYN 86
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKP 137
+++ VME+++GG L V ++ E+ ++ A+ Y H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 138 ENLLLDEHGNLKVSDFGLSALA--ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADI 195
+++LL G +K+SDFG A E + L+ GTP ++APEVI+R Y G++ DI
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV----GTPYWMAPEVISRLPY-GTEVDI 201
Query: 196 WSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLLSKILDPNPN 252
WS G+++ ++ G P+ + ++ R+I K + + +R L +L P+
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPS 261
Query: 253 TRISMTKIMENSWFR 267
R + +++++ + +
Sbjct: 262 QRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 94/316 (29%), Positives = 145/316 (45%), Gaps = 53/316 (16%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
RY + +G G F V AR+ TG +VAIK I K V + + RE+ +++ +RH
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV-LAKRTYRELKLLKHLRHE 69
Query: 71 NVVELYEVMAS-KTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
N++ L ++ S IYFV E + G +L + L++ + + Q++ + Y HS G
Sbjct: 70 NIISLSDIFISPLEDIYFVTE-LLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG 128
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV-INRRGY 188
V HRDLKP N+L++E+ +LK+ DFGL+ + QD + T Y APE+ + + Y
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYRAPEIMLTWQKY 183
Query: 189 DGSKADIWSCGVILYVLLAG--YLPFHD-------------------------SNLMEMY 221
D + DIWS G I +L G P D N +
Sbjct: 184 D-VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242
Query: 222 RKIGKAE-----FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSIS 276
+ + K E KF N P LL K+L +P RIS + + + + + P
Sbjct: 243 QSLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALAHPY-----LAPYHD 296
Query: 277 ETEEKEWAPVDADAVF 292
T+E PV A+ F
Sbjct: 297 PTDE----PV-AEEKF 307
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 69/206 (33%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
+YE +GQGTF +V AR+ KT VA+K + E + I + REI +++L++H
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL-REIKILQLLKHE 71
Query: 71 NVVELYEVMASKTK--------IYFVMEYVK---GGELFGKVAKGKLKEDAARKYFQQLI 119
NVV L E+ +K Y V E+ + G L K K L E +K + L+
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE--IKKVMKMLL 129
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS-ALAESKHQDGLLHTT-CGTPAY 177
+ + Y H + HRD+K N+L+ + G LK++DFGL+ A + SK+ +T T Y
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 178 VAPEV-INRRGYDGSKADIWSCGVIL 202
PE+ + R Y G D+W G I+
Sbjct: 190 RPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 72/209 (34%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRLVRHP 70
EL RL G+G V R TGM A+K I D L+ QI RE+ + + + P
Sbjct: 5 ELSRL-GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ----KQILRELEINKSCKSP 59
Query: 71 NVVELYE--VMASKTKIYFVMEYVKGGEL---FGKVAK--GKLKEDAARKYFQQLISAVD 123
+V+ Y + S + I MEY +GG L + KV K G++ E K + ++ +
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
Y HSR + HRD+KP N+LL G +K+ DFG+S + L T GT Y+APE I
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS----LAGTFTGTSFYMAPERI 175
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPF 212
+ Y +D+WS G+ L + PF
Sbjct: 176 QGKPYS-ITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 81/253 (32%), Positives = 129/253 (50%), Gaps = 17/253 (6%)
Query: 30 RNLKTGMSVAIKIID-KEKVL-KVGMIDQIKR------EISVMRLVRHPNVVELYEVMAS 81
RN T VA + D KEKV+ K M++ ++ E+ + H +V+ ++ S
Sbjct: 77 RNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136
Query: 82 KTKIYFVMEYVKGGELFGKVAKGKLKEDAARK------YFQQLISAVDYCHSRGVCHRDL 135
K+ +MEY GG+L K K +LKE + F Q++ A+D HSR + HRDL
Sbjct: 137 DDKLLLIMEYGSGGDL-NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDL 195
Query: 136 KPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADI 195
K N+ L G +K+ DFG S + + CGTP Y+APE+ R+ Y KAD+
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS-KKADM 254
Query: 196 WSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FPNWFAPEVRRLLSKILDPNPNTR 254
WS GVILY LL + PF + E+ +++ ++ FP + ++ LL +L NP R
Sbjct: 255 WSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALR 314
Query: 255 ISMTKIMENSWFR 267
+ +++ + +
Sbjct: 315 PTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 85/309 (27%), Positives = 138/309 (44%), Gaps = 57/309 (18%)
Query: 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREIS 62
G + ++++ +G+GT+ +V+ AR+ TG VA+K + D EK G REI
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE---GFPITAIREIK 58
Query: 63 VMRLVRHPNVVELYEVMASKTK----------IYFVMEYVKGGELFGKVAKG--KLKEDA 110
++R + H N+V L E++ K Y V EY+ +L G + G ED
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDH 117
Query: 111 ARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170
+ + +QL+ ++YCH + HRD+K N+LL+ G +K++DFGL+ L S ++ +T
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS--EESRPYT 175
Query: 171 T-CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVL---------------------LAG 208
T Y PE++ G D+WSCG IL L L G
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235
Query: 209 Y-----------LP-FHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRIS 256
LP F+ + YR+ + EF F LL +L +P+ R +
Sbjct: 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSF---IPTPALDLLDHMLTLDPSKRCT 292
Query: 257 MTKIMENSW 265
+ + + W
Sbjct: 293 AEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 81/273 (29%), Positives = 135/273 (49%), Gaps = 31/273 (11%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ +EL + +G GT+ V+ ARN+ TG AIK+I E ++ Q EI +M+ +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKH 65
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCHSR 128
N+V + + K++ ME+ GG L G L E ++ + + Y HS+
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSA-----LAESKHQDGLLHTTCGTPAYVAPEV- 182
G HRD+K N+LL ++G++K++DFG+SA +A+ K + GTP ++APEV
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK-------SFIGTPYWMAPEVA 178
Query: 183 -INRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP--------- 232
+ R+G DIW+ G+ L P D + M + K+ F+ P
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS 238
Query: 233 NWFAPEVRRLLSKILDPNPNTRISMTKIMENSW 265
N F V+ L+K NP R + K++++ +
Sbjct: 239 NSFHHFVKMALTK----NPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 71/255 (27%), Positives = 134/255 (52%), Gaps = 9/255 (3%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+G+G+ V A +G VA+K +D K + ++ E+ +MR +H NVVE+Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN---EVVIMRDYQHENVVEMYN 84
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKP 137
+++ VME+++GG L V ++ E+ ++ A+ H++GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144
Query: 138 ENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWS 197
+++LL G +K+SDFG A + + GTP ++APE+I+R Y G + DIWS
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 198 CGVILYVLLAGYLPFHDS---NLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254
G+++ ++ G P+ + M+M R + K + +P ++ L ++L +P R
Sbjct: 202 LGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261
Query: 255 ISMTKIMENSWFRKG 269
+ +++++ + K
Sbjct: 262 ATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 78/269 (28%), Positives = 130/269 (48%), Gaps = 23/269 (8%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
YEL + +G GT+ V+ ARNL TG A+KII E +I Q EI +++ +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKH 65
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCHSR 128
N+V + S+ K++ MEY GG L G L E ++ + + Y HS+
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSA-----LAESKHQDGLLHTTCGTPAYVAPEV- 182
G HRD+K N+LL ++G++K++DFG++A +A+ K + GTP ++APEV
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK-------SFIGTPYWMAPEVA 178
Query: 183 -INRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNW-----FA 236
+ + G DIW+ G+ L P D + M + K+ F+ P ++
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWS 238
Query: 237 PEVRRLLSKILDPNPNTRISMTKIMENSW 265
+ L NP R + +++ + +
Sbjct: 239 STFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 78/306 (25%), Positives = 129/306 (42%), Gaps = 64/306 (20%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIK--------IIDKEKVLKVGMIDQIKREI 61
RY+ +G G + +V A + KTG VAIK I ++ RE+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY---------REL 65
Query: 62 SVMRLVRHPNVVELYEVMASKT------KIYFVMEYVKGGELFGKVAKGKLKEDAARKYF 115
+++ + H NV+ L +V + +Y V + G +L V KL +D +
Sbjct: 66 RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLV 124
Query: 116 QQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP 175
Q++ + Y HS G+ HRDLKP N+ ++E LK+ DFGL+ + + + T
Sbjct: 125 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATR 179
Query: 176 AYVAPEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPF---------------------- 212
Y APE++ N Y+ + DIWS G I+ LL G F
Sbjct: 180 WYRAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238
Query: 213 --------HDSNLMEMYRKIGKAEFK--FPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
N ++ ++ K +FK F P LL K+L +P+ RI+ + +
Sbjct: 239 LLQKISSESARNYIQSLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAAEALA 297
Query: 263 NSWFRK 268
+ + +
Sbjct: 298 HPYLAE 303
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ + R +G G+F V++AR+++T VAIK + I +E+ ++ +RH
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGEL-FGKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
PN +E + + VMEY G +V K L+E + + Y HS
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI---NR 185
HRD+K N+LL E G +K++DFG ++L ++ GTP ++APEVI +
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDE 188
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM 218
YDG K D+WS G+ L P + N M
Sbjct: 189 GQYDG-KVDVWSLGITCIELAERKPPLFNMNAM 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 83/310 (26%), Positives = 132/310 (42%), Gaps = 61/310 (19%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL----KVGMIDQIKREISVMRL 66
YE+ LG+GTF +V+ AR +KTG VA+K K+L K G REI +++
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKK 63
Query: 67 VRHPNVVELYEVMASKTK--------IYFVMEYVKGGELFGKVAKG--KLKEDAARKYFQ 116
++HPNVV L ++ + +Y V Y+ +L G + KL E + Y
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYML 122
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
QL+ ++Y H + HRD+K N+L+D G LK++DFGL+ + + GT
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 177 YV---------APE-VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK 226
Y PE ++ R Y + DIW G + + + ++ I K
Sbjct: 183 YTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241
Query: 227 A-----EFKFPNW-------------------------FAPEVRRLLSKILDPNPNTRIS 256
E +P W PE LLSK+L +P R++
Sbjct: 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT 301
Query: 257 MTKIMENSWF 266
+ +E+ +F
Sbjct: 302 ASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 83/297 (27%), Positives = 138/297 (46%), Gaps = 51/297 (17%)
Query: 10 QRYE-LGRLLGQGTFAKVHYARNLKTGMSVAIK-IIDKEK---VLKVGMIDQIKREISVM 64
++YE L ++ G+G++ V RN +TG VAIK ++ E + K+ + REI ++
Sbjct: 1 EKYEKLSKI-GEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL-----REIRML 54
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAV 122
+ ++HPN+V L EV K K++ V EY L K +G + E +K Q + AV
Sbjct: 55 KQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAV 113
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV 182
++CH HRD+KPEN+L+ + G +K+ DFG + + T Y APE+
Sbjct: 114 NFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG--PGDDYTDYVATRWYRAPEL 171
Query: 183 INRRGYDGSKADIWSCGVILYVLLAGYLPF--HDSNLMEMY---RKIGK----------- 226
+ G D+W+ G + LL G P S++ ++Y + +G
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230
Query: 227 -----------------AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266
E KFPN +P + L L +P R+S +++E+ +F
Sbjct: 231 NQFFKGLSIPEPETREPLESKFPNISSPAL-SFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 69/208 (33%), Positives = 111/208 (53%), Gaps = 15/208 (7%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDK-EKVLKVGMIDQIKREISVMRLVR 68
RY+ +G+G + V A + TG+ VAIK I E + REI ++R +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT---FCQRTLREIKILRRFK 61
Query: 69 HPNVVELYEVMASKT-----KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVD 123
H N++ + +++ + +Y V E ++ +L+ + L D + + Q++ +
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLK 120
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH-QDGLLHTTCGTPAYVAPEV 182
Y HS V HRDLKP NLLL+ + +LK+ DFGL+ +A+ +H G L T Y APE+
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 183 -INRRGYDGSKA-DIWSCGVILYVLLAG 208
+N +GY +KA DIWS G IL +L+
Sbjct: 181 MLNSKGY--TKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 4e-26
Identities = 41/58 (70%), Positives = 45/58 (77%), Gaps = 2/58 (3%)
Query: 314 LNAFDIISFSAGFDLSGLFEEREK--RKEVRFTSNKPVSTIISKLEGIAKLLRLKVKK 369
LNAFD+IS S+G DLSGLFEE +K +KE RFTS KP S IISKLE IAK L KVKK
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVKK 58
|
Length = 58 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-26
Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 24/261 (9%)
Query: 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELY 76
+LG+GT+ V+ AR+L T + +AIK I + V + EI++ ++H N+V+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV---QPLHEEIALHSYLKHRNIVQYL 71
Query: 77 EVMASKTKIYFVMEYVKGGELFG----KVAKGKLKEDAARKYFQQLISAVDYCHSRGVCH 132
+ ME V GG L K K E Y +Q++ + Y H + H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 133 RDLKPENLLLDEH-GNLKVSDFGLSALAESKHQDGL---LHTTCGTPAYVAPEVINR--R 186
RD+K +N+L++ + G +K+SDFG SK G+ T GT Y+APEVI++ R
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFG-----TSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHD--SNLMEMYRKIG--KAEFKFPNWFAPEVRRL 242
GY G+ ADIWS G + + G PF + M+ K+G K + P + E +
Sbjct: 187 GY-GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-KVGMFKIHPEIPESLSAEAKNF 244
Query: 243 LSKILDPNPNTRISMTKIMEN 263
+ + +P+P+ R S ++++
Sbjct: 245 ILRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 71/217 (32%), Positives = 116/217 (53%), Gaps = 30/217 (13%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII--------DKEKVLKVGMIDQIKRE 60
+++YE+ + LG+G + V A + +T VA+K I D ++ RE
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF---------RE 56
Query: 61 ISVMR-LVRHPNVVELYEVMASK--TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQ 117
I ++ L HPN+V+L V+ ++ IY V EY++ +L + L++ R Q
Sbjct: 57 IMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQ 115
Query: 118 LISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS-ALAESK--HQDGLLHTTCGT 174
L+ A+ Y HS V HRDLKP N+LL+ +K++DFGL+ +L+E + ++ +L T
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 175 PAYVAPEVI--NRRGYDGSKA-DIWSCGVILYVLLAG 208
Y APE++ + R Y +K D+WS G IL +L G
Sbjct: 176 RWYRAPEILLGSTR-Y--TKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 49/138 (35%), Positives = 80/138 (57%), Gaps = 1/138 (0%)
Query: 20 QGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVM 79
+G F KV+ R A+K++ K ++ M+ Q++ E + L + P +V LY +
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 80 ASKTKIYFVMEYVKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPE 138
S +Y VMEY+ GG++ + G E+ A KY ++ A+DY H G+ HRDLKP+
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPD 133
Query: 139 NLLLDEHGNLKVSDFGLS 156
N+L+ G++K++DFGLS
Sbjct: 134 NMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-25
Identities = 83/288 (28%), Positives = 137/288 (47%), Gaps = 50/288 (17%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKE----KVLKVGMIDQIKREISVM 64
MQRY++ RL+G+G +V+ A + VA+K I ++ +LK + RE +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLK----KRFLREAKIA 56
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKG---GELFGKV-AKGKLKEDAARK------- 113
+ HP +V +Y + + +Y+ M Y++G L V K L ++ A K
Sbjct: 57 ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 114 -YFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD------- 165
F ++ + ++Y HS+GV HRDLKP+N+LL G + + D+G + + + +D
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 166 --GLLHTT-------CGTPAYVAPEVINRRGYDGS-KADIWSCGVILYVLLAGYLPFHDS 215
+ +++ GTP Y+APE + G S DI++ GVILY +L P+
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRR- 233
Query: 216 NLMEMYRKIG-KAEFKFPNWFAP--EVRRLLSKI----LDPNPNTRIS 256
+ RKI + P AP E+ LS+I L +P R S
Sbjct: 234 ---KKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYS 278
|
Length = 932 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 67/219 (30%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 15 GRLLGQGTFAKVHYARNLKTGMSVAIK--IIDKEKVLKV-GMIDQIKREISVMRLVRHPN 71
G +LG+G + V Y G +A+K +D VL ++++ E+ +++ ++H N
Sbjct: 5 GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGV 130
+V+ I ME+V GG + + + G L E KY +Q++ V Y H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 131 CHRDLKPENLLLDEHGNLKVSDFG----LSALAESKHQDGLLHTTCGTPAYVAPEVINRR 186
HRD+K N++L +G +K+ DFG L+ + +L + GTP ++APEVIN
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG 225
GY G K+DIWS G ++ + G P + + IG
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 81/321 (25%), Positives = 128/321 (39%), Gaps = 61/321 (19%)
Query: 1 MENKGSILMQRYE-LGRLLGQGTFAKVHYARNLKTGMSVAIKII-----------DKEKV 48
M S +RY G LG+GT+ KV A + TG VAIK + D++ V
Sbjct: 2 MSFSIS---ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLV 58
Query: 49 LKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKV--AKGKL 106
G+ RE+ +M ++H N++ L +V I VM+ + KV K +L
Sbjct: 59 GMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRL 116
Query: 107 KEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS---------- 156
E + Q+++ ++ H HRDL P N+ ++ G K++DFGL+
Sbjct: 117 TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 157 ALAESKHQDGLLHTTCG--TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD 214
L++ + T T Y APE++ D+WS G I LL G F
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236
Query: 215 SNLMEMYRKI---------------------------GKAEFK--FPNWFAPEVRRLLSK 245
N ++ +I + K FPN + LL
Sbjct: 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAI-DLLQS 295
Query: 246 ILDPNPNTRISMTKIMENSWF 266
+L NP RIS + +++ +F
Sbjct: 296 LLKLNPLERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 71/259 (27%), Positives = 134/259 (51%), Gaps = 9/259 (3%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
Y R++G+G++ +V R+ G IK ++ + ++E ++ ++HPN
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPN 60
Query: 72 VVELYEVMASKT-KIYFVMEYVKGGELFGKVA--KGKL-KEDAARKYFQQLISAVDYCHS 127
+V E + +Y VM + +GG+L+ K+ KGKL E+ ++F Q+ A+ Y H
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
+ + HRDLK +N+ L +KV D G++ + E+ Q + T GTP Y++PE+ + +
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFSNKP 178
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM-YRKIGKAEFKFPNWFAPEVRRLLSKI 246
Y+ K+D+W+ G +Y + F+ ++ + YR I P ++PE+ L++ +
Sbjct: 179 YN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATM 237
Query: 247 LDPNPNTRISMTKIMENSW 265
L P R S+ I+ +
Sbjct: 238 LSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 77/282 (27%), Positives = 120/282 (42%), Gaps = 50/282 (17%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKR----EISVMRLVRHPN 71
+G+G F V+ LK VA+K + + +KR E +++ HPN
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVK------TCRSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 72 VVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISA---VDYCH 126
+V+L V K IY VME V GG L F + K +L +K Q + A ++Y
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLT---VKKLLQMSLDAAAGMEYLE 110
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP----AYVAPEV 182
S+ HRDL N L+ E+ LK+SDFG+S + + G+ + G + APE
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 183 INRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR- 240
+N Y S++D+WS G++L+ G P +P + R
Sbjct: 167 LNYGRYT-SESDVWSYGILLWETFSLGDTP-------------------YPGMSNQQTRE 206
Query: 241 RLLSKILDPNPN-TRISMTKIMENSWFRKGLVKPSISETEEK 281
R+ S P P + ++M W +PS SE +
Sbjct: 207 RIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNE 248
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 75/265 (28%), Positives = 119/265 (44%), Gaps = 25/265 (9%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL 66
I + +LG +G+G F V G VA+K + + E SVM
Sbjct: 3 INSKELKLGATIGKGEFGDVM--LGDYRGQKVAVKCLKDD----STAAQAFLAEASVMTT 56
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYC- 125
+RHPN+V+L V+ +Y V EY+ G L V + + A QQL A+D C
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL---VDYLRSRGRAVITLAQQLGFALDVCE 113
Query: 126 -----HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA-YVA 179
+ HRDL N+L+ E KVSDFGL+ A G L P + A
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWTA 167
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAP 237
PE + R +K+D+WS G++L+ + + G +P+ L ++ + K + P P
Sbjct: 168 PEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPP 226
Query: 238 EVRRLLSKILDPNPNTRISMTKIME 262
EV +++ + +P R + ++ E
Sbjct: 227 EVYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 3e-24
Identities = 68/221 (30%), Positives = 116/221 (52%), Gaps = 20/221 (9%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR-LVRHP 70
+EL ++G GT+ +V+ R++KTG AIK++D + + ++IK EI++++ H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE----EEIKLEINMLKKYSHHR 73
Query: 71 NVVELYEVMASKT------KIYFVMEYVKGGELFGKVAKGK---LKEDAARKYFQQLISA 121
N+ Y K+ +++ VME+ G + V K LKED ++++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+ + H+ V HRD+K +N+LL E+ +K+ DFG+S A+ G +T GTP ++APE
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPE 191
Query: 182 VI----NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM 218
VI N ++DIWS G+ + G P D + M
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 87/287 (30%), Positives = 131/287 (45%), Gaps = 46/287 (16%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
LG+G++A V+ R+ TG VA+K I + E+ I RE S+++ ++H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI----REASLLKDLKHANIVTL 68
Query: 76 YEVMASKTKIYFVMEYV-KGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRD 134
++++ +K + V EY+ + + G L R + QL+ + YCH R V HRD
Sbjct: 69 HDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRD 128
Query: 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI-NRRGYDGSKA 193
LKP+NLL+ E G LK++DFGL A A+S + T Y P+V+ Y S
Sbjct: 129 LKPQNLLISERGELKLADFGL-ARAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTS-L 185
Query: 194 DIWSCGVILYVLLAGYLPFHDSN-----LMEMYRKIG------------KAEFKFPNWF- 235
D+W G I Y + G F S L +++R +G EFK P F
Sbjct: 186 DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK-PYSFP 244
Query: 236 ----------------APEVRRLLSKILDPNPNTRISMTKIMENSWF 266
P L K L P RIS + M++ +F
Sbjct: 245 FYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 70/230 (30%), Positives = 110/230 (47%), Gaps = 30/230 (13%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKII---DKEKVLKVGMIDQIKREISVMRLV 67
RY R LG G+ V A + VA+K I D + V REI ++R +
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV------KHALREIKIIRRL 59
Query: 68 RHPNVVELYEVMASKTK--------------IYFVMEYVKGGELFGKVAKGKLKEDAARK 113
H N+V++YEV+ +Y V EY++ +L + +G L E+ AR
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARL 118
Query: 114 YFQQLISAVDYCHSRGVCHRDLKPENLLLD-EHGNLKVSDFGLSALAESKHQ-DGLLHTT 171
+ QL+ + Y HS V HRDLKP N+ ++ E LK+ DFGL+ + + + G L
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 172 CGTPAYVAPE-VINRRGYDGSKA-DIWSCGVILYVLLAGYLPFHDSNLME 219
T Y +P +++ Y +KA D+W+ G I +L G F ++ +E
Sbjct: 179 LVTKWYRSPRLLLSPNNY--TKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 11/217 (5%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+ L R LG G F +V K + VAIKI+ + +LK ++E+ ++ +RH +
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDF---QKEVQALKRLRHKH 63
Query: 72 VVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQ-QLISAVDYCHSR 128
++ L+ V + +Y + E ++ G L F + +G++ A+ Q+ + Y +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY 188
HRDL N+L+ E KV+DFGL+ L K L + APE + +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 189 DGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
+K+D+WS G++LY + G +P+ N E+Y +I
Sbjct: 182 S-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 73/247 (29%), Positives = 119/247 (48%), Gaps = 12/247 (4%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG+G F +V + TG A K ++K+++ K + E ++ V +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 78 VMASKTKIYFVMEYVKGGELFGKV-----AKGKLKEDAARKYFQQLISAVDYCHSRGVCH 132
+KT + VM + GG+L + E A Y Q+IS +++ H R + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSK 192
RDLKPEN+LLD GN+++SD GL+ E K GTP ++APE++ YD S
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS- 177
Query: 193 ADIWSCGVILYVLLAGYLPF----HDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248
D ++ GV LY ++A PF E+ ++I +P+ F+P + +L
Sbjct: 178 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237
Query: 249 PNPNTRI 255
+P R+
Sbjct: 238 KDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 16 RLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQ----IKREISVMRLV 67
+ LG+G F KV R TG VA+K L +Q +REI ++R +
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFEREIEILRTL 63
Query: 68 RHPNVVELYEVM--ASKTKIYFVMEYVKGGELFGKVAKGKLKEDAAR--KYFQQLISAVD 123
H N+V+ V + +MEY+ G L + + + + + R + Q+ +D
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMD 123
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA-YVAPEV 182
Y S+ HRDL N+L++ +K+SDFGL+ + + +P + APE
Sbjct: 124 YLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 183 INRRGYDGSKADIWSCGVILYVLL 206
+ + S +D+WS GV LY L
Sbjct: 184 LRTSKFS-SASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-23
Identities = 76/247 (30%), Positives = 124/247 (50%), Gaps = 38/247 (15%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
+ G + YE+ + +G G F +V ++ +T K I + LK Q+ E++
Sbjct: 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVN 64
Query: 63 VMRLVRHPNVVELYEVMASKT--KIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYF 115
VMR ++H N+V + +K K+Y +ME+ G+L + K GK++E A
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 116 QQLISAVDYCHS-------RGVCHRDLKPENLLLD-----------EHGNL------KVS 151
+QL+ A+ YCH+ V HRDLKP+N+ L + NL K+
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 152 DFGLSALAESKHQDGLLHTTCGTPAYVAPEVI--NRRGYDGSKADIWSCGVILYVLLAGY 209
DFGLS ++ + + H+ GTP Y +PE++ + YD K+D+W+ G I+Y L +G
Sbjct: 185 DFGLS---KNIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGK 240
Query: 210 LPFHDSN 216
PFH +N
Sbjct: 241 TPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 88/299 (29%), Positives = 133/299 (44%), Gaps = 55/299 (18%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKT--GMSVAIK----IIDKEKVLKVGMIDQIKREISVM 64
RYEL + LGQG + V ARN +T +VAIK + K+ + K + RE+ ++
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----RELKLL 55
Query: 65 RLVR-HPNVVELYE---VMASK-TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYF-QQL 118
R R H N+ LY+ V ++Y E ++ +L + G+ DA + F Q+
Sbjct: 56 RHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA--LAESKHQDGLLHTTCGTPA 176
+ + Y HS V HRDLKP NLL++ LK+ DFGL+ G + T
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 177 YVAPEV-INRRGYDGSKA-DIWSCGVILYVLLAGYLPFHDSNLM---------------E 219
Y APE+ ++ + Y +KA D+WS G IL LL F + + E
Sbjct: 175 YRAPEIMLSFQSY--TKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232
Query: 220 MYRKIGKAE-------------FKFPNWF---APEVRRLLSKILDPNPNTRISMTKIME 262
+IG + F + F P LL K+L +P RIS+ + +E
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 4e-23
Identities = 71/265 (26%), Positives = 127/265 (47%), Gaps = 16/265 (6%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
R+LG+G F +V + TG A K ++K+++ K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 76 YEVMASKTKIYFVMEYVKGGEL---FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCH 132
+K + V+ + GG+L + + +E A Y ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSK 192
RDLKPEN+LLD+HG++++SD GL+ + + GT Y+APEV+ Y S
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRVGTVGYMAPEVVKNERYTFS- 181
Query: 193 ADIWSCGVILYVLLAGYLPFHDSNLM----EMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248
D W+ G +LY ++AG PF E+ R + + + ++ F+P+ R L +L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 249 PNPNTRI-----SMTKIMENSWFRK 268
+P R+ ++ E+ F++
Sbjct: 242 KDPKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVMRL 66
RY+ +G G + V A + ++G VAIK K+ + + RE+ ++R
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRH 60
Query: 67 VRHPNVVELYEVMASKTK----IYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISA 121
+H N++ + +++ +Y VM+ + +L + + L E+ R + QL+
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT--CGTPAYVA 179
+ Y HS V HRDLKP NLL++E L++ DFG++ S + T T Y A
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 180 PEVINRRGYDGSKADIWSCGVIL 202
PE++ + D+WS G I
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 5e-23
Identities = 66/195 (33%), Positives = 103/195 (52%), Gaps = 8/195 (4%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKII-DKEKVLKVGMIDQIKREISVMRLVRH 69
++E+ ++G+G + V R+ +T VAIK D E+ +V + RE+ ++R ++
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVK--ETTLRELKMLRTLKQ 59
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQLISAVDYCHS 127
N+VEL E + K+Y V EYV+ EL ++ G + R Y QLI A+ +CH
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIHWCHK 118
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
+ HRD+KPENLL+ + LK+ DFG A S+ + T Y +PE++
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGF-ARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 188 YDGSKADIWSCGVIL 202
Y G D+WS G IL
Sbjct: 178 Y-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 5e-23
Identities = 74/257 (28%), Positives = 116/257 (45%), Gaps = 17/257 (6%)
Query: 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVV 73
+ LG G F VH + + + VAIK+I +E + D E VM + HPN+V
Sbjct: 8 FLKELGSGQFGVVHLGK-WRGKIDVAIKMI-REGAMSE---DDFIEEAKVMMKLSHPNLV 62
Query: 74 ELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVC 131
+LY V + I+ V EY+ G L + + KGKL + + A++Y S G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 132 HRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP---AYVAPEVINRRGY 188
HRDL N L+ E +KVSDFGL+ D ++ GT + PEV + +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYV----LDDQYTSSQGTKFPVKWAPPEVFDYSRF 178
Query: 189 DGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKI 246
SK+D+WS GV+++ V G +P+ + E+ + P EV ++
Sbjct: 179 S-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC 237
Query: 247 LDPNPNTRISMTKIMEN 263
P R + K++
Sbjct: 238 WHEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 6e-23
Identities = 65/248 (26%), Positives = 119/248 (47%), Gaps = 13/248 (5%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
R+LG+G F +V + TG A K ++K+++ K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 76 YEVMASKTKIYFVMEYVKGGEL---FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCH 132
+K + V+ + GG+L + E+ A Y ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG-LLHTTCGTPAYVAPEVINRRGYDGS 191
RDLKPEN+LLD++G++++SD GL+ + +G + GT Y+APEV+ Y S
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV----EIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181
Query: 192 KADIWSCGVILYVLLAGYLPFHDS----NLMEMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247
D W G ++Y ++ G PF E+ R++ + + ++ F+ R + ++L
Sbjct: 182 -PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240
Query: 248 DPNPNTRI 255
+P R+
Sbjct: 241 TKDPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 6e-23
Identities = 74/247 (29%), Positives = 118/247 (47%), Gaps = 14/247 (5%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG+G F +V + TG A K +DK+++ K E ++ V P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 78 VMASKTKIYFVMEYVKGGEL---FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRD 134
SKT + VM + GG+L V + L+ + Y Q+ + + HS + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT-CGTPAYVAPEVINRRGYDGSKA 193
+KPEN+LLD+ GN ++SD GL+ + +DG T GT Y+APE++ Y
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV----ELKDGKTITQRAGTNGYMAPEILKEEPYSYP-V 175
Query: 194 DIWSCGVILYVLLAGYLPFHDSNLM----EMYRKIGKAEFKFPNW-FAPEVRRLLSKILD 248
D ++ G +Y ++AG PF D E+ R+ + E KF + F E + + L
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235
Query: 249 PNPNTRI 255
P R+
Sbjct: 236 KKPEDRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 8e-23
Identities = 77/269 (28%), Positives = 129/269 (47%), Gaps = 31/269 (11%)
Query: 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV--RH--PNV 72
+G GT +V+ R KTG +A+K ++ + G ++ KR + + +V H P +
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRILMDLDVVLKSHDCPYI 76
Query: 73 VELYEVMASKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSR- 128
V+ Y + + ++ ME + K+ K G + ED K ++ A+ Y +
Sbjct: 77 VKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHT-TCGTPAYVAPEVIN-- 184
GV HRD+KP N+LLD GN+K+ DFG+S L +SK T + G AY+APE I+
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK-----AKTRSAGCAAYMAPERIDPP 189
Query: 185 --RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL-MEMYRKIGKAEFKFPNW---FAPE 238
YD +AD+WS G+ L L G P+ + E+ KI + E F+P+
Sbjct: 190 DPNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248
Query: 239 VRRLLSKILDPNPNTRISMTKIMENSWFR 267
+ L + R +++++ + R
Sbjct: 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 8e-23
Identities = 70/281 (24%), Positives = 135/281 (48%), Gaps = 24/281 (8%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG+G + V+ + TG+++A+K I E L +QI E+ ++ P +V+ Y
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 78 VMASKTKIYFVMEYVKGGEL----FGKVAKGKLKEDAARKYFQQLISAVDYCHSR-GVCH 132
+ +Y MEY+ G L G VA + ED R+ ++ + + + H
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGS- 191
RD+KP N+L++ +G +K+ DFG+S + L T G +Y+APE I G + +
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 192 ----KADIWSCGVILYVLLAGYLPF----HDSNLMEMYRKIGKAEFKFPNWFAPEVRRLL 243
++D+WS G+ + + G P+ + + ++ + P+ ++ + + +
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFV 242
Query: 244 SKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWA 284
+K L+ PN R + +++E+ W LVK ++ + EW
Sbjct: 243 AKCLNKIPNRRPTYAQLLEHPW----LVKYKNADVDMAEWV 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 1e-22
Identities = 72/243 (29%), Positives = 121/243 (49%), Gaps = 27/243 (11%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR-LVRHP 70
+EL L+G GT+ +V+ R++KTG AIK++D + ++IK+EI++++ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 71 NVVELYEVMASKT------KIYFVMEYVKGG---ELFGKVAKGKLKEDAARKYFQQLISA 121
N+ Y K +++ VME+ G +L LKE+ ++++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+ + H V HRD+K +N+LL E+ +K+ DFG+S A+ G +T GTP ++APE
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPE 181
Query: 182 VI----NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAP 237
VI N K+D+WS G+ + G P D + M +A F P AP
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFLIPRNPAP 234
Query: 238 EVR 240
++
Sbjct: 235 RLK 237
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 74/286 (25%), Positives = 128/286 (44%), Gaps = 33/286 (11%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKII---DKEKVLKVGMIDQIKREISVMRLVRHPNVVE 74
LG G V +++ TG +A K++ K V K QI RE+ +M R P +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK-----QILRELQIMHECRSPYIVS 67
Query: 75 LYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR-GVCH 132
Y ++ I ME++ G L K G + + K ++ + Y ++ + H
Sbjct: 68 FYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGS 191
RD+KP N+L++ G +K+ DFG+S L S + T GT Y++PE I Y
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINS-----IADTFVGTSTYMSPERIQGGKYT-V 181
Query: 192 KADIWSCGVILYVLLAGYLPFHDSN-----------LMEMYRKIGKAEF-KFP-NWFAPE 238
K+D+WS G+ + L G PF SN ++++ ++I + + P + F +
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED 241
Query: 239 VRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWA 284
+R + L +P R + ++ F + S + + WA
Sbjct: 242 LRDFVDACLLKDPTERPTPQQLCAMPPF---IQALRASNVDLQAWA 284
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 84/314 (26%), Positives = 138/314 (43%), Gaps = 52/314 (16%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
RY + +G G + V A + +TG VAIK + + ++ + RE+ +++ ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKH 73
Query: 70 PNVVELYEVMASKTKI------YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAV 122
NV+ L +V + Y VM ++ G GK+ K KL ED + Q++ +
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV 182
Y H+ G+ HRDLKP NL ++E LK+ DFGL ++ D + T Y APEV
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL-----ARQTDSEMTGYVVTRWYRAPEV 186
Query: 183 INRRGYDGSKADIWSCGVILYVLLAGYLPF----HDSNLMEMYRKIGKAEFKF------- 231
I + DIWS G I+ +L G F H LME+ + G +F
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 232 --PNWFA--PEVRR----------------LLSKILDPNPNTRISMTKIMENSWFRKGLV 271
N+ P R+ +L K+L + +RI+ + + + +F
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE---- 302
Query: 272 KPSISETEEKEWAP 285
+ E++ AP
Sbjct: 303 --EFHDPEDETEAP 314
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 91/305 (29%), Positives = 139/305 (45%), Gaps = 50/305 (16%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
RY++ ++G+G++ V A + TG VAIK I + V +I REI ++RL+RHP
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHP 59
Query: 71 NVVELYEVMASKTK-----IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ----QLISA 121
++VE+ +M ++ IY V E + +L + K +D ++ Q QL+ A
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVI---KANDDLTPEHHQFFLYQLLRA 115
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT-CGTPAYVAP 180
+ Y H+ V HRDLKP+N+L + LK+ DFGL+ +A + + T T Y AP
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 181 EVINRRGYDGSKA-DIWSCGVILYVLLAGYLPFHDSN----------------------- 216
E+ + A DIWS G I +L G F N
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235
Query: 217 --------LMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267
L M +K KFPN P RLL ++L +P R + + + + +F
Sbjct: 236 RNEKARRYLSSMRKKQPVPFSQKFPN-ADPLALRLLERLLAFDPKDRPTAEEALADPYF- 293
Query: 268 KGLVK 272
KGL K
Sbjct: 294 KGLAK 298
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 68/204 (33%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMS-VAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
Q+YE +G+G + KV AR+LK G VA+K + + + + GM RE++V+R +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 59
Query: 69 ---HPNVVELYEVMA-----SKTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQL 118
HPNVV L++V +TK+ V E+V KV + + + + QL
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
+ +D+ HS V HRDLKP+N+L+ G +K++DFGL+ + + L + T Y
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYR 176
Query: 179 APEVINRRGYDGSKADIWSCGVIL 202
APEV+ + Y + D+WS G I
Sbjct: 177 APEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 69/225 (30%), Positives = 110/225 (48%), Gaps = 14/225 (6%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
L +RY + +G G + V A + +TG VAIK + + ++ + RE+++++ +
Sbjct: 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHM 71
Query: 68 RHPNVVELYEVMASKT------KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISA 121
+H NV+ L +V S Y VM Y++ K+ L ED + Q++
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+ Y HS G+ HRDLKP NL ++E LK+ DFGL ++H D + T Y APE
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL-----ARHADAEMTGYVVTRWYRAPE 184
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK 226
VI + DIWS G I+ +L G F + ++ +I K
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 4e-22
Identities = 73/249 (29%), Positives = 118/249 (47%), Gaps = 19/249 (7%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
R +G G+F V++AR+++T VAIK + I +E+ ++ ++HPN +E
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 76 YEVMASKTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHR 133
+ + VMEY G +L +V K L+E + + Y HS + HR
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI---NRRGYDG 190
D+K N+LL E G +K++DFG +++A ++ GTP ++APEVI + YDG
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDG 203
Query: 191 SKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF------KFPNWFAPEVRRLLS 244
K D+WS G+ L P + N M I + E ++ ++F V L
Sbjct: 204 -KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 262
Query: 245 KILDPNPNT 253
KI P +
Sbjct: 263 KIPQDRPTS 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 35/280 (12%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG+GT+A V+ R+ T VA+K I E + G RE+S+++ ++H N+V L++
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 78 VMASKTKIYFVMEYV-KGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLK 136
++ ++ + V EY+ K + + + + + QL+ ++YCH R V HRDLK
Sbjct: 72 IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131
Query: 137 PENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIW 196
P+NLL++E G LK++DFGL A A+S + T Y P+++ ++ D+W
Sbjct: 132 PQNLLINERGELKLADFGL-ARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMW 189
Query: 197 SCGVILYVLLAGYLPFHDSNLME----MYRKIG------------KAEFK---FPNWFAP 237
G I Y + G F S + E ++R +G EFK +P + A
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRAD 249
Query: 238 EVRR-----------LLSKILDPNPNTRISMTKIMENSWF 266
+ LLSK+L RIS + M++ +F
Sbjct: 250 CLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 6e-22
Identities = 67/248 (27%), Positives = 120/248 (48%), Gaps = 13/248 (5%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
R+LG+G F +V + TG A K ++K+++ K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 76 YEVMASKTKIYFVMEYVKGGEL---FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCH 132
+K + V+ + GG+L + +E+ A Y +++ ++ H +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG-LLHTTCGTPAYVAPEVINRRGYDGS 191
RDLKPEN+LLD++G++++SD GL+ K +G + GT Y+APEV+N + Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV----KIPEGESIRGRVGTVGYMAPEVLNNQRY-TL 180
Query: 192 KADIWSCGVILYVLLAGYLPFHDS----NLMEMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247
D W G ++Y ++ G PF E+ R++ + E + F+ E + + +L
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 248 DPNPNTRI 255
+P R+
Sbjct: 241 TKDPKQRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 8e-22
Identities = 78/277 (28%), Positives = 136/277 (49%), Gaps = 30/277 (10%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR-LVRHP 70
+E+ +G+GT+ KV+ N K G A+KI+D + ++I+ E ++++ L HP
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHP 79
Query: 71 NVVELYEVMASKTK-----IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDY- 124
NVV+ Y + K ++ V+E GG + ++ KG L ++ + +IS + Y
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVKGLLI--CGQRLDEAMISYILYG 136
Query: 125 -------CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAY 177
H+ + HRD+K N+LL G +K+ DFG+SA S +T+ GTP +
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFW 194
Query: 178 VAPEVIN-RRGYDGS---KADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK---AEFK 230
+APEVI + YD S + D+WS G+ L G P D + ++ KI +
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254
Query: 231 FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267
P + +S+ L + R S+T ++E+ + +
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 76/293 (25%), Positives = 129/293 (44%), Gaps = 42/293 (14%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+RY+ +G G + V A + KTG+ VA+K + + + + RE+ +++ ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 75
Query: 70 PNVVELYEVMASKTKI-----YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDY 124
NV+ L +V + +++ ++ G +L V KL +D + Q++ + Y
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 125 CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVIN 184
HS + HRDLKP NL ++E LK+ DFGL ++H D + T Y APE++
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCELKILDFGL-----ARHTDDEMTGYVATRWYRAPEIML 190
Query: 185 RRGYDGSKADIWSCGVILYVLLAGYLPF----HDSNLMEMYRKIGKAE------------ 228
+ DIWS G I+ LL G F H L + R +G
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250
Query: 229 ------------FKFPNWFA---PEVRRLLSKILDPNPNTRISMTKIMENSWF 266
F N F P LL K+L + + RI+ + + +++F
Sbjct: 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 70/254 (27%), Positives = 123/254 (48%), Gaps = 21/254 (8%)
Query: 17 LLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRLVRHPNVVE 74
LLG+G F +V + LK VA+K D + LK+ + + + +++ HPN+V+
Sbjct: 2 LLGKGNFGEV-FKGTLKDKTPVAVKTCKEDLPQELKIKFLSEAR----ILKQYDHPNIVK 56
Query: 75 LYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCH 132
L V + IY VME V GG+ F + K +LK K+ + + Y S+ H
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP----AYVAPEVINRRGY 188
RDL N L+ E+ LK+SDFG+ S+ +D ++++ G + APE +N Y
Sbjct: 117 RDLAARNCLVGENNVLKISDFGM-----SRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 189 DGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKI 246
S++D+WS G++L+ + G P+ + ++ K P +V +++ +
Sbjct: 172 S-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRC 230
Query: 247 LDPNPNTRISMTKI 260
D P R +++
Sbjct: 231 WDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 32/276 (11%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQ-IKREISVMR-LVRH 69
+E+ +G+GT+ KV N K G A+KI+D + ID+ I+ E ++++ L H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP-----IHDIDEEIEAEYNILKALSDH 74
Query: 70 PNVVELYEVMASKT-----KIYFVMEYVKGGELFGKVAKGKLK------EDAARKYFQQL 118
PNVV+ Y + K +++ V+E GG + + KG LK E +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-TDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAY 177
+ + + H HRD+K N+LL G +K+ DFG+SA L ++ + +T+ GTP +
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR---NTSVGTPFW 190
Query: 178 VAPEVIN-----RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK---AEF 229
+APEVI YD ++ D+WS G+ L G P D + M KI +
Sbjct: 191 MAPEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249
Query: 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSW 265
P ++ E + K L + R +++ ++++ +
Sbjct: 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 87/326 (26%), Positives = 135/326 (41%), Gaps = 80/326 (24%)
Query: 11 RYELGRLLGQGTFAKVHYAR--NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+YE+ +G+GT+ +V+ A+ N K G AIK +K G+ REI+++R ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 69 HPNVVELYEVMASKT--KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ---------Q 117
H NVV L EV +Y + +Y + +L+ + K A R Q
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII---KFHRQAKRVSIPPSMVKSLLWQ 116
Query: 118 LISAVDYCHSRGVCHRDLKPENLLL----DEHGNLKVSDFGL-----SALAESKHQDGLL 168
+++ V Y HS V HRDLKP N+L+ E G +K+ D GL + L D ++
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 169 HTTCGTPAYVAPEVI-NRRGYDGSKA-DIWSCGVILYVLLA-------------GYLPFH 213
T Y APE++ R Y +KA DIW+ G I LL PF
Sbjct: 177 VTIW----YRAPELLLGARHY--TKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230
Query: 214 DSNL--------------------MEMYRKIGKAEF--KFPN-----WF------APEVR 240
L M Y + K +P+ W +
Sbjct: 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290
Query: 241 RLLSKILDPNPNTRISMTKIMENSWF 266
LL K+L+ +P RI+ + +E+ +F
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 81/281 (28%), Positives = 136/281 (48%), Gaps = 35/281 (12%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG+GT+A V R+ T VA+K I E + G RE+S+++ ++H N+V L++
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 78 VMASKTKIYFVMEYV-KGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLK 136
++ + + V EY+ K + + + + + Q++ + YCH R V HRDLK
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131
Query: 137 PENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIW 196
P+NLL++E G LK++DFGL A A+S + T Y P+V+ ++ D+W
Sbjct: 132 PQNLLINERGELKLADFGL-ARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQIDMW 189
Query: 197 SCGVILYVLLAGYLPFHDSNLME----MYRKIGKA------------EFK---FPNW--- 234
G I + + +G F S + + ++R +G EFK FP +
Sbjct: 190 GVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQ 249
Query: 235 ----FAPEVR----RLLSKILDPNPNTRISMTKIMENSWFR 267
AP + LL+K L RIS + M++++FR
Sbjct: 250 PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 78/293 (26%), Positives = 136/293 (46%), Gaps = 42/293 (14%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-- 68
+YE +G G + V+ AR+ +G VA+K + + + + G+ RE+++++ +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 69 -HPNVVELYEVMAS-----KTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQLIS 120
HPN+V L +V A+ +TK+ V E+V KV L + + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
+D+ H+ + HRDLKPEN+L+ G +K++DFGL+ + + L T Y AP
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAP 176
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPF----HDSNLMEMYRKIG-KAEFKFP--- 232
EV+ + Y + D+WS G I + F L +++ IG E +P
Sbjct: 177 EVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235
Query: 233 ----NWFAPEVRR---------------LLSKILDPNPNTRISMTKIMENSWF 266
F+P R LL ++L NP+ RIS + +++ +F
Sbjct: 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 66/234 (28%), Positives = 114/234 (48%), Gaps = 15/234 (6%)
Query: 34 TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELY-EVMASKTKIYFVMEYV 92
TG VAIK++ + + + +RE ++ + HPN+V L A ++ V EYV
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 93 KGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NL 148
G L +A G L + Q++ A+ H++G+ HRDLKP+N+++ + G +
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 149 KVSDFGLSALAESKHQDGLLHTT-----CGTPAYVAPEVINRRGYDGS-KADIWSCGVIL 202
KV DFG+ L + T GTP Y APE + RG + +D+++ G+I
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL--RGEPVTPNSDLYAWGLIF 179
Query: 203 YVLLAGYLPFHDSNLME-MYRKIGKAEFKFPNWFAPE-VRRLLSKILDPNPNTR 254
L G +++ E +Y+++ + P W A + ++L K L+ +P R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 3e-21
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 16/217 (7%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
+ LG G F VH + + + VAIK I++ + + I++ K VM + HP +V+L
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQL 64
Query: 76 YEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHR 133
Y V + +Y V E+++ G L + + +GKL +D Q + ++Y HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP---AYVAPEVINRRGYDG 190
DL N L+ G +KVSDFG++ D ++ G + PEV N Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYV----LDDEYTSSSGAKFPVKWSPPEVFNFSKYS- 179
Query: 191 SKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGK 226
SK+D+WS GV+++ V G +PF + E+ I +
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 84/280 (30%), Positives = 131/280 (46%), Gaps = 35/280 (12%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG+GT+A V R+ T VA+K I E + G RE+S+++ ++H N+V L++
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ-QLISAVDYCHSRGVCHRDLK 136
++ ++ + V EY+ G L K F QL+ + YCH R + HRDLK
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130
Query: 137 PENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIW 196
P+NLL++E G LK++DFGL A A+S + T Y P+V+ + D+W
Sbjct: 131 PQNLLINEKGELKLADFGL-ARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMW 188
Query: 197 SCGVILYVLLAGYLPFHDSNLME----MYRKIG------------KAEFK---FPNWFAP 237
G ILY + G F S + E ++R +G EF+ FP + A
Sbjct: 189 GVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQ 248
Query: 238 EVRR-----------LLSKILDPNPNTRISMTKIMENSWF 266
+ LLS +L +RIS + +S+F
Sbjct: 249 PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 79/285 (27%), Positives = 129/285 (45%), Gaps = 42/285 (14%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG+G++A V+ + G VA+K+I + + G+ RE S+++ ++H N+V L++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDL 135
++ +K + FV EY+ +L + + G L R + QL+ + Y H + + HRDL
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 136 KPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT-CGTPAYVAPEVINRRGYDGSKAD 194
KP+NLL+ G LK++DFG LA +K +++ T Y P+V+ S D
Sbjct: 130 KPQNLLISYLGELKLADFG---LARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALD 186
Query: 195 IWSCGVILYVLLAGYLPFHD-SNLMEMYRKI---------------GKAEFKFPNWF--- 235
IW G I +L G F S++ E KI K P WF
Sbjct: 187 IWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPC 246
Query: 236 --------------APEVRRLLSKILDPNPNTRISMTKIMENSWF 266
P+ L S++L P RIS + + +F
Sbjct: 247 KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 15/260 (5%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
R +G G+F V++AR+++ VAIK + I +E+ ++ +RHPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 76 YEVMASKTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHR 133
+ + VMEY G +L +V K L+E + + Y HS + HR
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI---NRRGYDG 190
D+K N+LL E G +K+ DFG +++ + GTP ++APEVI + YDG
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 191 SKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF--PNWFAPEVRRLLSKILD 248
K D+WS G+ L P + N M I + E ++ R + L
Sbjct: 194 -KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252
Query: 249 PNPNTRISMTKIMENSWFRK 268
P R + ++++ + +
Sbjct: 253 KIPQDRPTSEVLLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 5e-21
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 17/216 (7%)
Query: 60 EISVMRLVR-HPNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQ 117
E V +L++ +PN ++LY + + +M+Y+K G+LF + +GKL E +K +Q
Sbjct: 58 EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ 117
Query: 118 LISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
L+ A++ H + H D+K EN+L D + + D+GL + GT
Sbjct: 118 LVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC---KIIGTPSCYD---GTLD 171
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-----NLMEMYRKIGKAEFKF 231
Y +PE I YD S D W+ GV+ Y LL G PF + +L + ++ K + F
Sbjct: 172 YFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-KLPF 229
Query: 232 PNWFAPEVRRLLSKILDPNPNTRISMTK-IMENSWF 266
+ + +L N N R++ I+++ +
Sbjct: 230 IKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 69/258 (26%), Positives = 117/258 (45%), Gaps = 15/258 (5%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+G G+F V++A N T VA+K + I +E+ ++ ++HPN +E
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 78 VMASKTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDL 135
+ + VMEY G +L +V K L+E + + Y HS + HRD+
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 136 KPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI---NRRGYDGSK 192
K N+LL E G +K++DFG ++ + ++ GTP ++APEVI + YDG K
Sbjct: 148 KAGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDG-K 200
Query: 193 ADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF--PNWFAPEVRRLLSKILDPN 250
D+WS G+ L P + N M I + + N + R + L
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKI 260
Query: 251 PNTRISMTKIMENSWFRK 268
P R + +++ + + R+
Sbjct: 261 PQERPASAELLRHDFVRR 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 6e-21
Identities = 70/252 (27%), Positives = 123/252 (48%), Gaps = 13/252 (5%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG G + +V+ K ++VA+K + KE ++V ++ +E +VM+ ++HPN+V+L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEV---EEFLKEAAVMKEIKHPNLVQLLG 69
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ---QLISAVDYCHSRGVCHRD 134
V + Y + E++ G L + + +E A Q+ SA++Y + HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVINRRGYDGSKA 193
L N L+ E+ +KV+DFGLS L H P + APE + + K+
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPESLAYNKFS-IKS 186
Query: 194 DIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNP 251
D+W+ GV+L+ + G P+ +L ++Y + K + P P+V L+ NP
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNP 246
Query: 252 NTRISMTKIMEN 263
+ R S +I +
Sbjct: 247 SDRPSFAEIHQA 258
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 8e-21
Identities = 69/253 (27%), Positives = 120/253 (47%), Gaps = 15/253 (5%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+G+G F +V R VA+K + L + + +E +++ HPN+V L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 78 VMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDL 135
V K IY VME V+GG+ F + +LK + + + ++Y S+ HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 136 KPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP----AYVAPEVINRRGYDGS 191
N L+ E LK+SDFG+S + +DG+ +T G + APE +N Y S
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEALNYGRYS-S 175
Query: 192 KADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILDP 249
++D+WS G++L+ + G +P+ + + + I + P V RL+ + +
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 250 NPNTRISMTKIME 262
+P R S + + +
Sbjct: 236 DPGQRPSFSTVHQ 248
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 62/201 (30%), Positives = 89/201 (44%), Gaps = 26/201 (12%)
Query: 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID--QIKREISVMRLVRHPN 71
L R LG G F +V T VA+K LK G + +E +M+ +RH
Sbjct: 10 LERKLGAGQFGEVWMGTWNGT-TKVAVK------TLKPGTMSPEAFLQEAQIMKKLRHDK 62
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARK-YFQQLI-------SAVD 123
+V+LY V + + IY V EY+ G L LK +K QL+ +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDF-----LKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEV 182
Y SR HRDL N+L+ E+ K++DFGL+ L E P + APE
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA--REGAKFPIKWTAPEA 175
Query: 183 INRRGYDGSKADIWSCGVILY 203
N + K+D+WS G++L
Sbjct: 176 ANYGRFT-IKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIK--------IIDKEKVLKVGMIDQIKREISVMRLVRH 69
+G+G + V A+N +T VAIK ID ++ L REI ++R + H
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL---------REIKLLRHLDH 63
Query: 70 PNVVELYEVMASKTK-----IYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVD 123
NV+ + ++M + +Y V E + +L + + L +D + + QL+ +
Sbjct: 64 ENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLK 122
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
Y HS V HRDLKP NLLL+ + +LK+ DFGL+ K + T Y APE++
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELL 180
Query: 184 -NRRGYDGSKADIWSCGVILYVLL 206
N Y + D+WS G I LL
Sbjct: 181 LNCSEY-TTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 68/251 (27%), Positives = 118/251 (47%), Gaps = 13/251 (5%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
R+LG+G F +V + TG A K ++K+++ K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 76 YEVMASKTKIYFVMEYVKGGEL---FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCH 132
+K + V+ + GG+L + E A Y +L ++ + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGS 191
RDLKPEN+LLD+ G++++SD GL+ + E + G + GT Y+APEVIN Y S
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAPEVINNEKYTFS 181
Query: 192 KADIWSCGVILYVLLAGYLPFHDSNLM----EMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247
D W G ++Y ++ G PF E+ R++ + + ++ F+ + + + +L
Sbjct: 182 -PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240
Query: 248 DPNPNTRISMT 258
NP R+
Sbjct: 241 TKNPKERLGCR 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 7e-20
Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
YE LG+G++A V+ ++ G VA+K+I ++ + G RE S+++ ++H N
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKHAN 64
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRG 129
+V L++++ +K + V EYV +L + K G L + + + QL+ + Y H R
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG---TPAYVAPEVINRR 186
+ HRDLKP+NLL+ + G LK++DFGL A A+S HT T Y P+V+
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGL-ARAKSVPS----HTYSNEVVTLWYRPPDVLLGS 178
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPF 212
+ D+W G I ++ G F
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 9e-20
Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 11/220 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+RY+ +G G + V A + + VA+K + + + + RE+ +++ ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKH 73
Query: 70 PNVVELYEVMASKTKI-----YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDY 124
NV+ L +V T I +++ + G +L V KL ++ + QL+ + Y
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 125 CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVIN 184
HS G+ HRDLKP N+ ++E L++ DFGL ++ D + T Y APE++
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGL-----ARQADDEMTGYVATRWYRAPEIML 188
Query: 185 RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI 224
+ DIWS G I+ LL G F ++ ++ ++I
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 16/221 (7%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+G+ VH A++ T VA+K I+ + K + +++EI R ++HPN
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPN 60
Query: 72 VVELYEVMASKTKIYFVMEYVKGG---ELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
++ +++Y V + G +L L E A + +++A+DY HS+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDF--GLSALAESKHQ----DGLLHTTCGTPAYVAPEV 182
G HR +K ++LL G + +S +S + K Q D + P +++PEV
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP-WLSPEV 179
Query: 183 I--NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMY 221
+ N +GY+ K+DI+S G+ L G++PF D +M
Sbjct: 180 LQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 80/274 (29%), Positives = 134/274 (48%), Gaps = 39/274 (14%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKR-----EISVMRLVRHPNV 72
LG+G + V R++ TG +A+K I V +Q KR +IS MR V P
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRAT----VNSQEQ-KRLLMDLDIS-MRSVDCPYT 62
Query: 73 VELYEVMASKTKIYFVMEYVKGG--ELFGKVAKGKL--KEDAARKYFQQLISAVDYCHSR 128
V Y + + ++ ME + + + KV L ED K ++ A++Y HS+
Sbjct: 63 VTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122
Query: 129 -GVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAES--KHQDGLLHTTCGTPAYVAPEVIN 184
V HRD+KP N+L++ +G +K+ DFG+S L +S K D G Y+APE IN
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA------GCKPYMAPERIN 176
Query: 185 ----RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP------NW 234
++GYD K+D+WS G+ + L G P+ + ++++ K + P
Sbjct: 177 PELNQKGYD-VKSDVWSLGITMIELATGRFPY--DSWKTPFQQL-KQVVEEPSPQLPAEK 232
Query: 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
F+PE + ++K L N R + +++++ +F
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 77/306 (25%), Positives = 134/306 (43%), Gaps = 55/306 (17%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
+++RY+ + +G G V A + G++VA+K + + + RE+ +++ V
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCV 77
Query: 68 RHPNVVELYEVMASKTK------IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISA 121
H N++ L V + +Y VME + +V +L + Q++
Sbjct: 78 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCG 135
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+ + HS G+ HRDLKP N+++ LK+ DFGL+ A + ++ T Y APE
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPE 192
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI------GKAEFK----- 230
VI GY DIWS G I+ L+ G + F ++ ++ + K+ AEF
Sbjct: 193 VILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 231 --------------------FPNWFAP-----------EVRRLLSKILDPNPNTRISMTK 259
FP+W P + R LLSK+L +P+ RIS+ +
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311
Query: 260 IMENSW 265
+ + +
Sbjct: 312 ALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 15/212 (7%)
Query: 10 QRYELGRLLGQGTFAKVH---YARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL 66
+ LGR +G+G F V+ Y ++VA+K V ++ +E +MR
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQ 63
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDY 124
HP++V+L V+ ++ ++ VME GEL + +V K L + Y QL +A+ Y
Sbjct: 64 FDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 125 CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT-P-AYVAPEV 182
S+ HRD+ N+L+ +K+ DFGLS E + + G P ++APE
Sbjct: 123 LESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE---DESYYKASKGKLPIKWMAPES 179
Query: 183 INRRGYDGSKADIWSCGVILY-VLLAGYLPFH 213
IN R + S +D+W GV ++ +L+ G PF
Sbjct: 180 INFRRFT-SASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 6e-19
Identities = 75/259 (28%), Positives = 121/259 (46%), Gaps = 19/259 (7%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+Q+ LG ++G+G F V TG VA+K I K V ++ E +VM +
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNI-KCDVTAQAFLE----ETAVMTKLH 57
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAAR--KYFQQLISAVDYC 125
H N+V L V+ +Y VME + G L + +G+ + ++ + ++Y
Sbjct: 58 HKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
S+ + HRDL N+L+ E G KVSDFGL A S D + + APE +
Sbjct: 117 ESKKLVHRDLAARNILVSEDGVAKVSDFGL-ARVGSMGVD----NSKLPVKWTAPEALKH 171
Query: 186 RGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLL 243
+ + SK+D+WS GV+L+ V G P+ +L E+ + K + P +V L+
Sbjct: 172 KKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230
Query: 244 SKILDPNPNTRISMTKIME 262
+ + P R S K+ E
Sbjct: 231 TSCWETEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 63/243 (25%), Positives = 100/243 (41%), Gaps = 29/243 (11%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
I + LG+G F KV+ + SVAIK + + KV + ++E
Sbjct: 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQEA 59
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELF---------GKVAKGKLKEDAAR 112
+M ++HPN+V L V + + EY+ G+L V E
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 113 KYFQ--------QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164
Q+ + ++Y S HRDL N L+ E +K+SDFGLS S
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179
Query: 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVL----LAGYLPFHDSNLMEM 220
+ + ++ PE I G +++DIWS GV+L+ + L Y F + ++EM
Sbjct: 180 YRVQSKSLLPVRWMPPEAI-LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238
Query: 221 YRK 223
R
Sbjct: 239 IRS 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 62/243 (25%), Positives = 115/243 (47%), Gaps = 29/243 (11%)
Query: 21 GTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA 80
G KV + +T + +K + K + + I + V PN+V L++ +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTI-IPHCV--PNMVCLHKYIV 55
Query: 81 SKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPEN 139
S+ ++ V+++ +GG+L+ ++K + E+ +++ +++ A+D H G+ RDL P N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 140 LLLDEHGNLKVSDFG-LSALAESKHQDGLLHTTCGTPAYVAPEV--INRRGYDGSKADIW 196
+LLD+ G+++++ F S + +S + + Y APEV I+ + D W
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAV------ENMYCAPEVGGISE---ETEACDWW 166
Query: 197 SCGVILYVLLAG--YLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254
S G IL+ LL G + H S + P W + E R LL ++L NP R
Sbjct: 167 SLGAILFELLTGKTLVECHPSGINT------HTTLNIPEWVSEEARSLLQQLLQFNPTER 220
Query: 255 ISM 257
+
Sbjct: 221 LGA 223
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 82/312 (26%), Positives = 134/312 (42%), Gaps = 60/312 (19%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
+++RY+ + +G G V A + TG +VAIK + + V + RE+ +M+LV
Sbjct: 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLV 72
Query: 68 RHPNVVELYEVMASKTK------IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISA 121
H N++ L V + +Y VME + +V + L + Q++
Sbjct: 73 NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMSYLLYQMLCG 130
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+ + HS G+ HRDLKP N+++ LK+ DFG LA + ++ T Y APE
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPE 187
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK------AEFK----- 230
VI GY DIWS G I+ ++ G + F ++ ++ + KI + EF
Sbjct: 188 VILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246
Query: 231 --------------------FPNWFAP------------EVRRLLSKILDPNPNTRISMT 258
FP+ P + R LLSK+L +P RIS+
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 259 KIME----NSWF 266
++ N W+
Sbjct: 307 DALQHPYINVWY 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 77/276 (27%), Positives = 124/276 (44%), Gaps = 34/276 (12%)
Query: 16 RLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
R LG+G F KV R TG VA+K + E I +K+EI ++R + H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHEN 67
Query: 72 VVELYEVMASK---TKIYFVMEYVKGGELFGKVAKGKLKEDAAR--KYFQQLISAVDYCH 126
+V+ Y+ + ++ I +ME++ G L + + K K + + KY Q+ +DY
Sbjct: 68 IVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAY-VAPE-VIN 184
SR HRDL N+L++ +K+ DFGL+ E+ + + +P + APE +I
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 185 RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF------------- 231
+ Y S D+WS GV LY LL Y S + + IG +
Sbjct: 187 SKFYIAS--DVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243
Query: 232 ----PNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263
P EV +L+ K + P+ R + ++E
Sbjct: 244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 7e-18
Identities = 70/218 (32%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG G F V Y + + VAIK+I KE + D+ E VM + H +V+LY
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSE---DEFIEEAKVMMKLSHEKLVQLYG 66
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS-------AVDYCHSRGV 130
V + IY V EY+ G L L+E R QL+ + Y S+
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNY-----LREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV---APEVINRRG 187
HRDL N L+D+ G +KVSDFGLS D ++ G+ V PEV+
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 188 YDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
+ SK+D+W+ GV+++ V G +P+ N E K+
Sbjct: 178 FS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 8e-18
Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 10/195 (5%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG G V+ A +L T +A+K+I + + V + QI E+ ++ P ++ Y
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKP 137
+ +I E++ GG L K+ E + ++ + Y S + HRD+KP
Sbjct: 67 AFFVENRISICTEFMDGGSL---DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKP 123
Query: 138 ENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWS 197
N+L++ G +K+ DFG+S ++ + + T GT AY+APE I+ Y G +D+WS
Sbjct: 124 SNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERISGEQY-GIHSDVWS 178
Query: 198 CGVILYVLLAGYLPF 212
G+ L G P+
Sbjct: 179 LGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 35/221 (15%)
Query: 7 ILMQRYELGRLLGQGTFAKVH--YARNLKTG---MSVAIKIIDKEKVLKVGMIDQIK--R 59
+ ++ L R LGQG+F V+ A+ + G VAIK +++ M ++I+
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----SMRERIEFLN 58
Query: 60 EISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKY----- 114
E SVM+ +VV L V+++ VME + G+L + + + +
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118
Query: 115 ---FQ---QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAES----KH 163
Q ++ + Y ++ HRDL N ++ E +K+ DFG++ + E+ K
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 164 QDGLLHTTCGTPA-YVAPEVINRRGYDGSKADIWSCGVILY 203
GLL P ++APE + + G +K+D+WS GV+L+
Sbjct: 179 GKGLL------PVRWMAPESL-KDGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG G V ++ +G+ +A K+I E +K + +QI RE+ V+ P +V Y
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG-------- 129
S +I ME++ GG L LKE A++ ++++ V RG
Sbjct: 71 AFYSDGEISICMEHMDGGSL-----DQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 130 -VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY 188
+ HRD+KP N+L++ G +K+ DFG+S + D + ++ GT +Y++PE + Y
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 189 DGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK 226
++DIWS G+ L L G P + E+ G+
Sbjct: 180 S-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR 216
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 16 RLLGQGTFAKVHYARNLKTG---MSVAIKIIDKEKVLKVGMIDQIK----REISVMRLVR 68
+++G G F +V R G + VAIK LK G D+ + E S+M
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIK------TLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCH 126
HPN++ L V+ + + EY++ G L F + GK + + S + Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG-TPA-YVAPEVIN 184
HRDL N+L++ + KVSDFGLS E + T G P + APE I
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS--EATYTTKGGKIPIRWTAPEAIA 181
Query: 185 RRGYDGSKADIWSCGVILY-VLLAGYLPFHD 214
R + S +D+WS G++++ V+ G P+ D
Sbjct: 182 YRKFT-SASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 74/265 (27%), Positives = 123/265 (46%), Gaps = 33/265 (12%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
+G G F V L+ VAIK I +E + + E VM + HP +V+LY
Sbjct: 12 IGSGQFGLVWLGYWLEK-RKVAIKTI-REGAMSE---EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 78 VMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDL 135
V ++ I V E+++ G L + + +GK ++ + + Y S V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 136 KPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP---AYVAPEVINRRGYDGSK 192
N L+ E+ +KVSDFG++ D ++ GT + +PEV + Y SK
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFV----LDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SK 181
Query: 193 ADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNP 251
+D+WS GV+++ V G P+ + + E+ I A F+ + P RL S+
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI-NAGFRL---YKP---RLASQ------ 228
Query: 252 NTRISMTKIMENSWFRKGLVKPSIS 276
S+ ++M++ W + +PS S
Sbjct: 229 ----SVYELMQHCWKERPEDRPSFS 249
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID--QIKREISVMRLVRHP 70
+L R LG G F +V T VA+K LK G +D E +M+ +RHP
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNT-TPVAVK------TLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGEL---FGKVAKGKLKEDAARKYFQQLISAVDYCHS 127
+++LY V + IY V E +K G L A LK Q+ S + Y +
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVINRR 186
+ HRDL N+L+ E+ KV+DFGL+ + K P + APE
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARVI--KEDIYEAREGAKFPIKWTAPEAALYN 179
Query: 187 GYDGSKADIWSCGVILYVLLA-GYLPF 212
+ K+D+WS G++L ++ G +P+
Sbjct: 180 RFS-IKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 72/260 (27%), Positives = 125/260 (48%), Gaps = 19/260 (7%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
M+ +L + +G+G F V G VA+K I + + + E SVM +R
Sbjct: 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMTQLR 57
Query: 69 HPNVVELYEVMAS-KTKIYFVMEYVKGGELFGKV-AKGK--LKEDAARKYFQQLISAVDY 124
H N+V+L V+ K +Y V EY+ G L + ++G+ L D K+ + A++Y
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 125 CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVIN 184
+ HRDL N+L+ E KVSDFGL+ A S G L + APE +
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-----WTAPEALR 172
Query: 185 RRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRL 242
+ + +K+D+WS G++L+ + + G +P+ L ++ ++ K + P+ P V +
Sbjct: 173 EKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231
Query: 243 LSKILDPNPNTRISMTKIME 262
+ + + TR S ++ E
Sbjct: 232 MKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 69/298 (23%), Positives = 122/298 (40%), Gaps = 61/298 (20%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG G V + +G+ +A K+I E +K + +QI RE+ V+ P +V Y
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVC------ 131
S +I ME++ GG L +V K A + + ++ + RG+
Sbjct: 67 AFYSDGEISICMEHMDGGSL-DQVLK------KAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 132 ---HRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY 188
HRD+KP N+L++ G +K+ DFG+S + D + ++ GT +Y++PE + Y
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 189 DGSKADIWSCGVILYVLLAGYLP-----------FHDSNLMEMYRKIGKAEF-------- 229
++DIWS G+ L + G P + E K
Sbjct: 176 -TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234
Query: 230 ------------------KFPN-WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
K P+ F+ E + + K L NP R + ++ ++ + ++
Sbjct: 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 9/210 (4%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE 77
LG G V + +G+ +A K+I E +K + +QI RE+ V+ P +V Y
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 78 VMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDL 135
S +I ME++ GG L + K G++ E K +I + Y + + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130
Query: 136 KPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADI 195
KP N+L++ G +K+ DFG+S + D + ++ GT +Y++PE + Y ++DI
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 185
Query: 196 WSCGVILYVLLAGYLPFHDSNLMEMYRKIG 225
WS G+ L + G P + E+ G
Sbjct: 186 WSMGLSLVEMAIGRYPIPPPDAKELELMFG 215
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 7e-17
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 11 RYELGRLLGQGTFAKVHYAR---NLKTGMSVAIKIIDKEKVLKVGMIDQIKR----EISV 63
++ +++G G F +V R K + VAIK LK G ++ +R E S+
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIK------TLKAGYTEKQRRDFLSEASI 58
Query: 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISA 121
M HPN++ L V+ + V EY++ G L F + G+ + + S
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASG 118
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA---YV 178
+ Y G HRDL N+L++ + KVSDFGLS + E + +TT G +
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIPIRWT 176
Query: 179 APEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHD 214
APE I R + S +D+WS G++++ V+ G P+ +
Sbjct: 177 APEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 19/222 (8%)
Query: 9 MQRYELGRLLGQGTFAKVHYA------RNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
E ++LG G F V+ +K + VAIK++ +E K +I E
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVK--IPVAIKVLREETSPKA--NKEILDEAY 61
Query: 63 VMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLIS 120
VM V HP+VV L + S + + + + G L V K + + Q+
Sbjct: 62 VMASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG-TP-AYV 178
+ Y + + HRDL N+L+ ++K++DFGL+ L + + H G P ++
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD--EKEYHAEGGKVPIKWM 178
Query: 179 APEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219
A E I R Y K+D+WS GV ++ L+ G P+ +E
Sbjct: 179 ALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 78/327 (23%), Positives = 136/327 (41%), Gaps = 59/327 (18%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
+++RY+ + +G G V A + +VAIK + + + RE+ +M+ V
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCV 73
Query: 68 RHPNVVELYEVMASKTK------IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISA 121
H N++ L V + +Y VME + +V + +L + Q++
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCG 131
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+ + HS G+ HRDLKP N+++ LK+ DFGL+ A + ++ T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE 188
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK--------------- 226
VI GY DIWS G I+ ++ + F + ++ + K+ +
Sbjct: 189 VILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 227 ------------AEFKFPNWF---------------APEVRRLLSKILDPNPNTRISMTK 259
A FP F A + R LLSK+L +P RIS+ +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307
Query: 260 IME----NSWFRKGLVKPSISETEEKE 282
++ N W+ V+ + +K+
Sbjct: 308 ALQHPYINVWYDPAEVEAPPPQIYDKQ 334
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 12/219 (5%)
Query: 17 LLGQGTFAKVHYARNLKTG---MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVV 73
LG G+F V +G + VA+K + +K+ + +D +E ++M + H N++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLI 59
Query: 74 ELYEVMASKTKIYFVMEYVKGGELFG---KVAKGKLKEDAARKYFQQLISAVDYCHSRGV 130
LY V+ + + V E G L K A G Y Q+ + + Y S+
Sbjct: 60 RLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVINRRGYD 189
HRDL N+LL +K+ DFGL ++ P A+ APE + R +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 190 GSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA 227
+D+W GV L+ + G P+ + ++ +KI K
Sbjct: 179 -HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE 216
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 76/301 (25%), Positives = 120/301 (39%), Gaps = 53/301 (17%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV----GMIDQIKREISVMRLVR 68
E R +G G F V + + G VA+K K+ V ++ RE+ ++ +
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALK-----KMPNVFQNLVSCKRVFRELKMLCFFK 57
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGK------VAKGKLKEDAARKYFQQLISAV 122
H NV+ +++ F YV EL V+ L D + + Q++ +
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVT-ELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGL 116
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT--CGTPAYVAP 180
Y HS G+ HRD+KP NLL++ + LK+ DFGL+ + E D H T T Y AP
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE---PDESKHMTQEVVTQYYRAP 173
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFH----------------DSNLMEM---- 220
E++ + S DIWS G I LL + F +L M
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233
Query: 221 -------YRKIGKAE-----FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
R K + + E LL ++L +P+ RIS + + + +
Sbjct: 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293
Query: 269 G 269
G
Sbjct: 294 G 294
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 17/243 (6%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
+++RY+ + +G G V A + +VAIK + + + RE+ +M+ V
Sbjct: 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCV 80
Query: 68 RHPNVVELYEVMASKTK------IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISA 121
H N++ L V + +Y VME + +V + +L + Q++
Sbjct: 81 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCG 138
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+ + HS G+ HRDLKP N+++ LK+ DFGL+ A + ++ T Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE 195
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI----GKAEFKFPNWFAP 237
VI GY DIWS G I+ ++ G + F ++ ++ + K+ G +F P
Sbjct: 196 VILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 238 EVR 240
VR
Sbjct: 255 TVR 257
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 48/163 (29%), Positives = 83/163 (50%), Gaps = 9/163 (5%)
Query: 48 VLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GK 105
VLK+G E +++ V HP+V+ + + + S V+ + +L+ + K
Sbjct: 95 VLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRP 153
Query: 106 LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165
L D A +Q++ + Y H++ + HRD+K EN+ +++ + + D G +
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213
Query: 166 -GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA 207
GL GT APEV+ R Y+ SKADIWS G++L+ +LA
Sbjct: 214 LGL----AGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 73/268 (27%), Positives = 128/268 (47%), Gaps = 44/268 (16%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ Y+LG ++G G+F V+ A + T VAIK + ++ K RE+ +M+ + H
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK-------NRELLIMKNLNH 118
Query: 70 PNVVELYE------VMASKTKIYF--VMEYVKGGELFGKVAKGKLKEDAA------RKYF 115
N++ L + ++ I+ VME++ + K K + + A + Y
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 116 QQLISAVDYCHSRGVCHRDLKPENLLLDEHGN-LKVSDFGLSALAESKHQDGLLHTTCGT 174
QL A+ Y HS+ +CHRDLKP+NLL+D + + LK+ DFG SA Q + + +
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVSYIC--S 233
Query: 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSNLMEMYRKI--------- 224
Y APE++ + D+WS G I+ ++ GY F S++ ++ R I
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293
Query: 225 -------GKAEFKFPNWFAPEVRRLLSK 245
A+ KFP+ +++++ K
Sbjct: 294 QLKEMNPNYADIKFPDVKPKDLKKVFPK 321
|
Length = 440 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 31/279 (11%)
Query: 12 YELGRLLGQGTFAKVHYARNLK----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
+ LGR+LG+G F V A+ LK + VA+K++ K + I++ RE + M+
Sbjct: 1 FTLGRMLGKGEFGSVREAQ-LKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEF 58
Query: 68 RHPNVVELYEV-MASKTK-----IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLI-- 119
HPNV++L V + S+ K ++ ++K G+L + ++ E+ Q L+
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 120 -----SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174
S ++Y S+ HRDL N +L+E+ + V+DFGLS + + C +
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQGCAS 175
Query: 175 P---AYVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRK-IGKAEF 229
++A E + Y + +D+W+ GV ++ ++ G P+ E+Y I
Sbjct: 176 KLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL 234
Query: 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKI---MENSW 265
K P +V L+ + P P R S + +E W
Sbjct: 235 KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 65/274 (23%), Positives = 119/274 (43%), Gaps = 37/274 (13%)
Query: 17 LLGQGTFAKVHYARNLKTG---MSVAIKIIDKEKVLKVGMIDQIKR----EISVMRLVRH 69
++G G F +V R G + VAIK LK G ++ +R E S+M H
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIK------TLKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHS 127
PN++ L V+ + + E+++ G L F + G+ + + + + Y
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA---YVAPEVIN 184
HRDL N+L++ + KVSDFGLS E D ++ G + APE I
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 185 RRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLL 243
R + S +D+WS G++++ V+ G P+ D + ++ I + +++ P
Sbjct: 185 YRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLP----------- 231
Query: 244 SKILDPNPNTRISMTKIMENSWFRKGLVKPSISE 277
P + ++ ++M + W + +P +
Sbjct: 232 -----PPMDCPTALHQLMLDCWQKDRNARPKFGQ 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 16 RLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQI----KREISVMRLV 67
R+LG+G F KV N TG VA+K LK Q K+EI++++ +
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVK------TLKRECGQQNTSGWKKEINILKTL 63
Query: 68 RHPNVVELYEVMASK---TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDY 124
H N+V+ Y+ S+ + +MEYV G L + K KL + QQ+ + Y
Sbjct: 64 YHENIVK-YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 125 CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAY-VAPEVI 183
HS+ HRDL N+LLD +K+ DFGL+ H+ + +P + A E +
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 184 NRRGYDGSKADIWSCGVILYVLL 206
+ + +D+WS GV LY LL
Sbjct: 183 KENKFSYA-SDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 64/197 (32%), Positives = 87/197 (44%), Gaps = 21/197 (10%)
Query: 18 LGQGTFAKVH---YARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVE 74
LG G F V Y + VA+K + +E + + RE SVM + HP +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--AAGKKEFLREASVMAQLDHPCIVR 60
Query: 75 LYEVMASKTKIYFVMEYVKGGELF------GKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
L V + + VME G L ++ LKE A Q+ + Y S+
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELA-----HQVAMGMAYLESK 114
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT-P-AYVAPEVINRR 186
HRDL N+LL K+SDFG+S A D TT G P + APE IN
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 187 GYDGSKADIWSCGVILY 203
+ SK+D+WS GV L+
Sbjct: 174 KFS-SKSDVWSYGVTLW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 51/191 (26%), Positives = 97/191 (50%), Gaps = 16/191 (8%)
Query: 56 QIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLK-EDA---- 110
Q++ EI + + H N++++ E++ S+ Y + + +L+ + +D
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLK 267
Query: 111 -ARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169
R +QL+ AV+Y H + + HRD+K EN+ L+ G + + DFG +A+ K ++ +
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEKEREAFDY 326
Query: 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDS------NLMEMYR 222
GT A +PE++ GY DIWSCG+IL +L+ + P D L+++
Sbjct: 327 GWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385
Query: 223 KIGKAEFKFPN 233
+ + +FP+
Sbjct: 386 SLSVCDEEFPD 396
|
Length = 501 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIK---IIDKEKVLKVGMIDQIKREI-SVMRLVR 68
+LG +G+G F V+ + +G +A+K EK K ++ ++ VMR
Sbjct: 8 DLG-EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQK-----RLLMDLDVVMRSSD 61
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGG-ELFGKVAKGKLK----EDAARKYFQQLISAVD 123
P +V+ Y + + + ME + + F K LK E+ K + A++
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 124 YCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAES--KHQDGLLHTTCGTPAYVA 179
Y + HRD+KP N+LLD +GN+K+ DFG+S L +S K +D G Y+A
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA------GCRPYMA 175
Query: 180 PEVIN---RRGYDGSKADIWSCGVILYVLLAGYLPF 212
PE I+ R GYD ++D+WS G+ LY + G P+
Sbjct: 176 PERIDPSARDGYD-VRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 13 ELGRLLGQGTFAKV---HYARNLKTGMSVAIKIIDKEKVLKVGMID--QIKREISVMRLV 67
+L + LG G F +V +Y + K VAIK LK G + E ++M+ +
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHTK----VAIK------SLKQGSMSPEAFLAEANLMKQL 58
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKG-KLKEDAARKYFQQLISAVDY 124
+HP +V LY V+ ++ IY + EY++ G L F K +G KL + Q+ + +
Sbjct: 59 QHPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 125 CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH---QDGLLHTTCGTPAYVAPE 181
+ HRDL+ N+L+ E K++DFGL+ L E ++G + APE
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI----KWTAPE 173
Query: 182 VINRRGYDGSKADIWSCGVILY-VLLAGYLPF 212
IN G K+D+WS G++L ++ G +P+
Sbjct: 174 AIN-YGTFTIKSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK----VGMIDQIKREISVMRLVRHPNVV 73
+G+GT+ V+ A+ K G +KE LK G+ REI+++R ++HPNV+
Sbjct: 9 VGRGTYGHVYKAKR-KDGKD------EKEYALKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 74 ELYEVMASKT--KIYFVMEYVKGGEL----FGKVAKG-----KLKEDAARKYFQQLISAV 122
L +V S + K++ + +Y + F + +K +L + Q++ +
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 123 DYCHSRGVCHRDLKPENLLL----DEHGNLKVSDFGLSALAESKHQD-GLLHTTCGTPAY 177
Y H+ V HRDLKP N+L+ E G +K++D G + L S + L T Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 178 VAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH 213
APE++ + DIW+ G I LL FH
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 36/271 (13%)
Query: 17 LLGQGTFAKVHYAR----NLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRLVRHP 70
LG+G F V R TG VA+K + + L+ +REI +++ ++H
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR-----DFEREIEILKSLQHD 65
Query: 71 NVVELYEVM--ASKTKIYFVMEYVKGGELFGKVAKGKLKEDAAR--KYFQQLISAVDYCH 126
N+V+ V A + + VMEY+ G L + K + + D + Y Q+ ++Y
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAY-VAPEVINR 185
S+ HRDL N+L++ +K+ DFGL+ + + + +P + APE +
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK-----------AEFKFPNW 234
+ +D+WS GV+LY L Y S E R +G E N
Sbjct: 186 SKFS-VASDVWSFGVVLYELFT-YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243
Query: 235 FAP-------EVRRLLSKILDPNPNTRISMT 258
P E+ ++ + + +P+ R S +
Sbjct: 244 RLPAPPGCPAEIYAIMKECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 24/263 (9%)
Query: 17 LLGQGTFAKVHYARNLKTGMS-----VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
LG+G F +V A+ V +K + K K + + +RE+ + R + H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLSHKN 69
Query: 72 VVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
VV L + Y ++EY G+L F + K K ++ + A+ + G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 130 V--------CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA-YVAP 180
+ HRDL N L+ +KVS LS + + + P ++AP
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS--KDVYNSEYYKLRNALIPLRWLAP 187
Query: 181 EVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI--GKAEFKFPNWFAP 237
E + + +K+D+WS GV+++ V G LPF+ + E+ ++ GK E P
Sbjct: 188 EAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPS 246
Query: 238 EVRRLLSKILDPNPNTRISMTKI 260
+ +L+++ NP R S +++
Sbjct: 247 RLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 9e-14
Identities = 73/298 (24%), Positives = 128/298 (42%), Gaps = 51/298 (17%)
Query: 14 LGRLLGQGTFAKVHYA-----RNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
LG+ LG+G F KV A + +VA+K++ KE + D + E ++++ V
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML-KENASSSELRDLLS-EFNLLKQVN 61
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFG------KVAKGKLKEDAARK--------- 113
HP+V++LY + + ++EY K G L KV L D R
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 114 ----------YFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163
+ Q+ + Y + HRDL N+L+ E +K+SDFGLS +
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--RDVYE 179
Query: 164 QDGLLHTTCG-TPA-YVAPEVINRRGYDGSKADIWSCGVILYVLLA-------GYLPFHD 214
+D + + G P ++A E + Y +++D+WS GV+L+ ++ G P
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238
Query: 215 SNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVK 272
NL++ ++ + P + E+ L+ P+ R + I + K +VK
Sbjct: 239 FNLLKTGYRMER-----PENCSEEMYNLMLTCWKQEPDKRPTFADI--SKELEKMMVK 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK----VGMIDQIKREISVMRLVRHPNVV 73
+G+GT+ V+ A+ K G D++ LK G+ REI+++R ++HPNV+
Sbjct: 9 VGRGTYGHVYKAKR-KDGKD------DRDYALKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 74 ELYEVMASKT--KIYFVMEYVKGGEL----FGKVAKG-----KLKEDAARKYFQQLISAV 122
L +V S K++ + +Y + F + +K +L + Q++ +
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 123 DYCHSRGVCHRDLKPENLLL----DEHGNLKVSDFGLSALAESKHQD-GLLHTTCGTPAY 177
Y H+ V HRDLKP N+L+ E G +K++D G + L S + L T Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 178 VAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH 213
APE++ + DIW+ G I LL FH
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 30/218 (13%)
Query: 11 RYELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR 65
R LG+ LG+G F +V A N +VA+K++ K+ + + D + E+ +M+
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVS-EMEMMK 70
Query: 66 LV-RHPNVVELYEVMASKTKIYFVMEYVKGGEL-----------------FGKVAKGKLK 107
++ +H N++ L V + +Y V+EY G L + + L
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 108 EDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167
+ + Q+ +++ S+ HRDL N+L+ E +K++DFGL+ + H D
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA--RDIHHIDYY 188
Query: 168 LHTTCG-TPA-YVAPEVINRRGYDGSKADIWSCGVILY 203
TT G P ++APE + R Y ++D+WS GV+L+
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 64/272 (23%), Positives = 111/272 (40%), Gaps = 27/272 (9%)
Query: 14 LGRLLGQGTFAKVHYA--RNLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVMRLV 67
L R LG+G F KV +L+ + + K LK + + RE ++
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAV---KTLKETASNDARKDFEREAELLTNF 65
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGEL---------------FGKVAKGKLKEDAAR 112
+H N+V+ Y V V EY++ G+L G+L
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 113 KYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC 172
+ Q+ S + Y S+ HRDL N L+ +K+ DFG+S + + T
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKA-EFK 230
++ PE I R + +++D+WS GV+L+ + G P++ + E+ I + +
Sbjct: 186 LPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ 244
Query: 231 FPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
P EV ++ +P RI++ I E
Sbjct: 245 RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 13 ELGRLLGQGTFAKVHYA-RNLKTGMSVAIKIIDKEKVLKVGM--IDQIKREISVMRLVRH 69
+L + LG G F +V N T ++V K LK G + E ++M+ ++H
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTKVAV--------KTLKPGTMSVQAFLEEANLMKTLQH 60
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKV---AKGKLKEDAARKYFQQLISAVDYCH 126
+V LY V+ + IY + EY+ G L + GK+ + Q+ + Y
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVINR 185
+ HRDL+ N+L+ E K++DFGL+ + E P + APE IN
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA--REGAKFPIKWTAPEAIN- 177
Query: 186 RGYDGSKADIWSCGVILY-VLLAGYLPF 212
G K+D+WS G++LY ++ G +P+
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 76/269 (28%), Positives = 124/269 (46%), Gaps = 32/269 (11%)
Query: 17 LLGQGTFAKVHYARNLKTG--MSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVV 73
++G+G F +V AR K G M AIK + KE K D E+ V+ +L HPN++
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRD-FAGELEVLCKLGHHPNII 71
Query: 74 ELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKED----------AARKYFQQLIS--- 120
L + +Y +EY G L + K ++ E A+ QQL+
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 121 ----AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT-P 175
+DY + HRDL N+L+ E+ K++DFGL S+ Q+ + T G P
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL-----SRGQEVYVKKTMGRLP 186
Query: 176 A-YVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFP 232
++A E +N Y + +D+WS GV+L+ +++ G P+ E+Y K+ + + P
Sbjct: 187 VRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 245
Query: 233 NWFAPEVRRLLSKILDPNPNTRISMTKIM 261
EV L+ + P R S +I+
Sbjct: 246 LNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 26/270 (9%)
Query: 14 LGRLLGQGTFAKVHYARNLK----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
LG++LG+G F V L + + VA+K + K + I++ E + M+ H
Sbjct: 3 LGKILGEGEFGSV-MEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 70 PNVVELYEV---MASKTKI---YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLI---- 119
PNV++L V +S KI ++ ++K G+L + +L + Q L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 120 ---SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS--ALAESKHQDGLLHTTCGT 174
++Y +R HRDL N +L E + V+DFGLS + ++ G
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG--RIAKMP 178
Query: 175 PAYVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRK-IGKAEFKFP 232
++A E + R Y SK+D+W+ GV ++ + G P+ E+Y K P
Sbjct: 179 VKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP 237
Query: 233 NWFAPEVRRLLSKILDPNPNTRISMTKIME 262
E+ L+ +P R + TK+ E
Sbjct: 238 EDCLDELYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 66/246 (26%), Positives = 111/246 (45%), Gaps = 15/246 (6%)
Query: 18 LGQGTFAKVH--YARNLKTGMSVAIKII---DKEKVLKVGMIDQIKREISVMRLVRHPNV 72
LG G F V + K+ +VA+KI+ + + LK D++ RE +VM+ + +P +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALK----DELLREANVMQQLDNPYI 58
Query: 73 VELYEVMASKTKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVC 131
V + + +++ + VME + G L + K K + E + Q+ + Y
Sbjct: 59 VRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 132 HRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA-YVAPEVINRRGYDG 190
HRDL N+LL K+SDFGLS + T P + APE +N +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS- 176
Query: 191 SKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILD 248
SK+D+WS GV+++ + G P+ E+ + I E + P PE+ L+
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT 236
Query: 249 PNPNTR 254
+ R
Sbjct: 237 YGVDER 242
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 59 REISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQ 117
REI +++ + H ++ L K+ + VM K +LF V G L + A ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 118 LISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC----G 173
L+ A+ Y H RG+ HRD+K EN+ LDE N + DFG A K C G
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG----AACKLDAHPDTPQCYGWSG 249
Query: 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPF 212
T +PE++ Y +K DIWS G++L+ + +
Sbjct: 250 TLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 25/231 (10%)
Query: 16 RLLGQGTFAKVHYARNLKTG----MSVAIKIIDKEKVLKVGMIDQIKR----EISVMRLV 67
+++G G F +V + LK ++VAIK LK G ++ ++ E S+M
Sbjct: 11 KVIGAGEFGEV-FRGILKMPGRKEVAVAIK------TLKPGYTEKQRQDFLSEASIMGQF 63
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYC 125
H N++ L V+ + EY++ G L + + G+ + + + + Y
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA---YVAPEV 182
HRDL N+L++ + KVSDFGLS + E + +TT G + APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIRWTAPEA 181
Query: 183 INRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKAEFKFP 232
I R + S +D+WS G++++ V+ G P+ D + E+ + I F+ P
Sbjct: 182 IAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 32/268 (11%)
Query: 17 LLGQGTFAKVHYARNLKTG--MSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVV 73
++G+G F +V A K G M+ AIK++ KE + D E+ V+ +L HPN++
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKML-KEFASENDHRD-FAGELEVLCKLGHHPNII 66
Query: 74 ELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKED----------AARKYFQQLIS-AV 122
L ++ +Y +EY G L + K ++ E A+ QQL+ A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 123 D------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT-P 175
D Y + HRDL N+L+ E+ K++DFGL S+ ++ + T G P
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGL-----SRGEEVYVKKTMGRLP 181
Query: 176 A-YVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFP 232
++A E +N Y +K+D+WS GV+L+ +++ G P+ E+Y K+ + + P
Sbjct: 182 VRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKP 240
Query: 233 NWFAPEVRRLLSKILDPNPNTRISMTKI 260
EV L+ + P R +I
Sbjct: 241 RNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 13 ELGRLLGQG--TFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
EL ++G+G V+ AR TG V ++ I+ E M+ ++ E+ V +L HP
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHP 59
Query: 71 NVVELYEVMASKTKIYFV---MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHS 127
N+V + +++ V M Y +L + E A Q ++ A+DY H
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 119
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAY-------VAP 180
G HR +K ++L+ G + +S GL + + L P Y ++P
Sbjct: 120 MGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177
Query: 181 EVI--NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM 220
EV+ N +GYD +K+DI+S G+ L G++PF D +M
Sbjct: 178 EVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 71/288 (24%), Positives = 127/288 (44%), Gaps = 63/288 (21%)
Query: 16 RLLGQGTFAKVH---YARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV 72
R++G+G F V+ + + A+K +++ + + ++Q +E +M+ HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 73 VELYEVMASKTKI-YFVMEYVKGGEL------------------FG-KVAKGKLKEDAAR 112
+ L + V+ Y+K G+L FG +VAKG
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKG-------- 110
Query: 113 KYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL-HTT 171
++Y S+ HRDL N +LDE +KV+DFGL+ K + HT
Sbjct: 111 ---------MEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG 161
Query: 172 CGTPA-YVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEF 229
P ++A E + + + +K+D+WS GV+L+ L+ G P+ D + ++ + +
Sbjct: 162 AKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-- 218
Query: 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISE 277
RRLL P+P + ++M + W K ++P+ SE
Sbjct: 219 ----------RRLLQPEYCPDP-----LYEVMLSCWHPKPEMRPTFSE 251
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 5e-12
Identities = 76/268 (28%), Positives = 122/268 (45%), Gaps = 32/268 (11%)
Query: 17 LLGQGTFAKVHYARNLKTG--MSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVV 73
++G+G F +V AR K G M AIK + KE K D E+ V+ +L HPN++
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRD-FAGELEVLCKLGHHPNII 59
Query: 74 ELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDA---ARKY-------FQQLI---- 119
L + +Y +EY G L + K ++ E A QQL+
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 120 ---SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT-P 175
+DY + HRDL N+L+ E+ K++DFGL S+ Q+ + T G P
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL-----SRGQEVYVKKTMGRLP 174
Query: 176 A-YVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFP 232
++A E +N Y + +D+WS GV+L+ +++ G P+ E+Y K+ + + P
Sbjct: 175 VRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 233
Query: 233 NWFAPEVRRLLSKILDPNPNTRISMTKI 260
EV L+ + P R S +I
Sbjct: 234 LNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 5e-12
Identities = 67/202 (33%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMI--DQIKREISVMRLVRHPNVVEL 75
LGQG F +V + VAIK LK G + + +E VM+ +RH +V+L
Sbjct: 14 LGQGCFGEV-WMGTWNGTTRVAIK------TLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 66
Query: 76 YEVMASKTKIYFVMEYVKGGEL--FGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCH 132
Y V+ S+ IY V EY+ G L F K GK L+ Q+ S + Y H
Sbjct: 67 YAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVINRRGYDGS 191
RDL+ N+L+ E+ KV+DFGL+ L E P + APE G
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTA--RQGAKFPIKWTAPEAA-LYGRFTI 182
Query: 192 KADIWSCGVILYVLLA-GYLPF 212
K+D+WS G++L L G +P+
Sbjct: 183 KSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 29/232 (12%)
Query: 18 LGQGTFAKVHYARNLKTGMS----VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVV 73
LG+ F K++ GM VAIK + + + + ++E S+M + HPN+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 74 ELYEVMASKTKIYFVMEYVKGGELF--------------GKVAKGKLKEDAARKYFQ--- 116
L V+ + + + EY+ G+L G +K F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 117 -QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP 175
Q+ + ++Y S H+DL N+L+ E ++K+SD GLS S + +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 176 AYVAPEVINRRGYDGSKADIWSCGVILYVL----LAGYLPFHDSNLMEMYRK 223
++ PE I + S +DIWS GV+L+ + L Y F + ++EM RK
Sbjct: 191 RWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 62/237 (26%), Positives = 116/237 (48%), Gaps = 33/237 (13%)
Query: 14 LGRLLGQGTFAKVHYARNL-------KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL 66
LG+ LG+G F +V A L K ++VA+K++ K+ + + D + E+ +M++
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 76
Query: 67 V-RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKE-----DAAR-----KYF 115
+ +H N++ L +Y ++EY G L + + D AR F
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 116 QQLIS-------AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168
+ L+S ++Y S+ HRDL N+L+ E+ +K++DFGL+ + + D
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--RDVNNIDYYK 194
Query: 169 HTTCG--TPAYVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYR 222
TT G ++APE + R Y ++D+WS GV+++ + G P+ + E+++
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 10 QRYELGRLLGQGTFAKVHYAR-------NLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
R LG+ LG+G F +V A ++VA+K++ K+ + D I E+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLIS-EME 69
Query: 63 VMRLV-RHPNVVELYEVMASKTKIYFVMEYVKGGEL-----------------FGKVAKG 104
+M+L+ +H N++ L V + +Y ++EY G L KV +
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129
Query: 105 KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164
+L Q+ ++Y SR HRDL N+L+ E +K++DFG LA H
Sbjct: 130 QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFG---LARGVHD 186
Query: 165 -DGLLHTTCG-TPA-YVAPEVINRRGYDGSKADIWSCGVILY 203
D T+ G P ++APE + R Y ++D+WS G++++
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 20/221 (9%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV 72
E+GR G V+ AR+ TG V ++I D E + + ++ E+ + RHPN+
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNI 61
Query: 73 VELYEVMASKTKIYFV---MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
+ + V + + ++ + M Y L + E + ++Y H G
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAE-----SKHQ---DGLLHTTCGTPAYVAPE 181
HR++K ++L+ G + +S GLS L K + D +T P +++PE
Sbjct: 122 YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPE 178
Query: 182 VINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM 220
++ + GY+ K+DI+S G+ L G +PF D +M
Sbjct: 179 LLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDMLRTQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 70/266 (26%), Positives = 116/266 (43%), Gaps = 27/266 (10%)
Query: 18 LGQGTFAKVHYAR--NL---KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV 72
LG+G F KV A NL + M VA+K + ++ + D +RE ++ +++H ++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQD-FQREAELLTVLQHQHI 69
Query: 73 VELYEVMASKTKIYFVMEYVKGGEL------FGKVAK----------GKLKEDAARKYFQ 116
V Y V + V EY++ G+L G AK G+L
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
Q+ S + Y S HRDL N L+ + +K+ DFG+S S + T
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKA-EFKFPNW 234
++ PE I R + +++DIWS GV+L+ + G P++ + E I + E + P
Sbjct: 190 WMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRT 248
Query: 235 FAPEVRRLLSKILDPNPNTRISMTKI 260
PEV ++ P R+ + I
Sbjct: 249 CPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 70/290 (24%), Positives = 111/290 (38%), Gaps = 65/290 (22%)
Query: 13 ELGRLLGQGTFAKVHYA-----RNLKTGMSVAIKII-------DKEKVLKVGMIDQIKRE 60
L R LG G F +V+ + VA+K + D+ L E
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM---------E 59
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARK------Y 114
+M H N+V L V + + ++E + GG+L K L+E+ R
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL-----KSFLRENRPRPERPSSLT 114
Query: 115 FQQLIS-AVD------YCHSRGVCHRDLKPENLLLDEHGN---LKVSDFGLS-----ALA 159
+ L+ A D Y HRD+ N LL G K++DFG++ A
Sbjct: 115 MKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY 174
Query: 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDG---SKADIWSCGVILY-VLLAGYLPF--- 212
K +L ++ PE DG SK D+WS GV+L+ + GY+P+
Sbjct: 175 YRKGGRAMLPIK-----WMPPEAF----LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225
Query: 213 HDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
+ +ME G+ + P V R+++ P R + I+E
Sbjct: 226 TNQEVMEFVTGGGRLD--PPKGCPGPVYRIMTDCWQHTPEDRPNFATILE 273
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMI--DQIKREISVMRLVRHP 70
+L + LG G F +V + VA+K LK G + + E +M+ +RH
Sbjct: 9 QLIKKLGNGQFGEV-WMGTWNGNTKVAVK------TLKPGTMSPESFLEEAQIMKKLRHD 61
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGK-LKEDAARKYFQQLISAVDYCHS 127
+V+LY V+ S+ IY V EY+ G L F K +G+ LK Q+ + + Y
Sbjct: 62 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVINRR 186
HRDL+ N+L+ + K++DFGL+ L E P + APE
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA--RQGAKFPIKWTAPEAA-LY 177
Query: 187 GYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKI 224
G K+D+WS G++L L+ G +P+ N E+ ++
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 56/231 (24%), Positives = 101/231 (43%), Gaps = 29/231 (12%)
Query: 18 LGQGTFAKVHYARNLKTG-----MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV 72
LG+ F KV+ T +VAIK + K+K + + ++ K E + ++HPN+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 73 VELYEVMASKTKIYFVMEYVKGGELF-----------------GKVAKGKLKEDAARKYF 115
V L V+ + + + Y +L K K L+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 116 QQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP 175
Q+ + +++ S V H+DL N+L+ + N+K+SD GL + L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 176 AYVAPEVINRRGYDGSKADIWSCGVILYVL----LAGYLPFHDSNLMEMYR 222
+++PE I G +DIWS GV+L+ + L Y + + +++EM R
Sbjct: 191 RWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 72/274 (26%), Positives = 119/274 (43%), Gaps = 35/274 (12%)
Query: 18 LGQGTFAKVHYA--RNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRLVRHPNVV 73
LG G F V + K + VAIK++ + EK ++ D++ RE +M + +P +V
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR----DEMMREAEIMHQLDNPYIV 58
Query: 74 ELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVC 131
+ V ++ + VME GG L F K ++ + Q+ + Y +
Sbjct: 59 RMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 132 HRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVINRRGYDG 190
HRDL N+LL K+SDFGLS + + P + APE IN R +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS- 176
Query: 191 SKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLL--SKIL 247
S++D+WS G+ ++ + G P Y+K+ PEV + K L
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKP---------YKKMK----------GPEVMSFIEQGKRL 217
Query: 248 DPNPNTRISMTKIMENSWFRKGLVKPSISETEEK 281
D M +M++ W K +P+ ++ EE+
Sbjct: 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEER 251
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 64/245 (26%), Positives = 115/245 (46%), Gaps = 43/245 (17%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGM---------SVAIKIIDKEKVLKVGMIDQIKREI 61
R LG+ LG+G F +V A + G+ VA+K++ + K + D I E+
Sbjct: 19 RLVLGKPLGEGCFGQVVMAEAI--GLDKEKPNRVTKVAVKMLKSDATEK-DLSDLIS-EM 74
Query: 62 SVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKY------ 114
+M+++ +H N++ L +Y ++EY G L + + + +Y
Sbjct: 75 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL---RARRPPGMEYCYNPTQ 131
Query: 115 -------FQQLIS-------AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160
F+ L+S ++Y S+ HRDL N+L+ E +K++DFGL+ +
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA--RD 189
Query: 161 SKHQDGLLHTTCGT-PA-YVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNL 217
H D TT G P ++APE + R Y ++D+WS GV+L+ + G P+ +
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPV 248
Query: 218 MEMYR 222
E+++
Sbjct: 249 EELFK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 32/88 (36%), Positives = 50/88 (56%), Gaps = 1/88 (1%)
Query: 116 QQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP 175
+QL+SA+DY H G+ HRD+K EN+L++ ++ + DFG + A + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 176 AYVAPEVINRRGYDGSKADIWSCGVILY 203
APEV+ Y S DIWS G++++
Sbjct: 327 DTNAPEVLAGDPYTPS-VDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 14 LGRLLGQGTFAKVHYAR--NL---KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
L R LG+G F KV A NL K M VA+K + K + +RE ++ ++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQ 65
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKV---------------AKGKLKEDAA 111
H ++V+ Y V + V EY+K G+L F + AKG+L
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 112 RKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT 171
Q+ S + Y S+ HRDL N L+ + +K+ DFG+S S + T
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILY 203
++ PE I R + +++D+WS GVIL+
Sbjct: 186 MLPIRWMPPESIMYRKFT-TESDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG--MIDQIKREISVMRLVRHPNVVEL 75
LGQG F +V + VAIK LK G M + +E +M+ +RH +V L
Sbjct: 14 LGQGCFGEV-WMGTWNGTTKVAIK------TLKPGTMMPEAFLQEAQIMKKLRHDKLVPL 66
Query: 76 YEVMASKTKIYFVMEYVKGGEL--FGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCH 132
Y V+ S+ IY V E++ G L F K GK LK Q+ + Y H
Sbjct: 67 YAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVINRRGYDGS 191
RDL+ N+L+ ++ K++DFGL+ L E P + APE G
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTA--RQGAKFPIKWTAPEAA-LYGRFTI 182
Query: 192 KADIWSCGVILYVLLA-GYLPF 212
K+D+WS G++L L+ G +P+
Sbjct: 183 KSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 25/268 (9%)
Query: 14 LGRLLGQGTFAKVHYAR--NLKTGMSVAIKIIDKEKVLKVGMIDQIK---REISVMRLVR 68
L R LG+G F KV A NL KI+ K LK + K RE ++ ++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQD---KILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGEL--FGK--------VAKG----KLKEDAARKY 114
H ++V+ Y V + V EY+K G+L F + +A+G +L +
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 115 FQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174
QQ+ + + Y S+ HRDL N L+ E+ +K+ DFG+S S + T
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 175 PAYVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKAE-FKFP 232
++ PE I R + +++D+WS GV+L+ + G P++ + E+ I + + P
Sbjct: 186 IRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 244
Query: 233 NWFAPEVRRLLSKILDPNPNTRISMTKI 260
EV L+ P+ R+++ +I
Sbjct: 245 RTCPKEVYDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 40/237 (16%)
Query: 11 RYELGRLLGQGTFAKVHYA--RNLKTGMS--VAIK-IIDKEKVLKVGMIDQIKREISVMR 65
R L LL +GTF ++ Y + K G V +K + D ++V ++ Q E ++
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ---ESCLLY 63
Query: 66 LVRHPNVVELYEVMASKTKIYFVME-YVKGGELFGKVAKGKLKE-DAARKYFQ------- 116
+ H N++ + V + FV+ Y+ G L + + +L E + +
Sbjct: 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 117 -QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS---------ALAESKHQDG 166
Q+ + Y H RGV H+D+ N ++DE +K++D LS L +++++
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-- 181
Query: 167 LLHTTCGTP-AYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMY 221
P ++A E + + Y S +D+WS GV+L+ L+ G P+ + + EM
Sbjct: 182 --------PVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 6/168 (3%)
Query: 48 VLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLK 107
V+K G E ++R + HP++++L ++ K AK +
Sbjct: 121 VIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIA 180
Query: 108 EDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167
+ ++ A+ Y H + HRD+K EN+ ++ G++ + DFG + + +
Sbjct: 181 ICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK- 239
Query: 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS 215
+ GT A APE++ R Y G DIWS G++L+ + HDS
Sbjct: 240 YYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC----HDS 282
|
Length = 391 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 64/250 (25%), Positives = 114/250 (45%), Gaps = 53/250 (21%)
Query: 11 RYELGRLLGQGTFAKVHYARNL-------KTGMSVAIKIIDKEKVLKVGMIDQIKREISV 63
R LG+ LG+G F +V A + ++VA+K++ + K + + E+ +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK--DLSDLVSEMEM 70
Query: 64 MRLV-RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKE-------------- 108
M+++ +H N++ L +Y ++EY +KG L+E
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYA---------SKGNLREYLRARRPPGMDYSF 121
Query: 109 DAAR-----KYFQQLIS-------AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156
D + F+ L+S ++Y S+ HRDL N+L+ E +K++DFG
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG-- 179
Query: 157 ALAESKHQ-DGLLHTTCGT-PA-YVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPF 212
LA H D TT G P ++APE + R Y ++D+WS GV+L+ + G P+
Sbjct: 180 -LARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPY 237
Query: 213 HDSNLMEMYR 222
+ E+++
Sbjct: 238 PGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 20/220 (9%)
Query: 13 ELGRLLGQGTFAKVHYAR-NLKTGMSVAIKIIDKEKVLKVGM--IDQIKREISVMRLVRH 69
+L + LG G F +V A N T ++V K +K G ++ E +VM+ ++H
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTKVAV--------KTMKPGSMSVEAFLAEANVMKTLQH 60
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKG-KLKEDAARKYFQQLISAVDYCH 126
+V+L+ V+ +K IY + E++ G L F K +G K + Q+ + +
Sbjct: 61 DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVINR 185
R HRDL+ N+L+ K++DFGL+ + E + P + APE IN
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINF 177
Query: 186 RGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKI 224
+ K+D+WS G++L ++ G +P+ + E+ R +
Sbjct: 178 GSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 34/232 (14%)
Query: 11 RYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR 65
Y R +GQG F +V AR + VA+K++ +E M +RE ++M
Sbjct: 8 EYV--RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMA 63
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYF-------- 115
HPN+V+L V A + + EY+ G+L F + + + +
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 116 -------------QQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162
+Q+ + + Y R HRDL N L+ E+ +K++DFGLS S
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183
Query: 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFH 213
++ PE I Y +++D+W+ GV+L+ + + G P++
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYY 234
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 27/271 (9%)
Query: 14 LGRLLGQGTFAKVHYAR--NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
LG+ LG+G F V + + + VA+K + + M D + E M+ HPN
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHPN 61
Query: 72 VVELYEV--MASKTKIY----FVMEYVKGGELFGKVAKGKLKE-------DAARKYFQQL 118
V+ L V +++ Y ++ ++K G+L + +L + K+ +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT---CGTP 175
S ++Y S+ HRDL N +L+E+ N+ V+DFGLS K +G + P
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS----KKIYNGDYYRQGRIAKMP 177
Query: 176 A-YVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKA-EFKFP 232
++A E + R Y +K+D+WS GV ++ + G P+ E+Y + + K P
Sbjct: 178 VKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236
Query: 233 NWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263
+ L+S NP R S +
Sbjct: 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 9e-10
Identities = 55/233 (23%), Positives = 96/233 (41%), Gaps = 22/233 (9%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKV-LKVGMIDQIKREISVMRLVRHPNVVELY 76
+G G F KV GMS A ++ + + +E+ R + HPNV++
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 77 EVMASKTKIYFVMEYVKGGELFGKVAKGKLKED-AARKYFQQ-----LISAVDYCHSRGV 130
V+E+ G+L + + A+K Q + S + + H
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT--CGTP-AYVAPEVINRRG 187
H DL N L ++K+ D+G LA ++ + T P ++APE++ RG
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYG---LALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 188 YD------GSKADIWSCGVILYVLL-AGYLPFHD-SNLMEMYRKIGKAEFKFP 232
D K++IWS GV ++ L A P+ D S+ + + + + + K P
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 46/174 (26%), Positives = 73/174 (41%), Gaps = 29/174 (16%)
Query: 10 QRYELGRLLGQGTFAKVHY--ARNLKT--GMS----------VAIKIIDKEKVLKVGMID 55
Q+ L LG+G F +VH A L G VA+K++ + V K D
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RADVTKTARND 63
Query: 56 QIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG---------ELFGKVAKGKL 106
+K EI +M +++PN++ L V S + + EY++ G E+
Sbjct: 64 FLK-EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 107 KEDAARKYF----QQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156
+ Q+ S + Y S HRDL N L+ H +K++DFG+S
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 12/207 (5%)
Query: 8 LMQRYELGRL--LGQGTFAKVHYARNLKTG----MSVAIKIIDKEKVLKVGMIDQIKREI 61
+++ EL R+ LG G F V+ + G + VAIKI+++ K + + E
Sbjct: 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEA 60
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK--LKEDAARKYFQQLI 119
+M + HP++V L V S T I V + + G L V + K + + Q+
Sbjct: 61 LIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIA 119
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
+ Y R + HRDL N+L+ ++K++DFGL+ L E ++ ++A
Sbjct: 120 KGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLL 206
E I+ R + ++D+WS GV ++ L+
Sbjct: 180 LECIHYRKFT-HQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 16 RLLGQGTFAKVHYARNLKTG----MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
++LG G F V+ + G + VAIK + + K +I E VM V +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 70
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ----QLISAVDYCHS 127
V L + + T + + + + G L V + K ++ +Y Q+ ++Y
Sbjct: 71 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSAL--AESK--HQDGLLHTTCGTP-AYVAPEV 182
R + HRDL N+L+ ++K++DFGL+ L A+ K H +G P ++A E
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG-----GKVPIKWMALES 182
Query: 183 INRRGYDGSKADIWSCGVILYVLLA-GYLPF 212
I R Y ++D+WS GV ++ L+ G P+
Sbjct: 183 ILHRIYT-HQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 65/271 (23%), Positives = 106/271 (39%), Gaps = 45/271 (16%)
Query: 18 LGQGTFAKVHYARNLKTG----------MSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
LGQGTF ++ +SV +K++ + + S+M +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFF----ETASLMSQL 58
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKL----KEDAARKYFQQLISA 121
H ++V+LY V I V EYVK G L F K + K D A +QL SA
Sbjct: 59 SHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVA----KQLASA 113
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGN-------LKVSDFGLSALAESKHQDGLLHTTCGT 174
+ Y + + H ++ +N+L+ +G +K+SD G+ S+ +
Sbjct: 114 LHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE-------RVE 166
Query: 175 PA-YVAPEVI-NRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKA-EFK 230
++APE I N + AD WS G L + G P + E R
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP 226
Query: 231 FPNWFAPEVRRLLSKILDPNPNTRISMTKIM 261
P+ E+ L+++ +P R S I+
Sbjct: 227 MPDC--AELANLINQCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 48/244 (19%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
QR+++ LLG+GTF KV A + K A+KI+ V K K EI M VR
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV--RNVPK--YTRDAKIEIQFMEKVRQ 184
Query: 70 PNVVELYEVMASKTKIYF---------VM-EYVKGGELFGKVAK-GKLKEDAARKYFQQL 118
+ + + +M K + YF VM +Y G L + K G + Q
Sbjct: 185 ADPADRFPLM--KIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQT 240
Query: 119 ISAVDYCHSR-GVCHRDLKPENLLLD----------------EHGNLKVSDFGLSALAES 161
A+DY H+ + H DLKPEN+L++ + +++ D G +
Sbjct: 241 GVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG--GCCDE 298
Query: 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPF--HDS---- 215
+H + T Y +PEV+ G+ S D+WS G I+Y L G L + HD+
Sbjct: 299 RHSRTAI---VSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHL 354
Query: 216 NLME 219
+LME
Sbjct: 355 HLME 358
|
Length = 467 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 114 YFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173
Y Q+ +++ SR HRDL N+LL E+ +K+ DFGL A K D + +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGSAR 237
Query: 174 TP-AYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGK--AEF 229
P ++APE I + Y +++D+WS GV+L+ + + G P+ + E + + K
Sbjct: 238 LPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
+ P PE+ R++ +P R + + ++E
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 39/173 (22%), Positives = 66/173 (38%), Gaps = 26/173 (15%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKT-GMSVAIKIIDKE---------KVLKVGMIDQIK- 58
Q LG+G F +VH S + KVL+ D +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 59 ---REISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARK 113
+E+ ++ + PN+ L V + +MEY++ G+L F + + A
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 114 YF----------QQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156
Q+ S + Y S HRDL N L+ ++ +K++DFG+S
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 43/153 (28%), Positives = 79/153 (51%), Gaps = 6/153 (3%)
Query: 114 YFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173
Y Q+ +++ SR HRDL N+LL E+ +K+ DFGL A K D +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGDAR 236
Query: 174 TP-AYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMY-RKIGKA-EF 229
P ++APE I + Y +++D+WS GV+L+ + + G P+ + E + R++ +
Sbjct: 237 LPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
+ P + PE+ ++ NP R + ++++E
Sbjct: 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 32/88 (36%), Positives = 49/88 (55%), Gaps = 10/88 (11%)
Query: 75 LYEVMASKTKIYFVMEYVKGGELFGKV---AKGKLKEDA-ARKYFQQLISAVDYCHSRGV 130
L ++M SK Y V Y L GKV KG +E+ + +Q++ A+D HS G+
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276
Query: 131 CHRDLKPENLLLDE-HGNLKVSDFGLSA 157
HRD+KP+N++ E G+ K+ D G +A
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 42/277 (15%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKE-KVLKVGMIDQIK----REISVMRLVRHP 70
LG G F +V Y + I K L+ G DQ K +E +M HP
Sbjct: 1 NFLGSGAFGEV-YEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHP 59
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVD------- 123
N+V+L V Y +ME ++GG+L + + ++ L++ +
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDAR-----VERFGPPLLTLKELLDICLD 114
Query: 124 ------YCHSRGVCHRDLKPENLLLDEHGN-----LKVSDFGLSA-LAES----KHQDGL 167
Y HRDL N L+ E G +K+ DFGL+ + +S K +GL
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI-G 225
L ++APE + G +++D+WS GV+++ +L G P+ N E+ + +
Sbjct: 175 LPVR-----WMAPESL-LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228
Query: 226 KAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
+ P ++ +L++ +P+ R + +I E
Sbjct: 229 GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 63/265 (23%), Positives = 114/265 (43%), Gaps = 21/265 (7%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTG-----MSVAIKIIDKEKVLKVGMIDQIKREISVM- 64
G+ LG G F KV A M VA+K++ K + + E+ +M
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKML-KPTA-HSSEREALMSELKIMS 93
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK---LKEDAARKYFQQLISA 121
L H N+V L I + EY G+L + + + L + + Q+
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS--ALAESKHQDGLLHTTCGTPA-YV 178
+ + S+ HRDL N+LL +K+ DFGL+ + +S + ++ P ++
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY---VVKGNARLPVKWM 210
Query: 179 APEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEFKFPN-WFA 236
APE I Y ++D+WS G++L+ + + G P+ + + K+ K ++ A
Sbjct: 211 APESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA 269
Query: 237 P-EVRRLLSKILDPNPNTRISMTKI 260
P E+ ++ D +P R + +I
Sbjct: 270 PAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 43/154 (27%), Positives = 80/154 (51%), Gaps = 6/154 (3%)
Query: 114 YFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173
Y Q+ +++ SR HRDL N+LL E+ +K+ DFGL A K D +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGDAR 242
Query: 174 TP-AYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMY-RKIGKA-EF 229
P ++APE I R Y ++D+WS GV+L+ + + G P+ + E + R++ +
Sbjct: 243 LPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263
+ P++ PE+ + + P+ R + ++++E+
Sbjct: 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 68/266 (25%), Positives = 109/266 (40%), Gaps = 28/266 (10%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV--GMIDQIKREISV--------MRLV 67
LG+GT ++ YA L EK +KV ++D R+IS+ MR V
Sbjct: 3 LGRGTRTQI-YAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV 61
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQLISAVDYC 125
H ++V LY V + V E+V+ G +LF L K +QL SA+ Y
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL 121
Query: 126 HSRGVCHRDLKPENLLLDEHG-------NLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
+ + H ++ +N+LL G +K+SD G+ S+ + ++
Sbjct: 122 EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQE------CVERIPWI 175
Query: 179 APEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAP 237
APE + AD WS G L+ + G +P D L E R +
Sbjct: 176 APECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE-GQCMLVTPSCK 234
Query: 238 EVRRLLSKILDPNPNTRISMTKIMEN 263
E+ L++ ++ +PN R IM +
Sbjct: 235 ELADLMTHCMNYDPNQRPFFRAIMRD 260
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 30/167 (17%)
Query: 18 LGQGTFAKVHYAR----------------NLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
LG+G F +VH + + VA+K++ +E K D +K EI
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDANKNARNDFLK-EI 70
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAA---------- 111
+M ++ PN++ L V + + + EY++ G+L +++ + +E A
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 112 --RKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156
Q+ S + Y S HRDL N L+ ++ +K++DFG+S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 14 LGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKR----EISVM 64
+ R+LG G F ++ R K + VAI L+ G D+ +R E +
Sbjct: 9 IERILGTGRFGEL--CRGCLKLPSKRELPVAIH------TLRAGCSDKQRRGFLAEALTL 60
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAV 122
H N+V L V+ + V EY+ G L F + +G+L L S +
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGM 120
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV---A 179
Y G H+ L +L++ K+S F L E K + ++TT + V A
Sbjct: 121 KYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSE--AIYTTMSGKSPVLWAA 176
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHD 214
PE I + + S +D+WS G++++ +++ G P+ D
Sbjct: 177 PEAI-QYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 26/201 (12%)
Query: 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQI-KREISVMRLVRHPNVVEL 75
++ +G + +++K GM +K I+ ++ I EI+ M ++HPN+V+L
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEIND--------VNSIPSSEIADMGKLQHPNIVKL 748
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCH---SRGVCH 132
+ S+ Y + EY++G L +V + L + RK + A+ + H S V
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNL-SEVLRN-LSWERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 133 RDLKPENLLLD--EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDG 190
+L PE +++D + +L++S GL + AYVAPE +
Sbjct: 807 GNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFI---------SSAYVAPETRETKDIT- 856
Query: 191 SKADIWSCGVILYVLLAGYLP 211
K+DI+ G+IL LL G P
Sbjct: 857 EKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 16 RLLGQGTFAKVHYARNLKTG----MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
++LG G F V+ + G + VAIK++ + K +I E VM V P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPY 70
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRG 129
V L + + T + V + + G L V K ++ + Q+ + Y
Sbjct: 71 VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG-TP-AYVAPEVINRRG 187
+ HRDL N+L+ ++K++DFGL+ L + + H G P ++A E I R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE--YHADGGKVPIKWMALESILHRR 187
Query: 188 YDGSKADIWSCGVILYVLLA-GYLPF 212
+ ++D+WS GV ++ L+ G P+
Sbjct: 188 FT-HQSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-07
Identities = 31/131 (23%), Positives = 59/131 (45%), Gaps = 19/131 (14%)
Query: 40 IKIIDKEKVLKVG----MIDQIKREISVMRLVRH-----PNVVELYEVMASKTKIYFVME 90
+ D++ VLK+ +RE+++++L+ P V+ E S Y +ME
Sbjct: 17 LGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGE---SDGWSYLLME 73
Query: 91 YVKGGELFGKVAKGKLKEDAARKYFQQL--ISAVDYCHSRGVCHRDLKPENLLLDEHGNL 148
+++G L + KED A + + L + + +CH DL P N+L+D+ L
Sbjct: 74 WIEGETL--DEVSEEEKEDIAEQLAELLAKLHQLP---LLVLCHGDLHPGNILVDDGKIL 128
Query: 149 KVSDFGLSALA 159
+ D+ +
Sbjct: 129 GIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 33/217 (15%)
Query: 10 QRYELGRLLGQGTFAKVH--YARNLKTG---MSVAIKIIDKEKVLKVGMIDQIKREISVM 64
++ L R LGQG+F V+ AR++ G VA+K +++ L+ + + E SVM
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARK------YFQQL 118
+ +VV L V++ VME + G+L K L+ +A Q++
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL--KSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 119 IS-------AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAES----KHQDG 166
I + Y +++ HRDL N ++ +K+ DFG++ + E+ K G
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILY 203
LL ++APE + + G + +D+WS GV+L+
Sbjct: 182 LLPVR-----WMAPESL-KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 69/269 (25%), Positives = 119/269 (44%), Gaps = 38/269 (14%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI--------SVMRLVRH 69
LGQGTF K+ + ++ + ++ E +LKV +D+ R S+M + H
Sbjct: 3 LGQGTFTKIF--KGIRREVGDYGELHKTEVLLKV--LDKSHRNYSESFFEAASMMSQLSH 58
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKY--FQQLISAVDYCHS 127
++V Y V + V EYVK G L + K K + + K +QL A+ +
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 128 RGVCHRDLKPENLLL-----DEHGN---LKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
+G+ H ++ +N+LL + GN +K+SD G+S K + LL +V
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK--EILLERI----PWVP 172
Query: 180 PEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI----GKAEFKFPNW 234
PE I AD WS G L+ + G P + ++ +K+ + + P W
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL---SALDSQKKLQFYEDRHQLPAPKW 229
Query: 235 FAPEVRRLLSKILDPNPNTRISMTKIMEN 263
E+ L+++ +D P+ R S I+ +
Sbjct: 230 --TELANLINQCMDYEPDFRPSFRAIIRD 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 13/222 (5%)
Query: 15 GRLLGQGTFAKVHYARNLKTGMS----VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
+LLG G F VH + G S VAIK I + +I + M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQT--FQEITDHMLAMGSLDHA 69
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSR 128
+V L + + V + G L V + L + Q+ + Y
Sbjct: 70 YIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVINRRG 187
+ HR+L N+LL ++++DFG++ L + ++ TP ++A E I
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK-YFYSEHKTPIKWMALESILFGR 187
Query: 188 YDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE 228
Y ++D+WS GV ++ +++ G P+ E+ + K E
Sbjct: 188 YT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 27/234 (11%)
Query: 48 VLKVGMIDQIKREI--------SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFG 99
VLKV +D R+I S+M V H ++ ++ V ++ V E+V+ G L
Sbjct: 48 VLKV--LDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDV 105
Query: 100 KVAKGKLKEDAARKYF--QQLISAVDYCHSRGVCHRDLKPENLLLDEHG-------NLKV 150
+ K K + A K QQL SA+ Y + + H ++ +N+LL G +K+
Sbjct: 106 CLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKL 165
Query: 151 SDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCG-VILYVLLAGY 209
SD G+S A S+ + ++APE + + AD WS G +L + G
Sbjct: 166 SDPGVSFTALSREE------RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219
Query: 210 LPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263
+P + E R K + + P E+ L+S+ L P R S I+ +
Sbjct: 220 VPLKERTPSEKERFYEK-KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 41/175 (23%), Positives = 74/175 (42%), Gaps = 38/175 (21%)
Query: 18 LGQGTFAKVH--------------YARNLKTGMS--VAIKIIDKEKVLKVGMIDQIKREI 61
LG+G F +VH + N++ G VA+KI+ + K D +K E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLK-EV 70
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ----- 116
++ ++ PN++ L V + + + EY++ G+L ++ L +
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 117 ---------------QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156
Q+ S + Y S HRDL N L+ E+ +K++DFG+S
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 51/215 (23%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 10 QRYELGRLLGQGTFAKVH--YARNL---KTGMSVAIKIIDKEKVLKVGMIDQIKREISVM 64
++ + R LGQG+F V+ A+ + + VAIK +++ ++ + + E SVM
Sbjct: 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVM 63
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAA--------RKYFQ 116
+ +VV L V++ +ME + G+L + + + + +K Q
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 117 ---QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAES----KHQDGLL 168
++ + Y ++ HRDL N ++ E +K+ DFG++ + E+ K GLL
Sbjct: 124 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILY 203
+++PE + + G + +D+WS GV+L+
Sbjct: 184 PVR-----WMSPESL-KDGVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 36/153 (23%), Positives = 61/153 (39%), Gaps = 23/153 (15%)
Query: 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP---- 70
+L+ +G A+++ L IK + K ++ K ++ I R R
Sbjct: 1 MKLIKRGAEAEIYLGDFLG------IKAVIKWRIPKRYRHPELDERIRRERTRREARIMS 54
Query: 71 -------NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVD 123
NV +Y V I VMEY++G L + + +++ V
Sbjct: 55 RARKAGVNVPAVYFVDPENFII--VMEYIEGEPLKDLINSN---GMEELELSREIGRLVG 109
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156
HS G+ H DL N++L G + + DFGL+
Sbjct: 110 KLHSAGIIHGDLTTSNMILSG-GKIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 62/260 (23%), Positives = 108/260 (41%), Gaps = 42/260 (16%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK--REISVMRLVRHPNVVEL 75
+G G F KV + +G + A +++ KE + + +Q+K E R ++H N+++
Sbjct: 3 IGNGWFGKV-ILGEVNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAA------RKYFQQLISAVDYCHSRG 129
T VME+ G+L G + + E ++ ++ + + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT--CGTP-AYVAPEVI--- 183
H DL N LL +K+ D+GLS K+++ T P ++APE++
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHN---KYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 184 --NRRGYDGSK-ADIWSCGVILYVLLA-GYLPF-HDSN-------LMEMYRKIGKAEFKF 231
N D +K +++WS GV ++ L G P+ H S+ + E K+ K K
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237
Query: 232 PN-----------WFAPEVR 240
P W PE R
Sbjct: 238 PLSDRWYEVMQFCWLQPEQR 257
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 20/60 (33%), Positives = 34/60 (56%), Gaps = 1/60 (1%)
Query: 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP 232
GTP Y+APE++ + + G D W+ GV L+ L G PF+D ++++ I + +P
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 31/100 (31%), Positives = 44/100 (44%), Gaps = 16/100 (16%)
Query: 119 ISAVDYCHSRG----VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174
I AV C HR K N+LL + + G S ++ Q
Sbjct: 19 IWAV--CLQCLGALRELHRQAKSGNILLTW--DGLLKLDG-SVAFKTPEQSR------PD 67
Query: 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD 214
P ++APEVI + Y KADI+S G+ LY L LP+++
Sbjct: 68 PYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNE 106
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 17/39 (43%), Positives = 27/39 (69%)
Query: 116 QQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFG 154
+Q+++ + H G+ HRD+KPENLL+ G +K+ DFG
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 47/215 (21%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQ--IKREISVMRLVRHPNVVEL 75
+G G F KV + + T VA +++ KE +Q ++ R+++HPN+++
Sbjct: 3 IGNGWFGKVLLSE-IYTDTGVA-RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 76 YEVMASKTKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQL---ISA-VDYCHSRGV 130
V EY + G+L +++ + + ++ Q++ I+A V + H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT---TCGTPAYVAPEVINRRG 187
H DL N L +KV D+G+ S++++ + T C ++APE++
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYGIGP---SRYKEDYIETEDDKCVPLRWLAPELVGEF- 176
Query: 188 YDG-------SKADIWSCGVILYVLLA-GYLPFHD 214
+ G +++W+ GV L+ L P+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 8e-04
Identities = 17/66 (25%), Positives = 34/66 (51%), Gaps = 5/66 (7%)
Query: 88 VMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN 147
VMEY+ G EL + ++ ED + +++ + + G+ H DL N+L+D+
Sbjct: 109 VMEYIDGVEL----YRVRVLEDPE-EVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163
Query: 148 LKVSDF 153
+ + D+
Sbjct: 164 IYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLDEHGNL-KVSDFGLSALAESKHQDGLLHTTCGTP 175
Q+ + + S+ HRDL N+LL HG + K+ DFGL A + ++ P
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILL-THGRITKICDFGL-ARDIRNDSNYVVKGNARLP 279
Query: 176 A-YVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEFKF-- 231
++APE I Y ++D+WS G++L+ + + G P+ + + K+ K ++
Sbjct: 280 VKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS 338
Query: 232 PNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
P E+ ++ D +P R + +I++
Sbjct: 339 PECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH--TTCGT 174
Q+ +++ S+ HRDL N+LL + +K+ DFGL+ + H + +T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA--RDIMHDSNYVSKGSTFLP 302
Query: 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFH----DSNLMEMYRKIGKAEF 229
++APE I Y + +D+WS G++L+ + + G P+ DS Y KI K+ +
Sbjct: 303 VKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF---YNKI-KSGY 357
Query: 230 KF--PNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
+ P+ EV ++ K + P R S + +
Sbjct: 358 RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 50/242 (20%), Positives = 99/242 (40%), Gaps = 26/242 (10%)
Query: 37 SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELY----EVMASKTKIYFVMEYV 92
V I+ K +ID + EI +R + N++++Y +++ ++ ++EY
Sbjct: 45 EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 93 KGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKP------ENLLLDEH 145
G L + L ++ + +L A+D C + KP + L+ E+
Sbjct: 105 TRGYL-----REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN 159
Query: 146 GNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILY 203
LK+ GL + S + Y + +++N Y K DI+S GV+L+
Sbjct: 160 YKLKIICHGLEKILSSPPFKNV-----NFMVYFSYKMLNDIFSEYT-IKDDIYSLGVVLW 213
Query: 204 VLLAGYLPFHDSNLMEMYRKIGK--AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIM 261
+ G +PF + E+Y I K P E++ ++ + R ++ +I+
Sbjct: 214 EIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
Query: 262 EN 263
N
Sbjct: 274 YN 275
|
Length = 283 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 20/66 (30%), Positives = 36/66 (54%), Gaps = 4/66 (6%)
Query: 88 VMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN 147
VMEY++G EL + +L + + +++ V + RG+ H DL N+L+ E G+
Sbjct: 185 VMEYIEGVEL----YRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240
Query: 148 LKVSDF 153
+ V D+
Sbjct: 241 IVVIDW 246
|
Length = 304 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 58/295 (19%), Positives = 99/295 (33%), Gaps = 104/295 (35%)
Query: 24 AKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-----RHP-------- 70
A+VH A LK+G VA+K V + G+ ++I+ ++ ++R + R P
Sbjct: 139 AQVHRAV-LKSGEEVAVK------VQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDL 191
Query: 71 -NVVELYE-------------VMASKTKIYF---------------------VMEYVKG- 94
VV+ +E A + + F ME++ G
Sbjct: 192 VEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGI 251
Query: 95 --GELFGKVAKG----KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNL 148
++ + G +L E R + +QL+ D G H D P N+L+ G +
Sbjct: 252 KISDIAALKSAGIDRKELAELLVRAFLRQLL--RD-----GFFHADPHPGNILVRSDGRI 304
Query: 149 KVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAG 208
+ DFG+ + K + L +A R YD V + G
Sbjct: 305 VLLDFGIVGRLDPKFRRYLAEL------LLA---FLNRDYD---------RVAELHVELG 346
Query: 209 YLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263
Y+P A +R +L I IS +I++
Sbjct: 347 YVPPDTDRDP----------------LAAAIRAVLEPIYGKPLEE-ISFGEILDK 384
|
Length = 517 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 28/108 (25%), Positives = 55/108 (50%), Gaps = 6/108 (5%)
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH--TTCGT 174
Q+ + +++ S+ HRDL N+L+ E +K+ DFGL+ + + +T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA--RDIMRDSNYISKGSTFLP 304
Query: 175 PAYVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMY 221
++APE I Y + +D+WS G++L+ + G P+ + + E +
Sbjct: 305 LKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 472 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.21 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.16 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.14 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.1 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.97 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.83 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.78 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.72 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.58 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.43 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.31 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.29 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.26 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.24 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.24 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.09 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.07 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.89 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.85 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.83 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.8 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.79 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.78 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.77 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 97.75 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.69 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.66 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.59 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.46 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.45 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.31 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.11 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.1 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.09 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.06 | |
| PLN02236 | 344 | choline kinase | 96.8 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.78 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.62 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.39 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.24 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.18 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.97 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.94 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.93 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.51 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.35 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.17 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.48 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-63 Score=500.19 Aligned_cols=340 Identities=53% Similarity=0.893 Sum_probs=278.3
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK--VGMIDQIKREISVMRLVR-HPNVVELYEVMASK 82 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 82 (472)
....++|++++.||+|+||+|++|.+..+|+.||+|+++++.... ....+.+.+|+.++++++ ||||+++++++.+.
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 367889999999999999999999999999999999888764331 135678889999999999 99999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~-g~vkl~DFGla~~~~ 160 (472)
+++|+||||+.||+|++++.. +++.|.+++++|+||++|++|||++||+||||||||||+|.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999976 899999999999999999999999999999999999999999 999999999999774
Q ss_pred cccCCCcccccCCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCC-CHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWF-APE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~ 238 (472)
..+..+.+.||||.|+|||++.+.+ |++.++|||||||+||.|++|+.||++.+...++.+|.++.+.+|.|+ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 3456689999999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCccccc-CCCCCCCCcccccc-c--CCCCCCcccCCCC--CCccccccccccCCCC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWFRK-GLVKPSISETEEKE-W--APVDADAVFSPSG--STSTVAESKNELAKPC 312 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f~~-~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 312 (472)
+++||++||.+||.+|+|+.+|++||||+. .............. . .+...+....... .......... ...+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 329 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQKENPLPSDELPSEVAPSAPSAPSAKDSVSPVETEDEKPLSPTSTP-ESLPL 329 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhccCCCCCccccccccccccccccccccccccccccccccccccccc-ccccc
Confidence 999999999999999999999999999998 43322111100000 0 0000000000000 0000000000 00355
Q ss_pred CCCchhhhc-cCCCC--CCCCchhhhhhcccceeeccCC
Q 012053 313 NLNAFDIIS-FSAGF--DLSGLFEEREKRKEVRFTSNKP 348 (472)
Q Consensus 313 ~~~~f~~~~-~s~~~--~ls~l~~~~~~~~~~rf~s~~~ 348 (472)
..+++++++ ++.+. +++++++....++..+|.+..+
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (370)
T KOG0583|consen 330 SLNAYDLGSSLSTGINEALSGLFENEKEKEEPRFASLTS 368 (370)
T ss_pred ccChhhhcccccccccccccccccccccchhhhhhhccc
Confidence 778888877 88888 8999988654456677776654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-61 Score=489.55 Aligned_cols=262 Identities=37% Similarity=0.718 Sum_probs=248.4
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|..++.||+|||++||.+++..+|+.||+|++.+..+.+....+.+.+||+|++.|+|||||++|++|++.+++|+|+|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 79999999999999999999999999999999999988888899999999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 91 YVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
+|..++|..++++ +.++|.+++.+++||+.||.|||+++|+|||||..||||+++-++||+|||||+....... .-.
T Consensus 99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E--rk~ 176 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE--RKK 176 (592)
T ss_pred ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc--ccc
Confidence 9999999999875 6899999999999999999999999999999999999999999999999999998875432 246
Q ss_pred ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCC
Q 012053 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~ 249 (472)
+.||||.|+|||++...++. ..+||||+||++|.||.|++||...+..+.|.+|...++.+|..+|.++++||.+||++
T Consensus 177 TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~ 255 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRP 255 (592)
T ss_pred eecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcC
Confidence 88999999999999988875 89999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcCChhhhhcCcccccCCCCCCC
Q 012053 250 NPNTRISMTKIMENSWFRKGLVKPSI 275 (472)
Q Consensus 250 dP~~Rpt~~eil~hp~f~~~~~~~~~ 275 (472)
||.+|||+++||.|+||+.+..+...
T Consensus 256 ~P~~Rpsl~~vL~h~Ff~~g~~p~~l 281 (592)
T KOG0575|consen 256 NPSERPSLDEVLDHPFFKSGFTPARL 281 (592)
T ss_pred CcccCCCHHHHhcCHhhhCCCcCCCC
Confidence 99999999999999999887765443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-61 Score=471.97 Aligned_cols=259 Identities=39% Similarity=0.733 Sum_probs=232.6
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchh----hHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG----MIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+.+.|.+.+.||+|+||.|.+|.++.||+.||||++++++..... -...+.+|++||+.|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 567899999999999999999999999999999999988765422 2345779999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CCeEEecCcchhhh
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH---GNLKVSDFGLSALA 159 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~---g~vkl~DFGla~~~ 159 (472)
..|+||||+.||+|++++.. +.+.|+..+.+++||+.|+.|||++||+||||||+|||+..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 99999999999999999865 789999999999999999999999999999999999999766 67999999999987
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCC--CCcccchhhhHHHHHHhcCCCCCCCCcHHH-HHHHHhccCCCCC--CC
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYD--GSKADIWSCGVILYVLLAGYLPFHDSNLME-MYRKIGKAEFKFP--NW 234 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~--~~~~DiwSlGvil~~lltG~~Pf~~~~~~~-~~~~i~~~~~~~~--~~ 234 (472)
. ....+.|.||||.|+|||++...++. ..+.|+|||||+||.+|+|++||.+..... ++++|.++.+.+- .|
T Consensus 330 g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 330 G---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred c---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 5 34567899999999999999877643 457899999999999999999998866554 8899999987764 34
Q ss_pred --CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 235 --FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 235 --~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
++.++.+||.+||..||+.|||++|+|+||||+..
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 79999999999999999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-60 Score=485.99 Aligned_cols=259 Identities=44% Similarity=0.838 Sum_probs=245.5
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.|-|+++++||.|+-|.|.+|++..||+.+|||++.+...........+.+||.||+.+.|||++++|++++++.++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 57899999999999999999999999999999999888544445567799999999999999999999999999999999
Q ss_pred EEecCCCcccchhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 89 MEYVKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
+||++||+||+++. +|+++|.++.++|+||+.|+.|||..+|+||||||+|+|||..+++||+|||+|.+-. .+..
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV---PGKL 167 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc---CCcc
Confidence 99999999999985 5899999999999999999999999999999999999999999999999999998643 3567
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L 247 (472)
+.+.||+|.|.|||++.+..|+|.++||||||||||.||||.+||++.+...++.++.++.+.+|..+++++++||++||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRML 247 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHh
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcCChhhhhcCcccccCC
Q 012053 248 DPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+.||.+|+|++||++|||+....
T Consensus 248 ~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred ccCccccccHHHHhhCchhhcCC
Confidence 99999999999999999998754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-58 Score=443.11 Aligned_cols=259 Identities=36% Similarity=0.715 Sum_probs=241.1
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-.+.|++++.||+|+||+||.++.+.|++.+|+|+++|..+.+....+.++.|..||..++||.||+++..|++.+++|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 44678999999999999999999999999999999999999888778899999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+|+||+.||+|+..+.+ +.++|..++.|+..|+.||.|||++||+||||||||||||.+|+++|+||||++......
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-- 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-- 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC--
Confidence 99999999999999975 899999999999999999999999999999999999999999999999999998654322
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHh
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLS 244 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~ 244 (472)
....+.|||+.|||||++.+.+|+ ..+|.||||+++|+|++|.+||.+.+...++++|.++.. ..|..++.+++++|+
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 235678999999999999999997 889999999999999999999999999999999999994 455559999999999
Q ss_pred cccCCCCCCcC----ChhhhhcCccccc
Q 012053 245 KILDPNPNTRI----SMTKIMENSWFRK 268 (472)
Q Consensus 245 ~~L~~dP~~Rp----t~~eil~hp~f~~ 268 (472)
++|..||.+|. ++.+|.+||||..
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCccccc
Confidence 99999999996 6889999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-58 Score=428.94 Aligned_cols=256 Identities=40% Similarity=0.786 Sum_probs=244.5
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
.-.++|+++++||.|+||+|.+++++.+|..+|+|+++++.+.+....+...+|..+|+.+.||.++++++.+.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 55678999999999999999999999999999999999999988888999999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||++||+|+.++++ ++++|..++.|+.||+.||+|||+++|++|||||||||||.+|.+||+|||+|+....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---- 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---- 196 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence 99999999999999987 8999999999999999999999999999999999999999999999999999986543
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
...+.||||.|+|||++..++|. .++|.|||||++|||++|++||.+.+...+|++|..+...+|..+++++++||++
T Consensus 197 -rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 197 -RTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred -cEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 35788999999999999999986 8899999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCcC-----ChhhhhcCccccc
Q 012053 246 ILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 246 ~L~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
+|+.|-.+|. ...+|.+||||+.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999994 5779999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-57 Score=455.37 Aligned_cols=260 Identities=34% Similarity=0.700 Sum_probs=242.5
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 86 (472)
-..+|.+++.||+|+|++|++|+++.+++.||||+++|+.+.++...+.+.+|-.+|.+| +||.|++||..|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 356899999999999999999999999999999999999998888889999999999999 7999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+|+||+++|+|.++|.+ |.|+|..++.|+.||+.||+|||++|||||||||||||||.||+++|+|||.|+.+......
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 99999999999999987 89999999999999999999999999999999999999999999999999999876432211
Q ss_pred -----------CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCC
Q 012053 166 -----------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNW 234 (472)
Q Consensus 166 -----------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~ 234 (472)
..-.+++||..|++||++.... .++.+|||+||||||.|++|.+||.+.+...++++|....+.+|+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~ 309 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG 309 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence 1124578999999999997654 4689999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+++.+++||+++|..||.+|+|+.+|.+||||..
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 9999999999999999999999999999999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-55 Score=423.52 Aligned_cols=257 Identities=31% Similarity=0.548 Sum_probs=232.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-EE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-KI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~ 85 (472)
+..+..+.+..||+|+.|+||+++++.|++.+|+|++... .+....+++.+|+.|++..+||+||++|+.|..+. .+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 3445788899999999999999999999999999999433 23466789999999999999999999999999999 59
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+++|||++||+|.+.+.. |+++|....+++.++++||.|||. ++|+||||||+|||++..|.+||||||.+......
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999999998876 899999999999999999999995 99999999999999999999999999999876543
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC-----cHHHHHHHHhcc-CCCCCCC-CC
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-----NLMEMYRKIGKA-EFKFPNW-FA 236 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~-----~~~~~~~~i~~~-~~~~~~~-~s 236 (472)
...+..||..|||||.+.+..|. .++||||||++++|+++|+.||... +..+++..|..+ .+.+|.. +|
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS 308 (364)
T ss_pred ---hcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence 45788999999999999988876 8899999999999999999999874 677888888875 4567776 99
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+++++||..||++||.+|||+.|+++|||+++..
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9999999999999999999999999999998743
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=421.96 Aligned_cols=259 Identities=38% Similarity=0.679 Sum_probs=235.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
-..++|.+.+.||+|+||+||+|+++.++..||||.+.+.+.. ....+.+..||.||+.++|||||++++++.+++.+|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 4567999999999999999999999999999999999988753 356788999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC------CCeEEecCcchhhh
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH------GNLKVSDFGLSALA 159 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~------g~vkl~DFGla~~~ 159 (472)
||||||+||+|.+++.+ ++++|..++.+++||+.||++||+++|+||||||+||||+.+ -.+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999999976 699999999999999999999999999999999999999865 35899999999987
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---CCCCCCC
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF---KFPNWFA 236 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s 236 (472)
.. .....+.||+|.|||||++....|+ .|+|+||+|+|||++++|+.||+..+..+++..+.++.. .++.+++
T Consensus 166 ~~---~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 166 QP---GSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS 241 (429)
T ss_pred Cc---hhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence 63 3456889999999999999888888 799999999999999999999999999999888877653 3456688
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+...+|+...|..+|..|.+..+-+.|++.....
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8889999999999999999999999999987643
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-54 Score=424.57 Aligned_cols=270 Identities=36% Similarity=0.664 Sum_probs=238.6
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch-----------hhHHHHHHHHHHHHhcCCCCe
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV-----------GMIDQIKREISVMRLVRHPNV 72 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~hpnI 72 (472)
.+....+.|++++.||+|.||+|.+|++..+++.||||++++...... .-.+.+++||.||+++.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 355678899999999999999999999999999999999987543321 124689999999999999999
Q ss_pred eeEEEEEEeC--CEEEEEEEecCCCcccchhccCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeE
Q 012053 73 VELYEVMASK--TKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 73 v~l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vk 149 (472)
|+|+++..+. +++|||+|||..|.+...-..+. +++.+++.|+++++.||+|||.+||+||||||.|+||+++|.+|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 9999999664 68999999999998865555566 99999999999999999999999999999999999999999999
Q ss_pred EecCcchhhhhcc---cCCCcccccCCCCcccChhhhcc---cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHH
Q 012053 150 VSDFGLSALAESK---HQDGLLHTTCGTPAYVAPEVINR---RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRK 223 (472)
Q Consensus 150 l~DFGla~~~~~~---~~~~~~~~~~gt~~Y~aPE~l~~---~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~ 223 (472)
|+|||.+..+... ..+..+....|||.|+|||.+.+ ..+.+.+.||||+||+||.|+.|++||.+....+++.+
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 9999998866332 22234556899999999999977 55778999999999999999999999999999999999
Q ss_pred HhccCCCCCCC--CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCCCC
Q 012053 224 IGKAEFKFPNW--FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKP 273 (472)
Q Consensus 224 i~~~~~~~~~~--~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~~~ 273 (472)
|......+|.. +.+++++||.+||++||.+|+++.+|..|||.......+
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 99999988876 789999999999999999999999999999998765433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-54 Score=431.35 Aligned_cols=260 Identities=37% Similarity=0.690 Sum_probs=234.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-.+.|++++.||+|+||.||+|+.+.||+.+|+|+++++.....+.++.++.|-++|....+|+||+||..|.+..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 44678999999999999999999999999999999999998877788899999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc---
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK--- 162 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~--- 162 (472)
|||||++||++..++.+ +.|+|+.++.|+.+++.|++.+|+.|+|||||||+|+|||..|++||+||||+.-....
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999999998865 89999999999999999999999999999999999999999999999999998633210
Q ss_pred -----------------cCCC-------------------------cccccCCCCcccChhhhcccCCCCCcccchhhhH
Q 012053 163 -----------------HQDG-------------------------LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGV 200 (472)
Q Consensus 163 -----------------~~~~-------------------------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGv 200 (472)
..+. .....+|||.|||||++.+.+|. ..+|.|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHHH
Confidence 0000 01224699999999999999986 8999999999
Q ss_pred HHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCCC--CCHHHHHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012053 201 ILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPNW--FAPEVRRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 201 il~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~--~s~~l~~li~~~L~~dP~~Rpt---~~eil~hp~f~~ 268 (472)
|+||||.|++||.+.++.+.+++|.... +.+|.. +++++++||.+||. ||.+|.. ++||.+||||+.
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 9999999999999999999999998765 555544 78999999999999 9999985 889999999986
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-55 Score=422.14 Aligned_cols=265 Identities=41% Similarity=0.757 Sum_probs=248.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
-+-.||++.++||.|+||+|.+|++...|+.||||.|.++++.+...+-.+++||+||..|+||||+.+|++|++.+++.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 35669999999999999999999999999999999999999988888889999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||..+|+|++++.. +.|+|.+++++|+||++|+.|||.++++|||||.+|||||.|+++||+||||+.++.. .
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---K 206 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc---c
Confidence 99999999999999975 8999999999999999999999999999999999999999999999999999998764 4
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
..+.++||+|.|.+||++.+.+|.++..|-|||||+||.|..|..||++.+...+.++|.++.+.-|. -+.++.-||+.
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRw 285 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRW 285 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHH
Confidence 56889999999999999999999999999999999999999999999999999999999999887776 56678999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCCCCCCC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKGLVKPSI 275 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~~~~~~~ 275 (472)
||..||.+|.|+.+|-.|=|..=++.-+..
T Consensus 286 mLmVNP~RRATieDiAsHWWvNwgy~~~V~ 315 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHWWVNWGYNMPVI 315 (668)
T ss_pred HHhcCcccchhHHHHhhhheeecccccccc
Confidence 999999999999999999888877664443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-53 Score=436.08 Aligned_cols=260 Identities=32% Similarity=0.635 Sum_probs=245.6
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTK 84 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 84 (472)
.+-.+.|.+++.||+|+||+|++|..+.+++.+|||+++|..+.....++..+.|.+|+...+ ||.+++++.+|.++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 466789999999999999999999999999999999999999988888999999999998885 9999999999999999
Q ss_pred EEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 85 IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+|+||||+.||++..++..+.++|..++.|+..++.||.|||++||||||||.+|||||.+|.+||+|||+++.... .
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~ 521 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--Q 521 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC--C
Confidence 99999999999988888889999999999999999999999999999999999999999999999999999985442 2
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~ 244 (472)
.....|.||||.|||||++.+..|. ...|.|||||+||+||.|..||.+.+..+++..|...++.+|.|+|.++.++++
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMR 600 (694)
T ss_pred CCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHH
Confidence 3357899999999999999998886 899999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCcCCh-----hhhhcCccccc
Q 012053 245 KILDPNPNTRISM-----TKIMENSWFRK 268 (472)
Q Consensus 245 ~~L~~dP~~Rpt~-----~eil~hp~f~~ 268 (472)
++|..||++|..+ .+|..||||+.
T Consensus 601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 601 RLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHhccCcccccCCCCCCchhhhhCCcccc
Confidence 9999999999976 68999999986
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=396.02 Aligned_cols=260 Identities=36% Similarity=0.738 Sum_probs=234.8
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
...+.+.|++-+.||+|.|+.||++.+..+|+.+|+|+++..+... ...+.+.+|+.|-+.|+|||||+|++.+.+.+.
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 4567789999999999999999999999999999999998776544 356889999999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CCeEEecCcchhhhh
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH---GNLKVSDFGLSALAE 160 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~---g~vkl~DFGla~~~~ 160 (472)
.|+|+|++.|++|+.-|.. --++|..+-.+++||+++|.|||.+||+|||+||+|+||-.. .-+||+|||+|....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999999999766654 578999999999999999999999999999999999999543 359999999998766
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC--C--CC
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN--W--FA 236 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~s 236 (472)
. ........|||.|||||++...+|. ..+|||++|||||-|+.|++||.+.+...+|+.|..+.+.+|. | ++
T Consensus 165 ~---g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 165 D---GEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred C---ccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence 2 2335677899999999999888775 7899999999999999999999999999999999999887765 3 89
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+++++||++||..||++|+|+.|.|+|||+.+.
T Consensus 241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-54 Score=401.62 Aligned_cols=248 Identities=32% Similarity=0.594 Sum_probs=223.2
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEE-EEEeC-C
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE-VMASK-T 83 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~~-~ 83 (472)
......|++.+.||+|+||+||++.+..+|..||.|.+.-... +....+.+..|+.+|++|+|||||++++ .+..+ .
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 3445569999999999999999999999999999999985543 3456678899999999999999999999 45444 4
Q ss_pred EEEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCcEEEcCCCCeEEecCc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHS--RG--VCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~--~g--iiHrDIKp~NILld~~g~vkl~DFG 154 (472)
.+++|||||.+|+|...|+. ..++|..+|+++.||+.||..||+ .. |+||||||.||+|+.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 59999999999999998853 469999999999999999999999 45 9999999999999999999999999
Q ss_pred chhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-CC-
Q 012053 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FP- 232 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~~- 232 (472)
|++.+..... ..++.+|||.||+||++...+|+ +++||||+||++|||++-..||.+.+...+..+|..++++ +|
T Consensus 174 L~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 174 LGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred hHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 9998876543 35778999999999999999997 9999999999999999999999999999999999999876 67
Q ss_pred CCCCHHHHHHHhcccCCCCCCcCCh
Q 012053 233 NWFAPEVRRLLSKILDPNPNTRISM 257 (472)
Q Consensus 233 ~~~s~~l~~li~~~L~~dP~~Rpt~ 257 (472)
..+|.++..+|..|+..||..||+.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc
Confidence 5689999999999999999999997
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=383.15 Aligned_cols=259 Identities=38% Similarity=0.722 Sum_probs=243.4
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
.+.-.++|++++.||.|-||.||+|+.+.++-.||+|++.++.+...+...++.+|++|...|+||||+++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 34557899999999999999999999999999999999999988887888999999999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 85 IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+|+++||...|+|+..+.. .+++|..+..|+.|++.|+.|||.++|+||||||+|+|++.+|.+||+|||-+.....
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 9999999999999999873 4699999999999999999999999999999999999999999999999998875542
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRR 241 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~ 241 (472)
+.-.+.|||..|.+||...+.+++ ...|+|++|++.||++.|.+||...+..+.|++|.+..+.+|..++.++++
T Consensus 177 ----~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 177 ----NKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAAD 251 (281)
T ss_pred ----CCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHH
Confidence 234688999999999999999887 789999999999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCcCChhhhhcCccccc
Q 012053 242 LLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
||.+||..+|.+|.+..|+++|||+..
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHHHHh
Confidence 999999999999999999999999975
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-52 Score=405.23 Aligned_cols=259 Identities=32% Similarity=0.608 Sum_probs=222.8
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--EEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT--KIYF 87 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~l 87 (472)
.+|..++.||+|+||.||++.+..+|+..|||.+...... ..+.+.+|+.+|+.++|||||+++|...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 4699999999999999999999999999999999776322 2678999999999999999999999854444 7999
Q ss_pred EEEecCCCcccchhcc-C-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCeEEecCcchhhhhc-cc
Q 012053 88 VMEYVKGGELFGKVAK-G-KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSDFGLSALAES-KH 163 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~-~g~vkl~DFGla~~~~~-~~ 163 (472)
+|||++||+|.+.+.+ + +++|..+++|.+||++||.|||++||+||||||+|||++. +|.+||+|||++..... ..
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 9999999999999986 4 7999999999999999999999999999999999999999 79999999999987664 11
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC-CcHHHHHHHHhccC--CCCCCCCCHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAE--FKFPNWFAPEVR 240 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~s~~l~ 240 (472)
.........|||.|||||++........++|||||||++.||+||..||.. .......-++.... +.+|.++|++++
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~ 253 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK 253 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence 112234578999999999998633344589999999999999999999987 44444444554433 678999999999
Q ss_pred HHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
+||.+||..||++|||++++|+|||.+....
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999999999999999999999987543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=392.65 Aligned_cols=255 Identities=29% Similarity=0.485 Sum_probs=218.6
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
|++|+.+.++|+|+||.||+++++.||+.||||.+-.+. .+....+-..|||.+|++++|||+|.++++|..+.++++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 578999999999999999999999999999999985443 2223445678999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
+|||+..-| +.++. .++++..++.|++|++.|+.|||+++++||||||||||++.+|.+||||||+|+....+. .
T Consensus 80 FE~~dhTvL-~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d 156 (396)
T KOG0593|consen 80 FEYCDHTVL-HELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--D 156 (396)
T ss_pred eeecchHHH-HHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--c
Confidence 999977544 44443 679999999999999999999999999999999999999999999999999999876532 3
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC------------------
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------------ 228 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------------ 228 (472)
..+..+.|.+|.|||.+.+...++.+.||||+||++.||++|.+.|++.+..+....|.+.-
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 35678899999999999987667899999999999999999999999987766555543210
Q ss_pred -CCCC------------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012053 229 -FKFP------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 229 -~~~~------------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
..+| +.++.-+.+|+.+||+.||.+|++.++++.||||.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 0111 12456788999999999999999999999999994
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=418.34 Aligned_cols=257 Identities=33% Similarity=0.624 Sum_probs=240.7
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|.+.+.||+|+||.||+|+.+.+.+.||+|.++|.... ......+.+|++|++.++|||||.+++.|++..++++|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 57899999999999999999999999999999999987654 35678899999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
+||+.| +|+.++.. +.++|+.++.++.+++.||.|||+++|.|||+||.|||++.+|.+|+||||+|+....+ ...
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--TSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC--cee
Confidence 999987 99999976 79999999999999999999999999999999999999999999999999999977653 334
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L 247 (472)
+....|||.|||||++.+..|+ ..+|+||||||+||+++|++||...+...+...|.......|...+..+.+|+..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 6677899999999999988887 889999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcCChhhhhcCcccccCC
Q 012053 248 DPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
.+||.+|.|-.+++.|||.+...
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999998644
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-52 Score=411.97 Aligned_cols=263 Identities=31% Similarity=0.519 Sum_probs=230.4
Q ss_pred CcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEe
Q 012053 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMAS 81 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 81 (472)
.+-.++++||.++++||.|+||.||+|....+|+.||||.+.+.... .+..-. .||+..|++++ ||||++|.+++.+
T Consensus 3 ~~~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~n-LREvksL~kln~hpniikL~Evi~d 80 (538)
T KOG0661|consen 3 LTQVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMN-LREVKSLRKLNPHPNIIKLKEVIRD 80 (538)
T ss_pred ceehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHH-HHHHHHHHhcCCCCcchhhHHHhhc
Confidence 34567899999999999999999999999999999999999766533 233333 38999999999 9999999999988
Q ss_pred CC-EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhh
Q 012053 82 KT-KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 82 ~~-~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~ 158 (472)
.+ .+|+||||++ .+|+++++. ..|+|..++.|+.||+.||+|+|.+|++|||+||||||+..+..+||+|||||+.
T Consensus 81 ~~~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 81 NDRILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred cCceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc
Confidence 77 9999999995 589999965 4799999999999999999999999999999999999999999999999999998
Q ss_pred hhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc------------
Q 012053 159 AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK------------ 226 (472)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~------------ 226 (472)
..+... .+..+.|.+|+|||++...++++.+.|+||+|||++|+.+-++.|.+.+..+...+|..
T Consensus 160 v~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 160 VRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 776543 57788999999999999999999999999999999999999999999888777766642
Q ss_pred -------cCCCCCC-----------CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 227 -------AEFKFPN-----------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 227 -------~~~~~~~-----------~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
-++.+|. ..++++.+||.+||.+||.+|||+.|+++||||+....
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 1233332 25789999999999999999999999999999997654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=407.75 Aligned_cols=255 Identities=37% Similarity=0.756 Sum_probs=233.5
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++..++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 46789999999999999999999999999999999987654444556788999999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||||+.|++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---- 171 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence 9999999999998865 68999999999999999999999999999999999999999999999999998755321
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~ 246 (472)
..+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..+...+|.++++.+++||.+|
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 249 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHH
Confidence 2356899999999999877764 89999999999999999999999988888899998888999999999999999999
Q ss_pred cCCCCCCcCC-----hhhhhcCccccc
Q 012053 247 LDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 247 L~~dP~~Rpt-----~~eil~hp~f~~ 268 (472)
|+.||.+|++ ++++++||||+.
T Consensus 250 L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 250 LQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred hhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 9999999997 799999999986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=407.61 Aligned_cols=260 Identities=41% Similarity=0.740 Sum_probs=242.2
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+.|=|.+.++||+|-|+.|.+|++.-||+.||||++++.+... -....+.+|+..|+.++|||||+||++..+.+++||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 4556999999999999999999999999999999999988654 344678899999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-cCCCCeEEecCcchhhhhcccC
Q 012053 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL-DEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl-d~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+|+-.+|+|+++|.+ ..+.|+.+++||.||+.|+.|||+..++||||||+|+.+ ..-|-+||.|||++..+...
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-- 172 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-- 172 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence 9999999999999965 579999999999999999999999999999999999865 56789999999998876543
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~ 244 (472)
..+.+.||+..|.|||++.+..|+.++.||||||||||-|.+|++||...+..+....|....+..|..++.+.++||.
T Consensus 173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQ 251 (864)
T ss_pred -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHH
Confidence 3478999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCcCChhhhhcCcccccCCC
Q 012053 245 KILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
.||..||++|.+.++|..++|++.+..
T Consensus 252 sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHhcCchhhccHHHHhccccccCCCC
Confidence 999999999999999999999997654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=406.79 Aligned_cols=259 Identities=39% Similarity=0.741 Sum_probs=236.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 85 (472)
-+..+|++++.||+|.||.||.++++.+|+.+|+|++.+.........+.+.+|+.||+++. |||||.++++|++.+.+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34568999999999999999999999999999999999887765455678999999999998 99999999999999999
Q ss_pred EEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC----CCeEEecCcchhhhhc
Q 012053 86 YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH----GNLKVSDFGLSALAES 161 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~----g~vkl~DFGla~~~~~ 161 (472)
|+|||+|.||+|++.+....++|..+..++.|++.++.|||+.||+||||||+|+|+... +.+|++|||+|.....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999999999976569999999999999999999999999999999999999543 4799999999997765
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC--CC--CCH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP--NW--FAP 237 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~--~~--~s~ 237 (472)
....++.||||.|+|||++...+|. ..+||||+|+++|.|++|..||.+.+....+..+..+.+.++ .| ++.
T Consensus 192 ---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 192 ---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred ---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 3457889999999999999877775 899999999999999999999999999888889998887654 33 789
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.++++|++||..||.+|+|+.++|+|||++..
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999998764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=398.49 Aligned_cols=253 Identities=32% Similarity=0.670 Sum_probs=230.6
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654433344567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----T 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----c
Confidence 99999999999865 67999999999999999999999999999999999999999999999999998765321 2
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++.+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 346799999999999877764 8999999999999999999999999888889999888889999999999999999999
Q ss_pred CCCCCcCC-----hhhhhcCccccc
Q 012053 249 PNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rpt-----~~eil~hp~f~~ 268 (472)
.||.+|++ ++++++||||..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=399.37 Aligned_cols=250 Identities=38% Similarity=0.677 Sum_probs=225.3
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+.|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445567789999999999999999999999999999999999999
Q ss_pred cccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCC
Q 012053 96 ELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174 (472)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 174 (472)
+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccceecC
Confidence 99988865 67999999999999999999999999999999999999999999999999998753221 1223456899
Q ss_pred CcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCc
Q 012053 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254 (472)
Q Consensus 175 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 254 (472)
+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++++.+||++||..||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999877765 8999999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----ChhhhhcCccccc
Q 012053 255 I-----SMTKIMENSWFRK 268 (472)
Q Consensus 255 p-----t~~eil~hp~f~~ 268 (472)
| ++.++++||||..
T Consensus 238 ~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=400.36 Aligned_cols=258 Identities=33% Similarity=0.549 Sum_probs=227.1
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKI 85 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 85 (472)
..+.|+.+++||+|+||.||+|++..+|+.||+|.+..+.. +.+......|||.||++|+||||++|.+...+. ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 35578999999999999999999999999999999987653 346667788999999999999999999998776 789
Q ss_pred EEEEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|||+||++. +|.-++... +|++.+++.|++||+.||+|||++||+|||||..|||||.+|++||+|||||+++....
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999999965 888888774 79999999999999999999999999999999999999999999999999999887654
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC----------CCCC-
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE----------FKFP- 232 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~----------~~~~- 232 (472)
. ..++..+-|.+|.|||.+.+..-++.+.|+||+||||.||++|++.|.+.+..+...+|.+.- ..+|
T Consensus 273 ~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 273 S-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred C-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 3 336677889999999999998877899999999999999999999999999888887775320 0111
Q ss_pred ------------------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 233 ------------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 ------------------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..+++.+.+|+..||..||.+|.|+.++|+++||..
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 125778899999999999999999999999999954
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=400.97 Aligned_cols=258 Identities=31% Similarity=0.621 Sum_probs=232.9
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTG-MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
..+-.++|++.+.||+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4456778999999999999999999976654 789999997765444455677889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|+||||+.||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 99999999999999999865 6899999999999999999999999999999999999999999999999999876432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~l 242 (472)
...+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..+...+|..++++++++
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 184 ----RTYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred ----CcceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 12456899999999999876664 8999999999999999999999999888889999988888999999999999
Q ss_pred HhcccCCCCCCcC-----ChhhhhcCccccc
Q 012053 243 LSKILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
|++||+.||.+|+ |++++++||||..
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999996 8999999999975
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=392.57 Aligned_cols=249 Identities=36% Similarity=0.642 Sum_probs=224.2
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012053 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999765544444567788999999999999999999999999999999999999999
Q ss_pred cchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCc
Q 012053 98 FGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176 (472)
Q Consensus 98 ~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 176 (472)
.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcc
Confidence 998865 689999999999999999999999999999999999999999999999999987543221 22345689999
Q ss_pred ccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcC-
Q 012053 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRI- 255 (472)
Q Consensus 177 Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp- 255 (472)
|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|..+++++++||.+||..||.+||
T Consensus 159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999887765 78999999999999999999999988888889988888899999999999999999999999997
Q ss_pred --ChhhhhcCcccccC
Q 012053 256 --SMTKIMENSWFRKG 269 (472)
Q Consensus 256 --t~~eil~hp~f~~~ 269 (472)
++.+++.||||.+.
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57899999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=391.59 Aligned_cols=254 Identities=31% Similarity=0.580 Sum_probs=226.9
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH---hcCCCCeeeEEEEEEeCCEEEEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR---LVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
|++++.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.++. .++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999998765444445567778877664 56799999999999999999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|||++|++|...+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--GDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC--CCcc
Confidence 99999999999888889999999999999999999999999999999999999999999999999998643221 1223
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+.+..+......+|..+++++.++|.+||.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 456899999999999877664 8899999999999999999999998888888888888888898999999999999999
Q ss_pred CCCCCcC-----ChhhhhcCccccc
Q 012053 249 PNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
.||.+|| ++.++++||||+.
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999 6899999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=391.89 Aligned_cols=250 Identities=37% Similarity=0.674 Sum_probs=224.7
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++..++.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444455677889999999999999999999999999999999999999
Q ss_pred cccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCC
Q 012053 96 ELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174 (472)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 174 (472)
+|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccccccCC
Confidence 99888865 57999999999999999999999999999999999999999999999999998753221 1223456899
Q ss_pred CcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCc
Q 012053 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254 (472)
Q Consensus 175 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 254 (472)
+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||++||..||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 999999999877664 8999999999999999999999988888888888888888999999999999999999999999
Q ss_pred C-----ChhhhhcCccccc
Q 012053 255 I-----SMTKIMENSWFRK 268 (472)
Q Consensus 255 p-----t~~eil~hp~f~~ 268 (472)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=385.49 Aligned_cols=262 Identities=32% Similarity=0.541 Sum_probs=229.6
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+-.+.|++...||.|.-+.||+|+.+.+++.||||+++.++... .++.+.+|+..|+.++||||++++..|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 344568999999999999999999999999999999999988654 378999999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 86 YFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|+||.|+.+|++.+++.. ..++|..+..++++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+......
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999999975 57999999999999999999999999999999999999999999999999987755443
Q ss_pred cCCC--cccccCCCCcccChhhhc--ccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC------
Q 012053 163 HQDG--LLHTTCGTPAYVAPEVIN--RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP------ 232 (472)
Q Consensus 163 ~~~~--~~~~~~gt~~Y~aPE~l~--~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~------ 232 (472)
.... .+.+..|||+|||||++. ..||+ .|+||||||++..||.+|..||....++.+.-.-.++.++.+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 3221 126779999999999953 35776 899999999999999999999999888876555444544322
Q ss_pred ----CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 233 ----NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 233 ----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
..++..++.+|..||+.||.+|||++++++|+||++..
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 12567899999999999999999999999999999753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-50 Score=403.00 Aligned_cols=254 Identities=31% Similarity=0.566 Sum_probs=229.9
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
..+|....+||+|+-|.||.|+...+++.||||.++.....+ .+-+.+|+.+|+..+|+|||++++.|--++.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 347999999999999999999999999999999998876543 46789999999999999999999999888999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|||++||+|.+.+....++|.++..+.++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+...... -
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R 426 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--R 426 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--c
Confidence 99999999999999999999999999999999999999999999999999999999999999999999877654432 3
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc---cCCCCCCCCCHHHHHHHhc
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK---AEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~---~~~~~~~~~s~~l~~li~~ 245 (472)
.+.+|||+|||||+...+.|. ++.||||||++++||+-|++||...++......|.. ..+..|..+|+++++|+.+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG-~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccccCCCCccchhhhhhcccC-ccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 577899999999999988885 999999999999999999999987766654444433 3456678899999999999
Q ss_pred ccCCCCCCcCChhhhhcCccccc
Q 012053 246 ILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
||+.||.+|+++.|+|+||||+.
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhhh
Confidence 99999999999999999999964
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=388.34 Aligned_cols=264 Identities=32% Similarity=0.537 Sum_probs=236.5
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
+.+=.+.|++++.||.|.-|+||+|+.+.++..+|+|+++++.........++..|-.||+.++||.++.||..|+++..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 45556789999999999999999999999999999999999988776778889999999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 85 IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.|++||||+||+|..+..+ +.+++..++.|+..++.||+|||..|||+||||||||||-++|++.|+||.|+.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999888765 4799999999999999999999999999999999999999999999999998643110
Q ss_pred ---------------------------------ccC---------------------CCcccccCCCCcccChhhhcccC
Q 012053 162 ---------------------------------KHQ---------------------DGLLHTTCGTPAYVAPEVINRRG 187 (472)
Q Consensus 162 ---------------------------------~~~---------------------~~~~~~~~gt~~Y~aPE~l~~~~ 187 (472)
... +......+||-.|+|||++.+.+
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 00112346999999999999999
Q ss_pred CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCC--CCHHHHHHHhcccCCCCCCcCC----hhhhh
Q 012053 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNW--FAPEVRRLLSKILDPNPNTRIS----MTKIM 261 (472)
Q Consensus 188 ~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--~s~~l~~li~~~L~~dP~~Rpt----~~eil 261 (472)
.. .++|.|+|||++||||.|..||.+.+..+.+.+|......+|.. ++..+++||+++|.+||++|.. +.||.
T Consensus 312 Hg-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 312 HG-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CC-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 75 89999999999999999999999999999999999988888764 6789999999999999999998 99999
Q ss_pred cCcccccC
Q 012053 262 ENSWFRKG 269 (472)
Q Consensus 262 ~hp~f~~~ 269 (472)
+||||+..
T Consensus 391 ~HpFF~gV 398 (459)
T KOG0610|consen 391 RHPFFEGV 398 (459)
T ss_pred cCccccCC
Confidence 99999863
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=391.48 Aligned_cols=250 Identities=37% Similarity=0.682 Sum_probs=224.2
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||.||++++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444345567788999999999999999999999999999999999999
Q ss_pred cccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCC
Q 012053 96 ELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174 (472)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 174 (472)
+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccccccCC
Confidence 99888865 57999999999999999999999999999999999999999999999999998753221 1223456899
Q ss_pred CcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCc
Q 012053 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254 (472)
Q Consensus 175 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 254 (472)
+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++++.+||.+||..||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999777664 8999999999999999999999998888888888888888899999999999999999999999
Q ss_pred C-----ChhhhhcCccccc
Q 012053 255 I-----SMTKIMENSWFRK 268 (472)
Q Consensus 255 p-----t~~eil~hp~f~~ 268 (472)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 8 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=375.02 Aligned_cols=257 Identities=37% Similarity=0.721 Sum_probs=230.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-----KVGMIDQIKREISVMRLV-RHPNVVELYEVMAS 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (472)
..++|+-.+.||.|..+.|..+.++.+|..+|+|+++..... .....+.-.+|+.||+++ .||+|+++++++++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 456889999999999999999999999999999999643221 123456678899999987 59999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
+...|+|+|.++.|+|+|++.. -.++|.+++++++||++|+.|||.++|+||||||+|||+|+|-++||+|||+|+...
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999999987 479999999999999999999999999999999999999999999999999999776
Q ss_pred cccCCCcccccCCCCcccChhhhcc------cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC--C
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINR------RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF--P 232 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~------~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~--~ 232 (472)
... .+...||||+|.|||.+.. .+| +...|+||||||+|.|+.|.+||.....+-+.+.|..+.+.+ |
T Consensus 175 ~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 175 PGE---KLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred Cch---hHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 433 3677899999999999843 344 367999999999999999999999999999999999888765 6
Q ss_pred CC--CCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 233 NW--FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 ~~--~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.| ++.+.++||++||+.||.+|+|++|+|+||||.+
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 66 7899999999999999999999999999999975
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=405.48 Aligned_cols=261 Identities=43% Similarity=0.790 Sum_probs=245.2
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
.-.+.|.+.++||.|.|++|.+|++..++..||||++++...... ....+.+|+.+|+.++|||||+++.+.++...+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 446789999999999999999999999999999999998876543 3445899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||+.+|++++++.+ +++.+.+++.+|.|+++|++|||+++|+|||||++||||+.+-++||+|||++..+.. .
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~---~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY---G 208 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc---c
Confidence 99999999999999976 7899999999999999999999999999999999999999999999999999998864 3
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
..+.+.||++.|.|||++.+..|+++.+|+||+|++||.|+.|.+||++.+..++..+...+.+.+|-.++.+..++|++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk 288 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK 288 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence 45789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCCC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
+|.++|.+|+++++|+.|.|....+.
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred hhccCccccCCHHHhhhhcccchhhh
Confidence 99999999999999999999976543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=397.69 Aligned_cols=257 Identities=32% Similarity=0.587 Sum_probs=222.3
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444455678899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC----
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ---- 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~---- 164 (472)
||++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999865 6899999999999999999999999999999999999999999999999999875432100
Q ss_pred -----------------------------CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC
Q 012053 165 -----------------------------DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS 215 (472)
Q Consensus 165 -----------------------------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~ 215 (472)
.......+||+.|+|||++.+.+++ .++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012346899999999999887776 7999999999999999999999998
Q ss_pred cHHHHHHHHhcc--CCCCCCC--CCHHHHHHHhcccCCCCC---CcCChhhhhcCccccc
Q 012053 216 NLMEMYRKIGKA--EFKFPNW--FAPEVRRLLSKILDPNPN---TRISMTKIMENSWFRK 268 (472)
Q Consensus 216 ~~~~~~~~i~~~--~~~~~~~--~s~~l~~li~~~L~~dP~---~Rpt~~eil~hp~f~~ 268 (472)
+..+.+.++... ...+|+. ++++++++|.+|+. +|. .||++++|++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 888888887653 3445543 68999999999775 444 5689999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-49 Score=363.76 Aligned_cols=255 Identities=32% Similarity=0.513 Sum_probs=223.6
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.||...+.||+|+||.||+|++..||+.||||.+......+ +......|||+.|+.++|+||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 58999999999999999999999999999999998775432 44566789999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||++. +|...|+. -.++...++.|+.+++.||+|||++.|+||||||.|+|++++|.+||+|||+|+.+......
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-- 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-- 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence 99954 89988876 46999999999999999999999999999999999999999999999999999998765543
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-----C------------
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-----K------------ 230 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-----~------------ 230 (472)
....+-|.+|.|||.+.+...++...|+||.|||+.||+-|.+-|.+.+..+....|-+.-. .
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 23347899999999999888778999999999999999999999999887777666643110 0
Q ss_pred ---CC--------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 231 ---FP--------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 231 ---~~--------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+| ...++++.+|+.+||..||.+|+|+.|+++|+||+.
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 11 113678899999999999999999999999999986
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=378.76 Aligned_cols=262 Identities=36% Similarity=0.663 Sum_probs=243.0
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+..+-++.|+.++.||+|+||+|-+++.+.+|+.+|||+++++.+.....+..-..|-++|+..+||.+..|...|.+.+
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34578899999999999999999999999999999999999998877666777778999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
++|+||||++||+|+-.+.+ ..++|+.++.|...|+.||.|||+++|++||||.+|+|||.+|++||+||||++.-..
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence 99999999999999888765 6799999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~l 242 (472)
......+.||||.|.|||++....|. .+.|.|.+||++|||++|++||...+...++..|......+|..++++++.|
T Consensus 321 -~g~t~kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 321 -YGDTTKTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred -ccceeccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHH
Confidence 22346889999999999999888875 8999999999999999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCcC-----ChhhhhcCccccc
Q 012053 243 LSKILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
+..+|..||++|. .+.||++|+||..
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 9999999999998 4789999999975
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=388.50 Aligned_cols=251 Identities=31% Similarity=0.616 Sum_probs=221.3
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL-VRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||.||+|++..+|+.||+|++.+...........+..|..++.. .+||||+++++++.+++.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999987543323344567778888875 4899999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... .......+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCceeccCC
Confidence 999988865 68999999999999999999999999999999999999999999999999998643221 122356789
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|.++++++++||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999877765 889999999999999999999999888888888888888889999999999999999999999
Q ss_pred cCCh-hhhhcCcccccC
Q 012053 254 RISM-TKIMENSWFRKG 269 (472)
Q Consensus 254 Rpt~-~eil~hp~f~~~ 269 (472)
|+++ +++++||||+..
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9998 589999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=390.92 Aligned_cols=253 Identities=32% Similarity=0.580 Sum_probs=224.5
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999999865 6799999999999999999999999999999999999999999999999999875533 23
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCC------CCCHHHH
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPN------WFAPEVR 240 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~------~~s~~l~ 240 (472)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+.+..+.... ...|. .+++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 456899999999999877665 89999999999999999999999888877776665422 22222 3589999
Q ss_pred HHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 241 RLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+||.+||..+|.+||++.++++||||..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=395.83 Aligned_cols=257 Identities=34% Similarity=0.664 Sum_probs=223.3
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444455667889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC---
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD--- 165 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~--- 165 (472)
||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999998865 67999999999999999999999999999999999999999999999999998654321100
Q ss_pred ---------------------------------CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCC
Q 012053 166 ---------------------------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPF 212 (472)
Q Consensus 166 ---------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf 212 (472)
......+||+.|+|||++...++. .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011235799999999999877765 8999999999999999999999
Q ss_pred CCCcHHHHHHHHhccC--CCCCC--CCCHHHHHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012053 213 HDSNLMEMYRKIGKAE--FKFPN--WFAPEVRRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 213 ~~~~~~~~~~~i~~~~--~~~~~--~~s~~l~~li~~~L~~dP~~Rpt---~~eil~hp~f~~ 268 (472)
...+....+..+.... ..+|. .+++++++||.+||. +|.+|++ +.++++||||+.
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9988877777765433 33443 368999999999997 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=382.45 Aligned_cols=255 Identities=26% Similarity=0.444 Sum_probs=220.0
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++.+++..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987654433344567899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---Ce
Confidence 9999999877643 36899999999999999999999999999999999999999999999999998764321 12
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH----HHHHHHHhccCCCCCCCCCHHHHHHH
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL----MEMYRKIGKAEFKFPNWFAPEVRRLL 243 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~l~~li 243 (472)
....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+. ......+......++..+++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 2456799999999999877665 789999999999999999999987543 23333444555667778999999999
Q ss_pred hcccCCCCCCcCC-----hhhhhcCcccccC
Q 012053 244 SKILDPNPNTRIS-----MTKIMENSWFRKG 269 (472)
Q Consensus 244 ~~~L~~dP~~Rpt-----~~eil~hp~f~~~ 269 (472)
++||+.||.+||+ ++++++||||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999999997 8999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=395.20 Aligned_cols=257 Identities=33% Similarity=0.584 Sum_probs=220.0
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997655443345577889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc-----
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH----- 163 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~----- 163 (472)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999865 678999999999999999999999999999999999999999999999999975321100
Q ss_pred ------------------------------------CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc
Q 012053 164 ------------------------------------QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA 207 (472)
Q Consensus 164 ------------------------------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt 207 (472)
........+||+.|+|||++.+..+. .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 00011235799999999999877765 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHhcc--CCCCCC--CCCHHHHHHHhcccCCCCCCcC---ChhhhhcCccccc
Q 012053 208 GYLPFHDSNLMEMYRKIGKA--EFKFPN--WFAPEVRRLLSKILDPNPNTRI---SMTKIMENSWFRK 268 (472)
Q Consensus 208 G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~l~~li~~~L~~dP~~Rp---t~~eil~hp~f~~ 268 (472)
|+.||.+.+..+....+... ...+|. .+++++.++|.+|+ .+|.+|+ |+.++++||||+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999988877666655432 223333 47899999999976 5999999 9999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=396.40 Aligned_cols=258 Identities=32% Similarity=0.552 Sum_probs=221.0
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 69999999999999999999999999999999987665555566789999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC-----
Q 012053 91 YVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ----- 164 (472)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~----- 164 (472)
|++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999998865 6799999999999999999999999999999999999999999999999999754311000
Q ss_pred ----------------------------------------CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHH
Q 012053 165 ----------------------------------------DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYV 204 (472)
Q Consensus 165 ----------------------------------------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ 204 (472)
.....+.+||+.|+|||++.+.++. .++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence 0011345799999999999877765 89999999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHhc--cCCCCCC--CCCHHHHHHHhccc--CCCCCCcCChhhhhcCcccccC
Q 012053 205 LLAGYLPFHDSNLMEMYRKIGK--AEFKFPN--WFAPEVRRLLSKIL--DPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 205 lltG~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~s~~l~~li~~~L--~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
|++|..||...+..+...++.. ....+|. .+++++.+||.+|+ ..+|..|++++++++||||...
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999998877666555543 2344444 47899999999955 5566669999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=387.91 Aligned_cols=255 Identities=32% Similarity=0.589 Sum_probs=227.5
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCC-CeeeEEEEEEeCCEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP-NVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~ 89 (472)
+|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.+++.++|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544444566788899999999765 6889999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC--CCce
Confidence 99999999988865 67999999999999999999999999999999999999999999999999998643221 1223
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+.+..+......+|..+++++.++|++||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 456899999999999877664 7899999999999999999999999888888899888888999999999999999999
Q ss_pred CCCCCcCCh-----hhhhcCccccc
Q 012053 249 PNPNTRISM-----TKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rpt~-----~eil~hp~f~~ 268 (472)
.||.+|++. +++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999987 79999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=389.07 Aligned_cols=250 Identities=32% Similarity=0.650 Sum_probs=223.5
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+.........+.+..|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544334556677888888876 699999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCccccccc
Confidence 999988865 68999999999999999999999999999999999999999999999999998753221 122345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|+.||...+....+..+.......|.++++++.++|++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999876664 789999999999999999999999998889999988888999999999999999999999999
Q ss_pred cCCh------hhhhcCccccc
Q 012053 254 RISM------TKIMENSWFRK 268 (472)
Q Consensus 254 Rpt~------~eil~hp~f~~ 268 (472)
||++ ++++.||||..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 89999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=395.10 Aligned_cols=262 Identities=30% Similarity=0.548 Sum_probs=228.6
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 44678999999999999999999999999999999997654433344566789999999999999999999999999999
Q ss_pred EEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 87 FVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
+||||++||+|.+++..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-V 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-c
Confidence 999999999999999888899999999999999999999999999999999999999999999999999876532211 1
Q ss_pred cccccCCCCcccChhhhcccC---CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCC--CCCHHH
Q 012053 167 LLHTTCGTPAYVAPEVINRRG---YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPN--WFAPEV 239 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~---~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~l 239 (472)
.....+||+.|+|||++.... ..+.++|||||||++|+|++|..||.+.+....+.++.... ..+|. .++.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 124568999999999986542 34589999999999999999999999988888888886543 44555 479999
Q ss_pred HHHHhcccCCCCCC--cCChhhhhcCcccccC
Q 012053 240 RRLLSKILDPNPNT--RISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~--Rpt~~eil~hp~f~~~ 269 (472)
++||.+||+.+|.+ |+|++++++||||+..
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999999998 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=396.62 Aligned_cols=257 Identities=32% Similarity=0.611 Sum_probs=220.9
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||+||+|.+..+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997665444455678899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC---
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD--- 165 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~--- 165 (472)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999998865 67999999999999999999999999999999999999999999999999998632110000
Q ss_pred ------------------------------------------CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHH
Q 012053 166 ------------------------------------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILY 203 (472)
Q Consensus 166 ------------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~ 203 (472)
......+||+.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 000135799999999999877765 8999999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHhcc--CCCCCC--CCCHHHHHHHhcccCCCCCCc---CChhhhhcCccccc
Q 012053 204 VLLAGYLPFHDSNLMEMYRKIGKA--EFKFPN--WFAPEVRRLLSKILDPNPNTR---ISMTKIMENSWFRK 268 (472)
Q Consensus 204 ~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~l~~li~~~L~~dP~~R---pt~~eil~hp~f~~ 268 (472)
+|++|..||...+..+.+..+... ...+|. .+++++++||.+||. +|.+| +|+.+++.||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988877777777542 344454 378999999999998 67765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=387.78 Aligned_cols=250 Identities=32% Similarity=0.618 Sum_probs=223.8
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+...........+..|..+++.+ +||||+++++++.+++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444556677899998865 799999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC--Ccccccccc
Confidence 999988865 67999999999999999999999999999999999999999999999999998753322 122345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|+.||...+....+..+......+|.++++++.++|.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999877665 789999999999999999999999999899999988888899999999999999999999999
Q ss_pred cC-------ChhhhhcCccccc
Q 012053 254 RI-------SMTKIMENSWFRK 268 (472)
Q Consensus 254 Rp-------t~~eil~hp~f~~ 268 (472)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 8999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=395.67 Aligned_cols=257 Identities=35% Similarity=0.618 Sum_probs=221.4
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.+|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 37999999999999999999999999999999998765444455678899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc-----
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH----- 163 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~----- 163 (472)
||++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999998865 679999999999999999999999999999999999999999999999999975321100
Q ss_pred ----------------------------------------CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHH
Q 012053 164 ----------------------------------------QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILY 203 (472)
Q Consensus 164 ----------------------------------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~ 203 (472)
......+.+||+.|+|||++.+.++. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00011235799999999999888776 8999999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHhcc--CCCCC--CCCCHHHHHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012053 204 VLLAGYLPFHDSNLMEMYRKIGKA--EFKFP--NWFAPEVRRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 204 ~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~l~~li~~~L~~dP~~Rpt---~~eil~hp~f~~ 268 (472)
+|++|+.||...+..+...++... ...+| ..+++++.++|.+|+ .+|.+|++ ++++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999999999988777666666542 23344 347999999999986 59999997 999999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=389.44 Aligned_cols=250 Identities=37% Similarity=0.678 Sum_probs=223.7
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445567788999999999999999999999999999999999999
Q ss_pred cccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 96 ELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 96 ~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
+|..++.. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++...... .......+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--CcccccccC
Confidence 99988865 579999999999999999999997 79999999999999999999999999998643221 122345679
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999877664 899999999999999999999999888888888888888889999999999999999999999
Q ss_pred cC-----ChhhhhcCccccc
Q 012053 254 RI-----SMTKIMENSWFRK 268 (472)
Q Consensus 254 Rp-----t~~eil~hp~f~~ 268 (472)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=394.39 Aligned_cols=263 Identities=30% Similarity=0.574 Sum_probs=227.3
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34567899999999999999999999999999999999765444334456688999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 86 YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|+||||++||+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~- 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM- 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc-
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999876542211
Q ss_pred CcccccCCCCcccChhhhcccC---CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCC--CCCHH
Q 012053 166 GLLHTTCGTPAYVAPEVINRRG---YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPN--WFAPE 238 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~---~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~ 238 (472)
....+.+||+.|+|||++.+.+ +.+.++|||||||++|+|++|..||...+....+.++... ...+|. .+++.
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 1124568999999999987543 3457999999999999999999999998888788777653 345555 36899
Q ss_pred HHHHHhcccCCCCCC--cCChhhhhcCcccccC
Q 012053 239 VRRLLSKILDPNPNT--RISMTKIMENSWFRKG 269 (472)
Q Consensus 239 l~~li~~~L~~dP~~--Rpt~~eil~hp~f~~~ 269 (472)
++++|.+||..++.+ |+|+.++++||||+..
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999866554 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=385.62 Aligned_cols=258 Identities=33% Similarity=0.618 Sum_probs=221.3
Q ss_pred CEEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVL-KVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (472)
+|++++.||+|+||.||++++. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 47899999999765432 223456788999999999 499999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 999999999999998865 6799999999999999999999999999999999999999999999999999876533222
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC----cHHHHHHHHhccCCCCCCCCCHHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS----NLMEMYRKIGKAEFKFPNWFAPEVR 240 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~l~ 240 (472)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..+++.+.
T Consensus 161 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 161 -ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred -CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 12335689999999999976654568899999999999999999999642 3344555666667778888999999
Q ss_pred HHHhcccCCCCCCcC-----ChhhhhcCcccccC
Q 012053 241 RLLSKILDPNPNTRI-----SMTKIMENSWFRKG 269 (472)
Q Consensus 241 ~li~~~L~~dP~~Rp-----t~~eil~hp~f~~~ 269 (472)
++|.+||..||++|| +++++++||||+..
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999 78899999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=391.88 Aligned_cols=257 Identities=33% Similarity=0.661 Sum_probs=226.8
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 57999999999999999999999999999999998765444455677899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc-----
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH----- 163 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~----- 163 (472)
||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999866 689999999999999999999999999999999999999999999999999987654322
Q ss_pred ----------------------CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHH
Q 012053 164 ----------------------QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMY 221 (472)
Q Consensus 164 ----------------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~ 221 (472)
.........||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 00123345799999999999887664 8999999999999999999999998887777
Q ss_pred HHHhc--cCCCCCCC--CCHHHHHHHhcccCCCCCCcCC-hhhhhcCccccc
Q 012053 222 RKIGK--AEFKFPNW--FAPEVRRLLSKILDPNPNTRIS-MTKIMENSWFRK 268 (472)
Q Consensus 222 ~~i~~--~~~~~~~~--~s~~l~~li~~~L~~dP~~Rpt-~~eil~hp~f~~ 268 (472)
.++.. ....+|.. +++++.+||.+||. ||.+|++ ++++++||||+.
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77766 44445444 59999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=383.93 Aligned_cols=251 Identities=35% Similarity=0.670 Sum_probs=222.1
Q ss_pred EeeEcccCCeEEEEEEEc---CCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 15 GRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVLK-VGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
++.||+|+||.||+|++. .+++.||+|++.+..... ......+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 478999999997654321 2334567899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 91 YVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
|+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--GTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--CCccc
Confidence 9999999998865 67899999999999999999999999999999999999999999999999998643221 12234
Q ss_pred ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCC
Q 012053 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~ 249 (472)
..+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||..
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 56899999999999877664 89999999999999999999999988888888888888899999999999999999999
Q ss_pred CCCCcC-----ChhhhhcCccccc
Q 012053 250 NPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 250 dP~~Rp-----t~~eil~hp~f~~ 268 (472)
||++|| +++++++||||..
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCC
Confidence 999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=382.85 Aligned_cols=250 Identities=35% Similarity=0.674 Sum_probs=220.4
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL-VRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+.........+.+..|..++.. .+||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999987654333444556677777765 4899999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccC
Confidence 999988865 689999999999999999999999999999999999999999999999999987543221 22345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|.+++.++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999877664 889999999999999999999999888888888888888889999999999999999999999
Q ss_pred cCChh-hhhcCccccc
Q 012053 254 RISMT-KIMENSWFRK 268 (472)
Q Consensus 254 Rpt~~-eil~hp~f~~ 268 (472)
||++. ++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 238 RLGVDGDIRQHPFFRG 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99875 8889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=384.37 Aligned_cols=255 Identities=32% Similarity=0.586 Sum_probs=227.3
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.|++++.||+|+||+||+|++..+++.||+|++.+...........+..|..++..+ +||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 489999999999999999999999999999999876544334455677788888777 5899999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||+++|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--CCcc
Confidence 99999999988865 68999999999999999999999999999999999999999999999999998743321 1223
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+......+|..+++++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 456899999999999877765 8999999999999999999999999888889999888888999999999999999999
Q ss_pred CCCCCcCCh-----hhhhcCccccc
Q 012053 249 PNPNTRISM-----TKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rpt~-----~eil~hp~f~~ 268 (472)
.||.+|++. .++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999985 79999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=378.20 Aligned_cols=253 Identities=29% Similarity=0.464 Sum_probs=212.6
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++.+.||.|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 56899999999999999999999999999999999754321 2235677999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--K 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--c
Confidence 999975 88887754 358999999999999999999999999999999999999999999999999987543221 1
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------------
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------- 227 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------- 227 (472)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||...+..+....+...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 2345678999999999876544458999999999999999999999887765544433211
Q ss_pred CCCC-----------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 228 EFKF-----------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 228 ~~~~-----------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
...+ ...+++++.+||++||+.||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0011 12367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=377.06 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=213.3
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||+||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 5899999999999999999999999999999999765432 234567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||+.++.+..+... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccc
Confidence 99998877655543 5799999999999999999999999999999999999999999999999999886543221 122
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------------C
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-------------------F 229 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 229 (472)
....||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+..+....+.... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 345799999999999877764 79999999999999999999998765543332221110 0
Q ss_pred CC-------------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 230 KF-------------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ~~-------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
.. ...+++++.+||.+||+.||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 01 11267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=385.03 Aligned_cols=250 Identities=31% Similarity=0.587 Sum_probs=218.5
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554445567788999999888 799999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....+.+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCccccccC
Confidence 999888754 68999999999999999999999999999999999999999999999999998642221 122345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC---------cHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS---------NLMEMYRKIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~l~~li~ 244 (472)
|+.|+|||++.+..++ .++|+|||||++|+|++|..||... .....+..+......+|..+++++.++|.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999877665 7999999999999999999999631 12234566677778889999999999999
Q ss_pred cccCCCCCCcCC------hhhhhcCccccc
Q 012053 245 KILDPNPNTRIS------MTKIMENSWFRK 268 (472)
Q Consensus 245 ~~L~~dP~~Rpt------~~eil~hp~f~~ 268 (472)
+||..||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 789999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=383.77 Aligned_cols=257 Identities=30% Similarity=0.581 Sum_probs=223.1
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765434445677889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-N 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-e
Confidence 99999999999865 57999999999999999999999999999999999999999999999999998765432211 1
Q ss_pred ccccCCCCcccChhhhcc-----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCC--CCCCHH
Q 012053 168 LHTTCGTPAYVAPEVINR-----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFP--NWFAPE 238 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~-----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~ 238 (472)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ..+| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999863 2333578999999999999999999999888777777765432 2333 357899
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+.+||.+||. +|.+|||++++++||||+.
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999998 9999999999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=381.47 Aligned_cols=251 Identities=34% Similarity=0.633 Sum_probs=220.9
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL-VRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+..............|..+++. ++||||+++++++.+++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999987643323344556678888876 5899999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|.+.+.. +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCceeeecC
Confidence 999998875 57999999999999999999999999999999999999999999999999998643221 122345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+.+..+......+|.+++.+++++|.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999877665 899999999999999999999999888888888877777888899999999999999999999
Q ss_pred cCChh-hhhcCcccccC
Q 012053 254 RISMT-KIMENSWFRKG 269 (472)
Q Consensus 254 Rpt~~-eil~hp~f~~~ 269 (472)
||++. ++++||||+..
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 238 RLGVKGDIRQHPFFREI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99996 89999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=373.94 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=222.7
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----C
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-----K 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~ 82 (472)
+..+|..++.||.|+||.|+.|.++.+|+.||||.+.... ...-.+++..||+.+|+.++|+||+.+++++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 4457777899999999999999999999999999986332 233457888999999999999999999999855 3
Q ss_pred CEEEEEEEecCCCcccchhccCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 83 TKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..+|+|+|++ +.+|...++.++ ++++.++.+++||+.||+|+|+.||+||||||.|+|++.++.+||+|||||+....
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 5799999999 679999998876 99999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc---------------
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK--------------- 226 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~--------------- 226 (472)
...++.++..+.|.+|.|||++.....++.+.||||+|||+.||++|++-|.+.+.......|..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 44445567788999999999987665556899999999999999999999998776555544421
Q ss_pred --------cCCCC--------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 227 --------AEFKF--------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 227 --------~~~~~--------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
..... -+..++.+.+|+.+||..||.+|+|++|+|+||||..-
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 01111 12468999999999999999999999999999999864
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=389.13 Aligned_cols=257 Identities=33% Similarity=0.618 Sum_probs=223.0
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+.|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+++.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998655444455678899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC----
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ---- 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~---- 164 (472)
||++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999865 6899999999999999999999999999999999999999999999999999874432110
Q ss_pred -----------------------------CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC
Q 012053 165 -----------------------------DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS 215 (472)
Q Consensus 165 -----------------------------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~ 215 (472)
.......+||+.|+|||++.+.++. .++|||||||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0112245899999999999887776 7999999999999999999999998
Q ss_pred cHHHHHHHHhcc--CCCCCCC--CCHHHHHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012053 216 NLMEMYRKIGKA--EFKFPNW--FAPEVRRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 216 ~~~~~~~~i~~~--~~~~~~~--~s~~l~~li~~~L~~dP~~Rpt---~~eil~hp~f~~ 268 (472)
+....+.++... ...+|+. +++++++||.+|+. ||.+|++ +.++++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 888877777643 3344543 78999999999874 9999984 799999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=380.42 Aligned_cols=250 Identities=34% Similarity=0.620 Sum_probs=219.6
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS-VMRLVRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765433333445555555 56889999999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccccccC
Confidence 999988865 67999999999999999999999999999999999999999999999999998743221 122345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+.+..+.......++.+++++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999877665 789999999999999999999999888888888888888888889999999999999999999
Q ss_pred cCCh----hhhhcCccccc
Q 012053 254 RISM----TKIMENSWFRK 268 (472)
Q Consensus 254 Rpt~----~eil~hp~f~~ 268 (472)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9998 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=382.27 Aligned_cols=251 Identities=33% Similarity=0.662 Sum_probs=224.4
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444566778899999887 699999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
++|...+.+ +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcccceec
Confidence 999988865 58999999999999999999999999999999999999999999999999998643221 122345679
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++++.+||.+||..||++
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999877765 799999999999999999999999888888888888888889899999999999999999999
Q ss_pred cCCh-----hhhhcCcccccC
Q 012053 254 RISM-----TKIMENSWFRKG 269 (472)
Q Consensus 254 Rpt~-----~eil~hp~f~~~ 269 (472)
|||+ .++++||||+..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 9999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=380.57 Aligned_cols=250 Identities=34% Similarity=0.609 Sum_probs=219.0
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS-VMRLVRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++..++.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997664433333445556655 46789999999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .......+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcccccC
Confidence 999888865 68999999999999999999999999999999999999999999999999998743221 112345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+++..+.......++..+.++.++|++||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999877765 799999999999999999999999888888888888877777789999999999999999999
Q ss_pred cCChh----hhhcCccccc
Q 012053 254 RISMT----KIMENSWFRK 268 (472)
Q Consensus 254 Rpt~~----eil~hp~f~~ 268 (472)
||++. ++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 99874 8999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=382.64 Aligned_cols=250 Identities=32% Similarity=0.601 Sum_probs=217.5
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554445567788999998776 799999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccC
Confidence 999888765 689999999999999999999999999999999999999999999999999987532211 12345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC---------CcHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD---------SNLMEMYRKIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~s~~l~~li~ 244 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.. ......+..+......+|..++.++.++|.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999877665 799999999999999999999952 112334556667778889999999999999
Q ss_pred cccCCCCCCcCC------hhhhhcCccccc
Q 012053 245 KILDPNPNTRIS------MTKIMENSWFRK 268 (472)
Q Consensus 245 ~~L~~dP~~Rpt------~~eil~hp~f~~ 268 (472)
+||..||++||| +.++++||||+.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=377.77 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=209.6
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++.+.||+|+||+||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.++...|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 46899999999999999999999999999999999754321 2234567899999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--H 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--c
Confidence 99996 567666654 579999999999999999999999999999999999999999999999999987543221 2
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH-HHHHHHHhcc--C---------------
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL-MEMYRKIGKA--E--------------- 228 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~--~--------------- 228 (472)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+... ......+... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 234567899999999987655455789999999999999999999987432 2222222110 0
Q ss_pred ----CC--CCC---------CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 229 ----FK--FPN---------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 229 ----~~--~~~---------~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+. .+. .+++++.+||.+||+.||++|||+.++++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 000 135678999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=378.19 Aligned_cols=250 Identities=34% Similarity=0.609 Sum_probs=219.2
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS-VMRLVRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765433333445555554 67889999999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .......+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccccccC
Confidence 999888765 67999999999999999999999999999999999999999999999999998743221 222345689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+......+|...+.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999877665 789999999999999999999999988888888888888888889999999999999999999
Q ss_pred cCChh----hhhcCccccc
Q 012053 254 RISMT----KIMENSWFRK 268 (472)
Q Consensus 254 Rpt~~----eil~hp~f~~ 268 (472)
|++.. ++++|+||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 99764 9999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=387.21 Aligned_cols=263 Identities=32% Similarity=0.572 Sum_probs=226.4
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34567999999999999999999999999999999999765443334456688999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 86 YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|+||||++||+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~- 197 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM- 197 (371)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-
Confidence 9999999999999999888899999999999999999999999999999999999999999999999999876532211
Q ss_pred CcccccCCCCcccChhhhcccC---CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCC--CCCHH
Q 012053 166 GLLHTTCGTPAYVAPEVINRRG---YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPN--WFAPE 238 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~---~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~ 238 (472)
....+.+||+.|+|||++...+ ..+.++|||||||++|+|++|..||...+....+.++.... ..+|. .++++
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 1124568999999999987543 34579999999999999999999999988888888876543 34443 58999
Q ss_pred HHHHHhcccCCCCCC--cCChhhhhcCcccccC
Q 012053 239 VRRLLSKILDPNPNT--RISMTKIMENSWFRKG 269 (472)
Q Consensus 239 l~~li~~~L~~dP~~--Rpt~~eil~hp~f~~~ 269 (472)
++++|.+||..++.+ |+++++|++|+||+..
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999854443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=379.76 Aligned_cols=255 Identities=32% Similarity=0.588 Sum_probs=226.3
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+..|+.+++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4789999999999999999999999999999998765444445567788999998886 577889999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccc
Confidence 99999999998865 689999999999999999999999999999999999999999999999999987533221 123
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456799999999999877664 8999999999999999999999998888888888888888899999999999999999
Q ss_pred CCCCCcCCh-----hhhhcCccccc
Q 012053 249 PNPNTRISM-----TKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rpt~-----~eil~hp~f~~ 268 (472)
.||.+|++. .++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 999999984 68999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=380.40 Aligned_cols=251 Identities=36% Similarity=0.654 Sum_probs=221.8
Q ss_pred EeeEcccCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012053 15 GRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
++.||+|+||+||++++. .+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 368999999999999874 57899999999765432 22345677899999999999999999999999999999999
Q ss_pred cCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccc
Q 012053 92 VKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 92 ~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
+.+++|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~ 157 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYS 157 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cceec
Confidence 999999998865 579999999999999999999999999999999999999999999999999987543321 22345
Q ss_pred cCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCC
Q 012053 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPN 250 (472)
Q Consensus 171 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~d 250 (472)
.+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++++.+||++||+.|
T Consensus 158 ~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred ccCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 6899999999999877664 799999999999999999999999888888888888888899999999999999999999
Q ss_pred CCCcCC-----hhhhhcCcccccC
Q 012053 251 PNTRIS-----MTKIMENSWFRKG 269 (472)
Q Consensus 251 P~~Rpt-----~~eil~hp~f~~~ 269 (472)
|.+||| +.+++.||||+..
T Consensus 237 P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 237 PANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HhHcCCCCCCCHHHHhCCCCcCCC
Confidence 999999 6779999999763
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=379.78 Aligned_cols=250 Identities=30% Similarity=0.517 Sum_probs=216.1
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcE-EEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-E
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMS-VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-K 84 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~-vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~ 84 (472)
+......+.+.||+|+||+||+|.+ .|+. ||+|++......... .+.+.+|+.+|.+++|||||+++|++.+.. .
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3345566778899999999999998 5566 999999876654433 779999999999999999999999998887 7
Q ss_pred EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEcCCC-CeEEecCcchhhh
Q 012053 85 IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRG-VCHRDLKPENLLLDEHG-NLKVSDFGLSALA 159 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~g-iiHrDIKp~NILld~~g-~vkl~DFGla~~~ 159 (472)
..+||||+++|+|++++.. +.++...+.+++.||+.|+.|||+++ ||||||||+|||++.++ ++||+|||+++..
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999999954 68999999999999999999999999 99999999999999998 9999999999876
Q ss_pred hcccCCCcccccCCCCcccChhhhc--ccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHh--ccCCCCCCCC
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVIN--RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG--KAEFKFPNWF 235 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~--~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~--~~~~~~~~~~ 235 (472)
.... .......||+.|||||++. ...|+ .++||||||+++|||+||..||.+.........+. .....+|..+
T Consensus 195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred cccc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 5432 1223368999999999998 44665 89999999999999999999999987755544443 3446677779
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++.+..||.+||..||.+||++.+|+.
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 999999999999999999999999975
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=382.11 Aligned_cols=249 Identities=31% Similarity=0.593 Sum_probs=216.8
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV---RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
||+|+||+||+|++..+|+.||+|++.+..............|..++... +||||+++++++.+.+.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443333344555677777655 699999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .......+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCccCccC
Confidence 999888865 67999999999999999999999999999999999999999999999999998753322 122346789
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCC-CCHHHHHHHhcccCCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNW-FAPEVRRLLSKILDPNPN 252 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~s~~l~~li~~~L~~dP~ 252 (472)
|+.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+..+...+|.. +++++.+||++||.+||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 9999999998765544589999999999999999999999988888888888777777754 799999999999999999
Q ss_pred CcC----ChhhhhcCccccc
Q 012053 253 TRI----SMTKIMENSWFRK 268 (472)
Q Consensus 253 ~Rp----t~~eil~hp~f~~ 268 (472)
+|| ++.++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 6899999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=374.71 Aligned_cols=250 Identities=30% Similarity=0.592 Sum_probs=218.4
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554445567788999999888 699999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCceecccC
Confidence 999888765 68999999999999999999999999999999999999999999999999998743221 122346789
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC-------CcHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-------SNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-------~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~ 246 (472)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.. ......+..+......+|..++..+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999877664 899999999999999999999953 12234556666677788888999999999999
Q ss_pred cCCCCCCcCCh------hhhhcCccccc
Q 012053 247 LDPNPNTRISM------TKIMENSWFRK 268 (472)
Q Consensus 247 L~~dP~~Rpt~------~eil~hp~f~~ 268 (472)
|..||.+|+++ .+|++||||+.
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 99999999984 69999999976
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=369.22 Aligned_cols=248 Identities=29% Similarity=0.479 Sum_probs=213.7
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012053 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||+|+||+||++.+..+|+.||+|.+.+.........+.+..|+.+++.++||||+++++++..++.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999766544334456678899999999999999999999999999999999999999
Q ss_pred cchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccC
Q 012053 98 FGKVA-----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC 172 (472)
Q Consensus 98 ~~~i~-----~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 172 (472)
...+. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccC
Confidence 87662 24699999999999999999999999999999999999999999999999999875543221 223457
Q ss_pred CCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH----HHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012053 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL----MEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 173 gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
||+.|+|||++.+..++ .++|||||||++|+|++|+.||..... ......+......++..+++++.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999877765 789999999999999999999976432 2334444455566777899999999999999
Q ss_pred CCCCCcC-----ChhhhhcCccccc
Q 012053 249 PNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
.||++|| |++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 7899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=377.03 Aligned_cols=250 Identities=35% Similarity=0.620 Sum_probs=218.0
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHH-HHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI-SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||+||+|++..+++.||+|++.+...........+..|. .+++.++||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999865433323333444444 456889999999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcccccC
Confidence 999998865 67999999999999999999999999999999999999999999999999998753221 222346689
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+......+++.+++++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999877665 789999999999999999999999888888888887777788889999999999999999999
Q ss_pred cCChh----hhhcCccccc
Q 012053 254 RISMT----KIMENSWFRK 268 (472)
Q Consensus 254 Rpt~~----eil~hp~f~~ 268 (472)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=374.38 Aligned_cols=257 Identities=27% Similarity=0.476 Sum_probs=218.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++++.||+|+||.||+|++..+|..+|+|++.... .....+.+.+|+.+|+.++||||+++++++..++.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 45689999999999999999999999999999999997643 2234577999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||++|++|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 99999999999999875 6799999999999999999999986 6999999999999999999999999998755322
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc------------------
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK------------------ 226 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~------------------ 226 (472)
......||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+..++...+..
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 22455799999999999877664 799999999999999999999977655443322211
Q ss_pred ----------------------------c-CCCCC-CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 227 ----------------------------A-EFKFP-NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 227 ----------------------------~-~~~~~-~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
. ....+ ..+++++++||.+||..||++|||+.+|++||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0 01111 13678999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=360.99 Aligned_cols=258 Identities=31% Similarity=0.432 Sum_probs=221.5
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA--SKTKI 85 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~ 85 (472)
..+.|+.+..|++|+||.||+|+|+.|++.||+|.++.+.- +.++-=.-.|||.+|...+|||||.+-++.. +-+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 35679999999999999999999999999999999987652 2233334569999999999999999999975 44679
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+|||||+. +|..++.. .++...+++.+..|++.|++|||.+.|+||||||+|+|+...|.+||+|||||+.++++.
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999999965 78888865 589999999999999999999999999999999999999999999999999999887753
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc----------------
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---------------- 227 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---------------- 227 (472)
. .++..+-|.+|.|||.+.+...++.+.|+||+|||+.||+++.+-|.+.+..+...+|.+.
T Consensus 232 k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 232 K--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3 3556678999999999998887778999999999999999999999998887777776421
Q ss_pred ---CCCCC------------CC-CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 ---EFKFP------------NW-FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---~~~~~------------~~-~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
...++ .. ++....+|+..+|..||.+|.|+.+.|+|+||.+.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 01111 11 45788899999999999999999999999999874
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=376.55 Aligned_cols=256 Identities=31% Similarity=0.502 Sum_probs=207.5
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----CEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK-----TKI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 85 (472)
||++.+.||+|+||.||+|++..+|+.||||.+..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 79999999999999999999999999999999864322 122345688999999999999999999987543 358
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 688888765 5799999999999999999999999999999999999999999999999999875433222
Q ss_pred C-CcccccCCCCcccChhhhccc-CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHh-----------------
Q 012053 165 D-GLLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG----------------- 225 (472)
Q Consensus 165 ~-~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~----------------- 225 (472)
. ......+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1 122346799999999998652 233579999999999999999999998765433221110
Q ss_pred ----------ccC-CCC---CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 226 ----------KAE-FKF---PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 226 ----------~~~-~~~---~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
... ..+ .+.+++++.++|.+||+.||++|||++++++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 000 000 1236788999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=368.02 Aligned_cols=254 Identities=25% Similarity=0.454 Sum_probs=218.8
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976554333334567789999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+.||+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---T 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---c
Confidence 9999999887743 469999999999999999999999999999999999999999999999999987643221 1
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH----HHHHHhccCCCCCCCCCHHHHHHH
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME----MYRKIGKAEFKFPNWFAPEVRRLL 243 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~----~~~~i~~~~~~~~~~~s~~l~~li 243 (472)
....+||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+... ....+......++..+++.+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 2345799999999999776654 78999999999999999999998765432 223344445566777899999999
Q ss_pred hcccCCCCCCcC-----ChhhhhcCccccc
Q 012053 244 SKILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 244 ~~~L~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
.+||..||++|| +++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=375.26 Aligned_cols=258 Identities=30% Similarity=0.567 Sum_probs=219.6
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||+||++++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444445667889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+.||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-cc
Confidence 99999999999864 5799999999999999999999999999999999999999999999999999865433221 11
Q ss_pred ccccCCCCcccChhhhcc----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCC---CCCCHH
Q 012053 168 LHTTCGTPAYVAPEVINR----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFP---NWFAPE 238 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~ 238 (472)
....+||+.|+|||++.. .+..+.++|||||||++|+|++|+.||...+..+.+..+.... +.+| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223579999999999863 2344578999999999999999999999888777777775432 3333 347899
Q ss_pred HHHHHhcccCCCCCC--cCChhhhhcCccccc
Q 012053 239 VRRLLSKILDPNPNT--RISMTKIMENSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~--Rpt~~eil~hp~f~~ 268 (472)
++++|++||..++++ |+++.++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999988654443 889999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=383.38 Aligned_cols=255 Identities=34% Similarity=0.566 Sum_probs=229.0
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
..|...+.||+|+||.||+|.+..+++.||+|+++.+... ...+.+.+|+.+|..++++||.++|+.+-.++.++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 4688889999999999999999999999999999887643 45688999999999999999999999999999999999
Q ss_pred EecCCCcccchhccCCC-CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 90 EYVKGGELFGKVAKGKL-KEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l-~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||+.||++.+.++.+.+ +|.++..++++++.|+.|||+++.+|||||+.|||+..+|++||+|||.+......... .
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--R 168 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc--c
Confidence 99999999999998765 99999999999999999999999999999999999999999999999998866543332 2
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhccc
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L 247 (472)
.+.+|||.|||||++...+|+ .++||||||++.+||++|.+||.+..++.....|.+.. +.+...+++.+++||..||
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 788999999999999988887 79999999999999999999999887765544444433 3444568999999999999
Q ss_pred CCCCCCcCChhhhhcCcccccC
Q 012053 248 DPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+.||+.||++.++|.|+|++..
T Consensus 248 ~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hcCcccCcCHHHHhhhHHHHhc
Confidence 9999999999999999999873
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=370.65 Aligned_cols=258 Identities=29% Similarity=0.523 Sum_probs=220.3
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||+||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999997654433344566889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-ee
Confidence 99999999999865 5799999999999999999999999999999999999999999999999999875543221 11
Q ss_pred ccccCCCCcccChhhhccc----CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCC---CCCHH
Q 012053 168 LHTTCGTPAYVAPEVINRR----GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPN---WFAPE 238 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~----~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~ 238 (472)
....+||+.|+|||++.+. +..+.++|||||||++|+|++|+.||...+..+.+.++.... +.+|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2345799999999998652 233578999999999999999999999888877777776533 33443 36899
Q ss_pred HHHHHhcccCCCCCC--cCChhhhhcCccccc
Q 012053 239 VRRLLSKILDPNPNT--RISMTKIMENSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~--Rpt~~eil~hp~f~~ 268 (472)
++++|.+||..++++ |++++++++||||+.
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876655 568999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=362.48 Aligned_cols=257 Identities=32% Similarity=0.500 Sum_probs=219.0
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCC----
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN-VVELYEVMASKT---- 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 83 (472)
+..|+.+++||+|+||+||+|+++.+|+.||+|.+..+.-. ++.-....+|+.+|+.++|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45688889999999999999999999999999999776532 234456689999999999999 999999998877
Q ss_pred --EEEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 84 --KIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
.+|+|+||++ -+|..++.. ..++...++.+++||+.||+|||++||+||||||+|||++++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 8999999995 478888764 25888899999999999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---------
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--------- 227 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--------- 227 (472)
+....+.. .....++|.+|.|||++.+...++...||||+|||++||++++.-|.+.+..+...+|-+.
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 96654332 2566789999999999999866678999999999999999999999998877666665321
Q ss_pred ---------CCCCCCC------------CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 ---------EFKFPNW------------FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---------~~~~~~~------------~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
...++.| .+++..+++.+||+.+|.+|.|+..++.||||...
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1122332 13478899999999999999999999999999874
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=388.76 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=206.1
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
..++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 4568999999999999999999999999999999886542 2345799999999999999999886432
Q ss_pred ---CEEEEEEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CeEEecC
Q 012053 83 ---TKIYFVMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDF 153 (472)
Q Consensus 83 ---~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-~vkl~DF 153 (472)
..+|+||||+++ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 257799999976 5655543 35799999999999999999999999999999999999999765 6999999
Q ss_pred cchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------
Q 012053 154 GLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------ 227 (472)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------ 227 (472)
|+|+...... .....+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+.+.++...
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9998654322 1235678999999999876544458999999999999999999999887665444433211
Q ss_pred -----------CC------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 228 -----------EF------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 228 -----------~~------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.. .+|...++++.+||.+||..||.+|||+.|+++||||..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 01 124456789999999999999999999999999999976
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=371.78 Aligned_cols=258 Identities=28% Similarity=0.535 Sum_probs=220.3
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||+||++++..+++.||+|++.+...........+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654444444566889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+.+|+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ce
Confidence 99999999999965 5799999999999999999999999999999999999999999999999999865432211 11
Q ss_pred ccccCCCCcccChhhhcc----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCC---CCCHH
Q 012053 168 LHTTCGTPAYVAPEVINR----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPN---WFAPE 238 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~ 238 (472)
....+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+..+.+.++.... ..+|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234589999999999862 2334579999999999999999999999988888888776543 33333 47899
Q ss_pred HHHHHhcccCCCCCC--cCChhhhhcCccccc
Q 012053 239 VRRLLSKILDPNPNT--RISMTKIMENSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~--Rpt~~eil~hp~f~~ 268 (472)
+++||++||..++.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999665544 789999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=391.63 Aligned_cols=259 Identities=31% Similarity=0.519 Sum_probs=226.1
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT---- 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (472)
..++|++.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+.++..++|+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 457999999999999999999999999999999999776543 244567889999999999999999998875432
Q ss_pred ----EEEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCc
Q 012053 84 ----KIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 84 ----~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFG 154 (472)
.+++||||+++|+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 47899999999999988753 468999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCC
Q 012053 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPN 233 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~ 233 (472)
+++............+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+.+.++..+.. .+|.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 267 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 98865543333334567899999999999877665 899999999999999999999999888777777665543 4677
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 234 WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.+++++.++|.+||..||.+|||+.++++|||++.
T Consensus 268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 89999999999999999999999999999999875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=364.46 Aligned_cols=251 Identities=33% Similarity=0.493 Sum_probs=207.1
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEE-----
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLK-TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV---RHPNVVELYEVMA----- 80 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----- 80 (472)
++|++++.||+|+||+||+|++.. ++..||+|.+....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999865 47889999987554322 2334566788887766 6999999999985
Q ss_pred eCCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
....+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999996 578777754 458999999999999999999999999999999999999999999999999987
Q ss_pred hhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC--------
Q 012053 158 LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-------- 229 (472)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-------- 229 (472)
..... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+.+.++.....
T Consensus 159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccCC---cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 65432 223456799999999999776665 789999999999999999999998877666655532110
Q ss_pred -------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 230 -------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 -------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
...+.+++.+++||.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=366.97 Aligned_cols=257 Identities=29% Similarity=0.477 Sum_probs=213.6
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-+++|++.+.||+|+||+||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 357899999999999999999999999999999998755422 223457789999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 9999975 77776654 458999999999999999999999999999999999999999999999999987543322
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------------------
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------ 227 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------ 227 (472)
.......+|+.|+|||++.+....+.++|||||||++|+|++|..||...+..+....+.+.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 12234578999999999876555568999999999999999999999877654443332210
Q ss_pred -CCCCC-----------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 -EFKFP-----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 -~~~~~-----------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
...++ +.+++++++||.+||..||.+|||+.|+++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 01111 2368899999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=373.57 Aligned_cols=255 Identities=30% Similarity=0.476 Sum_probs=213.9
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..+.|++++.||+|+||+||+|++..+|+.||||++.... .......+.+|+.+++.++|+||+++++++..++.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3567999999999999999999999999999999986543 22345678999999999999999999999999999999
Q ss_pred EEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 88 VMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||||+.+++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 150 v~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 224 (353)
T PLN00034 150 LLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--P 224 (353)
T ss_pred EEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--c
Confidence 9999999998653 3467888899999999999999999999999999999999999999999999876543211 1
Q ss_pred ccccCCCCcccChhhhcc----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcH---HHHHHHHh-ccCCCCCCCCCHHH
Q 012053 168 LHTTCGTPAYVAPEVINR----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNL---MEMYRKIG-KAEFKFPNWFAPEV 239 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~---~~~~~~i~-~~~~~~~~~~s~~l 239 (472)
.....||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||..... ......+. ......+..+++++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 245679999999998743 23455789999999999999999999974332 22222222 23344566789999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
++||.+||..||++|||+.|+++||||...
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 999999999999999999999999999874
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=361.24 Aligned_cols=253 Identities=38% Similarity=0.794 Sum_probs=229.6
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||++.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997765544455678899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||+++++|.+++.. +.+++..+..++.||+.||.|||++|++|+||+|.|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999865 67999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccC
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+....+..+..+...+|..+++.++++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 35579999999999876654 47899999999999999999999988877778888888888888899999999999999
Q ss_pred CCCCCcC-----ChhhhhcCccccc
Q 012053 249 PNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
.||.+|+ +++++++||||+.
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 8999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=373.37 Aligned_cols=255 Identities=28% Similarity=0.494 Sum_probs=209.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC---
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT--- 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 83 (472)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 567899999999999999999999999999999999975532 2234567789999999999999999999986543
Q ss_pred ---EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 84 ---KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 84 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999976 4555543 458999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc--------------
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK-------------- 226 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~-------------- 226 (472)
.. .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..
T Consensus 175 ~~---~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 TN---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cC---ccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 21 223456789999999999877765 789999999999999999999987654333222110
Q ss_pred --------cCCC---------CCC-----------CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 227 --------AEFK---------FPN-----------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 227 --------~~~~---------~~~-----------~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.... ++. ..++++++||.+||..||++|||+.|+++||||..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0000 111 13578999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=386.69 Aligned_cols=256 Identities=28% Similarity=0.472 Sum_probs=223.2
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCC-CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKT-GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... ......+.+|+.+|+.++||||+++++++..++.+|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 44599999999999999999998877 7889999875432 2334567889999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 88 VMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
||||++||+|.+.+.. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999876642 46899999999999999999999999999999999999999999999999999865443
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRR 241 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~ 241 (472)
.........+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+....+..+.. ..|..+++++.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 222234566899999999999877664 889999999999999999999998888777777765544 456678999999
Q ss_pred HHhcccCCCCCCcCChhhhhcCccccc
Q 012053 242 LLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+|.+||..||++|||+.+++.|+|++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999974
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=377.58 Aligned_cols=258 Identities=31% Similarity=0.532 Sum_probs=237.6
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE-EEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK-IYF 87 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~l 87 (472)
+++|++++.+|+|+||.+++++++..++.+++|.++...... .......+|+.++++++|||||.+++.|..++. .++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 578999999999999999999999999999999998877544 334578899999999999999999999988887 999
Q ss_pred EEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 88 VMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
||+||+||+|.+.|.+ .-++|+.+..|+.||+.|+.|||+++|+|||||+.||++..++.|||.|||+|+......
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 9999999999999965 259999999999999999999999999999999999999999999999999999887543
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLL 243 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li 243 (472)
....+..|||.||+||++.+.+|. .++|||||||++|||++-+++|.+.+...+..+|.++. .+.|..++.+++.+|
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence 346788999999999999999986 89999999999999999999999999999999998887 678888999999999
Q ss_pred hcccCCCCCCcCChhhhhcCcccccCC
Q 012053 244 SKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+.||..+|..||++.++|.+|..+...
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 999999999999999999999887543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=368.76 Aligned_cols=257 Identities=27% Similarity=0.453 Sum_probs=216.9
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++||||+++++++.+++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45689999999999999999999999999999999987653 2234567899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||+.|++|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 99999999999999865 6799999999999999999999985 79999999999999999999999999987653321
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHH--------------------
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI-------------------- 224 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i-------------------- 224 (472)
....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...........+
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 2345799999999999776654 7899999999999999999999765443222111
Q ss_pred ------------------------hcc-CCCCC-CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 225 ------------------------GKA-EFKFP-NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 225 ------------------------~~~-~~~~~-~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
... ....+ ..+++++++||.+||+.||++|||+.+++.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 111 11111 13678899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=354.70 Aligned_cols=256 Identities=34% Similarity=0.672 Sum_probs=221.6
Q ss_pred cCCcccCCEEEE-eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 012053 4 KGSILMQRYELG-RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMAS 81 (472)
Q Consensus 4 ~g~~l~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (472)
+..-+.+.|.+- +.||-|-.|+|-.+.++.||+.+|+|++... ...++|++..-+. .|||||.++++|++
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 344466778876 6799999999999999999999999998433 3467888887655 59999999999854
Q ss_pred ----CCEEEEEEEecCCCcccchhcc-C--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CCeEEe
Q 012053 82 ----KTKIYFVMEYVKGGELFGKVAK-G--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH---GNLKVS 151 (472)
Q Consensus 82 ----~~~~~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~---g~vkl~ 151 (472)
...+.+|||+++||+|+++|.. | .++|.++..+++||..|+.|||+.+|.||||||||+|...+ ..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 4568899999999999999975 3 59999999999999999999999999999999999999654 469999
Q ss_pred cCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc----HHHHHHHHhcc
Q 012053 152 DFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN----LMEMYRKIGKA 227 (472)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~ 227 (472)
|||+|+.... ...+.+.|-||+|+|||++....|+ ...|+||+||++|.||+|++||.... ...+..+|..+
T Consensus 207 DfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 207 DFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred ccccccccCC---CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 9999987653 3457899999999999999888876 78999999999999999999997643 34677889888
Q ss_pred CCCCCC--C--CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 228 EFKFPN--W--FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 228 ~~~~~~--~--~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
.+.||. | +|.+++++|+.+|..+|.+|.|+.++++|||+.....
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 888764 4 7899999999999999999999999999999987544
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=356.91 Aligned_cols=252 Identities=40% Similarity=0.685 Sum_probs=213.4
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
|++++.||+|+||+||++.+..+++.||+|++........ ......+|+.+++.++||||+++++++......|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999988764332 223445699999999999999999999999999999999
Q ss_pred cCCCcccchhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccc
Q 012053 92 VKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 92 ~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
+.+++|.+++. .+.+++..+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||++.... ........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccc
Confidence 99999999997 5889999999999999999999999999999999999999999999999999987531 12223456
Q ss_pred cCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---HHHHHHHHhccCCCCCC----CCCHHHHHHH
Q 012053 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKIGKAEFKFPN----WFAPEVRRLL 243 (472)
Q Consensus 171 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~~~~~----~~s~~l~~li 243 (472)
..+|+.|+|||++......+.++||||||+++++|++|..||...+ ......+........+. ..++++.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 7889999999998734445689999999999999999999999873 33333333322221111 1238999999
Q ss_pred hcccCCCCCCcCChhhhhcCccc
Q 012053 244 SKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=377.55 Aligned_cols=250 Identities=20% Similarity=0.321 Sum_probs=205.6
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++++.||+|+||.||+|++..+++.||+|.... ..+.+|+.+|+.++||||+++++++..+...|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 345689999999999999999999999999999997532 34678999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+|||++. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....... .
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~ 237 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A 237 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence 9999995 678777754 679999999999999999999999999999999999999999999999999987543221 1
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc-------HHHHHHHH--------------
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN-------LMEMYRKI-------------- 224 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-------~~~~~~~i-------------- 224 (472)
......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.... .......+
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 223456899999999999877664 89999999999999999998875321 01111111
Q ss_pred ------------hcc----CCCCCC-----CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 225 ------------GKA----EFKFPN-----WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 225 ------------~~~----~~~~~~-----~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
... ....|. .++.++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 000 011111 14568999999999999999999999999999986
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=371.87 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=213.5
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK---- 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (472)
.+.++|++++.||.|+||+||+|.+..+++.||+|.+.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 3567999999999999999999999999999999998754321 12345677899999999999999999987543
Q ss_pred --CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 --TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
...|+++|++ +++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 4579999988 7789888887889999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC------------
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------ 228 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------ 228 (472)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2 12456799999999999775555689999999999999999999998766544433332110
Q ss_pred -----------CCC--------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 229 -----------FKF--------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 229 -----------~~~--------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
... ....++.+.+||.+||..||.+|||+.++++||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 001 12356778999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=375.27 Aligned_cols=257 Identities=26% Similarity=0.448 Sum_probs=213.9
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----EE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-----KI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 85 (472)
.|++++.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 47899999999999999999999999999999865422 2234567889999999999999999999998776 89
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999996 467776654 6799999999999999999999999999999999999999999999999999876543221
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc------------------
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK------------------ 226 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~------------------ 226 (472)
.......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 159 -KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred -ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 2233456899999999998765556899999999999999999999988766554443321
Q ss_pred -----cCC---------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 227 -----AEF---------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 227 -----~~~---------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
... .+....++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 111 12234578999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=380.00 Aligned_cols=253 Identities=31% Similarity=0.470 Sum_probs=218.4
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-C-----CCeeeEEEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-H-----PNVVELYEV 78 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~ 78 (472)
++++..||+|++.||+|+||.|.+|.+..|++.||||+++... ....+...|+.||..|+ | -|+|+++++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 4566679999999999999999999999999999999998765 55678889999999997 4 489999999
Q ss_pred EEeCCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC--CeEEecC
Q 012053 79 MASKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG--NLKVSDF 153 (472)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g--~vkl~DF 153 (472)
|...++.|||+|.+ +.+|+++++. .+++...++.+++||+.||.+||+.||||+|||||||||.+-+ .+||+||
T Consensus 257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence 99999999999999 5689999976 4689999999999999999999999999999999999997544 6999999
Q ss_pred cchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------
Q 012053 154 GLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------ 227 (472)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------ 227 (472)
|.|+.... ...+.+-+..|+|||++.+.+|+ .+.||||||||++||++|.+.|.+.+..+.+..|...
T Consensus 336 GSSc~~~q-----~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 336 GSSCFESQ-----RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred ccccccCC-----cceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 99986532 23478899999999999999997 7899999999999999999999998887777666310
Q ss_pred ----------------------------------------------CCCCCCC-----------CCHHHHHHHhcccCCC
Q 012053 228 ----------------------------------------------EFKFPNW-----------FAPEVRRLLSKILDPN 250 (472)
Q Consensus 228 ----------------------------------------------~~~~~~~-----------~s~~l~~li~~~L~~d 250 (472)
....|.. -...+.+||.+||+.|
T Consensus 410 ~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~d 489 (586)
T KOG0667|consen 410 KMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWD 489 (586)
T ss_pred HHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccC
Confidence 0001100 0135789999999999
Q ss_pred CCCcCChhhhhcCccccc
Q 012053 251 PNTRISMTKIMENSWFRK 268 (472)
Q Consensus 251 P~~Rpt~~eil~hp~f~~ 268 (472)
|.+|+|..++|+||||..
T Consensus 490 P~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 490 PAERITPAQALNHPFLTG 507 (586)
T ss_pred chhcCCHHHHhcCccccc
Confidence 999999999999999985
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=358.41 Aligned_cols=254 Identities=27% Similarity=0.486 Sum_probs=215.9
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+.+++.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999976654443444567789999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+.|++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---T 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---c
Confidence 9999999888743 369999999999999999999999999999999999999999999999999986543221 1
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH---HHHHH-HhccCCCCCCCCCHHHHHHH
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM---EMYRK-IGKAEFKFPNWFAPEVRRLL 243 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~---~~~~~-i~~~~~~~~~~~s~~l~~li 243 (472)
.....||+.|+|||++.+..+. .++||||+|+++|+|++|..||...... ..... ........+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 2345799999999999877664 7899999999999999999999864321 11111 22223345667899999999
Q ss_pred hcccCCCCCCcCC-----hhhhhcCccccc
Q 012053 244 SKILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 244 ~~~L~~dP~~Rpt-----~~eil~hp~f~~ 268 (472)
.+||+.||.+||| +.++++||||+.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=352.07 Aligned_cols=256 Identities=29% Similarity=0.555 Sum_probs=220.2
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK--VGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+.|++.+.||+|+||.||.|.+..+++.||+|.+....... ......+.+|+.+++.++||||+++++++..+...|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987543221 1234678899999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC-
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD- 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~- 165 (472)
|+||++|++|.+.+.. +.+++..++.++.|++.||.|||+.|++||||+|+||+++.+++++|+|||++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999998865 67999999999999999999999999999999999999999999999999998754332211
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCCCCCHHHHHHH
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPNWFAPEVRRLL 243 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~l~~li 243 (472)
.......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+......++... ...+|..+++++.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 11134568899999999987664 48999999999999999999999887666555554433 3456777899999999
Q ss_pred hcccCCCCCCcCChhhhhcCccc
Q 012053 244 SKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
++||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=357.76 Aligned_cols=250 Identities=29% Similarity=0.461 Sum_probs=205.2
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEe-----C
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV---RHPNVVELYEVMAS-----K 82 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 82 (472)
+|++.+.||+|+||+||+|++..+|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 6999999999999999999999999999999987543221 2234456788777765 69999999999754 3
Q ss_pred CEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
..++++|||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999975 77777754 35899999999999999999999999999999999999999999999999998865
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-----------
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE----------- 228 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~----------- 228 (472)
.... ......||+.|+|||++.+..+. .++|||||||++|+|++|..||..........++....
T Consensus 159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SCQM---ALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cCcc---cCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 4322 12345789999999999776654 89999999999999999999998776655444432100
Q ss_pred C----------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 229 F----------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 ~----------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
. .+.+.++.++.++|.+||+.||++|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112367789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=367.87 Aligned_cols=254 Identities=24% Similarity=0.429 Sum_probs=206.7
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (472)
.+-.++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 455679999999999999999999853 356789999986543 223446788999999999 899999999988
Q ss_pred EeC-CEEEEEEEecCCCcccchhcc-------------------------------------------------------
Q 012053 80 ASK-TKIYFVMEYVKGGELFGKVAK------------------------------------------------------- 103 (472)
Q Consensus 80 ~~~-~~~~lV~E~~~gg~L~~~i~~------------------------------------------------------- 103 (472)
... ..+|+||||+++|+|.+++..
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 654 468999999999999888753
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCC
Q 012053 104 --------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP 175 (472)
Q Consensus 104 --------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~ 175 (472)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............+++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 237788899999999999999999999999999999999999999999999987653222111122345678
Q ss_pred cccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH-HHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCCC
Q 012053 176 AYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME-MYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNPN 252 (472)
Q Consensus 176 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~ 252 (472)
.|+|||++.+..+. .++|||||||++|+|++ |..||.+..... ....+..+ ....|..+++++.++|.+||..||.
T Consensus 241 ~y~aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 319 (338)
T cd05102 241 KWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK 319 (338)
T ss_pred cccCcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 89999999777665 89999999999999997 999998755433 33333333 3445667899999999999999999
Q ss_pred CcCChhhhhc
Q 012053 253 TRISMTKIME 262 (472)
Q Consensus 253 ~Rpt~~eil~ 262 (472)
+|||+.+|++
T Consensus 320 ~RPs~~el~~ 329 (338)
T cd05102 320 ERPTFSALVE 329 (338)
T ss_pred hCcCHHHHHH
Confidence 9999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=369.42 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=210.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK---- 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (472)
.+.++|++++.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 567899999999999999999999999999999999875432 223456778999999999999999999998543
Q ss_pred --CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 --TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
...|+||||+.+ +|.+.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 5555553 358999999999999999999999999999999999999999999999999987643
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------- 227 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------- 227 (472)
.. .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+...
T Consensus 171 ~~---~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 TS---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred Cc---cccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 32 123456799999999999877765 7899999999999999999999877654433222110
Q ss_pred ---------C-----CC---------------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 ---------E-----FK---------------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---------~-----~~---------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
. .. .+...+.++++||.+||..||++|||+.|+++||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 00 011135678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=356.85 Aligned_cols=251 Identities=33% Similarity=0.534 Sum_probs=213.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT---- 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (472)
..=+|+-.+.+|.|+||.||.|....+++.||||.+-.++..+ .+|+.+|+.++|||||+|..+|....
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 3447999999999999999999999999999999986665433 37999999999999999999884332
Q ss_pred -EEEEEEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CCeEEecCcch
Q 012053 84 -KIYFVMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLS 156 (472)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~-g~vkl~DFGla 156 (472)
...+||||++. +|++.++ +.+++.-.++-|.+||++||.|||+.||+||||||.|||+|.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 34589999954 8888887 4689999999999999999999999999999999999999976 89999999999
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc----------
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK---------- 226 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~---------- 226 (472)
+....+..+ .+...|..|+|||.+.+...++.+.||||.||++.||+-|++-|.+.+..+....|.+
T Consensus 174 K~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 174 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 987655443 4567799999999998887777999999999999999999999999877665554431
Q ss_pred -------cCCC------------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 227 -------AEFK------------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 227 -------~~~~------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+.. +....++++.+|+.++|..+|.+|.++.|++.||||..-
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 0111 122368999999999999999999999999999999863
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=355.66 Aligned_cols=247 Identities=29% Similarity=0.465 Sum_probs=207.2
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012053 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||+|+||.||++++..+|+.||+|.+.............+..|+.+++.++||||+++++++.++..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443323334566799999999999999999999999999999999999999
Q ss_pred cchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCC
Q 012053 98 FGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174 (472)
Q Consensus 98 ~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 174 (472)
.+.+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ......||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCC
Confidence 887743 358999999999999999999999999999999999999999999999999987654321 12345799
Q ss_pred CcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH----HHHHHHHhccCCCCC-CCCCHHHHHHHhcccCC
Q 012053 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL----MEMYRKIGKAEFKFP-NWFAPEVRRLLSKILDP 249 (472)
Q Consensus 175 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~~~-~~~s~~l~~li~~~L~~ 249 (472)
+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ..............+ ..+++++++||++||+.
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999987775 4899999999999999999999976422 233333333333332 35899999999999999
Q ss_pred CCCCcCCh----hhhhcCccccc
Q 012053 250 NPNTRISM----TKIMENSWFRK 268 (472)
Q Consensus 250 dP~~Rpt~----~eil~hp~f~~ 268 (472)
||.+||++ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 66789999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=358.08 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=214.2
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-.++|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 467899999999999999999999999999999998754322 223457789999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
||||+. ++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 999997 478777754 468999999999999999999999999999999999999999999999999987543222
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------------------
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------ 227 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------ 227 (472)
.......+++.|+|||++.+....+.++|||||||++|+|++|++||...+..+....+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 12234567899999999876655568999999999999999999999887665444332210
Q ss_pred -CCCCC-----------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 228 -EFKFP-----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 228 -~~~~~-----------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
....| ..+++++++||.+||..||.+|||++++++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 01111 246888999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=383.22 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=203.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC------CCeeeEEEEEEe
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH------PNVVELYEVMAS 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~ 81 (472)
..++|++++.||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3578999999999999999999999999999999996432 223456678888877754 458899999876
Q ss_pred C-CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCC------------
Q 012053 82 K-TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHG------------ 146 (472)
Q Consensus 82 ~-~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g------------ 146 (472)
+ .++|+|||++ |++|.+++.+ +.+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 5 5789999988 7788887754 689999999999999999999998 5999999999999998766
Q ss_pred ----CeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHH
Q 012053 147 ----NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR 222 (472)
Q Consensus 147 ----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~ 222 (472)
.+||+|||++..... .....+||+.|+|||++.+..|. .++|||||||++|+|++|++||...+..+...
T Consensus 282 ~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred CCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 499999998753221 12456899999999999887775 78999999999999999999998766544433
Q ss_pred HHhccCCCCC----------------------------C--------------CCCHHHHHHHhcccCCCCCCcCChhhh
Q 012053 223 KIGKAEFKFP----------------------------N--------------WFAPEVRRLLSKILDPNPNTRISMTKI 260 (472)
Q Consensus 223 ~i~~~~~~~~----------------------------~--------------~~s~~l~~li~~~L~~dP~~Rpt~~ei 260 (472)
.+......+| . ..++.+.+||.+||..||.+|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 3321110000 0 013557799999999999999999999
Q ss_pred hcCcccccCC
Q 012053 261 MENSWFRKGL 270 (472)
Q Consensus 261 l~hp~f~~~~ 270 (472)
|+||||.+..
T Consensus 436 L~Hp~~~~~~ 445 (467)
T PTZ00284 436 TTHPYVLKYY 445 (467)
T ss_pred hcCccccccC
Confidence 9999998743
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=354.71 Aligned_cols=255 Identities=26% Similarity=0.451 Sum_probs=219.0
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+|+.++|+||+++++.+..++..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999977654443444567889999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+.+++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---S 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---c
Confidence 9999999877743 369999999999999999999999999999999999999999999999999986543211 1
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHH----HHHHhccCCCCCCCCCHHHHHHH
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM----YRKIGKAEFKFPNWFAPEVRRLL 243 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~l~~li 243 (472)
.....|++.|+|||.+.+..+. .++|+|||||++|+|++|..||........ ...+......++..+++++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 2345799999999999776664 789999999999999999999987655332 23334444556677899999999
Q ss_pred hcccCCCCCCcCC-----hhhhhcCcccccC
Q 012053 244 SKILDPNPNTRIS-----MTKIMENSWFRKG 269 (472)
Q Consensus 244 ~~~L~~dP~~Rpt-----~~eil~hp~f~~~ 269 (472)
.+||+.||++||| +.++++|+||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=363.13 Aligned_cols=258 Identities=29% Similarity=0.508 Sum_probs=230.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-.+-|+.-+.||+|+||+||-++-+.||+.+|+|.+++..+.+........+|-.||.+++.+.||.+-..|++++.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34567889999999999999999999999999999999888776666666789999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-C--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 87 FVMEYVKGGELFGKVAK-G--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+||..++||+|.-.|.+ | .++|..++.|+.+|+.||++||+++|++||+||+|||||+.|+++|+|+|||..+....
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 99999999999766654 4 79999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc----HHHHHHHHhccCCCCCCCCCHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN----LMEMYRKIGKAEFKFPNWFAPEV 239 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~l 239 (472)
. ....+||.+|||||++.+..|+ ...|.|||||++|+|+.|+.||.... ..+.-+.+......+|..+|+++
T Consensus 342 ~---~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 342 P---IRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred c---cccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence 2 3455999999999999888875 89999999999999999999997643 33555667777888999999999
Q ss_pred HHHHhcccCCCCCCcCC-----hhhhhcCccccc
Q 012053 240 RRLLSKILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt-----~~eil~hp~f~~ 268 (472)
+++.+.+|..||++|.. ++++.+||||+.
T Consensus 418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 99999999999999985 569999999986
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=368.82 Aligned_cols=255 Identities=28% Similarity=0.445 Sum_probs=210.5
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK---- 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (472)
.+.++|++++.||+|+||.||.|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 457899999999999999999999999999999999975432 223456778999999999999999999987543
Q ss_pred --CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 --TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
..+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 468999999965 5655554 358899999999999999999999999999999999999999999999999997653
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC------------
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------ 228 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------ 228 (472)
.. .......||+.|+|||++.+..+. .++|||||||++|+|++|..||...+..+.+.++....
T Consensus 178 ~~---~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 TS---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred CC---CcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 32 123456799999999999887765 78999999999999999999998876655544432210
Q ss_pred ----------CC--------------------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 229 ----------FK--------------------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 229 ----------~~--------------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.. .....+.++++||.+||..||.+|||+.++++||||..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 00112467899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=344.17 Aligned_cols=252 Identities=26% Similarity=0.537 Sum_probs=217.9
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-KTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV~ 89 (472)
+|++++.||.|++|.||++.+..+++.||+|.+...... ....+.+.+|+.+++.++|||++++++.+.. +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999999999999999765432 2345678899999999999999999998864 45789999
Q ss_pred EecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 90 EYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 90 E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||+++++|.+++.. ..+++.+++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++....... .
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--D 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC--C
Confidence 99999999988864 358999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHhc
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSK 245 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~~ 245 (472)
......|++.|+|||++.+..+. .++|+||||+++++|++|..||...+.......+..+.. ..+..+++++.++|.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 23456789999999998776654 789999999999999999999988776666555555443 4566789999999999
Q ss_pred ccCCCCCCcCChhhhhcCccc
Q 012053 246 ILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f 266 (472)
||++||.+|||+.+++.||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=347.36 Aligned_cols=255 Identities=29% Similarity=0.578 Sum_probs=219.3
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc------hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK------VGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
+|.++..||.|+||.||+|.+..+++.+|+|.+....... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 6889999999999999999999899999999986543321 2344678899999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
.+++|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999875 679999999999999999999999999999999999999999999999999988665321
Q ss_pred CC----CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012053 164 QD----GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 164 ~~----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
.. .......|++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+....+.++... ....|..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 11 111234688999999999776654 7899999999999999999999887665555444433 34566778999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+.++|.+||++||.+||++.+|++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=352.76 Aligned_cols=255 Identities=29% Similarity=0.517 Sum_probs=220.2
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
..+|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+..+...|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 46999999999999999999999999999999999765432 246788999999999999999999999999999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|||++|++|.+++..+.+++.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........ ..
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~ 173 (296)
T cd06654 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 173 (296)
T ss_pred ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--cc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999876433221 12
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---CCCCCCCCCHHHHHHHhc
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~l~~li~~ 245 (472)
....|++.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+... ....+..+++.+.++|.+
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred CcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence 34578999999999877655 48999999999999999999999877654333222222 223455688999999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
||..||++|||+.+|++||||...
T Consensus 253 ~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 253 CLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=396.21 Aligned_cols=259 Identities=32% Similarity=0.568 Sum_probs=231.2
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.+.|++++.||+|+||+|.+++++.+++.||+|++++-...+......|+.|-.||.--+.+=|++++..|.++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 45799999999999999999999999999999999885544445567899999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|||++||+|..++.+ ++++|+.++.|+..|+.||+.+|+.|+|||||||+|||||.+|++||+|||.+......+. -.
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~-V~ 232 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT-VR 232 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc-EE
Confidence 999999999999987 5799999999999999999999999999999999999999999999999998776553322 22
Q ss_pred ccccCCCCcccChhhhcc----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCC--CCCCHHH
Q 012053 168 LHTTCGTPAYVAPEVINR----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFP--NWFAPEV 239 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~l 239 (472)
....+|||.|++||++.. .+.+|..+|.||+||++|||+.|..||...+..+.|.+|..- .+.|| ..+|+++
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeea 312 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEA 312 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHH
Confidence 356789999999999953 356688999999999999999999999999999999999754 67888 4589999
Q ss_pred HHHHhcccCCCCCCcCC---hhhhhcCcccccC
Q 012053 240 RRLLSKILDPNPNTRIS---MTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt---~~eil~hp~f~~~ 269 (472)
++||.+++. +|..|.. +++|..||||...
T Consensus 313 kdLI~~ll~-~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 313 KDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred HHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence 999999876 5788888 9999999999863
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=355.54 Aligned_cols=258 Identities=34% Similarity=0.608 Sum_probs=225.1
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998776544345677899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC-
Q 012053 90 EYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD- 165 (472)
Q Consensus 90 E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~- 165 (472)
||+.|++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999998864 46999999999999999999999999999999999999999999999999998754321110
Q ss_pred --------------------------CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH
Q 012053 166 --------------------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME 219 (472)
Q Consensus 166 --------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~ 219 (472)
.......||..|+|||++.+..+ +.++||||||+++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123468999999999987665 479999999999999999999999888777
Q ss_pred HHHHHhccCCCCCCC--CCHHHHHHHhcccCCCCCCcCC----hhhhhcCccccc
Q 012053 220 MYRKIGKAEFKFPNW--FAPEVRRLLSKILDPNPNTRIS----MTKIMENSWFRK 268 (472)
Q Consensus 220 ~~~~i~~~~~~~~~~--~s~~l~~li~~~L~~dP~~Rpt----~~eil~hp~f~~ 268 (472)
.+..+......++.. +++++.++|.+||..||++||| ++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 777766655555544 6899999999999999999999 999999999986
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=350.26 Aligned_cols=252 Identities=31% Similarity=0.475 Sum_probs=208.3
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++++.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999999999999998654322 2334678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 91 YVKGGELFGKVAK----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|+. ++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.+|.++|+|||++....... .
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--R 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--c
Confidence 997 477776643 468999999999999999999999999999999999999999999999999987543221 1
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------------------C
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------E 228 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------~ 228 (472)
......+++.|+|||++.+....+.++|||||||++|+|++|..||...........+... .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2234467899999999876554457899999999999999999999876543222211100 0
Q ss_pred -----------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 229 -----------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 -----------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
......+++++.++|.+||+.||.+|||+.+|++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00122368899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=354.48 Aligned_cols=253 Identities=27% Similarity=0.483 Sum_probs=214.4
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999986542 2234567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||++|++|.+++.. +.+++..+..++.|++.||.|||+ .|++||||||+|||++.++.++|+|||++...... .
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc----c
Confidence 99999999999865 679999999999999999999998 59999999999999999999999999998654322 2
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--------------------
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------------- 227 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------------- 227 (472)
....+|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 245678999999999876655 47899999999999999999999765544333222111
Q ss_pred -----------------CCCCCC-CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 -----------------EFKFPN-WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 -----------------~~~~~~-~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
....|. .+++++++||.+||..||++|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 011111 267889999999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=368.80 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=208.4
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLK--TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
+.++..+|++++.||+|+||.||+|.... ++..||+|.+.... ...+|+.+|+.++||||+++++++...
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 45667789999999999999999997643 56789999886542 346899999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..+|++||++. ++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999999995 578777754 6899999999999999999999999999999999999999999999999999876544
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH---HHHHHHHhc----c-------
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL---MEMYRKIGK----A------- 227 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~---~~~~~~i~~----~------- 227 (472)
...........||+.|+|||++....+. .++|||||||++|+|++|..||.+... ...+..+.+ .
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 3222223356799999999999877765 789999999999999999999976431 111111110 0
Q ss_pred ------------------CCCCCC-----CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 228 ------------------EFKFPN-----WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 228 ------------------~~~~~~-----~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.+..|. .++.++.++|++||..||++|||+.+++.||||.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 011111 24668899999999999999999999999999986
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=350.82 Aligned_cols=255 Identities=29% Similarity=0.528 Sum_probs=221.4
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.....+|+|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 579999999999999999999999999999999875432 23467889999999999999999999999999999999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
||+.+++|..++..+.+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~ 173 (296)
T cd06655 96 EYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRS 173 (296)
T ss_pred EecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCC
Confidence 999999999999888899999999999999999999999999999999999999999999999999875543221 123
Q ss_pred ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---CCCCCCCCCHHHHHHHhcc
Q 012053 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~l~~li~~~ 246 (472)
...|++.|+|||.+.+..+. .++|||||||++|+|++|..||...+.......+... ....+..+++.+.++|.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 252 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252 (296)
T ss_pred CcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHH
Confidence 45789999999998776654 7899999999999999999999887665444444322 2334556889999999999
Q ss_pred cCCCCCCcCChhhhhcCcccccCC
Q 012053 247 LDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
|..||.+|||+.+|+.||||+...
T Consensus 253 l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 253 LEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred hhcChhhCCCHHHHhhChHhhhcc
Confidence 999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=346.92 Aligned_cols=253 Identities=31% Similarity=0.636 Sum_probs=218.9
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEEEecC
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
.+.||+|+|+.|--+.+..+|..+|||++++.. .....++.+|++++.+.+ |+||++|+++|+++++.|||||-+.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 378999999999999999999999999998873 345688999999999985 9999999999999999999999999
Q ss_pred CCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---CeEEecCcchhhhhcc-----cC
Q 012053 94 GGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NLKVSDFGLSALAESK-----HQ 164 (472)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g---~vkl~DFGla~~~~~~-----~~ 164 (472)
||+|...|.+ ..++|.++.++.++|+.||+|||.+||.||||||+|||-.... -+|||||.|..-.... ..
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 9999888865 6799999999999999999999999999999999999996554 4899999986533221 12
Q ss_pred CCcccccCCCCcccChhhhc----ccCCCCCcccchhhhHHHHHHhcCCCCCCCC---------------cHHHHHHHHh
Q 012053 165 DGLLHTTCGTPAYVAPEVIN----RRGYDGSKADIWSCGVILYVLLAGYLPFHDS---------------NLMEMYRKIG 225 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~----~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~---------------~~~~~~~~i~ 225 (472)
...+.+.||+..|||||+.. ...++..++|.||||||||.||+|++||.+. =...++..|.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 23466789999999999863 2233448999999999999999999999642 1346788899
Q ss_pred ccCCCCCCC----CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 226 KAEFKFPNW----FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 226 ~~~~~~~~~----~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
.+.+.||.. +|.+++++|+.+|..|+..|.++.++++|||++...
T Consensus 320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 999999963 899999999999999999999999999999998643
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=346.38 Aligned_cols=252 Identities=30% Similarity=0.614 Sum_probs=223.2
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.++...|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 59999999999999999999999999999999987665444567889999999999999999999999999999999999
Q ss_pred ecCCCcccchhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 91 YVKGGELFGKVAKG-KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 91 ~~~gg~L~~~i~~~-~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
|+.|++|.+.+... .+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---ccc
Confidence 99999999998764 89999999999999999999999999999999999999999999999999987654322 234
Q ss_pred ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---HHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 012053 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~s~~l~~li~~~ 246 (472)
...|+..|+|||.+....+ +.++|+||||+++|+|++|..||...+ ...............|..+++++.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5678999999999977664 489999999999999999999998766 334433434356677778899999999999
Q ss_pred cCCCCCCcCCh--hhhhcCccc
Q 012053 247 LDPNPNTRISM--TKIMENSWF 266 (472)
Q Consensus 247 L~~dP~~Rpt~--~eil~hp~f 266 (472)
|..||.+||+. .++++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=342.23 Aligned_cols=255 Identities=31% Similarity=0.533 Sum_probs=219.9
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+++.++|+||+++++.+..+...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999987654322 4578899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 90 EYVKGGELFGKVAK----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 90 E~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|+++|++|.+++.. +.+++..++.++.||+.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999864 45899999999999999999999999999999999999999999999999998876543322
Q ss_pred --CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCC-----CCCCH
Q 012053 166 --GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFP-----NWFAP 237 (472)
Q Consensus 166 --~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~-----~~~s~ 237 (472)
.......|++.|+|||++......+.++|+||||+++++|++|..||...+....+.++..... .++ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 1224457899999999987664456899999999999999999999988776665555544332 121 24678
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
++.+++.+||..||++|||+.+|+.||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=356.10 Aligned_cols=246 Identities=28% Similarity=0.439 Sum_probs=193.6
Q ss_pred EeeEcccCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEEEEEEE
Q 012053 15 GRLLGQGTFAKVHYARNL--KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--KTKIYFVME 90 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 90 (472)
+++||+|+||+||+|++. .+++.||+|.+..... ...+.+|+.+|+.++||||+++++++.. +..+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 578999999999999976 4678999999865432 2457789999999999999999999854 567899999
Q ss_pred ecCCCcccchhcc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCCeEEecCcch
Q 012053 91 YVKGGELFGKVAK----------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL----DEHGNLKVSDFGLS 156 (472)
Q Consensus 91 ~~~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl----d~~g~vkl~DFGla 156 (472)
|+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9854 67666531 258999999999999999999999999999999999999 45678999999999
Q ss_pred hhhhcccC-CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH---------HHHHHHHhc
Q 012053 157 ALAESKHQ-DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL---------MEMYRKIGK 226 (472)
Q Consensus 157 ~~~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~---------~~~~~~i~~ 226 (472)
........ .......+||+.|+|||++.+....+.++|||||||++|+|++|..||..... ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 86543221 12234568899999999998765556899999999999999999999964321 111111100
Q ss_pred ----------------------------cCCCC----------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 227 ----------------------------AEFKF----------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 227 ----------------------------~~~~~----------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
..... ....++++.+||.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000 01134678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=352.21 Aligned_cols=256 Identities=30% Similarity=0.517 Sum_probs=219.6
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++......|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 47999999999999999999999999999999999754432 236688999999999999999999999999999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|||+++++|.+++.+..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~ 172 (297)
T cd06656 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (297)
T ss_pred ecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--Cc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999875433221 12
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---CCCCCCCCCHHHHHHHhc
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~l~~li~~ 245 (472)
....|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+... ....|..+++.+.++|.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR 251 (297)
T ss_pred CcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence 34578999999999987665 48899999999999999999999876543322222221 223455678899999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
||..+|++|||+.++++||||+...
T Consensus 252 ~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 252 CLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HccCChhhCcCHHHHhcCchhcccc
Confidence 9999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=345.90 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=212.0
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|++..+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 5899999999999999999999999999999998654321 123356789999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||++++.|..++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cc
Confidence 99999888777654 5799999999999999999999999999999999999999999999999999886543221 12
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------------CC
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------------EF 229 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------------~~ 229 (472)
....++..|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+....+... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 33467889999999876554568999999999999999999999876654333222110 00
Q ss_pred CC------------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 230 KF------------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ~~------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
.. .+.++..+.+||.+||++||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00 12357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=348.78 Aligned_cols=256 Identities=33% Similarity=0.499 Sum_probs=220.9
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.||.|+||.||+|.+..+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++..+...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 467999999999999999999998899999999986542 23456788999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 999999999998865 4699999999999999999999999999999999999999999999999998876543222
Q ss_pred cccccCCCCcccChhhhccc----CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---CCCCCCCHHH
Q 012053 167 LLHTTCGTPAYVAPEVINRR----GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF---KFPNWFAPEV 239 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~----~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~l 239 (472)
......||+.|+|||.+... ...+.++|+||||+++|+|++|..||...+......++..... ..+..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 12345689999999997532 2234689999999999999999999988877666666665432 3456688999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.++|.+||+.+|.+||++.++++||||.+.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=346.10 Aligned_cols=255 Identities=32% Similarity=0.551 Sum_probs=223.0
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.++...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 579999999999999999999999999999999876532 233467889999999999999999999999999999999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
||+.+++|.+++..+++++..++.++.|++.|+.|||++|++||||+|+||++++++.++|+|||++........ ...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~ 156 (274)
T cd06609 79 EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRN 156 (274)
T ss_pred EeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccc
Confidence 999999999999888999999999999999999999999999999999999999999999999999876654321 123
Q ss_pred ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCC-CCHHHHHHHhccc
Q 012053 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNW-FAPEVRRLLSKIL 247 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~-~s~~l~~li~~~L 247 (472)
...|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+.... ...+.. +++++.+++.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 4578899999999987765 489999999999999999999998776665555554443 334444 7899999999999
Q ss_pred CCCCCCcCChhhhhcCcccccC
Q 012053 248 DPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
..+|++|||++++++||||++.
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCC
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=350.74 Aligned_cols=252 Identities=29% Similarity=0.498 Sum_probs=208.1
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
||++.+.||.|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+.+.+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999999975432 22334567789999999999999999999999999999999
Q ss_pred ecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 91 YVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 91 ~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|+.+ +|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++....... ...
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCc
Confidence 9975 6766664 3679999999999999999999999999999999999999999999999999987654321 112
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCC-CCcHHHHHHHHhccC-------------------
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSNLMEMYRKIGKAE------------------- 228 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~-~~~~~~~~~~i~~~~------------------- 228 (472)
....+++.|+|||++.+....+.++|||||||++|+|++|..||. ..+..+.+..+.+..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 345678999999998776555689999999999999999988854 444334333332100
Q ss_pred C----------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 229 F----------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 ~----------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+ ...+.++++++++|.+||..||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=370.78 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=204.7
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
...+|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|+.++||||+++++++..++..|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 45589999999999999999999999999999996422 235689999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|||++. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999995 578777754 46999999999999999999999999999999999999999999999999999865433222
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC--------cHHHHHHHHhccCC--------
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS--------NLMEMYRKIGKAEF-------- 229 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~--------~~~~~~~~i~~~~~-------- 229 (472)
......+||+.|+|||++.+..++ .++|||||||++|+|++|..|+... ....+.+.+.....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 222345799999999999877765 8999999999999999987665321 11222222222111
Q ss_pred ---------------------CCCC-----CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 230 ---------------------KFPN-----WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 230 ---------------------~~~~-----~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..+. .+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 1111 14568999999999999999999999999999974
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=338.81 Aligned_cols=252 Identities=27% Similarity=0.473 Sum_probs=221.0
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|++.+.||+|+||.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999998765433 2445678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|++|++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--F 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc--h
Confidence 9999999998865 4689999999999999999999999999999999999999999999999999876543221 2
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHhcc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~~~ 246 (472)
....+|++.|+|||++.+..++ .++|+||||+++++|++|..||...+......++..... .++..+++++.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 2345789999999999877654 789999999999999999999998887777776665543 34446889999999999
Q ss_pred cCCCCCCcCChhhhhcCccc
Q 012053 247 LDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~f 266 (472)
|+.+|++||++.+++.|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=342.56 Aligned_cols=254 Identities=26% Similarity=0.496 Sum_probs=216.1
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc---chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL---KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+|++++.||.|+||+||+|.+ .+|+.+|+|.+...... .......+.+|+.+++.++|+||+++++++.+....|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999986 58899999998754321 12334678999999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC--
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ-- 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~-- 164 (472)
++||++|++|.+++.+ +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999876 6799999999999999999999999999999999999999999999999999876532111
Q ss_pred --CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---CCCCCCCCCHHH
Q 012053 165 --DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEV 239 (472)
Q Consensus 165 --~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~l 239 (472)
........|++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 1122345689999999999776654 7899999999999999999999876655444333322 234566789999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 240 RRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
.++|.+||.++|.+|||+.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=350.52 Aligned_cols=258 Identities=33% Similarity=0.644 Sum_probs=221.3
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997765433345567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC----
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ---- 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~---- 164 (472)
||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999865 6799999999999999999999999999999999999999999999999998764211000
Q ss_pred ---------CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC--
Q 012053 165 ---------DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN-- 233 (472)
Q Consensus 165 ---------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~-- 233 (472)
........|+..|+|||.+....+ +.++|+||||+++|+|++|..||.+....+....+.......|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 001123467889999999877665 48999999999999999999999988777777776665443332
Q ss_pred -CCCHHHHHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012053 234 -WFAPEVRRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 234 -~~s~~l~~li~~~L~~dP~~Rpt---~~eil~hp~f~~ 268 (472)
.+++++.++|.+||..||++||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 47899999999999999999998 689999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=356.72 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=206.7
Q ss_pred EEEeeEccc--CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 13 ELGRLLGQG--TFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 13 ~i~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+++++||+| +||+||++.+..+|+.||+|.++..... ....+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 357889999 7899999999999999999999765432 2445678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC--
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD-- 165 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~-- 165 (472)
|+++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999998853 45999999999999999999999999999999999999999999999999865433211110
Q ss_pred ---CcccccCCCCcccChhhhccc-CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-----------
Q 012053 166 ---GLLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK----------- 230 (472)
Q Consensus 166 ---~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~----------- 230 (472)
.......++..|+|||++.+. ...+.++|||||||++|+|++|..||..................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 111234577889999998753 22347899999999999999999999875543332222111100
Q ss_pred -----------------------------------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 231 -----------------------------------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 231 -----------------------------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
....+++++.+||.+||+.||++|||++++++||||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 11124678999999999999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=388.77 Aligned_cols=263 Identities=28% Similarity=0.483 Sum_probs=218.6
Q ss_pred CcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-
Q 012053 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS- 81 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 81 (472)
..|.+..++|++++.||+|+||+||+|.+..++..||+|++...... ......+.+|+.+|+.++|||||+++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 35788899999999999999999999999999999999999765433 2345678899999999999999999998854
Q ss_pred -CCEEEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCcEEEcC----
Q 012053 82 -KTKIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSR-------GVCHRDLKPENLLLDE---- 144 (472)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~-------giiHrDIKp~NILld~---- 144 (472)
...+|+||||+.+++|.+++.. +.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4679999999999999988854 5799999999999999999999984 4999999999999964
Q ss_pred -------------CCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhccc-CCCCCcccchhhhHHHHHHhcCCC
Q 012053 145 -------------HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCGVILYVLLAGYL 210 (472)
Q Consensus 145 -------------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~lltG~~ 210 (472)
.+.+||+|||++...... ......+||+.|+|||++.+. ...+.++||||||||||+|++|..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 234899999998765332 223456799999999998643 234579999999999999999999
Q ss_pred CCCCCcHH-HHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 211 PFHDSNLM-EMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 211 Pf~~~~~~-~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
||...+.. .....+...........++++.+||.+||..+|.+|||+.++|.|||++..
T Consensus 242 PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 242 PFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 99876544 333333333222224478999999999999999999999999999999753
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=346.45 Aligned_cols=254 Identities=30% Similarity=0.495 Sum_probs=215.2
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999999999999999765432 2345678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 91 YVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|+ +++|.+++.. +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99 9999998854 5799999999999999999999999999999999999999999999999999886644321 223
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------------C
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-------------------F 229 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 229 (472)
....|+..|+|||.+.+....+.++||||||+++|+|++|.+||........+..+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 456789999999998766555689999999999999999998887766554444332110 0
Q ss_pred C-----------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012053 230 K-----------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 230 ~-----------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
. ..+..+.++.++|.+||..||++|||++++++||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 1123568899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=339.61 Aligned_cols=252 Identities=29% Similarity=0.587 Sum_probs=220.7
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||+|+||+||++.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999998765432 2345678999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+.+++|.+.+.. ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--L 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--h
Confidence 9999999988854 3589999999999999999999999999999999999999999999999999876543221 1
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHhcc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~~~ 246 (472)
.....|++.|+|||++.+..+ +.++|+|||||++++|++|..||...+..+....+..+.. ..+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 223468899999999876655 4789999999999999999999998888777777665543 45667899999999999
Q ss_pred cCCCCCCcCChhhhhcCccc
Q 012053 247 LDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~f 266 (472)
|+.+|.+||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=347.69 Aligned_cols=261 Identities=31% Similarity=0.459 Sum_probs=220.3
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
++-...++|++++.||.|+||.||+|.+..+++.+|+|.+.... ......+.+|+.+++.++||||+++++++..++
T Consensus 6 ~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred cccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 44455678999999999999999999999999999999986543 234577889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.+|+||||++|++|...+.+ +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999999999999877643 5799999999999999999999999999999999999999999999999998765332
Q ss_pred ccCCCcccccCCCCcccChhhhccc----CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---CCCCC
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRR----GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF---KFPNW 234 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~----~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~ 234 (472)
... ......+++.|+|||.+... ...+.++|+|||||++|+|++|..||...+....+.++..... ..+..
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06644 163 TLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240 (292)
T ss_pred ccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcc
Confidence 211 12345688999999998532 1224689999999999999999999988776665555544322 33456
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
++.++.++|.+||..||++||+++++++||||...
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 78899999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=345.27 Aligned_cols=250 Identities=24% Similarity=0.436 Sum_probs=210.7
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|++..+++.||+|.+..... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 468999999999999999999999999999999876532 234467889999999999999999999999999999999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++...... ...
T Consensus 79 e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAK 151 (279)
T ss_pred ecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----ccc
Confidence 99999988543 46889999999999999999999999999999999999999999999999998755322 224
Q ss_pred ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH-------HHHHHHHhccC-CCC-CCCCCHHHH
Q 012053 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL-------MEMYRKIGKAE-FKF-PNWFAPEVR 240 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~-------~~~~~~i~~~~-~~~-~~~~s~~l~ 240 (472)
..+||+.|+|||++.+..+. .++|+||||+++|+|++|..||..... ......+.... ... ....++++.
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred CCCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 56899999999999877654 899999999999999999999965221 12222222221 222 234788999
Q ss_pred HHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 241 RLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
++|.+||+.||.+||+++++++||||+..
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=344.07 Aligned_cols=253 Identities=27% Similarity=0.449 Sum_probs=211.8
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe-----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMAS----- 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----- 81 (472)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 3578999999999999999999999999999999987543 2235788999999998 69999999999865
Q ss_pred -CCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 82 -KTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
...+|++|||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 3578999999999999998864 368999999999999999999999999999999999999999999999999987
Q ss_pred hhhcccCCCcccccCCCCcccChhhhccc----CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC--CC
Q 012053 158 LAESKHQDGLLHTTCGTPAYVAPEVINRR----GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF--KF 231 (472)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~----~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--~~ 231 (472)
...... .......|++.|+|||++... ...+.++|||||||++|+|++|..||.+.........+..... ..
T Consensus 160 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 160 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred eccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 653321 223456799999999998532 1234789999999999999999999987665544444333221 12
Q ss_pred CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 232 PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 232 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+..++.++.+||.+||..||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 33478899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=343.90 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=212.2
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..+..+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 35689999999999999999999999999999999865432 233568899999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||||+.+++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-- 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence 9999999999988864 6899999999999999999999999999999999999999999999999999876533211
Q ss_pred cccccCCCCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC-----CCCCHHH
Q 012053 167 LLHTTCGTPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-----NWFAPEV 239 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~l 239 (472)
......|++.|+|||.+... ...+.++|+||+||++|+|++|..||...........+....+..+ ..++.++
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 12345789999999987532 2234789999999999999999999976654443333333332222 2367899
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcc
Q 012053 240 RRLLSKILDPNPNTRISMTKIMENSW 265 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~ 265 (472)
.+||++||..+|++|||+++|++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=344.49 Aligned_cols=255 Identities=30% Similarity=0.489 Sum_probs=216.9
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
-|++.+.||+|+||+||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 4788999999999999999999999999999986543 2345678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 91 YVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|+.+++|...+.. +++++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++....... ...
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~ 160 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR 160 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence 9999999887753 579999999999999999999999999999999999999999999999999987543221 122
Q ss_pred cccCCCCcccChhhhcc----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---CCCCCCCCHHHHH
Q 012053 169 HTTCGTPAYVAPEVINR----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRR 241 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~l~~ 241 (472)
....||+.|+|||++.. ....+.++|||||||++|+|++|..||...+.......+.... ...|..++.++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 34578999999999842 1223468999999999999999999998877666555554332 2345568899999
Q ss_pred HHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 242 LLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+|.+||..||.+|||+.++++||||+...
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 99999999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=346.49 Aligned_cols=246 Identities=19% Similarity=0.263 Sum_probs=211.3
Q ss_pred CCEEEE--eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CC
Q 012053 10 QRYELG--RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS----KT 83 (472)
Q Consensus 10 ~~y~i~--~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~ 83 (472)
+.++.. ..||+|++|.||+|.. +|+.||||.+.+.........+.+.+|+.+|++++||||+++++++.+ ..
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 344444 6799999999999987 899999999987654444446788899999999999999999999866 45
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.+++||||++||+|.+++.. +.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 78999999999999999876 5799999999999999999999984 999999999999999999999999999886533
Q ss_pred ccCCCcccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCCCCCH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPNWFAP 237 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~ 237 (472)
. .....||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+..+.+..+... .+..|..+++
T Consensus 176 ~-----~~~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 249 (283)
T PHA02988 176 P-----PFKNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPL 249 (283)
T ss_pred c-----cccccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcH
Confidence 2 134578999999999875 344 58999999999999999999999998887777777433 4456656899
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++.++|.+||+.||++|||+.++++.
T Consensus 250 ~l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 250 EIKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999999999999999999864
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=342.04 Aligned_cols=256 Identities=28% Similarity=0.525 Sum_probs=214.6
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc-------hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK-------VGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+....... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6999999999999999999999999999999986432111 123457889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999998876 68999999999999999999999999999999999999999999999999998765432
Q ss_pred cCCCcccccCCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCC----CC
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPN----WF 235 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~----~~ 235 (472)
..........|+..|+|||.+.... ..+.++|+||||++++++++|..||...+.......+... ...++. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222233456899999999987654 2357899999999999999999999876655444333222 222332 35
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+.++.++|.+||.++|.+|||++++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=345.55 Aligned_cols=248 Identities=30% Similarity=0.515 Sum_probs=204.5
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH---hcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012053 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR---LVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
.||+|+||.||++.+..+++.+|+|.+.+.............+|..+++ ..+||||+.+++++..++..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997765433222233445544444 3479999999999999999999999999
Q ss_pred CCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccC
Q 012053 94 GGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC 172 (472)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 172 (472)
|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcC
Confidence 9999888865 679999999999999999999999999999999999999999999999999986543221 23457
Q ss_pred CCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---HHHHHHHHhccCCCCCCCCCHHHHHHHhcccCC
Q 012053 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 173 gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~ 249 (472)
||+.|+|||.+......+.++||||+||++|+|++|..||.... ..............+|..+++++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998643334578999999999999999999997532 222222223344567777999999999999999
Q ss_pred CCCCcC-----ChhhhhcCccccc
Q 012053 250 NPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 250 dP~~Rp-----t~~eil~hp~f~~ 268 (472)
||++|+ |+.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=344.39 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=212.0
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999865532 2345678899999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|||+++++|.+++.. +.+++.+++.++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cc
Confidence 999999999998864 689999999999999999999999999999999999999999999999999987543221 11
Q ss_pred ccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC-----CCCCHHHH
Q 012053 168 LHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-----NWFAPEVR 240 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~l~ 240 (472)
.....|++.|+|||++.. ....+.++|+|||||++|+|++|..||...........+.......+ ..++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 234579999999999742 22234789999999999999999999976554433333333322222 23678899
Q ss_pred HHHhcccCCCCCCcCChhhhhcCcc
Q 012053 241 RLLSKILDPNPNTRISMTKIMENSW 265 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~ 265 (472)
++|.+||..+|++|||+++|++|||
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=340.77 Aligned_cols=247 Identities=38% Similarity=0.720 Sum_probs=219.1
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012053 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++...|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999989999999999876655445567899999999999999999999999999999999999999999
Q ss_pred cchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCc
Q 012053 98 FGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176 (472)
Q Consensus 98 ~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 176 (472)
.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 999876 578999999999999999999999999999999999999999999999999987664332 1234578999
Q ss_pred ccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc--HHHHHHHHh--ccCCCCCCCCCHHHHHHHhcccCCCCC
Q 012053 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN--LMEMYRKIG--KAEFKFPNWFAPEVRRLLSKILDPNPN 252 (472)
Q Consensus 177 Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~--~~~~~~~i~--~~~~~~~~~~s~~l~~li~~~L~~dP~ 252 (472)
|+|||.+....++ .++|+||||+++|+|++|..||.... ....+.++. .....+|...++++.++|.+||..||.
T Consensus 158 ~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999998776664 78999999999999999999998766 666666666 445677777899999999999999999
Q ss_pred CcCC-----hhhhhcCccccc
Q 012053 253 TRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 253 ~Rpt-----~~eil~hp~f~~ 268 (472)
+||+ ++|+++||||+.
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=372.42 Aligned_cols=254 Identities=30% Similarity=0.505 Sum_probs=226.3
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+-|+|+..||.|+||+||+|.++.++-..|-|+|.... .+.++.+.-||.||..+.||+||+|++.|-.+++++++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 45889999999999999999999999899999986543 456788889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|||.||-....+.. ..|+|.+++.+.+|+++||.|||+++|||||||..|||+.-+|.++|+|||.+.........
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk-- 186 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK-- 186 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhh--
Confidence 99999998877754 68999999999999999999999999999999999999999999999999998754332222
Q ss_pred ccccCCCCcccChhhhc-----ccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC---CCCCCCHHH
Q 012053 168 LHTTCGTPAYVAPEVIN-----RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK---FPNWFAPEV 239 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~-----~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~l 239 (472)
-.++.|||+|||||+.. ..+|+ +++||||||++|++|..+.+|-...+++..+-+|.+..++ -|..++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 35689999999999863 45666 8999999999999999999999999999988888876643 366789999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+|+.+||..||..||++++|++||||+..
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 999999999999999999999999999853
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=347.60 Aligned_cols=254 Identities=29% Similarity=0.467 Sum_probs=214.0
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ...+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 57999999999999999999999899999999986544322 34567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||++++.|..+... +.+++..++.++.||+.||.|||++|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--ccc
Confidence 99999988877654 469999999999999999999999999999999999999999999999999987654322 223
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------------C
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-------------------F 229 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 229 (472)
....++..|+|||++.+....+.++||||||+++|+|++|..||......+....+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 345688999999998765555688999999999999999999998766544333322100 0
Q ss_pred ------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 230 ------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
..++.++..+.+|+.+||+.+|.+|||+.+|++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=353.20 Aligned_cols=261 Identities=32% Similarity=0.578 Sum_probs=237.3
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKT 83 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 83 (472)
..+-...|..+..||+|+||+|-+|..+.+.+.+|||++++..+.....++--..|-++|.... -|.+++++.+|.+-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 3455668999999999999999999999999999999999988776666666667888888774 688999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|+||||++||+|...|.+ |++.|..+..|+..|+-||-|||++||++||||.+|||||.+|++||+|||+++.-..
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence 99999999999999888876 9999999999999999999999999999999999999999999999999999875333
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~l 242 (472)
......+.||||.|+|||++...+|. ..+|.||+||+||||++|+.||++.+..++++.|..-+..+|..+|.++.++
T Consensus 503 -~~~TTkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~i 580 (683)
T KOG0696|consen 503 -DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAI 580 (683)
T ss_pred -CCcceeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHH
Confidence 22345789999999999999888875 8899999999999999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCcCCh-----hhhhcCccccc
Q 012053 243 LSKILDPNPNTRISM-----TKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~-----~eil~hp~f~~ 268 (472)
....|...|.+|... .+|.+||||+.
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 999999999999865 58999999985
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=347.22 Aligned_cols=258 Identities=32% Similarity=0.460 Sum_probs=215.8
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
||++.+.||+|+||.||+|.+..+|+.||+|.+...... .......+.+|+.+++.++|+||+++++++.+....|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 699999999999999999999999999999999765433 122345677899999999999999999999999999999
Q ss_pred EEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+ +++|.+++... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-- 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--
Confidence 9999 88999998763 699999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-----------------
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF----------------- 229 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~----------------- 229 (472)
......+++.|+|||.+.+....+.++|||||||++|+|++|.+||...+..+.+.++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223345788999999986655556899999999999999999888887665554444422100
Q ss_pred -----------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 230 -----------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 230 -----------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
......+.++.++|.+||.+||++|||+.+++.||||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 001224678999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=347.11 Aligned_cols=255 Identities=26% Similarity=0.488 Sum_probs=216.7
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999999999999999986542 2233467889999999999999999999999999999999
Q ss_pred EecCCCcccchhccC----CCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 90 EYVKGGELFGKVAKG----KLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
||++|++|..++..+ .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999998888654 79999999999999999999997 59999999999999999999999999998754322
Q ss_pred CCcccccCCCCcccChhhhcccCC-----CCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHH---Hhcc-CCCCCCCC
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGY-----DGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRK---IGKA-EFKFPNWF 235 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~-----~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~---i~~~-~~~~~~~~ 235 (472)
......|++.|+|||.+.+... .+.++|+|||||++|+|++|..||........+.. +... ...+|..+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 2245578999999999854432 25789999999999999999999976554443332 2222 34566668
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
++++.++|.+||..+|.+||+++++++||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=341.73 Aligned_cols=256 Identities=26% Similarity=0.514 Sum_probs=215.4
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc---chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL---KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+|+.++.||+|+||.||.|.+..+++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588999999999999999999999999999998754321 12345788999999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CeEEecCcchhhhhcccCC
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-~vkl~DFGla~~~~~~~~~ 165 (472)
||||+.|++|.+++.. +++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999998865 6799999999999999999999999999999999999998876 5999999998765432111
Q ss_pred --CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHH---h--ccCCCCCCCCCHH
Q 012053 166 --GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI---G--KAEFKFPNWFAPE 238 (472)
Q Consensus 166 --~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i---~--~~~~~~~~~~s~~ 238 (472)
.......||..|+|||.+.+..+. .++|+||||+++++|++|..||...........+ . ......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 111234688999999998776654 7899999999999999999999754432222222 1 2234566678899
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
+.+++.+||..+|.+|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=339.68 Aligned_cols=256 Identities=28% Similarity=0.515 Sum_probs=214.9
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--KVGMIDQIKREISVMRLVRHPNVVELYEVMAS--KTKI 85 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 85 (472)
..|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3699999999999999999999999999999998754322 12345678899999999999999999999865 4678
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc-
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH- 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~- 163 (472)
|+++||+++++|.+++.. +.+++...+.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999998865 579999999999999999999999999999999999999999999999999987553221
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc--cCCCCCCCCCHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK--AEFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~l~~ 241 (472)
.........++..|+|||.+.+..++ .++||||+||++|+|++|+.||..........++.. ....+|..+++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 11112335688999999999776654 789999999999999999999987765554444332 234556778899999
Q ss_pred HHhcccCCCCCCcCChhhhhcCcccc
Q 012053 242 LLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
+| +||..+|++|||+++|++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=344.42 Aligned_cols=256 Identities=34% Similarity=0.704 Sum_probs=228.0
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 88 (472)
++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++..++..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765544455677889999999998 99999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC--
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD-- 165 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~-- 165 (472)
|||+.+++|.+++.+ +.+++..++.++.|++.||.|||++|++|+||+|+||+++.+++++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999876 48999999999999999999999999999999999999999999999999998765433211
Q ss_pred ----------------CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC
Q 012053 166 ----------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF 229 (472)
Q Consensus 166 ----------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~ 229 (472)
.......|+..|+|||++....+ +.++|+||||++++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 11233467899999999876554 4789999999999999999999998887777777777778
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCCh----hhhhcCccc
Q 012053 230 KFPNWFAPEVRRLLSKILDPNPNTRISM----TKIMENSWF 266 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~----~eil~hp~f 266 (472)
.+|..+++.+.++|.+||+.+|.+|||+ .++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=347.50 Aligned_cols=253 Identities=20% Similarity=0.321 Sum_probs=205.1
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcC----------------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLK----------------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp 70 (472)
+..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.+|+.++||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCC
Confidence 346799999999999999999998632 345799999875432 23456788999999999999
Q ss_pred CeeeEEEEEEeCCEEEEEEEecCCCcccchhccC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 012053 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKG--------------------KLKEDAARKYFQQLISAVDYCHSRGV 130 (472)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--------------------~l~e~~~~~i~~ql~~al~yLH~~gi 130 (472)
||+++++++.+.+..|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999999999999999999999998887432 35778899999999999999999999
Q ss_pred eecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc--C
Q 012053 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA--G 208 (472)
Q Consensus 131 iHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt--G 208 (472)
+||||||+|||++.++.+||+|||++................+++.|+|||++....+ +.++||||||+++|+|++ +
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999999875533221111233456788999999876665 489999999999999986 6
Q ss_pred CCCCCCCcHHHHHHHHhc--------cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 209 YLPFHDSNLMEMYRKIGK--------AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 209 ~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
..||...+.......+.. .....|+.+++.+.+||.+||+.||++|||+.+|.+
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 788877665544433321 112345567899999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=361.78 Aligned_cols=254 Identities=23% Similarity=0.405 Sum_probs=208.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTG-----MSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMA 80 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (472)
+..++|++++.||+|+||.||+|++..+| ..||+|.+...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 34568999999999999999999875443 57999999765422 3356788999999999 8999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc---------------------------------------------------------
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAK--------------------------------------------------------- 103 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~--------------------------------------------------------- 103 (472)
.....|+||||+++|+|.+++..
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999887642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 104 --------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 104 --------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
.++++..+++++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 247888999999999999999999999999999999999999999999999987553322111112
Q ss_pred ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc--CCCCCCCCCHHHHHHHhcc
Q 012053 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA--EFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~l~~li~~~ 246 (472)
+..+++.|+|||++....+. .++|||||||++|+|++ |..||........+...... ....|..+++++.++|.+|
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC 351 (374)
T ss_pred CCCCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence 23356689999999776654 89999999999999997 99999876544333333322 3456677899999999999
Q ss_pred cCCCCCCcCChhhhhcC
Q 012053 247 LDPNPNTRISMTKIMEN 263 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~h 263 (472)
|+.||.+|||+.++++.
T Consensus 352 l~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 352 WNLEPTERPTFSQISQL 368 (374)
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=334.82 Aligned_cols=252 Identities=28% Similarity=0.545 Sum_probs=221.8
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++++.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987654332 445678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+++++|.+.+.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--M 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--c
Confidence 9999999998865 3689999999999999999999999999999999999999999999999999876543321 2
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-CCCCCCHHHHHHHhcc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FPNWFAPEVRRLLSKI 246 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~l~~li~~~ 246 (472)
.....|++.|+|||.+.+..+. .++|+||||+++++|++|..||...+..+....+..+.+. .+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3456789999999998776654 7899999999999999999999988887777777665443 3455789999999999
Q ss_pred cCCCCCCcCChhhhhcCccc
Q 012053 247 LDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~f 266 (472)
|..+|.+|||+.++++|||+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=341.58 Aligned_cols=256 Identities=29% Similarity=0.577 Sum_probs=219.4
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR---HPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 87 (472)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++ |||++++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 58899999999999999999999999999999865432 234567889999999997 9999999999999999999
Q ss_pred EEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 88 VMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||||++|++|.+++..+.+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~ 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--K 157 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--c
Confidence 99999999999999888999999999999999999999999999999999999999999999999999876544322 1
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCC-CCHHHHHHHhc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNW-FAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~-~s~~l~~li~~ 245 (472)
.....|+..|+|||.+......+.++|+||||+++|+|++|..||...........+.... ..++.. ++.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 2345789999999998655444689999999999999999999998876655544433332 223332 78899999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
||+.||++|||+.+++.|+||++..
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhccc
Confidence 9999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=340.83 Aligned_cols=254 Identities=28% Similarity=0.465 Sum_probs=213.1
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASK---- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~---- 82 (472)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +|||++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 4678999999999999999999999999999999986543 2235678899999988 799999999998653
Q ss_pred -CEEEEEEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 83 -TKIYFVMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
+..|+||||++|++|.+++. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 46899999999999988774 257899999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhcccC----CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---C
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRG----YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---F 229 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~----~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~ 229 (472)
......... .....|++.|+|||.+.... ..+.++|||||||++|+|++|+.||...+.......+.+.. .
T Consensus 176 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 176 AQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred hhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 765432211 23456899999999985432 12578999999999999999999998876655555554432 2
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012053 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
..+..++.++.++|.+||+.+|++||++.+|++||||+
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 23445778899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=342.41 Aligned_cols=249 Identities=32% Similarity=0.517 Sum_probs=207.8
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHH---HHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012053 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI---SVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei---~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
.||+|+||.||+|.+..+++.||+|.+.+..............|. ..++...||||+++++++...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999999876443222222233343 34455679999999999999999999999999
Q ss_pred CCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccC
Q 012053 94 GGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC 172 (472)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 172 (472)
|++|..++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... ....+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcC
Confidence 9999888865 679999999999999999999999999999999999999999999999999987543221 23557
Q ss_pred CCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC---cHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCC
Q 012053 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS---NLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 173 gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~ 249 (472)
|+..|+|||.+.+....+.++||||+|+++|+|++|..||... ........+......+|..+++++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999875433457899999999999999999999876 3334444444455667777899999999999999
Q ss_pred CCCCcC-----ChhhhhcCcccccC
Q 012053 250 NPNTRI-----SMTKIMENSWFRKG 269 (472)
Q Consensus 250 dP~~Rp-----t~~eil~hp~f~~~ 269 (472)
+|.+|| ++.++++||||+..
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.16 Aligned_cols=251 Identities=33% Similarity=0.581 Sum_probs=219.3
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999999865433 2446788999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CeEEecCcchhhhhcccCCC
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-~vkl~DFGla~~~~~~~~~~ 166 (472)
|++|++|.+++.. ..+++..+..++.|++.+|.|||++|++|+||||+||+++.++ .++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 9999999999865 2489999999999999999999999999999999999998655 579999999876543222
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhc
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~ 245 (472)
.....|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+.... ..++..+++++.+++.+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 158 -AYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred -ccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 234568999999999876654 478999999999999999999998887776666665443 35667789999999999
Q ss_pred ccCCCCCCcCChhhhhcCccc
Q 012053 246 ILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f 266 (472)
||.+||.+|||+.++++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=343.83 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=216.1
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTG-----MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
-.++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 3568999999999999999999986555 689999986543 223456789999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH 145 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~ 145 (472)
...|++|||+++++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 999999999999999888753 357889999999999999999999999999999999999999
Q ss_pred CCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 012053 146 GNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKI 224 (472)
Q Consensus 146 g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i 224 (472)
+.++|+|||++................+++.|+|||.+....++ .++|||||||++|+|++ |..||.+.+..+....+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999998754332222223345678899999998776654 89999999999999998 99999988887777777
Q ss_pred hccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 225 GKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 225 ~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.... ...|..+++++.+|+.+||+.||.+|||+.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6544 34567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=358.31 Aligned_cols=246 Identities=25% Similarity=0.377 Sum_probs=199.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
..+|++++.||+|+||.||+|.+..+++.||+|+..+.. ...|+.+++.++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 457999999999999999999999999999999854332 34699999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---P 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---c
Confidence 99995 577777753 57999999999999999999999999999999999999999999999999998753321 1
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCC-CCCcH----------HHHHHHHhc---cCCCCC
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPF-HDSNL----------MEMYRKIGK---AEFKFP 232 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf-~~~~~----------~~~~~~i~~---~~~~~~ 232 (472)
......||+.|+|||++.+..+. .++|||||||++|+|+++..|+ ..... ..+...+.. ....++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 12345799999999999877765 8999999999999999865554 32111 011111110 001111
Q ss_pred ------------------------------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 233 ------------------------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 ------------------------------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124567788999999999999999999999999975
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=343.00 Aligned_cols=257 Identities=30% Similarity=0.504 Sum_probs=221.7
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.+.|+..+.||.|+||.||.|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.++...|+|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3578899999999999999999999999999999875532 23457889999999999999999999999999999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|||+.|++|.+++..+++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999876543221 12
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhccc
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L 247 (472)
....++..|+|||.+.+..+ +.++|+|||||++|+|++|..||...........+... ....+..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 33468889999999876665 48999999999999999999999887666555444333 23344457889999999999
Q ss_pred CCCCCCcCChhhhhcCcccccCC
Q 012053 248 DPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+.+|++||++.+++.|+||.+..
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhcc
Confidence 99999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.63 Aligned_cols=251 Identities=33% Similarity=0.544 Sum_probs=216.4
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++++.....+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999976532 2457889999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.+++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 999999999988854 5899999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccCCCCcccChhhhccc---CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-----CCCCCCHH
Q 012053 167 LLHTTCGTPAYVAPEVINRR---GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-----FPNWFAPE 238 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~---~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~ 238 (472)
......++..|+|||.+... .++ .++|+||||+++|+|++|..||.+.+.......+....+. .+..++.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred ccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 12345789999999998765 454 7899999999999999999999887665544444444222 22335788
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCcc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSW 265 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~ 265 (472)
+.++|.+||..+|..|||+.+|+.|+|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=336.65 Aligned_cols=256 Identities=29% Similarity=0.532 Sum_probs=214.5
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccc--cchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV--LKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--KTKI 85 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 85 (472)
.+|++++.||+|+||.||.|.+..+|..||+|.+..... ......+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999999864321 122345788999999999999999999999866 3578
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|++|||++|++|.+++.+ +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999998865 5789999999999999999999999999999999999999999999999999876533211
Q ss_pred -CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCCCCCHHHHH
Q 012053 165 -DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPNWFAPEVRR 241 (472)
Q Consensus 165 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~l~~ 241 (472)
........|+..|+|||++.+..+ +.++||||||+++|+|++|..||...........+... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 111234568999999999977665 48899999999999999999999876555444444332 23455667888999
Q ss_pred HHhcccCCCCCCcCChhhhhcCcccc
Q 012053 242 LLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
+|++|+. +|++||++++|++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=334.68 Aligned_cols=248 Identities=31% Similarity=0.582 Sum_probs=216.3
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||.|+||.||++.+..+++.+|+|.++.... ....+.+.+|+.+++.++||||+++++.+.+++.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2345778899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+++++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ .
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--Y 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--c
Confidence 9999999888753 4589999999999999999999999999999999999999999999999999875543221 1
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHhcc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~~~ 246 (472)
.....|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..+.. ..|..++..+.++|.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 234568999999999877665 4789999999999999999999998887777766665544 35667889999999999
Q ss_pred cCCCCCCcCChhhhhcC
Q 012053 247 LDPNPNTRISMTKIMEN 263 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~h 263 (472)
|+.||.+|||+.+|+.-
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=346.83 Aligned_cols=258 Identities=31% Similarity=0.469 Sum_probs=213.3
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKI 85 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 85 (472)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 4578999999999999999999999999999999987543221 2233456899999999999999999998655 578
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999965 67777654 579999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc----------------
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---------------- 227 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---------------- 227 (472)
. ......+++.|+|||++.+....+.++|||||||++|+|++|..||...+..+.+..+...
T Consensus 163 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 K--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred C--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 1 1223346888999999876554568999999999999999999999988776665554321
Q ss_pred ---CCCCC-----------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 ---EFKFP-----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---~~~~~-----------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+..+ .++++++.++|.+||++||++|||+.+++.||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 11111 2358899999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=341.57 Aligned_cols=247 Identities=31% Similarity=0.523 Sum_probs=211.6
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012053 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765443333445667899999999999999999999999999999999999999
Q ss_pred cchhcc-C--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCC
Q 012053 98 FGKVAK-G--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174 (472)
Q Consensus 98 ~~~i~~-~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 174 (472)
.+++.. + .+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... .......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---CccccccCC
Confidence 988854 3 6999999999999999999999999999999999999999999999999998765431 122345678
Q ss_pred CcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH----HHHHHHHhccCCCCCCCCCHHHHHHHhcccCCC
Q 012053 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL----MEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPN 250 (472)
Q Consensus 175 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~d 250 (472)
..|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ..+...+.......+..+++++.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999877664 4789999999999999999999976543 333333444455667778999999999999999
Q ss_pred CCCcC-----ChhhhhcCccccc
Q 012053 251 PNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 251 P~~Rp-----t~~eil~hp~f~~ 268 (472)
|.+|| ++.++++||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.59 Aligned_cols=253 Identities=29% Similarity=0.526 Sum_probs=218.2
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
||+..+.||+|+||+||+|.+..+++.||+|.+...... .....+.+.+|+.+++.++||||+++++++.....+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 688999999999999999999889999999998654321 123457789999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
+||+++++|.+++.+ +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 999999999999876 569999999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc--cCCCCCCCCCHHHHHHHhc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK--AEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~l~~li~~ 245 (472)
.....|++.|+|||.+......+.++|+||||+++|+|++|..||..........++.. ....++..+++++.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 24567899999999987655245889999999999999999999987765554444443 2335566789999999999
Q ss_pred ccCCCCCCcCChhhhhcCccc
Q 012053 246 ILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f 266 (472)
||..+|.+|||+.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=357.72 Aligned_cols=248 Identities=33% Similarity=0.654 Sum_probs=222.3
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||.|-||+||-|.++.+|+.||||+|++.+... ...+++++|++||+.+.||.||.+.-.|++.+++|+|||.+.|.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 78999999999999999999999999999987654 34489999999999999999999999999999999999999876
Q ss_pred cccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---CeEEecCcchhhhhcccCCCcccc
Q 012053 96 ELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 96 ~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g---~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
-|.-.+. +|+|+|...+.++.||+.||+|||-+||+|+|||||||||.... .+||||||+|+++..+.- -.+
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---Rrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---RRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh---hhh
Confidence 6655554 48999999999999999999999999999999999999997655 599999999998876443 356
Q ss_pred cCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC--C--CCHHHHHHHhcc
Q 012053 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN--W--FAPEVRRLLSKI 246 (472)
Q Consensus 171 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~s~~l~~li~~~ 246 (472)
.+|||.|.|||++..++|. ..-|+||.|||+|.-+.|..||.... ++..+|.++.+.+|+ | +++++.+||..+
T Consensus 726 VVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~L 802 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNL 802 (888)
T ss_pred hcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence 7899999999999999998 78999999999999999999997654 455678888887774 3 899999999999
Q ss_pred cCCCCCCcCChhhhhcCcccccCC
Q 012053 247 LDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
|+..-.+|+|++..+.|||++...
T Consensus 803 LqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 803 LQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHhcchHhhccchhhhcch
Confidence 999999999999999999999754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=358.81 Aligned_cols=254 Identities=23% Similarity=0.393 Sum_probs=207.5
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARN-----LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMA 80 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (472)
+..++|++++.||+|+||+||+|.+ ..++..||+|++..... ....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 4456899999999999999999974 34677899999865432 23346788999999999 8999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhccC--------------------------------------------------------
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAKG-------------------------------------------------------- 104 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~~-------------------------------------------------------- 104 (472)
..+..|+||||++||+|.+++...
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 999999999999999998877431
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 105 --------------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 105 --------------------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 367888999999999999999999999999999999999999999999999876543222
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH-HHHHHHhcc-CCCCCCCCCHHHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM-EMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
........++..|+|||++.+..+. .++|||||||++|+|++ |..||...... .....+..+ ....|...+.++.+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 348 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD 348 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHH
Confidence 1111223456779999999777664 89999999999999998 99999875543 333333333 23345667899999
Q ss_pred HHhcccCCCCCCcCChhhhhcC
Q 012053 242 LLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h 263 (472)
||.+||++||++|||+.+|++.
T Consensus 349 li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 349 IMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=361.71 Aligned_cols=258 Identities=33% Similarity=0.604 Sum_probs=239.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-....+++.+||-|+||.|=++........+|+|++++..+.+....+.+..|-.||...+.|.||++|..|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34556788999999999999998875555569999999998888888899999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
++||-|-||+|...++. |.+++..++.|+..+++|++|||++||++|||||+|++||.+|-+||.|||+|+.......
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K- 575 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK- 575 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc-
Confidence 99999999999999975 8999999999999999999999999999999999999999999999999999998876544
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCCCCCHHHHHHH
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPNWFAPEVRRLL 243 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~l~~li 243 (472)
.-++||||.|+|||++..++.+ .++|.||||+++||||+|.+||.+.+++..|..|.++ .+.+|..++..+.+||
T Consensus 576 --TwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 576 --TWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred --eeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 5789999999999999999988 8999999999999999999999999999999999887 4688999999999999
Q ss_pred hcccCCCCCCcCC-----hhhhhcCccccc
Q 012053 244 SKILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 244 ~~~L~~dP~~Rpt-----~~eil~hp~f~~ 268 (472)
+++...+|.+|.. +.+|..|.||..
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 9999999999996 789999999964
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=338.46 Aligned_cols=252 Identities=33% Similarity=0.507 Sum_probs=212.1
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC-----
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASK----- 82 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~----- 82 (472)
.++|++.+.||+|+||.||+|.+..+++.+|+|++..... ..+.+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 5799999999999999999999998999999999876542 346789999999998 699999999999654
Q ss_pred -CEEEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 83 -TKIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
..+|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 458999999999999887753 57999999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhcccC----CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRG----YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF--- 229 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~----~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--- 229 (472)
....... .......|++.|+|||++.... ..+.++||||||+++|+|++|..||..........++.....
T Consensus 161 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 161 AQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred eecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 7543322 1223456899999999985422 234689999999999999999999987666555555544422
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
..+..++.++++||.+||..||++|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2233367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=343.20 Aligned_cols=252 Identities=30% Similarity=0.487 Sum_probs=209.7
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++++.||.|+||.||+|.+..+|+.||||.+...... ......+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 489999999999999999999999999999998654322 2334578899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+. ++|..++.. +.+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cc
Confidence 996 578777643 568999999999999999999999999999999999999999999999999987654322 11
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------------------CC
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------EF 229 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------~~ 229 (472)
.....+++.|+|||.+.+....+.++||||||+++|+|+||..||...+......++... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 234467889999999876665568899999999999999999999876554333222110 00
Q ss_pred C-----------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 230 K-----------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ~-----------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
. ..+.++++++++|.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 1 112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=341.86 Aligned_cols=255 Identities=32% Similarity=0.532 Sum_probs=215.2
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+.+|+.+++.++|+||+++++++..++..|++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 589999999999999999999999999999999865432 2244578899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||+.++.+..+..+ ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 99998777666654 5699999999999999999999999999999999999999999999999999887654332 123
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--------------------
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-------------------- 228 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------- 228 (472)
....+++.|+|||++.+....+.++||||||+++|+|++|..||...+..+....+....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 446788999999999877345589999999999999999999998765544333221100
Q ss_pred ------------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 229 ------------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 ------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
..++..+++++.+||.+||..+|++|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 01233458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=341.14 Aligned_cols=252 Identities=29% Similarity=0.456 Sum_probs=210.6
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE------
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMA------ 80 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~------ 80 (472)
..++|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4579999999999999999999999999999999986543 2345688899999988 6999999999984
Q ss_pred eCCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
....+|++|||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 35689999999999999988854 458999999999999999999999999999999999999999999999999987
Q ss_pred hhhcccCCCcccccCCCCcccChhhhcc-----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-C-
Q 012053 158 LAESKHQDGLLHTTCGTPAYVAPEVINR-----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-K- 230 (472)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~- 230 (472)
...... .......|++.|+|||.+.. ..+ +.++|+|||||++|+|++|..||...........+..... .
T Consensus 170 ~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 170 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhccc--cCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 654321 12245678999999999853 233 4689999999999999999999987665444433333221 1
Q ss_pred CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 231 FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 231 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
.+..++.++.+||++||..||.+|||+.+|++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 223478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=351.24 Aligned_cols=260 Identities=29% Similarity=0.482 Sum_probs=211.6
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4578999999999999999999999999999999986432 223456678899999999999999999987544
Q ss_pred CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 83 TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
...|+++||+.+ +|.+.+..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 358999999964 8888888788999999999999999999999999999999999999999999999999998765432
Q ss_pred cC-CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc---------------
Q 012053 163 HQ-DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK--------------- 226 (472)
Q Consensus 163 ~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~--------------- 226 (472)
.. .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 21 11223457899999999876544445899999999999999999999977654332221110
Q ss_pred ---------cC--CC-----CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 227 ---------AE--FK-----FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 227 ---------~~--~~-----~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
.. .. ..+..++++.++|.+||+.||.+|||+.++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00 00 1123578899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=346.41 Aligned_cols=255 Identities=27% Similarity=0.496 Sum_probs=218.8
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 45666788999999999999999999999999986543 234567889999999999999999999999999999999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
||+++++|.+++..+.+++.+++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ ...
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 176 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK 176 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence 999999999988888899999999999999999999999999999999999999999999999999875433221 123
Q ss_pred ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---CCCCCCCCHHHHHHHhcc
Q 012053 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~l~~li~~~ 246 (472)
...|++.|+|||.+.+..+. .++||||||+++|+|++|..||...+.......+.... ......++..+.+++.+|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 45789999999998776654 78999999999999999999998877665555544322 222234788999999999
Q ss_pred cCCCCCCcCChhhhhcCcccccCC
Q 012053 247 LDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
|..||++|||++++++||||+...
T Consensus 256 l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 256 LVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred ccCChhHCcCHHHHhhChhhhccC
Confidence 999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=344.56 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=206.8
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT---- 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (472)
..++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 456899999999999999999999999999999998654322 123345678999999999999999999986543
Q ss_pred ----EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 84 ----KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 84 ----~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
..|+||||+.+ +|.+.+.. ..+++.+++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 56999999964 77777654 379999999999999999999999999999999999999999999999999987
Q ss_pred hhhcccCC--CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC------
Q 012053 158 LAESKHQD--GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF------ 229 (472)
Q Consensus 158 ~~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~------ 229 (472)
........ .......++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 65432221 1223456788999999986654445789999999999999999999987765443332221100
Q ss_pred -------------CCC-------------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 230 -------------KFP-------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 -------------~~~-------------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
.++ ...++.+.++|.+||..||.+|||++++++||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 011 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=337.71 Aligned_cols=251 Identities=20% Similarity=0.305 Sum_probs=211.6
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
-.++|++.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+.+++.++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4568999999999999999999875 3567899999876532 2334678899999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999998865 47999999999999999999999999999999999999999999999999986643221
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
... ......++..|+|||++.+..+. .++|||||||++|++++ |..||...+.......+..+ ....|..++..+.
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd05064 161 AIY-TTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH 238 (266)
T ss_pred chh-cccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 110 11123456789999998776664 79999999999999775 99999988877777766554 3455667889999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012053 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+++.+||..+|.+|||+.+|++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=337.47 Aligned_cols=250 Identities=37% Similarity=0.693 Sum_probs=220.4
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012053 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||.|+||.||++.+..+|+.+|+|++...........+.+.+|+.+++.++||||+++++.+..+...|++|||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999776544445567899999999999999999999999999999999999999999
Q ss_pred cchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC------CCcccc
Q 012053 98 FGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ------DGLLHT 170 (472)
Q Consensus 98 ~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~------~~~~~~ 170 (472)
.+++.+ +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 998876 6899999999999999999999999999999999999999999999999999876543321 012234
Q ss_pred cCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCC--CHHHHHHHhcccC
Q 012053 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWF--APEVRRLLSKILD 248 (472)
Q Consensus 171 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--s~~l~~li~~~L~ 248 (472)
..+++.|+|||.+....+ +.++|+||||+++|+|++|..||........+..+.......|... ++.+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568889999999876664 4889999999999999999999998888888888877666666665 8999999999999
Q ss_pred CCCCCcCCh---hhhhcCccccc
Q 012053 249 PNPNTRISM---TKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rpt~---~eil~hp~f~~ 268 (472)
.+|.+|||+ .++++||||++
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=341.48 Aligned_cols=253 Identities=31% Similarity=0.513 Sum_probs=206.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 57899999999999999999999999999999998754322 1223466899999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.+ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-- 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-- 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence 999975 88887754 4689999999999999999999999999999999999999999999999999875432211
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHhcc------------------
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIGKA------------------ 227 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~------------------ 227 (472)
......+++.|+|||++.+....+.++||||+|+++|+|++|..||.... ..+....+...
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 12234578899999998765444578999999999999999999997654 22222211100
Q ss_pred -CCCC-----------CCCCC--HHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 228 -EFKF-----------PNWFA--PEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 228 -~~~~-----------~~~~s--~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
.... ...++ .++.++|.+||.++|.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=339.41 Aligned_cols=253 Identities=27% Similarity=0.475 Sum_probs=210.1
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE-----e
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMA-----S 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~-----~ 81 (472)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 4679999999999999999999999999999999986532 1235678899999998 6999999999873 4
Q ss_pred CCEEEEEEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 82 KTKIYFVMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
+...|+||||++|++|.+.+. .+.+++..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 567999999999999988764 246899999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhccc----CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---C
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRR----GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---F 229 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~----~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~ 229 (472)
........ ......|++.|+|||++... ...+.++|||||||++|+|++|..||..........++.... .
T Consensus 172 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd06638 172 AQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249 (286)
T ss_pred eecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcc
Confidence 76533211 12345699999999997532 223478999999999999999999998776554444433221 2
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
..|..++.++.++|.+||+.||++|||+.++++|+||
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2345568899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=334.60 Aligned_cols=250 Identities=30% Similarity=0.526 Sum_probs=216.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .+.+.+|+.+++.++||||+++++++.++...|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3689999999999999999999998899999999865431 57899999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
+||+.+++|.+++.. ..+++..++.++.|++.|+.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999998864 5789999999999999999999999999999999999999999999999999886644321
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---CCCCCCCCCHHHHHHH
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLL 243 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~l~~li 243 (472)
......|+..|+|||++.+..++ .++||||||+++|+|++|..||...........+... ....+..++.++.++|
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred ccccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence 12344588999999999877664 7899999999999999999999876654443333222 2233445788999999
Q ss_pred hcccCCCCCCcCChhhhhcCccc
Q 012053 244 SKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
.+||+.||++|||+.+++.||||
T Consensus 234 ~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=350.87 Aligned_cols=256 Identities=30% Similarity=0.503 Sum_probs=210.5
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK---- 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (472)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 467899999999999999999999999999999999865432 223446677899999999999999999998543
Q ss_pred --CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 --TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
...|+||||+.+ +|.+.+... +++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 777776544 9999999999999999999999999999999999999999999999999987653
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------- 227 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------- 227 (472)
... ......||+.|+|||.+.+..+. .++|||||||++|+|++|..||...+....+.++...
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 TSF---MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCC---CCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 321 12345689999999999887765 8899999999999999999999876654433333110
Q ss_pred ---------CCC--------------C-------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 ---------EFK--------------F-------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---------~~~--------------~-------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
... + +...+++++++|.+||+.||++|||+.++++||||+.-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 000 0 11235678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=338.03 Aligned_cols=255 Identities=30% Similarity=0.519 Sum_probs=220.9
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
=|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 478899999999999999999999999999998654322 345678899999999999999999999999999999999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccc
Q 012053 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
|+.+++|.+++..+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 83 ~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~ 160 (277)
T cd06641 83 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNT 160 (277)
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhcc
Confidence 99999999999888899999999999999999999999999999999999999999999999999875433211 1233
Q ss_pred cCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhcccCC
Q 012053 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 171 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~ 249 (472)
..|+..|+|||.+....+. .++|+||+||++|+|++|..||...........+.... ..++..++.++.++|.+||..
T Consensus 161 ~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 4688999999998766554 78999999999999999999998877666555554432 345566889999999999999
Q ss_pred CCCCcCChhhhhcCcccccCC
Q 012053 250 NPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 250 dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+|.+||++.+++.||||.+..
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhhh
Confidence 999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=332.56 Aligned_cols=255 Identities=33% Similarity=0.604 Sum_probs=216.8
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
||++.+.||+|+||.||.|.+..+++.||+|.+...... ....+.+.+|+.+++.++|+||+++++++.+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 799999999999999999999889999999999766533 3456889999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC-c-
Q 012053 91 YVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG-L- 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~-~- 167 (472)
|+.+++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9999999999876 468999999999999999999999999999999999999999999999999988654332211 1
Q ss_pred ccccCCCCcccChhhhcccC--CCCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHh-ccCCCCCCCC--CHHHHH
Q 012053 168 LHTTCGTPAYVAPEVINRRG--YDGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIG-KAEFKFPNWF--APEVRR 241 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~--~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~-~~~~~~~~~~--s~~l~~ 241 (472)
.....+++.|+|||.+.... ..+.++||||||++++++++|..||.... .......+. .....+|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22457889999999987654 23578999999999999999999997653 222222222 2234555554 899999
Q ss_pred HHhcccCCCCCCcCChhhhhcCccc
Q 012053 242 LLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+|.+||+.+|.+|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=333.02 Aligned_cols=252 Identities=32% Similarity=0.606 Sum_probs=219.1
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA--SKTKIYFV 88 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV 88 (472)
+|++.+.||.|+||.||+|.+..+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++. .+...|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 599999999999999999999999999999998765432 344567889999999999999999999875 34678999
Q ss_pred EEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCcEEEcCCCCeEEecCcchhh
Q 012053 89 MEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCH-----SRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH-----~~giiHrDIKp~NILld~~g~vkl~DFGla~~ 158 (472)
|||+++++|.+++.. +.+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999888753 57999999999999999999999 89999999999999999999999999999887
Q ss_pred hhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCH
Q 012053 159 AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAP 237 (472)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~ 237 (472)
...... ......|++.|+|||.+....+ +.++|+||||+++++|++|..||...+.......+..... .++..++.
T Consensus 160 ~~~~~~--~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDSS--FAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCcc--cccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 654322 1234578999999999877665 4789999999999999999999998877777777766554 45667889
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
++.+++.+||..+|++|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.54 Aligned_cols=247 Identities=28% Similarity=0.442 Sum_probs=192.7
Q ss_pred EEeeEcccCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCEEEEEE
Q 012053 14 LGRLLGQGTFAKVHYARNLK--TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA--SKTKIYFVM 89 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lV~ 89 (472)
.+.+||+|+||+||+|++.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .+..+|+||
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 34689999999999999754 668999999865432 245778999999999999999999984 456889999
Q ss_pred EecCCCcccchhcc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCCeEEecCcc
Q 012053 90 EYVKGGELFGKVAK----------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL----DEHGNLKVSDFGL 155 (472)
Q Consensus 90 E~~~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl----d~~g~vkl~DFGl 155 (472)
||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99865 66665531 258899999999999999999999999999999999999 5667899999999
Q ss_pred hhhhhcccCC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH---------HHHHHHh
Q 012053 156 SALAESKHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM---------EMYRKIG 225 (472)
Q Consensus 156 a~~~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~---------~~~~~i~ 225 (472)
++........ .......||+.|+|||++.+....+.++|||||||++|+|+||..||...... ....++.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 9865432211 12344578999999999977655568999999999999999999999643211 0000000
Q ss_pred c----------------------------cCC----------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 226 K----------------------------AEF----------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 226 ~----------------------------~~~----------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
. ... ......+..+.+||.+||+.||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000 0011134568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=354.14 Aligned_cols=241 Identities=29% Similarity=0.493 Sum_probs=210.8
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.+.+++.||+|-||+||+|.+. ....||+|.+...... .+.+.+|+.+|+.|+|+|||++++++..+.-+|||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 3456789999999999999983 2348999999765432 2567799999999999999999999999889999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|++.|+|.+++.. +.+...+...++.||++|++||+++++|||||...|||++++..+||+|||||+......
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~---- 357 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE---- 357 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc----
Confidence 9999999999976 479999999999999999999999999999999999999999999999999999443211
Q ss_pred ccccCC---CCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHH
Q 012053 168 LHTTCG---TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRL 242 (472)
Q Consensus 168 ~~~~~g---t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~l 242 (472)
.....| ...|+|||.+....++ .+||||||||+|+||+| |+.||...+..+....+.++. .+.|..+|+++.++
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~l 436 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYEL 436 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHH
Confidence 112222 3359999999888776 89999999999999999 999999999999999998874 68889999999999
Q ss_pred HhcccCCCCCCcCChhhhh
Q 012053 243 LSKILDPNPNTRISMTKIM 261 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil 261 (472)
+..||..+|++|||++.+.
T Consensus 437 M~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 437 MKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHhhCCcccCCCHHHHH
Confidence 9999999999999999664
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=359.88 Aligned_cols=249 Identities=30% Similarity=0.528 Sum_probs=216.7
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCc
Q 012053 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGE 96 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~ 96 (472)
.||+|+||+||.|+|..|....|||.+..... ....-++.||...++|+|.|||+++|.+..++++-++||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 69999999999999999999999999965532 345779999999999999999999999999999999999999999
Q ss_pred ccchhcc--CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCCeEEecCcchhhhhcccCCCccccc
Q 012053 97 LFGKVAK--GKL--KEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD-EHGNLKVSDFGLSALAESKHQDGLLHTT 171 (472)
Q Consensus 97 L~~~i~~--~~l--~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld-~~g~vkl~DFGla~~~~~~~~~~~~~~~ 171 (472)
|.++++. |++ +|...-.|.+||++||.|||++.|+|||||-+|+|++ -.|.+||+|||-++...... ....++
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC--cccccc
Confidence 9999975 788 8999999999999999999999999999999999996 57899999999988765432 335678
Q ss_pred CCCCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCCCc-HH-HHHH-HHhccCCCCCCCCCHHHHHHHhcc
Q 012053 172 CGTPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHDSN-LM-EMYR-KIGKAEFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 172 ~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~-~~~~-~i~~~~~~~~~~~s~~l~~li~~~ 246 (472)
-||.-|||||++... +| +.++|||||||++.||.||++||.... +. .+++ -+.+..+++|..++.+++.||.+|
T Consensus 737 TGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred ccchhhhChHhhccCCcCC-CchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 899999999998532 44 689999999999999999999997633 22 3332 123456778888999999999999
Q ss_pred cCCCCCCcCChhhhhcCcccccCCC
Q 012053 247 LDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
+.+||..||++.++|.+||++.+..
T Consensus 816 Fepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred cCCCcccCccHHHhccCcccccCCC
Confidence 9999999999999999999998744
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=348.74 Aligned_cols=256 Identities=29% Similarity=0.434 Sum_probs=215.1
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT---- 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (472)
+.++|++++.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+|+.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 56799999999999999999999999999999999865432 2234467889999999999999999999987654
Q ss_pred --EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 --KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.+|+||||+ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 468999999 77898888878899999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC------------
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF------------ 229 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~------------ 229 (472)
. .....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+....+.++.....
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 171 E-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred C-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 1 23346789999999987644456889999999999999999999987765544443322111
Q ss_pred -------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 230 -------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 230 -------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
.....+++++.++|.+||..||++|||+.+++.||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 11235788899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=339.93 Aligned_cols=254 Identities=31% Similarity=0.444 Sum_probs=207.9
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCE----
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTK---- 84 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 84 (472)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 5799999999999999999999999999999998654322 233456788999999995 6999999999877665
Q ss_pred -EEEEEEecCCCcccchhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCeEEecCcch
Q 012053 85 -IYFVMEYVKGGELFGKVAK------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSDFGLS 156 (472)
Q Consensus 85 -~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~-~g~vkl~DFGla 156 (472)
.|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 77777642 35899999999999999999999999999999999999998 889999999998
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--------
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-------- 228 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------- 228 (472)
....... .......+++.|+|||++.+....+.++||||||+++|+|++|..||...+....+.++....
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 7543321 112334678899999998665444689999999999999999999998876655444332210
Q ss_pred ---------CCC-----------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012053 229 ---------FKF-----------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 229 ---------~~~-----------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
... .+.+++++.++|.+||.+||.+|||+.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000 123688899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=337.68 Aligned_cols=251 Identities=32% Similarity=0.503 Sum_probs=210.5
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||.|++|.||+|.+..+|+.||||.+...... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 599999999999999999999999999999998765321 234567789999999999999999999999999999999
Q ss_pred ecCCCcccchhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 91 YVKGGELFGKVAK----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|+.+ +|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 9975 77777653 3589999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC------------------
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------------ 228 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------------ 228 (472)
......+++.|+|||.+.+....+.++||||||+++|+|++|..||.+.+..+.+.++....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 12345678999999998765555689999999999999999999998876655444432110
Q ss_pred CC-----------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 229 FK-----------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 ~~-----------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
.. ..+..++.+.++|.+||+.||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=342.96 Aligned_cols=255 Identities=29% Similarity=0.504 Sum_probs=218.8
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+.|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457788999999999999999999999999999875432 234567899999999999999999999999999999999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
||+++++|.+++..+.+++..++.++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRN 159 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhh
Confidence 999999999999888899999999999999999999999999999999999999999999999999876543221 122
Q ss_pred ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhcccC
Q 012053 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~ 248 (472)
...|+..|+|||.+.+..+. .++|+||||+++|+|++|..||...........+... ....+..++.++.++|.+||.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 34688999999999877654 7899999999999999999999876555444444333 233444578899999999999
Q ss_pred CCCCCcCChhhhhcCcccccC
Q 012053 249 PNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 249 ~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+|.+|||+.+++.||||...
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999763
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=336.70 Aligned_cols=252 Identities=29% Similarity=0.504 Sum_probs=217.1
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||.|+||.||+|.+..+++.+|+|.+...... .....+.+|+.+++.++||||+++++.+...+..|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 4789999999999999999999999999999998765422 34567889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||+.+++|.+++.. ..+++..+..++.|++.|+.|||+ .|++|+||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 99999999998864 679999999999999999999999 9999999999999999999999999999876643222
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC-----cHHHHHHHHhcc-CCCCCCC-CCHHH
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-----NLMEMYRKIGKA-EFKFPNW-FAPEV 239 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~-----~~~~~~~~i~~~-~~~~~~~-~s~~l 239 (472)
....++..|+|||.+.+..+. .++||||||+++|+|++|..||... ........+... ....+.. +++++
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred --hcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 226789999999999777654 8899999999999999999999764 233334443332 2344444 78999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 240 RRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.++|.+||..||.+|||+.+++.||||+.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=337.40 Aligned_cols=248 Identities=32% Similarity=0.529 Sum_probs=205.2
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC--CEEEEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASK--TKIYFV 88 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lV 88 (472)
|++++.||+|+||.||+|.+..+++.||+|.+.+..... .. ....+|+.+++++. ||||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 789999999999999999999999999999986543211 11 23347888888885 99999999999887 899999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++|++||||||+||+++. +.+||+|||++........
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 999975 77777654 56899999999999999999999999999999999999999 9999999999876543221
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------------------C
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------E 228 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------~ 228 (472)
.....+++.|+|||.+...+..+.++|||||||++|+|++|..||...+..+.+..+... .
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 233568899999998766666668999999999999999999999887665544443211 1
Q ss_pred CCCC-----------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 229 FKFP-----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 ~~~~-----------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+.+| ..++.++.++|.+||.++|++|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2357899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=332.62 Aligned_cols=251 Identities=30% Similarity=0.555 Sum_probs=212.5
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++...+..|+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999987654444455667889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 90 EYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
||+++++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999887742 4589999999999999999999999999999999999999999999999999876543221
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc--HHHHHHHHhccCC-CC-CCCCCHHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN--LMEMYRKIGKAEF-KF-PNWFAPEVR 240 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~--~~~~~~~i~~~~~-~~-~~~~s~~l~ 240 (472)
......|++.|+|||.+.+..++ .++|+||||+++|+|++|..||.... .......+..... .. +..++..+.
T Consensus 162 --~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 162 --AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred --HHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 12345689999999999877664 78999999999999999999996543 2344444443332 22 234778899
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012053 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++|.+||..+|.+|||+.++++.
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=341.51 Aligned_cols=256 Identities=30% Similarity=0.515 Sum_probs=218.9
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++.+.||+|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 4799999999999999999999988999999999864432 2346788999999999999999999999999999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
+||+++++|.+++.+..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~ 172 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KR 172 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cc
Confidence 9999999999999888899999999999999999999999999999999999999999999999998775443221 12
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---CCCCCCCCCHHHHHHHhc
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~l~~li~~ 245 (472)
....|++.|+|||.+....+ +.++|+||||+++|++++|..||...+.......+... .+..+..++..++++|++
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred ccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 34468999999999877665 47899999999999999999999876654433333221 122334467899999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
||..+|.+||++.+++.|+||+...
T Consensus 252 ~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 252 CLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=347.77 Aligned_cols=257 Identities=29% Similarity=0.447 Sum_probs=211.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
+.++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 45799999999999999999999999999999999866543 3456788999999999999999999876543
Q ss_pred ---------CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCeEEec
Q 012053 83 ---------TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSD 152 (472)
Q Consensus 83 ---------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~-~g~vkl~D 152 (472)
...|+||||+. ++|.+.+..+.+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 36899999996 58888887788999999999999999999999999999999999999974 55789999
Q ss_pred CcchhhhhcccC-CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---
Q 012053 153 FGLSALAESKHQ-DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--- 228 (472)
Q Consensus 153 FGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--- 228 (472)
||++........ .+......|+..|+|||.+......+.++|||||||++|+|++|..||...+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875532211 1112334688999999987654445589999999999999999999998766544443332110
Q ss_pred ----------------------C-----CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 229 ----------------------F-----KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 229 ----------------------~-----~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
. .+.+.++.++.+||.+||.+||.+|||+.+++.||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 0 012346788999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=393.53 Aligned_cols=259 Identities=32% Similarity=0.573 Sum_probs=226.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.-||+-+.+||.|.||.||.|.+..+|+..|+|-+.-.... ......+.+|..++..++|||+|++||+-...+..||.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 44899999999999999999999999999999999766544 45678899999999999999999999999999999999
Q ss_pred EEecCCCcccchhccCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc--CC
Q 012053 89 MEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH--QD 165 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~--~~ 165 (472)
||||+||+|.+.++.|+ .+|...+.|..|++.|+.|||++||+||||||+||+|+.+|.+|++|||.|..+.... -.
T Consensus 1313 MEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 99999999999998864 7788888899999999999999999999999999999999999999999988665432 22
Q ss_pred CcccccCCCCcccChhhhcccCC--CCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGY--DGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~--~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
+.+....|||.|||||++.+..- .+.++|||||||++.||+||+.||...+ ...+..++..+ .+++|..+|++.++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence 45667889999999999976432 2468999999999999999999997643 33444445444 57889999999999
Q ss_pred HHhcccCCCCCCcCChhhhhcCccccc
Q 012053 242 LLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
||.+||+.||++|.++.||++|.|-+.
T Consensus 1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 999999999999999999999988654
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=337.53 Aligned_cols=252 Identities=30% Similarity=0.428 Sum_probs=204.0
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+|+.+++.++|+||+++++++..+...|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 6899999999999999999999999999999998655322 22345678999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+. ++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+++++|+|||++........ .
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--T 159 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--C
Confidence 9996 566655543 5688999999999999999999999999999999999999999999999999875433221 1
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhc---------------cC---
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGK---------------AE--- 228 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~---------------~~--- 228 (472)
.....+++.|+|||.+.+....+.++||||||+++|+|++|..||...+.. +...++.. ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 234467999999999876543457899999999999999999999765432 22221110 00
Q ss_pred -----CCCCC---------CCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 229 -----FKFPN---------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 -----~~~~~---------~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
...+. ..++++.+++.+||..||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 125688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=342.22 Aligned_cols=255 Identities=29% Similarity=0.539 Sum_probs=218.9
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
-|+....||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 35566789999999999999999999999999865432 234668899999999999999999999999999999999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccc
Q 012053 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
|+++++|...+....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........ ....
T Consensus 99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 176 (297)
T cd06659 99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKS 176 (297)
T ss_pred cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccc
Confidence 99999999888778899999999999999999999999999999999999999999999999999875433221 1234
Q ss_pred cCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---CCCCCCCCHHHHHHHhccc
Q 012053 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 171 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~l~~li~~~L 247 (472)
.+|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.... ...+..+++.+.++|.+||
T Consensus 177 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 177 LVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred eecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 678999999999977665 489999999999999999999998877666555554332 2233457889999999999
Q ss_pred CCCCCCcCChhhhhcCcccccCCC
Q 012053 248 DPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
..+|++||++.++++||||.+...
T Consensus 256 ~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 256 TREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred cCCcccCcCHHHHhhChhhccCCC
Confidence 999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=341.33 Aligned_cols=254 Identities=33% Similarity=0.447 Sum_probs=212.7
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKIY 86 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 86 (472)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999999999999999755432 23344667899999999999999999998877 8999
Q ss_pred EEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 87 FVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 99999975 88887754 358999999999999999999999999999999999999999999999999988654432
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-----------------
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA----------------- 227 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~----------------- 227 (472)
.......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+....+.++...
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 12234567899999999876655568899999999999999999999887666555443211
Q ss_pred --------------CCCCCCC-CCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 228 --------------EFKFPNW-FAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 228 --------------~~~~~~~-~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
...++.. +++.+.++|.+||+.||++|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0112222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=336.13 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=211.9
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
.+..++|++.+.||+|+||.||.|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3567899999999999999999998752 457899999864332 123456889999999999999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhccC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeE
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAKG-----------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~~-----------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vk 149 (472)
.++..++||||+++++|.+++... .++...+..++.|++.||.|||++|++||||||+||++++++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 999999999999999999887541 256788899999999999999999999999999999999999999
Q ss_pred EecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC
Q 012053 150 VSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE 228 (472)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~ 228 (472)
|+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999875432211111123456788999999877665 488999999999999999 799998887777666555543
Q ss_pred -CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 229 -FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 229 -~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
...+...++.+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 45667788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.27 Aligned_cols=254 Identities=28% Similarity=0.509 Sum_probs=219.2
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|...+.||+|++|.||++.+..+++.+|+|.++.... ...+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 56667899999999999999999999999999864432 334668899999999999999999999999999999999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccc
Q 012053 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
|+.|++|.+++..+++++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++........ ....
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~ 174 (285)
T cd06648 97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKS 174 (285)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cccc
Confidence 99999999999888899999999999999999999999999999999999999999999999998775433221 1234
Q ss_pred cCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC---CCCCCHHHHHHHhccc
Q 012053 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF---PNWFAPEVRRLLSKIL 247 (472)
Q Consensus 171 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~s~~l~~li~~~L 247 (472)
..|++.|+|||.+.+..+. .++||||+|+++|+|++|..||...+.......+....... +..+++.+.++|.+||
T Consensus 175 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred ccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 5689999999998776654 78999999999999999999998877776666665543222 2337889999999999
Q ss_pred CCCCCCcCChhhhhcCcccccCC
Q 012053 248 DPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
..+|++|||+.++++||||++..
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ccChhhCcCHHHHccCcccccCC
Confidence 99999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=332.50 Aligned_cols=246 Identities=33% Similarity=0.616 Sum_probs=208.8
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhcCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
+.||+|+||.||+|.+..+|+.||+|.+.+...........+..|..++ ...+||||+++++++..++.+|+|+||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999765433223333445555544 456899999999999999999999999999
Q ss_pred Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 95 GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 95 g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
++|.+++.. +.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999998865 6799999999999999999999999999999999999999999999999998875432 134468
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC----CCCCCHHHHHHHhcccCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF----PNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s~~l~~li~~~L~~ 249 (472)
++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+....+..+....... +..+++++.++|.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999877664 589999999999999999999999888777777765554333 334789999999999999
Q ss_pred CCCCcCC---hhhhhcCccccc
Q 012053 250 NPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 250 dP~~Rpt---~~eil~hp~f~~ 268 (472)
||++||| ++|++.||||++
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 9999995 579999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=336.81 Aligned_cols=257 Identities=31% Similarity=0.463 Sum_probs=210.5
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++.+.||+|++|+||+|.+..+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998654322 23346788999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-C--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCeEEecCcchhhhhcccC
Q 012053 89 MEYVKGGELFGKVAK-G--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~-~g~vkl~DFGla~~~~~~~~ 164 (472)
|||+.+ +|.+.+.. . .+++..++.++.||+.||.|||++|++||||+|+||+++. ++.+||+|||++........
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 999964 67666643 2 3688999999999999999999999999999999999985 45799999999875433211
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC----------------
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---------------- 228 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---------------- 228 (472)
......+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+...++....
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 159 --TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred --ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 12344678999999998765545589999999999999999999998776554444332100
Q ss_pred -----CC--------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 229 -----FK--------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 229 -----~~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.. ..+.+++++.++|.+||+.+|++||++.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 113467889999999999999999999999999999863
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=337.90 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=215.9
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.||+|+||+||++.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 468999999999999999999999999999999986543 223457889999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+++++|.+++.. +.+++..++.++.+++.||.|||+ +|++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 999999999988865 679999999999999999999997 699999999999999999999999999986543221
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-----------HHHHHHhcc-CCCCCCC
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-----------EMYRKIGKA-EFKFPNW 234 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-----------~~~~~i~~~-~~~~~~~ 234 (472)
....+|+..|+|||++.+..+. .++|+|||||++|+|++|..||...... .....+... ...++..
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred -cCccccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 2345799999999998766554 7899999999999999999999864431 222333222 2233333
Q ss_pred -CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 235 -FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 235 -~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
++.++.+||.+||+.||.+|||+.++++|+||.+..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 778999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=336.75 Aligned_cols=258 Identities=21% Similarity=0.292 Sum_probs=212.7
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
+..++|++.+.||+|+||.||+|.++. .+..||+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456799999999999999999997652 3558999998654321 233457789999999999999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEE
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK-----------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl 150 (472)
.+..|+||||+.+|+|.+++.. ..++...+..++.||+.||.|||++||+||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999998853 12466788999999999999999999999999999999999999999
Q ss_pred ecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-C
Q 012053 151 SDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-E 228 (472)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~ 228 (472)
+|||+++...............++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||......+....+... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999875433221111123345778999999876665 479999999999999998 79999887777766665544 3
Q ss_pred CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc------Ccccc
Q 012053 229 FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME------NSWFR 267 (472)
Q Consensus 229 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~------hp~f~ 267 (472)
...+...++.+.+++.+||+.||++|||+.++++ ||||+
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 4556677899999999999999999999999987 77775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=343.78 Aligned_cols=251 Identities=28% Similarity=0.504 Sum_probs=221.3
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
-|.++.+||+|+||.||+|+++.+|+.+|||.+.-+. .+..+.+||.||++++.|++|++||.+...+.+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3678899999999999999999999999999986553 35788999999999999999999999999999999999
Q ss_pred ecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 91 YVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 91 ~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||..|++.+.++ +.+|+|.++..+++..+.||+|||...-+|||||..||||+.+|..||+|||.|........ .-
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--KR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--KR 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--hh
Confidence 999999999886 36899999999999999999999999999999999999999999999999999876543322 13
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---CCCCCCCCHHHHHHHhc
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~l~~li~~ 245 (472)
.+..|||.|||||++..-+|+ .++||||||++..||..|++||.+-.++...--|-... +.-|..+|.++.+||++
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred CccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence 578999999999999999998 68999999999999999999998877765443333322 22345578899999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
||..+|++|.|+.++++|||+++.
T Consensus 266 CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HhcCCHHHHHHHHHHhhhhhhcCC
Confidence 999999999999999999999864
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=330.40 Aligned_cols=252 Identities=31% Similarity=0.598 Sum_probs=216.9
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||+|+||.||++.+..+|..+|+|.+...... ....+.+.+|+.+++.++||||+++++.+......|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 699999999999999999999999999999999765332 2334678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC-eEEecCcchhhhhcccCCC
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN-LKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~-vkl~DFGla~~~~~~~~~~ 166 (472)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||++++++. ++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-- 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence 9999999998864 25899999999999999999999999999999999999998865 69999999876543221
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHhc
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSK 245 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~~ 245 (472)
......|++.|+|||++....+. .++|+||||+++++|++|..||...+.......+..... ..++.++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 12345689999999998766554 789999999999999999999988777666665554433 3455678899999999
Q ss_pred ccCCCCCCcCChhhhhcCccc
Q 012053 246 ILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f 266 (472)
||..+|++|||+.+++.||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=335.58 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=211.9
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEc----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNL----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
-...|++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3467999999999999999999864 456789999986533 2233467889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 012053 84 KIYFVMEYVKGGELFGKVAK------------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH 145 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~------------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~ 145 (472)
..|+||||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 99999999999999888742 247889999999999999999999999999999999999999
Q ss_pred CCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 012053 146 GNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKI 224 (472)
Q Consensus 146 g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i 224 (472)
+.+||+|||++................++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.+.......+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999876543322222234456778999999876665 489999999999999998 99999887666655555
Q ss_pred hcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 225 GKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 225 ~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
... ....+..+++++.+++.+||+.||.+||++.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 443 345667789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=331.14 Aligned_cols=251 Identities=25% Similarity=0.434 Sum_probs=215.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+....|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++..++.+|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 34567999999999999999999999999999999986543 22456889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 87 FVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
++|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999998854 358999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
... .....+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+..+....+... ....|..+++++.+
T Consensus 159 ~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd05052 159 YTA-HAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE 236 (263)
T ss_pred eec-cCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 111 1122345679999998776664 78999999999999998 99999988777777776554 45667778999999
Q ss_pred HHhcccCCCCCCcCChhhhhcC
Q 012053 242 LLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h 263 (472)
+|.+||..||++|||+.++++.
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHccCCcccCCCHHHHHHH
Confidence 9999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=348.01 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=216.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE--
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK-- 84 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 84 (472)
.+.++|++.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4677999999999999999999999999999999998654322 2344667889999999999999999998765554
Q ss_pred ----EEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 85 ----IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 85 ----~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
.|+|+||+ +++|.+++..+++++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6799999888889999999999999999999999999999999999999999999999999987653
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-----------
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF----------- 229 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~----------- 229 (472)
.. .....+++.|+|||.+.+....+.++||||||+++|+|++|+.||.+.+....+..+.....
T Consensus 170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred cc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 22 23457889999999986644556899999999999999999999988776655544422110
Q ss_pred --------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 230 --------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 230 --------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
.....+++++.++|.+||.+||++|||+.+|+.||||++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 01123588999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=332.97 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=214.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKT-----GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
+..++|++.+.||+|+||.||+|.+... +..||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 5678999999999999999999998644 47899999865432 2334567899999999999999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEE
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK-----------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl 150 (472)
....|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 9999999999999999988753 23678899999999999999999999999999999999999999999
Q ss_pred ecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-C
Q 012053 151 SDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-E 228 (472)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~ 228 (472)
+|||+++...............++..|+|||.+....+ +.++|||||||++|++++ |..||.+.+.......+... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 99999876543322122234567889999999876655 488999999999999998 99999887777666666543 3
Q ss_pred CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 229 FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 229 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
...|..++.++.++|.+||..+|++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 45677789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=336.39 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=213.2
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ....+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998753 468899999865432 224578899999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCe
Q 012053 84 KIYFVMEYVKGGELFGKVAK---------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNL 148 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~v 148 (472)
..|+||||+++++|.+++.. ..+++..+..++.||+.|+.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 99999999999999988853 247889999999999999999999999999999999999999999
Q ss_pred EEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc
Q 012053 149 KVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA 227 (472)
Q Consensus 149 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~ 227 (472)
+|+|||++................+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999998754322211112334567889999999877664 78999999999999998 99999888877777777665
Q ss_pred CC-CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 228 EF-KFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 228 ~~-~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.. ..+..++.++.+++.+||..||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54 345568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.41 Aligned_cols=252 Identities=35% Similarity=0.635 Sum_probs=221.8
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||.|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 699999999999999999999989999999999765432 2445678899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 91 YVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 91 ~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|+++++|.+.+.. ..+++..+..++.+++.||.|||++|++|+||+|+||+++.+++++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 9999999988854 569999999999999999999999999999999999999999999999999987654432
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHh
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLS 244 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~ 244 (472)
......+|++.|+|||.+....+. .++|+||+|+++++|++|..||...+.......+.... ..+|..++.++.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 123455789999999998776654 78999999999999999999998887777666665543 3456678899999999
Q ss_pred cccCCCCCCcCChhhhhcCccc
Q 012053 245 KILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+||..+|.+|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.69 Aligned_cols=255 Identities=26% Similarity=0.459 Sum_probs=205.1
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV-MRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
++|++.+.||+|+||.||+|.+..+|+.||+|.+....... ....+..|+.+ ++.++||||+++++++..++..|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987653221 22344456554 6778999999999999999999999
Q ss_pred EEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 89 MEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|||++ ++|.+.+.. ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 466555432 4689999999999999999999998 9999999999999999999999999998765322
Q ss_pred cCCCcccccCCCCcccChhhhccc---CCCCCcccchhhhHHHHHHhcCCCCCCCC-cHHHHHHHHh-ccCCCCC-CCCC
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRR---GYDGSKADIWSCGVILYVLLAGYLPFHDS-NLMEMYRKIG-KAEFKFP-NWFA 236 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~---~~~~~~~DiwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~-~~~~~~~-~~~s 236 (472)
. ......|+..|+|||.+.+. ...+.++|+|||||++|+|++|..||... ...+.+..+. .....+| ..++
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 1 11235688999999988542 11247899999999999999999999753 2223233332 2233343 3478
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
.++.++|.+||..+|.+|||+.++++||||++..
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=336.16 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=211.8
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
..+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 457999999999999999999853 345679999986542 234567899999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeE
Q 012053 84 KIYFVMEYVKGGELFGKVAK--------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vk 149 (472)
.+|+||||+++++|.+++.. ..+++..++.++.||+.||+|||++|++||||||+|||+++++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 99999999999999988753 2489999999999999999999999999999999999999999999
Q ss_pred EecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC
Q 012053 150 VSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE 228 (472)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~ 228 (472)
|+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||...+.......+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999998755332211112234567889999998776554 79999999999999998 999998887777777776665
Q ss_pred -CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 229 -FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 229 -~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
...+..+++++.+++.+||++||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3455668899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=341.76 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=209.7
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMS----VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
..+|++.+.||+|+||+||+|.+..+++. ||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 45899999999999999999998766664 8999986432 223456788999999999999999999998765 5
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.++++||+.+|+|.+.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 7899999999999998875 36899999999999999999999999999999999999999999999999999876433
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
..........++..|+|||.+.+..+. .++|||||||++|+|++ |..||.+....+....+... ....+..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 221112223456789999999777665 89999999999999998 99999887766554444333 3455667889999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012053 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+++.+||..||.+|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.76 Aligned_cols=254 Identities=32% Similarity=0.554 Sum_probs=220.4
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|++|.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4699999999999999999999999999999998765421 34577899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+++++|.+++.. +.+++..++.++.|++.|+.|||+ .|++||||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 99999999999975 789999999999999999999999 99999999999999999999999999998765432221
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC---cHHHHHHHHhcc-CCCCCCC-CCHHHHHH
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS---NLMEMYRKIGKA-EFKFPNW-FAPEVRRL 242 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~---~~~~~~~~i~~~-~~~~~~~-~s~~l~~l 242 (472)
.....++..|+|||.+....+ +.++|+||||+++|+|++|..||... ...+....+... ....+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 234568899999999876644 48999999999999999999999776 444555554433 3445555 78999999
Q ss_pred HhcccCCCCCCcCChhhhhcCccccc
Q 012053 243 LSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
|.+||.++|++|||+.++++||||+.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=341.19 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=205.6
Q ss_pred CEEEEeeEcccCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLK--TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKIY 86 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 86 (472)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 8999999999874422234456778999999999999999999999888 8899
Q ss_pred EEEEecCCCcccchhc-----c-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC----CCCeEEecCcch
Q 012053 87 FVMEYVKGGELFGKVA-----K-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE----HGNLKVSDFGLS 156 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~-----~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~----~g~vkl~DFGla 156 (472)
+||||+.+ +|.+.+. . +.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 5555442 1 36899999999999999999999999999999999999999 899999999998
Q ss_pred hhhhcccC-CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH---------HHHHH--
Q 012053 157 ALAESKHQ-DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME---------MYRKI-- 224 (472)
Q Consensus 157 ~~~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~---------~~~~i-- 224 (472)
........ .......++|+.|+|||++.+....+.++|||||||++++|++|+.||....... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86543322 1112345789999999998765544588999999999999999999997543211 00000
Q ss_pred ------------------------hccCCCCC-----------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 225 ------------------------GKAEFKFP-----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 225 ------------------------~~~~~~~~-----------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
......++ ...+.++.++|.+||++||++|||+.++++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00001111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=336.59 Aligned_cols=251 Identities=32% Similarity=0.481 Sum_probs=209.1
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
|++.+.||.|++|.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 68899999999999999999999999999999765422 23345678899999999999999999999999999999999
Q ss_pred cCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 92 VKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 92 ~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
+. ++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ ..
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--cc
Confidence 95 5888887653 589999999999999999999999999999999999999999999999999875432211 12
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--------------------
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-------------------- 228 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------- 228 (472)
....+++.|+|||++.+....+.++|+||||+++|+|++|..||...+......++.+..
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334578899999988765444578999999999999999999998776544333322110
Q ss_pred ---------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 229 ---------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 ---------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
......+++++.++|.+||++||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=325.15 Aligned_cols=254 Identities=31% Similarity=0.568 Sum_probs=219.7
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKIYFV 88 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV 88 (472)
+|++.+.||+|++|.||.|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ..+|++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 589999999999999999999989999999999766532 34567889999999999999999999999988 899999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
+||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999876 4899999999999999999999999999999999999999999999999999887655432111
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHh--ccCCCCCCCCCHHHHHHHh
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIG--KAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~--~~~~~~~~~~s~~l~~li~ 244 (472)
.....++..|+|||.+....+ +.++||||||+++++|++|..||.... .......+. ......|..++..+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 244678999999999876654 489999999999999999999998765 333333333 2344567778999999999
Q ss_pred cccCCCCCCcCChhhhhcCccc
Q 012053 245 KILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+||..||.+||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=329.95 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=213.2
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.++|++.+.||+|+||+||+|.+..+ ...||+|.+.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 35799999999999999999998654 4589999986543 223446688899999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|++|||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999999865 579999999999999999999999999999999999999999999999999998765221
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
.........+++.|+|||.+.+..+. .++||||||+++|+|++ |..||...........+... ....+...++.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11111123456789999998776654 79999999999999998 99999887777666666554 33455668999999
Q ss_pred HHhcccCCCCCCcCChhhhhcC
Q 012053 242 LLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h 263 (472)
++.+||+.+|++||++.+|+++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=325.07 Aligned_cols=252 Identities=33% Similarity=0.601 Sum_probs=221.0
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++|||++++++++.+....|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 699999999999999999999999999999999776532 2456789999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 91 YVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
|+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||++......... ..
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--cc
Confidence 9999999998865 68999999999999999999999999999999999999999999999999998866543221 23
Q ss_pred ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHh-ccCCCCCCCCCHHHHHHHhcccC
Q 012053 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG-KAEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~s~~l~~li~~~L~ 248 (472)
...++..|+|||.+.+..+ +.++||||||+++++|++|..||...+......++. .....++..+++.+.++|.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4578999999999876664 588999999999999999999998766554444443 34455677789999999999999
Q ss_pred CCCCCcCChhhhhcCccc
Q 012053 249 PNPNTRISMTKIMENSWF 266 (472)
Q Consensus 249 ~dP~~Rpt~~eil~hp~f 266 (472)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=338.00 Aligned_cols=259 Identities=28% Similarity=0.511 Sum_probs=213.4
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT- 83 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 83 (472)
|.+..++|++.+.||+|+||.||+|.+..+|+.||+|.++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 667889999999999999999999999999999999999755322 123356778999999999999999999986654
Q ss_pred ---------EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEec
Q 012053 84 ---------KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSD 152 (472)
Q Consensus 84 ---------~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~D 152 (472)
.+|+|+||+++ +|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 89999999976 56666654 4799999999999999999999999999999999999999999999999
Q ss_pred CcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---
Q 012053 153 FGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF--- 229 (472)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--- 229 (472)
||++........ .......+++.|+|||.+.+....+.++|||||||++++|++|+.||...+.......+.....
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999876543221 1122335688899999987655456899999999999999999999987766555444432100
Q ss_pred ---------------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 230 ---------------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 ---------------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
.....+++.+.++|.+||..||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=345.26 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=211.1
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
+.++|++.+.||+|+||.||+|++..+++.||||.+....... .....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 4578999999999999999999999999999999987543222 2345677899999999999999999987544
Q ss_pred CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
...|+|+||+. ++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999995 578777755 6899999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--------------
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------- 227 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------- 227 (472)
.. .......++..|+|||.+......+.++|||||||++|+|++|+.||...+....+..+...
T Consensus 161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 KG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred Cc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 21 22344578999999999865444568999999999999999999999876543322222100
Q ss_pred --------------CC---CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 228 --------------EF---KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 228 --------------~~---~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.. ...+.+++++.++|.+||+.+|++|||++++++||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00 112347889999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=339.00 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=208.1
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcE--EEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMS--VAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKT 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (472)
+-.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++..++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 3457899999999999999999999888765 466665432 2223456788999999999 8999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 012053 84 KIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG 146 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g 146 (472)
.+|+||||+++++|.+++.. ..+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 99999999999999988753 2478999999999999999999999999999999999999999
Q ss_pred CeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHh
Q 012053 147 NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIG 225 (472)
Q Consensus 147 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~ 225 (472)
.+||+|||++........ .....++..|+|||.+.+..+ +.++|||||||++|+|+| |..||...+..+.+..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 162 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred cEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 999999999863321111 111234667999999876654 489999999999999998 999998877777666665
Q ss_pred cc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 226 KA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 226 ~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.. ....+..+++++.+||.+||+.+|++|||+++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 43 233455578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=328.66 Aligned_cols=244 Identities=26% Similarity=0.446 Sum_probs=204.0
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||.||+|++..+++.||+|.+.... .......+.+|+.+++.++||||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999886432 2344567899999999999999999999999999999999999999
Q ss_pred cccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 96 ELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 99998864 3689999999999999999999999999999999999999999999999999875432111100111123
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNP 251 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP 251 (472)
+..|+|||.+.+..+. .++||||||+++|+|++ |..||...........+... ....+..++..+.+++.+||..+|
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 4569999998766654 78999999999999997 99999876665555555433 445666788999999999999999
Q ss_pred CCcCChhhhhc
Q 012053 252 NTRISMTKIME 262 (472)
Q Consensus 252 ~~Rpt~~eil~ 262 (472)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.96 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=208.5
Q ss_pred EEEEeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE----
Q 012053 12 YELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK---- 84 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 84 (472)
|++++.||+|+||.||.|....+ +..||+|.+...... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67899999999999999987653 478999998754332 2345678999999999999999999998865544
Q ss_pred --EEEEEEecCCCcccchhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcc
Q 012053 85 --IYFVMEYVKGGELFGKVAK-------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 85 --~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGl 155 (472)
.+++|||+++++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999887732 3589999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCC
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPN 233 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 233 (472)
+................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+.+..+... ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 876543222111222345678999999876655 489999999999999999 99999887777776666544 455677
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 234 WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+++++.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=337.40 Aligned_cols=257 Identities=27% Similarity=0.423 Sum_probs=216.1
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.....+|++.+.||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.++||||+++++++..++..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 44567899999999999999999999999999999998755443444556788999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||+.| +|.+.+. .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 999999975 5655553 35799999999999999999999999999999999999999999999999998865432
Q ss_pred CCCcccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCC-CCCCCHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKF-PNWFAPEV 239 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~-~~~~s~~l 239 (472)
.....|++.|+|||++.+ .+..+.++||||||+++|+|++|..||...+.......+.... ... +..++.++
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence 124568899999998742 2334578999999999999999999998877665544444332 222 23467899
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.++|.+||..||++||++.+|+.||||...
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=345.14 Aligned_cols=260 Identities=26% Similarity=0.423 Sum_probs=212.2
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE----eCC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA----SKT 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~ 83 (472)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+|+.++||||+++++++. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 34789999999999999999999999999999999875432 2234567788999999999999999999875 345
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 7899999995 578888764 57999999999999999999999999999999999999999999999999998755332
Q ss_pred cC--CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc--------------
Q 012053 163 HQ--DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK-------------- 226 (472)
Q Consensus 163 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~-------------- 226 (472)
.. ........|+..|+|||.+......+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 21 11123457899999999986644456899999999999999999999987654332222111
Q ss_pred ----------cC--CCC-----CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 227 ----------AE--FKF-----PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 227 ----------~~--~~~-----~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.. ... .+..++++.++|.+||+.+|.+|||+++++.||||.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 00 001 13368899999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=346.89 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=207.4
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEV 78 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 78 (472)
..+-.+||++++.||+|+||.||+|++.. +++.||+|++..... ....+.+.+|+.+++++ +||||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 34556799999999999999999997543 457899999865432 23346678899999999 79999999998
Q ss_pred EEe-CCEEEEEEEecCCCcccchhcc------------------------------------------------------
Q 012053 79 MAS-KTKIYFVMEYVKGGELFGKVAK------------------------------------------------------ 103 (472)
Q Consensus 79 ~~~-~~~~~lV~E~~~gg~L~~~i~~------------------------------------------------------ 103 (472)
+.. +..+|++|||+++++|.+++..
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 754 4678999999999999887742
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCC
Q 012053 104 --------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP 175 (472)
Q Consensus 104 --------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~ 175 (472)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++................++.
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 257889999999999999999999999999999999999999999999999998654322211122345677
Q ss_pred cccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHH-HHHhcc-CCCCCCCCCHHHHHHHhcccCCCCC
Q 012053 176 AYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMY-RKIGKA-EFKFPNWFAPEVRRLLSKILDPNPN 252 (472)
Q Consensus 176 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~-~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~ 252 (472)
.|+|||++.+..+. .++|||||||++|+|++ |..||.+....+.. ..+... ....|...++++.+++.+||+.+|+
T Consensus 240 ~y~aPE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 240 KWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred cccCcHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 89999999877765 78999999999999998 99999875433322 233322 2344566889999999999999999
Q ss_pred CcCChhhhhcC
Q 012053 253 TRISMTKIMEN 263 (472)
Q Consensus 253 ~Rpt~~eil~h 263 (472)
+||++.++++|
T Consensus 319 ~RPs~~ell~~ 329 (337)
T cd05054 319 DRPTFSELVEI 329 (337)
T ss_pred hCcCHHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=327.24 Aligned_cols=255 Identities=28% Similarity=0.521 Sum_probs=215.9
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccc--cchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV--LKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKI 85 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 85 (472)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+++|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999999864321 1224456889999999999999999999998664 568
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
++++||+++++|.+++.. +.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999998865 6799999999999999999999999999999999999999999999999999876533211
Q ss_pred C-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCCCCCHHHHH
Q 012053 165 D-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPNWFAPEVRR 241 (472)
Q Consensus 165 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~l~~ 241 (472)
. .......|+..|+|||.+.+..++ .++|+|||||++|+|++|..||..........++... ...+|..+++++.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 1 112345689999999999776654 7899999999999999999999887666555554432 34567789999999
Q ss_pred HHhcccCCCCCCcCChhhhhcCccc
Q 012053 242 LLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+|.+||. +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=343.81 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=211.3
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 457999999999999999999999999999999998754321 22346678899999999999999999988543
Q ss_pred -CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 83 -TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
...|++++++ |++|.+.+..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 3478888887 78898888778899999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------- 228 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------- 228 (472)
. .....|++.|+|||++.+....+.++|||||||++|+|++|+.||...+.......+....
T Consensus 173 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 173 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred c-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 1 2345789999999998764444578999999999999999999998765544333321110
Q ss_pred ----------CCC--------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 229 ----------FKF--------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 229 ----------~~~--------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
... ....++++.++|.+||++||.+|||+.++++||||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 000 112578899999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=329.13 Aligned_cols=248 Identities=29% Similarity=0.495 Sum_probs=207.3
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012053 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
....||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++|+||+++++++..++..|+|+||++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 44689999999999999999999999999865432 334678899999999999999999999999999999999999
Q ss_pred CCcccchhcc--CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCeEEecCcchhhhhcccCCCcc
Q 012053 94 GGELFGKVAK--GKL--KEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 94 gg~L~~~i~~--~~l--~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~-~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
+++|.+.+.. +.+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++........ ..
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~ 166 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CT 166 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--cc
Confidence 9999998865 455 88899999999999999999999999999999999986 67899999999875533221 12
Q ss_pred cccCCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCCcHH--HHHH-HHhccCCCCCCCCCHHHHHHHh
Q 012053 169 HTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDSNLM--EMYR-KIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~--~~~~-~i~~~~~~~~~~~s~~l~~li~ 244 (472)
....|++.|+|||.+.... ..+.++|+||+|+++|+|++|..||...... .... ........+|..+++++.+++.
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHH
Confidence 3346899999999986533 2357899999999999999999999764322 1211 1223344567778999999999
Q ss_pred cccCCCCCCcCChhhhhcCccc
Q 012053 245 KILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+||+.+|.+|||+.+++.||||
T Consensus 247 ~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 247 RCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=332.51 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=211.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
-.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS--EQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34689999999999999999999987 778999998864432 22345678899999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---CeEEe
Q 012053 83 TKIYFVMEYVKGGELFGKVAKG--------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NLKVS 151 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g---~vkl~ 151 (472)
...|+||||+.|++|.+++... .+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 9999999999999999988542 489999999999999999999999999999999999998765 59999
Q ss_pred cCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CC
Q 012053 152 DFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EF 229 (472)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~ 229 (472)
|||++................++..|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99998865322111111122345679999999776654 89999999999999997 99999987776666555433 44
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..|..++..+.+++.+||..+|++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5667789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=332.57 Aligned_cols=244 Identities=28% Similarity=0.489 Sum_probs=203.6
Q ss_pred cCCEEEEeeE--cccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q 012053 9 MQRYELGRLL--GQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~L--G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (472)
.++|++.+.+ |+|+||.||++.+..++..+|+|++....... .|+.+...+ +||||+++++.+...+..
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 4577887777 99999999999999999999999987653221 123333322 699999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-~vkl~DFGla~~~~~~~ 163 (472)
|+||||+++++|.+++.. +.+++.+++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 999999999999999876 4899999999999999999999999999999999999999998 9999999988754321
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHH----HHHHhccCCCCCCCCCHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM----YRKIGKAEFKFPNWFAPEV 239 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~l 239 (472)
....|++.|+|||++.+..+. .++||||||+++|+|++|..||........ ...........++.+++.+
T Consensus 164 -----~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 164 -----SCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred -----ccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence 234689999999999877765 789999999999999999999975433221 1111233345556789999
Q ss_pred HHHHhcccCCCCCCcCC-hhhhhcCcccc
Q 012053 240 RRLLSKILDPNPNTRIS-MTKIMENSWFR 267 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt-~~eil~hp~f~ 267 (472)
.++|.+||++||.+||+ ++++++||||+
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 99999999999999996 69999999996
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=336.03 Aligned_cols=253 Identities=22% Similarity=0.340 Sum_probs=213.8
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKT-----GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
-..+|++.+.||+|+||+||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 345789999999999999999987543 5789999987543 223456788999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH 145 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~ 145 (472)
...++++||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 999999999999999888741 347888999999999999999999999999999999999999
Q ss_pred CCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 012053 146 GNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKI 224 (472)
Q Consensus 146 g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i 224 (472)
+.+||+|||+++...............+++.|+|||.+....+ +.++|||||||++|+|++ |..||.+....+.+..+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999876533222222234456789999999876665 478999999999999998 89999888877777777
Q ss_pred hccCC-CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 225 GKAEF-KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 225 ~~~~~-~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..... ..+..++..+.+++.+||+.+|.+||++.+|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 66553 4567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=337.34 Aligned_cols=255 Identities=22% Similarity=0.421 Sum_probs=212.7
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLK-------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYE 77 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 77 (472)
++..++|.+++.||+|+||.||+|++.. ++..+|+|.+..... ......+.+|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4566899999999999999999998753 235799999976432 23346788899999999 7999999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012053 78 VMASKTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NI 140 (472)
++...+..|+||||+.+++|.+++.. ..+++.+++.++.|++.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 99999999999999999999998854 2478899999999999999999999999999999999
Q ss_pred EEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH
Q 012053 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~ 219 (472)
+++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 999999999999999875532211111122234578999999877665 489999999999999998 899998887777
Q ss_pred HHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 220 MYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....+.... ...|..++.++.++|.+||..+|.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 766665553 35667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=354.09 Aligned_cols=251 Identities=27% Similarity=0.447 Sum_probs=218.9
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|.=++.||+|+||.||.|++..+.+.||||.+........+--..+.+|+..|+.++|||++.+.++|-.+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46667889999999999999999999999999987655444445678899999999999999999999999999999999
Q ss_pred ecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 91 YVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 91 ~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||-| +-.|++. +.++.|.++..+..+.+.||.|||+++.||||||..||||.+.|.|||+|||.|..... .
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------A 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------A 179 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------h
Confidence 9965 5566653 57899999999999999999999999999999999999999999999999999876543 3
Q ss_pred cccCCCCcccChhhhcc---cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCC-CCCCHHHHHHH
Q 012053 169 HTTCGTPAYVAPEVINR---RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFP-NWFAPEVRRLL 243 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~---~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~-~~~s~~l~~li 243 (472)
.+++|||+|||||++.. ..|+ -++||||||++.++|.-.++|+...+.+.....|..+. +.++ +.+|..+++|+
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hcccCCccccchhHheeccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 57899999999999853 3455 68999999999999999999999988886666666554 3333 33789999999
Q ss_pred hcccCCCCCCcCChhhhhcCcccccC
Q 012053 244 SKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
..||+.-|..|||.++++.|+|....
T Consensus 259 d~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHHHhhCcccCCcHHHHhhcchhccC
Confidence 99999999999999999999999764
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=325.85 Aligned_cols=245 Identities=27% Similarity=0.441 Sum_probs=213.5
Q ss_pred eeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEec
Q 012053 16 RLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYV 92 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (472)
+.||+|+||.||+|.+... +..||+|.+....... ..+.+.+|+.+++.++|+||+++++++.+...+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999999866 8999999997654322 4678899999999999999999999999999999999999
Q ss_pred CCCcccchhcc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 93 KGGELFGKVAK----------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 93 ~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
++++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999864 56899999999999999999999999999999999999999999999999998876543
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
..........+++.|+|||.+....+ +.++||||||+++|+|++ |..||...........+... ....|..+++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 21122334567889999999877655 489999999999999999 69999998887777777654 3456778899999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012053 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+++.+||..+|.+|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=333.88 Aligned_cols=254 Identities=23% Similarity=0.440 Sum_probs=213.6
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKT-----GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMA 80 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (472)
+-.++|++.+.||+|+||.||++.+... ...+|+|.+..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4457899999999999999999998644 37899999875432 23346688999999999 7999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD 143 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld 143 (472)
.+..+|++|||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 99999999999999999888742 4688999999999999999999999999999999999999
Q ss_pred CCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHH
Q 012053 144 EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYR 222 (472)
Q Consensus 144 ~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~ 222 (472)
.++.+||+|||++................++..|+|||++.+..++ .++|||||||++|+|++ |..||......+.+.
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999998865432211111223356789999998766654 78999999999999997 999999888777777
Q ss_pred HHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 223 KIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 223 ~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+.... ...+...+.++.+|+.+||..||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 665543 34566688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.60 Aligned_cols=250 Identities=30% Similarity=0.595 Sum_probs=212.1
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||.|+||.||+|++..+++.+|||.+.............+.+|+.+++.++||||+++++++..++..|++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999987654444445577889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 90 EYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
||++|++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999888752 4689999999999999999999999999999999999999999999999999876543221
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH--HHHHHHHhccCCC-C-CCCCCHHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL--MEMYRKIGKAEFK-F-PNWFAPEVR 240 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~--~~~~~~i~~~~~~-~-~~~~s~~l~ 240 (472)
.....+|++.|+|||.+.+..+. .++|+||||+++|+|++|..||..... ......+...... . +..+++++.
T Consensus 162 --~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 162 --AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred --ccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 22345789999999999776654 789999999999999999999975433 3444444333222 2 235788999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012053 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++|.+||..||++|||+.+|++
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=331.01 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=210.8
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--KTKIYF 87 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 87 (472)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 579999999999999999999999999999999875532 2345678999999999999999999998854 447999
Q ss_pred EEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 88 VMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 88 V~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
||||++|++|.+++. .+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 999999999987653 246899999999999999999999999999999999999999999999999998754332
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC-----cHHHHHHHHhccC-CCCC----
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-----NLMEMYRKIGKAE-FKFP---- 232 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~-----~~~~~~~~i~~~~-~~~~---- 232 (472)
. .....++..|+|||.+.+..++ .++||||||+++|+|++|..||... ...+....+.... ...+
T Consensus 159 ~----~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 L----AGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred c----cccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 2 1234678899999998776665 7899999999999999999999865 2233333333311 1111
Q ss_pred --CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 233 --NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 233 --~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
..+++++.++|.+||..+|.+|||+.|++.||||++..
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 12467899999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=342.95 Aligned_cols=262 Identities=29% Similarity=0.428 Sum_probs=215.3
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC--
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASK-- 82 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~-- 82 (472)
..+.++|++.+.||+|+||.||+|.+..+|+.+|+|.+.+..... .....+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 356789999999999999999999999899999999986543221 2345677899999999 999999999998643
Q ss_pred CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 83 TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
...|+||||+. ++|...+..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 46899999997 48988887778899999999999999999999999999999999999999999999999998865433
Q ss_pred cCC---CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-----------
Q 012053 163 HQD---GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE----------- 228 (472)
Q Consensus 163 ~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~----------- 228 (472)
... .......||+.|+|||++.+....+.++||||||+++|+|++|+.||..........++....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 221 223345689999999988665555689999999999999999999998765544333321110
Q ss_pred --------------------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 229 --------------------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 229 --------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
....+.++.++.++|.+||+.||++|||+.++++||||++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 01112368899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=339.12 Aligned_cols=258 Identities=29% Similarity=0.463 Sum_probs=213.1
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-KTKIY 86 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~ 86 (472)
+.++|++++.||.|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 56799999999999999999999999999999999865432 22345678899999999999999999999865 56889
Q ss_pred EEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 87 FVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
++|||+ +++|...+..+++++..+..++.||+.||.|||++||+||||+|.||+++.++.++|+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160 (328)
T ss_pred EEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence 999998 56888888878899999999999999999999999999999999999999999999999999875422
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc--------------------
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK-------------------- 226 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~-------------------- 226 (472)
......+++.|+|||++.+....+.++||||||+++|+|++|..||...+....+..+.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 123456788999999886644445899999999999999999999987654322211110
Q ss_pred ------cCCCC-----CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCCC
Q 012053 227 ------AEFKF-----PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVK 272 (472)
Q Consensus 227 ------~~~~~-----~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~~ 272 (472)
..... .+.+++++.++|.+||+.+|++|||+++++.||||.....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00011 13467899999999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=326.97 Aligned_cols=246 Identities=26% Similarity=0.461 Sum_probs=209.3
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+.|++.+.||+|+||.||++.+. ++..+|+|.+...... .+.+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 56999999999999999999875 4568999998654322 356888999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-S 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-c
Confidence 99999999998864 56899999999999999999999999999999999999999999999999988754321111 0
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~ 245 (472)
.....++..|+|||++.+..+. .++|+||||+++|+|++ |+.||...+..+....+..+. ...|...+.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1122345689999998776654 79999999999999999 999999888877777776653 33456678899999999
Q ss_pred ccCCCCCCcCChhhhhc
Q 012053 246 ILDPNPNTRISMTKIME 262 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~ 262 (472)
||..+|.+|||++++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=330.11 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=206.4
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe------CC
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGM--SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS------KT 83 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 83 (472)
|.+++.||+|+||.||+|.+..++. .+|+|.+..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999877765 699999865432 22445778899999999999999999998632 23
Q ss_pred EEEEEEEecCCCcccchhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 84 KIYFVMEYVKGGELFGKVAK-------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
..+++|||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999877631 34889999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCC
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNW 234 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~ 234 (472)
................+++.|+|||.+.+..+. .++||||||+++|+|++ |..||........+..+..+. ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 865432211111233567789999998776654 79999999999999999 899998877777777776554 345666
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++..+.++|.+||+.||.+|||+.+|+++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=325.51 Aligned_cols=250 Identities=30% Similarity=0.584 Sum_probs=212.7
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999987654444444678899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 90 EYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 90 E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
||+++++|.+++.. ..+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999888742 4589999999999999999999999999999999999999999999999999875543221
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc--HHHHHHHHhccCC-CCCC-CCCHHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN--LMEMYRKIGKAEF-KFPN-WFAPEVR 240 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~--~~~~~~~i~~~~~-~~~~-~~s~~l~ 240 (472)
......|++.|+|||.+.+..+. .++|+||||+++|+|++|..||.... .......+..+.. ..|. .++.++.
T Consensus 162 --~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 162 --AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred --ccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 12345789999999999877665 78999999999999999999996543 3344444443322 3343 5788999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012053 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++|.+||.++|++|||+.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=325.81 Aligned_cols=246 Identities=40% Similarity=0.757 Sum_probs=221.4
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012053 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||.|+||.||.+.+..+++.+|+|++.+.........+.+.+|+.+++.++||||+++++.+..+..+|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999889999999999887655545667899999999999999999999999999999999999999999
Q ss_pred cchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCc
Q 012053 98 FGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176 (472)
Q Consensus 98 ~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 176 (472)
.+++.. +.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 999876 479999999999999999999999999999999999999999999999999987654322 12344578999
Q ss_pred ccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCC
Q 012053 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRIS 256 (472)
Q Consensus 177 Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt 256 (472)
|+|||...+... +.++|+||||+++|++++|..||...+....+..+......+|..++.++.++|.+||..||+.|||
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999876654 4789999999999999999999988887777888877778888889999999999999999999999
Q ss_pred h---hhhhcCccc
Q 012053 257 M---TKIMENSWF 266 (472)
Q Consensus 257 ~---~eil~hp~f 266 (472)
+ .++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 899999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=371.08 Aligned_cols=253 Identities=27% Similarity=0.457 Sum_probs=206.8
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++++.||+|+||.||+|.+..+|+.||+|++...........+++.+|+.+++.++||||+++++++.+++..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 47999999999999999999999999999999999765433334557789999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 89 MEYVKGGELFGKVAK------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
|||++|++|.+++.. ..++...+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999887742 23456778899999999999999999999999999999999999999999999
Q ss_pred hhhhcccCC----------------CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHH
Q 012053 157 ALAESKHQD----------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM 220 (472)
Q Consensus 157 ~~~~~~~~~----------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~ 220 (472)
......... ......+||+.|+|||++.+..++ .++|||||||++|+|+||..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 765211100 011234799999999999877664 899999999999999999999987554433
Q ss_pred HHH-HhccCCCC--CCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 221 YRK-IGKAEFKF--PNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 221 ~~~-i~~~~~~~--~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
... ........ ...+++.+.+++.+||..||++|++..+.+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 222 11111111 1347889999999999999999987665543
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=363.89 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=197.5
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCC-CcEEEEEEe--------------ecccccchhhHHHHHHHHHHHHhcCC
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKT-GMSVAIKII--------------DKEKVLKVGMIDQIKREISVMRLVRH 69 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i--------------~~~~~~~~~~~~~~~~Ei~il~~l~h 69 (472)
+..+.++|++++.||+|+||+||+|..+.. +...+.|.+ .+...........+.+|+.+|+.++|
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 345678999999999999999999876543 233333311 11111112334568899999999999
Q ss_pred CCeeeEEEEEEeCCEEEEEEEecCCCcccchhccC------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q 012053 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKG------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD 143 (472)
Q Consensus 70 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld 143 (472)
|||+++++++...+..|+|+|++. ++|..++..+ ......++.++.||+.||.|||++||+||||||+|||++
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999999999999999999999985 4666665432 344677889999999999999999999999999999999
Q ss_pred CCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCC-CCCC--cHHHH
Q 012053 144 EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLP-FHDS--NLMEM 220 (472)
Q Consensus 144 ~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~P-f~~~--~~~~~ 220 (472)
.++.+||+|||++........ ......+||+.|+|||++.+..+. .++|||||||++|+|++|..+ |... .....
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999999986543222 122346799999999999887775 789999999999999998754 4332 11111
Q ss_pred HHHHhcc----CCCCC----------------------------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 221 YRKIGKA----EFKFP----------------------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 221 ~~~i~~~----~~~~~----------------------------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+.++... ...+| ..++.++.++|.+||..||++|||+.|+|+||||..
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 1111110 00010 124567888899999999999999999999999976
Q ss_pred C
Q 012053 269 G 269 (472)
Q Consensus 269 ~ 269 (472)
.
T Consensus 460 ~ 460 (501)
T PHA03210 460 E 460 (501)
T ss_pred C
Confidence 4
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=348.62 Aligned_cols=256 Identities=32% Similarity=0.593 Sum_probs=221.0
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
-|..++.||-|+||+|.+++...|...+|+|.+.+..+.....+..++.|-.||..-..+-||+||..|.+++.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 47889999999999999999999999999999999888877788899999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC-----
Q 012053 91 YVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ----- 164 (472)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~----- 164 (472)
|++||++..++.+ |-|.|+.++.|+..|.+|+++.|..|+|||||||+|||||.+|++||+||||++-+.....
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 9999999887755 8899999999999999999999999999999999999999999999999999874332110
Q ss_pred -------CC----------------------------cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCC
Q 012053 165 -------DG----------------------------LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGY 209 (472)
Q Consensus 165 -------~~----------------------------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~ 209 (472)
+. ..+..+||+.|+|||++...+|. ..+|.||.|||||+|+.|+
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhCC
Confidence 00 01223599999999999999987 7899999999999999999
Q ss_pred CCCCCCcHHHHHHHHhcc----CCCCCCCCCHHHHHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012053 210 LPFHDSNLMEMYRKIGKA----EFKFPNWFAPEVRRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 210 ~Pf~~~~~~~~~~~i~~~----~~~~~~~~s~~l~~li~~~L~~dP~~Rpt---~~eil~hp~f~~ 268 (472)
.||.+....+...++.+- .+.....+++++.++|.++. -+++.|.. .++|..||||+.
T Consensus 869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 999988776655555432 23444568999999998854 46778874 567999999985
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=333.47 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=209.7
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCC----------------cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTG----------------MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g----------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 71 (472)
-.++|++++.||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCC
Confidence 4578999999999999999999876544 56899998765322 44678899999999999999
Q ss_pred eeeEEEEEEeCCEEEEEEEecCCCcccchhccC------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 012053 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAKG------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPEN 139 (472)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~N 139 (472)
|+++++++..+...+++|||+.+++|.+++... .+++..++.++.|++.||.|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 999999999999999999999999999888542 58999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc--CCCCCCCCcH
Q 012053 140 LLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA--GYLPFHDSNL 217 (472)
Q Consensus 140 ILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt--G~~Pf~~~~~ 217 (472)
|+++.++.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999876533222222234456788999999876555 489999999999999998 7889987666
Q ss_pred HHHHHHHhcc--------CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 218 MEMYRKIGKA--------EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 218 ~~~~~~i~~~--------~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.......... ....+..++.++.++|.+||+.||.+|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 5555544322 12334557899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=335.61 Aligned_cols=260 Identities=30% Similarity=0.489 Sum_probs=208.5
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--- 81 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 81 (472)
|-...++|++.+.||.|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred CCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 3445789999999999999999999999999999999986543221 223456789999999999999999998743
Q ss_pred -----CCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCc
Q 012053 82 -----KTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 82 -----~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFG 154 (472)
...+|+||||+.+ +|...+.. ..+++..++.++.||+.||.|||++||+||||||+||++++++.++|+|||
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 3357999999965 56555543 479999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccCC---------CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHh
Q 012053 155 LSALAESKHQD---------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG 225 (472)
Q Consensus 155 la~~~~~~~~~---------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~ 225 (472)
++......... .......|++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 98765432211 111234578899999998665445588999999999999999999998877665555442
Q ss_pred ccCC-----------------------CCC-------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 226 KAEF-----------------------KFP-------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 226 ~~~~-----------------------~~~-------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
.... ..+ ..+++++.++|.+||..||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 2100 000 1244678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=349.74 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=207.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKT-----GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMA 80 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 80 (472)
+-.++|++++.||+|+||.||+|.+... +..||||++..... ....+.+.+|+.+|+.++ ||||+++++++.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3466888999999999999999987533 35799999965432 234567889999999996 999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc---------------------------------------------------------
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAK--------------------------------------------------------- 103 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~--------------------------------------------------------- 103 (472)
....+|+||||+++|+|.+++..
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999877642
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q 012053 104 ----------------------------------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD 143 (472)
Q Consensus 104 ----------------------------------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld 143 (472)
..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 1377888899999999999999999999999999999999
Q ss_pred CCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH-HHH
Q 012053 144 EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM-EMY 221 (472)
Q Consensus 144 ~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~-~~~ 221 (472)
.++.+||+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||...... ..+
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 9999999999998765432222122334577889999998776654 89999999999999997 99999875443 333
Q ss_pred HHHhcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 222 RKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 222 ~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..+... ....+..+++++.+++.+||..||++|||+.++.+.
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 344333 344556688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=355.35 Aligned_cols=244 Identities=36% Similarity=0.601 Sum_probs=216.8
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 86 (472)
..+.|++...+|.|+|+.|..+.+..+++..++|++.++.. ...+|+.++... +||||+++++++.++.+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 45689999999999999999999999999999999987732 234677666554 7999999999999999999
Q ss_pred EEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-cCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL-DEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl-d~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+|||.+.|+.|.+.+...+....++..|+.+|+.|+.|||++||+||||||+|||+ ++.|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 99999999999999987666558888999999999999999999999999999999 69999999999998865432
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhccCCCCCCCCCHHHHHHHh
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~s~~l~~li~ 244 (472)
..+.|-|..|+|||++...+|+ .++|+||||++||+||+|+.||...... ++..++..+.+. .++|.++++||+
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQ 544 (612)
T ss_pred --hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHH
Confidence 4567889999999999988887 8999999999999999999999875444 777777666555 889999999999
Q ss_pred cccCCCCCCcCChhhhhcCccc
Q 012053 245 KILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+||+.||.+|+++.+++.||||
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=347.71 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=208.6
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 87 (472)
...|++++.||.||.++||++... +...+|+|.+.... .+...+.-+.+||..|..|+ |.+||+||+|-..++.+|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 447999999999999999999974 44556666554332 24467888999999999995 9999999999999999999
Q ss_pred EEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 88 VMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
||||- ..+|..++.++ -++...++.|..|++.|+.++|.+||||.||||.|+|+ -.|.+||+|||+|..+......
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccc
Confidence 99986 45899998764 34445899999999999999999999999999999988 4679999999999987766555
Q ss_pred CcccccCCCCcccChhhhcccCC----------CCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHhcc--CCCCC
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGY----------DGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIGKA--EFKFP 232 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~----------~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~--~~~~~ 232 (472)
-.-.+.+||+.||+||.+....+ .+.++||||||||||+|+.|+.||..-. ...-+..|... .+.+|
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 55567799999999999854333 2578999999999999999999997643 33333334333 23566
Q ss_pred CCCCH-HHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 233 NWFAP-EVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 ~~~s~-~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..-+. ++.++++.||..||++|||+.++|+|||++-
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 54443 3999999999999999999999999999974
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=331.60 Aligned_cols=257 Identities=30% Similarity=0.582 Sum_probs=216.8
Q ss_pred CEEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVL-KVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (472)
.|++.+.||.|+||.||+|.+. .+|+.||+|++...... .....+.+.+|+.+++.+ +||||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999985 47899999999764332 223356788999999999 599999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++|++||||+|+|||++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 999999999999998865 6799999999999999999999999999999999999999999999999999876543221
Q ss_pred CCcccccCCCCcccChhhhccc-CCCCCcccchhhhHHHHHHhcCCCCCCCC----cHHHHHHHHhccCCCCCCCCCHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCGVILYVLLAGYLPFHDS----NLMEMYRKIGKAEFKFPNWFAPEV 239 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~lltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~l 239 (472)
.......|+..|+|||.+... ...+.++||||||+++|+|++|..||... ........+......+|..+++.+
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 161 -ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred -cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 122346789999999998643 23357899999999999999999999643 233444455555566777789999
Q ss_pred HHHHhcccCCCCCCcC-----ChhhhhcCccccc
Q 012053 240 RRLLSKILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
.+++.+||..||++|| ++.+++.||||++
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 9999999999999997 8899999999976
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=330.10 Aligned_cols=252 Identities=35% Similarity=0.544 Sum_probs=210.9
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CEEEEEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TKIYFVM 89 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 89 (472)
|++.+.||+|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.++|||++++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998764 2223446788999999999999999999999888 8999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++|++|+||||+||++++++.++|+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 78877765 4799999999999999999999999999999999999999999999999999876644321 11
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC------------------
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF------------------ 229 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~------------------ 229 (472)
.....++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23446788999999876654456899999999999999999999988776555444432100
Q ss_pred -----C--------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 230 -----K--------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 230 -----~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
. +...+++++.++|.+||..+|.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0 011137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=328.55 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=210.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGM----SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
+...+|++++.||+|+||+||+|.+..+|+ .||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 345689999999999999999999887776 489999865432 23456788999999999999999999998754
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
..++++||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 57899999999999998864 469999999999999999999999999999999999999999999999999988654
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
............+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+... ....+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence 32221111223456789999999777665 79999999999999998 99999877666655555443 33455668999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.++|.+||..||+.||++.++++.
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=326.16 Aligned_cols=247 Identities=28% Similarity=0.470 Sum_probs=208.7
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.+|++.+.||+|+||.||+|.+. ++..+|+|++.+.... .+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999885 5678999998654322 246778999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||++|++|.+++.. +.+++..++.++.||+.|+.|||++|++||||||+||+++.++.+||+|||++......... .
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence 99999999998864 46899999999999999999999999999999999999999999999999998754322111 0
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~ 245 (472)
.....++..|+|||.+.+..+. .++||||||+++|+|++ |..||...+..+....+... ....|...++++.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1111234579999998776664 78999999999999999 89999887777766666554 345566689999999999
Q ss_pred ccCCCCCCcCChhhhhcC
Q 012053 246 ILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h 263 (472)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=333.67 Aligned_cols=254 Identities=27% Similarity=0.490 Sum_probs=216.0
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
|+-...||+|+||.||++.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 334468999999999999999999999999985432 23456788999999999999999999999999999999999
Q ss_pred cCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccccc
Q 012053 92 VKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT 171 (472)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~ 171 (472)
+++++|.+++..+++++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ .....
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 9999999988878899999999999999999999999999999999999999999999999998765433221 12345
Q ss_pred CCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---CCCCCCCCHHHHHHHhcccC
Q 012053 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 172 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~l~~li~~~L~ 248 (472)
.|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+.... ......+++.+.+++.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 68999999999876555 479999999999999999999998876655544443322 22334578999999999999
Q ss_pred CCCCCcCChhhhhcCcccccCCC
Q 012053 249 PNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 249 ~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
.||.+||++.++++||||.+...
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCC
Confidence 99999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=334.31 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=211.5
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYE 77 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 77 (472)
+..+..++|++.+.||+|+||.||+|.+. .++..||+|.+..... ....+.+.+|+.+++++ +||||+++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 34566779999999999999999999752 3456899999865432 23456789999999999 7999999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCc
Q 012053 78 VMASKTKIYFVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFG 154 (472)
++...+..|++|||+.+++|.+++... .+++.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999999999988642 38999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc--CCCC
Q 012053 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA--EFKF 231 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~--~~~~ 231 (472)
++................+++.|+|||.+....+. .++||||+||++|+|++ |..||........+.+.... ....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 98755432211111223467789999998776654 79999999999999998 99999876655444333322 2334
Q ss_pred CCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 232 PNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 232 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+...++++.+++.+||.++|++|||+.+++..
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 56688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=340.30 Aligned_cols=261 Identities=26% Similarity=0.370 Sum_probs=213.3
Q ss_pred ccCCEEE-EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchh-----------hHHHHHHHHHHHHhcCCCCeeeE
Q 012053 8 LMQRYEL-GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG-----------MIDQIKREISVMRLVRHPNVVEL 75 (472)
Q Consensus 8 l~~~y~i-~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~l 75 (472)
+.+||.. .+.||.|+||+||+|.+..+++.||+|.+......... ....+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 5678875 57799999999999999999999999998654322100 11247789999999999999999
Q ss_pred EEEEEeCCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCc
Q 012053 76 YEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFG 154 (472)
++++..++..|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999996 588888765 579999999999999999999999999999999999999999999999999
Q ss_pred chhhhhccc------------CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHH
Q 012053 155 LSALAESKH------------QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR 222 (472)
Q Consensus 155 la~~~~~~~------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~ 222 (472)
++....... .........+++.|+|||.+.+....+.++|+|||||++|+|++|..||...+..+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 987654111 01112334578899999998765555689999999999999999999998877665544
Q ss_pred HHhccC-----C-----------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 223 KIGKAE-----F-----------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 223 ~i~~~~-----~-----------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+.... . ......+.++.++|.+||+.+|.+|||+++++.||||+..
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 432210 0 0012357889999999999999999999999999999864
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=325.10 Aligned_cols=249 Identities=22% Similarity=0.406 Sum_probs=210.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-.++|++++.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 45678999999999999999999864 567899999865432 2467889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 87 FVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
++|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999998854 468999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
.. ......++..|+|||.+....+ +.++|||||||++|+|++ |..||...........+... ....+..++.++.+
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05072 158 YT-AREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD 235 (261)
T ss_pred ee-ccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11 1122345678999999876655 478999999999999998 99999887776666666543 23334557899999
Q ss_pred HHhcccCCCCCCcCChhhhhc
Q 012053 242 LLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (472)
++.+||..+|++|||++++++
T Consensus 236 li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 236 IMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=327.84 Aligned_cols=247 Identities=24% Similarity=0.429 Sum_probs=213.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
..+|++++.||.|+||.||+|.+.. +..+|+|.+..... .....+.+|+.+++.++||||+++++++......|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4579999999999999999999977 89999999876542 2346788999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 89 MEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|||+++++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999999864 46899999999999999999999999999999999999999999999999998765332111
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHH
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLL 243 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li 243 (472)
.....++..|+|||.+....+. .++||||||+++|+|++ |..||...+..+.+..+... ....+..+++++.++|
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 1233456789999998776654 78999999999999998 89999888777777766543 3455667899999999
Q ss_pred hcccCCCCCCcCChhhhhc
Q 012053 244 SKILDPNPNTRISMTKIME 262 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~ 262 (472)
.+||..||.+|||+.+|++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=332.38 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=207.3
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGM--SVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 86 (472)
++|++.+.||+|+||.||+|.+..++. .+++|.+.... .....+.+.+|+.++.++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999877765 46888875322 223346788999999998 7999999999999999999
Q ss_pred EEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeE
Q 012053 87 FVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vk 149 (472)
++|||+++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 99999999999888753 2488899999999999999999999999999999999999999999
Q ss_pred EecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC
Q 012053 150 VSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE 228 (472)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~ 228 (472)
|+|||++........ ......+..|+|||++....+. .++|||||||++|+|++ |..||..........++....
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999864321111 1112234579999998776654 79999999999999997 999999888777777765542
Q ss_pred -CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 229 -FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 229 -~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
...|..+++++.+||.+||..+|.+|||+++|++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34566689999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=331.23 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=211.6
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
.++|.+.+.||+|+||.||+|.+.. ++..+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4579999999999999999998643 456799999864432 23467889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 012053 84 KIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG 146 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g 146 (472)
..++||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999998853 2378999999999999999999999999999999999999999
Q ss_pred CeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHh
Q 012053 147 NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIG 225 (472)
Q Consensus 147 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~ 225 (472)
.++|+|||++................+++.|+|||.+.+..+. .++||||||+++|+|++ |..||...+..+....+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999998755432221122344578899999998776654 78999999999999998 999998887777776666
Q ss_pred ccCC-CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 226 KAEF-KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 226 ~~~~-~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+.. ..+..++..+.+++.+||..||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5543 3455678999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=325.91 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=208.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++.+.||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+.+++.++||||+++++.+. ....|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 4567999999999999999999988655 4699999876443 2356889999999999999999999875 45689
Q ss_pred EEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 87 FVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+||||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999864 358999999999999999999999999999999999999999999999999987554322
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
. .......++..|+|||+..+..++ .++||||||+++|+|++ |..||.+.........+... ....+..++..+.+
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 157 Y-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 234 (262)
T ss_pred c-ccccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHH
Confidence 1 111233466789999998766664 89999999999999999 89999887776666666443 23445668899999
Q ss_pred HHhcccCCCCCCcCChhhhhc
Q 012053 242 LLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (472)
+|.+||.+||++|||+.++++
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=330.90 Aligned_cols=250 Identities=23% Similarity=0.399 Sum_probs=208.7
Q ss_pred CEEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 235799998865432 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012053 86 YFVMEYVKGGELFGKVAK-------------------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NI 140 (472)
|++|||+.+++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999887643 2478899999999999999999999999999999999
Q ss_pred EEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH
Q 012053 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~ 219 (472)
|+++++.+||+|||++...............+++..|+|||.+.+..+. .++||||||+++++|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999998755332221112234567789999998766554 88999999999999998 999998887777
Q ss_pred HHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 220 MYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....+... ....+..++.++.+++.+||+++|++||+++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~ 282 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 66655543 344566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=333.40 Aligned_cols=255 Identities=23% Similarity=0.426 Sum_probs=211.9
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLK-------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYE 77 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 77 (472)
.+..++|.+++.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3456799999999999999999998642 345799999865432 23456788999999999 6999999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012053 78 VMASKTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NI 140 (472)
++...+.+|++|||+.+|+|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 99999999999999999999988853 2478899999999999999999999999999999999
Q ss_pred EEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH
Q 012053 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~ 219 (472)
|++.++.+||+|||++................+++.|+|||++.+..+. .++||||||+++|+|++ |..||...+..+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999998765432211112223345689999998776554 79999999999999999 999998888777
Q ss_pred HHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 220 MYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+..+.... ...+..++.++.++|.+||..||++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 245 LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 777665543 34566688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=318.05 Aligned_cols=248 Identities=34% Similarity=0.575 Sum_probs=213.9
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|++.+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++||||+++++++......|+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999988999999999976543 345788999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 91 YVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 91 ~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 9999999998866 4799999999999999999999999999999999999999999999999999876654321 2
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-CCCCCCC--CCHHHHHHHhc
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-EFKFPNW--FAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~--~s~~l~~li~~ 245 (472)
....|+..|+|||.+....+ +.++|+||||+++|+|++|..||...+.......+... ....+.. ++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45578999999999876654 58899999999999999999999887544433333322 2222222 48899999999
Q ss_pred ccCCCCCCcCChhhhhcCcc
Q 012053 246 ILDPNPNTRISMTKIMENSW 265 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~ 265 (472)
||+.||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=362.40 Aligned_cols=246 Identities=32% Similarity=0.547 Sum_probs=206.8
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEE-EE---eC--
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEV-MA---SK-- 82 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~---~~-- 82 (472)
.+++|.+.|.+|||+.||+|.+...|..||+|.+-.. ++...+.+++||++|+.|+ |+|||.+++. .. .+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3788999999999999999999888899999997543 4566789999999999997 9999999993 21 11
Q ss_pred -CEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 83 -TKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRG--VCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~g--iiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
-.++|.||||.||.|-+++.. .+|+|.++++||.|+++||.+||... |||||||-|||||+.+|+.||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 257899999999999998864 57999999999999999999999997 999999999999999999999999988
Q ss_pred hhhhccc-CC-C--c---ccccCCCCcccChhhh---cccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc
Q 012053 157 ALAESKH-QD-G--L---LHTTCGTPAYVAPEVI---NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK 226 (472)
Q Consensus 157 ~~~~~~~-~~-~--~---~~~~~gt~~Y~aPE~l---~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~ 226 (472)
+-..... .. . . --...-|+.|+|||.+ .+.+. +.|+|||+|||+||-|+...+||++.... .|..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIln 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL----AILN 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEe
Confidence 6432211 00 0 0 0113469999999986 34455 48999999999999999999999887543 3677
Q ss_pred cCCCCCC--CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 227 AEFKFPN--WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 227 ~~~~~~~--~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.+.+|+ .++..+.+||+.||++||.+||++.+++.+
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 8888886 589999999999999999999999999874
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=324.11 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=210.2
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 34578999999999999999999974 457899999875432 2356889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 87 FVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
++|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999865 259999999999999999999999999999999999999999999999999988664221
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
... .....++..|+|||.+.+..+ +.++||||||+++|+|++ |+.||.+.+.......+... ....+...+..+.+
T Consensus 158 ~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 158 YEA-REGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYD 235 (261)
T ss_pred ccc-cCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 111 111223457999999876655 478999999999999999 99999887777766666544 23455668899999
Q ss_pred HHhcccCCCCCCcCChhhhhc
Q 012053 242 LLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (472)
++.+||..+|.+||++.+++.
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=322.70 Aligned_cols=250 Identities=27% Similarity=0.502 Sum_probs=219.7
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 6999999999999999999999999999999987654332 334567789999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 91 YVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 91 ~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999988755 56899999999999999999999999999999999999999999999999998876543
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHh
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLS 244 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~ 244 (472)
......|++.|+|||.+.+..+. .++|+||||+++++|++|+.||...+.......+....+ ..+..++.++++++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 22345689999999999776654 789999999999999999999998887776666655543 355568899999999
Q ss_pred cccCCCCCCcCChhhhhcCccc
Q 012053 245 KILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+||..+|++|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=329.72 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=211.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
+...+|++.+.||+|+||.||++... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 34568999999999999999999743 356789999876432 2345678999999999999999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH 145 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~ 145 (472)
.+..|++|||+.+++|.+++.. ..+++..++.++.||+.|+.|||++|++||||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 9999999999999999888754 247899999999999999999999999999999999999999
Q ss_pred CCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 012053 146 GNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKI 224 (472)
Q Consensus 146 g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i 224 (472)
+.++|+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...........+
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999998754322111112233457889999998877665 78999999999999998 99999887776666666
Q ss_pred hcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 225 GKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 225 ~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
... ....+..+++.+.++|.+||+.||.+||++++|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 544 34556678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=325.06 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=209.4
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++.+.||+|+||.||+|.+. ++..+|+|.+...... .+.+.+|+.+++.++||||+++++++. ....
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI 75 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence 356789999999999999999999875 6677999998765432 256889999999999999999999885 4568
Q ss_pred EEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 86 YFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|++|||+.+++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999999998864 35899999999999999999999999999999999999999999999999998765432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
... ......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.+..+....+... ....+...+..+.
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05070 156 EYT-ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLH 233 (260)
T ss_pred ccc-cccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 211 1112235567999999876655 479999999999999999 99999887777777766544 4456667889999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012053 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+++.+||.++|++|||++++.+
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=328.32 Aligned_cols=254 Identities=30% Similarity=0.540 Sum_probs=219.2
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..+.|++.+.||+|+||.||.|.+..++..||+|++..... ..+.+.+|+.+++.++|+||+++++++......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45679999999999999999999988899999999976542 34678899999999999999999999999999999
Q ss_pred EEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 88 VMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
++||++|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 99999999999999764 799999999999999999999999999999999999999999999999998875543221
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCC--CCCCCHHHHHH
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKF--PNWFAPEVRRL 242 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~--~~~~s~~l~~l 242 (472)
......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+.......+.... ... +..++.++.++
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 12344688999999998776654 78999999999999999999998877655544443322 222 23378899999
Q ss_pred HhcccCCCCCCcCChhhhhcCccccc
Q 012053 243 LSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
|.+||+.+|.+|||+.++++|+||.+
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=324.38 Aligned_cols=248 Identities=25% Similarity=0.425 Sum_probs=208.5
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.||+|+||.||+|.+. .+..+|+|.+...... .+.+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 357999999999999999999874 3456999998654322 35688999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.+++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999999999998864 46899999999999999999999999999999999999999999999999998754322111
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHh
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLS 244 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~ 244 (472)
......++..|+|||.+.+..+. .++||||||+++|+|++ |..||...+.......+.... ...+...++.+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 01112345679999999766654 78999999999999998 999998877766666665543 3345557899999999
Q ss_pred cccCCCCCCcCChhhhhcC
Q 012053 245 KILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~h 263 (472)
+||.+||.+|||+.+|+++
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=332.46 Aligned_cols=255 Identities=22% Similarity=0.430 Sum_probs=213.7
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLK-------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYE 77 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 77 (472)
.+..++|++.+.||+|+||.||+|++.. .+..||+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 4566799999999999999999997532 34579999986542 123456789999999999 8999999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012053 78 VMASKTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NI 140 (472)
++......|++|||+.+++|.+++.. ..++...+..++.||+.||.|||++|++||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 99999999999999999999988754 2467788999999999999999999999999999999
Q ss_pred EEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH
Q 012053 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~ 219 (472)
|++.++.+||+|||++................+++.|+|||++.+..++ .++||||||+++|+|++ |..||...+..+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 9999999999999998765432222222334567889999999776664 78999999999999998 889998888877
Q ss_pred HHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 220 MYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....+.... ...+..++.++.++|.+||.++|.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 777765443 34556688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=331.10 Aligned_cols=254 Identities=22% Similarity=0.398 Sum_probs=206.2
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV 88 (472)
+.|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...|++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4677889999999999999999999999999998765422 33467889999999986 99999999999999999999
Q ss_pred EEecCCC--cccchh---ccCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 89 MEYVKGG--ELFGKV---AKGKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 89 ~E~~~gg--~L~~~i---~~~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|||+.+. ++...+ ..+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 9998642 233332 135799999999999999999999975 9999999999999999999999999998765432
Q ss_pred cCCCcccccCCCCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCCCcH-HHHHHHHhccC-CCC----CCC
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHDSNL-MEMYRKIGKAE-FKF----PNW 234 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~~-~~~----~~~ 234 (472)
.. .....|++.|+|||++.+. ...+.++|||||||++|+|++|..||..... .+....+.... ... +..
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 21 2344689999999998765 2345799999999999999999999976542 22223332222 122 223
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+++++.+||.+||+.||++|||+++|+.||||+.
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 7889999999999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=327.63 Aligned_cols=251 Identities=27% Similarity=0.385 Sum_probs=202.1
Q ss_pred cCCE-EEEeeEcccCCeEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--
Q 012053 9 MQRY-ELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-- 81 (472)
Q Consensus 9 ~~~y-~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 81 (472)
.+|| ++.+.||+|+||+||++. ...++..||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4677 999999999999998865 335788999999875432 1234677899999999999999999998765
Q ss_pred CCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 82 KTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
...+|++|||+++++|.+++....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 34689999999999999999888899999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCC-cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH--HHH-------------HHHh
Q 012053 162 KHQDG-LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM--EMY-------------RKIG 225 (472)
Q Consensus 162 ~~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~--~~~-------------~~i~ 225 (472)
..... ......++..|+|||.+....+ +.++||||||+++|+|++|..||...... +.. ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 22111 1122345677999999876655 48999999999999999999998653211 100 0011
Q ss_pred c-cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 226 K-AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 226 ~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
. .....+..++.++.+++.+||.++|++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 122345667899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=338.83 Aligned_cols=257 Identities=30% Similarity=0.464 Sum_probs=216.0
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----EE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-----KI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 85 (472)
||++.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 79999999999999999999998999999999876432 1234567889999999999999999999987765 89
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|++|||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 478888866 5899999999999999999999999999999999999999999999999999886544321
Q ss_pred -CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC--------------
Q 012053 165 -DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-------------- 229 (472)
Q Consensus 165 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-------------- 229 (472)
........+|+.|+|||++.+....+.++|+||||+++|+|++|..||...+..+.+..+.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 01234456899999999998774455899999999999999999999988877665555432110
Q ss_pred -----------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 230 -----------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 230 -----------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
...+.+++++.++|.+||+.+|.+|||+.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0112367889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=337.57 Aligned_cols=254 Identities=20% Similarity=0.364 Sum_probs=204.0
Q ss_pred eeEccc--CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012053 16 RLLGQG--TFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 16 ~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
..||.| +||+||+|.+..+|+.||+|++....... ...+.+++|+.+++.++||||+++++++..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 99999999999999999999987654332 445789999999999999999999999999999999999999
Q ss_pred CCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC----
Q 012053 94 GGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG---- 166 (472)
Q Consensus 94 gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~---- 166 (472)
+++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999988864 358999999999999999999999999999999999999999999999998654332211110
Q ss_pred -cccccCCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---------------
Q 012053 167 -LLHTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF--------------- 229 (472)
Q Consensus 167 -~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~--------------- 229 (472)
......++..|+|||++.+.. ..+.++|||||||++|+|++|..||.................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011123566799999986532 235789999999999999999999987654433322221110
Q ss_pred --------------------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 230 --------------------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 230 --------------------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
..+..+++.+.+||++||..||++|||+.++++||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 01122567899999999999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=323.58 Aligned_cols=245 Identities=25% Similarity=0.372 Sum_probs=204.9
Q ss_pred eeEcccCCeEEEEEEE--cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012053 16 RLLGQGTFAKVHYARN--LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
+.||+|+||+||+|.+ ..++..+|+|++..... .....+.+.+|+.+++.++||||+++++++. ....++||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 3689999999999965 45788999999865432 2345678899999999999999999999885 456789999999
Q ss_pred CCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC-ccccc
Q 012053 94 GGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG-LLHTT 171 (472)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~-~~~~~ 171 (472)
+++|.+++.. +.+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++.......... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 9999998865 579999999999999999999999999999999999999999999999999987654322110 01223
Q ss_pred CCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhcccCC
Q 012053 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 172 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~ 249 (472)
.+++.|+|||.+....+ +.++|+|||||++|+|++ |..||.+.+.......+..+. ...|..+++++.++|.+||+.
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~ 237 (257)
T cd05116 159 KWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY 237 (257)
T ss_pred CCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence 44678999999876554 478999999999999998 999999887777777666543 466777999999999999999
Q ss_pred CCCCcCChhhhhcC
Q 012053 250 NPNTRISMTKIMEN 263 (472)
Q Consensus 250 dP~~Rpt~~eil~h 263 (472)
||++||++++|...
T Consensus 238 ~p~~Rp~~~~i~~~ 251 (257)
T cd05116 238 GVDERPGFAVVELR 251 (257)
T ss_pred CchhCcCHHHHHHH
Confidence 99999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=331.89 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=216.6
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
...|+..+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.++|||++++++++..++..|+|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 34588999999999999999999999999999999765444445567788999999999999999999999999999999
Q ss_pred EEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.| +|.+.+. .+++++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 999975 6666653 36799999999999999999999999999999999999999999999999998765432
Q ss_pred cccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-C-CCCCCHHHHHH
Q 012053 167 LLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-F-PNWFAPEVRRL 242 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~-~~~~s~~l~~l 242 (472)
.....|++.|+|||.+.. .+..+.++|||||||++|+|++|..||...+.......+...... . +..+++.++++
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 234578999999999742 233457899999999999999999999887766655555544322 2 23478899999
Q ss_pred HhcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 243 LSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
|.+||+.+|.+||++.++++|+|+.....
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 99999999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.07 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=207.3
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMS----VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
-.++|++++.||+|+||+||+|.+..+++. +++|.+.... .......+..|+.+++.++||||+++++++. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 356899999999999999999999887774 6677764322 1233467788888999999999999999875 45
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..++++||+++|+|.+++.. +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 67899999999999999864 5789999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEV 239 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l 239 (472)
...........++..|+|||.+.+..++ .++||||||+++|+|++ |..||.+.........+..+. ...+...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence 2222222344577889999998766654 89999999999999998 999998877666555554443 34455577899
Q ss_pred HHHHhcccCCCCCCcCChhhhhcC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+++.+|+..||++|||+.++++.
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=336.26 Aligned_cols=257 Identities=23% Similarity=0.425 Sum_probs=213.6
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeE
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKT-------GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVEL 75 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l 75 (472)
+.++...+|++++.||+|+||.||+|++... +..||+|.+.... .....+.+.+|+.+++++ +||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3456667899999999999999999987532 2368999886432 223457788999999999 79999999
Q ss_pred EEEEEeCCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 012053 76 YEVMASKTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPE 138 (472)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~ 138 (472)
++++...+.+|++|||+++|+|.+++.. ..++...+..++.||+.||.|||++|++||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 9999999999999999999999988753 13677889999999999999999999999999999
Q ss_pred cEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcH
Q 012053 139 NLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNL 217 (472)
Q Consensus 139 NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~ 217 (472)
|||++.++.+||+|||+++...............++..|+|||++.+..+. .++||||||+++|+|++ |..||...+.
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999998755432211112223345679999999776665 78999999999999998 8999998887
Q ss_pred HHHHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 218 MEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 218 ~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+.+..+.... ...+..++.++.++|.+||+.+|.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 77777665543 35566688999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=338.69 Aligned_cols=254 Identities=31% Similarity=0.479 Sum_probs=208.6
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
+.++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 46799999999999999999999999999999999875432 223345678999999999999999999998654
Q ss_pred -CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 83 -TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..+|+|+||+.. +|.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred CceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 357999999964 565543 34799999999999999999999999999999999999999999999999999875422
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--------------
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------- 227 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------- 227 (472)
. .....+|+.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 E-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred C-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 1 234567899999999876444558999999999999999999999887655444433221
Q ss_pred ---------CCCC--------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 ---------EFKF--------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---------~~~~--------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
...+ .+..++++.+||.+||+.||++|||+++++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000 12357789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=364.46 Aligned_cols=149 Identities=33% Similarity=0.656 Sum_probs=139.2
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++++.||.|+||+||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876555555667899999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
|||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999865 678999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.86 Aligned_cols=252 Identities=23% Similarity=0.389 Sum_probs=210.9
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGM---SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+.|++.+.||+|+||.||+|.+..+++ .||+|.+.... .......+.+|+.+++.++||||+++++++.++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999987665 69999986542 233457789999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||+.+++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999988864 568999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCcccccC---CCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012053 164 QDGLLHTTC---GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 164 ~~~~~~~~~---gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
......... .+..|+|||.+....+. .++|||||||++|++++ |..||...+.......+... ..+.+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 211111111 24579999999776664 78999999999999886 99999887777666666433 23445567899
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.+++.+||..+|.+||++.+|+..
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=340.26 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=205.6
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARN-----LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (472)
..-.+||++++.||+|+||+||+|.+ ..+++.||||++..... ......+.+|+.++..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 34457999999999999999999985 34678999999975432 23356788999999999 689999999987
Q ss_pred Ee-CCEEEEEEEecCCCcccchhcc-------------------------------------------------------
Q 012053 80 AS-KTKIYFVMEYVKGGELFGKVAK------------------------------------------------------- 103 (472)
Q Consensus 80 ~~-~~~~~lV~E~~~gg~L~~~i~~------------------------------------------------------- 103 (472)
.. +..+|++|||+++|+|.+++..
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 54 4578999999999999887743
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccc
Q 012053 104 -------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 104 -------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 1367788899999999999999999999999999999999999999999999876532221111223
Q ss_pred cCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH-HHHHHHhc-cCCCCCCCCCHHHHHHHhccc
Q 012053 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM-EMYRKIGK-AEFKFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 171 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~-~~~~~i~~-~~~~~~~~~s~~l~~li~~~L 247 (472)
..+++.|+|||++.+..+. .++||||||+++|+|++ |..||...... .....+.. .....|.+.++++.+++.+||
T Consensus 241 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl 319 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW 319 (343)
T ss_pred CCCCcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHc
Confidence 3456789999998776664 78999999999999996 99999775433 22333322 234566778899999999999
Q ss_pred CCCCCCcCChhhhhcC
Q 012053 248 DPNPNTRISMTKIMEN 263 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~h 263 (472)
..||++|||+.+|++|
T Consensus 320 ~~~p~~Rps~~eil~~ 335 (343)
T cd05103 320 HGEPSQRPTFSELVEH 335 (343)
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=330.33 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=213.9
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.+.|...+.||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.++|||++++++++.+....|+|
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34577888999999999999999999999999999765544444556788999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.| +|.+.+.. +.+++.++..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 100 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------ 172 (313)
T cd06633 100 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------ 172 (313)
T ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence 999964 67666643 578999999999999999999999999999999999999999999999999875422
Q ss_pred cccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-C-CCCCCCHHHHHH
Q 012053 167 LLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-K-FPNWFAPEVRRL 242 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~s~~l~~l 242 (472)
......|+..|+|||.+.. .+..+.++|||||||++|+|++|..||...+.......+..... . ....++..+++|
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 1234578999999999742 23345789999999999999999999988776555554443322 1 223467889999
Q ss_pred HhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 243 LSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+.+||+.+|.+||++.+++.||||+...
T Consensus 253 i~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 253 VDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.01 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=207.2
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 4567899999999999999999988554 4699998865432 2356788999999999999999999885 45689
Q ss_pred EEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 87 FVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
++|||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||++++++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999998864 248999999999999999999999999999999999999999999999999987653321
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
.. ......++..|+|||...+..+ +.++||||||+++|+|++ |..||.+....+....+... ....+..++..+.+
T Consensus 157 ~~-~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 157 YT-ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHE 234 (260)
T ss_pred cc-ccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 11 1122345678999999876655 489999999999999999 99999988777766666544 23456668899999
Q ss_pred HHhcccCCCCCCcCChhhhhc
Q 012053 242 LLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (472)
++++||.+||++||+++++++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=330.49 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=204.5
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCC--------------cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeee
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTG--------------MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVE 74 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g--------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 74 (472)
.++|++.+.||+|+||.||+|++..++ ..||+|.+.... .....+.+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 468999999999999999999875432 359999987543 2234567899999999999999999
Q ss_pred EEEEEEeCCEEEEEEEecCCCcccchhccC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 012053 75 LYEVMASKTKIYFVMEYVKGGELFGKVAKG-------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLL 141 (472)
Q Consensus 75 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-------------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NIL 141 (472)
+++++......|+||||+.+++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 999999999999999999999998887432 3688899999999999999999999999999999999
Q ss_pred EcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc--CCCCCCCCcHHH
Q 012053 142 LDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA--GYLPFHDSNLME 219 (472)
Q Consensus 142 ld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt--G~~Pf~~~~~~~ 219 (472)
++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ |..||...+...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999875432221111223345678999999876665 489999999999999988 778888766555
Q ss_pred HHHHHhc--------cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 220 MYRKIGK--------AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 220 ~~~~i~~--------~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
....+.. .....++.+++.+.+||.+||+.||++|||+++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4443321 112334557899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=321.25 Aligned_cols=260 Identities=32% Similarity=0.598 Sum_probs=231.4
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTK 84 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (472)
.+-.+.|++++.||+|+|++|.+++.+.|.+.+|+|+++++-+...+.++.+..|-.+..+- +||.+|-++.+|.++..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 35567899999999999999999999999999999999998888777888999999988664 79999999999999999
Q ss_pred EEEEEEecCCCcccchhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 85 IYFVMEYVKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+++|.||++||+|.-.+. .++++|+.++.|...|+.||.|||++||++||||.+|+|+|..|++||+|+|+++.-- .
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l--~ 403 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--G 403 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC--C
Confidence 999999999999965554 4789999999999999999999999999999999999999999999999999987432 2
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC-------CcH-HHHHHHHhccCCCCCCCC
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-------SNL-MEMYRKIGKAEFKFPNWF 235 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-------~~~-~~~~~~i~~~~~~~~~~~ 235 (472)
.....++.||||.|+|||++.+..| +...|.|+|||+++||++|+.||+- .+. .-+++-|......+|..+
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl 482 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL 482 (593)
T ss_pred CCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence 3345688999999999999998887 5999999999999999999999962 222 345666778889999999
Q ss_pred CHHHHHHHhcccCCCCCCcCC------hhhhhcCccccc
Q 012053 236 APEVRRLLSKILDPNPNTRIS------MTKIMENSWFRK 268 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt------~~eil~hp~f~~ 268 (472)
|-.+..+++..|.+||.+|.. ..++..|+||+.
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 999999999999999999984 579999999984
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=321.92 Aligned_cols=249 Identities=24% Similarity=0.416 Sum_probs=209.5
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..+.|++++.||+|+||.||+|.+ .+++.||+|.+...... ...+.+|+.+++.++||||+++++++. .+..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 35678999999999999999999986 46788999998765432 357889999999999999999999874 5678
Q ss_pred EEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 86 YFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|++|||+.+++|.+++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999999998754 46899999999999999999999999999999999999999999999999998765421
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
... ......++..|+|||.+....+ +.++||||||+++|++++ |.+||.+.+.......+... ....+...+.++.
T Consensus 156 ~~~-~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 156 EYT-AREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELY 233 (260)
T ss_pred Ccc-cccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 111 1122345678999999876655 478999999999999999 99999988777766666544 2345566889999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012053 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++|.+||..+|++|||++++++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.73 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=210.1
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGM---SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.++|++++.||+|+||.||+|.+..++. .+|+|.+..... ......+.+|+.+++.++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999875543 799999865432 23456789999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||+++++|.+++.. +.+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999999865 468999999999999999999999999999999999999999999999999988654322
Q ss_pred CCCc-ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012053 164 QDGL-LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 164 ~~~~-~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
.... .....++..|+|||.+.+..+ +.++|+||||+++|++++ |..||......+....+... ..+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 1110 111223568999999977665 489999999999999886 99999887766666666544 2344455789999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012053 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+++.+||+.+|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.70 Aligned_cols=252 Identities=21% Similarity=0.348 Sum_probs=204.5
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcC----------------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLK----------------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 71 (472)
..++|++.+.||+|+||+||++.+.. ++..||+|.+.... .......+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCC
Confidence 35689999999999999999986532 34579999986543 2234567889999999999999
Q ss_pred eeeEEEEEEeCCEEEEEEEecCCCcccchhccC------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 012053 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAKG------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPEN 139 (472)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~N 139 (472)
|+++++++......|+||||+.+++|.+++... .+++..+..++.||+.||+|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 999999999999999999999999999887542 36678899999999999999999999999999999
Q ss_pred EEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc--CCCCCCCCcH
Q 012053 140 LLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA--GYLPFHDSNL 217 (472)
Q Consensus 140 ILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt--G~~Pf~~~~~ 217 (472)
||++.++.++|+|||++................+++.|+|||......+ +.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999999875533221111223345678999998876655 489999999999999998 7899987665
Q ss_pred HHHHHHHh--------ccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 218 MEMYRKIG--------KAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 218 ~~~~~~i~--------~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.+...... ......+..+++.+.+|+.+||+.||++|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54443321 1122345567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=318.78 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=211.0
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 89 (472)
..+.+..||.|+.|.|++++.+.+|...|||.+.+.. +.+..+++...+.++-..+ .|+||+.+|+|..+..+++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3456788999999999999999999999999997664 2345677888888876665 899999999999999999999
Q ss_pred EecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 90 EYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 90 E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|.+.. -+..++. +++++|..+-++...++.||.||.++ ||+|||+||+|||+|+.|++||||||++........
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 98843 2333333 37899999999999999999999965 999999999999999999999999999876644332
Q ss_pred cccccCCCCcccChhhhccc---CCCCCcccchhhhHHHHHHhcCCCCCCCC-cHHHHHHHHhccCCCC-C--CCCCHHH
Q 012053 167 LLHTTCGTPAYVAPEVINRR---GYDGSKADIWSCGVILYVLLAGYLPFHDS-NLMEMYRKIGKAEFKF-P--NWFAPEV 239 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~---~~~~~~~DiwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~~~~~~~-~--~~~s~~l 239 (472)
.+...|.+.|||||.+... .|+ .++||||||++|+||.||+.||... ...+...++.+..++. | ..+|+.+
T Consensus 248 -htrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 248 -HTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDF 325 (391)
T ss_pred -cccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence 2456799999999998543 455 7899999999999999999999884 3457777777655433 2 2389999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
.+|+..||..|+.+||.+.++|+|||+....
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 9999999999999999999999999998643
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=323.96 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=212.6
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGM----SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
..++|++++.||+|+||+||+|.+..+|+ .+|+|.+..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45689999999999999999999877765 589998865542 2345678899999999999999999999987 7
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..++||||+.+|+|.+.+.. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 89999999999999998865 4699999999999999999999999999999999999999999999999999886543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEV 239 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l 239 (472)
...........++..|+|||.+....+. .++|+||||+++|++++ |..||......+....+.... ...|...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2221111122345689999998766554 79999999999999998 999999888777776666543 45666788999
Q ss_pred HHHHhcccCCCCCCcCChhhhhc
Q 012053 240 RRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.+++.+||..||+.|||+.++++
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=327.77 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=211.3
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
-.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45689999999999999999998753 678999999865432 23456788999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-----------------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPEN 139 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-----------------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~N 139 (472)
...|++|||+.+++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 999999999999999888753 137888899999999999999999999999999999
Q ss_pred EEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH
Q 012053 140 LLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM 218 (472)
Q Consensus 140 ILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~ 218 (472)
|+++.++.++|+|||++................+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998754322211111223456779999998776654 79999999999999997 88999887777
Q ss_pred HHHHHHhccCC-CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 219 EMYRKIGKAEF-KFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 219 ~~~~~i~~~~~-~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+....+..+.. ..+..++.++.+||.+||..||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77766665543 456678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=326.59 Aligned_cols=257 Identities=33% Similarity=0.586 Sum_probs=214.8
Q ss_pred CEEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVL-KVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKI 85 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (472)
+|++.+.||+|+||.||++.+. .+++.||||.+.+.... .....+.+.+|+.+++.+ +||||+++++.+..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999998765432 223456788999999999 599999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||||+.+++|.+.+.. +.+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 999999999999988865 6799999999999999999999999999999999999999999999999999876543221
Q ss_pred CCcccccCCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCCc----HHHHHHHHhccCCCCCCCCCHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDSN----LMEMYRKIGKAEFKFPNWFAPEV 239 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~l 239 (472)
......+|++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||.... ..+....+.......|..+++++
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 161 -ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred -cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 1123356899999999986543 24578999999999999999999996432 23344445555667777789999
Q ss_pred HHHHhcccCCCCCCcCC---hhhhhcCccccc
Q 012053 240 RRLLSKILDPNPNTRIS---MTKIMENSWFRK 268 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt---~~eil~hp~f~~ 268 (472)
.++|.+||+.||++||| +.++++||||+.
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~ 271 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence 99999999999999998 467799999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=316.49 Aligned_cols=252 Identities=28% Similarity=0.469 Sum_probs=206.0
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-----eCC
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA-----SKT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~ 83 (472)
.+||++.+.||+|||+.||++.+..+++.+|+|.+..... +..+...+|++..++++|||+++++++.. ...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4599999999999999999999999999999999977652 45678899999999999999999998752 334
Q ss_pred EEEEEEEecCCCcccchhcc----C-CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 84 KIYFVMEYVKGGELFGKVAK----G-KLKEDAARKYFQQLISAVDYCHSRG--VCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~----~-~l~e~~~~~i~~ql~~al~yLH~~g--iiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
..|+++.|...|+|.+.+.. | -++|.++..|+.+|++||++||+.. ++||||||.|||+.+.+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 59999999999999998853 3 6999999999999999999999998 999999999999999999999999988
Q ss_pred hhhhcccCCCc-------ccccCCCCcccChhhhcccCCC--CCcccchhhhHHHHHHhcCCCCCCCCcH--HHHHHHHh
Q 012053 157 ALAESKHQDGL-------LHTTCGTPAYVAPEVINRRGYD--GSKADIWSCGVILYVLLAGYLPFHDSNL--MEMYRKIG 225 (472)
Q Consensus 157 ~~~~~~~~~~~-------~~~~~gt~~Y~aPE~l~~~~~~--~~~~DiwSlGvil~~lltG~~Pf~~~~~--~~~~~~i~ 225 (472)
+...-.-..+. -.....|..|+|||.+.-+.+. +.++|||||||+||+|+.|.-||+..-. ..+.-.+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 75432211110 1122468999999998654332 5799999999999999999999953211 01111223
Q ss_pred ccCCCCCC--CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 226 KAEFKFPN--WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 226 ~~~~~~~~--~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+.+.+|. .+|..+.++|+.||+.||.+||++.+++.+
T Consensus 257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 44555553 389999999999999999999999999875
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=319.52 Aligned_cols=249 Identities=26% Similarity=0.422 Sum_probs=211.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++......|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 56789999999999999999999975 557899999876543 2357889999999999999999999999989999
Q ss_pred EEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 87 FVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+||||+++++|.+++.. ..+++..+..++.||+.|+.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999998865 368999999999999999999999999999999999999999999999999987654311
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
.. ......++..|+|||.+.+..+ +.++|+||||+++|+|++ |+.||.+.+.......+... ....+...+.++.+
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 158 YT-AREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235 (261)
T ss_pred hh-hhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11 0112234568999999876655 488999999999999998 99999887777777776554 34456667899999
Q ss_pred HHhcccCCCCCCcCChhhhhc
Q 012053 242 LLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (472)
++.+||..+|.+||+++++++
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=327.67 Aligned_cols=251 Identities=32% Similarity=0.511 Sum_probs=211.3
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
|++.+.||+|++|.||+|.+..+|+.+|+|.+...... ......+.+|+.+++.++||||+++++++..++..|+|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999998765432 23456788999999999999999999999999999999999
Q ss_pred cCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 92 VKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 92 ~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
+.+ +|.+.+.. +.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 975 77777755 489999999999999999999999999999999999999999999999999987654432 1223
Q ss_pred ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------------CC
Q 012053 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-------------------FK 230 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~~ 230 (472)
...++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+.+.++.... ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 34688899999998776445689999999999999999999998877665554442210 00
Q ss_pred -----------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 231 -----------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 231 -----------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
..+.++.++.++|.+||.+||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=318.90 Aligned_cols=244 Identities=26% Similarity=0.484 Sum_probs=210.8
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-.+.|++.+.||.|+||.||+|.+ .|+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 456899999999999999999987 589999999975532 35778899999999999999999999999999999
Q ss_pred EEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 88 VMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
||||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 99999999999998652 69999999999999999999999999999999999999999999999999987653211
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRL 242 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~l 242 (472)
....++..|+|||.+....+ +.++||||||++++++++ |..||...+.......+... ....+..+++++.++
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKV 231 (256)
T ss_pred ----ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHH
Confidence 12344667999999876555 478999999999999997 99999888777666655544 345566789999999
Q ss_pred HhcccCCCCCCcCChhhhhcC
Q 012053 243 LSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h 263 (472)
|.+||..+|++|||+.++++.
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HHHHhccChhhCcCHHHHHHH
Confidence 999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=325.24 Aligned_cols=247 Identities=31% Similarity=0.528 Sum_probs=203.5
Q ss_pred EEEeeEcccCCeEEEEEEEc----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 13 ELGRLLGQGTFAKVHYARNL----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.+.+.||.|+||.||+|... ..+..|+||.+.... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence 57899999999999999997 356789999995432 223468899999999999999999999999988889999
Q ss_pred EEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 89 MEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||+++|+|.+++... .+++.....++.||+.||.|||+++++|+||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999998764 7999999999999999999999999999999999999999999999999998766322111
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHH
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLL 243 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li 243 (472)
.......+...|+|||.+....+ +.++||||||+++||+++ |..||.+.+..+...++.... ...+..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 11233456778999999877665 489999999999999999 789999988887777775543 455667899999999
Q ss_pred hcccCCCCCCcCChhhhhc
Q 012053 244 SKILDPNPNTRISMTKIME 262 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~ 262 (472)
.+||..||.+|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=346.36 Aligned_cols=253 Identities=24% Similarity=0.417 Sum_probs=216.6
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
..|..+...++..||+|.||+||+|++-. .||||+++...... +.++.+++|+.+++.-+|-||+-+.|++..+..
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 45667778899999999999999999854 59999998877554 478999999999999999999999999988887
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|+.+|+|.+|+..+.- -+|.....+.|++||+.|+.|||.++|||||||..||+|.+++.|||+||||+....--
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 999999999999999864 57999999999999999999999999999999999999999999999999998865544
Q ss_pred cCCCcccccCCCCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-----CCCCC
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-----FPNWF 235 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~ 235 (472)
..+..+...-|...|||||++... ...++.+||||||+++|||+||.+||...+...++-.+.++... .-...
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~ 621 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC 621 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence 444456677789999999998543 23358999999999999999999999966666665555555321 12235
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+.++++|+..||..++++||.+.+||.
T Consensus 622 pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 622 PKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 669999999999999999999999987
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=319.22 Aligned_cols=242 Identities=29% Similarity=0.490 Sum_probs=206.8
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEE-EeCCEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVM-ASKTKIY 86 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~ 86 (472)
-+.+|++.+.||+|+||.||++.. .|..||+|.+.... ..+.+.+|+.+++.++|+|++++++++ ..++..|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 456899999999999999999976 58899999985432 245688999999999999999999975 5567899
Q ss_pred EEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 87 FVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
++|||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999999988642 48899999999999999999999999999999999999999999999999887543211
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
....++..|+|||++....+. .++|||||||++|+|++ |..||...+.......+... ....+..+++.+.+
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYD 230 (256)
T ss_pred -----CCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 233456789999998776654 78999999999999997 99999888777766666544 34456678999999
Q ss_pred HHhcccCCCCCCcCChhhhhc
Q 012053 242 LLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (472)
+|.+||..+|++|||+.++++
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=300.07 Aligned_cols=255 Identities=31% Similarity=0.526 Sum_probs=215.1
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.+|.-.++||+|+||+||+|+++.+++.||+|.++...- +++.-....+||.+|+.++|.|||+++++..++.++-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 467778999999999999999999999999999976653 2345567789999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|||. .+|..+... |.++.+.++.++.|++.||.|||++++.|||+||.|+|++.||.+|++|||+++-++.+-. -
T Consensus 81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr--c 157 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--C 157 (292)
T ss_pred HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE--e
Confidence 9995 467666654 7899999999999999999999999999999999999999999999999999997654321 1
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-------CC----CCCC--
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-------EF----KFPN-- 233 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-------~~----~~~~-- 233 (472)
.+..+-|.+|.+|.++.+...++...|+||-|||+.|+.. |++.|.+.+..+...+|-+. .+ .+|.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 3445679999999999988877789999999999999985 77778888877776666321 00 0111
Q ss_pred ----------------CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 234 ----------------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 234 ----------------~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.++..-++|+.++|.-+|.+|+++++.++||||..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 12345678999999999999999999999999975
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=342.62 Aligned_cols=255 Identities=23% Similarity=0.386 Sum_probs=209.0
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~ 79 (472)
.+-.++|.+++.||+|+||.||+|++. .+++.||+|++..... ......+.+|+.+|..+. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 455668999999999999999999964 3456899999975432 233457889999999997 99999999999
Q ss_pred EeCCEEEEEEEecCCCcccchhccC-------------------------------------------------------
Q 012053 80 ASKTKIYFVMEYVKGGELFGKVAKG------------------------------------------------------- 104 (472)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~------------------------------------------------------- 104 (472)
...+..|+||||+.+|+|.+++...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 9999999999999999998887431
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012053 105 --------------------------------------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 105 --------------------------------------------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NI 140 (472)
.+++..++.++.||+.||.|||++|++||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 256677889999999999999999999999999999
Q ss_pred EEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH
Q 012053 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~ 219 (472)
|++.++.+||+|||++................+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||......+
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 999999999999999876533221111223467889999999977665 488999999999999998 899998755444
Q ss_pred HH-HHHhcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 220 MY-RKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~-~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.. ..+..+ ....|..++.++.+++.+||..+|.+||++++|++.
T Consensus 350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33 333333 345667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=318.14 Aligned_cols=243 Identities=26% Similarity=0.388 Sum_probs=203.3
Q ss_pred eeEcccCCeEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEec
Q 012053 16 RLLGQGTFAKVHYARNLKTG---MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYV 92 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (472)
+.||+|+||.||+|.+..++ ..+|+|.+...... ...+.+.+|+.+++.++||||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876654 78999998766532 34567889999999999999999999876 45689999999
Q ss_pred CCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC-cccc
Q 012053 93 KGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG-LLHT 170 (472)
Q Consensus 93 ~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~-~~~~ 170 (472)
.+++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999976 469999999999999999999999999999999999999999999999999987654322110 0111
Q ss_pred cCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhcccC
Q 012053 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 171 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~ 248 (472)
..++..|+|||.+....+. .++||||||+++|+|++ |..||...+.......+.... ...|..+++.+.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 1234679999998766654 79999999999999998 999998877766666665443 45667789999999999999
Q ss_pred CCCCCcCChhhhhc
Q 012053 249 PNPNTRISMTKIME 262 (472)
Q Consensus 249 ~dP~~Rpt~~eil~ 262 (472)
++|++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=319.70 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=211.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGM---SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+..++|+..+.||+|+||.||+|.+..++. .+|+|.+..... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 345689999999999999999999876655 799999865432 233567889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..|+||||+++++|.+++.. +.+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999988854 5799999999999999999999999999999999999999999999999999875543
Q ss_pred ccCCCcc-cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012053 162 KHQDGLL-HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 162 ~~~~~~~-~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
....... .....++.|+|||++....++ .++|||||||++|+|++ |..||...+.......+... ..+.+..++.+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 238 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA 238 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2211111 111234579999998776664 89999999999999997 99999887777777666543 22334457899
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.+++.+||..+|+.||++.+|++.
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=318.36 Aligned_cols=243 Identities=26% Similarity=0.395 Sum_probs=202.0
Q ss_pred eEcccCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 17 LLGQGTFAKVHYARNL--KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++. ....|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999875 345679999986543 2234567899999999999999999999885 4578999999999
Q ss_pred Ccccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC-ccccc
Q 012053 95 GELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG-LLHTT 171 (472)
Q Consensus 95 g~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~-~~~~~ 171 (472)
++|.+++.. +.+++..+++++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999998853 579999999999999999999999999999999999999999999999999987554322111 01112
Q ss_pred CCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhcccCC
Q 012053 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 172 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~ 249 (472)
.+++.|+|||.+....+ +.++||||||+++|++++ |..||.+.........+..+ ...+|...++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 33578999999876665 478999999999999996 99999988777666666553 3566777899999999999999
Q ss_pred CCCCcCChhhhhcC
Q 012053 250 NPNTRISMTKIMEN 263 (472)
Q Consensus 250 dP~~Rpt~~eil~h 263 (472)
||++||++.+|.+.
T Consensus 238 ~~~~Rp~~~~i~~~ 251 (257)
T cd05115 238 KWEDRPNFAKVEER 251 (257)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=325.01 Aligned_cols=251 Identities=34% Similarity=0.541 Sum_probs=211.3
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999997654 2223456778899999999999999999999999999999999
Q ss_pred cCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 92 VKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 92 ~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
+. ++|.+++... .+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~ 156 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYT 156 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccC
Confidence 97 4899988764 799999999999999999999999999999999999999999999999999876543221 223
Q ss_pred ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc------------------CCCC
Q 012053 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------EFKF 231 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------~~~~ 231 (472)
...++..|+|||.+......+.++||||||+++++|++|..||...+....+.++... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 4456788999999876645568999999999999999999999887665554443210 0011
Q ss_pred C-----------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 232 P-----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 232 ~-----------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+ +.++.++.++|++||..||++||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1246789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=329.08 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=213.3
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
...+|+..+.||+|+||.||+|++..+++.+|+|.+.............+.+|+.+++.++|||++++++++......|+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 34568889999999999999999999999999999875443333445678899999999999999999999999999999
Q ss_pred EEEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 88 VMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
||||+. |+|.+.+. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 999996 46766653 35689999999999999999999999999999999999999999999999998875432
Q ss_pred CcccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-C-CCCCCCHHHHH
Q 012053 166 GLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-K-FPNWFAPEVRR 241 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~-~~~~~s~~l~~ 241 (472)
.....|++.|+|||.+.+ .+..+.++|||||||++|+|++|..||...+.......+..... . .+..++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 134568999999999752 22335789999999999999999999987665544444443332 2 23357889999
Q ss_pred HHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 242 LLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+|.+||..+|++||++.++++|||+...
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=321.91 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=210.6
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcC----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLK----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS- 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 81 (472)
+-.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345789999999999999999999876 36889999886432 23446778899999999999999999998755
Q ss_pred CCEEEEEEEecCCCcccchhcc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEec
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK---------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSD 152 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~D 152 (472)
+...++++||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5778999999999999888754 3588999999999999999999999999999999999999999999999
Q ss_pred CcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCC
Q 012053 153 FGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFK 230 (472)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~ 230 (472)
||+++...............++..|+|||++.+..+. .++||||||+++|++++ |..||...+..+....+..+ ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 9998754322111111223467789999999776654 88999999999999999 99999988777776665544 234
Q ss_pred CCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 231 FPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 231 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.+..+++++.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 45567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=322.70 Aligned_cols=249 Identities=31% Similarity=0.487 Sum_probs=205.5
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEeCCE----
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV---RHPNVVELYEVMASKTK---- 84 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 84 (472)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999988899999999975432 222334566788887766 59999999999987776
Q ss_pred -EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 85 -IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 85 -~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
+|++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 78777754 358999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-----CC-----
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-----FK----- 230 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-----~~----- 230 (472)
.... .....+++.|+|||++.+..+. .++|+||+||++|+|++|..||...+..+.+.++.... ..
T Consensus 159 ~~~~---~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FEMA---LTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CCcc---cccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 3221 2344578899999999776654 78999999999999999999998877666555543210 00
Q ss_pred ------C-----------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 231 ------F-----------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 231 ------~-----------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
+ .+.+++.+.++|.+||+.||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01245778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=321.95 Aligned_cols=252 Identities=30% Similarity=0.538 Sum_probs=212.6
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
||.+.+.||+|+||.||++.+..++..+++|++...... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 799999999999999999999888887888877543321 112334567899999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 89 MEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|||+++++|.+.+.. ..+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999887742 46999999999999999999999999999999999999975 569999999987653321
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRL 242 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~l 242 (472)
.......|++.|+|||.+.+..++ .++|+||||+++|+|++|..||..........++.... ...+..++.++.++
T Consensus 160 --~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 160 --DLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred --ccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 122345688999999998776665 78999999999999999999998877766666665443 34566688999999
Q ss_pred HhcccCCCCCCcCChhhhhcCccc
Q 012053 243 LSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=330.98 Aligned_cols=257 Identities=30% Similarity=0.428 Sum_probs=205.8
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCC--CcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe----CC
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKT--GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMAS----KT 83 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~ 83 (472)
+|++.+.||+|+||.||++++..+ +..||+|.+..... .......+.+|+.+++.+ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 699999999999999999999888 99999999864321 122345678899999998 59999999987533 25
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|+++||+. ++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999985 578887754 67999999999999999999999999999999999999999999999999998765432
Q ss_pred cC--CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------
Q 012053 163 HQ--DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------- 227 (472)
Q Consensus 163 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------- 227 (472)
.. ........||+.|+|||++.+....+.++||||||+++|+|++|..||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 21 112234578999999998765433458999999999999999999999876543332221110
Q ss_pred ---------------CCC---CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 ---------------EFK---FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---------------~~~---~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
... ..+..+..+.+++.+||+.||.+|||+.+++.||||++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 000 112257889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=320.14 Aligned_cols=242 Identities=26% Similarity=0.435 Sum_probs=200.8
Q ss_pred eeEcccCCeEEEEEEEcCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEec
Q 012053 16 RLLGQGTFAKVHYARNLKTGM--SVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEYV 92 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (472)
+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999988776 46888876432 223446788999999999 7999999999999999999999999
Q ss_pred CCCcccchhccC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcc
Q 012053 93 KGGELFGKVAKG-----------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 93 ~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGl 155 (472)
++++|.+++... .+++..++.++.|++.||+|||++|++||||||+|||+++++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999888542 378999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCC
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPN 233 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 233 (472)
+........ ......++.|+|||++....+ +.++||||||+++|+|++ |..||.+.+....+..+... ....+.
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhhh---ccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 753221111 112234667999999876655 479999999999999997 99999887777777666544 234555
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 234 WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.++.++.+++.+||..||.+|||+.+++..
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=315.89 Aligned_cols=244 Identities=27% Similarity=0.409 Sum_probs=205.7
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++.+....|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999877 999999998765432 34567889999999999999999999999999999999999999
Q ss_pred cccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 96 ELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
+|.+++.. ..+++..+..++.+++.||.|||++|++||||||+||+++.++.++|+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99998854 4689999999999999999999999999999999999999999999999999875542211111112234
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNP 251 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP 251 (472)
+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+... ....|..++.++.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999876655 489999999999999999 89999887766666665543 344566788999999999999999
Q ss_pred CCcCChhhhhcC
Q 012053 252 NTRISMTKIMEN 263 (472)
Q Consensus 252 ~~Rpt~~eil~h 263 (472)
++|||+.++++.
T Consensus 237 ~~Rp~~~ell~~ 248 (251)
T cd05041 237 ENRPSFSEIYNE 248 (251)
T ss_pred hhCcCHHHHHHH
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=315.52 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=209.5
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 47999999999999999999875 4778999998654432 356889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+.+++|.+++.. +.+++..++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++......... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence 99999999988864 56899999999999999999999999999999999999999999999999998754322111 1
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~ 245 (472)
.....++..|+|||.+.+..+. .++||||||+++|+|++ |..||...........+..+. ...|...+.++.+|+.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred cCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 1122346789999998766654 78999999999999998 999999888777777766543 33455578999999999
Q ss_pred ccCCCCCCcCChhhhhcC
Q 012053 246 ILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h 263 (472)
||..+|++|||+.++++.
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HcccChhhCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=324.04 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=208.9
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASK 82 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (472)
+..+-.+.|++.+.||+|+||+||+|.+..+++.||||.+.+.... .....+.+|+.++... .||||+++++++.+.
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 3445678899999999999999999999888999999999765322 2234556677766666 499999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
...|++|||+.+ .|.+.+.. +.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++...
T Consensus 87 ~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999999854 56555543 579999999999999999999997 59999999999999999999999999998765
Q ss_pred hcccCCCcccccCCCCcccChhhhcccC---CCCCcccchhhhHHHHHHhcCCCCCCCCcH-HHHHHHHhccC-CCCCC-
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRG---YDGSKADIWSCGVILYVLLAGYLPFHDSNL-MEMYRKIGKAE-FKFPN- 233 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~---~~~~~~DiwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~~-~~~~~- 233 (472)
..... .....+++.|+|||.+.+.. ..+.++||||||+++|+|++|+.||..... .+.+..+.... ...+.
T Consensus 166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06618 166 VDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN 242 (296)
T ss_pred cCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence 33221 12345788999999986542 234789999999999999999999976432 33444443332 22332
Q ss_pred -CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 234 -WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 234 -~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.++.++.+||.+||..||.+|||+.+++.||||..
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 36889999999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=323.17 Aligned_cols=249 Identities=32% Similarity=0.490 Sum_probs=206.6
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 90 (472)
|++.+.||+|+||+||+|.+..+++.||||.+...... .......+|+..++.++ ||||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78999999999999999999989999999998654321 11223457899999999 9999999999999999999999
Q ss_pred ecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 91 YVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 91 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|+ +++|.+.+.. ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 99 7788887764 2689999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------------C
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------------E 228 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------------~ 228 (472)
.....++..|+|||++......+.++|+||||+++++|++|..||...+..+.+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568899999998865554568999999999999999999999877665544433210 0
Q ss_pred CC-----------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 229 FK-----------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 229 ~~-----------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
.. .....++++.++|++||..||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=315.87 Aligned_cols=243 Identities=25% Similarity=0.448 Sum_probs=205.3
Q ss_pred eeEcccCCeEEEEEEEcC-CCc--EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEec
Q 012053 16 RLLGQGTFAKVHYARNLK-TGM--SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYV 92 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 92 (472)
+.||+|+||.||+|.+.. +++ .||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999776543 456789999999999999999999999988 8999999999
Q ss_pred CCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC-Ccc
Q 012053 93 KGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD-GLL 168 (472)
Q Consensus 93 ~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~-~~~ 168 (472)
++++|.+.+.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 99999999865 35899999999999999999999999999999999999999999999999998866432211 111
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc--CCCCCCCCCHHHHHHHhc
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA--EFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~l~~li~~ 245 (472)
....++..|+|||.+....+. .++|||||||++|+|++ |..||...+..+....+... ....+..++..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 234577899999998776664 78999999999999998 99999887777666665532 233455678999999999
Q ss_pred ccCCCCCCcCChhhhhc
Q 012053 246 ILDPNPNTRISMTKIME 262 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~ 262 (472)
||..+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=328.72 Aligned_cols=247 Identities=23% Similarity=0.422 Sum_probs=198.0
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcccchh
Q 012053 22 TFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKV 101 (472)
Q Consensus 22 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 101 (472)
++|.||.+++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..|++|||+.+++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445666677777999999999976532 2345678999999999999999999999999999999999999999999988
Q ss_pred cc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC-----CCcccccCC
Q 012053 102 AK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ-----DGLLHTTCG 173 (472)
Q Consensus 102 ~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~-----~~~~~~~~g 173 (472)
.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+........ ........+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 64 4689999999999999999999999999999999999999999999999998764432111 111233457
Q ss_pred CCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHH-HHHhccC----------------------
Q 012053 174 TPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMY-RKIGKAE---------------------- 228 (472)
Q Consensus 174 t~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~-~~i~~~~---------------------- 228 (472)
+..|+|||++... ++ +.++|+||+||++|+|++|..||......... .++....
T Consensus 171 ~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 171 NLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred cccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 8899999998653 34 47899999999999999999999876543322 2221100
Q ss_pred -----------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 229 -----------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 229 -----------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
...+..+++++.+|+.+||..||++|||+.++++||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 001112346788999999999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=319.59 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=211.0
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
.++|++++.||+|+||+||+|+... +.+.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4689999999999999999999754 346799998865432 234577899999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-C---------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecC
Q 012053 84 KIYFVMEYVKGGELFGKVAK-G---------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDF 153 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~---------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DF 153 (472)
..|+||||+++++|.+++.. + .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999998864 3 5899999999999999999999999999999999999999999999999
Q ss_pred cchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccCC--C
Q 012053 154 GLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEF--K 230 (472)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~--~ 230 (472)
|++........ .......+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||........+..+..... .
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 98764322111 11233456778999999876655 478999999999999998 8999988776666666664443 3
Q ss_pred CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 231 FPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 231 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+..++..+.+++.+||..+|.+|||+.+++..
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 455688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.01 Aligned_cols=249 Identities=23% Similarity=0.392 Sum_probs=208.4
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 467789999999999999999999864 55679999886543 234678899999999999999999999887 778
Q ss_pred EEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 86 YFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|++|||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999999998864 35788999999999999999999999999999999999999999999999998755332
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~ 240 (472)
.. .......++..|+|||++....+ +.++|+|||||++|++++ |..||...+.......+.... ...+...+.++.
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 156 EY-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 233 (260)
T ss_pred Cc-ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHH
Confidence 11 11122335677999999876554 478999999999999998 999999877766666655442 344566889999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012053 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+++.+||+.+|++||++.++++
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=341.22 Aligned_cols=241 Identities=26% Similarity=0.455 Sum_probs=210.9
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
|-++...-++-||.|+.|.||+|+. .++.||||.++.- -..+|+-|+.|+||||+.+.|+|...-.++
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 4444445567899999999999987 6789999987432 235788899999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
||||||..|.|+..++. +.++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++......
T Consensus 189 IiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-- 266 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-- 266 (904)
T ss_pred EeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh--
Confidence 99999999999999987 579999999999999999999999999999999999999999999999999988665432
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCCCCCHHHHHHH
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPNWFAPEVRRLL 243 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~l~~li 243 (472)
..-.++||..|||||++...+.. .|+|||||||+|||||||..||.+-+...++.-+..+. ...|..++..++-||
T Consensus 267 -TkMSFaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~ 344 (904)
T KOG4721|consen 267 -TKMSFAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLL 344 (904)
T ss_pred -hhhhhhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHH
Confidence 23568999999999999876654 89999999999999999999999887776665555443 456788999999999
Q ss_pred hcccCCCCCCcCChhhhhcC
Q 012053 244 SKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~h 263 (472)
+.||.-.|..||++.+|+.|
T Consensus 345 Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 345 KQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHHHhcCCCCCccHHHHHHH
Confidence 99999999999999999988
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.03 Aligned_cols=247 Identities=28% Similarity=0.467 Sum_probs=210.4
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTG----MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+++.+.||.|+||.||++.+..++ ..||+|.+...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 367899999999999999998766 89999999655321 245788999999999999999999999999999999
Q ss_pred EEEecCCCcccchhccC-C--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 88 VMEYVKGGELFGKVAKG-K--LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~-~--l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+|||+++++|.+.+... . +++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999998653 2 99999999999999999999999999999999999999999999999999876543311
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRL 242 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~l 242 (472)
... ....+++.|+|||.+....+ +.++||||||+++++|++ |..||...+.......+.... ...+..++.++.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 110 11236789999999865544 589999999999999998 899998877777777766543 34566689999999
Q ss_pred HhcccCCCCCCcCChhhhhc
Q 012053 243 LSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~ 262 (472)
+.+||..||++|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=321.36 Aligned_cols=238 Identities=25% Similarity=0.342 Sum_probs=198.1
Q ss_pred eeEcccCCeEEEEEEEcCCCc-------EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 16 RLLGQGTFAKVHYARNLKTGM-------SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~-------~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+.||+|+||.||+|.+..++. .+|+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999999866544 48888875443 23456788899999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC--------eEEecCcchhh
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN--------LKVSDFGLSAL 158 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~--------vkl~DFGla~~ 158 (472)
|||+.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999999865 35899999999999999999999999999999999999987765 69999998764
Q ss_pred hhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcC-CCCCCCCcHHHHHHHHhccCCCCCCCCCH
Q 012053 159 AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAG-YLPFHDSNLMEMYRKIGKAEFKFPNWFAP 237 (472)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 237 (472)
... .....+++.|+|||++.+....+.++||||||+++|+|++| ..||...+..... .+......+|...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence 432 13356889999999997655456889999999999999998 5666655544332 233445567777788
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++.++|.+||+.||++|||+++|++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=342.74 Aligned_cols=255 Identities=25% Similarity=0.527 Sum_probs=221.7
Q ss_pred ccCCEE-EEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE-
Q 012053 8 LMQRYE-LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK- 84 (472)
Q Consensus 8 l~~~y~-i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 84 (472)
-.+||- ....||+|+|-+||+|.|..+|-.||.-.+..+.+. .....+++..|+.+|+.|+||||+++|+++.+..+
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~ 116 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK 116 (632)
T ss_pred CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence 345653 457899999999999999999999998766554443 34557899999999999999999999999977665
Q ss_pred -EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEEcC-CCCeEEecCcchhhh
Q 012053 85 -IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR--GVCHRDLKPENLLLDE-HGNLKVSDFGLSALA 159 (472)
Q Consensus 85 -~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~--giiHrDIKp~NILld~-~g~vkl~DFGla~~~ 159 (472)
+.+|+|++..|+|+.|.++ ++++...++.|++||+.||.|||++ -|+|||||-+||+|+. -|.|||+|+|||++.
T Consensus 117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 8899999999999999987 7899999999999999999999998 5999999999999975 478999999999987
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC-CcHHHHHHHHhccCCC--CCCCCC
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAEFK--FPNWFA 236 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~~~--~~~~~s 236 (472)
..... ....|||.|||||.+. ..|+ ..+||||||+.++||+|+..||.. .+...+|+++..+..+ +..--.
T Consensus 197 r~s~a----ksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 197 RKSHA----KSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred hcccc----ceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC
Confidence 65443 4578999999999986 5676 899999999999999999999975 7788999999877543 233346
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
|++++||.+||.. .+.|+|+.|+|.||||...
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 8999999999999 9999999999999999874
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=311.98 Aligned_cols=243 Identities=26% Similarity=0.456 Sum_probs=203.4
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+.||+|+||.||+|.. .++..+|+|.+..... ......+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4799999999999986 4788999999865432 233456889999999999999999999999999999999999999
Q ss_pred cccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCC
Q 012053 96 ELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173 (472)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~g 173 (472)
+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........ .......+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 99998864 4689999999999999999999999999999999999999999999999999864322111 11112344
Q ss_pred CCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCC
Q 012053 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNP 251 (472)
Q Consensus 174 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP 251 (472)
++.|+|||++....+ +.++||||||+++|++++ |..||...........+... ....+..++..+.+++.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 677999999876555 478999999999999998 99999887776666665544 345566789999999999999999
Q ss_pred CCcCChhhhhcC
Q 012053 252 NTRISMTKIMEN 263 (472)
Q Consensus 252 ~~Rpt~~eil~h 263 (472)
++|||+.++++.
T Consensus 236 ~~Rp~~~~l~~~ 247 (250)
T cd05085 236 ENRPKFSELQKE 247 (250)
T ss_pred ccCCCHHHHHHH
Confidence 999999999753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=362.06 Aligned_cols=255 Identities=31% Similarity=0.531 Sum_probs=209.3
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe------
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS------ 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (472)
....|+.++.||+||||.||+++++-+|..||||.|.... .......+.+|+..|.+|+|||||++|..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4557889999999999999999999999999999998765 33556789999999999999999999842100
Q ss_pred --------------------------------------------------------------------------------
Q 012053 82 -------------------------------------------------------------------------------- 81 (472)
Q Consensus 82 -------------------------------------------------------------------------------- 81 (472)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CEEEEEEEecCCCcccchhccCCCC--HHHHHHHHHHHHHHHHHHH
Q 012053 82 -------------------------K--------TKIYFVMEYVKGGELFGKVAKGKLK--EDAARKYFQQLISAVDYCH 126 (472)
Q Consensus 82 -------------------------~--------~~~~lV~E~~~gg~L~~~i~~~~l~--e~~~~~i~~ql~~al~yLH 126 (472)
+ ..+|+-||||+...|.+++..+.+. ...+|++|++|++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1278999999999999999887764 8899999999999999999
Q ss_pred hCCceecCCCCCcEEEcCCCCeEEecCcchhhhh----c------------ccCCCcccccCCCCcccChhhhcccC--C
Q 012053 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE----S------------KHQDGLLHTTCGTPAYVAPEVINRRG--Y 188 (472)
Q Consensus 127 ~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~----~------------~~~~~~~~~~~gt~~Y~aPE~l~~~~--~ 188 (472)
++|||||||||.||+||+++.|||+|||+|+... . ...++..+..+||..|+|||++.+.. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998722 0 11122345678999999999997766 2
Q ss_pred CCCcccchhhhHHHHHHhcCCCCCCCC-cHHHHHHHHhccCCCCCCC----CCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 189 DGSKADIWSCGVILYVLLAGYLPFHDS-NLMEMYRKIGKAEFKFPNW----FAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 189 ~~~~~DiwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~----~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+..|+|+|||||||+||+. ||... ........+.++.++.|.. --+.-.++|++||+.||++|||+.|+|++
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 3489999999999999994 56543 3334555566666665532 23567899999999999999999999999
Q ss_pred cccc
Q 012053 264 SWFR 267 (472)
Q Consensus 264 p~f~ 267 (472)
.||.
T Consensus 872 ~llp 875 (1351)
T KOG1035|consen 872 ELLP 875 (1351)
T ss_pred cCCC
Confidence 9985
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=316.15 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=208.8
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
...+|.+.+.||+|+||.||+|.+... ...||+|....... ....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 446799999999999999999987644 35799998865432 2345678899999999999999999999875 45
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 7899999999999999865 35899999999999999999999999999999999999999999999999998755332
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
... ......+++.|+|||.+....+. .++||||||+++|++++ |..||......+....+... ....|..+++++.
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 161 SYY-KASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238 (270)
T ss_pred cce-ecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 111 01122345689999998766654 88999999999999986 99999888776666666554 3456677899999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012053 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++|.+||..+|.+|||+.++++.
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=315.57 Aligned_cols=228 Identities=26% Similarity=0.455 Sum_probs=193.3
Q ss_pred cCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcccch
Q 012053 21 GTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK 100 (472)
Q Consensus 21 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 100 (472)
|.||+||+|++..+++.||+|.+.+.. ...+|...+....||||+++++++......|+||||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997653 123455555566799999999999999999999999999999998
Q ss_pred hcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccC
Q 012053 101 VAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179 (472)
Q Consensus 101 i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~a 179 (472)
+.+ +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++++|||++...... .....++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccC
Confidence 865 57999999999999999999999999999999999999999999999999987654332 223456788999
Q ss_pred hhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCCh--
Q 012053 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISM-- 257 (472)
Q Consensus 180 PE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~-- 257 (472)
||.+....+ +.++|+||+|+++|+|++|+.||....... .......+|.++++.++++|.+||+.||++|||+
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876665 478999999999999999999876432211 0112345778899999999999999999999986
Q ss_pred ---hhhhcCccc
Q 012053 258 ---TKIMENSWF 266 (472)
Q Consensus 258 ---~eil~hp~f 266 (472)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 899999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.74 Aligned_cols=238 Identities=25% Similarity=0.340 Sum_probs=194.5
Q ss_pred eeEcccCCeEEEEEEEcCC------------CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 16 RLLGQGTFAKVHYARNLKT------------GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~------------g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+.||+|+||.||+|..... ...||+|++.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4689999999999985322 2358899876543 234457888999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC-------eEEecCc
Q 012053 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN-------LKVSDFG 154 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~-------vkl~DFG 154 (472)
..++||||+++++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999887754 56999999999999999999999999999999999999987764 8999999
Q ss_pred chhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHh-cCCCCCCCCcHHHHHHHHhccCCCCCC
Q 012053 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLL-AGYLPFHDSNLMEMYRKIGKAEFKFPN 233 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll-tG~~Pf~~~~~~~~~~~i~~~~~~~~~ 233 (472)
++...... ....|+..|+|||.+......+.++|||||||++|+|+ +|..||......+.. .+.........
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 87654321 23467889999999865454568999999999999997 689998776554432 23333344444
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 234 WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..++++.+||.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=316.41 Aligned_cols=244 Identities=19% Similarity=0.292 Sum_probs=191.9
Q ss_pred eeEcccCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012053 16 RLLGQGTFAKVHYARNLK--TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 469999999999996532 34578888875432 22334567889999999999999999999999999999999999
Q ss_pred CCcccchhccC------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 94 GGELFGKVAKG------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 94 gg~L~~~i~~~------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
+|+|.+++... ..++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999988642 246788899999999999999999999999999999999999999999999864322111111
Q ss_pred ccccCCCCcccChhhhccc------CCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHH-hccCCC-----CCCC
Q 012053 168 LHTTCGTPAYVAPEVINRR------GYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKI-GKAEFK-----FPNW 234 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~------~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i-~~~~~~-----~~~~ 234 (472)
.....+++.|+|||++... ...+.++|||||||++|+|++ |..||......+....+ ...... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233467789999997532 223578999999999999999 88999877665544443 332222 2335
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+++.+.+++..|+ .||++|||+++|++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=316.43 Aligned_cols=244 Identities=23% Similarity=0.385 Sum_probs=203.1
Q ss_pred eeEcccCCeEEEEEEEcCCC------cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 16 RLLGQGTFAKVHYARNLKTG------MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+.||+|+||.||+|.+.... ..+|+|.+.+... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46999999999999986544 6899999865421 133467889999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-----CeEEecCcch
Q 012053 90 EYVKGGELFGKVAK--------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-----NLKVSDFGLS 156 (472)
Q Consensus 90 E~~~gg~L~~~i~~--------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-----~vkl~DFGla 156 (472)
||+++++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999988853 2478899999999999999999999999999999999999887 8999999998
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCC
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNW 234 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 234 (472)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+... .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 75533221111223356788999999876655 589999999999999998 99999887776666665443 3455667
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++..+.++|.+||..+|.+||++.+|++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8899999999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=336.35 Aligned_cols=252 Identities=28% Similarity=0.449 Sum_probs=214.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCc---E-EEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGM---S-VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~-vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
+..++-.+.++||+|+||+||+|..+..+. . ||+|....+..........+.+|+++|+.++|||||++||+...+
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 344555677999999999999999876433 3 899998764434456678899999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
.-+|+|||+|.||+|.+++.+. .++..+..+++.+.+.||+|||+++++||||-..|+|++.++.+||+||||++...
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999999999999873 49999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccC-CCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccCC--CCCCCCC
Q 012053 161 SKHQDGLLHTTC-GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEF--KFPNWFA 236 (472)
Q Consensus 161 ~~~~~~~~~~~~-gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s 236 (472)
.... ....+ -...|+|||.+...-| +.++||||+||++||+++ |..||.+....+...+|....+ ..|...+
T Consensus 314 ~~~~---~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p 389 (474)
T KOG0194|consen 314 QYVM---KKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTP 389 (474)
T ss_pred ceee---ccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCH
Confidence 1111 11112 3457999999987755 589999999999999999 8999999999999999966544 4556678
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.++..++.+|+..||+.|||+.++.+
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHH
Confidence 88999999999999999999999965
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=325.75 Aligned_cols=254 Identities=31% Similarity=0.500 Sum_probs=210.1
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC--C----CeeeEEE
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH--P----NVVELYE 77 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--p----nIv~l~~ 77 (472)
.|.++.+||+++.+||+|+||+|-.+.+..++..||||+++.-. ...+..+-|+.+|+++.+ | -+|.+.+
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 47788999999999999999999999999999999999985432 334566779999999842 2 3788999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC----------
Q 012053 78 VMASKTKIYFVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE---------- 144 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~---------- 144 (472)
+|+-.+++++|+|.+ |-++++.+..+ +++...++.+++||+.+++|||+.+++|.||||||||+-+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 999999999999998 77999999873 6999999999999999999999999999999999999831
Q ss_pred ----------CCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC
Q 012053 145 ----------HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD 214 (472)
Q Consensus 145 ----------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~ 214 (472)
+..++|+|||.|+...... ++.+.|..|.|||++.+-+++ .++||||+||||+||.+|...|..
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceeccc
Confidence 3358999999988654322 566789999999999999997 899999999999999999999987
Q ss_pred CcHHH---HHHHHhc------------------cCCCCCCCC-------------------------CHHHHHHHhcccC
Q 012053 215 SNLME---MYRKIGK------------------AEFKFPNWF-------------------------APEVRRLLSKILD 248 (472)
Q Consensus 215 ~~~~~---~~~~i~~------------------~~~~~~~~~-------------------------s~~l~~li~~~L~ 248 (472)
.+..+ +.++|.. +....|... ..++.+||++||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 55333 3333321 111111110 1257899999999
Q ss_pred CCCCCcCChhhhhcCccccc
Q 012053 249 PNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rpt~~eil~hp~f~~ 268 (472)
.||.+|+|+.|+|.||||..
T Consensus 392 fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 392 FDPARRITLREALSHPFFAR 411 (415)
T ss_pred cCccccccHHHHhcCHHhhc
Confidence 99999999999999999975
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=321.65 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=206.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGM----SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
.++|++.+.||+|+||.||+|.+..+|+ .||+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4579999999999999999999988776 468888765432 22334688999999999999999999998654 4
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.++++||+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 6799999999999998865 36899999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
..........++..|+|||.+.+..+. .++||||||+++|+|++ |..||.+.........+... ....+...+..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 221112234467789999998766654 88999999999999997 99999876655544444333 2344556788999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012053 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+++.+||..+|++||+++++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=318.00 Aligned_cols=250 Identities=27% Similarity=0.424 Sum_probs=201.4
Q ss_pred CEEEEeeEcccCCeEEEEEEE----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CE
Q 012053 11 RYELGRLLGQGTFAKVHYARN----LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--TK 84 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 84 (472)
-|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 368999999999999999974 4578899999986543 223456789999999999999999999998775 67
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.|+||||++|++|.+++.+ ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 8999999999999998865 35899999999999999999999999999999999999999999999999998865432
Q ss_pred cCC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---------------HHHHHHHHhc
Q 012053 163 HQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---------------LMEMYRKIGK 226 (472)
Q Consensus 163 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---------------~~~~~~~i~~ 226 (472)
... .......|+..|+|||++.+..+. .++||||||+++|+|+++..|+.... .......+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 221 112234577789999998776554 78999999999999999877653211 0111111111
Q ss_pred -cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 227 -AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 227 -~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.....+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1233455688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=318.68 Aligned_cols=237 Identities=26% Similarity=0.343 Sum_probs=193.9
Q ss_pred eEcccCCeEEEEEEEcCC------------------------CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe
Q 012053 17 LLGQGTFAKVHYARNLKT------------------------GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV 72 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~------------------------g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 72 (472)
+||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999975322 2358899886543 2334568889999999999999
Q ss_pred eeEEEEEEeCCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----
Q 012053 73 VELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---- 146 (472)
Q Consensus 73 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g---- 146 (472)
+++++++......|+||||+++|+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999888854 6799999999999999999999999999999999999998654
Q ss_pred ---CeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHH-hcCCCCCCCCcHHHHHH
Q 012053 147 ---NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVL-LAGYLPFHDSNLMEMYR 222 (472)
Q Consensus 147 ---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~l-ltG~~Pf~~~~~~~~~~ 222 (472)
.+|++|||++...... ....+++.|+|||.+.+....+.++||||||+++|+| ++|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999987543221 2345788999999986644446899999999999998 47999998765544332
Q ss_pred HHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 223 KIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 223 ~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
........|...++++.++|.+||+.+|++|||+.+|+++
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2223344555567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=311.64 Aligned_cols=242 Identities=28% Similarity=0.485 Sum_probs=204.5
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..++|++.+.||+|+||.||.+.. +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++..+ ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 346899999999999999999864 78899999986432 235788999999999999999999998655 4799
Q ss_pred EEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 88 VMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 9999999999998864 25899999999999999999999999999999999999999999999999988754321
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRL 242 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~l 242 (472)
......+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+..+....+.++. ...+..+++++.++
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 122334568999999876655 478999999999999997 999999887777666665542 33455688999999
Q ss_pred HhcccCCCCCCcCChhhhhcC
Q 012053 243 LSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h 263 (472)
+.+||..+|+.|||++++++.
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=315.52 Aligned_cols=251 Identities=23% Similarity=0.396 Sum_probs=200.0
Q ss_pred cCCEEEEeeEcccCCeEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Q 012053 9 MQRYELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--K 82 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 82 (472)
..+|++.+.||+|+||.||.|. +..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 3589999999999999999997 44578999999986543 2345678899999999999999999998643 4
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
..+|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 578999999999999999864 468999999999999999999999999999999999999999999999999988654
Q ss_pred cccCCCcc-cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH----------------HHHH
Q 012053 161 SKHQDGLL-HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME----------------MYRK 223 (472)
Q Consensus 161 ~~~~~~~~-~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~----------------~~~~ 223 (472)
........ ....++..|+|||.+.+..+ +.++||||||+++|+|++|..|+....... +...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 32211101 11223456999999876655 479999999999999999987765432110 1111
Q ss_pred Hhc-cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 224 IGK-AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 224 i~~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.. .....+..++.++.+||.+||..+|++|||+.+|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 111 1233455688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=317.14 Aligned_cols=262 Identities=29% Similarity=0.437 Sum_probs=210.7
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CC
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTG----MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-KT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~ 83 (472)
...|+++..||+|+||.||+|....++ +.+|||.+..++- ..+.....-||+..++.++|||++.|..++-+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 347999999999999999999665543 3689999976643 22445667899999999999999999999866 88
Q ss_pred EEEEEEEecCCCcccchhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC----CCeEEecC
Q 012053 84 KIYFVMEYVKGGELFGKVAK------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH----GNLKVSDF 153 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~----g~vkl~DF 153 (472)
.+++++||++. +|.+.|.- ..++...++.+++||++|+.|||++-|+||||||.|||+..+ |.+||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999965 78777742 358999999999999999999999999999999999999877 89999999
Q ss_pred cchhhhhcccCCC-cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH---------HHHHHH
Q 012053 154 GLSALAESKHQDG-LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL---------MEMYRK 223 (472)
Q Consensus 154 Gla~~~~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~---------~~~~~~ 223 (472)
|+++++...-..- .....+-|.+|.|||.+.+...++.+.||||.|||+.||+|-++-|.+... .+...+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999887653321 234556799999999999988888999999999999999999888764321 122222
Q ss_pred Hhcc--C---------CCCCCC--------------------------CCHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 224 IGKA--E---------FKFPNW--------------------------FAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 224 i~~~--~---------~~~~~~--------------------------~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
|... - ...|.+ -++...+|+.+||+.||.+|+|+++.|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 2110 0 011111 14568899999999999999999999999999
Q ss_pred ccCCCC
Q 012053 267 RKGLVK 272 (472)
Q Consensus 267 ~~~~~~ 272 (472)
.+...+
T Consensus 341 ~~d~lp 346 (438)
T KOG0666|consen 341 TEDPLP 346 (438)
T ss_pred ccCCCC
Confidence 986554
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=311.47 Aligned_cols=245 Identities=23% Similarity=0.390 Sum_probs=198.9
Q ss_pred eeEcccCCeEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCCEEEEEEEe
Q 012053 16 RLLGQGTFAKVHYARNLK---TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA-SKTKIYFVMEY 91 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~ 91 (472)
+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..|++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998754 34579999975432 2234567889999999999999999999764 56678999999
Q ss_pred cCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC--Cc
Q 012053 92 VKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD--GL 167 (472)
Q Consensus 92 ~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~--~~ 167 (472)
+.+++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 999999999865 45678888999999999999999999999999999999999999999999998754321110 01
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~ 245 (472)
.....+++.|+|||.+....+. .++|||||||++|+|++ |.+||...+..+....+.... ...+..+++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1233467789999998776654 79999999999999999 567787777666666555443 34455678999999999
Q ss_pred ccCCCCCCcCChhhhhcC
Q 012053 246 ILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h 263 (472)
||.++|++||++.++++.
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=313.10 Aligned_cols=244 Identities=18% Similarity=0.242 Sum_probs=192.8
Q ss_pred eeEcccCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012053 16 RLLGQGTFAKVHYARNL--KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
+.||+|+||.||+|... .++..+|+|.+...... .....+.+|+.+++.++||||+++++++.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 35578999988655321 233568889999999999999999999999999999999999
Q ss_pred CCcccchhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 94 GGELFGKVAK------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 94 gg~L~~~i~~------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
+|+|.+++.. ...++..++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999998853 1356778889999999999999999999999999999999999999999999865432211111
Q ss_pred ccccCCCCcccChhhhcccC------CCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHH-HhccCCCC-----CCC
Q 012053 168 LHTTCGTPAYVAPEVINRRG------YDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRK-IGKAEFKF-----PNW 234 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~------~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~-i~~~~~~~-----~~~ 234 (472)
.....|++.|+|||++.+.. ..+.++||||||+++|+|++ |..||......+.... +....... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22346788999999985432 12578999999999999996 9999987665544332 22222222 223
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.++.+.+++.+|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=317.90 Aligned_cols=255 Identities=14% Similarity=0.189 Sum_probs=192.7
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhh--------HHHHHHHHHHHHhcCCCCee
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGM--------IDQIKREISVMRLVRHPNVV 73 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~hpnIv 73 (472)
+++..++|++.+.||+|+||+||+|.+..+ +..+|+|+........... ......++..++.+.|+||+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 346678999999999999999999998877 6778888754332110000 01122333445667899999
Q ss_pred eEEEEEEeCC----EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCe
Q 012053 74 ELYEVMASKT----KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNL 148 (472)
Q Consensus 74 ~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~v 148 (472)
++++++.... ..|+++|++.. ++.+.+.. ...++..++.++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 9999865443 45788887743 45555544 357889999999999999999999999999999999999999999
Q ss_pred EEecCcchhhhhcccCC-----CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH-HH---
Q 012053 149 KVSDFGLSALAESKHQD-----GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL-ME--- 219 (472)
Q Consensus 149 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~-~~--- 219 (472)
+|+|||+|+........ .......||+.|+|||++.+..+. .++|||||||++|+|++|.+||...+. ..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999765432111 112334799999999999877764 899999999999999999999986532 11
Q ss_pred -----HHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 220 -----MYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 220 -----~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
...++......++ ..++++.+++..|+..+|.+||++++|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKIK-NANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhccC-CCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2233333333333 46889999999999999999999999975
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=313.84 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=205.3
Q ss_pred EEEEeeEcccCCeEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----
Q 012053 12 YELGRLLGQGTFAKVHYARNLK---TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT----- 83 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 83 (472)
|++.+.||+|+||.||+|.+.. ++..||||++...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6788999999999999998653 5789999999654322 234567889999999999999999999885432
Q ss_pred -EEEEEEEecCCCcccchhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcc
Q 012053 84 -KIYFVMEYVKGGELFGKVAK-------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 84 -~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGl 155 (472)
..++++||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 35789999999999776532 2478999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCC
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPN 233 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 233 (472)
+................+++.|++||.+....++ .++|||||||++|+|++ |..||...+..+.+..+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8865332211112233456789999998776665 78999999999999999 99999888777776666544 344556
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 234 WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..++.+.+++.+||..+|+.|||+.+++..
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=311.38 Aligned_cols=249 Identities=28% Similarity=0.561 Sum_probs=209.3
Q ss_pred CEEEEeeEcccCCeEEEEEEEcC-CCcEEEEEEeecccc-------cchhhHHHHHHHHHHHHh-cCCCCeeeEEEEEEe
Q 012053 11 RYELGRLLGQGTFAKVHYARNLK-TGMSVAIKIIDKEKV-------LKVGMIDQIKREISVMRL-VRHPNVVELYEVMAS 81 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~ 81 (472)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.+++. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 688999999864321 122344567788888864 799999999999999
Q ss_pred CCEEEEEEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeEEecCcc
Q 012053 82 KTKIYFVMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vkl~DFGl 155 (472)
++..|++|||++|++|.+++. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999988763 2469999999999999999999996 7899999999999999999999999999
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-CC-C
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FP-N 233 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~~-~ 233 (472)
+....... ......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+...... .+ .
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 87654322 2345678999999999976555 58999999999999999999999888777666666554432 22 2
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 234 WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+++++.++|.+||+.||++||++.|+.++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=309.37 Aligned_cols=235 Identities=25% Similarity=0.305 Sum_probs=193.2
Q ss_pred eeEcccCCeEEEEEEEcCCC----------cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 16 RLLGQGTFAKVHYARNLKTG----------MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g----------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 47999999999999998776 3578887654431 14678899999999999999999999887 778
Q ss_pred EEEEEecCCCcccchhcc-C-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-------CeEEecCcch
Q 012053 86 YFVMEYVKGGELFGKVAK-G-KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-------NLKVSDFGLS 156 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-------~vkl~DFGla 156 (472)
|+||||+.+++|.+++.. + .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999999875 3 689999999999999999999999999999999999999888 7999999998
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhccc-CCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccCCCCCCC
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEFKFPNW 234 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 234 (472)
..... .....++..|+|||++... ...+.++||||||+++|+|++ |..||...+......... .....+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 76433 1234577889999998765 344588999999999999999 688887765433332222 22223333
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
....+.++|.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3478999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=312.22 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=203.6
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcC----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CC
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLK----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--KT 83 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 83 (472)
..|++.+.||+|+||.||+|.... +++.+|+|++...... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 468899999999999999998643 4889999999765432 345789999999999999999999999877 56
Q ss_pred EEEEEEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 KIYFVMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..|++|||+++++|.+++... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 899999999999999998764 499999999999999999999999999999999999999999999999999886642
Q ss_pred ccCCC-cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH---------------HHHHHh
Q 012053 162 KHQDG-LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME---------------MYRKIG 225 (472)
Q Consensus 162 ~~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~---------------~~~~i~ 225 (472)
..... ......++..|+|||.+....+ +.++||||||+++++|++|..||....... ....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 21110 1112244567999999876655 478999999999999999999986542211 112222
Q ss_pred c-cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 226 K-AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 226 ~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
. .....+..++.++.+++.+||..+|++|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2 123445567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=324.33 Aligned_cols=246 Identities=29% Similarity=0.447 Sum_probs=195.4
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-EEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-KIYFV 88 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lV 88 (472)
++|.-...||+|+||.||+|.- .+|..||||.+....... ..++.+|+.++.+++|||+|+|+|||.+.+ ..+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV 150 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV 150 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence 4677778999999999999986 455999999876654321 355999999999999999999999999988 59999
Q ss_pred EEecCCCcccchhcc--C-CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 89 MEYVKGGELFGKVAK--G-KLKEDAARKYFQQLISAVDYCHSRG---VCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~-~l~e~~~~~i~~ql~~al~yLH~~g---iiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
+||++.|+|.+.+.. + .+++....+|+.+++.||+|||+.. |+||||||.|||||++.+.||+|||+|......
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence 999999999999865 3 7899999999999999999999863 999999999999999999999999999654431
Q ss_pred cCCCccccc-CCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc------HHHHH-HHHhccC------
Q 012053 163 HQDGLLHTT-CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN------LMEMY-RKIGKAE------ 228 (472)
Q Consensus 163 ~~~~~~~~~-~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~------~~~~~-~~i~~~~------ 228 (472)
.....+. .||.+|+|||.+.. +..+.++|||||||+|.||+||+.|.+... ..+.. ..+..+.
T Consensus 231 --~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 231 --DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred --ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 1112233 89999999999876 445589999999999999999998887532 11111 1112211
Q ss_pred CCCC-CCCC--HH---HHHHHhcccCCCCCCcCChhhhhc
Q 012053 229 FKFP-NWFA--PE---VRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 229 ~~~~-~~~s--~~---l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
..+. ...+ .+ +..+..+|++.+|..||++.++++
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 2223 23 446778999999999999999854
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=307.77 Aligned_cols=244 Identities=17% Similarity=0.271 Sum_probs=192.3
Q ss_pred eeEcccCCeEEEEEEEcCC--CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012053 16 RLLGQGTFAKVHYARNLKT--GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
+.||+|+||+||++..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 4699999999999975433 34566777654432 2345678899999999999999999999999999999999999
Q ss_pred CCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 94 GGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 94 gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
+|+|.+++.+ ..+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999998864 24677788899999999999999999999999999999999999999999987542221111112
Q ss_pred cccCCCCcccChhhhcccC------CCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC------CCCCCCC
Q 012053 169 HTTCGTPAYVAPEVINRRG------YDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE------FKFPNWF 235 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~------~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~------~~~~~~~ 235 (472)
...+|++.|+|||++.... ..+.++||||||+++|+|++ |..||...+..+.+..+.+.. ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999974321 12468999999999999996 578998776666655543322 2233457
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++.+.+++..|+ .+|.+|||+++|++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 67999999999965
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=308.21 Aligned_cols=269 Identities=27% Similarity=0.425 Sum_probs=218.2
Q ss_pred CCCcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012053 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 1 m~~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
|..++-...+.|+-..++|+|.||+||+|+...+|+.||+|++-.+.- +.+.-....+|+.+|..++|+|++.++++|.
T Consensus 8 ~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 8 MYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred ccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 345666778899999999999999999999999999999988644321 2244455679999999999999999999874
Q ss_pred e--------CCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEE
Q 012053 81 S--------KTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 81 ~--------~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl 150 (472)
+ ...+|+|+.+|+. +|+.++.. -+++..++.++++++..||.|+|...|+|||+||+|+||+.+|.+||
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEe
Confidence 3 2358999999964 78888865 47999999999999999999999999999999999999999999999
Q ss_pred ecCcchhhhhcccC--CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-
Q 012053 151 SDFGLSALAESKHQ--DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA- 227 (472)
Q Consensus 151 ~DFGla~~~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~- 227 (472)
+|||+++.+..... ....+..+-|.+|.+||.+.+...++++.|||+-|||+.+|+|+.+-|.+.........|...
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 99999976543322 122345567999999999998887789999999999999999999998877665544444211
Q ss_pred -CC--------------------CCCC-------------CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 228 -EF--------------------KFPN-------------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 228 -~~--------------------~~~~-------------~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
.+ ++|. .-.+++.+|+.++|..||.+|++++++++|.||.+...
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 00 0111 11457889999999999999999999999999987543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=338.66 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=216.4
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
-...-++.+.||+|+||+||+|+-.. ....||||.++... .......|+||+++|..++|||||+|+|+|..+
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 34466788999999999999998643 34579999997654 334678899999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC
Q 012053 83 TKIYFVMEYVKGGELFGKVAK---------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN 147 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~ 147 (472)
+-+|+|+||+..|+|..++.. .+|+..+.+.++.||+.|+.||-++.++||||-..|.|+.++-.
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 999999999999999887642 12788999999999999999999999999999999999999999
Q ss_pred eEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhc
Q 012053 148 LKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGK 226 (472)
Q Consensus 148 vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~ 226 (472)
|||+||||++-.-+...........-..+|||||.+....|. .+|||||+||+|||+++ |..||.+....+..+.|..
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 999999999865443322222223345689999999888876 78999999999999998 9999999998888888877
Q ss_pred cC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhh
Q 012053 227 AE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIM 261 (472)
Q Consensus 227 ~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil 261 (472)
+. ...|..+|+++.+|+..||+.+|++||++.||-
T Consensus 721 g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 721 GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 65 688999999999999999999999999999984
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=332.50 Aligned_cols=241 Identities=33% Similarity=0.540 Sum_probs=197.7
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC------
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT------ 83 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------ 83 (472)
+-|...+.||+||||.||+++++.+|+.||||.+++.... .-.+..-+|+++|++++|||||+++++=++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 5688899999999999999999999999999999876533 34678889999999999999999999865544
Q ss_pred EEEEEEEecCCCcccchhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE--cCCCC--eEEecCcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL--DEHGN--LKVSDFGL 155 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl--d~~g~--vkl~DFGl 155 (472)
...+|||||.||+|+..+.+ .+|+|.+.+.++..+..||.|||++||+||||||.||++ .++|. .||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 56899999999999999975 479999999999999999999999999999999999988 34454 79999999
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc-----HHHHHHHHhc----
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN-----LMEMYRKIGK---- 226 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-----~~~~~~~i~~---- 226 (472)
|+-...+ ....+..||+.|.+||.+...++++..+|.||+||++|+++||.+||.... ..-++..+.+
T Consensus 171 Arel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 9976543 357788999999999999866666789999999999999999999996421 1123332221
Q ss_pred ----------c------CCCCCCCCCHH----HHHHHhcccCCCCCCcC
Q 012053 227 ----------A------EFKFPNWFAPE----VRRLLSKILDPNPNTRI 255 (472)
Q Consensus 227 ----------~------~~~~~~~~s~~----l~~li~~~L~~dP~~Rp 255 (472)
+ .+++|..+++. +..++..+|..+|.+|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 12233344443 44567788999999999
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=316.21 Aligned_cols=265 Identities=29% Similarity=0.464 Sum_probs=219.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc----hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK----VGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
.+.+||-++.+||+|||++||+|-|...+++||+|+-...+.++ ....+...+|..|.+.|.||.||++|++|.-+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 57789999999999999999999999999999999976554433 23456677999999999999999999999655
Q ss_pred -CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEEc---CCCCeEEecCcc
Q 012053 83 -TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR--GVCHRDLKPENLLLD---EHGNLKVSDFGL 155 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~--giiHrDIKp~NILld---~~g~vkl~DFGl 155 (472)
+..|-|+|||+|.+|.-+++. .-++|.+++.|+.||+.||.||... .|||.||||.||||- ..|.+||+||||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 567889999999999888876 4689999999999999999999976 599999999999994 456799999999
Q ss_pred hhhhhcccCCC-----cccccCCCCcccChhhhccc---CCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HH--HHHH
Q 012053 156 SALAESKHQDG-----LLHTTCGTPAYVAPEVINRR---GYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EM--YRKI 224 (472)
Q Consensus 156 a~~~~~~~~~~-----~~~~~~gt~~Y~aPE~l~~~---~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~--~~~i 224 (472)
+++......+. +.....||-+|.+||.+.-. +-.+.+.||||.|||+|.++.|+.||...... ++ +..|
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 99876544331 34456899999999987432 23357899999999999999999999765332 22 2223
Q ss_pred hc-cCCCCC--CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 225 GK-AEFKFP--NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 225 ~~-~~~~~~--~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
.+ .+..|| +.+++++++||++||...-+.|.++.++-.||+|.....
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~r 749 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIR 749 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhh
Confidence 33 344555 458999999999999999999999999999999976443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=329.76 Aligned_cols=254 Identities=29% Similarity=0.489 Sum_probs=223.1
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE-----eC
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMA-----SK 82 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~-----~~ 82 (472)
.+.|++.+.+|.|.+|+||+++++.+++..|+|+.+... ..-+.++.|.+||+.+ .|||++.+|+++. .+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 457999999999999999999999999999999987654 3347788999999887 5999999999984 35
Q ss_pred CEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
+.+|||||||.||+.-|+++. +++.|..+..+++.++.|+.+||.+.++|||||-.|||++.+|.|||+|||+++..
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 789999999999999998875 58999999999999999999999999999999999999999999999999999876
Q ss_pred hcccCCCcccccCCCCcccChhhhccc-----CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC---C
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRR-----GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK---F 231 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~-----~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~---~ 231 (472)
..... .-.+..|||.|||||++... .|+ .++|+||||++..||..|.+|+-+..++...-+|.+++++ -
T Consensus 174 dsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr 250 (953)
T KOG0587|consen 174 DSTVG--RRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR 250 (953)
T ss_pred ecccc--cccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence 65433 34688999999999998533 243 6899999999999999999999999888777777665532 2
Q ss_pred CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 232 PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 232 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
|..++.++.++|+.||..|..+||++.++++|||+..+
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 45578999999999999999999999999999999854
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=334.23 Aligned_cols=254 Identities=20% Similarity=0.312 Sum_probs=179.5
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCC----CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEE----
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKT----GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEV---- 78 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~---- 78 (472)
.-.++|++.+.||+|+||.||+|++..+ +..||+|.+...... +....| .++...+.++..+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3467899999999999999999999988 999999987543211 111111 1122222223222211
Q ss_pred --EEeCCEEEEEEEecCCCcccchhccCCC---------------------CHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 012053 79 --MASKTKIYFVMEYVKGGELFGKVAKGKL---------------------KEDAARKYFQQLISAVDYCHSRGVCHRDL 135 (472)
Q Consensus 79 --~~~~~~~~lV~E~~~gg~L~~~i~~~~l---------------------~e~~~~~i~~ql~~al~yLH~~giiHrDI 135 (472)
...+..+++|+||+.+++|.+++....+ .+..+..++.||+.||.|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2456789999999999999888764321 23456789999999999999999999999
Q ss_pred CCCcEEEcC-CCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCC---------------------CCcc
Q 012053 136 KPENLLLDE-HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD---------------------GSKA 193 (472)
Q Consensus 136 Kp~NILld~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~---------------------~~~~ 193 (472)
||+|||++. ++.+||+|||+|+...... .......+||+.|+|||.+...... ..++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 6799999999997654322 1223567899999999976432211 1356
Q ss_pred cchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC---------------------CCCCCHHHHHHHhcccCCCCC
Q 012053 194 DIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF---------------------PNWFAPEVRRLLSKILDPNPN 252 (472)
Q Consensus 194 DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------~~~~s~~l~~li~~~L~~dP~ 252 (472)
|||||||+||+|+++..|+... .......+....... .........+||.+||+.||+
T Consensus 361 DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999999999987775432 112222222111111 111223455899999999999
Q ss_pred CcCChhhhhcCcccccC
Q 012053 253 TRISMTKIMENSWFRKG 269 (472)
Q Consensus 253 ~Rpt~~eil~hp~f~~~ 269 (472)
+|||+.++|+||||+..
T Consensus 440 kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 440 QRISAKAALAHPYFDRE 456 (566)
T ss_pred cCCCHHHHhCCcCcCCC
Confidence 99999999999999763
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=336.02 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=212.2
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGM-----SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
..+-++++.||+|+||.||.|....... .||||.+.+.. +.+....+.+|..+|+.++|||||+++|++-+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 3467889999999999999998875333 38888876543 4566788999999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcc
Q 012053 84 KIYFVMEYVKGGELFGKVAKG--------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGl 155 (472)
..++++||+.||+|..+|++. .++......++.||+.|+.||+++++|||||...|+||++...+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999753 488899999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHH-HHhccCCCCCC
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYR-KIGKAEFKFPN 233 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~-~i~~~~~~~~~ 233 (472)
|+-.-.......-....-...|||||.+....+ +.++|||||||++||++| |..||.+.+..+... -...+....|.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~ 927 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS 927 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence 993322111100001112246999999987555 589999999999999998 999999988877766 44556788899
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 234 WFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.++..+.+++..||..+|++||++..|++
T Consensus 928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999999999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=288.82 Aligned_cols=239 Identities=47% Similarity=0.850 Sum_probs=207.7
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcccchh
Q 012053 22 TFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKV 101 (472)
Q Consensus 22 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 101 (472)
+||.||+|.+..+|+.+|+|++....... ..+.+.+|+..++.++|+||+++++++......++++||+.+++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 68999999999899999999997654322 1578999999999999999999999999999999999999999999998
Q ss_pred ccC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccCh
Q 012053 102 AKG-KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180 (472)
Q Consensus 102 ~~~-~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP 180 (472)
... .+++..++.++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||++....... ......++..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCH
Confidence 764 48999999999999999999999999999999999999999999999999988654432 23456789999999
Q ss_pred hhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC-CcHHHHHHHHhccCCCCCCC---CCHHHHHHHhcccCCCCCCcCC
Q 012053 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAEFKFPNW---FAPEVRRLLSKILDPNPNTRIS 256 (472)
Q Consensus 181 E~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~---~s~~l~~li~~~L~~dP~~Rpt 256 (472)
|.+....++ .++||||||++++++++|..||.. .+.......+.......... ++.++.+++.+||..+|++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999766665 699999999999999999999988 55556666665554443332 7889999999999999999999
Q ss_pred hhhhhcCccc
Q 012053 257 MTKIMENSWF 266 (472)
Q Consensus 257 ~~eil~hp~f 266 (472)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=316.66 Aligned_cols=255 Identities=32% Similarity=0.507 Sum_probs=215.5
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC------CCCeeeEEE
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR------HPNVVELYE 77 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~------hpnIv~l~~ 77 (472)
-|.+|.+||.+....|+|-||+|..|.+...|..||||+|....+ +.+.=.+|+.||+.|+ .-|+++|+.
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 478999999999999999999999999999999999999987653 3355678999999996 358999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhcc-C---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC-eEEec
Q 012053 78 VMASKTKIYFVMEYVKGGELFGKVAK-G---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN-LKVSD 152 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~-~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~-vkl~D 152 (472)
.|...+++|||+|-+ ..+|.+.+.+ | +|....++.|++||+.||..|...||+|.||||+|||++++.+ +||||
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence 999999999999988 4578888875 3 5889999999999999999999999999999999999998764 89999
Q ss_pred CcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC
Q 012053 153 FGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP 232 (472)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~ 232 (472)
||.|..+... ..+.+.-+..|.|||++.+..|+ ...|+||.||+||||.||+..|++.....++.........+|
T Consensus 581 fGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 581 FGSASFASEN----EITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred Cccccccccc----cccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 9998766533 23445567789999999999998 889999999999999999999998776666554432222222
Q ss_pred CC-----------------------------------------------------C-------CHHHHHHHhcccCCCCC
Q 012053 233 NW-----------------------------------------------------F-------APEVRRLLSKILDPNPN 252 (472)
Q Consensus 233 ~~-----------------------------------------------------~-------s~~l~~li~~~L~~dP~ 252 (472)
.. + -..+++|+.+||..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 11 1 13588999999999999
Q ss_pred CcCChhhhhcCccccc
Q 012053 253 TRISMTKIMENSWFRK 268 (472)
Q Consensus 253 ~Rpt~~eil~hp~f~~ 268 (472)
+|.|+.++|.||||..
T Consensus 736 KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 736 KRITVNQALKHPFITE 751 (752)
T ss_pred hcCCHHHHhcCCcccC
Confidence 9999999999999964
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=286.56 Aligned_cols=251 Identities=27% Similarity=0.512 Sum_probs=205.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC--E
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKT--K 84 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~--~ 84 (472)
..++|++++++|+|.|++||.|++..+++.++||+++.-+ .+.+++|+.||+.|. ||||++++++..+.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3568999999999999999999999999999999986543 367999999999997 999999999986653 4
Q ss_pred EEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CCeEEecCcchhhhhccc
Q 012053 85 IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~-g~vkl~DFGla~~~~~~~ 163 (472)
..+|+||++..+...+. ..++.-.++.|+.+|+.||+||||.||+|||+||.|+++|.. ..++|+|+|||.+.....
T Consensus 110 paLiFE~v~n~Dfk~ly--~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY--PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred chhHhhhhccccHHHHh--hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 67999999876653332 458889999999999999999999999999999999999965 469999999998875432
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC-CcHHHHHHHHh-------------ccCC
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIG-------------KAEF 229 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~-------------~~~~ 229 (472)
..+..+.+..|-.||.+..-......-|+|||||+|..|+..+.||.. .+..+..-+|. +-..
T Consensus 188 ---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 188 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred ---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 245667888999999997766666899999999999999999999853 33333332321 1111
Q ss_pred CC-------------CCC-----------CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 230 KF-------------PNW-----------FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 230 ~~-------------~~~-----------~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+ .+| .++++.+|+.++|..|-.+|+|+.|.+.||||...
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 11 111 46999999999999999999999999999999753
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=292.77 Aligned_cols=252 Identities=24% Similarity=0.451 Sum_probs=207.1
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV-MRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.+-+..||.|+||+|++-.++.+|+..|||.|+.... +....++..|... ++.-+.||||++||..-.++..|+.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3445679999999999999999999999999987664 2344667777765 566689999999999999999999999
Q ss_pred ecCCCcc---cchh---ccCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 91 YVKGGEL---FGKV---AKGKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 91 ~~~gg~L---~~~i---~~~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
++.- +| +.++ .+..++|..+-.+....+.||.||... .|+|||+||+|||||..|.+||||||++......-
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 9954 33 2222 236899999999999999999999865 89999999999999999999999999987554321
Q ss_pred CCCcccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHhccCCCC---CC---C
Q 012053 164 QDGLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIGKAEFKF---PN---W 234 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~~~~~---~~---~ 234 (472)
. .+.-.|...|||||.+.. .+|+ .++||||||++|||+.||..|+..-+ ..+....+..+.++. +. .
T Consensus 223 A---kT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~ 298 (361)
T KOG1006|consen 223 A---KTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH 298 (361)
T ss_pred H---hhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence 1 134578999999999853 4566 89999999999999999999998744 456666776665543 22 2
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
++..+.++|.-||.+|-+.||.+.+++.+||++...
T Consensus 299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 788999999999999999999999999999998654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.01 Aligned_cols=261 Identities=20% Similarity=0.284 Sum_probs=189.9
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEc----------------CCCcEEEEEEeecccccc-h----------hhHHHHHH
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNL----------------KTGMSVAIKIIDKEKVLK-V----------GMIDQIKR 59 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~----------------~~g~~vAiK~i~~~~~~~-~----------~~~~~~~~ 59 (472)
+-.++|++.++||+|+||.||+|.+. ..++.||||.+....... . ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45679999999999999999999753 245689999986432110 0 01122335
Q ss_pred HHHHHHhcCCCCe-----eeEEEEEEe--------CCEEEEEEEecCCCcccchhcc-----------------------
Q 012053 60 EISVMRLVRHPNV-----VELYEVMAS--------KTKIYFVMEYVKGGELFGKVAK----------------------- 103 (472)
Q Consensus 60 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~i~~----------------------- 103 (472)
|+.++..++|.++ +++++++.. ++..|+||||+.+++|.+++..
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766554 677777643 4568999999999999887642
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChh
Q 012053 104 --GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181 (472)
Q Consensus 104 --~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE 181 (472)
..+++..++.++.|++.+|.|||++||+||||||+|||++.++.+||+|||++........ .......+|+.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChh
Confidence 1235677889999999999999999999999999999999999999999999865432211 1112234589999999
Q ss_pred hhcccCC--------------------C-CCcccchhhhHHHHHHhcCCC-CCCCCcH-----------HHHHHHHhccC
Q 012053 182 VINRRGY--------------------D-GSKADIWSCGVILYVLLAGYL-PFHDSNL-----------MEMYRKIGKAE 228 (472)
Q Consensus 182 ~l~~~~~--------------------~-~~~~DiwSlGvil~~lltG~~-Pf~~~~~-----------~~~~~~i~~~~ 228 (472)
++..... . ..+.||||+||++|+|++|.+ ||.+... ....+.+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 9753321 1 124799999999999999986 7754211 11122223333
Q ss_pred CCCC--CCCCHHHHHHHhcccCCCC---CCcCChhhhhcCccccc
Q 012053 229 FKFP--NWFAPEVRRLLSKILDPNP---NTRISMTKIMENSWFRK 268 (472)
Q Consensus 229 ~~~~--~~~s~~l~~li~~~L~~dP---~~Rpt~~eil~hp~f~~ 268 (472)
+.++ +..++..++|+.+||..+| .+|+|++|+|+||||..
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 4443 3478999999999999766 68999999999999964
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=293.39 Aligned_cols=134 Identities=29% Similarity=0.511 Sum_probs=117.9
Q ss_pred cCCccc-CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-----C---CCeee
Q 012053 4 KGSILM-QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-----H---PNVVE 74 (472)
Q Consensus 4 ~g~~l~-~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~ 74 (472)
.|.++. +||.+.++||-|-|++||+|.|..+.+.||+|+.+... ...+....||.+|++++ | .+||+
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 477777 89999999999999999999999999999999987654 33466779999999884 2 47999
Q ss_pred EEEEEE----eCCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEE
Q 012053 75 LYEVMA----SKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLL 142 (472)
Q Consensus 75 l~~~~~----~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILl 142 (472)
|++.|. .+.++++|+|++ |.+|..+|.. +.++...++.|++||+.||+|||.+ ||||.||||+|||+
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 999995 456999999999 7788888865 5799999999999999999999976 99999999999998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=286.60 Aligned_cols=253 Identities=29% Similarity=0.481 Sum_probs=210.2
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK---- 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (472)
+.-.||.-++.+|.|+- .|..|-|.-+++.||+|.+..... .....++..+|...+..++|+||++++.+|.-.
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~-n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ-NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc-cCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 34568999999999999 788899999999999999876633 344567888999999999999999999998543
Q ss_pred --CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 --TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
...|+|||++.. +|...+. -.++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 358999999954 6766665 457778899999999999999999999999999999999999999999999998654
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------- 227 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------- 227 (472)
.. -.++..+.|..|.|||++.+.+|. ..+||||+||++.||++|...|.+.+..+.+.++...
T Consensus 170 ~~---~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 170 TD---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cc---cccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 32 235667899999999999999865 8899999999999999999999887665555544210
Q ss_pred --------------CCC----CCCC-----------CCHHHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012053 228 --------------EFK----FPNW-----------FAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 228 --------------~~~----~~~~-----------~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
.+. +|++ -+..+++++.+||..||++|.+++++|.|||++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 011 1221 134688999999999999999999999999997
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=305.98 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=218.1
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcC-CC--cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLK-TG--MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~-~g--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
-.++..+.++||+|.||.|+.|.+.. +| -.||||.+...... ..++.|.+|+.+|..|+|||+++|||+..+ ..
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 34566788999999999999999875 33 36999999776543 267899999999999999999999999877 67
Q ss_pred EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 85 IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+.+|||++++|+|.+.+.+ ..|-......|+.||+.|+.||.++++|||||-..||||-....+||+||||.+-...
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 8899999999999999975 5688899999999999999999999999999999999999999999999999987765
Q ss_pred ccCCCccc-ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012053 162 KHQDGLLH-TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 162 ~~~~~~~~-~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
....-.+. ...-...|+|||.+....+. .++|||++||++|||++ |+.||.+.+...+.++|..+ ....|+.++.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csed 343 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSED 343 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHH
Confidence 43321111 11223469999999887776 89999999999999998 89999999999888888754 46778889999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
+.+++..||..+|++|||+..|.+.-+..
T Consensus 344 IY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 344 IYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 99999999999999999999997654443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=301.54 Aligned_cols=200 Identities=30% Similarity=0.562 Sum_probs=181.8
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHH-----HHHHHHHHHHhcC---CCCeeeEEEEEEe
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID-----QIKREISVMRLVR---HPNVVELYEVMAS 81 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~-----~~~~Ei~il~~l~---hpnIv~l~~~~~~ 81 (472)
..|..++.||+|+||.|++|.++.+...|+||.|.|+++.-..+++ .+--||+||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 3599999999999999999999999999999999998876433322 2457999999998 9999999999999
Q ss_pred CCEEEEEEEec-CCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 82 KTKIYFVMEYV-KGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 82 ~~~~~lV~E~~-~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
++.+|++||-- +|-+||++|+. .+++|.++..+|+|++.|+++||++||+|||||-||+.+|.+|-+||+|||.|...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 99999999965 45699999986 57999999999999999999999999999999999999999999999999998876
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCC
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH 213 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~ 213 (472)
. .+...+..||..|.|||++.+..|-+..-|||+||++||.++..+.||.
T Consensus 721 k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 K----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred c----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 4 3557789999999999999999999999999999999999999998885
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=296.50 Aligned_cols=242 Identities=26% Similarity=0.466 Sum_probs=213.0
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
..+..+||-|-||+||.|.++...-.||||.++.+. -.++.+..|+.+|+.++|||+|+|+++|..+--.|||+||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 345678999999999999999988999999986543 2357889999999999999999999999999999999999
Q ss_pred cCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 92 VKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 92 ~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
+..|+|.++++. .-++.-....++.||..|++||..+++|||||...|.|+.++..+|++||||+++......
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY---- 420 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY---- 420 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce----
Confidence 999999999975 3477778889999999999999999999999999999999999999999999998765332
Q ss_pred cccCC---CCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHH
Q 012053 169 HTTCG---TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLL 243 (472)
Q Consensus 169 ~~~~g---t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li 243 (472)
....| ..-|.|||-+....+. .++|||+|||+|||+.| |--||.+-+....|..+.++ ...-|..+++.+.+|+
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLM 499 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELM 499 (1157)
T ss_pred ecccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHH
Confidence 22233 3459999998777665 89999999999999998 89999999999999888766 4677899999999999
Q ss_pred hcccCCCCCCcCChhhhhc
Q 012053 244 SKILDPNPNTRISMTKIME 262 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~ 262 (472)
+.||+++|..||+++||-+
T Consensus 500 raCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 500 RACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHhcCCcccCccHHHHHH
Confidence 9999999999999999843
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=280.79 Aligned_cols=257 Identities=26% Similarity=0.454 Sum_probs=209.4
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----EEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-----KIY 86 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~ 86 (472)
.+-.+.||.|+||.||.+.|..+|+.||+|.+..-. .+--..+++.+|+.+|.-.+|.|++..+++..... .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 445688999999999999999999999999885432 22234578889999999999999999998875543 477
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+++|++. .+|...|.. ..++.+.++-+++||++||+|||+.||.||||||.|+|++.|..+||||||+++..+....
T Consensus 134 V~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~- 211 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR- 211 (449)
T ss_pred HHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh-
Confidence 8888884 477777755 7899999999999999999999999999999999999999999999999999997654332
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHh--------------------
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG-------------------- 225 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~-------------------- 225 (472)
..++..+-|.+|.|||++.+...++.+.||||.|||+.||+..+..|...++.+..+.|.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 234455678899999999888777789999999999999999999998876655444432
Q ss_pred ---ccCCCCCC-----------CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 226 ---KAEFKFPN-----------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 226 ---~~~~~~~~-----------~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
++...-|. .-..+...++..+|.+||.+|.+.++.+.|++..++..
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 12222221 12346778999999999999999999999999877654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=331.98 Aligned_cols=237 Identities=24% Similarity=0.354 Sum_probs=187.5
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
..|...+.||+|+||.||+|.+..++..||+|.+...... ...|+.++++++|||||++++++.+....|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3466678899999999999999999999999998644321 235688999999999999999999999999999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCH---SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH---~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||+++|+|.+++. .+++..+.+++.|++.|++||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR--NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred eCCCCCcHHHHHh--cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 9999999999985 4889999999999999999999 6699999999999999999888775 665443211
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc-----HHHHHHHHhc-c------CCCC---
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN-----LMEMYRKIGK-A------EFKF--- 231 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-----~~~~~~~i~~-~------~~~~--- 231 (472)
.....||+.|+|||++.+..+. .++||||+||++|||+||+.||+... .....+.... . ....
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 1234689999999999877665 89999999999999999999985421 1111111000 0 0001
Q ss_pred ---CCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 232 ---PNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 232 ---~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.....++.+++.+||+.||++|||+.++++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00112356789999999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=293.46 Aligned_cols=255 Identities=21% Similarity=0.356 Sum_probs=210.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-..+..++++||+|-||+|.+++- ..+..||+|.++..... .....+.+||++|.+|+||||++++++|..++.+++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 345778999999999999999985 45699999999876543 346789999999999999999999999999999999
Q ss_pred EEEecCCCcccchhccCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 88 VMEYVKGGELFGKVAKGK---LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~~---l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||++.|+|.+++.... +.-....+++.||+.|++||.+.+++||||.+.|+|+|.++++||+|||+++..-+...
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999999997652 24455677999999999999999999999999999999999999999999985544333
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHh--cCCCCCCCCcHHHHHHHHhc--------cCCCCCCC
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLL--AGYLPFHDSNLMEMYRKIGK--------AEFKFPNW 234 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll--tG~~Pf~~~~~~~~~~~i~~--------~~~~~~~~ 234 (472)
...-...+-...|||||.+....+. .++|+|++|+++||++ +...||.+.......+.... .....|.-
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~ 771 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA 771 (807)
T ss_pred eeeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence 2222233445689999998877775 7999999999999875 57899988776655554321 12345777
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
++.++.+++.+|+..+-.+||+++++.. +|++
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~--~lq~ 803 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHL--FLQE 803 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHH--HHHH
Confidence 8999999999999999999999999943 3543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=303.67 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=218.5
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTG---MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
-..-.|.+.||.|.||+|+.|+.+..| ..||||.++.... +.....+..|+.||-+..||||++|.|+.....-+
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 345568899999999999999988766 4699999976543 34557788999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
.+|+||+++|+|..+++. |.|+..++.-+++.|+.|++||-+.|++||||...|||++.|-.+|++||||++..+...
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999999998865 789999999999999999999999999999999999999999999999999999776544
Q ss_pred CCCcccccCCC--CcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHH
Q 012053 164 QDGLLHTTCGT--PAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEV 239 (472)
Q Consensus 164 ~~~~~~~~~gt--~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l 239 (472)
+....+.-|- .+|.|||.+....+. .++||||+||++||.++ |+.||.+.+..+....|..+ ..+.|..++..+
T Consensus 786 -~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL 863 (996)
T KOG0196|consen 786 -EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL 863 (996)
T ss_pred -CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence 3333343343 469999999888775 78999999999998776 99999999888888888765 355666799999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..|+..||++|-.+||.+.+|+.+
T Consensus 864 ~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 864 YQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999875
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.38 Aligned_cols=244 Identities=28% Similarity=0.461 Sum_probs=205.6
Q ss_pred EEEEeeEcccCCeEEEEEEEcCC--Cc--EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKT--GM--SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~--g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..+.+.||+|-||.||.|....- |+ .||||..+.+... +..+.+..|..+|+.++||||++++|++.+ .-.|+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 34567899999999999987542 33 5888988665432 336789999999999999999999999965 46899
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|||+++-|+|..++.. ..++......|..||..||.|||+..++||||...|||+.....+||+||||++.......
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y- 546 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY- 546 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch-
Confidence 9999999999999975 5799999999999999999999999999999999999999999999999999997764322
Q ss_pred CcccccCCC--CcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHH
Q 012053 166 GLLHTTCGT--PAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241 (472)
Q Consensus 166 ~~~~~~~gt--~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~ 241 (472)
.+...|. .-|||||-+.-..+. .++|||-|||.+||++. |..||.+-...+..-.+.++ ..++|+.++|.+..
T Consensus 547 --YkaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYs 623 (974)
T KOG4257|consen 547 --YKASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYS 623 (974)
T ss_pred --hhccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHH
Confidence 2233333 359999998777665 78999999999999775 99999987666666566555 47899999999999
Q ss_pred HHhcccCCCCCCcCChhhhhc
Q 012053 242 LLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~ 262 (472)
|+.+||..+|.+||++.+|..
T Consensus 624 lmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 624 LMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHhccCcccCCcHHHHHH
Confidence 999999999999999988754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.25 Aligned_cols=256 Identities=29% Similarity=0.490 Sum_probs=224.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-.++|++++.+|.|+||.||+|+|+.+++..|+|+++.+... ...-+..|+-+++..+|||||.+++.+-....+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 356899999999999999999999999999999999876543 34667899999999999999999999999999999
Q ss_pred EEEecCCCcccchhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 88 VMEYVKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
.||||.||+|.+.-. .|.++|.++....+..+.|++|||+.|-+|||||-.|||+++.|.+|++|||.+..+...-.
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-- 167 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-- 167 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh--
Confidence 999999999998765 48999999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccCCCCcccChhhhc---ccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC-----CCCCHH
Q 012053 167 LLHTTCGTPAYVAPEVIN---RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-----NWFAPE 238 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~---~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~ 238 (472)
.-..+.|||+|||||+-. ..+|. ..+|||++|++..|+---+.|..+...+.....+.+..++.| ...++.
T Consensus 168 KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 125678999999999862 34554 899999999999999999999888777766666666665544 347889
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+-+|++.+|..+|++|||++.+|.|||....
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999999999999764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=304.66 Aligned_cols=244 Identities=28% Similarity=0.442 Sum_probs=196.8
Q ss_pred EEeeEcccCCeE-EEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEEEe
Q 012053 14 LGRLLGQGTFAK-VHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 14 i~~~LG~G~fg~-Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
--+.+|.|+-|+ ||+|.. .|+.||||.+-.+ ..+...+|+..|+.. +|||||++|+.-.+....|+..|.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred cHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 346789999986 788887 7889999987443 346788999999988 499999999999999999999999
Q ss_pred cCCCcccchhccC-C----CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CC--CeEEecCcchhhhhc
Q 012053 92 VKGGELFGKVAKG-K----LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE---HG--NLKVSDFGLSALAES 161 (472)
Q Consensus 92 ~~gg~L~~~i~~~-~----l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~---~g--~vkl~DFGla~~~~~ 161 (472)
|. .+|.++++.. . ......+.++.|++.||++||+.+|+||||||.||||+. ++ +++|+|||+++....
T Consensus 585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 95 5899999763 1 111446789999999999999999999999999999976 34 689999999987765
Q ss_pred ccCC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcC-CCCCCCCcHHHHHHHHhccCCCCCC---CCC
Q 012053 162 KHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAG-YLPFHDSNLMEMYRKIGKAEFKFPN---WFA 236 (472)
Q Consensus 162 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG-~~Pf~~~~~~~~~~~i~~~~~~~~~---~~s 236 (472)
.... ....+..||-+|+|||++..... ..++|||||||++|+.++| .+||.+.-.. ...|.++++..-. .-.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPD 740 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCch
Confidence 4332 23556779999999999976654 4689999999999998886 9999775433 2345555543321 111
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.++.+||.+||.++|..||++.++|.||+|-..
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 289999999999999999999999999999763
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=278.82 Aligned_cols=248 Identities=25% Similarity=0.481 Sum_probs=197.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH--hcCCCCeeeEEEEEE----
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR--LVRHPNVVELYEVMA---- 80 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~---- 80 (472)
.+...-.+.+.||+|-||+||+|.+ .|+.||||++.... .....+|.+|.+ .|+|+||+.+++.-.
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 3456788999999999999999998 78999999996543 245678888886 569999999998753
Q ss_pred eCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEcCCCCeEEec
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR--------GVCHRDLKPENLLLDEHGNLKVSD 152 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~--------giiHrDIKp~NILld~~g~vkl~D 152 (472)
+-+++|||++|-+.|+|+|++.+..++-+...+++..++.||++||.. .|.|||||..|||+..||...|+|
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 235799999999999999999999999999999999999999999954 499999999999999999999999
Q ss_pred Ccchhhhhccc--CCCcccccCCCCcccChhhhccc----CCCC-CcccchhhhHHHHHHhcC----------CCCCCC-
Q 012053 153 FGLSALAESKH--QDGLLHTTCGTPAYVAPEVINRR----GYDG-SKADIWSCGVILYVLLAG----------YLPFHD- 214 (472)
Q Consensus 153 FGla~~~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~----~~~~-~~~DiwSlGvil~~lltG----------~~Pf~~- 214 (472)
+|||-...... -+-..+..+||.+|||||++... -+.+ ..+||||||+++||++.. ++||.+
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 99997665432 22335678999999999998532 1222 358999999999999862 578864
Q ss_pred ----CcHHHHHHHH--hccCCCCCCCC-CH----HHHHHHhcccCCCCCCcCChhhhhc
Q 012053 215 ----SNLMEMYRKI--GKAEFKFPNWF-AP----EVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 215 ----~~~~~~~~~i--~~~~~~~~~~~-s~----~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++..++..-+ .+..+.+|.++ +. .+..+++.||..||..|.|+--|..
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 3344444332 33455566543 32 3557899999999999999877653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=282.98 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=198.4
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--cCCCCeeeEEEEEEeCC----
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL--VRHPNVVELYEVMASKT---- 83 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~---- 83 (472)
...++.+.+|+|.||.||+|.. +++.||||++.... .+.+.+|-+|.+. ++|+||++++++-...+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 3567889999999999999986 77999999986543 3567788888765 57999999999876555
Q ss_pred EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEEcCCCCeEEecCc
Q 012053 84 KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR---------GVCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~---------giiHrDIKp~NILld~~g~vkl~DFG 154 (472)
.++||+||.+.|+|.+++....+++....+++..+++||+|||+. .|+|||||..|||+.+|+...|+|||
T Consensus 282 eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 899999999999999999999999999999999999999999964 59999999999999999999999999
Q ss_pred chhhhhcccCCCcccccCCCCcccChhhhcccCCC-----CCcccchhhhHHHHHHhcCC------------CCCC----
Q 012053 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD-----GSKADIWSCGVILYVLLAGY------------LPFH---- 213 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~-----~~~~DiwSlGvil~~lltG~------------~Pf~---- 213 (472)
||..+......+.....+||.+|||||++.+.--. -.+.||||+|.+|||+++.. +||.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99988876666667778999999999999653211 13689999999999999843 3343
Q ss_pred -CCcHHHHHHHH--hccCCCCCCCC-----CHHHHHHHhcccCCCCCCcCChhhhh
Q 012053 214 -DSNLMEMYRKI--GKAEFKFPNWF-----APEVRRLLSKILDPNPNTRISMTKIM 261 (472)
Q Consensus 214 -~~~~~~~~~~i--~~~~~~~~~~~-----s~~l~~li~~~L~~dP~~Rpt~~eil 261 (472)
.+...++...+ .+.++.+|..+ ...+++.+..||+.||+.|.|+.=+.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 12333333333 34455555432 34688999999999999999987443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=264.55 Aligned_cols=256 Identities=26% Similarity=0.462 Sum_probs=205.5
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEE-EEeCC
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEV-MASKT 83 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~-~~~~~ 83 (472)
.-+.+.|.|.+.||+|-||++.+|+++.+++.+++|.+.+.... ...+.+|...--.| .|.||+.-|++ |++.+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 34677899999999999999999999999999999999876533 46677888765445 59999998887 67888
Q ss_pred EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CCCCeEEecCcchhhhhc
Q 012053 84 KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD--EHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld--~~g~vkl~DFGla~~~~~ 161 (472)
.++++|||++-|+|...+...++.|....+++.|+++|+.|+|+++++|||||.+||||- +.-++||||||+.+..+.
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999999999999998999999999999999999999999999999999999993 233799999998775432
Q ss_pred ccCCCcccccCCCCcccChhhhcccC----CCCCcccchhhhHHHHHHhcCCCCCCCCcH----HHHHHHHhcc-CCCCC
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRG----YDGSKADIWSCGVILYVLLAGYLPFHDSNL----MEMYRKIGKA-EFKFP 232 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~----~~~~~~DiwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~-~~~~~ 232 (472)
......-+..|.+||++.... ...+.+|+|.||+++|.+|||.+||..... ...+.++.+. ....|
T Consensus 176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred -----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 223334567899999874321 123678999999999999999999985332 2333344333 33444
Q ss_pred C---CCCHHHHHHHhcccCCCCCCc---CChhhhhcCcccccCC
Q 012053 233 N---WFAPEVRRLLSKILDPNPNTR---ISMTKIMENSWFRKGL 270 (472)
Q Consensus 233 ~---~~s~~l~~li~~~L~~dP~~R---pt~~eil~hp~f~~~~ 270 (472)
. .+++.+.++.++-|.++|++| .++.......|.....
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i 294 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLI 294 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhh
Confidence 3 378999999999999999999 6777777778876543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=275.56 Aligned_cols=256 Identities=27% Similarity=0.474 Sum_probs=203.4
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEe
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLK---TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMAS 81 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 81 (472)
..+.+.|.++.+||+|+|+.||+|.+.. .++.||+|.+.... ...++.+|+++|..+. +.||+++.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3467789999999999999999999987 78999999986543 3467999999999885 9999999999999
Q ss_pred CCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCeEEecCcchhhhh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSDFGLSALAE 160 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~-~g~vkl~DFGla~~~~ 160 (472)
+++..+||||.+..+..++.. .++..+++.|++.++.||.++|.+||+||||||.|+|.+. .+.-.|+|||||...+
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~--~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR--SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CCeeEEEecccCccCHHHHHh--cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999998876666554 4678899999999999999999999999999999999975 4578999999987221
Q ss_pred ccc------C-------------------------CCcc-----------cccCCCCcccChhhhcccCCCCCcccchhh
Q 012053 161 SKH------Q-------------------------DGLL-----------HTTCGTPAYVAPEVINRRGYDGSKADIWSC 198 (472)
Q Consensus 161 ~~~------~-------------------------~~~~-----------~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSl 198 (472)
... . .+.. ....||++|.|||++.+.+-.+.++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 100 0 0000 012499999999999998888899999999
Q ss_pred hHHHHHHhcCCCCCCCCc-----HHHHHH--------HH----hc------c-----------------------CC---
Q 012053 199 GVILYVLLAGYLPFHDSN-----LMEMYR--------KI----GK------A-----------------------EF--- 229 (472)
Q Consensus 199 Gvil~~lltG~~Pf~~~~-----~~~~~~--------~i----~~------~-----------------------~~--- 229 (472)
|||+..++++..||.... ..++.. +. .+ . ..
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 999999999999985321 111100 00 00 0 00
Q ss_pred CC---CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 230 KF---PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 230 ~~---~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.. ...++..+.+|+.+||+.||.+|.|+++.|.||||..
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00 0114558899999999999999999999999999974
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=294.03 Aligned_cols=252 Identities=25% Similarity=0.473 Sum_probs=209.9
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLK-------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEV 78 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~ 78 (472)
+..++..+.+.||+|+||.|++|.-.. ....||||.+...... ...+.+..|+.+|+.+. ||||+.+.++
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 334455677899999999999997431 1457999998665433 45678999999999985 9999999999
Q ss_pred EEeCCEEEEEEEecCCCcccchhccCC-----------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 012053 79 MASKTKIYFVMEYVKGGELFGKVAKGK-----------------LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLL 141 (472)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~~-----------------l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NIL 141 (472)
+...+.+++|+||+..|+|.++++..+ ++......++.||+.|++||++.+++||||-..|||
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL 450 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence 999999999999999999999987655 899999999999999999999999999999999999
Q ss_pred EcCCCCeEEecCcchhhhhcccCCCcccccCCCC--cccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCc-H
Q 012053 142 LDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP--AYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSN-L 217 (472)
Q Consensus 142 ld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~--~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~-~ 217 (472)
+..+..+||+|||+|+.......- ......|+. .|||||.+....|. .++||||+||+|||+++ |..||.+.. .
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~ft-~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVFT-SKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred ecCCCEEEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCccc-ccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999999854332211 011122333 39999999886554 89999999999999998 899998854 5
Q ss_pred HHHHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 218 MEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 218 ~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.+++..+..+. ...|..+++++.++++.||+.+|++||++.++.+
T Consensus 529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 56677676665 4788889999999999999999999999999975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=245.97 Aligned_cols=212 Identities=47% Similarity=0.831 Sum_probs=186.3
Q ss_pred EcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcc
Q 012053 18 LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL 97 (472)
Q Consensus 18 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L 97 (472)
||+|++|.||++.+..+++.+++|++....... ..+.+.+|+.+++.++|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997664321 346789999999999999999999999999999999999999999
Q ss_pred cchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCeEEecCcchhhhhcccCCCcccccCCC
Q 012053 98 FGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSDFGLSALAESKHQDGLLHTTCGT 174 (472)
Q Consensus 98 ~~~i~~~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~-~g~vkl~DFGla~~~~~~~~~~~~~~~~gt 174 (472)
.+++... .++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9998764 7999999999999999999999999999999999999999 89999999999876543221 12345678
Q ss_pred CcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCc
Q 012053 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254 (472)
Q Consensus 175 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 254 (472)
..|++||.+......+.++|+|++|++++++ ..+.+++.+|+..||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987653445889999999999999 678999999999999999
Q ss_pred CChhhhhcCc
Q 012053 255 ISMTKIMENS 264 (472)
Q Consensus 255 pt~~eil~hp 264 (472)
|++.++++++
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=246.73 Aligned_cols=210 Identities=26% Similarity=0.486 Sum_probs=170.8
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH-hcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR-LVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
...-+..||+|+||.|-+.++..+|...|+|.+...-- ....+++.+|+++.. ....|.+|.+||.+.....+++.|
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 33456789999999999999999999999999965432 344567778888764 457999999999999999999999
Q ss_pred EecCCCcccch----hcc-CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 90 EYVKGGELFGK----VAK-GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 90 E~~~gg~L~~~----i~~-~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|.+.. +|..+ +.. +.++|..+-+++-.++.||.|||++ .++|||+||.|||++.+|++|+||||++......
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS- 202 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS- 202 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh-
Confidence 99854 55332 233 5799999999999999999999987 8999999999999999999999999998765432
Q ss_pred CCCcccc-cCCCCcccChhhhc----ccCCCCCcccchhhhHHHHHHhcCCCCCCC-CcHHHHHHHHhccC
Q 012053 164 QDGLLHT-TCGTPAYVAPEVIN----RRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAE 228 (472)
Q Consensus 164 ~~~~~~~-~~gt~~Y~aPE~l~----~~~~~~~~~DiwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~ 228 (472)
...+ ..|...|||||.+. ..+|+ .++||||||++++||.+++.||+. ..+.+...++....
T Consensus 203 ---iAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 203 ---IAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred ---hHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 1222 56888999999874 34665 899999999999999999999976 44556666665543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=247.40 Aligned_cols=218 Identities=43% Similarity=0.718 Sum_probs=186.1
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
|++.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++++...+..++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999888999999999765432 2467889999999999999999999999999999999999
Q ss_pred cCCCcccchhccC-C-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 92 VKGGELFGKVAKG-K-LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 92 ~~gg~L~~~i~~~-~-l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
+.+++|.+++... . +++..+..++.+++.++.+||++|++|+||+|.||+++.++.++|+|||++........ ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 9999999998763 4 89999999999999999999999999999999999999999999999999886654321 1224
Q ss_pred ccCCCCcccChhhh-cccCCCCCcccchhhhHHHHHHhcCCCCCCC--CcHHHHHHHHhccCCCCCC
Q 012053 170 TTCGTPAYVAPEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFHD--SNLMEMYRKIGKAEFKFPN 233 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l-~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~--~~~~~~~~~i~~~~~~~~~ 233 (472)
...++..|++||.+ ....+. .++|+||||+++++|++|+.||.. .+...+.+.+..+.....+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 45788899999998 444444 689999999999999999999977 3444777777776654443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=283.07 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=210.6
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGM----SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
.+-++.||.|+||+||+|.+...|+ +||||++...... +....+.+|+-+|..++|||+++|++++.... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3456889999999999999987776 5888887655432 34577889999999999999999999997766 889
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
|++|+++|.|.++++. +.+.....+.|..||+.|+.|||.++++||||-..|+|+..-..+||.|||+|+.......+
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999864 67999999999999999999999999999999999999999999999999999987664443
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHH
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLL 243 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li 243 (472)
-......-.+.|||=|.+....|. .++||||+||++||++| |..|+.+....++-..+..+ +...|+..+-++.-++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 222222234568999988777765 89999999999999998 99999998888777666655 3678888999999999
Q ss_pred hcccCCCCCCcCChhhhhc
Q 012053 244 SKILDPNPNTRISMTKIME 262 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~ 262 (472)
.+||..|+..||+++++.+
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=287.11 Aligned_cols=260 Identities=29% Similarity=0.505 Sum_probs=211.2
Q ss_pred cCCE-EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecc---cccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 9 MQRY-ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKE---KVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 9 ~~~y-~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~---~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
...| .....+|.|++|.|+.+......+.++.|.+... ..........+..|+.+-..+.|||++.....+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 3455 4678899999999999988888887887766522 11111222337778888889999999887777766666
Q ss_pred EEEEEEecCCCcccchhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 85 IYFVMEYVKGGELFGKVAKG-KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~-~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
.+.+||||++ +|+..+... .++..++..++.||+.||+|+|+.||.|||+||+|+++..+|.+||+|||.+..+....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 6666999999 999999875 89999999999999999999999999999999999999999999999999998877666
Q ss_pred CC--CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHH--HHHHhc-------cCCCCC
Q 012053 164 QD--GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM--YRKIGK-------AEFKFP 232 (472)
Q Consensus 164 ~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~--~~~i~~-------~~~~~~ 232 (472)
.. ......+|+..|+|||++.+..|+....||||+|++++.|.+|+.||......+. +..... +...+-
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 55 4566789999999999999999999999999999999999999999976543321 111111 111122
Q ss_pred CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 233 NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 233 ~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
..++...+.+|.+||++||.+|.|+++|++.+||+..
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 2367788999999999999999999999999999864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=291.52 Aligned_cols=199 Identities=17% Similarity=0.233 Sum_probs=147.0
Q ss_pred hcCC-CCeeeEEEEE-------EeCCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 012053 66 LVRH-PNVVELYEVM-------ASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDL 135 (472)
Q Consensus 66 ~l~h-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDI 135 (472)
.++| +||++++++| .....+++++||+ +++|++++.. +.+++.+++.+++||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4455 5777888876 2334577888987 6699999965 46999999999999999999999999999999
Q ss_pred CCCcEEEcC-------------------CCCeEEecCcchhhhhcccC-------C-------CcccccCCCCcccChhh
Q 012053 136 KPENLLLDE-------------------HGNLKVSDFGLSALAESKHQ-------D-------GLLHTTCGTPAYVAPEV 182 (472)
Q Consensus 136 Kp~NILld~-------------------~g~vkl~DFGla~~~~~~~~-------~-------~~~~~~~gt~~Y~aPE~ 182 (472)
||+||||+. ++.+|++|||+++....... . ......+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 44566667776653211000 0 00112468999999999
Q ss_pred hcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHhcccCCCCCCcCChhhhh
Q 012053 183 INRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSKILDPNPNTRISMTKIM 261 (472)
Q Consensus 183 l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil 261 (472)
+.+..| +.++|||||||+||||++|..|+..... ....+..... ..+....+...+++.+||.++|.+|||+.|++
T Consensus 187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 988777 4899999999999999999998764321 1111111111 11111245678899999999999999999999
Q ss_pred cCccccc
Q 012053 262 ENSWFRK 268 (472)
Q Consensus 262 ~hp~f~~ 268 (472)
+||||..
T Consensus 264 ~h~~~~~ 270 (793)
T PLN00181 264 QSEFINE 270 (793)
T ss_pred hchhhhh
Confidence 9999976
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-27 Score=230.52 Aligned_cols=255 Identities=36% Similarity=0.609 Sum_probs=213.0
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCC-CeeeEEEEEEeCCEEEEEEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP-NVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lV~E 90 (472)
|.+.+.||.|+||.||.+.+. ..+|+|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999986 88999999877654433577899999999999988 79999999988888999999
Q ss_pred ecCCCcccchhccC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CeEEecCcchhhhhcccCC
Q 012053 91 YVKGGELFGKVAKG----KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 91 ~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-~vkl~DFGla~~~~~~~~~ 165 (472)
++.++++.+.+... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999999777654 699999999999999999999999999999999999999999 6999999998755433322
Q ss_pred C----cccccCCCCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCCCcH----HHHHHHHhccCCC-CCCC
Q 012053 166 G----LLHTTCGTPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHDSNL----MEMYRKIGKAEFK-FPNW 234 (472)
Q Consensus 166 ~----~~~~~~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~-~~~~ 234 (472)
. .....+||+.|+|||.+... .......|+||+|++++++++|..||..... ......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 24677899999999999874 4556899999999999999999999887653 4555555544433 2222
Q ss_pred CC--------HHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 235 FA--------PEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 235 ~s--------~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.. ..+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 22 478999999999999999999999988766553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=242.95 Aligned_cols=172 Identities=24% Similarity=0.248 Sum_probs=136.7
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcC-CCcEEEEEEeecccc--cchhhHHHHHHHHHHHHhcCCCCeee-EEEEEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLK-TGMSVAIKIIDKEKV--LKVGMIDQIKREISVMRLVRHPNVVE-LYEVMA 80 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~ 80 (472)
-..+.++|++.+.||+|+||+||+|++.. +++.||||.+..... ........+.+|+.+|+.++|+|++. ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 35788999999999999999999999876 678889998753311 12234567999999999999999985 5442
Q ss_pred eCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEcCCCCeEEecCcchhhh
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDL-KPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDI-Kp~NILld~~g~vkl~DFGla~~~ 159 (472)
+..|+||||++|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++++||+|||+|+..
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 458999999999999632 11 11 1468899999999999999999999 999999999999999999999876
Q ss_pred hcccCCCc------ccccCCCCcccChhhhccc
Q 012053 160 ESKHQDGL------LHTTCGTPAYVAPEVINRR 186 (472)
Q Consensus 160 ~~~~~~~~------~~~~~gt~~Y~aPE~l~~~ 186 (472)
........ +.+.++++.|+|||.+...
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 54332222 2466789999999988543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=235.63 Aligned_cols=253 Identities=20% Similarity=0.283 Sum_probs=207.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEE-E
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKT-----GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVM-A 80 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~ 80 (472)
+-..|+++.-.+-+|+||.||.|++++. .+.|-+|.+.... ..-....+..|-..+..+.|||+..+.++. +
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 4456889999999999999999988753 2345556553332 223456778888899999999999999997 4
Q ss_pred eCCEEEEEEEecCCCcccchhc-----c----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEe
Q 012053 81 SKTKIYFVMEYVKGGELFGKVA-----K----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVS 151 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~-----~----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~ 151 (472)
+.+..++++.+..-|+|..++. . +.++-.+...++.|++.|++|||++||+|.||...|.+||+.-++||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 5567888899998889988775 1 246777888899999999999999999999999999999999999999
Q ss_pred cCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-C
Q 012053 152 DFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-F 229 (472)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 229 (472)
|=.|++-.-....+..-........||+||.+....|. .++|+|||||+||||+| |+.|+-+-++.+++..++.+. .
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 99998855443333222233345579999999988886 78999999999999998 999999999999998888764 5
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.-|-.+++++-.++.-||..+|++||+.+|+..
T Consensus 518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 667789999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=221.72 Aligned_cols=158 Identities=22% Similarity=0.264 Sum_probs=127.8
Q ss_pred Ccccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccC
Q 012053 95 GELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC 172 (472)
Q Consensus 95 g~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 172 (472)
|+|.+++.. +.+++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 578888864 46999999999999999999999999 999999999999999 9988765331 236
Q ss_pred CCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhccCCCC-------CCCCCH--HHHHH
Q 012053 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGKAEFKF-------PNWFAP--EVRRL 242 (472)
Q Consensus 173 gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~-------~~~~s~--~l~~l 242 (472)
||+.|+|||++.+..+. .++|||||||++|+|++|..||...... ..+..+....... +..++. ++.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999887775 7999999999999999999999765432 3333332221111 122333 69999
Q ss_pred HhcccCCCCCCcCChhhhhcCccccc
Q 012053 243 LSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
|.+||..||.+|||+.++++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-27 Score=233.57 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=195.7
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhcCC----CCeeeEEEEE-EeCCE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTG-MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH----PNVVELYEVM-ASKTK 84 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 84 (472)
+|.+.+.||+|+||.||++.+..++ ..+|+|+......... ..++.|+.++..+.. +++..+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998774 6899999866532211 267889999998873 6999999999 58889
Q ss_pred EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-----CeEEecCcch
Q 012053 85 IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-----NLKVSDFGLS 156 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-----~vkl~DFGla 156 (472)
.|+||+.+ |.+|.++... +.++..++.+++.|++.+|+++|+.|++||||||+|++++..+ .+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 8888887642 6799999999999999999999999999999999999998653 5999999999
Q ss_pred hhhh--cccCC-----Cc-ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhc--
Q 012053 157 ALAE--SKHQD-----GL-LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK-- 226 (472)
Q Consensus 157 ~~~~--~~~~~-----~~-~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~-- 226 (472)
+... ..... .. .....||..|+++.+..+... +.+.|+||++.++.+|+.|.+||..........++..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8332 11111 11 123459999999999887765 4899999999999999999999977553222222222
Q ss_pred -cCC-C-CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 227 -AEF-K-FPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 227 -~~~-~-~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
... . +....+.++..+...+-..+...+|.+..+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 111 1 233356778888888888999999999988765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=254.89 Aligned_cols=238 Identities=34% Similarity=0.611 Sum_probs=208.2
Q ss_pred eEcccCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEEEec
Q 012053 17 LLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVMEYV 92 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 92 (472)
.+|+|+||+|++++.. ..|..+|+|+..+...... ....-+.|..++..++ ||.+|+++..+.++++.|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~-~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR-DRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccc-cccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 4799999999987643 4678899999877654322 2225567888888887 999999999999999999999999
Q ss_pred CCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccccc
Q 012053 93 KGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT 171 (472)
Q Consensus 93 ~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~ 171 (472)
.||+|+..+.. ..+.+.....+...++-+++++|+.||+|||+|++||+++.+|++++.|||+++..-... ..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hc
Confidence 99999988876 578899999999999999999999999999999999999999999999999998764422 22
Q ss_pred CCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCC
Q 012053 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNP 251 (472)
Q Consensus 172 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP 251 (472)
|||..|||||+.. +.. ..+|.||+|+++++|+||..||.. +....|.+..+.+|..++.++++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999997 444 689999999999999999999988 677788889999999999999999999999999
Q ss_pred CCcCCh-----hhhhcCccccc
Q 012053 252 NTRISM-----TKIMENSWFRK 268 (472)
Q Consensus 252 ~~Rpt~-----~eil~hp~f~~ 268 (472)
..|... .+|++|+||+.
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred HHHhccCcchhHHHhccchhee
Confidence 999865 69999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=214.78 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=203.5
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEeC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH-PNVVELYEVMASK 82 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~ 82 (472)
+..+..++|.++++||.|+||.+|+|.+..+|+.||||+-..... ..++..|..+.+.|++ ..|..+..+..+.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 345778899999999999999999999999999999999754432 2467789999999975 7888888889999
Q ss_pred CEEEEEEEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CCeEEecCcchh
Q 012053 83 TKIYFVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH---GNLKVSDFGLSA 157 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~---g~vkl~DFGla~ 157 (472)
.+-.+||+.. |.+|.++.. .+.++..+++-++-|++.-++|+|.++++||||||+|+|..-+ ..+.++|||||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 9999999998 778888875 3689999999999999999999999999999999999998644 358999999999
Q ss_pred hhhcccCCC-----cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---HHHHHHHHhccCC
Q 012053 158 LAESKHQDG-----LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKIGKAEF 229 (472)
Q Consensus 158 ~~~~~~~~~-----~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~ 229 (472)
.+....... .-....||..|.+-....+... +.+.|+-|+|.+|.++.-|.+||.+-. ...-|++|..-..
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 776543321 1223469999999877766554 478999999999999999999998743 3455666665544
Q ss_pred CC-----CCCCCHHHHHHHhcccCCCCCCcCChhhh
Q 012053 230 KF-----PNWFAPEVRRLLSKILDPNPNTRISMTKI 260 (472)
Q Consensus 230 ~~-----~~~~s~~l~~li~~~L~~dP~~Rpt~~ei 260 (472)
.. ...+|.++.-.+.-|-..--++-|+..-+
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 43 35688899988888877777777876544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=219.72 Aligned_cols=247 Identities=20% Similarity=0.352 Sum_probs=204.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 85 (472)
++.-.|+++++||+|+||..+.|.+..+++.||||.-.... .+.+++.|....+.|. .++|...|.+...+-+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 44458999999999999999999999999999999864432 3468999999999986 79999999999888888
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-----CeEEecCcchhh
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-----NLKVSDFGLSAL 158 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-----~vkl~DFGla~~ 158 (472)
.||||++ |-+|.|+..- ++|+...+..++.|++.-++|+|++.+|+|||||+|+||..-+ .+.|+|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999999 7788888764 5799999999999999999999999999999999999997544 489999999998
Q ss_pred hhcccCCC-----cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC---CcHHHHHHHHhccCCC
Q 012053 159 AESKHQDG-----LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD---SNLMEMYRKIGKAEFK 230 (472)
Q Consensus 159 ~~~~~~~~-----~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~---~~~~~~~~~i~~~~~~ 230 (472)
+....... ....-.||..||+-....+...+ .+.|+-|||-+++++|-|.+||.+ .+..+-|++|....-.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 76654322 22344699999998888887765 889999999999999999999986 5566778888755433
Q ss_pred -----CCCCCCHHHHHHHhcccCCCCCCcCChhhh
Q 012053 231 -----FPNWFAPEVRRLLSKILDPNPNTRISMTKI 260 (472)
Q Consensus 231 -----~~~~~s~~l~~li~~~L~~dP~~Rpt~~ei 260 (472)
+...++.++...++-.-..+-.+-|+++-+
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 234577788877776666666777777644
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=207.51 Aligned_cols=176 Identities=16% Similarity=0.220 Sum_probs=138.4
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHH------HHHHHHHHHhcCCCCeeeEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQ------IKREISVMRLVRHPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~~~~ 79 (472)
.++.++|++.+.||.|+||.||++.+ ++..+|+|++..+.......... +.+|+..+.++.||+|..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 36789999999999999999999755 57789999997665444444333 68999999999999999999886
Q ss_pred EeC--------CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEe
Q 012053 80 ASK--------TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVS 151 (472)
Q Consensus 80 ~~~--------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~ 151 (472)
... +..+++|||++|.+|.+.. .+++. ...+++.++..||+.|++|||+||.||+++.+| ++|+
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~---~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP---EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh---hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 533 3589999999999997763 23332 456999999999999999999999999999998 9999
Q ss_pred cCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHh
Q 012053 152 DFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLL 206 (472)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll 206 (472)
|||........... ........|. .++|+||||+++..+.
T Consensus 177 Dfg~~~~~~e~~a~--------------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK--------------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH--------------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 99976544221110 1133445566 7899999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=198.80 Aligned_cols=142 Identities=20% Similarity=0.253 Sum_probs=113.3
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchh-----------------------hHHHHHHHHHHHHhcCCCC
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG-----------------------MIDQIKREISVMRLVRHPN 71 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpn 71 (472)
...||+|+||.||+|.+. +|+.||||+++........ ......+|+.+++.+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999765321111 0123456999999998887
Q ss_pred eeeEEEEEEeCCEEEEEEEecCCCcccch-hccCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEcCCCCeE
Q 012053 72 VVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYC-HSRGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~-i~~~~l~e~~~~~i~~ql~~al~yL-H~~giiHrDIKp~NILld~~g~vk 149 (472)
+.....+.... .|+||||+.|+++... +..+++++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 75544433222 3899999999877654 4457899999999999999999999 799999999999999998 57899
Q ss_pred EecCcchhhhh
Q 012053 150 VSDFGLSALAE 160 (472)
Q Consensus 150 l~DFGla~~~~ 160 (472)
|+|||+|....
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=238.61 Aligned_cols=259 Identities=32% Similarity=0.561 Sum_probs=220.6
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLK-TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIY 86 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 86 (472)
...|.+.+.||+|+|+.|-++.+.. +...+|+|.+.... ......+.+..|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5679999999999999999888754 34567777775543 23345677788999988887 999999999999999999
Q ss_pred EEEEecCCCcccchh-ccC--CCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEcCCC-CeEEecCcchhhhhc
Q 012053 87 FVMEYVKGGELFGKV-AKG--KLKEDAARKYFQQLISAVDYCH-SRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAES 161 (472)
Q Consensus 87 lV~E~~~gg~L~~~i-~~~--~l~e~~~~~i~~ql~~al~yLH-~~giiHrDIKp~NILld~~g-~vkl~DFGla~~~~~ 161 (472)
++++|..|+++++.+ ... ..+...+..++.|+..++.|+| ..++.||||||+|.+++.++ +++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 653 6888899999999999999999 99999999999999999999 999999999998877
Q ss_pred -ccCCCcccccCC-CCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH-HHHHHhcc--C--CCCCCC
Q 012053 162 -KHQDGLLHTTCG-TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME-MYRKIGKA--E--FKFPNW 234 (472)
Q Consensus 162 -~~~~~~~~~~~g-t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~-~~~~i~~~--~--~~~~~~ 234 (472)
..........|| ++.|+|||.+.+..|.+...|+||+|+++..+++|..||....... .+..+... . ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 666667788899 9999999999988888999999999999999999999998754432 22222222 2 222334
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
++....+++.++|..+|..|.+.+++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 7889999999999999999999999999999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=233.68 Aligned_cols=220 Identities=32% Similarity=0.628 Sum_probs=176.1
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
.-..|..++++..|+||.||+++|+.+.+.+|+ .++++... +++ |+.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li-------lRn---ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-------LRN---ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccchh-------hhc---cccccCCccee--------------
Confidence 345799999999999999999999999999999 45554322 111 44444555555
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC-
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD- 165 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~- 165 (472)
|+-...++. |.++.+. +.+++|||+-||+|||+||+|+||..-|++|+.|||++.........
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 333334433 5566554 77999999999999999999999999999999999998643211100
Q ss_pred ------------CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC
Q 012053 166 ------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN 233 (472)
Q Consensus 166 ------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 233 (472)
-.....||||.|+|||++...+|- ..+|.|++|+|+|+++-|..||.++..++++..+......+|.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 112345999999999999999985 8899999999999999999999999999999999888777765
Q ss_pred C---CCHHHHHHHhcccCCCCCCcC---ChhhhhcCccccc
Q 012053 234 W---FAPEVRRLLSKILDPNPNTRI---SMTKIMENSWFRK 268 (472)
Q Consensus 234 ~---~s~~l~~li~~~L~~dP~~Rp---t~~eil~hp~f~~ 268 (472)
. ++++++++|.++|+.+|..|. ..-++.+|+||+.
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 4 789999999999999999996 4568889999985
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=193.22 Aligned_cols=142 Identities=19% Similarity=0.249 Sum_probs=115.7
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch-----------------------hhHHHHHHHHHHHHhcCCCC
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV-----------------------GMIDQIKREISVMRLVRHPN 71 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----------------------~~~~~~~~Ei~il~~l~hpn 71 (472)
.+.||+|+||.||+|.+. +|+.||||+++....... .......+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 899999999986531100 01234568999999999998
Q ss_pred eeeEEEEEEeCCEEEEEEEecCCCcccc-hhccCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeE
Q 012053 72 VVELYEVMASKTKIYFVMEYVKGGELFG-KVAKGKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vk 149 (472)
+.....+.... .|+||||++|+++.. .+..+++++..+..++.|++.++.++|+ +||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 86555544333 489999999885543 3556788999999999999999999999 9999999999999999 88999
Q ss_pred EecCcchhhhh
Q 012053 150 VSDFGLSALAE 160 (472)
Q Consensus 150 l~DFGla~~~~ 160 (472)
|+|||+|....
T Consensus 158 liDFG~a~~~~ 168 (190)
T cd05145 158 IIDVSQAVELD 168 (190)
T ss_pred EEEcccceecC
Confidence 99999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=201.16 Aligned_cols=234 Identities=26% Similarity=0.360 Sum_probs=151.5
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC----------CCCeeeEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR----------HPNVVELYEVMA 80 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~----------hpnIv~l~~~~~ 80 (472)
.+..++.||.|+++.||.+.+..||+.+|+|++...........+.+++|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3567889999999999999999999999999987655434455777877775554432 223333333321
Q ss_pred ---------eC---CE-----EEEEEEecCCCcccchhcc----CCC----CHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 012053 81 ---------SK---TK-----IYFVMEYVKGGELFGKVAK----GKL----KEDAARKYFQQLISAVDYCHSRGVCHRDL 135 (472)
Q Consensus 81 ---------~~---~~-----~~lV~E~~~gg~L~~~i~~----~~l----~e~~~~~i~~ql~~al~yLH~~giiHrDI 135 (472)
.. +. .+++|+-+ .++|.+.+.- ... .......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 12 35677776 4577665431 222 12222344589999999999999999999
Q ss_pred CCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccC-------CCCCcccchhhhHHHHHHhcC
Q 012053 136 KPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG-------YDGSKADIWSCGVILYVLLAG 208 (472)
Q Consensus 136 Kp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-------~~~~~~DiwSlGvil~~lltG 208 (472)
+|+|++++.+|.+.|+||+.....+.... ....+..|.+||...... ..+.+.|.|+||+++|.|+||
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999987665443221 133457899999874431 124788999999999999999
Q ss_pred CCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCc
Q 012053 209 YLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTR 254 (472)
Q Consensus 209 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 254 (472)
.+||.......... ..+.....++..++.||+.+|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~----~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPE----WDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSG----GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccccc----ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99998654332111 0233333788999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=189.10 Aligned_cols=192 Identities=19% Similarity=0.252 Sum_probs=144.5
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhh-HHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGM-IDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~-~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 89 (472)
..+...|++|+||+||++.. .+..++.+.+.......... ...+.+|+++|++|. |++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678999999999998876 77888877776554322111 225789999999995 5889999886 3469999
Q ss_pred EecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEcCCCCeEEecCcchhhhhcccCC---
Q 012053 90 EYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDL-KPENLLLDEHGNLKVSDFGLSALAESKHQD--- 165 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDI-Kp~NILld~~g~vkl~DFGla~~~~~~~~~--- 165 (472)
||+.|.+|...+..+ ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 78 SYLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eeecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 999999987543221 2357889999999999999999999 799999999999999999999854322210
Q ss_pred -C-------cccccCCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCC
Q 012053 166 -G-------LLHTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDS 215 (472)
Q Consensus 166 -~-------~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~ 215 (472)
. .......++.|++|+...--. ..-...+.++.|+-+|.++|+.+++..+
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 011234788999998753322 1224679999999999999999986543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-23 Score=224.52 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=182.0
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccc-ccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEK-VLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
.|...+.||.+-|=+|.+|.+. .| .|+||++-+.. ...-....+-.+|++ ...++|||.+.+.-+.+++...|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6889999999999999999984 44 49999997654 222222333344555 66779999999999988888899999
Q ss_pred EecCCCcccchhccCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc--cCCC
Q 012053 90 EYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK--HQDG 166 (472)
Q Consensus 90 E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~--~~~~ 166 (472)
+|+.. +|+|++..++ +..-+.+.|+.||+.||..||..||+|+|||.||||+..-..+.|+||..-+..--+ ....
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 99954 8999998765 677888999999999999999999999999999999999999999999754321111 1110
Q ss_pred ---cccccCCCCcccChhhhcccC----------CCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC--CC
Q 012053 167 ---LLHTTCGTPAYVAPEVINRRG----------YDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE--FK 230 (472)
Q Consensus 167 ---~~~~~~gt~~Y~aPE~l~~~~----------~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~--~~ 230 (472)
...+...-.+|+|||.+...+ .-+++.||||+||+++||++ |++||.-..... |+.-.... ..
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a-Yr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA-YRSGNADDPEQL 258 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh-HhccCccCHHHH
Confidence 122334455799999985422 12467899999999999988 688884322111 11110000 00
Q ss_pred CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 231 FPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 231 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+..--+..+++||..|++.||.+|.++++.|+.
T Consensus 259 Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 000013468999999999999999999999875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=185.38 Aligned_cols=132 Identities=20% Similarity=0.265 Sum_probs=108.5
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-----CCCCeeeEEEEEEeCC---EEE
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-----RHPNVVELYEVMASKT---KIY 86 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~ 86 (472)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ .||||++++++++++. .+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 47899999999995 7667666 6999876532 2346789999999999 5799999999998874 444
Q ss_pred -EEEEe--cCCCcccchhccCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCcEEEcCC----CCeEEecCc
Q 012053 87 -FVMEY--VKGGELFGKVAKGKLKEDAARKYFQQLISAV-DYCHSRGVCHRDLKPENLLLDEH----GNLKVSDFG 154 (472)
Q Consensus 87 -lV~E~--~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al-~yLH~~giiHrDIKp~NILld~~----g~vkl~DFG 154 (472)
+|||| +.+++|.+++.++.+++. ..++.|++.++ +|||+++|+||||||+|||++.+ ++++|+||+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 557999999988777777 35678888777 99999999999999999999743 379999954
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=195.81 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=176.3
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCc-----------------------------------EEEEEEeeccccc--c
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGM-----------------------------------SVAIKIIDKEKVL--K 50 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----------------------------------~vAiK~i~~~~~~--~ 50 (472)
-.+.|++++.||+|.-+.||.|+-..+|. +.|||.+-.-... .
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 34679999999999999999887553211 3566655221111 1
Q ss_pred hhhHHHHHHHHH------HH--------Hh--------cCCCCeeeEEEEEEe---------------------------
Q 012053 51 VGMIDQIKREIS------VM--------RL--------VRHPNVVELYEVMAS--------------------------- 81 (472)
Q Consensus 51 ~~~~~~~~~Ei~------il--------~~--------l~hpnIv~l~~~~~~--------------------------- 81 (472)
....+.+.+|.. .+ +. -+|||||++.++|.+
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 122333334321 11 11 259999999887632
Q ss_pred CCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE--cCCC--CeEEecCcchh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL--DEHG--NLKVSDFGLSA 157 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl--d~~g--~vkl~DFGla~ 157 (472)
+..+|+||...+ .+|..++-.+..+-...+-++.|+++|+.|||.+||.|||+|.+|||+ |+|+ .+.|+|||.+-
T Consensus 315 ~~tlylvMkrY~-~tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 315 PKTLYLVMKRYR-QTLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred CceEEEehhcch-hhHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 335899998874 488888888888889999999999999999999999999999999998 4444 48999999754
Q ss_pred hhhcccC----CCcccccCCCCcccChhhhcccC-----CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHH--HHHhc
Q 012053 158 LAESKHQ----DGLLHTTCGTPAYVAPEVINRRG-----YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMY--RKIGK 226 (472)
Q Consensus 158 ~~~~~~~----~~~~~~~~gt~~Y~aPE~l~~~~-----~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~--~~i~~ 226 (472)
--....- ....-..-|.-.-||||+....+ .+-.++|.|++|.+.||+++...||.....+.+- ..-..
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~ 473 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES 473 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh
Confidence 2221100 01112345777899999985332 1124899999999999999999999875443221 11122
Q ss_pred cCCCCCCCCCHHHHHHHhcccCCCCCCcCChh
Q 012053 227 AEFKFPNWFAPEVRRLLSKILDPNPNTRISMT 258 (472)
Q Consensus 227 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~ 258 (472)
.-+.+|..+++.+++++..+|++||++|++..
T Consensus 474 qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 474 QLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred hCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 33567888999999999999999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.4e-21 Score=181.58 Aligned_cols=143 Identities=18% Similarity=0.197 Sum_probs=115.2
Q ss_pred EEEEeeEcccCCeEEEEEE-EcCCCcEEEEEEeecccccc---------------------hhhHHHHHHHHHHHHhcCC
Q 012053 12 YELGRLLGQGTFAKVHYAR-NLKTGMSVAIKIIDKEKVLK---------------------VGMIDQIKREISVMRLVRH 69 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~-~~~~g~~vAiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~h 69 (472)
|++.+.||+|+||.||+|. +..+|+.||+|++....... ......+.+|+.+++.+.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7899999999999999999 66799999999997543110 0012346789999999975
Q ss_pred C--CeeeEEEEEEeCCEEEEEEEecCCCcccchh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEcCC
Q 012053 70 P--NVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCHSRG-VCHRDLKPENLLLDEH 145 (472)
Q Consensus 70 p--nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i-~~~~l~e~~~~~i~~ql~~al~yLH~~g-iiHrDIKp~NILld~~ 145 (472)
. .++++++. ...|+||||+.|.+|.... ....+.+..+..++.||+.++.+||++| |+||||||+||+++ +
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~ 184 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D 184 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence 3 34455543 2358999999998887665 3456777778899999999999999999 99999999999999 8
Q ss_pred CCeEEecCcchhhh
Q 012053 146 GNLKVSDFGLSALA 159 (472)
Q Consensus 146 g~vkl~DFGla~~~ 159 (472)
+.++|+|||.+...
T Consensus 185 ~~i~LiDFg~a~~~ 198 (237)
T smart00090 185 GKVVIIDVSQSVEL 198 (237)
T ss_pred CCEEEEEChhhhcc
Confidence 89999999987754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.8e-22 Score=184.02 Aligned_cols=242 Identities=20% Similarity=0.361 Sum_probs=196.4
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-++...+..+|.+.-.|+.|+|++ .|..++.|+++-.... ......+..|.-.|+...||||+.+++.+.+..++.+
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred chhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 345566788999999999999998 5667888887655432 2334568889999999999999999999999999999
Q ss_pred EEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCCeEEe--cCcchhhhh
Q 012053 88 VMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRG--VCHRDLKPENLLLDEHGNLKVS--DFGLSALAE 160 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~g--iiHrDIKp~NILld~~g~vkl~--DFGla~~~~ 160 (472)
+..|++-|+|+..+..+ ..+..++.+++.++++|+.|||+.. |.---|....+++|++-..+|+ |--++-
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--- 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--- 341 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---
Confidence 99999999999999764 3678899999999999999999874 4445688899999998876664 221111
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCC--CcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHH--hccCCCCCCCCC
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDG--SKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI--GKAEFKFPNWFA 236 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~--~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i--~~~~~~~~~~~s 236 (472)
.. ....-.|.||+||.++.++.+. .++|+|||.+++|||.|.+.||.+-++++.--+| ......+|+.++
T Consensus 342 -qe-----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis 415 (448)
T KOG0195|consen 342 -QE-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGIS 415 (448)
T ss_pred -ec-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCcc
Confidence 11 1234578999999998776542 4799999999999999999999998887655444 345678999999
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhh
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIM 261 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil 261 (472)
+....|+.-|+..||.+||.++.|+
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceeh
Confidence 9999999999999999999998874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=169.31 Aligned_cols=137 Identities=23% Similarity=0.335 Sum_probs=116.1
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV-----GMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+.||+|++|.||+|.+ +|..+++|+......... .....+.+|+.++..+.|++|+....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 788899998754332111 123467889999999999999888888777888999999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhh
Q 012053 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~ 158 (472)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988865322 7889999999999999999999999999999999 78999999998764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.1e-20 Score=201.15 Aligned_cols=236 Identities=19% Similarity=0.330 Sum_probs=176.5
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
...|.|-+.||+|+||+||.|.+.. |+.||+|+-.....+.--...+++..+. +. --+.|..++..+.-.+.-++|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccCCcceee
Confidence 4589999999999999999999866 9999999987776554333344433333 11 135566666666677778999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-------CCCCeEEecCcchhhhh
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD-------EHGNLKVSDFGLSALAE 160 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld-------~~g~vkl~DFGla~~~~ 160 (472)
+||.+-|+|.+++.. +.+++..+..+..|++..|+.||..||||+||||+|.||. .+--++|+|||-|.-..
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 999999999999976 6799999999999999999999999999999999999993 22349999999876443
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-C----CCCCCC
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-F----KFPNWF 235 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~----~~~~~~ 235 (472)
--.....+...++|-.+-.+|...++.+. +.+|.|.|..+++.||.|+.- + ...+. . .++..+
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~-------q----~~~g~~~~~~~~~~Ry~ 920 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYM-------E----VKNGSSWMVKTNFPRYW 920 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHH-------H----hcCCcceeccccchhhh
Confidence 32222346678899999999999999886 999999999999999998532 1 22221 1 122222
Q ss_pred CHH-HHHHHhcccCCCCCCcCChhhh
Q 012053 236 APE-VRRLLSKILDPNPNTRISMTKI 260 (472)
Q Consensus 236 s~~-l~~li~~~L~~dP~~Rpt~~ei 260 (472)
..+ .-+++..+|.+|-..=|...+|
T Consensus 921 ~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 921 KRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred hHHHHHHHHHHHhCcCcccchhHHHH
Confidence 222 3467788888555444555554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=167.55 Aligned_cols=139 Identities=19% Similarity=0.278 Sum_probs=110.3
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch-------------------hhHHHHHHHHHHHHhcCCCC-
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV-------------------GMIDQIKREISVMRLVRHPN- 71 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~hpn- 71 (472)
|.+.+.||+|+||.||++.+. +|+.||||++........ .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 889999999999999999874 899999999865431000 01123678899999998774
Q ss_pred -eeeEEEEEEeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEE
Q 012053 72 -VVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 72 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl 150 (472)
++..++ ....++||||++|++|...... .....++.+++.++.++|+.||+||||||+||++++++.++|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 444443 2345899999999988765431 346678899999999999999999999999999999999999
Q ss_pred ecCcchhhhh
Q 012053 151 SDFGLSALAE 160 (472)
Q Consensus 151 ~DFGla~~~~ 160 (472)
+|||++....
T Consensus 167 iDfg~~~~~~ 176 (198)
T cd05144 167 IDWPQMVSTD 176 (198)
T ss_pred EECCccccCC
Confidence 9999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.7e-19 Score=164.42 Aligned_cols=133 Identities=21% Similarity=0.294 Sum_probs=109.2
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeecccccc-----hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEe
Q 012053 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK-----VGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 91 (472)
.||+|+||+||+|.. +|..+++|......... .....++.+|+.+++.+.|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 77899999965432211 11246678999999999988776665566667778999999
Q ss_pred cCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhh
Q 012053 92 VKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~ 158 (472)
++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887754321 7899999999999999999999999999999 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-18 Score=185.38 Aligned_cols=140 Identities=21% Similarity=0.290 Sum_probs=113.6
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-----KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
..|...+.||+|+||+||++.+. +..+++|+....... .....+.+.+|+.+++.++|++++.++.+......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34567899999999999999874 444555543222111 11123568899999999999999988888777778
Q ss_pred EEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 85 IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
.++||||++|++|.+.+. ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999988775 457789999999999999999999999999999 6788999999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=158.66 Aligned_cols=138 Identities=20% Similarity=0.304 Sum_probs=102.0
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHH---------------------HHHHHHHHHHhcCCC--C
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID---------------------QIKREISVMRLVRHP--N 71 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~hp--n 71 (472)
++.||+|+||+||.|.+. +|+.||||++............ ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999986 8999999998764322111111 114567777666544 3
Q ss_pred eeeEEEEEEeCCEEEEEEEecCCCcccc-hhccCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeE
Q 012053 72 VVELYEVMASKTKIYFVMEYVKGGELFG-KVAKGKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 72 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vk 149 (472)
+.+++++ ...++||||++|+.+.. .+...... ..++.++.+++.++.++|+ +||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 5555554 23589999999965432 22221111 6788999999999999999 9999999999999999 89999
Q ss_pred EecCcchhhh
Q 012053 150 VSDFGLSALA 159 (472)
Q Consensus 150 l~DFGla~~~ 159 (472)
|+|||.+...
T Consensus 155 liDfg~a~~~ 164 (187)
T cd05119 155 IIDVPQAVEI 164 (187)
T ss_pred EEECcccccc
Confidence 9999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-19 Score=182.55 Aligned_cols=248 Identities=23% Similarity=0.316 Sum_probs=167.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEE-------E
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYE-------V 78 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-------~ 78 (472)
...+.+.+-.+..+++.+....-..+ .+.++-+..+..+ ........+++-.+.-..|-+..-+.+ .
T Consensus 243 ~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~ 319 (516)
T KOG1033|consen 243 SGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES 319 (516)
T ss_pred cccccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence 34566667777777777765543322 2333333332222 122334455555555544433332222 1
Q ss_pred E-----EeCCEEEEEEEecCCCcccchhccC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeE
Q 012053 79 M-----ASKTKIYFVMEYVKGGELFGKVAKG----KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLK 149 (472)
Q Consensus 79 ~-----~~~~~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vk 149 (472)
+ ....+.|+.|++|.-.+|.+++... ..+......++.|++.|++| +|.+|||+||.||+...++.+|
T Consensus 320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence 1 1133589999999999999999753 36677889999999999999 9999999999999999999999
Q ss_pred EecCcchhhhhccc----CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHH
Q 012053 150 VSDFGLSALAESKH----QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKI 224 (472)
Q Consensus 150 l~DFGla~~~~~~~----~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i 224 (472)
|.|||+........ .........||..||+||.+.+..|. .++||||||+||+||+. =..+|... .....+
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~ 472 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFERI---ATLTDI 472 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHHH---Hhhhhh
Confidence 99999977554333 11123456799999999999998886 89999999999999997 23333221 222233
Q ss_pred hccCCCCCCCC-CHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 225 GKAEFKFPNWF-APEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 225 ~~~~~~~~~~~-s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
..+.++..-+. -|+-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 473 r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 33333211111 2455689999999999999977777666664
|
|
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.7e-19 Score=129.74 Aligned_cols=60 Identities=68% Similarity=1.025 Sum_probs=48.3
Q ss_pred CCCCCCchhhhccCCCCCCCCchhhhhh---cccceeeccCCHHHHHHHHHHHHhHcCcEEEE
Q 012053 310 KPCNLNAFDIISFSAGFDLSGLFEEREK---RKEVRFTSNKPVSTIISKLEGIAKLLRLKVKK 369 (472)
Q Consensus 310 ~~~~~~~f~~~~~s~~~~ls~l~~~~~~---~~~~rf~s~~~~~~i~~~l~~~~~~l~~~v~~ 369 (472)
+|..+|||||||||+|||||+||++... ++++||+|+.||++|++|||++|+.+||+|+|
T Consensus 1 ~p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 1 KPKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp --EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CCccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 3668999999999999999999986543 57999999999999999999999999999986
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=159.40 Aligned_cols=137 Identities=18% Similarity=0.301 Sum_probs=107.4
Q ss_pred eeEc-ccCCeEEEEEEEcCCCcEEEEEEeecccc----c------chhhHHHHHHHHHHHHhcCCCCe--eeEEEEEEeC
Q 012053 16 RLLG-QGTFAKVHYARNLKTGMSVAIKIIDKEKV----L------KVGMIDQIKREISVMRLVRHPNV--VELYEVMASK 82 (472)
Q Consensus 16 ~~LG-~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~----~------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~ 82 (472)
..|| .||.|+||.+.. .+..++||.+..... . ......++.+|+.++..++|++| ++++++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888888876 478999998864321 0 11223568899999999998875 6777764332
Q ss_pred -C---EEEEEEEecCC-CcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 83 -T---KIYFVMEYVKG-GELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 83 -~---~~~lV~E~~~g-g~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
. ..++|||+++| .+|.+++..+.+++.. +.+|+.+|.+||++||+||||||+|||++.++.++|+|||.+.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 2 23599999998 6888888777777654 5689999999999999999999999999999999999999876
Q ss_pred h
Q 012053 158 L 158 (472)
Q Consensus 158 ~ 158 (472)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 4
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.5e-18 Score=172.88 Aligned_cols=199 Identities=25% Similarity=0.378 Sum_probs=156.2
Q ss_pred HHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCcE
Q 012053 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGV-CHRDLKPENL 140 (472)
Q Consensus 64 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~al~yLH~~gi-iHrDIKp~NI 140 (472)
|+.+.|.|+.+++|.+.++...+.|.+||.-|+|.+.+... .++......++++|+.||.|+|+..| +|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 46788999999999999999999999999999999999774 57777788899999999999998865 9999999999
Q ss_pred EEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCC------CCCcccchhhhHHHHHHhcCCCCCCC
Q 012053 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY------DGSKADIWSCGVILYVLLAGYLPFHD 214 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~------~~~~~DiwSlGvil~~lltG~~Pf~~ 214 (472)
++|....+||+|||+..+..............-..-|.|||.+..... -+.+.||||+|++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999776542111111112223446899999876422 24679999999999999999999976
Q ss_pred C----cHHHHHHHHhc-cCCCCCC------CCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 215 S----NLMEMYRKIGK-AEFKFPN------WFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 215 ~----~~~~~~~~i~~-~~~~~~~------~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
. ...+...++.+ +...+-+ .+.+++..++.+|+..+|..||++++|-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 2 22345555555 2222211 24557899999999999999999998854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-16 Score=139.12 Aligned_cols=132 Identities=23% Similarity=0.322 Sum_probs=113.8
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCCEEEEEEEe
Q 012053 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH--PNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 91 (472)
+++.||.|.++.||++.+ .+..+++|.+..... ...+.+|+.+++.++| .++++++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 468899999999999998 447899999865532 3568899999999976 5899999998888899999999
Q ss_pred cCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEcCCCCeEEecCcchhh
Q 012053 92 VKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR---GVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~---giiHrDIKp~NILld~~g~vkl~DFGla~~ 158 (472)
+.|+.+... +......++.+++.++.++|.. +++|+|++|+||+++.++.++++|||++..
T Consensus 75 ~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877654 5667778899999999999985 799999999999999989999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.1e-17 Score=178.37 Aligned_cols=261 Identities=25% Similarity=0.432 Sum_probs=210.7
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
-.+.+.+.+-+-.|+++.++.+.-..+|...++|+..+.........+.+..+-.++-...+|-++.....+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45567888899999999999999888888888887654433322223444445555555566777776666667788999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc----
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK---- 162 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~---- 162 (472)
+++|+.|++|...+.. +..+++-++.++..+..+++|||+..+.|||++|.|+|...+|..+++|||........
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999999999999987 66899999999999999999999999999999999999999999999999843211100
Q ss_pred ------------------cCC-------CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH
Q 012053 163 ------------------HQD-------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL 217 (472)
Q Consensus 163 ------------------~~~-------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~ 217 (472)
... ..-....||+.|.+||.+.+... +..+|.|+.|+++++.++|..||.+...
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 000 01223468999999999987765 4789999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCC---CCCHHHHHHHhcccCCCCCCcCChh---hhhcCcccccC
Q 012053 218 MEMYRKIGKAEFKFPN---WFAPEVRRLLSKILDPNPNTRISMT---KIMENSWFRKG 269 (472)
Q Consensus 218 ~~~~~~i~~~~~~~~~---~~s~~l~~li~~~L~~dP~~Rpt~~---eil~hp~f~~~ 269 (472)
...++.|.+.....|. ..++++++++.++|..+|.+|..+. ++-.|+||+..
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 9999999888776654 3789999999999999999999988 89999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.9e-16 Score=162.10 Aligned_cols=257 Identities=19% Similarity=0.221 Sum_probs=196.9
Q ss_pred cccCCEEEEeeEcc--cCCeEEEEEEE--cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEe
Q 012053 7 ILMQRYELGRLLGQ--GTFAKVHYARN--LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMAS 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~--G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 81 (472)
....++.+...+|. |.+|.||.+.. ..++..+|+|.-+.... .......-.+|+...+.++ |+|.++.+..++.
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCccccc
Confidence 44557788899999 99999999998 88999999998322111 0011122346777777775 9999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc-C-CCCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCcEEEcCC-CCeEEecCc
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK-G-KLKEDAARKYFQQLIS----AVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFG 154 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~ql~~----al~yLH~~giiHrDIKp~NILld~~-g~vkl~DFG 154 (472)
.+..|+-+|++. .+|..+... . -+++..++..+.+... ||.++|+.+++|-|+||+||+...+ ...+++|||
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 999999999994 677777654 4 4899999999999999 9999999999999999999999999 889999999
Q ss_pred chhhhhcccCCCcc---cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC--cHHHHHHHHhccCC
Q 012053 155 LSALAESKHQDGLL---HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS--NLMEMYRKIGKAEF 229 (472)
Q Consensus 155 la~~~~~~~~~~~~---~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~--~~~~~~~~i~~~~~ 229 (472)
+...+....-.... ....|...|++||...+ ..+...|+|++|.+..+-.+|..+.... +.....+.+. ...
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~ 345 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPL 345 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cch
Confidence 98776554322211 12257778999998754 4467899999999999999887765443 2222111111 222
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.+....+.++...+..|++.+|-.|++.+.+++|+++..
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 333445677888999999999999999999999998875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.7e-14 Score=150.22 Aligned_cols=141 Identities=22% Similarity=0.311 Sum_probs=98.2
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch-------------------------------hhHH------HHH
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV-------------------------------GMID------QIK 58 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-------------------------------~~~~------~~~ 58 (472)
+.||.|++|.||+|+. .+|+.||||+......... .... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999986 5899999999865321000 0001 134
Q ss_pred HHHHHHHhcC-----CCCeeeEEEEEEeCCEEEEEEEecCCCcccchhccC--CCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 012053 59 REISVMRLVR-----HPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKG--KLKEDAARKYFQQLIS-AVDYCHSRGV 130 (472)
Q Consensus 59 ~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~-al~yLH~~gi 130 (472)
+|+..+.+++ ++++.-..-+....+..++||||++|++|.+..... ..+ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 4555555442 344432222233345679999999999998876432 222 2345566655 4788999999
Q ss_pred eecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 131 iHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
+|+|+||.||+++.+|.++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.9e-15 Score=158.11 Aligned_cols=144 Identities=22% Similarity=0.397 Sum_probs=100.2
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--------------------------c-----hhhHHHH
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--------------------------K-----VGMIDQI 57 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--------------------------~-----~~~~~~~ 57 (472)
...|+. +.||.|++|.||.|+...+|+.||||+.++.... + .+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456777 8999999999999999888999999999754210 0 0122333
Q ss_pred HHHHHH------HHhcC----CCCeeeEEEEE-EeCCEEEEEEEecCCCcccch--hcc-C----CCCHHHHHHHHHHHH
Q 012053 58 KREISV------MRLVR----HPNVVELYEVM-ASKTKIYFVMEYVKGGELFGK--VAK-G----KLKEDAARKYFQQLI 119 (472)
Q Consensus 58 ~~Ei~i------l~~l~----hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~--i~~-~----~l~e~~~~~i~~ql~ 119 (472)
.+|++. +.+++ +.+.+.+-.++ +-.+..++||||+.|+.+.+. +.. + .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 444443 33332 33333333333 235567899999999999764 322 3 355566666666665
Q ss_pred HHHHHHHhCCceecCCCCCcEEEcCCC----CeEEecCcchhhhh
Q 012053 120 SAVDYCHSRGVCHRDLKPENLLLDEHG----NLKVSDFGLSALAE 160 (472)
Q Consensus 120 ~al~yLH~~giiHrDIKp~NILld~~g----~vkl~DFGla~~~~ 160 (472)
..|++|+|+||.||+++.+| .++++|||++....
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 48999999999999999988 99999999987554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.4e-13 Score=124.01 Aligned_cols=141 Identities=18% Similarity=0.230 Sum_probs=104.5
Q ss_pred EeeEcccCCeEEEEEEEcC------CCcEEEEEEeecccc-------------------cchhhHHH----HHHHHHHHH
Q 012053 15 GRLLGQGTFAKVHYARNLK------TGMSVAIKIIDKEKV-------------------LKVGMIDQ----IKREISVMR 65 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~-------------------~~~~~~~~----~~~Ei~il~ 65 (472)
...||.|--+.||.|.... .+..+|||+...... .+...... .++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 357999999742110 00111223 348999999
Q ss_pred hcCC--CCeeeEEEEEEeCCEEEEEEEecCCCcccc-hhccCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEE
Q 012053 66 LVRH--PNVVELYEVMASKTKIYFVMEYVKGGELFG-KVAKGKLKEDAARKYFQQLISAVDYC-HSRGVCHRDLKPENLL 141 (472)
Q Consensus 66 ~l~h--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~i~~ql~~al~yL-H~~giiHrDIKp~NIL 141 (472)
++.. -++++++++ ..-++||||+.+..+.. .+....+++..+..++.+++.+|..+ |..|++|+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9863 566677765 45689999997754432 33344566777888899999999999 8999999999999999
Q ss_pred EcCCCCeEEecCcchhhhh
Q 012053 142 LDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 142 ld~~g~vkl~DFGla~~~~ 160 (472)
++ ++.+.|+|||.|....
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 97 4689999999776543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-13 Score=123.12 Aligned_cols=127 Identities=20% Similarity=0.320 Sum_probs=97.2
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEEEEEecC
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~ 93 (472)
++.|+.|.++.||.++. .+..|++|+...... ......+|+.+++.+.+.++ .+++.+.. +..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999987 478999999755431 11245789999998875554 45555433 33589999999
Q ss_pred CCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 94 GGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGV-----CHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 94 gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~gi-----iHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
|.++... ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 11123457899999999999985 9999999999999 6789999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.9e-13 Score=138.59 Aligned_cols=171 Identities=18% Similarity=0.331 Sum_probs=131.0
Q ss_pred EEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcccchhccCCCC
Q 012053 28 YARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLK 107 (472)
Q Consensus 28 ~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~ 107 (472)
.|..+.++.+|.|.+.+.+.- ...+.+++-+.-|+.++||||+++++.++.++.+|+|+|.+.. |..+++. ++
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~--l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE--LG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH--hH
Confidence 355677899999999876643 4456788889999999999999999999999999999999864 4444443 33
Q ss_pred HHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhccc
Q 012053 108 EDAARKYFQQLISAVDYCH-SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR 186 (472)
Q Consensus 108 e~~~~~i~~ql~~al~yLH-~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~ 186 (472)
...+..-++||+.||.||| ..+++|++|.-..|+++..|..||.+|.++........ ......---.|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 7777888999999999998 56899999999999999999999999998764432221 01111112246677765333
Q ss_pred CCCCCcccchhhhHHHHHHhcCCC
Q 012053 187 GYDGSKADIWSCGVILYVLLAGYL 210 (472)
Q Consensus 187 ~~~~~~~DiwSlGvil~~lltG~~ 210 (472)
+ -..|.|.|||++++++.|.+
T Consensus 181 ~---~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 181 E---WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred c---cchhhhhHHHHHHHHhCccc
Confidence 2 24799999999999999943
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.4e-14 Score=144.42 Aligned_cols=253 Identities=19% Similarity=0.177 Sum_probs=189.9
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEc-CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNL-KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASK 82 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (472)
.....++|.++..||.|.|+.|+....+ .++..+++|.+.+......+... -..|+.+...+ .|.++++++..+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccc
Confidence 4566788999999999999999987765 67889999988665433222111 22456666555 499999999999999
Q ss_pred CEEEEEEEecCCCcccchhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~-g~vkl~DFGla~~~~ 160 (472)
...|+-.|||+++++...+. ...+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||.++...
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 99999999999998766553 3568999999999999999999999999999999999999886 788999999886422
Q ss_pred cccCCCcccccCCCCccc-ChhhhcccCCCCCcccchhhhHHHHHHhcCCCC-CCCCcHHHHHHHHhccCCCCCCCCCHH
Q 012053 161 SKHQDGLLHTTCGTPAYV-APEVINRRGYDGSKADIWSCGVILYVLLAGYLP-FHDSNLMEMYRKIGKAEFKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~-aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~P-f~~~~~~~~~~~i~~~~~~~~~~~s~~ 238 (472)
... ....++-.+. .+|++........++|++|||..+.+.++|..- +.... ...|..+.....+....+
T Consensus 419 ~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~~~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 FSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIRSGDTPNLPGLKLQ 489 (524)
T ss_pred eec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc----ceeeecccccCCCchHHh
Confidence 211 1122333455 355555554456899999999999999998643 22221 223344544444445578
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
+..+...+..+++..|+.+.++..|+-|.
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhh
Confidence 88999999999999999999998876553
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.4e-13 Score=126.78 Aligned_cols=202 Identities=19% Similarity=0.308 Sum_probs=141.8
Q ss_pred HHHhcCCCCeeeEEEEEEeC-----CEEEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC--Cc
Q 012053 63 VMRLVRHPNVVELYEVMASK-----TKIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSR--GV 130 (472)
Q Consensus 63 il~~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~--gi 130 (472)
-|-.+-|.|||+++.|+.+. ....+++||+..|++..++++ ..+......+|+-||+.||.|||+. -|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34455699999999998544 458899999999999888864 3588899999999999999999988 59
Q ss_pred eecCCCCCcEEEcCCCCeEEecCcchhhhhc--ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcC
Q 012053 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAES--KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAG 208 (472)
Q Consensus 131 iHrDIKp~NILld~~g~vkl~DFGla~~~~~--~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG 208 (472)
+|+++..+-|++..+|-+|+.---......+ ...........+-++|.|||.=..... +.++|||++|....+|..|
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHh
Confidence 9999999999999999888742211110000 000011122346788999996433333 3579999999999999988
Q ss_pred CCCCCC-CcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 209 YLPFHD-SNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 209 ~~Pf~~-~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..--.. .+....-..+.+.-+.... +--+.+|.+||+..|+.||++.+++.||..-+
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~len---~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGLEN---GLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eeccCCCcceeehhhhhhhheeeccC---ccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 765222 2222222222222222211 12357899999999999999999999997754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.5e-11 Score=114.21 Aligned_cols=139 Identities=21% Similarity=0.285 Sum_probs=110.1
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEeC---CEEEEEEE
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH--PNVVELYEVMASK---TKIYFVME 90 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lV~E 90 (472)
+.||.|..+.||++... +|+.+++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999873 4689999997654321 124568899999999976 4467788777654 36789999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 012053 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHS------------------------------------------- 127 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~------------------------------------------- 127 (472)
|++|.++.+.+..+.+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9999988876654567888888888899999988884
Q ss_pred -------------CCceecCCCCCcEEEcC--CCCeEEecCcchh
Q 012053 128 -------------RGVCHRDLKPENLLLDE--HGNLKVSDFGLSA 157 (472)
Q Consensus 128 -------------~giiHrDIKp~NILld~--~g~vkl~DFGla~ 157 (472)
..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23589999999999998 5668999999765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4e-11 Score=107.90 Aligned_cols=135 Identities=21% Similarity=0.287 Sum_probs=102.6
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchh-----hHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG-----MIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
..+++|+-+.+|.+.. -|..+++|.=.+....... ...+-.+|+.++..++--.|.-.+=+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999866 4555666653332222222 23556789999998876666666656667777889999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
|++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++...+ +.++||||+...
T Consensus 80 ~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99998888888765 245667777888899999999999999999997665 999999998743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.8e-10 Score=103.34 Aligned_cols=144 Identities=19% Similarity=0.252 Sum_probs=109.3
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchh-----hHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG-----MIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.+..|-+|+-+.|+.+.+ .|+...||.=.......+. ...+.++|+.+|.++.--.|.-..=++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567889999999999987 8889888864333222211 245678999999988766666655566666777899
Q ss_pred EEecCC-Ccccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC---eEEecCcchhhh
Q 012053 89 MEYVKG-GELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN---LKVSDFGLSALA 159 (472)
Q Consensus 89 ~E~~~g-g~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~---vkl~DFGla~~~ 159 (472)
|||++| .++.+++.. ..........++++|-+.+.-||.++|+|+||..+||+|..+|+ +.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999988 366666643 22333334788999999999999999999999999999977663 589999997654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6e-10 Score=113.58 Aligned_cols=210 Identities=16% Similarity=0.251 Sum_probs=156.0
Q ss_pred CeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCEEEEEEEecCC-Ccc
Q 012053 23 FAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS----KTKIYFVMEYVKG-GEL 97 (472)
Q Consensus 23 fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~~~g-g~L 97 (472)
-.+.|++....+|..|++|.++-.+.... ...-.-+++++++.|+|+|++.++|.+ +..+++|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 35789999999999999999954433221 122344778999999999999999863 4578999999987 466
Q ss_pred cchh----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 98 FGKV----------------AKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 98 ~~~i----------------~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.++. ...+.+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+-+++|+..|+..+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5542 113578999999999999999999999999999999999999999999998887665543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCC-CCCCcHHHH-HHHHhccCCCCCCCCCHHH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLP-FHDSNLMEM-YRKIGKAEFKFPNWFAPEV 239 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~P-f~~~~~~~~-~~~i~~~~~~~~~~~s~~l 239 (472)
.. .+ -+... .+-|.=.||.+++.|.||..- |........ ... +...++.++
T Consensus 446 d~--------------~~--~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------I~~~yS~D~ 498 (655)
T KOG3741|consen 446 DP--------------TE--PLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------ITTTYSTDL 498 (655)
T ss_pred CC--------------Cc--chhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------hhhhhhHHH
Confidence 22 01 11111 356888999999999999654 222222222 222 223478899
Q ss_pred HHHHhcccCCCCCCcCChhhhhcC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+++|.-+...++.. -++.+++.+
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999998887 788888754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.8e-10 Score=104.82 Aligned_cols=128 Identities=23% Similarity=0.368 Sum_probs=85.8
Q ss_pred EEEEEEEcCCCcEEEEEEeeccc-----------------------ccchhhHHHHHHHHHHHHhcCCC--CeeeEEEEE
Q 012053 25 KVHYARNLKTGMSVAIKIIDKEK-----------------------VLKVGMIDQIKREISVMRLVRHP--NVVELYEVM 79 (472)
Q Consensus 25 ~Vy~a~~~~~g~~vAiK~i~~~~-----------------------~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~ 79 (472)
.||.|.. .+|..+|+|+..... ....-.....++|..+|..+..- ++++++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899987 578899999974310 00111245678999999999865 566777553
Q ss_pred EeCCEEEEEEEecC--CCcccchhccCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 80 ASKTKIYFVMEYVK--GGELFGKVAKGKLKEDAARKYFQQLISAVDY-CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 80 ~~~~~~~lV~E~~~--gg~L~~~i~~~~l~e~~~~~i~~ql~~al~y-LH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
+ -++||||+. |..+. .+....++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.+
T Consensus 80 --~--~~ivME~I~~~G~~~~-~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLP-RLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp --T--TEEEEE--EETTEEGG-CHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred --C--CEEEEEecCCCccchh-hHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 2 369999998 54443 3433333355667788888885555 579999999999999999887 8999999976
Q ss_pred hhh
Q 012053 157 ALA 159 (472)
Q Consensus 157 ~~~ 159 (472)
...
T Consensus 154 v~~ 156 (188)
T PF01163_consen 154 VDS 156 (188)
T ss_dssp EET
T ss_pred eec
Confidence 643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.9e-11 Score=125.36 Aligned_cols=154 Identities=19% Similarity=0.380 Sum_probs=114.0
Q ss_pred HHHHHHHHHHhC-CceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC------C-CcccccCCCCcccChhhhcccCC
Q 012053 117 QLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ------D-GLLHTTCGTPAYVAPEVINRRGY 188 (472)
Q Consensus 117 ql~~al~yLH~~-giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~------~-~~~~~~~gt~~Y~aPE~l~~~~~ 188 (472)
+.++|+.|+|.. +++|++|.|++|.++.+|.+||+.|+++........ + .......-...|.|||++.. ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 344899999966 899999999999999999999999998765433111 0 00111124567999999877 45
Q ss_pred CCCcccchhhhHHHHHHh-cCCCCCCCCcHHHHHHHH----hccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 189 DGSKADIWSCGVILYVLL-AGYLPFHDSNLMEMYRKI----GKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 189 ~~~~~DiwSlGvil~~ll-tG~~Pf~~~~~~~~~~~i----~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+.++|+||+|+++|.+. .|..-+...+....+..- ....+.....+++++++-+.++|..++..||++.+++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 568999999999999999 455445444333222221 112334556789999999999999999999999999999
Q ss_pred cccccCCC
Q 012053 264 SWFRKGLV 271 (472)
Q Consensus 264 p~f~~~~~ 271 (472)
|||.....
T Consensus 266 ~ff~D~~~ 273 (700)
T KOG2137|consen 266 PFFSDPGL 273 (700)
T ss_pred cccCCchh
Confidence 99987543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.7e-09 Score=102.98 Aligned_cols=131 Identities=17% Similarity=0.093 Sum_probs=93.8
Q ss_pred EEEEEEEcCCCcEEEEEEeeccccc---ch-----hhHHHHHHHHHHHHhcCCCCe--eeEEEEEEe-----CCEEEEEE
Q 012053 25 KVHYARNLKTGMSVAIKIIDKEKVL---KV-----GMIDQIKREISVMRLVRHPNV--VELYEVMAS-----KTKIYFVM 89 (472)
Q Consensus 25 ~Vy~a~~~~~g~~vAiK~i~~~~~~---~~-----~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~-----~~~~~lV~ 89 (472)
.|+.... .|+.|.||........ +. .-.....+|...+..+..-+| +.+.++.+. ....|+||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555443 6778999976332211 00 001136789998888854333 344445433 23578999
Q ss_pred EecCCC-cccchhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-------CCCeEEecCcchh
Q 012053 90 EYVKGG-ELFGKVA---KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-------HGNLKVSDFGLSA 157 (472)
Q Consensus 90 E~~~gg-~L~~~i~---~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~-------~g~vkl~DFGla~ 157 (472)
|++++. +|.+++. ....++.....++.+++..+.-||..||+|+|+++.|||++. ++.+.++||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999886 7887775 345677888899999999999999999999999999999975 4579999999765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.1e-09 Score=100.38 Aligned_cols=137 Identities=23% Similarity=0.319 Sum_probs=103.1
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccc-----------c------cc--hhhHHHHHHHHHHHHhcCCC--
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEK-----------V------LK--VGMIDQIKREISVMRLVRHP-- 70 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~-----------~------~~--~~~~~~~~~Ei~il~~l~hp-- 70 (472)
+.++..||.|.-|.||.|.+ ..|..+|||.=+... . .. .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 34789999999999999997 478999999742110 0 00 01134567899999999644
Q ss_pred CeeeEEEEEEeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEE
Q 012053 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl 150 (472)
.+.+.+++ +...+|||+++|-.|...- ++......++..|++-+.-.-..||+|+|+.+-||+++++|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 77777765 4568999999998876542 234555566667777666666899999999999999999999999
Q ss_pred ecCcchh
Q 012053 151 SDFGLSA 157 (472)
Q Consensus 151 ~DFGla~ 157 (472)
+||--+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9996443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=5e-08 Score=97.56 Aligned_cols=232 Identities=20% Similarity=0.254 Sum_probs=148.9
Q ss_pred EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-cCCCCeee--------EEEEEEeCC
Q 012053 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL-VRHPNVVE--------LYEVMASKT 83 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~--------l~~~~~~~~ 83 (472)
..++.||+|+-+.+|-.-.. +.. +-|++.+..... +. +....|.. -.||-+-. |+|- ....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~-----~a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAA-----QA-QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGK 83 (637)
T ss_pred CCCccccCCccceeeecchh--hch-hheeecCCCchH-----HH-HHHHHhccCCCCcchhhhhcccHHHhhCC-Cccc
Confidence 35688999999999865432 223 447776543211 11 12222322 24654433 2221 1222
Q ss_pred EEEEEEEecCCCcc-cchhc----cC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcc
Q 012053 84 KIYFVMEYVKGGEL-FGKVA----KG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 84 ~~~lV~E~~~gg~L-~~~i~----~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGl 155 (472)
.+-+.|..+.|..= ..+.. +. ...+..+.+.++.|+.+...||..|..-+|+.++|+|+++++.+.|.|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 37788999888532 22221 11 367788999999999999999999999999999999999999999988653
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCC----CCcccchhhhHHHHHHhcC-CCCCCCC-------cHHHHHHH
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD----GSKADIWSCGVILYVLLAG-YLPFHDS-------NLMEMYRK 223 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~----~~~~DiwSlGvil~~lltG-~~Pf~~~-------~~~~~~~~ 223 (472)
-.+ ...+......+|.+.|.+||...-..+. +...|.|.||+++|+|+.| ++||.+- +..+ ..
T Consensus 164 fqi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~ 238 (637)
T COG4248 164 FQI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TD 238 (637)
T ss_pred eee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hh
Confidence 221 1222334456799999999976422211 3568999999999998886 9999652 2222 12
Q ss_pred HhccCC-----------CCC---CC--CCHHHHHHHhcccCC--CCCCcCChhh
Q 012053 224 IGKAEF-----------KFP---NW--FAPEVRRLLSKILDP--NPNTRISMTK 259 (472)
Q Consensus 224 i~~~~~-----------~~~---~~--~s~~l~~li~~~L~~--dP~~Rpt~~e 259 (472)
|..+.+ +-| +| +++++..|..+|+.. ++.-|||++.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 222111 111 12 678999999998864 3668998764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=7.3e-08 Score=90.46 Aligned_cols=105 Identities=21% Similarity=0.356 Sum_probs=84.1
Q ss_pred HHHHHHHHHHHHhcCCCC--eeeEEEEEEeC----CEEEEEEEecCCC-cccchhcc-CCCCHHHHHHHHHHHHHHHHHH
Q 012053 54 IDQIKREISVMRLVRHPN--VVELYEVMASK----TKIYFVMEYVKGG-ELFGKVAK-GKLKEDAARKYFQQLISAVDYC 125 (472)
Q Consensus 54 ~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~i~~-~~l~e~~~~~i~~ql~~al~yL 125 (472)
.....+|...+..+..-+ .++++++.+.. ...|+|+|+++|. +|.+.+.. ..++......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 356788988888775333 44566665442 2468999999885 78888765 3477788889999999999999
Q ss_pred HhCCceecCCCCCcEEEcCCC---CeEEecCcchhh
Q 012053 126 HSRGVCHRDLKPENLLLDEHG---NLKVSDFGLSAL 158 (472)
Q Consensus 126 H~~giiHrDIKp~NILld~~g---~vkl~DFGla~~ 158 (472)
|.+||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999996553
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.3e-07 Score=88.47 Aligned_cols=141 Identities=20% Similarity=0.292 Sum_probs=96.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHH------HHHHHHHHHHhcC---CCCeeeEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID------QIKREISVMRLVR---HPNVVELYE 77 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~------~~~~Ei~il~~l~---hpnIv~l~~ 77 (472)
++.++|.+.+.+-......|.+..- +|+.+++|....+....+.... ...+++..+..++ -.....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 6778999999999988888876654 7899999998665433222211 1233444444442 233333333
Q ss_pred EEE-----eCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEec
Q 012053 78 VMA-----SKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSD 152 (472)
Q Consensus 78 ~~~-----~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~D 152 (472)
+.+ -....+++|||++|.+|.+... +++ .+...|.+++.-+|+.|++|+|.+|.|++++.++ ++++|
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID 177 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID 177 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence 322 2244568999999988866532 333 2446678889999999999999999999998655 99999
Q ss_pred Ccchh
Q 012053 153 FGLSA 157 (472)
Q Consensus 153 FGla~ 157 (472)
|+..+
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 98544
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.7e-07 Score=87.31 Aligned_cols=137 Identities=15% Similarity=0.142 Sum_probs=99.2
Q ss_pred cccCCeEEEEEEEcCCCcEEEEEEeecccc--cc-hhhHHHHHHHHHHHHhcCCCC--eeeEEEEEEe----CCEEEEEE
Q 012053 19 GQGTFAKVHYARNLKTGMSVAIKIIDKEKV--LK-VGMIDQIKREISVMRLVRHPN--VVELYEVMAS----KTKIYFVM 89 (472)
Q Consensus 19 G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~-~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~----~~~~~lV~ 89 (472)
|+||-+-|+.... .|+.+=+|.-...-. .. ..-...+.+|+..|+.+..-+ ++++...... .-..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5588899988765 555677787531110 01 123467889999998885322 4444422211 23478999
Q ss_pred EecCC-CcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC--eEEecCcchh
Q 012053 90 EYVKG-GELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN--LKVSDFGLSA 157 (472)
Q Consensus 90 E~~~g-g~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~--vkl~DFGla~ 157 (472)
|-+.| -+|.+++..+ +.++.....++.+++..+.-||+.|+.|+|+.+.|||++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98865 4888887653 4577888899999999999999999999999999999997777 9999997544
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.60 E-value=9.2e-07 Score=83.67 Aligned_cols=139 Identities=18% Similarity=0.203 Sum_probs=100.8
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc---------------------hhhHHHHHHHHHHHHhcC--CCCe
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK---------------------VGMIDQIKREISVMRLVR--HPNV 72 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~--hpnI 72 (472)
-.|+.|--+.||+|.. .++..+|+|++......- .-......+|+..|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3566777778999985 678999999985422110 011234567888888885 4556
Q ss_pred eeEEEEEEeCCEEEEEEEecCCC-cccchhccCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeEE
Q 012053 73 VELYEVMASKTKIYFVMEYVKGG-ELFGKVAKGKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 73 v~l~~~~~~~~~~~lV~E~~~gg-~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vkl 150 (472)
.+.+.+.. -.|||||+... .-.-.+..-++...++..+..++++.+.-|-. .|++|+||+.-|||+. ++.+.|
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 67777654 47999999553 11223333344555788899999999998877 8999999999999999 888999
Q ss_pred ecCcchhhhh
Q 012053 151 SDFGLSALAE 160 (472)
Q Consensus 151 ~DFGla~~~~ 160 (472)
+|||-|....
T Consensus 208 ID~~QaV~~~ 217 (268)
T COG1718 208 IDVSQAVTID 217 (268)
T ss_pred EECccccccC
Confidence 9999776544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.58 E-value=8e-07 Score=84.66 Aligned_cols=132 Identities=15% Similarity=0.153 Sum_probs=84.5
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEEEEEEeCCEEEEEEEecC
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~lV~E~~~ 93 (472)
..||.|..+.||+. .|..+++|...... ....+.+|.++++.+..-+ +.+.+++.+..+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999973 25567889875432 2345789999999986443 4678888888888899999999
Q ss_pred CCc-ccch---------------------hcc---CCCCHHH-HHHHHHHH----------HH-HHHHHH----hCCcee
Q 012053 94 GGE-LFGK---------------------VAK---GKLKEDA-ARKYFQQL----------IS-AVDYCH----SRGVCH 132 (472)
Q Consensus 94 gg~-L~~~---------------------i~~---~~l~e~~-~~~i~~ql----------~~-al~yLH----~~giiH 132 (472)
|.. +... +.. ...+... ...+..++ .. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 1100 111 0011000 00110010 11 111222 124789
Q ss_pred cCCCCCcEEEcCCCCeEEecCcchh
Q 012053 133 RDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 133 rDIKp~NILld~~g~vkl~DFGla~ 157 (472)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.2e-07 Score=83.78 Aligned_cols=136 Identities=21% Similarity=0.299 Sum_probs=82.5
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCC--CeeeEEEEE---EeCCEEEEEE
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP--NVVELYEVM---ASKTKIYFVM 89 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lV~ 89 (472)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+... .+.+++... ......|++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998743 59999997544 2346788999999888533 356677644 3344689999
Q ss_pred EecCCCcccc----------------hhc---c-----CCCCHHH---------HHHH------------HHHHHH-HHH
Q 012053 90 EYVKGGELFG----------------KVA---K-----GKLKEDA---------ARKY------------FQQLIS-AVD 123 (472)
Q Consensus 90 E~~~gg~L~~----------------~i~---~-----~~l~e~~---------~~~i------------~~ql~~-al~ 123 (472)
++++|..+.. .+. . ..+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 110 0 0001000 0000 111222 233
Q ss_pred HHHh-------CCceecCCCCCcEEEc-CCCCeEEecCcchh
Q 012053 124 YCHS-------RGVCHRDLKPENLLLD-EHGNLKVSDFGLSA 157 (472)
Q Consensus 124 yLH~-------~giiHrDIKp~NILld-~~g~vkl~DFGla~ 157 (472)
.+++ ..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 3599999999999999 66667899998654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.3e-07 Score=95.17 Aligned_cols=138 Identities=23% Similarity=0.353 Sum_probs=94.0
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccc---------------------------cch----hhHHH------HH
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV---------------------------LKV----GMIDQ------IK 58 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---------------------------~~~----~~~~~------~~ 58 (472)
+.|+.++-|.||.|+. .+|+.||||+....-. .-. +..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5688999999999997 4599999999754210 000 11122 23
Q ss_pred HHHHHHHhcC-----CCCeeeEEEEEEeCCEEEEEEEecCCCcccchh--ccCCCCHH-----HHHHHHHHHHHHHHHHH
Q 012053 59 REISVMRLVR-----HPNVVELYEVMASKTKIYFVMEYVKGGELFGKV--AKGKLKED-----AARKYFQQLISAVDYCH 126 (472)
Q Consensus 59 ~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i--~~~~l~e~-----~~~~i~~ql~~al~yLH 126 (472)
+|...+.+++ .|++.-..=+++-.+.-.++|||+.|-.+.+.. ....++.. -+..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~------- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL------- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 4444444442 455554444555567788999999999888774 44455533 3333334433
Q ss_pred hCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 127 ~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..|++|.|.+|.||+++.+|.+.+.|||+......
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 38999999999999999999999999998765443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=4.7e-08 Score=102.21 Aligned_cols=239 Identities=20% Similarity=0.185 Sum_probs=166.4
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN-VVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~ 89 (472)
.|....-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++.++..++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 3455677899999999999986665444 6665433 34556889999999999 777777788888999999
Q ss_pred EecCCC-cccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 90 EYVKGG-ELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 90 E~~~gg-~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
+++.++ +-...... -.+.+-+.....+.-..+++++|+.-=+||| ||+..+ +..+..||+.........
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--- 385 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--- 385 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc---
Confidence 999887 32222211 1344445556666778899999998778998 777655 678999999876554332
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCC---CCCCCHHHHH
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKF---PNWFAPEVRR 241 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~---~~~~s~~l~~ 241 (472)
...+..+|+.++|||+.....++ ...|+|++|.--.++.-|.+|-..... ....+..+. +.+ ..|-+.+-++
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw~~~~~~~ 462 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAWSPVFHRD 462 (829)
T ss_pred ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhcCcccccC
Confidence 23567899999999998888777 689999999887888888777433110 000011110 000 1122222234
Q ss_pred HHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 242 LLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+...|+..-|..|+.....+-|.+|..-
T Consensus 463 ~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 463 FPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred CcccccCCCCCCCcchhhHHHHHHhccC
Confidence 7788999999999999999888888653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.31 E-value=5.5e-06 Score=79.56 Aligned_cols=74 Identities=16% Similarity=0.174 Sum_probs=53.7
Q ss_pred eEcccCC-eEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 17 LLGQGTF-AKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 17 ~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
.|-.|.. +.||.... .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 4455555 78898865 34788889875432 235678999998884 44466888888777788999999999
Q ss_pred Cccc
Q 012053 95 GELF 98 (472)
Q Consensus 95 g~L~ 98 (472)
.+|.
T Consensus 77 ~~l~ 80 (244)
T cd05150 77 VPAA 80 (244)
T ss_pred ccHh
Confidence 7664
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.1e-05 Score=91.08 Aligned_cols=82 Identities=20% Similarity=0.342 Sum_probs=59.1
Q ss_pred EEeeEcccCCeEEEEEEEcCCC--cEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCe--eeEEEEEEeC---CEE
Q 012053 14 LGRLLGQGTFAKVHYARNLKTG--MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNV--VELYEVMASK---TKI 85 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~ 85 (472)
-++.|+.|.++.+|+......+ ..+++|........ .....+.+|+.+|+.+. |+++ .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3578899999999998764332 46777876543321 12356889999999995 6665 7788877654 468
Q ss_pred EEEEEecCCCcc
Q 012053 86 YFVMEYVKGGEL 97 (472)
Q Consensus 86 ~lV~E~~~gg~L 97 (472)
|+||||++|..+
T Consensus 120 flVME~v~G~~~ 131 (822)
T PLN02876 120 FYIMEYLEGRIF 131 (822)
T ss_pred eEEEEecCCccc
Confidence 999999998643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.8e-05 Score=73.64 Aligned_cols=130 Identities=19% Similarity=0.295 Sum_probs=96.7
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccc-------------cchhhHHHHHHHHHHHHhcC------CCCeeeEE
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV-------------LKVGMIDQIKREISVMRLVR------HPNVVELY 76 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------hpnIv~l~ 76 (472)
..||+|+.=.||. + .......||++..... ......++..+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5789999999984 3 3456788999876650 01123466777877766665 78999999
Q ss_pred EEEEeCCEEEEEEEecCCC------cccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----
Q 012053 77 EVMASKTKIYFVMEYVKGG------ELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---- 146 (472)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg------~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g---- 146 (472)
|+.+++.-.-+|+|.+... +|.+++..+.+++ .. ...+-+-.+||-+++|+.+|++|.||++..++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~ 159 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF 159 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence 9999999999999987642 5777787777877 33 34445566788899999999999999996433
Q ss_pred CeEEec
Q 012053 147 NLKVSD 152 (472)
Q Consensus 147 ~vkl~D 152 (472)
.+.|+|
T Consensus 160 ~lvlID 165 (199)
T PF10707_consen 160 RLVLID 165 (199)
T ss_pred EEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=6.3e-06 Score=74.11 Aligned_cols=129 Identities=21% Similarity=0.316 Sum_probs=94.7
Q ss_pred EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCee-eEEEEEEeCCEEEEEEEe
Q 012053 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVV-ELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lV~E~ 91 (472)
++.+.||+|++|.||++.+ .|..+|+|+-..+. ....+..|+++|..+.-.++. ++|.+.. .++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence 3567899999999999998 67799999865443 346789999999999876664 5665543 3455999
Q ss_pred cCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC-CCcEEEcCCCCeEEecCcchhh
Q 012053 92 VKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLK-PENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 92 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIK-p~NILld~~g~vkl~DFGla~~ 158 (472)
+.|-+|......+ + ++-+..+++.-.-|-..||-|..|. |..++|-.++.+.|+||.-|+.
T Consensus 94 i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998776554322 2 3334456666666777899999997 5555555666999999998774
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.24 E-value=5.4e-06 Score=92.44 Aligned_cols=202 Identities=19% Similarity=0.243 Sum_probs=140.1
Q ss_pred HHHHHHHHHHhcCCCCeeeEEEEEEeCC----EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 012053 56 QIKREISVMRLVRHPNVVELYEVMASKT----KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGV 130 (472)
Q Consensus 56 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~gi 130 (472)
...-|+..+....|+|++.++.+..... ...+..|++..-++...+.. +..+...++.+..+++.|+.|+|+...
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 3445666778889999999999864433 23355688888888888866 789999999999999999999999955
Q ss_pred eecCCCCC---cEEEcCCCCeEEe--cCcchhhhhcccCCCcccccCCCCcccChhhhcccCCC-CCcccchhhhHHHHH
Q 012053 131 CHRDLKPE---NLLLDEHGNLKVS--DFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD-GSKADIWSCGVILYV 204 (472)
Q Consensus 131 iHrDIKp~---NILld~~g~vkl~--DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~~DiwSlGvil~~ 204 (472)
.|.-+... +-..+..+.+.++ ||+.+......... ....-+..+.+||....+.+. +...|+|.+|..+..
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 55544444 3334455566666 88877655433221 223345567888877655443 234699999999999
Q ss_pred HhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 205 LLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 205 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+..|..+-....... .+ .+.....+..++..+|+..++++|+++.+++.|+|.+..
T Consensus 385 ~~~~~~i~~~~~~~~---~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 385 LSQGEDISEKSAVPV---SL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhcCcccccccchh---hh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 998865521111110 00 011112267888999999999999999999999998753
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.2e-05 Score=70.85 Aligned_cols=128 Identities=20% Similarity=0.254 Sum_probs=90.1
Q ss_pred CCEEEEeeEcccCC-eEEEEEEEcCCCcEEEEEEeec---c-------cccch--------hhHHHHHHHHHHHHhc---
Q 012053 10 QRYELGRLLGQGTF-AKVHYARNLKTGMSVAIKIIDK---E-------KVLKV--------GMIDQIKREISVMRLV--- 67 (472)
Q Consensus 10 ~~y~i~~~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~---~-------~~~~~--------~~~~~~~~Ei~il~~l--- 67 (472)
..++.++.||.|+- |.||+++- +|+.+|+|++.. . ..... ...+-+..|.++.-+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999987 888999999421 0 00000 1234567777776555
Q ss_pred CCCCe--eeEEEEEEeC------------------CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHh
Q 012053 68 RHPNV--VELYEVMASK------------------TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHS 127 (472)
Q Consensus 68 ~hpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~ 127 (472)
.+.++ |+.+|++.-. ...-||.||++... .+ ..+-+.+|.+-+..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~----~~~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PL----QIRDIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------cc----chhHHHHHHHHHHHHHH
Confidence 45666 9999997221 12346677665533 12 23345678888899999
Q ss_pred CCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 128 ~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
.||+-+|+++.|.. + =+|+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc---C--CEEEecccC
Confidence 99999999999985 3 489999853
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.9e-05 Score=83.42 Aligned_cols=140 Identities=21% Similarity=0.272 Sum_probs=89.0
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc----------------------------hhhHHHHHHHHHHH---
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK----------------------------VGMIDQIKREISVM--- 64 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~----------------------------~~~~~~~~~Ei~il--- 64 (472)
+.||.-+.|.|+.|+-+ +|+.||||+-+..-... .+..+.+..|++.+
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 67899999999999975 59999999964321000 01122222232222
Q ss_pred -------HhcCCCC------eeeEEEEEEeCCEEEEEEEecCCCcccch--hccCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 012053 65 -------RLVRHPN------VVELYEVMASKTKIYFVMEYVKGGELFGK--VAKGKLKEDAARKYFQQLISAVDYCHSRG 129 (472)
Q Consensus 65 -------~~l~hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~--i~~~~l~e~~~~~i~~ql~~al~yLH~~g 129 (472)
+.+.|-+ |.++|- .-.+...|+|||++|..+.|. +.+..++...+...+.+...- -+-..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~--qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLE--QIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHH--HHHhcC
Confidence 2233444 344433 334567899999999877654 455666666444333332221 122468
Q ss_pred ceecCCCCCcEEEcC----CCCeEEecCcchhhhh
Q 012053 130 VCHRDLKPENLLLDE----HGNLKVSDFGLSALAE 160 (472)
Q Consensus 130 iiHrDIKp~NILld~----~g~vkl~DFGla~~~~ 160 (472)
++|.|-+|.||+++. ++.+.+-|||+.....
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999984 5689999999877554
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.4e-05 Score=74.77 Aligned_cols=74 Identities=9% Similarity=0.051 Sum_probs=47.5
Q ss_pred EeeEcccCCe-EEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCC---CeeeEEEEEEeC---CEEEE
Q 012053 15 GRLLGQGTFA-KVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP---NVVELYEVMASK---TKIYF 87 (472)
Q Consensus 15 ~~~LG~G~fg-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~l 87 (472)
++.|+.|+.. .||... ..+++|+..... ....+.+|..+|+.+... -+.++++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567777776 488652 357778754321 235788999999888532 344555544332 24589
Q ss_pred EEEecCCCccc
Q 012053 88 VMEYVKGGELF 98 (472)
Q Consensus 88 V~E~~~gg~L~ 98 (472)
+|++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999997663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.89 E-value=6.3e-05 Score=69.51 Aligned_cols=99 Identities=20% Similarity=0.293 Sum_probs=81.3
Q ss_pred HHHHHHHHhcCC-CCeeeEEEEEEeCCEEEEEEEecCCCcccch----hccCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 012053 58 KREISVMRLVRH-PNVVELYEVMASKTKIYFVMEYVKGGELFGK----VAKGKLKEDAARKYFQQLISAVDYCHS---RG 129 (472)
Q Consensus 58 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~----i~~~~l~e~~~~~i~~ql~~al~yLH~---~g 129 (472)
..|.-+|+.+.+ +++++++|+|- .++|.||...+++... ..-...++....+++.++++.+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999976 69999999983 3678899987766532 122357889999999999999999997 45
Q ss_pred ceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 130 iiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
+.-.|++|+|+-++++|++|++|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8899999999999999999999998765443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0004 Score=68.95 Aligned_cols=79 Identities=9% Similarity=0.084 Sum_probs=56.9
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC---CCeeeEEEEEEe---CCEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH---PNVVELYEVMAS---KTKI 85 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~ 85 (472)
-.-.+.||.|..+.||.... .+..+.+|..+ ... ....+.+|...|+.+.. -.++++++++.. .+..
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~-~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 16 LSRVECISEQPYAALWALYD--SQGNPMPLMAR-SFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred hheeeecCCccceeEEEEEc--CCCCEEEEEec-ccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 34457899999999998864 33356777743 211 12578899999998853 367888887754 3678
Q ss_pred EEEEEecCCCcc
Q 012053 86 YFVMEYVKGGEL 97 (472)
Q Consensus 86 ~lV~E~~~gg~L 97 (472)
|+|||+++|.++
T Consensus 89 ~LVmE~i~G~~~ 100 (297)
T PRK10593 89 VLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCEec
Confidence 999999998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.0003 Score=72.34 Aligned_cols=79 Identities=19% Similarity=0.212 Sum_probs=55.7
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--c--hhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCEEEE
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--K--VGMIDQIKREISVMRLVR---HPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 87 (472)
.+.||.|.+..||.+.+...++.++||.-...... . .-..++...|...|+.+. -.++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 47899999999999998543368999985422110 0 113467788888888763 3467778777 3455789
Q ss_pred EEEecCCC
Q 012053 88 VMEYVKGG 95 (472)
Q Consensus 88 V~E~~~gg 95 (472)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00022 Score=67.86 Aligned_cols=75 Identities=19% Similarity=0.314 Sum_probs=49.2
Q ss_pred EeeEcccCCeEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCEEEEEEEec
Q 012053 15 GRLLGQGTFAKVHYARNLK-TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN-VVELYEVMASKTKIYFVMEYV 92 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~ 92 (472)
++.|..|-...+|++.... .++.|++|+....... .-...+|+.+++.+...+ .++++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4677888888999987532 3678999987543211 122357999999885433 345554432 2 3799999
Q ss_pred CCCcc
Q 012053 93 KGGEL 97 (472)
Q Consensus 93 ~gg~L 97 (472)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 99655
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=1.2e-06 Score=99.42 Aligned_cols=210 Identities=18% Similarity=0.123 Sum_probs=148.9
Q ss_pred HHHHHHHHhcCCCCeeeEEEEE--EeCCEEEEEEEecCCCcccchhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC-
Q 012053 58 KREISVMRLVRHPNVVELYEVM--ASKTKIYFVMEYVKGGELFGKVAKG-----KLKEDAARKYFQQLISAVDYCHSRG- 129 (472)
Q Consensus 58 ~~Ei~il~~l~hpnIv~l~~~~--~~~~~~~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~i~~ql~~al~yLH~~g- 129 (472)
..|..-++...|+++...+.-. .+....|..++|+.+|.+++.|.+| .+.+.-+....++.+.+..-+|+..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 3444455667899988777655 3345678999999999999998664 3445555555556577788877652
Q ss_pred ----ceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHH
Q 012053 130 ----VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVL 205 (472)
Q Consensus 130 ----iiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~l 205 (472)
.+|+++|+-|.+|..+-++++.++|+.+.... .........+++.|++|++...-.+. .++|+|..|+-+|.+
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLR 1433 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHH
Confidence 78999999999999999999999999883221 11223456788899999998777775 559999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 206 LAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 206 ltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
..|..+|..-....+...+.... +..+...|.++-.....+|-..-..||.-..++.-+.|.-+.
T Consensus 1434 s~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~~ 1499 (2724)
T KOG1826|consen 1434 SDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVGL 1499 (2724)
T ss_pred hcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccccc
Confidence 99988774433322222222222 334444455566666666767778899999888877776543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00014 Score=70.38 Aligned_cols=132 Identities=16% Similarity=0.207 Sum_probs=78.4
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEEEEEecCCC
Q 012053 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~~gg 95 (472)
.+..|-.+.+|+... +++.+++|....... ...-...+|..+++.+...++ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 456688889998873 677888997644321 110124689999998864333 44554432 36899999986
Q ss_pred cccch-----------------hccC-----CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceecCC
Q 012053 96 ELFGK-----------------VAKG-----KLKE-DAARKYFQQL---------ISAVDYCHS--------RGVCHRDL 135 (472)
Q Consensus 96 ~L~~~-----------------i~~~-----~l~e-~~~~~i~~ql---------~~al~yLH~--------~giiHrDI 135 (472)
.+... +..- +++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 65321 1110 1111 1222322222 111222211 24899999
Q ss_pred CCCcEEEcCCCCeEEecCcchhh
Q 012053 136 KPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 136 Kp~NILld~~g~vkl~DFGla~~ 158 (472)
.|.||++++++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00026 Score=69.95 Aligned_cols=135 Identities=16% Similarity=0.144 Sum_probs=84.0
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEEEE------EEeCCEEE
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELYEV------MASKTKIY 86 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~~~ 86 (472)
.+.|..|....+|+... ++..+++|+.... ....+..|+.+++.+.+.+ +.+++.. ...++..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56778888889998864 4457899987541 1256778888888875332 4455442 23456779
Q ss_pred EEEEecCCCcccch--------------hcc--CCCCH--------HHHH------------HHHHHHHHHHHHHHh---
Q 012053 87 FVMEYVKGGELFGK--------------VAK--GKLKE--------DAAR------------KYFQQLISAVDYCHS--- 127 (472)
Q Consensus 87 lV~E~~~gg~L~~~--------------i~~--~~l~e--------~~~~------------~i~~ql~~al~yLH~--- 127 (472)
+|++|++|..+... +.. ..+.. .... .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 99999999765320 000 00000 0000 011112333444443
Q ss_pred ----CCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 128 ----RGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 128 ----~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
.+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988777899998654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.75 E-value=7.2e-05 Score=52.40 Aligned_cols=42 Identities=24% Similarity=0.390 Sum_probs=35.9
Q ss_pred ceEEEEEEEEEEc-CceEEEEEEccCCCcHHHHHHHHHhhhhcc
Q 012053 386 GVLGMDAEIFEIT-PFFHLVEVKKSSGDTLEYQKVMNQEIRPAL 428 (472)
Q Consensus 386 g~l~~~~ev~e~~-~~~~lVe~~~~~Gd~lef~~~~~~~l~~~L 428 (472)
..+.|.+||+.+. ++++.|+||+.+||...|+++|.+ |-..|
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~-il~~l 45 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSK-ILNEL 45 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHH-HHHHT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHH-HHHHc
Confidence 4588999999997 899999999999999999999998 55544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=4.1e-05 Score=75.13 Aligned_cols=135 Identities=16% Similarity=0.241 Sum_probs=96.9
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccc-----------------cchhhHH--HHHHHHHHHHhcCC--C
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV-----------------LKVGMID--QIKREISVMRLVRH--P 70 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-----------------~~~~~~~--~~~~Ei~il~~l~h--p 70 (472)
|.+++.||-|.-+.||.+.+ ..|...++|.-+.... ..+-.+. ...+|+..|+.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56899999999999999987 5788999996422110 0001112 24578888988853 2
Q ss_pred CeeeEEEEEEeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEE
Q 012053 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl 150 (472)
-+++.+++ +..++|||++.|-.|...-. ...+..+...+..-+--|-.+|+||+|..--||++++++.+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v 243 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV 243 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence 34555554 45789999999988765431 1123345566677777888999999999999999999999999
Q ss_pred ecCcch
Q 012053 151 SDFGLS 156 (472)
Q Consensus 151 ~DFGla 156 (472)
+||--.
T Consensus 244 IDFPQm 249 (465)
T KOG2268|consen 244 IDFPQM 249 (465)
T ss_pred eechHh
Confidence 999643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00055 Score=68.18 Aligned_cols=137 Identities=17% Similarity=0.203 Sum_probs=82.0
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEEEE------EEeCCEE
Q 012053 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELYEV------MASKTKI 85 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~~ 85 (472)
-++.++.|.-..+|++.. .+ ..+++|+..... ..+.+..|+.++..|...+ +++++.. ....+..
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~-~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DV-GRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred eccccCCccccceEEEEe-CC-CcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 356777887789998864 33 467789875432 1244566777777774322 3444432 1234678
Q ss_pred EEEEEecCCCcccch--------------hcc--CCC--------CHHH-----HH----------HHHHHHHHHHHHHH
Q 012053 86 YFVMEYVKGGELFGK--------------VAK--GKL--------KEDA-----AR----------KYFQQLISAVDYCH 126 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~--------------i~~--~~l--------~e~~-----~~----------~i~~ql~~al~yLH 126 (472)
++++||++|..+... +.. ..+ .... .. .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 999999998543210 110 001 0000 00 00112233455553
Q ss_pred h-------CCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 127 S-------RGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 127 ~-------~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
. .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 589999999999999998877899998654
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00073 Score=67.26 Aligned_cols=139 Identities=21% Similarity=0.291 Sum_probs=89.8
Q ss_pred EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEEEEEEeCC--EEEEE
Q 012053 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELYEVMASKT--KIYFV 88 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~--~~~lV 88 (472)
.+++....|.--.+|...+ +++.+++. ... ...........++|+.+|+.+.--- +.+.++++.++. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 3444444444445666655 37888888 332 2223345677889999998885423 344555565554 67999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHH-HHHHHHHHHHh----------------------------------------
Q 012053 89 MEYVKGGELFGKVAKGKLKEDAARKYFQ-QLISAVDYCHS---------------------------------------- 127 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~-ql~~al~yLH~---------------------------------------- 127 (472)
|+|++|..+.+.......+ .+++. .+++.|.-||+
T Consensus 104 ~~~veGe~~~~~~~~~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 104 MEWVEGEVVWSALPPESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred EEEecceeccCcCCcccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 9999996443333222222 22223 56666666664
Q ss_pred ----------C--------CceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 128 ----------R--------GVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 128 ----------~--------giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
+ .++|+|+.+.||+++.++-+-|.||+++.+-
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1 3799999999999999999999999988753
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0026 Score=63.62 Aligned_cols=135 Identities=13% Similarity=0.158 Sum_probs=75.8
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEEE------EEEeCCEEE
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELYE------VMASKTKIY 86 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~------~~~~~~~~~ 86 (472)
.+.|+.|....+|.... ++..+++|++. .. . .+.+..|+.+++.|...+ +.+++. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t--~~g~~vLK~~~-~~--~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT--TQGEYVLTLFE-RL--T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe--CCCcEEEEEec-cC--C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 35567787789998875 33478999875 21 1 234445666666653212 334332 123456789
Q ss_pred EEEEecCCCcccc-----------hh---cc--CCC--------C--H--HHHH-----------HHHHH-HHHHHHHHH
Q 012053 87 FVMEYVKGGELFG-----------KV---AK--GKL--------K--E--DAAR-----------KYFQQ-LISAVDYCH 126 (472)
Q Consensus 87 lV~E~~~gg~L~~-----------~i---~~--~~l--------~--e--~~~~-----------~i~~q-l~~al~yLH 126 (472)
++++|++|..+.. .+ .. ..+ . . .... ..+.+ +...+..+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 9999999974421 00 00 001 0 0 0000 11111 111122222
Q ss_pred -------hCCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 127 -------SRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 127 -------~~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
..|++|+|++|.|||++.+...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2389999999999999966556899999754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0011 Score=65.77 Aligned_cols=75 Identities=15% Similarity=0.199 Sum_probs=49.2
Q ss_pred EeeEcccCCeEEEEEEEcC------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEE
Q 012053 15 GRLLGQGTFAKVHYARNLK------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIYF 87 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~l 87 (472)
++.|..|--..+|++.... +++.+++|+..... .......+|..+++.+...++ .++++++. + .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence 3556667777899887533 25889999975542 112346789999988864333 45565554 2 35
Q ss_pred EEEecCCCcc
Q 012053 88 VMEYVKGGEL 97 (472)
Q Consensus 88 V~E~~~gg~L 97 (472)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999998765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0031 Score=64.85 Aligned_cols=77 Identities=18% Similarity=0.080 Sum_probs=54.4
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-ch---hhHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCEEE
Q 012053 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-KV---GMIDQIKREISVMRLVR---HPNVVELYEVMASKTKIY 86 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~---~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 86 (472)
-.+.||.|....||+..+ .+..++||.-...... .. ...++...|...|+.+. ..++++++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 467889999999999887 3567999986532221 11 13456667788887764 247888888877 4467
Q ss_pred EEEEecCC
Q 012053 87 FVMEYVKG 94 (472)
Q Consensus 87 lV~E~~~g 94 (472)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999987
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.004 Score=62.43 Aligned_cols=141 Identities=22% Similarity=0.260 Sum_probs=99.0
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccc----------------------cchhh-HHHHHHHHHHHHhcCCC
Q 012053 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV----------------------LKVGM-IDQIKREISVMRLVRHP 70 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~----------------------~~~~~-~~~~~~Ei~il~~l~hp 70 (472)
+-..|..|.-+.||.|.. .+|..+|||++..+-. ....+ .-+...|+.-|++++..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 456788899999999985 6888899999743210 01112 23456788889998765
Q ss_pred CeeeEEEEEEeCCEEEEEEEecCC-CcccchhccCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEcCCCCe
Q 012053 71 NVVELYEVMASKTKIYFVMEYVKG-GELFGKVAKGKLKEDAARKYFQQLISAVDYCH-SRGVCHRDLKPENLLLDEHGNL 148 (472)
Q Consensus 71 nIv~l~~~~~~~~~~~lV~E~~~g-g~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH-~~giiHrDIKp~NILld~~g~v 148 (472)
.|.-.--+.-. ...|||+|+.. |--.-.+..-.++...+..+-+|++.-+.-|- ..+++|.||.--|+|+- +|.+
T Consensus 227 GIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKL 303 (520)
T ss_pred CCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEE
Confidence 55433222221 24699999953 22233445557888889999999988888774 56999999999999985 5689
Q ss_pred EEecCcchhh
Q 012053 149 KVSDFGLSAL 158 (472)
Q Consensus 149 kl~DFGla~~ 158 (472)
.|+|-+-+.-
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999886553
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0043 Score=60.92 Aligned_cols=30 Identities=27% Similarity=0.494 Sum_probs=25.0
Q ss_pred CceecCCCCCcEEEcCCCC-eEEecCcchhh
Q 012053 129 GVCHRDLKPENLLLDEHGN-LKVSDFGLSAL 158 (472)
Q Consensus 129 giiHrDIKp~NILld~~g~-vkl~DFGla~~ 158 (472)
.++|+|++|.|||++.+++ .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999997653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0012 Score=68.65 Aligned_cols=163 Identities=23% Similarity=0.257 Sum_probs=104.5
Q ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEEeC-CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 012053 55 DQIKREISVMRLVRHPNVVELYEVMASK-TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHR 133 (472)
Q Consensus 55 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHr 133 (472)
.++.-...+++.+.|+|...++++.... ....+|||++ +.+|.+.+..+.+-..... .+|+.|-
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~~--------------~~~~~~~ 91 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESLL--------------AHGVLHL 91 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhhc--------------cccccee
Confidence 4556678899999999999999987554 3578899999 6688888776543222111 2222222
Q ss_pred CCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCC
Q 012053 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH 213 (472)
Q Consensus 134 DIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~ 213 (472)
|+ ++++| .... .| | ...++++||||+|.++.++.-|...|.
T Consensus 92 -----~~-------~~~td----~~~t---------------~~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 92 -----NI-------IYITD----HFLT---------------KY--P------SPIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred -----hh-------hhccc----cccc---------------cC--C------CCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 22 23333 0000 00 0 011258999999999999999987776
Q ss_pred CCcHHHHHHHHhccCCCC------------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 214 DSNLMEMYRKIGKAEFKF------------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 214 ~~~~~~~~~~i~~~~~~~------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
.....+....+.+-.... -..++..+..+..+|+-..|..||...++++++-|.++..
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 544444333332211110 0113455778899999999999999999999999987644
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0039 Score=63.06 Aligned_cols=77 Identities=16% Similarity=0.100 Sum_probs=50.7
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-c---hhhHHHHHHHHHHHHhcC--CC-CeeeEEEEEEeCCEEEEEE
Q 012053 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-K---VGMIDQIKREISVMRLVR--HP-NVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~---~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV~ 89 (472)
.+|.|....||++.+...++.|+||.-...-.. . .-..++..-|..+|+... -| .++++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998544478999985422111 1 123466778888887764 34 45555554 344556999
Q ss_pred EecCCC
Q 012053 90 EYVKGG 95 (472)
Q Consensus 90 E~~~gg 95 (472)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0093 Score=60.52 Aligned_cols=136 Identities=17% Similarity=0.242 Sum_probs=81.0
Q ss_pred EEeeEcccCCeEEEEEEEcC----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEEE
Q 012053 14 LGRLLGQGTFAKVHYARNLK----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIYFV 88 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV 88 (472)
-++.|-.|-...+|++.... .++.|++|+..... ....++ .+|..+++.+..-++ .++++.+... .|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 34455558888999986432 34789999875542 122333 679999998865444 3566665332 57
Q ss_pred EEecCCCcccch-----------------hccCC------C-CHHHHHHHHHHHH-----------------HHHHHH--
Q 012053 89 MEYVKGGELFGK-----------------VAKGK------L-KEDAARKYFQQLI-----------------SAVDYC-- 125 (472)
Q Consensus 89 ~E~~~gg~L~~~-----------------i~~~~------l-~e~~~~~i~~ql~-----------------~al~yL-- 125 (472)
.||++|.+|... +.... . ....+..++.++. ..+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999987655311 11101 1 1223333332221 111111
Q ss_pred --H----hCCceecCCCCCcEEEcC-CCCeEEecCcchh
Q 012053 126 --H----SRGVCHRDLKPENLLLDE-HGNLKVSDFGLSA 157 (472)
Q Consensus 126 --H----~~giiHrDIKp~NILld~-~g~vkl~DFGla~ 157 (472)
. ...++|+|+++.|||+++ ++.+.++||..|.
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 225899999999999986 4679999998655
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.015 Score=57.62 Aligned_cols=29 Identities=38% Similarity=0.746 Sum_probs=25.2
Q ss_pred CCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 128 ~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999998543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.0084 Score=61.43 Aligned_cols=78 Identities=21% Similarity=0.252 Sum_probs=53.5
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhcC--CC-CeeeEEEEEEeCCEEEEE
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV---GMIDQIKREISVMRLVR--HP-NVVELYEVMASKTKIYFV 88 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lV 88 (472)
.+.||.|.-..||++.+...++.|+||.-...-.... -..++..-|..+|+... -| +++++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6789999999999999843467899997532221111 23577788999998774 34 45556654 34456788
Q ss_pred EEecCC
Q 012053 89 MEYVKG 94 (472)
Q Consensus 89 ~E~~~g 94 (472)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998865
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.033 Score=56.12 Aligned_cols=134 Identities=17% Similarity=0.269 Sum_probs=77.5
Q ss_pred eeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEEEEEe
Q 012053 16 RLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~ 91 (472)
+.|..|=...+|+...... +..|.+|+...... ..++ -.+|..+++.+..-++ +++++++. .+ +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVID-RERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehh
Confidence 4454477778998865432 34889998754321 1112 2578999998875555 45666653 22 58899
Q ss_pred cCCCcccc----------h-------hccCC------C-CHHHHHHHHHHH----------------------HHHHHHH
Q 012053 92 VKGGELFG----------K-------VAKGK------L-KEDAARKYFQQL----------------------ISAVDYC 125 (472)
Q Consensus 92 ~~gg~L~~----------~-------i~~~~------l-~e~~~~~i~~ql----------------------~~al~yL 125 (472)
++|..|.. . +.... . -...+..|+.++ ..-+..+
T Consensus 92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 171 (330)
T PLN02421 92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL 171 (330)
T ss_pred hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence 98765421 0 11111 1 112233333222 1111111
Q ss_pred ----HhC----CceecCCCCCcEEEcC-CCCeEEecCcchh
Q 012053 126 ----HSR----GVCHRDLKPENLLLDE-HGNLKVSDFGLSA 157 (472)
Q Consensus 126 ----H~~----giiHrDIKp~NILld~-~g~vkl~DFGla~ 157 (472)
.+. -++|.|+.|.|||+++ ++.++++||..|.
T Consensus 172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 112 2799999999999975 5789999998765
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.043 Score=54.19 Aligned_cols=75 Identities=12% Similarity=0.144 Sum_probs=49.1
Q ss_pred EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCEEEEEE
Q 012053 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR---HPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+-.+.+|.|.-..+|... .+++.+.+|+-.... ...+..|..-|+.|. --.+++++.+....+..||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 445778989999999877 588899999876221 245778888888884 445778999988877789999
Q ss_pred EecCCC
Q 012053 90 EYVKGG 95 (472)
Q Consensus 90 E~~~gg 95 (472)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.015 Score=54.39 Aligned_cols=29 Identities=38% Similarity=0.840 Sum_probs=20.8
Q ss_pred CceecCCCCCcEEE-cCCCCeEEecCcchh
Q 012053 129 GVCHRDLKPENLLL-DEHGNLKVSDFGLSA 157 (472)
Q Consensus 129 giiHrDIKp~NILl-d~~g~vkl~DFGla~ 157 (472)
.++|.|+.|.|||+ +.++.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 888999999998765
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.044 Score=55.10 Aligned_cols=133 Identities=20% Similarity=0.284 Sum_probs=80.0
Q ss_pred eEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC------eeeEEE----EEEeCCEEE
Q 012053 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN------VVELYE----VMASKTKIY 86 (472)
Q Consensus 17 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~----~~~~~~~~~ 86 (472)
.|.+ .-..||+... .+|.. ++|+.+.. .. ...+.-|+..|..|.-.+ +..+-| ......+.+
T Consensus 33 ~l~s-~eN~~f~~~~-~~g~~-iLki~~~~-~~----~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 33 GLNS-EENSNFRVQT-EDGRY-ILKIYRPG-WT----RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred cccc-ccCceEEEEe-cCCCe-EEEEecCC-CC----HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 3444 4556888876 34444 99998776 22 356778888888774211 222222 222224888
Q ss_pred EEEEecCCCcccc-h--------------h----------ccCC---CCHH-------------HHHHHHHHHHHHHHHH
Q 012053 87 FVMEYVKGGELFG-K--------------V----------AKGK---LKED-------------AARKYFQQLISAVDYC 125 (472)
Q Consensus 87 lV~E~~~gg~L~~-~--------------i----------~~~~---l~e~-------------~~~~i~~ql~~al~yL 125 (472)
-+.+|++|..+.. . + ..+. ..+. .-.....++...++.+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 9999999987762 1 0 0000 1111 0111233444555555
Q ss_pred HhC--------C--ceecCCCCCcEEEcCCCC-eEEecCcchh
Q 012053 126 HSR--------G--VCHRDLKPENLLLDEHGN-LKVSDFGLSA 157 (472)
Q Consensus 126 H~~--------g--iiHrDIKp~NILld~~g~-vkl~DFGla~ 157 (472)
.+. + +||+|+.|.||+++.+.. +.++|||-+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 543 4 999999999999999885 8999999654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.12 Score=51.34 Aligned_cols=29 Identities=21% Similarity=0.242 Sum_probs=26.8
Q ss_pred CceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 129 giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
+++|+|+.++|+|++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998655
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.029 Score=56.44 Aligned_cols=87 Identities=24% Similarity=0.343 Sum_probs=61.4
Q ss_pred CCCCeeeEEEEE-EeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCC
Q 012053 68 RHPNVVELYEVM-ASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEH 145 (472)
Q Consensus 68 ~hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~ 145 (472)
..++..+++-+- .+....|++|++- |+++.. +. --..+++..++++.+..++-+..+ ..-|||+...||||+ +
T Consensus 283 g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-ik--~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~ 357 (488)
T COG5072 283 GSVFLETLKVVSLDETLYLYLHFKDH-GTPISI-IK--ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E 357 (488)
T ss_pred cchhhhcceEEecCCceEEEEEEecC-Cceeee-ee--cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence 344444444443 3344567778775 555432 22 234567788888888877777655 688999999999999 9
Q ss_pred CCeEEecCcchhhh
Q 012053 146 GNLKVSDFGLSALA 159 (472)
Q Consensus 146 g~vkl~DFGla~~~ 159 (472)
|++.|+||-++++-
T Consensus 358 GnvtLIDfklsRl~ 371 (488)
T COG5072 358 GNVTLIDFKLSRLS 371 (488)
T ss_pred CceEEEEeeeeecc
Confidence 99999999999843
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.37 Score=48.42 Aligned_cols=71 Identities=15% Similarity=0.071 Sum_probs=44.0
Q ss_pred cCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEE---E--EEEeCCEEEEEEEecC
Q 012053 21 GTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELY---E--VMASKTKIYFVMEYVK 93 (472)
Q Consensus 21 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~---~--~~~~~~~~~lV~E~~~ 93 (472)
+.-..||.... .+|..+++|+.+.... ....+..|...+..|.... ++... + +...++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 34456888764 4677899999764432 2356778888887664211 22211 1 1233567889999998
Q ss_pred CCc
Q 012053 94 GGE 96 (472)
Q Consensus 94 gg~ 96 (472)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.065 Score=50.43 Aligned_cols=85 Identities=19% Similarity=0.197 Sum_probs=58.0
Q ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC--Ccee
Q 012053 55 DQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR--GVCH 132 (472)
Q Consensus 55 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~--giiH 132 (472)
..++.+.+++.++. .|+++..- +...+-+++|+|..... .. ..++..=+.+|.-.|+. +.+|
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--------~~----~N~i~agi~~L~~fH~~~~~~lH 166 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--------NF----SNFITAGIKDLMDFHSENQHCLH 166 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc--------ch----hHHHHHhHHHHHHhhccCCCeec
Confidence 44678888887763 46777632 44456789999854211 01 11111224667778843 7999
Q ss_pred cCCCCCcEEEcCCCCeEEecCcc
Q 012053 133 RDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 133 rDIKp~NILld~~g~vkl~DFGl 155 (472)
+|..|+||+-|..|.+||.|=+.
T Consensus 167 GD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 167 GDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999763
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.13 Score=52.94 Aligned_cols=76 Identities=14% Similarity=0.204 Sum_probs=45.7
Q ss_pred EEeeEcccCCeEEEEEEEcCC-CcE-----EEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEE
Q 012053 14 LGRLLGQGTFAKVHYARNLKT-GMS-----VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIY 86 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~-g~~-----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 86 (472)
.++.|..|--..+|++..... +.. |.+++..... ...=.-.+|+.+++.+...++ .++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~----~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN----SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC----ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 345565588889999875332 122 4444421111 111122578999999975555 566666643 6
Q ss_pred EEEEecCCCcc
Q 012053 87 FVMEYVKGGEL 97 (472)
Q Consensus 87 lV~E~~~gg~L 97 (472)
++.||++|..|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 99999999765
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.31 Score=56.59 Aligned_cols=135 Identities=14% Similarity=0.230 Sum_probs=75.7
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-------CCCeeeE-----EEEEEe-C
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-------HPNVVEL-----YEVMAS-K 82 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-------hpnIv~l-----~~~~~~-~ 82 (472)
+.|+ |..-.+|+... .+|..+++|+.+.... ...+..|..+|..|. -|.+++- +..... +
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~-----~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~ 103 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEP-----RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD 103 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccc-----hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence 5675 45677888764 5677899999876421 133445556665442 2333321 111211 2
Q ss_pred C--EEEEEEEecCCCcccch-----------------h----cc-------CCCCH-----------------HHHHHHH
Q 012053 83 T--KIYFVMEYVKGGELFGK-----------------V----AK-------GKLKE-----------------DAARKYF 115 (472)
Q Consensus 83 ~--~~~lV~E~~~gg~L~~~-----------------i----~~-------~~l~e-----------------~~~~~i~ 115 (472)
+ +.+.+++|++|..+.+. + .. ..+.+ ...+.++
T Consensus 104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l 183 (1013)
T PRK06148 104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV 183 (1013)
T ss_pred CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence 2 56778999999766431 0 00 00000 1112223
Q ss_pred HHHHHHHHH-----HH--hCCceecCCCCCcEEEcCCC--CeE-EecCcchh
Q 012053 116 QQLISAVDY-----CH--SRGVCHRDLKPENLLLDEHG--NLK-VSDFGLSA 157 (472)
Q Consensus 116 ~ql~~al~y-----LH--~~giiHrDIKp~NILld~~g--~vk-l~DFGla~ 157 (472)
.+++..+.- +. .+++||.|+.+.|||++.++ .+. |+|||.+.
T Consensus 184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 333333221 11 24799999999999999875 555 99999765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 472 | ||||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-66 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-66 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-66 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-65 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-65 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-65 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-65 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-61 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-61 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-60 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-60 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-60 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-60 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-59 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-59 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-59 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-59 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-57 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-57 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-55 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-54 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-54 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-54 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-53 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-53 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-53 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-53 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-53 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-52 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-52 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-52 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-52 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-52 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-52 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-52 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-52 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-52 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-52 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-52 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-52 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-52 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-52 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-52 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-52 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-52 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-51 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-51 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-51 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-51 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-51 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-51 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-51 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-51 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-51 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-50 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-50 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-50 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-50 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-48 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-47 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-47 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-47 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-47 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-47 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-47 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-47 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-47 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-47 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-47 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-47 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-47 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-46 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-46 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-46 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-46 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-46 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-46 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-46 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-46 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-46 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-46 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-46 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-45 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-45 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-45 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-45 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-45 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-45 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-45 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-45 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-45 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-45 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-45 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-45 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-45 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-44 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-44 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-44 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-44 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-44 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-44 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-44 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-44 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-44 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-44 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-44 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-44 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-44 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-44 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-44 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-44 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-44 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-44 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-44 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-44 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-44 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-44 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-44 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-44 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-44 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-44 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-44 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-44 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-44 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-44 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-44 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-44 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-44 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-44 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-44 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-44 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-44 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-44 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-44 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-44 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-44 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-44 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-44 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-43 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-43 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-43 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-43 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-43 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-43 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-43 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-43 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-43 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-43 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-43 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-43 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-43 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-43 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-43 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-43 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-43 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-43 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-43 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-43 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-43 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-43 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-43 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-43 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-43 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-43 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-43 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-43 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-43 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-43 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-43 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-43 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-43 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-43 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-43 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-43 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-43 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-43 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-43 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-43 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-43 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-43 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-43 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-43 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-43 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-43 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-43 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-43 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-43 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-43 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-43 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-43 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-43 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-42 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-42 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-42 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-42 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-42 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-42 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-42 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-42 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-42 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-42 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-42 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-42 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-41 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-40 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-40 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-40 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-40 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-40 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-40 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-40 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-39 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-39 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-38 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-38 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-38 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-38 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-38 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-38 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-38 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-37 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-37 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-37 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-37 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-37 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-37 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-37 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-37 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-37 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-37 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-37 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-37 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-37 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-37 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-37 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-37 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-37 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-37 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-37 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-36 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-36 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-36 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-36 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-36 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-36 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-36 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-36 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-36 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-36 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-36 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-36 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-36 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-36 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-36 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-35 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-35 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-35 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-35 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-35 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-35 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-35 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-35 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-35 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-35 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-35 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-34 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-34 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-34 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-34 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-34 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-34 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-34 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-34 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-33 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-33 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-33 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-33 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-33 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-33 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-32 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-32 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-32 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-31 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-31 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-31 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-31 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-31 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-30 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-30 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-30 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-30 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-30 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-30 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-30 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-30 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-30 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-30 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-30 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-30 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-30 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-30 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-30 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-30 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-30 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-30 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-30 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-30 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-29 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-29 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-29 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-29 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-29 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-29 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-28 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-28 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-28 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-28 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-28 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-28 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-28 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-28 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-28 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-28 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-27 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-27 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-27 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-27 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-27 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-27 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-27 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-27 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-27 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-27 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-27 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-27 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-27 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-27 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-27 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-27 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-27 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-27 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-27 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-27 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-27 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-27 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-27 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-27 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-27 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-27 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-27 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-27 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-27 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-27 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-27 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-27 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-27 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-27 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-26 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-26 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-26 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-26 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-26 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-26 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-26 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-26 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-26 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-26 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-26 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-26 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-26 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-26 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-26 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-26 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-26 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-26 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-26 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-26 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-26 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-26 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-26 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-26 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-26 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-26 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-26 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-26 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-26 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-26 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-26 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-26 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-26 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-26 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-26 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-26 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-26 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-26 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-26 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-26 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-26 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-25 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-25 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-25 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-25 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-25 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-25 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-25 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-25 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-25 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-25 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-25 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-25 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-25 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-24 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-24 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-24 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-24 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-23 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-23 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-23 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-23 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-22 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-22 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-22 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-22 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-21 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-21 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-21 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-21 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-21 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-21 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-21 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-21 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-21 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-21 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-21 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-21 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-21 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-21 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-21 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-21 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-21 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-21 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-21 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-21 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-21 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-21 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-21 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-21 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-21 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-21 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-21 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-21 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-21 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-21 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-21 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-21 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-21 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-21 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-21 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-21 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-21 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-21 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-21 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-21 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-21 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-21 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-21 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-21 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-21 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-21 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-21 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-21 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-21 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-21 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-21 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-21 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-21 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-21 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-21 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-21 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-21 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-21 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-20 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-20 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-20 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-20 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-20 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-20 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-20 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-20 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-20 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-20 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-20 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-20 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-20 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-20 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-20 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-20 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-20 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-20 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-20 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-20 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-20 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-20 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-20 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-20 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-20 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-20 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-20 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-20 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-20 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-20 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-19 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-19 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-19 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-19 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-19 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-19 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-19 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-19 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-19 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-19 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-19 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-19 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-19 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-19 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-19 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-19 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-19 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-19 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-19 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-19 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-19 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-19 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-18 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-18 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-18 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-18 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-18 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-17 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-16 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-16 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-16 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-16 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-16 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-16 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-16 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-16 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-16 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-16 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-16 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-15 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-15 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-15 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-14 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-14 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-13 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-13 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 8e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-13 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 8e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-13 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 9e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-12 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-12 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-12 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-12 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-12 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-12 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-12 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-12 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-12 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-12 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-12 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-12 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-12 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-12 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-12 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-12 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-12 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-12 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-12 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-11 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 6e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 9e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 9e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 9e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 |
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 494 bits (1273), Expect = e-175
Identities = 121/355 (34%), Positives = 179/355 (50%), Gaps = 20/355 (5%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
++ RY+ + +G G F R+ T VA+K I++ + + ++RE
Sbjct: 11 LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQRE 66
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLI 119
I R +RHPN+V EV+ + T + +MEY GGEL+ + G+ ED AR +FQQL+
Sbjct: 67 IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL 126
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEH--GNLKVSDFGLSALAESKHQDGLLHTTCGTPAY 177
S V YCHS +CHRDLK EN LLD LK+ DFG S + +T GTPAY
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---LHSQPKSTVGTPAY 183
Query: 178 VAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRK----IGKAEFKFPN 233
+APEV+ R+ YDG AD+WSCGV LYV+L G PF D YRK I ++ P+
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD 243
Query: 234 --WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAV 291
+PE L+S+I +P TRIS+ +I +SWF K L ++E+ +
Sbjct: 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPM 303
Query: 292 FSPSGSTSTVAESKNELAKPCNLNAFDIISFSAGFDLSGLFEEREKRKEVRFTSN 346
S ++E+ + L+ F + DL ++ + E+ S+
Sbjct: 304 QSLDTIMQIISEATIPAVRNRCLDDF----MTDNLDLDDDMDDFDSESEIDIDSS 354
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 491 bits (1267), Expect = e-174
Identities = 101/308 (32%), Positives = 160/308 (51%), Gaps = 6/308 (1%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
++ ++L + LG+G + +V A N T +VA+KI+D ++ + + IK+EI + +++
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKML 62
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCH 126
H NVV+ Y Y +EY GGELF + + E A+++F QL++ V Y H
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR 186
G+ HRD+KPENLLLDE NLK+SDFGL+ + +++ LL+ CGT YVAPE++ RR
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAEFKFPNW--FAPEVRRLL 243
+ D+WSCG++L +LAG LP+ S+ + Y + + W LL
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 244 SKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGSTSTVAE 303
KIL NP+ RI++ I ++ W+ K L K + S +
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSP 302
Query: 304 SKNELAKP 311
+ P
Sbjct: 303 VNSASRTP 310
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 489 bits (1262), Expect = e-174
Identities = 122/277 (44%), Positives = 175/277 (63%), Gaps = 4/277 (1%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
++ G + + Y LG LG GTF KV + TG VA+KI++++K+ + ++ +IKREI
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLIS 120
++L RHP++++LY+V+++ T + VMEYV GGELF G+++E AR+ FQQ++S
Sbjct: 63 QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AVDYCH V HRDLKPEN+LLD H N K++DFGLS + L T+CG+P Y AP
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAP 179
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVI+ R Y G + DIWSCGVILY LL G LPF D ++ +++KI F P + V
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA 239
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISE 277
LL +L +P R ++ I E+ WF++ L E
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE 276
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 488 bits (1259), Expect = e-174
Identities = 98/267 (36%), Positives = 154/267 (57%), Gaps = 6/267 (2%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
++ ++L + LG+G + +V A N T +VA+KI+D ++ + + IK+EI + +++
Sbjct: 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKML 62
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCH 126
H NVV+ Y Y +EY GGELF + + E A+++F QL++ V Y H
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR 186
G+ HRD+KPENLLLDE NLK+SDFGL+ + +++ LL+ CGT YVAPE++ RR
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAEFKFPNW--FAPEVRRLL 243
+ D+WSCG++L +LAG LP+ S+ + Y + + W LL
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 244 SKILDPNPNTRISMTKIMENSWFRKGL 270
KIL NP+ RI++ I ++ W+ K L
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPL 269
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 487 bits (1256), Expect = e-173
Identities = 98/288 (34%), Positives = 154/288 (53%), Gaps = 6/288 (2%)
Query: 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID-QIKREISVM 64
+ L+ +Y +G LLG+G++ KV + +T A+KI+ K+K+ ++ + +K+EI ++
Sbjct: 1 AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 65 RLVRHPNVVELYEVM--ASKTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQLIS 120
R +RH NV++L +V+ K K+Y VMEY G E+ V + + A YF QLI
Sbjct: 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID 120
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
++Y HS+G+ H+D+KP NLLL G LK+S G++ D T+ G+PA+ P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 181 EVIN-RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEV 239
E+ N + G K DIWS GV LY + G PF N+ +++ IGK + P P +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240
Query: 240 RRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVD 287
LL +L+ P R S+ +I ++SWFRK D
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKD 288
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 490 bits (1262), Expect = e-171
Identities = 123/291 (42%), Positives = 181/291 (62%), Gaps = 4/291 (1%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
++ G + + Y LG LG GTF KV ++ TG VA+KI++++K+ + ++ +I+REI
Sbjct: 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLIS 120
++L RHP++++LY+V+++ + I+ VMEYV GGELF G+L E +R+ FQQ++S
Sbjct: 68 QNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
VDYCH V HRDLKPEN+LLD H N K++DFGLS + L T+CG+P Y AP
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAP 184
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EVI+ R Y G + DIWS GVILY LL G LPF D ++ +++KI F P + P V
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI 244
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAV 291
LL +L +P R ++ I E+ WF++ L K E +D +A+
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEAL 295
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 472 bits (1216), Expect = e-166
Identities = 111/282 (39%), Positives = 177/282 (62%), Gaps = 6/282 (2%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
Y + LG+G+F KV A + KT VA+K I ++ + K M +++REIS ++L+RHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHSRG 129
++++LY+V+ + T I V+EY GGELF V K ++ ED R++FQQ+I A++YCH
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD 189
+ HRDLKPENLLLD++ N+K++DFGLS + L T+CG+P Y APEVIN + Y
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMT---DGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 190 GSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDP 249
G + D+WSCG++LYV+L G LPF D + +++K+ + P++ +P + L+ +++
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVA 245
Query: 250 NPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAV 291
+P RI++ +I + WF L E + + D+ V
Sbjct: 246 DPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQG-SYADSRIV 286
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 465 bits (1200), Expect = e-165
Identities = 96/296 (32%), Positives = 162/296 (54%), Gaps = 31/296 (10%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV---------- 51
+ + + +Y L +G+G++ V A N A+K++ K+K+++
Sbjct: 5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64
Query: 52 -------------GMIDQIKREISVMRLVRHPNVVELYEVM--ASKTKIYFVMEYVKGGE 96
G I+Q+ +EI++++ + HPNVV+L EV+ ++ +Y V E V G
Sbjct: 65 GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124
Query: 97 LFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156
+ L ED AR YFQ LI ++Y H + + HRD+KP NLL+ E G++K++DFG+S
Sbjct: 125 VMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 157 ALAESKHQDGLLHTTCGTPAYVAPEVIN--RRGYDGSKADIWSCGVILYVLLAGYLPFHD 214
E K D LL T GTPA++APE ++ R+ + G D+W+ GV LY + G PF D
Sbjct: 185 --NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 215 SNLMEMYRKIGKAEFKFPNW--FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
+M ++ KI +FP+ A +++ L++++LD NP +RI + +I + W +
Sbjct: 243 ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 464 bits (1196), Expect = e-164
Identities = 88/271 (32%), Positives = 158/271 (58%), Gaps = 5/271 (1%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
++ +++G LLG+G+FA V+ A ++ TG+ VAIK+IDK+ + K GM+ +++ E+ + ++
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFG--KVAKGKLKEDAARKYFQQLISAVDYCH 126
HP+++ELY +Y V+E GE+ K E+ AR + Q+I+ + Y H
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR 186
S G+ HRDL NLLL + N+K++DFGL+ + +T CGTP Y++PE+ R
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--HEKHYTLCGTPNYISPEIATRS 187
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246
+ G ++D+WS G + Y LL G PF + K+ A+++ P++ + E + L+ ++
Sbjct: 188 AH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246
Query: 247 LDPNPNTRISMTKIMENSWFRKGLVKPSISE 277
L NP R+S++ ++++ + + S E
Sbjct: 247 LRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 463 bits (1195), Expect = e-164
Identities = 89/271 (32%), Positives = 137/271 (50%), Gaps = 4/271 (1%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+RY GR LG+G FAK + T A KI+ K +LK +++ EIS+ R +
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHS 127
H +VV + ++ V+E + L + L E AR Y +Q++ Y H
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
V HRDLK NL L+E +K+ DFGL+ E + CGTP Y+APEV++++G
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE--YDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247
+ + D+WS G I+Y LL G PF S L E Y +I K E+ P P L+ K+L
Sbjct: 192 HSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 250
Query: 248 DPNPNTRISMTKIMENSWFRKGLVKPSISET 278
+P R ++ +++ + +F G + + T
Sbjct: 251 QTDPTARPTINELLNDEFFTSGYIPARLPIT 281
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 461 bits (1189), Expect = e-162
Identities = 89/271 (32%), Positives = 137/271 (50%), Gaps = 4/271 (1%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+RY GR LG+G FAK + T A KI+ K +LK +++ EIS+ R +
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHS 127
H +VV + ++ V+E + L + L E AR Y +Q++ Y H
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
V HRDLK NL L+E +K+ DFGL+ E + CGTP Y+APEV++++G
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE--YDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247
+ + D+WS G I+Y LL G PF S L E Y +I K E+ P P L+ K+L
Sbjct: 218 HSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML 276
Query: 248 DPNPNTRISMTKIMENSWFRKGLVKPSISET 278
+P R ++ +++ + +F G + + T
Sbjct: 277 QTDPTARPTINELLNDEFFTSGYIPARLPIT 307
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 457 bits (1178), Expect = e-161
Identities = 94/282 (33%), Positives = 156/282 (55%), Gaps = 9/282 (3%)
Query: 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV 63
K + +++GR LG+G F V+ AR + +A+K++ K ++ K G+ Q++REI +
Sbjct: 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 67
Query: 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAV 122
+RHPN++ +Y + +IY ++E+ GEL+ ++ K G+ E + + ++L A+
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV 182
YCH R V HRD+KPENLL+ G LK++DFG S A T CGT Y+ PE+
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRTMCGTLDYLPPEM 183
Query: 183 INRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242
I + +D K D+W GV+ Y L G PF + E +R+I + KFP + + + L
Sbjct: 184 IEGKTHDE-KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242
Query: 243 LSKILDPNPNTRISMTKIMENSWFRKGLVK---PSISETEEK 281
+SK+L +P R+ + +ME+ W + + P T+ K
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 456 bits (1176), Expect = e-161
Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 6/280 (2%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
K ++ +E+GR LG+G F V+ AR ++ +A+K++ K ++ K G+ Q++RE+
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 63 VMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISA 121
+ +RHPN++ LY T++Y ++EY G ++ ++ K K E Y +L +A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+ YCHS+ V HRD+KPENLLL G LK++DFG S A CGT Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLCGTLDYLPPE 177
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRR 241
+I R +D K D+WS GV+ Y L G PF + E Y++I + EF FP++ R
Sbjct: 178 MIEGRMHDE-KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 242 LLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEK 281
L+S++L NP+ R + +++E+ W KPS + +E
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKES 276
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 435 bits (1120), Expect = e-152
Identities = 113/289 (39%), Positives = 172/289 (59%), Gaps = 5/289 (1%)
Query: 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV 63
+ Y L + +G+G FAKV AR++ TG VAIKIIDK + L + ++ RE+ +
Sbjct: 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRI 67
Query: 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAV 122
M+++ HPN+V+L+EV+ ++ +Y +MEY GGE+F VA G++KE AR F+Q++SAV
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 127
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV 182
YCH + + HRDLK ENLLLD N+K++DFG S G L CG P Y APE+
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDAFCGAPPYAAPEL 184
Query: 183 INRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242
+ YDG + D+WS GVILY L++G LPF NL E+ ++ + +++ P + + + L
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244
Query: 243 LSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAV 291
L + L NP R ++ +IM++ W G + + E E D +
Sbjct: 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRI 293
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 427 bits (1099), Expect = e-149
Identities = 85/295 (28%), Positives = 144/295 (48%), Gaps = 16/295 (5%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID-----QIKREIS 62
Q+Y LG G F V A + + V +K I KEKVL+ I+ ++ EI+
Sbjct: 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIA 81
Query: 63 VMRLVRHPNVVELYEVMASKTKIYFVME-YVKGGELFGK-VAKGKLKEDAARKYFQQLIS 120
++ V H N++++ ++ ++ VME + G +LF +L E A F+QL+S
Sbjct: 82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
AV Y + + HRD+K EN+++ E +K+ DFG +A E + L +T CGT Y AP
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE---RGKLFYTFCGTIEYCAP 198
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
EV+ Y G + ++WS GV LY L+ PF + + +A P + E+
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELM 252
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPS 295
L+S +L P P R ++ K++ + W + + + E ++ + + S
Sbjct: 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAAS 307
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 424 bits (1092), Expect = e-148
Identities = 88/287 (30%), Positives = 141/287 (49%), Gaps = 20/287 (6%)
Query: 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQ---IKRE 60
Y LG LLG+G F V L + VAIK+I + +VL + E
Sbjct: 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE 84
Query: 61 ISVMRLVR----HPNVVELYEVMASKTKIYFVMEY-VKGGELFGK-VAKGKLKEDAARKY 114
++++ V HP V+ L + ++ V+E + +LF KG L E +R +
Sbjct: 85 VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF 144
Query: 115 FQQLISAVDYCHSRGVCHRDLKPENLLLD-EHGNLKVSDFGLSALAESKHQDGLLHTTCG 173
F Q+++A+ +CHSRGV HRD+K EN+L+D G K+ DFG AL D G
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL----LHDEPYTDFDG 200
Query: 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN 233
T Y PE I+R Y A +WS G++LY ++ G +PF ++I +AE FP
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPA 254
Query: 234 WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEE 280
+P+ L+ + L P P++R S+ +I+ + W + ++ ++
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKG 301
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 420 bits (1081), Expect = e-146
Identities = 81/290 (27%), Positives = 140/290 (48%), Gaps = 18/290 (6%)
Query: 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID---QIKRE 60
+ L +Y++G LLG G F V+ + + VAIK ++K+++ G + ++ E
Sbjct: 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 96
Query: 61 ISVMRLVRH--PNVVELYEVMASKTKIYFVMEYVKG-GELFGK-VAKGKLKEDAARKYFQ 116
+ +++ V V+ L + ++E + +LF +G L+E+ AR +F
Sbjct: 97 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 156
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLD-EHGNLKVSDFGLSALAESKHQDGLLHTTCGTP 175
Q++ AV +CH+ GV HRD+K EN+L+D G LK+ DFG AL +D + GT
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTR 212
Query: 176 AYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWF 235
Y PE I Y G A +WS G++LY ++ G +PF +I + + F
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRV 266
Query: 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEWAP 285
+ E + L+ L P+ R + +I + W + L+ +E +P
Sbjct: 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 406 bits (1045), Expect = e-140
Identities = 70/324 (21%), Positives = 135/324 (41%), Gaps = 51/324 (15%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK----------- 50
+ + Y + R L QG F K+ K A+K +K + K
Sbjct: 23 VKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 51 ---VGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELF--------- 98
D K E+ ++ +++ + ++ + ++Y + EY++ +
Sbjct: 81 ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 99 GKVAKGKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157
K + + + ++++ Y H+ + +CHRD+KP N+L+D++G +K+SDFG S
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 158 LAESKHQDGLLHTTCGTPAYVAPEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFHD-S 215
D + + GT ++ PE N Y+G+K DIWS G+ LYV+ +PF
Sbjct: 201 YMV----DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 216 NLMEMYRKIGKAEFKFP-------------------NWFAPEVRRLLSKILDPNPNTRIS 256
+L+E++ I ++P N+ + E L L NP RI+
Sbjct: 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
Query: 257 MTKIMENSWFRKGLVKPSISETEE 280
+++ W ++ ++E
Sbjct: 317 SEDALKHEWLADTNIEDLREFSKE 340
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 343 bits (883), Expect = e-117
Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 37/300 (12%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+E +LGQG F +V ARN AIK I + + I E+ ++ + H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNH 61
Query: 70 PNVVELYEV-------------MASKTKIYFVMEYVKGGELFGKVAKGKLK--EDAARKY 114
VV Y + K+ ++ MEY + G L+ + L D +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 115 FQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES------------K 162
F+Q++ A+ Y HS+G+ HRDLKP N+ +DE N+K+ DFGL+
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR 222
L + GT YVA EV++ G+ K D++S G+I + ++ Y + + +
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILK 239
Query: 223 KIGKAEFKFPNWFA----PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISET 278
K+ +FP F ++++ ++D +PN R ++ + W I E
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEA 299
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = e-110
Identities = 95/299 (31%), Positives = 150/299 (50%), Gaps = 22/299 (7%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-----KVGMID 55
M L Y + + LG G +V A KT VAIKII K K +
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 56 QIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKY 114
++ EI +++ + HP ++++ ++ Y V+E ++GGELF K V +LKE + Y
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 115 FQQLISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTT 171
F Q++ AV Y H G+ HRDLKPEN+LL +E +K++DFG S + + L+ T
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTL 176
Query: 172 CGTPAYVAPEVIN---RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL-MEMYRKIGKA 227
CGTP Y+APEV+ GY D WS GVIL++ L+GY PF + + + +I
Sbjct: 177 CGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 228 EFKFPN--WFA--PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKE 282
++ F W + L+ K+L +P R + + + + W + +K + +E
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 294
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 319 bits (820), Expect = e-107
Identities = 94/268 (35%), Positives = 146/268 (54%), Gaps = 13/268 (4%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
Y++ LG+G F+ V + TG+ A KII+ +K L +++RE + R ++H
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQH 64
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHSR 128
PN+V L++ + ++ Y V + V GGELF VA+ E A QQ++ ++ YCHS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 129 GVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
G+ HR+LKPENLLL + +K++DFGL+ H GTP Y++PEV+ +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAGTPGYLSPEVLKK 181
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN--W--FAPEVRR 241
Y DIW+CGVILY+LL GY PF D + +Y +I + +P+ W PE +
Sbjct: 182 DPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 242 LLSKILDPNPNTRISMTKIMENSWFRKG 269
L+ +L NP RI+ + ++ W
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNR 268
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-107
Identities = 103/274 (37%), Positives = 145/274 (52%), Gaps = 16/274 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
Q Y L +G+G++ +V A T + A K I K V +D+ K+EI +M+ + H
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHSR 128
PN++ LYE T IY VME GGELF + V K +E A + + ++SAV YCH
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 129 GVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
V HRDLKPEN L LK+ DFGL+A + ++ T GTP YV+P+V+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK---PGKMMRTKVGTPYYVSPQVL-E 181
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN--WFA--PEVRR 241
Y G + D WS GV++YVLL GY PF E+ KI + F FP W P+
Sbjct: 182 GLY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240
Query: 242 LLSKILDPNPNTRISMTKIMENSWFRKGLVKPSI 275
L+ ++L +P RI+ + +E+ WF K L
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 322 bits (826), Expect = e-106
Identities = 93/292 (31%), Positives = 149/292 (51%), Gaps = 22/292 (7%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-----KVGMIDQIKREIS 62
L Y + + LG G +V A KT VAI+II K K + ++ EI
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 63 VMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISA 121
+++ + HP ++++ ++ Y V+E ++GGELF K V +LKE + YF Q++ A
Sbjct: 193 ILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 251
Query: 122 VDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
V Y H G+ HRDLKPEN+LL +E +K++DFG S + + L+ T CGTP Y+
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYL 308
Query: 179 APEVI---NRRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAEFKF--P 232
APEV+ GY D WS GVIL++ L+GY PF + + + +I ++ F
Sbjct: 309 APEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367
Query: 233 NWFA--PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKE 282
W + L+ K+L +P R + + + + W + +K + +E
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 419
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-106
Identities = 89/271 (32%), Positives = 142/271 (52%), Gaps = 18/271 (6%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ R LG G F VH +G+ IK I+K++ ++QI+ EI V++ + H
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDH 79
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKV-----AKGKLKEDAARKYFQQLISAVDY 124
PN+++++EV +Y VME +GGEL ++ L E + +Q+++A+ Y
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 125 CHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
HS+ V H+DLKPEN+L H +K+ DFGL+ L +S GT Y+APE
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPE 196
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAP---E 238
V +R K DIWS GV++Y LL G LPF ++L E+ +K E + P +
Sbjct: 197 VF-KRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ 254
Query: 239 VRRLLSKILDPNPNTRISMTKIMENSWFRKG 269
LL ++L +P R S +++ + WF++
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-106
Identities = 91/282 (32%), Positives = 144/282 (51%), Gaps = 22/282 (7%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV------GMIDQIKREISV 63
+ YE +LG+G + V + T A+KIID + + +E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 64 MR-LVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISA 121
+R + HPN+++L + + T + V + +K GELF K L E RK + L+
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+ H + HRDLKPEN+LLD+ N+K++DFG S + L CGTP+Y+APE
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAPE 193
Query: 182 VI------NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF--PN 233
+I N GY G + D+WS GVI+Y LLAG PF M M R I ++F P
Sbjct: 194 IIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 234 W--FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKP 273
W ++ V+ L+S+ L P R + + + + +F++ +V+
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-105
Identities = 93/270 (34%), Positives = 150/270 (55%), Gaps = 20/270 (7%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ + +LG G F++V + TG A+K I K + ++ EI+V++ ++H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKH 65
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHSR 128
N+V L ++ S T Y VM+ V GGELF + + +G E A QQ++SAV Y H
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 129 GVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
G+ HRDLKPENLL +E+ + ++DFGLS + + +G++ T CGTP YVAPEV+ +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQ 181
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF--PNWFAPEV---- 239
+ Y D WS GVI Y+LL GY PF++ +++ KI + ++F P W ++
Sbjct: 182 KPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW--DDISESA 238
Query: 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG 269
+ + +L+ +PN R + K + + W
Sbjct: 239 KDFICHLLEKDPNERYTCEKALSHPWIDGN 268
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-105
Identities = 85/276 (30%), Positives = 148/276 (53%), Gaps = 21/276 (7%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV-----LKVGMIDQIKREISVM 64
Q+Y+ ++G+G + V + TG A+KI++ + + +RE ++
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 65 R-LVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAV 122
R + HP+++ L + S + ++ V + ++ GELF K L E R + L+ AV
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV 182
+ H+ + HRDLKPEN+LLD++ +++SDFG S E L CGTP Y+APE+
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE---PGEKLRELCGTPGYLAPEI 270
Query: 183 I------NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF--PNW 234
+ GY G + D+W+CGVIL+ LLAG PF + M R I + +++F P W
Sbjct: 271 LKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329
Query: 235 --FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
+ V+ L+S++L +P R++ + +++ +F +
Sbjct: 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-105
Identities = 97/282 (34%), Positives = 150/282 (53%), Gaps = 13/282 (4%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
M N + Y++ LG+G F+ V + TG+ A KII+ +K L +++RE
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLERE 78
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLI 119
+ R ++HPN+V L++ + ++ Y V + V GGELF VA+ E A QQ++
Sbjct: 79 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL 138
Query: 120 SAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
++ YCHS G+ HR+LKPENLLL + +K++DFGL+ H GTP
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPG 195
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN--W 234
Y++PEV+ + Y DIW+CGVILY+LL GY PF D + +Y +I + +P+ W
Sbjct: 196 YLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 254
Query: 235 --FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPS 274
PE + L+ +L NP RI+ + ++ W S
Sbjct: 255 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS 296
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = e-104
Identities = 88/267 (32%), Positives = 154/267 (57%), Gaps = 14/267 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+RY + +LG+G+F +V ++ T A+K+I+K K I RE+ +++ + H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDH 80
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHSR 128
PN+++L+E++ + Y V E GGELF + + + + E A + +Q+ S + Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 129 GVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
+ HRDLKPEN+LL ++ ++K+ DFGLS + Q+ + GT Y+APEV+ R
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEVL-R 196
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN--W--FAPEVRR 241
Y K D+WS GVILY+LL+G PF+ N ++ +++ ++ F W + + +
Sbjct: 197 GTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 242 LLSKILDPNPNTRISMTKIMENSWFRK 268
L+ K+L +P+ RI+ T+ +E+ W +K
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = e-104
Identities = 68/282 (24%), Positives = 128/282 (45%), Gaps = 20/282 (7%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
S+ + Y + + +G G +KV N + AIK ++ E+ + D + EI+
Sbjct: 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTL-DSYRNEIA 78
Query: 63 VMRLVRHPN--VVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLI 119
+ ++ + ++ LY+ + IY VME +L K + + Y++ ++
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNML 137
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
AV H G+ H DLKP N L+ + G LK+ DFG++ + + + GT Y+
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196
Query: 180 PEVINRRGYD----------GSKADIWSCGVILYVLLAGYLPFHD--SNLMEMYRKI-GK 226
PE I K+D+WS G ILY + G PF + + +++ I
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256
Query: 227 AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
E +FP+ +++ +L L +P RIS+ +++ + + +
Sbjct: 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-103
Identities = 99/279 (35%), Positives = 155/279 (55%), Gaps = 12/279 (4%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ Y+L LG+G F+ V + G A II+ +K L +++RE + RL++H
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK-LSARDHQKLEREARICRLLKH 69
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHSR 128
PN+V L++ ++ + Y + + V GGELF VA+ E A QQ++ AV +CH
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 129 GVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
GV HR+LKPENLLL + +K++DFGL+ E + Q GTP Y++PEV+ +
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRK 187
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN--W--FAPEVRR 241
Y G D+W+CGVILY+LL GY PF D + +Y++I + FP+ W PE +
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246
Query: 242 LLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEE 280
L++K+L NP+ RI+ + +++ W S +E
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQE 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-103
Identities = 67/314 (21%), Positives = 118/314 (37%), Gaps = 52/314 (16%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
M ++ + + L +LGQG A V R+ KTG AIK+ + L+ +D RE
Sbjct: 1 MGSQSTS-NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMRE 57
Query: 61 ISVMRLVRHPNVVELYEVMASKTK--IYFVMEYVKGGELFGKVAK----GKLKEDAARKY 114
V++ + H N+V+L+ + T +ME+ G L+ + + L E
Sbjct: 58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 115 FQQLISAVDYCHSRGVCHRDLKPENLLL----DEHGNLKVSDFGLSALAESKHQDGLLHT 170
+ ++ +++ G+ HR++KP N++ D K++DFG + E D +
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVS 174
Query: 171 TCGTPAYVAPEVINRRGYD-------GSKADIWSCGVILYVLLAGYLPFHDS----NLME 219
GT Y+ P++ R G+ D+WS GV Y G LPF E
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 220 MYRKIGKAE-------------------FKFPNW------FAPEVRRLLSKILDPNPNTR 254
+ KI + P + +L+ IL+ +
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294
Query: 255 ISMTKIMENSWFRK 268
+ +
Sbjct: 295 WGFDQFFAETSDIL 308
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 309 bits (792), Expect = e-102
Identities = 66/311 (21%), Positives = 117/311 (37%), Gaps = 52/311 (16%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
M ++ + + L +LGQG A V R+ KTG AIK+ + L+ +D RE
Sbjct: 1 MGSQSTS-NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMRE 57
Query: 61 ISVMRLVRHPNVVELYEVMASKTK--IYFVMEYVKGGELFGKVAK----GKLKEDAARKY 114
V++ + H N+V+L+ + T +ME+ G L+ + + L E
Sbjct: 58 FEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 115 FQQLISAVDYCHSRGVCHRDLKPENLLL----DEHGNLKVSDFGLSALAESKHQDGLLHT 170
+ ++ +++ G+ HR++KP N++ D K++DFG + E D +
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVS 174
Query: 171 TCGTPAYVAPEVINRRGYD-------GSKADIWSCGVILYVLLAGYLPFHD----SNLME 219
GT Y+ P++ R G+ D+WS GV Y G LPF E
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234
Query: 220 MYRKIGKAEF-------------------------KFPNWFAPEVRRLLSKILDPNPNTR 254
+ KI + + +L+ IL+ +
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294
Query: 255 ISMTKIMENSW 265
+ +
Sbjct: 295 WGFDQFFAETS 305
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-100
Identities = 84/288 (29%), Positives = 147/288 (51%), Gaps = 18/288 (6%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQ--IK 58
M + + YEL ++G+G F+ V N +TG A+KI+D K + +K
Sbjct: 15 MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK 74
Query: 59 REISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLK----EDAARK 113
RE S+ +++HP++VEL E +S +Y V E++ G +L + V + E A
Sbjct: 75 REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 114 YFQQLISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHT 170
Y +Q++ A+ YCH + HRD+KP +LL + +K+ FG++ +
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGG 192
Query: 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK 230
GTP ++APEV+ R Y G D+W CGVIL++LL+G LPF+ + ++ I K ++K
Sbjct: 193 RVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYK 250
Query: 231 F--PNW--FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPS 274
W + + L+ ++L +P RI++ + + + W ++
Sbjct: 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAY 298
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 308 bits (790), Expect = e-100
Identities = 88/269 (32%), Positives = 154/269 (57%), Gaps = 14/269 (5%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
+RY + +LG+G+F +V ++ T A+K+I+K K I RE+ +++ +
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKL 78
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCH 126
HPN+++L+E++ + Y V E GGELF + + + + E A + +Q+ S + Y H
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 127 SRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
+ HRDLKPEN+LL ++ ++K+ DFGLS + Q+ + GT Y+APEV+
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEVL 195
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF--PNW--FAPEV 239
Y K D+WS GVILY+LL+G PF+ N ++ +++ ++ F P W + +
Sbjct: 196 RGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253
Query: 240 RRLLSKILDPNPNTRISMTKIMENSWFRK 268
+ L+ K+L +P+ RI+ T+ +E+ W +K
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = e-100
Identities = 68/289 (23%), Positives = 128/289 (44%), Gaps = 20/289 (6%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ Y + + +G G +KV N + AIK ++ E+ +D + EI+ + ++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQQ 66
Query: 70 PN--VVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCH 126
+ ++ LY+ + IY VME +L K + + Y++ ++ AV H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR 186
G+ H DLKP N L+ + G LK+ DFG++ + + + GT Y+ PE I
Sbjct: 126 QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 187 GYD----------GSKADIWSCGVILYVLLAGYLPFHD--SNLMEMYRKI-GKAEFKFPN 233
K+D+WS G ILY + G PF + + +++ I E +FP+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 234 WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKE 282
+++ +L L +P RIS+ +++ + + + + E
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 293
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = e-100
Identities = 90/278 (32%), Positives = 141/278 (50%), Gaps = 23/278 (8%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVR 68
YE+ +G G+++ + T M A+KIIDK K EI ++ R +
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQ 74
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHS 127
HPN++ L +V +Y V E +KGGEL K + + E A + V+Y H+
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 128 RGVCHRDLKPENLLL----DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
+GV HRDLKP N+L ++++ DFG + + + ++GLL T C T +VAPEV+
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFA--KQLRAENGLLMTPCYTANFVAPEVL 192
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFH---DSNLMEMYRKIGKAEFKF--PNW--FA 236
R+GYD + DIWS GV+LY +L GY PF D E+ +IG +F W +
Sbjct: 193 ERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPS 274
+ L+SK+L +P+ R++ ++ + W P
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQ 289
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 1e-99
Identities = 93/318 (29%), Positives = 145/318 (45%), Gaps = 54/318 (16%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQ--IKREISVMRLV 67
++Y L +GQG++ V A +T AIKI++K K+ ++ D IK E+ +M+ +
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK------------------------ 103
HPN+ LYEV + I VME GG L K+
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 104 -----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL--DE 144
+E +Q+ SA+ Y H++G+CHRD+KPEN L ++
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 145 HGNLKVSDFGLSAL--AESKHQDGLLHTTCGTPAYVAPEVIN--RRGYDGSKADIWSCGV 200
+K+ DFGLS + + + T GTP +VAPEV+N Y G K D WS GV
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGV 264
Query: 201 ILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN--WFA--PEVRRLLSKILDPNPNTRIS 256
+L++LL G +PF N + ++ + F N + P R LLS +L+ N + R
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 257 MTKIMENSWFRKGLVKPS 274
+ +++ W + K
Sbjct: 325 AMRALQHPWISQFSDKIY 342
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 2e-99
Identities = 89/276 (32%), Positives = 146/276 (52%), Gaps = 16/276 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK---VGMIDQIKREISVMRL 66
YE+G LG G FA V R TG A K I K ++ ++I+RE++++R
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYC 125
+RHPN++ L+++ +KT + ++E V GGELF K L ED A ++ +Q++ V Y
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 126 HSRGVCHRDLKPENLLL----DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
HS+ + H DLKPEN++L + +K+ DFG++ E GTP +VAPE
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGNEFKNIFGTPEFVAPE 181
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-NWFA---P 237
++N G +AD+WS GVI Y+LL+G PF E I + F +F+
Sbjct: 182 IVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 238 EVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKP 273
+ + ++L +P R+++ + +E+SW + +
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = 2e-99
Identities = 68/293 (23%), Positives = 129/293 (44%), Gaps = 20/293 (6%)
Query: 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR 65
S+ + Y + + +G G +KV N + AIK ++ E+ +D + EI+ +
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLN 109
Query: 66 LVRHPN--VVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAV 122
++ + ++ LY+ + IY VME +L K + + Y++ ++ AV
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV 182
H G+ H DLKP N L+ + G LK+ DFG++ + + + G Y+ PE
Sbjct: 169 HTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 183 INRRGYD----------GSKADIWSCGVILYVLLAGYLPFHD--SNLMEMYRKI-GKAEF 229
I K+D+WS G ILY + G PF + + +++ I E
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKE 282
+FP+ +++ +L L +P RIS+ +++ + + + + E
Sbjct: 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 340
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = 3e-99
Identities = 93/276 (33%), Positives = 159/276 (57%), Gaps = 13/276 (4%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
+++ +I RY+ R+LG+G+F +V ++ TG A+K+I K +V + + + RE
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLI 119
+ +++ + HPN+++LYE K Y V E GGELF + +++ + E A + +Q++
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136
Query: 120 SAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
S + Y H + HRDLKPENLLL + N+++ DFGLS E+ + + GT
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAY 193
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF--PNW 234
Y+APEV++ Y K D+WS GVILY+LL+G PF+ +N ++ +K+ K ++ F P W
Sbjct: 194 YIAPEVLHGT-Y-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251
Query: 235 --FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
+ + L+ K+L P+ RIS +++ W +
Sbjct: 252 KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 2e-98
Identities = 93/270 (34%), Positives = 145/270 (53%), Gaps = 22/270 (8%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+E+ LG+G + V+ + T A+K++ K ++ EI V+ + H
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSH 107
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCHSR 128
PN+++L E+ + T+I V+E V GGELF + V KG E A +Q++ AV Y H
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 129 GVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
G+ HRDLKPENLL LK++DFGLS + E L+ T CGTP Y APE++
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE---HQVLMKTVCGTPGYCAPEILRG 224
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAEFKFPN--WFAPEV--- 239
Y G + D+WS G+I Y+LL G+ PF+D M+R+I E+ F + W EV
Sbjct: 225 CAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW--DEVSLN 281
Query: 240 -RRLLSKILDPNPNTRISMTKIMENSWFRK 268
+ L+ K++ +P R++ + +++ W
Sbjct: 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 308 bits (790), Expect = 4e-98
Identities = 73/292 (25%), Positives = 119/292 (40%), Gaps = 25/292 (8%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
+E+ LG G F V + TG VAIK +E K ++ EI +M+ + HP
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNHP 72
Query: 71 NVVELYEVMASKTKI------YFVMEYVKGGELFGKVAK----GKLKEDAARKYFQQLIS 120
NVV EV K+ MEY +GG+L + + LKE R + S
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGN---LKVSDFGLSALAESKHQDGLLHTTCGTPAY 177
A+ Y H + HRDLKPEN++L K+ D G + + Q L GT Y
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGTLQY 189
Query: 178 VAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSNLMEMYRKIGKAEFKFPNWFA 236
+APE++ ++ Y D WS G + + + G+ PF + ++ + K+ + + +
Sbjct: 190 LAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVK-----PSISETEEKEW 283
+ + P PN + W + L+ + +
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = 4e-98
Identities = 89/290 (30%), Positives = 151/290 (52%), Gaps = 23/290 (7%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMI----------DQI 57
+ + Y R LG G + +V + AIK+I K + K ++I
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 58 KREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQ 116
EIS+++ + HPN+++L++V K Y V E+ +GGELF + + + K E A +
Sbjct: 94 YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCG 173
Q++S + Y H + HRD+KPEN+LL + N+K+ DFGLS+ ++ L G
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLG 210
Query: 174 TPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP- 232
T Y+APEV+ ++ Y K D+WSCGVI+Y+LL GY PF N ++ +K+ K ++ F
Sbjct: 211 TAYYIAPEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
Query: 233 ---NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETE 279
+ E + L+ +L + N R + + + + W +K + S+ +
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 5e-98
Identities = 100/290 (34%), Positives = 152/290 (52%), Gaps = 28/290 (9%)
Query: 4 KGSILMQRYELG---RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
K S Q Y+L + LG+G+F+ + K+ + A+KII K ++E
Sbjct: 2 KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKE 55
Query: 61 ISVMRLVR-HPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQL 118
I+ ++L HPN+V+L+EV + + VME + GGELF + K E A ++L
Sbjct: 56 ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL 115
Query: 119 ISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP 175
+SAV + H GV HRDLKPENLL +++ +K+ DFG + L + L T C T
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTL 173
Query: 176 AYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN-------LMEMYRKIGKAE 228
Y APE++N+ GYD D+WS GVILY +L+G +PF + +E+ +KI K +
Sbjct: 174 HYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
Query: 229 FKF--PNWFA--PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPS 274
F F W E + L+ +L +PN R+ M+ + N W + G S
Sbjct: 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS 282
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 1e-97
Identities = 97/283 (34%), Positives = 153/283 (54%), Gaps = 15/283 (5%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
KG + + Y+ + LG G + +V R+ T + AIKII K + ++ E+
Sbjct: 30 SKKGHLS-EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEV 87
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLIS 120
+V++L+ HPN+++LY+ K Y VME KGGELF + + + K E A +Q++S
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS 147
Query: 121 AVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAY 177
V Y H + HRDLKPENLLL ++ +K+ DFGLSA+ E + GT Y
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE---NQKKMKERLGTAYY 204
Query: 178 VAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWF-- 235
+APEV+ ++ Y K D+WS GVIL++LLAGY PF E+ RK+ K ++ F +
Sbjct: 205 IAPEVLRKK-Y-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK 262
Query: 236 --APEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSIS 276
+ + L+ ++L + RIS + +E+ W ++ K
Sbjct: 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESG 305
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 4e-97
Identities = 87/284 (30%), Positives = 142/284 (50%), Gaps = 16/284 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK---VGMIDQIKREISVMRL 66
Y++G LG G FA V R TG+ A K I K + ++I+RE+S++R
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYC 125
V H NV+ L++V ++T + ++E V GGELF K L E+ A + +Q++ V+Y
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 126 HSRGVCHRDLKPENLLL----DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
H++ + H DLKPEN++L ++K+ DFGL+ E GTP +VAPE
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTPEFVAPE 188
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-NWFA---P 237
++N G +AD+WS GVI Y+LL+G PF E I + F +F+
Sbjct: 189 IVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE 247
Query: 238 EVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEK 281
+ + K+L R+++ + + + W + ++ E
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV 291
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 4e-97
Identities = 87/279 (31%), Positives = 145/279 (51%), Gaps = 16/279 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGM---IDQIKREISVMRL 66
Y+ G LG G FA V R TG+ A K I K + + I+RE+S+++
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYC 125
++HPNV+ L+EV +KT + ++E V GGELF K L E+ A ++ +Q+++ V Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 126 HSRGVCHRDLKPENLLL----DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
HS + H DLKPEN++L +K+ DFGL+ + GTP +VAPE
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPE 187
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-NWFA---P 237
++N G +AD+WS GVI Y+LL+G PF E + ++F +F+
Sbjct: 188 IVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 238 EVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSIS 276
+ + ++L +P R+++ +++ W + + ++S
Sbjct: 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS 285
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 295 bits (756), Expect = 9e-97
Identities = 87/283 (30%), Positives = 143/283 (50%), Gaps = 16/283 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK---VGMIDQIKREISVMRL 66
Y++G LG G FA V R TG+ A K I K + ++I+RE+S++R
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYC 125
V HPN++ L++V ++T + ++E V GGELF K L E+ A + +Q++ V+Y
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 126 HSRGVCHRDLKPENLLL----DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
H++ + H DLKPEN++L ++K+ DFGL+ E GTP +VAPE
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTPEFVAPE 188
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-NWFA---P 237
++N G +AD+WS GVI Y+LL+G PF E I + F +F+
Sbjct: 189 IVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 238 EVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEE 280
+ + K+L R+++ + + + W + ++ E
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRES 290
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 1e-93
Identities = 78/284 (27%), Positives = 128/284 (45%), Gaps = 17/284 (5%)
Query: 10 QRYEL-GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
Y L + LG+G FA V + TG A K + K + +I EI+V+ L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAK 86
Query: 69 H-PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDY 124
P V+ L+EV + ++I ++EY GGE+F + E+ + +Q++ V Y
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 125 CHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
H + H DLKP+N+LL G++K+ DFG+S L GTP Y+APE
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG---HACELREIMGTPEYLAPE 203
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-NWFA---P 237
++N + D+W+ G+I Y+LL PF + E Y I + + F+
Sbjct: 204 ILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ 262
Query: 238 EVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEK 281
+ +L NP R + + +SW ++ + E
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETS 306
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 285 bits (730), Expect = 4e-93
Identities = 86/294 (29%), Positives = 147/294 (50%), Gaps = 33/294 (11%)
Query: 2 ENKGSILMQRYELGR-LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
E K + Y+L + +LG G KV + +TG A+K++ + ++E
Sbjct: 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQE 71
Query: 61 ISVM-RLVRHPNVVELYEV----MASKTKIYFVMEYVKGGELFGK-VAKGKLK--EDAAR 112
+ + P++V + +V K + +ME ++GGELF + +G E A
Sbjct: 72 VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA 131
Query: 113 KYFQQLISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLH 169
+ + + +A+ + HS + HRD+KPENLL ++ LK++DFG + + L
Sbjct: 132 EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQ 187
Query: 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN----LMEMYRKIG 225
T C TP YVAPEV+ YD D+WS GVI+Y+LL G+ PF+ + M R+I
Sbjct: 188 TPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 226 KAEFKFPN--WFA--PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSI 275
++ FPN W + ++L+ +L +P R+++T+ M + W + +V P
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT 300
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 5e-93
Identities = 86/295 (29%), Positives = 145/295 (49%), Gaps = 39/295 (13%)
Query: 10 QRYELGR-LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
Y+L +LG+G A+V NL T A+KII+K+ + ++ RE+ ++ +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQ 68
Query: 69 -HPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKGKLKEDAARKYFQQLISAVDYCH 126
H NV+EL E + + Y V E ++GG + + E A Q + SA+D+ H
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 127 SRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAE-----SKHQDGLLHTTCGTPAYV 178
++G+ HRDLKPEN+L ++ +K+ DF L + + S L T CG+ Y+
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 179 APEVINR-----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNL---------------M 218
APEV+ YD + D+WS GVILY+LL+GY PF
Sbjct: 189 APEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247
Query: 219 EMYRKIGKAEFKFPN--WFA--PEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269
++ I + +++FP+ W + L+SK+L + R+S +++++ W +
Sbjct: 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 285 bits (730), Expect = 9e-93
Identities = 54/302 (17%), Positives = 97/302 (32%), Gaps = 54/302 (17%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-- 68
G +LGQ A + +TG S + + + I Q+K E+ +RL+R
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 69 -----------------------HPNVVELYEVMASKT--KIYFVME------YVKGGEL 97
++ + +F+ G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 98 FGKVAKGKLKEDAARKY-FQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156
+ K AR Q+I + H G+ H L+P +++LD+ G + ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRG----------YDGSKADIWSCGVILYVLL 206
+DG + + + PE+ RR D W+ G+++Y +
Sbjct: 254 ------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 207 AGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWF 266
LP + I F+ VR LL L R+ + ME +
Sbjct: 308 CADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
Query: 267 RK 268
+
Sbjct: 364 EQ 365
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 2e-92
Identities = 63/275 (22%), Positives = 125/275 (45%), Gaps = 16/275 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
++Y + LG+G F VH + + K + + + +K+EIS++ + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKG-KLKEDAARKYFQQLISAVDYCHS 127
N++ L+E S ++ + E++ G ++F + +L E Y Q+ A+ + HS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 128 RGVCHRDLKPENLLL--DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
+ H D++PEN++ +K+ +FG + + P Y APEV
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---PGDNFRLLFTAPEYYAPEVHQH 177
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-NWFA---PEVRR 241
+ D+WS G ++YVLL+G PF ++ I AE+ F F E
Sbjct: 178 DVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 242 LLSKILDPNPNTRISMTKIMENSWFRKGLVKPSIS 276
+ ++L +R++ ++ +++ W ++ + + S
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 4e-92
Identities = 90/291 (30%), Positives = 143/291 (49%), Gaps = 31/291 (10%)
Query: 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV 63
K +I+ ++LG G KV N +T A+K++ + +RE+ +
Sbjct: 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVEL 107
Query: 64 M-RLVRHPNVVELYEV----MASKTKIYFVMEYVKGGELFGK-VAKGKLK--EDAARKYF 115
R + P++V + +V A + + VME + GGELF + +G E A +
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 167
Query: 116 QQLISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTC 172
+ + A+ Y HS + HRD+KPENLL + LK++DFG + S L T C
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPC 224
Query: 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM----EMYRKIGKAE 228
TP YVAPEV+ YD D+WS GVI+Y+LL GY PF+ ++ + M +I +
Sbjct: 225 YTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283
Query: 229 FKFPN--WFA--PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSI 275
++FPN W EV+ L+ +L P R+++T+ M + W + P
Sbjct: 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 334
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 4e-91
Identities = 88/282 (31%), Positives = 136/282 (48%), Gaps = 17/282 (6%)
Query: 10 QRYELGRL--LGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
Y + + LG G F +VH TG+ +A KII + +++K EISVM +
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQL 143
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKG-KLKEDAARKYFQQLISAVDYC 125
H N+++LY+ SK I VMEYV GGELF + + + L E + +Q+ + +
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 126 HSRGVCHRDLKPENLLLDEHGN--LKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
H + H DLKPEN+L +K+ DFGL+ + L GTP ++APEV+
Sbjct: 204 HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK---PREKLKVNFGTPEFLAPEVV 260
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-NWFA---PEV 239
N D+WS GVI Y+LL+G PF N E I + F E
Sbjct: 261 NYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319
Query: 240 RRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEK 281
+ +SK+L + RIS ++ +++ W + +S ++K
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKK 361
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 277 bits (712), Expect = 6e-91
Identities = 89/264 (33%), Positives = 148/264 (56%), Gaps = 8/264 (3%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
++ G++LG+G+F+ V AR L T AIKI++K ++K + + RE VM + HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGV 130
V+LY K+YF + Y K GEL + K G E R Y +++SA++Y H +G+
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDG 190
HRDLKPEN+LL+E +++++DFG + + + + ++ GT YV+PE++ +
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211
Query: 191 SKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPN 250
S +D+W+ G I+Y L+AG PF N +++KI K E+ FP F P+ R L+ K+L +
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 251 PNTRI------SMTKIMENSWFRK 268
R+ + + +F
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFFES 294
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 280 bits (717), Expect = 1e-90
Identities = 73/273 (26%), Positives = 134/273 (49%), Gaps = 15/273 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
Y++ LG G F VH TG K I+ L +K EIS+M + H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHH 107
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGK-VAKG-KLKEDAARKYFQQLISAVDYCHS 127
P ++ L++ K ++ ++E++ GGELF + A+ K+ E Y +Q + + H
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 128 RGVCHRDLKPENLLL--DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
+ H D+KPEN++ + ++K+ DFGL+ D ++ T T + APE+++R
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN---PDEIVKVTTATAEFAAPEIVDR 224
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-NWFA---PEVRR 241
G D+W+ GV+ YVLL+G PF + +E + + + +++F + F+ PE +
Sbjct: 225 EPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283
Query: 242 LLSKILDPNPNTRISMTKIMENSWFRKGLVKPS 274
+ +L P R+++ +E+ W + +
Sbjct: 284 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 6e-89
Identities = 82/276 (29%), Positives = 135/276 (48%), Gaps = 15/276 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
Y++ LG G F VH TG + A K + + +++EI M ++RH
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRH 213
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHS 127
P +V L++ ++ + E++ GGELF KVA K+ ED A +Y +Q+ + + H
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 128 RGVCHRDLKPENLLLDEHG--NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
H DLKPEN++ LK+ DFGL+A + + T GT + APEV
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQSVKVTTGTAEFAAPEVAEG 330
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-NWFA---PEVRR 241
+ G D+WS GV+ Y+LL+G PF N E R + ++ + F+ + +
Sbjct: 331 KPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389
Query: 242 LLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISE 277
+ K+L +PNTR+++ + +E+ W G S+
Sbjct: 390 FIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 425
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 2e-88
Identities = 83/322 (25%), Positives = 156/322 (48%), Gaps = 16/322 (4%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
EN M++Y + +G+G+F K ++ + G IK I+ + + ++ +RE+
Sbjct: 16 ENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREV 74
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK---LKEDAARKYFQQL 118
+V+ ++HPN+V+ E +Y VM+Y +GG+LF ++ K +ED +F Q+
Sbjct: 75 AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
A+ + H R + HRD+K +N+ L + G +++ DFG++ + S + L GTP Y+
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYL 192
Query: 179 APEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FPNWFAP 237
+PE+ + Y+ +K+DIW+ G +LY L F ++ + KI F ++
Sbjct: 193 SPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSY 251
Query: 238 EVRRLLSKILDPNPNTRISMTKIMENSWFRKGL--------VKPSISETEEKEWAPVDAD 289
++R L+S++ NP R S+ I+E + K + + ++
Sbjct: 252 DLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIP 311
Query: 290 AVFSPSGSTSTVAESKNELAKP 311
A SG S ++ KP
Sbjct: 312 AKRPASGQNSISVMPAQKITKP 333
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 1e-86
Identities = 84/273 (30%), Positives = 140/273 (51%), Gaps = 17/273 (6%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+ YE+ +G G++ + R G + K +D + + E++++R ++
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELK 63
Query: 69 HPNVVELYE--VMASKTKIYFVMEYVKGGELFGKVAKGK-----LKEDAARKYFQQLISA 121
HPN+V Y+ + + T +Y VMEY +GG+L + KG L E+ + QL A
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 122 VDYCHSRG-----VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
+ CH R V HRDLKP N+ LD N+K+ DFGL+ + T GTP
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPY 181
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF-PNWF 235
Y++PE +NR Y+ K+DIWS G +LY L A PF + E+ KI + +F+ P +
Sbjct: 182 YMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
+ E+ +++++L+ R S+ +I+EN +
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 6e-86
Identities = 91/272 (33%), Positives = 155/272 (56%), Gaps = 12/272 (4%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
++ + + +++ + LG G+F +V ++ ++G A+KI+DK+KV+K+ I+ E
Sbjct: 33 PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLIS 120
+++ V P +V+L + +Y VMEYV GGE+F + + G+ E AR Y Q++
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
+Y HS + +RDLKPENLL+D+ G ++V+DFG +K G T CGTP +AP
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWTLCGTPEALAP 207
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
E+I +GY+ + D W+ GV++Y + AGY PF +++Y KI + +FP+ F+ +++
Sbjct: 208 EIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266
Query: 241 RLLSKILDPNPNTRISMTK-----IMENSWFR 267
LL +L + R K I + WF
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 7e-86
Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 35/300 (11%)
Query: 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR 65
+ R + R+L +G FA V+ A+++ +G A+K + + K I +E+ M+
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK---NRAIIQEVCFMK 80
Query: 66 -LVRHPNVVELY-------EVMASKTKIYFVMEYVKGGELF----GKVAKGKLKEDAARK 113
L HPN+V+ E + + ++ + G+L ++G L D K
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 114 YFQQLISAVDYCHSRG--VCHRDLKPENLLLDEHGNLKVSDFGLSA-------LAESKHQ 164
F Q AV + H + + HRDLK ENLLL G +K+ DFG + + S +
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 165 DGLLH---TTCGTPAYVAPEVIN--RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME 219
L+ T TP Y PE+I+ G K DIW+ G ILY+L PF D +
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL- 259
Query: 220 MYRKIGKAEFKFPNW--FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISE 277
+I ++ P L+ +L NP R+S+ +++ +
Sbjct: 260 ---RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 1e-85
Identities = 91/262 (34%), Positives = 164/262 (62%), Gaps = 12/262 (4%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+++ R LG G+F +VH R+ G A+K++ KE V+++ ++ E ++ +V HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGV 130
++ ++ +I+ +M+Y++GGELF + K + A+ Y ++ A++Y HS+ +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDG 190
+RDLKPEN+LLD++G++K++DFG +K+ + +T CGTP Y+APEV++ + Y+
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGF-----AKYVPDVTYTLCGTPDYIAPEVVSTKPYNK 182
Query: 191 SKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPN 250
S D WS G+++Y +LAGY PF+DSN M+ Y KI AE +FP +F +V+ LLS+++ +
Sbjct: 183 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 251 PNTRISMTK-----IMENSWFR 267
+ R+ + + + WF+
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFK 263
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 1e-83
Identities = 60/286 (20%), Positives = 114/286 (39%), Gaps = 24/286 (8%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ Y + LG+G F+ V L G A+K I + ++ +RE + RL H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNH 85
Query: 70 PNVVELYEV----MASKTKIYFVMEYVKGGELFG-----KVAKGKLKEDAARKYFQQLIS 120
PN++ L +K + + ++ + K G L+ K L ED +
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD-------GLLHTTCG 173
++ H++G HRDLKP N+LL + G + D G A +
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 174 TPAYVAPEVINRRGYD--GSKADIWSCGVILYVLLAGYLPFHDSNL-MEMYRKIGKAEFK 230
T +Y APE+ + + + + D+WS G +LY ++ G P+ + + +
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 231 FPNW--FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPS 274
P + + +LL+ ++ +P+ R + ++ +
Sbjct: 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 3e-82
Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 52/292 (17%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
K +I+ ++LG G KV N +T A+K++ + +RE+
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 62
Query: 63 VM-RLVRHPNVVELYEV----MASKTKIYFVMEYVKGGELFGK-VAKGKLK--EDAARKY 114
+ R + P++V + +V A + + VME + GGELF + +G E A +
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 115 FQQLISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTT 171
+ + A+ Y HS + HRD+KPENLL + LK++DFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166
Query: 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM----EMYRKIGKA 227
A E YD D+WS GVI+Y+LL GY PF+ ++ + M +I
Sbjct: 167 -------AKETT-GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217
Query: 228 EFKF--PNW--FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSI 275
+++F P W + EV+ L+ +L P R+++T+ M + W + P
Sbjct: 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 269
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 7e-82
Identities = 67/291 (23%), Positives = 112/291 (38%), Gaps = 27/291 (9%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR-LVRH 69
+ +LG G + R + VA+K I E RE+ ++R H
Sbjct: 25 SFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPEC------FSFADREVQLLRESDEH 77
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHS 127
PNV+ + + Y +E L V + QQ S + + HS
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 128 RGVCHRDLKPENLLLDEHGN-----LKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPE 181
+ HRDLKP N+L+ +SDFGL LA +H GT ++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 182 VINRRGYD--GSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEFKFPNWFA-- 236
+++ + DI+S G + Y +++ G PF S + +G +
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256
Query: 237 -PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSI----SETEEKE 282
R L+ K++ +P R S ++++ +F + S+ EKE
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKE 307
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 8e-82
Identities = 66/280 (23%), Positives = 119/280 (42%), Gaps = 36/280 (12%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
++ L+G G F +V A++ G + IK + ++ +RE+ + +
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD 62
Query: 69 HPNVVELYE----------------VMASKTKIYFVMEYVKGGELFGKVAKGK---LKED 109
H N+V + ++ ME+ G L + K + L +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 110 AARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169
A + F+Q+ VDY HS+ + +RDLKP N+ L + +K+ DFGL ++ DG
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN---DGKRT 179
Query: 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAE 228
+ GT Y++PE I+ + Y + D+++ G+IL LL + S R
Sbjct: 180 RSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG---- 234
Query: 229 FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
+ F + + LL K+L P R + ++I+ K
Sbjct: 235 -IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 257 bits (657), Expect = 5e-81
Identities = 79/365 (21%), Positives = 131/365 (35%), Gaps = 54/365 (14%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
+ N L ++LG G+ V + G VA+K + + D E
Sbjct: 6 IPNFEQSLKNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFC------DIALME 58
Query: 61 ISVMR-LVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK--------GKLKEDAA 111
I ++ HPNV+ Y + +Y +E L V KE
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 112 RKYFQQLISAVDYCHSRGVCHRDLKPENLLLD-------------EHGNLKVSDFGLSAL 158
+Q+ S V + HS + HRDLKP+N+L+ E+ + +SDFGL
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 159 AESKHQ--DGLLHTTCGTPAYVAPEVIN-------RRGYDGSKADIWSCGVILYVLL-AG 208
+S L+ GT + APE++ +R DI+S G + Y +L G
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL-TRSIDIFSMGCVFYYILSKG 236
Query: 209 YLPFHDSNLMEMYRKIGKAEFKFPNW-------FAPEVRRLLSKILDPNPNTRISMTKIM 261
PF D E I + F E L+S+++D +P R + K++
Sbjct: 237 KHPFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294
Query: 262 ENSWFRKGLVKPS----ISETEEKEWAPVDADAVFSPSGSTSTVAESKNELAKPCNLNAF 317
+ F K +S+ E E + + + V S + K
Sbjct: 295 RHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSGDWTVKFDKTFMD 354
Query: 318 DIISF 322
++ +
Sbjct: 355 NLERY 359
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 5e-80
Identities = 81/287 (28%), Positives = 146/287 (50%), Gaps = 12/287 (4%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
+ G + + + + +G+G F++V+ A L G+ VA+K + ++ +EI
Sbjct: 24 PDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK-----LKEDAARKYFQ 116
+++ + HPNV++ Y ++ V+E G+L + K + E KYF
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
QL SA+++ HSR V HRD+KP N+ + G +K+ D GL SK H+ GTP
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPY 201
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH--DSNLMEMYRKIGKAEFK--FP 232
Y++PE I+ GY+ K+DIWS G +LY + A PF+ NL + +KI + ++
Sbjct: 202 YMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS 260
Query: 233 NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETE 279
+ ++ E+R+L++ ++P+P R +T + + + S+
Sbjct: 261 DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 1e-79
Identities = 62/269 (23%), Positives = 109/269 (40%), Gaps = 11/269 (4%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
S Q ++ LG G++ +V R+ + G A+K ++ S
Sbjct: 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGS 109
Query: 63 VMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLIS 120
++ +HP V L + +Y E G L L E Y + +
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
A+ + HS+G+ H D+KP N+ L G K+ DFGL + G G P Y+AP
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---AGAGEVQEGDPRYMAP 225
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGY-LPFHDSNLMEMYRKIGKAEFKFPNWFAPEV 239
E++ Y + AD++S G+ + + LP ++ + E F + E+
Sbjct: 226 ELLQ-GSYG-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPE--FTAGLSSEL 281
Query: 240 RRLLSKILDPNPNTRISMTKIMENSWFRK 268
R +L +L+P+P R + ++ R+
Sbjct: 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 9e-79
Identities = 40/302 (13%), Positives = 86/302 (28%), Gaps = 48/302 (15%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
++ +L L G + V R+++ A+K+ ++++ +
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 70 PNVVELYEVM--------------------------ASKTKIYFVMEYVKG-----GELF 98
+ E + + +M
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 99 GKV--AKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156
V +G A QLI S+G+ H P+NL + G L + D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD-GSKADIWSCGVILYVLLAGYLPFHDS 215
++ + Y E +N + W G+ +Y + +LPF
Sbjct: 242 WKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 216 N--LMEMYRKIGKAEFKFPNWFAP-------EVRRLLSKILDPNPNTRISMTKIMENSWF 266
+ +++ + V+ L+ + L+ + R+ + ME F
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356
Query: 267 RK 268
+
Sbjct: 357 LQ 358
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 3e-78
Identities = 76/273 (27%), Positives = 149/273 (54%), Gaps = 10/273 (3%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
+ + +E+ R +G+G+F KV + T A+K ++K+K ++ + + +E+
Sbjct: 7 DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL 66
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLIS 120
+M+ + HP +V L+ + ++ V++ + GG+L + + KE+ + + +L+
Sbjct: 67 QIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
A+DY ++ + HRD+KP+N+LLDEHG++ ++DF ++A+ ++ + T GT Y+AP
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMAP 183
Query: 181 EVINRRGYDG-SKA-DIWSCGVILYVLLAGYLPFH---DSNLMEMYRKIGKAEFKFPNWF 235
E+ + R G S A D WS GV Y LL G P+H ++ E+ +P+ +
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW 243
Query: 236 APEVRRLLSKILDPNPNTRI-SMTKIMENSWFR 267
+ E+ LL K+L+PNP+ R ++ + +
Sbjct: 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 7e-77
Identities = 58/334 (17%), Positives = 113/334 (33%), Gaps = 46/334 (13%)
Query: 6 SILMQRYEL---GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
S L +R G +LGQ A + +TG S + + + I Q+K E+
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 63 VMRL----------------------VRHPNVVELYEVMASKTKIYFVMEYV-------- 92
+RL V+ P ++ V + ++ + +
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 93 ---KGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNL 148
G L + L A + Q+I + H G+ H L+P +++LD+ G +
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV 250
Query: 149 KVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSK----ADIWSCGVILYV 204
++ F + + + P A ++ + + D W+ G+ +Y
Sbjct: 251 FLTGFEH-LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309
Query: 205 LLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENS 264
+ LP D + I ++ P VR LL L R+ + ME
Sbjct: 310 IWCADLPNTDDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETP 365
Query: 265 WFRKGLVKPSISETEEKEWAPVDADAVFSPSGST 298
+ + + S + + + PSG++
Sbjct: 366 EYEQLRTELSAALPLYQTDGEPTREGGAPPSGTS 399
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 3e-75
Identities = 91/277 (32%), Positives = 149/277 (53%), Gaps = 13/277 (4%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVL-KVGMIDQI 57
I + +EL R+LG+G + KV R + TG A+K++ K ++
Sbjct: 9 RGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT 68
Query: 58 KREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQ 116
K E +++ V+HP +V+L + K+Y ++EY+ GGELF ++ + G ED A Y
Sbjct: 69 KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
++ A+ + H +G+ +RDLKPEN++L+ G++K++DFGL ES H + HT CGT
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC--KESIHDGTVTHTFCGTIE 186
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFA 236
Y+APE++ R G++ + D WS G ++Y +L G PF N + KI K + P +
Sbjct: 187 YMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLT 245
Query: 237 PEVRRLLSKILDPNPNTRISMTK-----IMENSWFRK 268
E R LL K+L N +R+ + + +FR
Sbjct: 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-74
Identities = 85/266 (31%), Positives = 139/266 (52%), Gaps = 12/266 (4%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
YE+ +++G+G F +V R+ T A+K++ K +++K E +M P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVC 131
VV+L+ +Y VMEY+ GG+L ++ + E AR Y +++ A+D HS G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 132 HRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD-- 189
HRD+KP+N+LLD+ G+LK++DFG + T GTP Y++PEV+ +G D
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 190 -GSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI--GKAEFKFPN--WFAPEVRRLLS 244
G + D WS GV LY +L G PF+ +L+ Y KI K FP+ + E + L+
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309
Query: 245 KILDPNPNTRI---SMTKIMENSWFR 267
L + R+ + +I + +F+
Sbjct: 310 AFLT-DREVRLGRNGVEEIKRHLFFK 334
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 4e-74
Identities = 93/265 (35%), Positives = 148/265 (55%), Gaps = 9/265 (3%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
M ++ +LLG+GTF KV R TG A+KI+ KE ++ + E V++ R
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS 127
HP + L + ++ FVMEY GGELF +++ E+ AR Y +++SA++Y HS
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
R V +RD+K ENL+LD+ G++K++DFGL E + T CGTP Y+APEV+
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247
Y + D W GV++Y ++ G LPF++ + ++ I E +FP +PE + LL+ +L
Sbjct: 182 YGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240
Query: 248 DPNPNTRISMTK-----IMENSWFR 267
+P R+ +ME+ +F
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 5e-74
Identities = 88/272 (32%), Positives = 143/272 (52%), Gaps = 9/272 (3%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
+ + +++G+G+F KV AR+ + A+K++ K+ +LK I E
Sbjct: 30 SSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSER 89
Query: 62 SVM-RLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLI 119
+V+ + V+HP +V L+ + K+YFV++Y+ GGELF + + E AR Y ++
Sbjct: 90 NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA 149
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
SA+ Y HS + +RDLKPEN+LLD G++ ++DFGL E+ + T CGTP Y+A
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLA 207
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEV 239
PEV++++ YD + D W G +LY +L G PF+ N EMY I +
Sbjct: 208 PEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA 266
Query: 240 RRLLSKILDPNPNTRI----SMTKIMENSWFR 267
R LL +L + R+ +I + +F
Sbjct: 267 RHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 5e-74
Identities = 94/276 (34%), Positives = 154/276 (55%), Gaps = 13/276 (4%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYAR---NLKTGMSVAIKIIDKEKVLKVGMIDQIK 58
E ++EL ++LGQG+F KV + A+K++ K + + K
Sbjct: 16 EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TK 74
Query: 59 REISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQ 117
E ++ V HP +V+L+ ++ K+Y ++++++GG+LF +++K E+ + Y +
Sbjct: 75 MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134
Query: 118 LISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAY 177
L A+D+ HS G+ +RDLKPEN+LLDE G++K++DFGLS ES + ++ CGT Y
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEY 192
Query: 178 VAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAP 237
+APEV+NRRG+ S AD WS GV+++ +L G LPF + E I KA+ P + +P
Sbjct: 193 MAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSP 251
Query: 238 EVRRLLSKILDPNPNTRISMTK-----IMENSWFRK 268
E + LL + NP R+ I +S+F
Sbjct: 252 EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 1e-73
Identities = 41/286 (14%), Positives = 97/286 (33%), Gaps = 29/286 (10%)
Query: 10 QRYELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM 64
+ + LLG+G FA+V+ A + K +K+ + + Q+ +
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMER---L 121
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGELF------GKVAKGKLKEDAARKYFQQL 118
+ ++ Y + V E G L + + + + ++
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 119 ISAVDYCHSRGVCHRDLKPENLLL-----------DEHGNLKVSDFGLSALAESKHQDGL 167
+ ++ H + H D+KP+N +L D L + D G S + + +
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAG-YLPFHDSNLMEMYRKIGK 226
C T + E+++ + ++ + D + +Y +L G Y+ + + +
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
Query: 227 AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVK 272
W E ++ I D + + + + F++
Sbjct: 301 RLPHLDMW--NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN 344
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 2e-73
Identities = 88/268 (32%), Positives = 144/268 (53%), Gaps = 6/268 (2%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
+ + ++ + L ++LG+G+F KV A KT AIK + K+ VL ++ E
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 63 VMRLV-RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLIS 120
V+ L HP + ++ +K ++FVMEY+ GG+L + K A Y ++I
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
+ + HS+G+ +RDLK +N+LLD+ G++K++DFG+ E+ D +T CGTP Y+AP
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAP 187
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240
E++ + Y+ S D WS GV+LY +L G PFH + E++ I +P W E +
Sbjct: 188 EILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK 246
Query: 241 RLLSKILDPNPNTRI-SMTKIMENSWFR 267
LL K+ P R+ I ++ FR
Sbjct: 247 DLLVKLFVREPEKRLGVRGDIRQHPLFR 274
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-73
Identities = 68/298 (22%), Positives = 111/298 (37%), Gaps = 32/298 (10%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+ +E + LG+G F V A+N + AIK I +++ RE+ + +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLE 61
Query: 69 HPNVVELYEV------------MASKTKIYFVMEYVKGGELFGKVAKGKLK----EDAAR 112
HP +V + + K +Y M+ + L +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 113 KYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES----------K 162
F Q+ AV++ HS+G+ HRDLKP N+ +KV DFGL +
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR 222
GT Y++PE I+ Y K DI+S G+IL+ LL Y +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELL--YPFSTQMERVRTLT 238
Query: 223 KIGKAEF-KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETE 279
+ +F P ++ +L P+P R I+EN+ F +
Sbjct: 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQ 296
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 5e-72
Identities = 81/274 (29%), Positives = 145/274 (52%), Gaps = 10/274 (3%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
N+ + + + +LG+G+F KV + T A+KI+ K+ V++ ++ E
Sbjct: 11 NGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE 70
Query: 61 ISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQL 118
V+ L + P + +L+ + ++YFVMEYV GG+L + + G+ KE A Y ++
Sbjct: 71 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 130
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
+ + S+G+ +RDLK +N++LD G++K++DFG+ E+ T CGTP Y+
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKTFCGTPDYI 188
Query: 179 APEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPE 238
APE+I + Y S D W+ GV+LY +LAG PF + E+++ I + +P + E
Sbjct: 189 APEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 247
Query: 239 VRRLLSKILDPNPNTRISMTK-----IMENSWFR 267
+ ++ +P R+ I E+++FR
Sbjct: 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 6e-72
Identities = 97/273 (35%), Positives = 151/273 (55%), Gaps = 10/273 (3%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
+ K + M +E +LLG+GTF KV + TG A+KI+ KE ++ + E
Sbjct: 140 KPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 199
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLIS 120
V++ RHP + L + ++ FVMEY GGELF +++ ED AR Y +++S
Sbjct: 200 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 259
Query: 121 AVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
A+DY HS + V +RDLK ENL+LD+ G++K++DFGL E + T CGTP Y+A
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLA 317
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEV 239
PEV+ Y + D W GV++Y ++ G LPF++ + +++ I E +FP PE
Sbjct: 318 PEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 376
Query: 240 RRLLSKILDPNPNTRISMTK-----IMENSWFR 267
+ LLS +L +P R+ IM++ +F
Sbjct: 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 8e-72
Identities = 84/275 (30%), Positives = 147/275 (53%), Gaps = 11/275 (4%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
+ + + + +E R+LG+G+F KV AR +TG A+K++ K+ +L+ ++ E
Sbjct: 14 VNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE 73
Query: 61 ISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQL 118
++ L HP + +L+ + +++FVME+V GG+L + K + E AR Y ++
Sbjct: 74 KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI 133
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
ISA+ + H +G+ +RDLK +N+LLD G+ K++DFG+ E T CGTP Y+
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYI 191
Query: 179 APEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPE 238
APE++ Y + D W+ GV+LY +L G+ PF N +++ I E +P W +
Sbjct: 192 APEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250
Query: 239 VRRLLSKILDPNPNTRI------SMTKIMENSWFR 267
+L + NP R+ I+ + +F+
Sbjct: 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 1e-71
Identities = 73/280 (26%), Positives = 139/280 (49%), Gaps = 18/280 (6%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
+ + + +E+ +++G+G F +V + A+KI++K ++LK + E
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 63 VMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLIS 120
V+ + L+ +Y VM+Y GG+L ++K +L E+ AR Y +++
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
A+D H HRD+KP+N+L+D +G+++++DFG L + GTP Y++P
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC-LKLMEDGTVQSSVAVGTPDYISP 245
Query: 181 EVIN-----RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI--GKAEFKFPN 233
E++ + Y G + D WS GV +Y +L G PF+ +L+E Y KI K F+FP
Sbjct: 246 EILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304
Query: 234 W---FAPEVRRLLSKILDPNPNTRI---SMTKIMENSWFR 267
+ + L+ +++ + R+ + ++ +F
Sbjct: 305 QVTDVSENAKDLIRRLICSREH-RLGQNGIEDFKKHPFFS 343
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 5e-71
Identities = 80/273 (29%), Positives = 150/273 (54%), Gaps = 19/273 (6%)
Query: 13 ELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVL-KVGMIDQIKREISVMRLVR 68
EL ++LG G + KV R + TG A+K++ K ++ K + + E V+ +R
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 69 H-PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCH 126
P +V L+ ++TK++ +++Y+ GGELF +++ + E + Y +++ A+++ H
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI--N 184
G+ +RD+K EN+LLD +G++ ++DFGLS + + + CGT Y+AP+++
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGG 235
Query: 185 RRGYDGSKADIWSCGVILYVLLAGYLPFH----DSNLMEMYRKIGKAEFKFPNWFAPEVR 240
G+D + D WS GV++Y LL G PF ++ E+ R+I K+E +P + +
Sbjct: 236 DSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 294
Query: 241 RLLSKILDPNPNTRISMTK-----IMENSWFRK 268
L+ ++L +P R+ I E+ +F+K
Sbjct: 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-70
Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 18/272 (6%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+E+ +++G+G F++V + +TG A+KI++K +LK G + + E V+
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRG 129
+ +L+ + +Y VMEY GG+L ++K ++ + AR Y +++ A+D H G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD 189
HRD+KP+N+LLD G+++++DFG + GTP Y++PE++ G
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGG 241
Query: 190 ------GSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI--GKAEFKFPN---WFAPE 238
G + D W+ GV Y + G PF+ + E Y KI K P E
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301
Query: 239 VRRLLSKILDPNPNTRI---SMTKIMENSWFR 267
R + ++L P TR+ + +F
Sbjct: 302 ARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-69
Identities = 84/282 (29%), Positives = 148/282 (52%), Gaps = 20/282 (7%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
+ +Q ++L R++G+G++AKV R KT A+K++ KE V ID ++ E
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 63 VMRLV-RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLIS 120
V HP +V L+ ++++++FV+EYV GG+L + + KL E+ AR Y ++
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
A++Y H RG+ +RDLK +N+LLD G++K++D+G+ E T CGTP Y+AP
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAP 179
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM---------EMYRKIGKAEFKF 231
E++ Y S D W+ GV+++ ++AG PF +++ I + + +
Sbjct: 180 EILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 238
Query: 232 PNWFAPEVRRLLSKILDPNPNTRI------SMTKIMENSWFR 267
P + + +L L+ +P R+ I + +FR
Sbjct: 239 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 230 bits (587), Expect = 1e-69
Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 17/273 (6%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+ R+LG+G F +V + TG A K ++K+++ K E ++ V
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELF-----GKVAKGKLKEDAARKYFQQLISAVD 123
+V L +KT + VM + GG++ +E A Y Q++S ++
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
+ H R + +RDLKPEN+LLD+ GN+++SD GL+ E K GTP ++APE++
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELL 361
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM----EMYRKIGKAEFKFPNWFAPEV 239
YD S D ++ GV LY ++A PF E+ +++ + +P+ F+P
Sbjct: 362 LGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 240 RRLLSKILDPNPNTRI-----SMTKIMENSWFR 267
+ +L +P R+ S + + FR
Sbjct: 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 9e-69
Identities = 84/283 (29%), Positives = 150/283 (53%), Gaps = 20/283 (7%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
+ S+ +Q ++L R++G+G++AKV R KT A++++ KE V ID ++ E
Sbjct: 44 KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 62 SVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLI 119
V HP +V L+ ++++++FV+EYV GG+L + + KL E+ AR Y ++
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
A++Y H RG+ +RDLK +N+LLD G++K++D+G+ E T CGTP Y+A
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIA 221
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM---------EMYRKIGKAEFK 230
PE++ Y S D W+ GV+++ ++AG PF +++ I + + +
Sbjct: 222 PEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280
Query: 231 FPNWFAPEVRRLLSKILDPNPNTRI------SMTKIMENSWFR 267
P + + +L L+ +P R+ I + +FR
Sbjct: 281 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-68
Identities = 81/274 (29%), Positives = 145/274 (52%), Gaps = 10/274 (3%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
N+ + + + +LG+G+F KV + T A+KI+ K+ V++ ++ E
Sbjct: 332 NGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE 391
Query: 61 ISVMRLV-RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQL 118
V+ L + P + +L+ + ++YFVMEYV GG+L + + G+ KE A Y ++
Sbjct: 392 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
+ + S+G+ +RDLK +N++LD G++K++DFG+ E+ T CGTP Y+
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKTFCGTPDYI 509
Query: 179 APEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPE 238
APE+I + Y S D W+ GV+LY +LAG PF + E+++ I + +P + E
Sbjct: 510 APEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 568
Query: 239 VRRLLSKILDPNPNTRISMTK-----IMENSWFR 267
+ ++ +P R+ I E+++FR
Sbjct: 569 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 3e-67
Identities = 74/273 (27%), Positives = 129/273 (47%), Gaps = 20/273 (7%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+ R+LG+G F +V + TG A K ++K+++ K E ++ V
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELF---GKVAKGKLKEDAARKYFQQLISAVDYC 125
VV L +K + V+ + GG+L + + E A Y ++ ++
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH--QDGLLHTTCGTPAYVAPEVI 183
H + +RDLKPEN+LLD+HG++++SD GL + H + + GT Y+APEV+
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLGL-----AVHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN----LMEMYRKIGKAEFKFPNWFAPEV 239
Y S D W+ G +LY ++AG PF E+ R + + ++ F+P+
Sbjct: 358 KNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416
Query: 240 RRLLSKILDPNPNTRI-----SMTKIMENSWFR 267
R L S++L +P R+ S ++ E+ F+
Sbjct: 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-66
Identities = 84/281 (29%), Positives = 145/281 (51%), Gaps = 18/281 (6%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
+E + M + + R++G+G F +V+ R TG A+K +DK+++ E
Sbjct: 180 VELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 61 ISVMRLV---RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQ 116
++ LV P +V + + K+ F+++ + GG+L +++ G E R Y
Sbjct: 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA 299
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
++I +++ H+R V +RDLKP N+LLDEHG++++SD GL+ H + GT
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHG 355
Query: 177 YVAPEVINRR-GYDGSKADIWSCGVILYVLLAGYLPFHDSNLM---EMYRKIGKAEFKFP 232
Y+APEV+ + YD S AD +S G +L+ LL G+ PF E+ R + P
Sbjct: 356 YMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414
Query: 233 NWFAPEVRRLLSKILDPNPNTRI-----SMTKIMENSWFRK 268
+ F+PE+R LL +L + N R+ ++ E+ +FR
Sbjct: 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 3e-64
Identities = 53/288 (18%), Positives = 95/288 (32%), Gaps = 34/288 (11%)
Query: 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR 65
S + +G G F V G AIK K V + ++ +
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLIS 120
L +H +VV + A + EY GG L +++ KE + Q+
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNL-------------------KVSDFGLSALAES 161
+ Y HS + H D+KP N+ + K+ D G
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---- 182
Query: 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMY 221
+ G ++A EV+ KADI++ + + + +
Sbjct: 183 --RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--- 237
Query: 222 RKIGKAEF-KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
+I + + P + E LL ++ P+P R S ++++S
Sbjct: 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 5e-61
Identities = 72/284 (25%), Positives = 119/284 (41%), Gaps = 21/284 (7%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+ +G+G+F +VH ++ +TG A+K + E E+ +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE--------VFRVEELVACAGLS 108
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS 127
P +V LY + + ME ++GG L + + G L ED A Y Q + ++Y H+
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 128 RGVCHRDLKPENLLLDEHGNL-KVSDFGLSA-LAESKHQDGLL--HTTCGTPAYVAPEVI 183
R + H D+K +N+LL G+ + DFG + L LL GT ++APEV+
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVR 240
+ D +K DIWS ++ +L G P+ + KI + P AP
Sbjct: 229 MGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFR----KGLVKPSISETEE 280
+ + + L P R S ++ GL P E +E
Sbjct: 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-59
Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 21/282 (7%)
Query: 2 ENKGSILMQRYEL-----GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQ 56
+ + +L YE +LG+GT+ V+ R+L + +AIK I +
Sbjct: 9 DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQP 65
Query: 57 IKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFG--KVAKGKLK--EDAAR 112
+ EI++ + ++H N+V+ + I ME V GG L + G LK E
Sbjct: 66 LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 113 KYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALAESKHQDGLLHTT 171
Y +Q++ + Y H + HRD+K +N+L++ + G LK+SDFG S + T
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETF 183
Query: 172 CGTPAYVAPEVIN--RRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAE 228
GT Y+APE+I+ RGY G ADIWS G + + G PF++ K+G +
Sbjct: 184 TGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK 242
Query: 229 F--KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
+ P + E + + K +P+P+ R ++ + + +
Sbjct: 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 195 bits (496), Expect = 1e-58
Identities = 70/330 (21%), Positives = 116/330 (35%), Gaps = 73/330 (22%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIID-------KEKVLK----------- 50
+ +E + +G+G F V A+N + AIK I +EKV++
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 51 -------------------------------------VGMIDQIKREISVMRLVRHPNVV 73
+D +I M N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 74 ELYEVMASKTKIYFVMEYVKGGELFGKVAKGK----LKEDAARKYFQQLISAVDYCHSRG 129
+ + K +Y M+ + L + + + F Q+ AV++ HS+G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAES----------KHQDGLLHTTCGTPAYVA 179
+ HRDLKP N+ +KV DFGL + GT Y++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPE 238
PE I+ Y K DI+S G+IL+ LL + + + + +F P+
Sbjct: 245 PEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQM--ERVRIITDVRNLKFPLLFTQKYPQ 301
Query: 239 VRRLLSKILDPNPNTRISMTKIMENSWFRK 268
++ +L P+P R T I+EN+ F
Sbjct: 302 EHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-56
Identities = 63/270 (23%), Positives = 129/270 (47%), Gaps = 19/270 (7%)
Query: 11 RYE-LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
R+ +G+G+F V+ + +T + VA + K+ K + K E +++ ++H
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQH 84
Query: 70 PNVVELY----EVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDY 124
PN+V Y + K I V E + G L + + +K R + +Q++ + +
Sbjct: 85 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144
Query: 125 CHSRG--VCHRDLKPENLLLDEH-GNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
H+R + HRDLK +N+ + G++K+ D GL+ L + GTP ++APE
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPE 200
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKI--GKAEFKFPNWFAPE 238
+ YD D+++ G+ + + P+ + N ++YR++ G F PE
Sbjct: 201 MYE-EKYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258
Query: 239 VRRLLSKILDPNPNTRISMTKIMENSWFRK 268
V+ ++ + N + R S+ ++ +++F++
Sbjct: 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-55
Identities = 80/268 (29%), Positives = 140/268 (52%), Gaps = 8/268 (2%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ + +G+G+F +V + +T VAIKIID E+ I+ I++EI+V+
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDS 79
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
P V + Y TK++ +MEY+ GG + G L E ++++ +DY HS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPEVINRRGY 188
HRD+K N+LL EHG +K++DFG++ L +++ + +T GTP ++APEVI + Y
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR---NTFVGTPFWMAPEVIKQSAY 196
Query: 189 DGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLSKIL 247
D SKADIWS G+ L G P + + M++ I K ++ ++ + L
Sbjct: 197 D-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 255
Query: 248 DPNPNTRISMTKIMENSWFRKGLVKPSI 275
+ P+ R + +++++ + + K S
Sbjct: 256 NKEPSFRPTAKELLKHKFILRNAKKTSY 283
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 7e-55
Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 20/276 (7%)
Query: 13 ELGRLLGQGTFAKVHYAR-NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+ +G G+F VH A + G VA+KI+ ++ +++ RE+++M+ +RHPN
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPN 95
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELF----GKVAKGKLKEDAARKYFQQLISAVDYCHS 127
+V + + V EY+ G L+ A+ +L E + ++Y H+
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 128 RG--VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT-CGTPAYVAPEVIN 184
R + HR+LK NLL+D+ +KV DFGLS L K L + GTP ++APEV+
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLR 212
Query: 185 RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK--FPNWFAPEVRRL 242
+ K+D++S GVIL+ L P+ + N ++ +G + P P+V +
Sbjct: 213 DEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI 271
Query: 243 LSKILDPNPNTRISMTKIME--NSWFRKGLVKPSIS 276
+ P R S IM+ + + P+ S
Sbjct: 272 IEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-54
Identities = 67/269 (24%), Positives = 121/269 (44%), Gaps = 28/269 (10%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV 72
E+G L+G+G F +V++ R VAI++ID E+ + + KRE+ R RH NV
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENV 91
Query: 73 VELYEVMASKTKIYFVMEYVKGGELFG--KVAKGKLKEDAARKYFQQLISAVDYCHSRGV 130
V S + + KG L+ + AK L + R+ Q+++ + Y H++G+
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLS---ALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
H+DLK +N+ D + ++DFGL + ++ ++ L G ++APE+I +
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 188 YDGS--------KADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK------AEFKFPN 233
D +D+++ G I Y L A PF + ++G ++
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG- 269
Query: 234 WFAPEVRRLLSKILDPNPNTRISMTKIME 262
E+ +L R + TK+M+
Sbjct: 270 ---KEISDILLFCWAFEQEERPTFTKLMD 295
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-54
Identities = 59/260 (22%), Positives = 121/260 (46%), Gaps = 15/260 (5%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV 72
+G+ +G G+F V+ + VA+K++ + K E+ V+R RH N+
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD---VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 73 VELYEVMASKTKIYFVMEYVKGGELFG--KVAKGKLKEDAARKYFQQLISAVDYCHSRGV 130
+ + ++ V ++ +G L+ ++ K + +Q +DY H++ +
Sbjct: 83 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD- 189
HRDLK N+ L E +K+ DFGL+ G+ ++APEVI + +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 190 -GSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGK-----AEFKFPNWFAPEVRRL 242
++D+++ G++LY L+ G LP+ + +N ++ +G+ K + ++RL
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 243 LSKILDPNPNTRISMTKIME 262
+++ L + R S +I+
Sbjct: 262 MAECLKKKRDERPSFPRILA 281
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-53
Identities = 77/281 (27%), Positives = 141/281 (50%), Gaps = 13/281 (4%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
++Y +GQG V+ A ++ TG VAI+ ++ ++ K + I EI VMR ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKN 76
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
PN+V + +++ VMEY+ GG L V + + E ++ + A+++ HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPEVINRRGY 188
V HRD+K +N+LL G++K++DFG A + + + T GTP ++APEV+ R+ Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAY 193
Query: 189 DGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLLSK 245
K DIWS G++ ++ G P+ + N + I E + P + R L++
Sbjct: 194 G-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 246 ILDPNPNTRISMTKIMENSWFRKGLVKPSISE--TEEKEWA 284
L+ + R S +++++ + + S++ KE
Sbjct: 253 CLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEAT 293
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-53
Identities = 66/269 (24%), Positives = 113/269 (42%), Gaps = 27/269 (10%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKII----DKEKVLKVGMIDQIKREISVMRLVR 68
E + +G+G F VH R +K VAIK + + + + + +RE+ +M +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFG--KVAKGKLKEDAARKYFQQLISAVDYCH 126
HPN+V+LY VME+V G+L+ +K + + ++Y
Sbjct: 82 HPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 127 SRG--VCHRDLKPENLLLDEHG-----NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
++ + HRDL+ N+ L KV+DFGL S+ + G ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL-----SQQSVHSVSGLLGNFQWMA 194
Query: 180 PEVINRRG--YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK----FPN 233
PE I Y KAD +S +ILY +L G PF + + ++ E P
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 234 WFAPEVRRLLSKILDPNPNTRISMTKIME 262
P +R ++ +P R + I++
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVK 282
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-53
Identities = 70/272 (25%), Positives = 149/272 (54%), Gaps = 11/272 (4%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ +G+G+ V AR +G VA+K++D K + + + E+ +MR +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQH 101
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
NVVE+Y+ +++ +ME+++GG L V++ +L E+ + ++ A+ Y H++G
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPEVINRRGY 188
V HRD+K +++LL G +K+SDFG A +++ + + GTP ++APEVI+R Y
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISRSLY 218
Query: 189 DGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLLSK 245
++ DIWS G+++ ++ G P+ + ++ +++ + + K + +P +R L +
Sbjct: 219 A-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER 277
Query: 246 ILDPNPNTRISMTKIMENSWFRKGLVKPSISE 277
+L +P R + +++++ + + + +
Sbjct: 278 MLVRDPQERATAQELLDHPFLLQTGLPECLVP 309
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 9e-53
Identities = 86/290 (29%), Positives = 138/290 (47%), Gaps = 26/290 (8%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
YEL ++G G A V A VAIK I+ EK +D++ +EI M HP
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCHHP 73
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELF---------GKVAKGKLKEDAARKYFQQLISA 121
N+V Y K +++ VM+ + GG + G+ G L E ++++
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLL--HTTCGTPAYV 178
++Y H G HRD+K N+LL E G+++++DFG+SA LA T GTP ++
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 179 APEVINR-RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI----------GKA 227
APEV+ + RGYD KADIWS G+ L G P+H M++ G
Sbjct: 194 APEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252
Query: 228 EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISE 277
+ + + R+++S L +P R + +++ + +F+K K + E
Sbjct: 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQE 302
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-52
Identities = 75/269 (27%), Positives = 114/269 (42%), Gaps = 30/269 (11%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL 66
I + E+ ++G+G F V A+ VAIK I+ E E+ +
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESES-----ERKAFIVELRQLSR 57
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELF----GKVAKGKLKEDAARKYFQQLISAV 122
V HPN+V+LY A + VMEY +GG L+ G A + Q V
Sbjct: 58 VNHPNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 123 DYCHSR---GVCHRDLKPENLLLDEHGN-LKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
Y HS + HRDLKP NLLL G LK+ DFG + + G+ A++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT-----ACDIQTHMTNNKGSAAWM 170
Query: 179 APEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-----FPN 233
APEV Y K D++S G+IL+ ++ PF + +I A
Sbjct: 171 APEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTRPPLIK 227
Query: 234 WFAPEVRRLLSKILDPNPNTRISMTKIME 262
+ L+++ +P+ R SM +I++
Sbjct: 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVK 256
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 2e-52
Identities = 83/306 (27%), Positives = 135/306 (44%), Gaps = 51/306 (16%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII----DKEKVLKVGMIDQI 57
EN M++YE L+G+G++ V RN TG VAIK D + V K+ M
Sbjct: 17 ENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM---- 72
Query: 58 KREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKG---GELFGKVAKGKLKEDAARKY 114
REI +++ +RH N+V L EV K + Y V E+V +L ++ L +KY
Sbjct: 73 -REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL--ELFPNGLDYQVVQKY 129
Query: 115 FQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174
Q+I+ + +CHS + HRD+KPEN+L+ + G +K+ DFG A + + T
Sbjct: 130 LFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF-ARTLAAPGEVYDDEVA-T 187
Query: 175 PAYVAPEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSNLMEMYRKIGKA----- 227
Y APE++ Y G D+W+ G ++ + G F DS++ ++Y I
Sbjct: 188 RWYRAPELLVGDVKY-GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY-HIMMCLGNLI 245
Query: 228 --------------EFKFPNWFAPEVRR------------LLSKILDPNPNTRISMTKIM 261
+ P E L K L +P+ R +++
Sbjct: 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305
Query: 262 ENSWFR 267
+ +F+
Sbjct: 306 HHDFFQ 311
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-52
Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 16/278 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ +E+ LG G F KV+ A+N +TG A K+I+ + + ++ EI ++ H
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDH 75
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHS 127
P +V+L K++ ++E+ GG + L E + +Q++ A+++ HS
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI---- 183
+ + HRDLK N+L+ G+++++DFG+S A++ + GTP ++APEV+
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 184 -NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEV 239
YD KADIWS G+ L + P H+ N M + KI K++ P+ ++ E
Sbjct: 194 MKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252
Query: 240 RRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISE 277
R L LD NP TR S +++E+ + ++ E
Sbjct: 253 RDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 176 bits (450), Expect = 5e-52
Identities = 76/302 (25%), Positives = 127/302 (42%), Gaps = 55/302 (18%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
+M++YE +G+G++ V RN TG VAIK E + REI +++ +
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQL 59
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKG---GELFGKVAKGKLKEDAARKYFQQLISAVDY 124
+HPN+V L EV K +++ V EY EL + + E + Q + AV++
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 125 CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV------ 178
CH HRD+KPEN+L+ +H +K+ DFG A + D V
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGF-ARLLTGPSDYYDD-------EVATRWYR 169
Query: 179 APEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSNLMEMYRKIGKA--------- 227
+PE++ Y G D+W+ G + LL+G + S++ ++Y I K
Sbjct: 170 SPELLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY-LIRKTLGDLIPRHQ 227
Query: 228 ----------EFKFPNWFAPEVRR------------LLSKILDPNPNTRISMTKIMENSW 265
K P+ E LL L +P R++ +++ + +
Sbjct: 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287
Query: 266 FR 267
F
Sbjct: 288 FE 289
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-51
Identities = 68/264 (25%), Positives = 130/264 (49%), Gaps = 21/264 (7%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGM-IDQIKREISVMRLVRHPN 71
L ++G G F KV+ A + G VA+K + + I+ +++E + +++HPN
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG-- 129
++ L V + + VME+ +GG L ++ ++ D + Q+ ++Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 130 -VCHRDLKPENLLLDE--------HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
+ HRDLK N+L+ + + LK++DFGL+ H+ + + G A++AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKM-SAAGAYAWMAP 183
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF--KFPNWFAPE 238
EVI + +D+WS GV+L+ LL G +PF + + + + + P+
Sbjct: 184 EVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEP 242
Query: 239 VRRLLSKILDPNPNTRISMTKIME 262
+L+ +P+P++R S T I++
Sbjct: 243 FAKLMEDCWNPDPHSRPSFTNILD 266
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-51
Identities = 81/296 (27%), Positives = 138/296 (46%), Gaps = 46/296 (15%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRL 66
MQ+YE +G+GT+ V A+N +T VA+K + D + G+ REI +++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE---GVPSSALREICLLKE 57
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYV----KGGELFGKVAKGKLKEDAARKYFQQLISAV 122
++H N+V L++V+ S K+ V E+ K + G L + + + QL+ +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV 182
+CHSR V HRDLKP+NLL++ +G LK+++FGL A A T Y P+V
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGL-ARAFGIPVRCYSAEVV-TLWYRPPDV 172
Query: 183 I-NRRGYDGSKADIWSCGVILYVLLAGYLP-FHDSNLMEMYRKIGKA------------- 227
+ + Y + D+WS G I L P F +++ + ++I +
Sbjct: 173 LFGAKLY-STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 228 ---EFK-FPNWFAPEVRR------------LLSKILDPNPNTRISMTKIMENSWFR 267
++K +P + A LL +L NP RIS + +++ +F
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 8e-51
Identities = 82/308 (26%), Positives = 133/308 (43%), Gaps = 69/308 (22%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGM-IDQIKREISVMR 65
+RYE LG+G FA V+ AR+ T VAIK I K G+ + REI +++
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL-REIKLLQ 67
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYV----KGGELFGKVAKGKLKEDAARKYFQQLISA 121
+ HPN++ L + K+ I V +++ + K L + Y +
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA----- 176
++Y H + HRDLKP NLLLDE+G LK++DFGL+ + G+P
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------------KSFGSPNRAYTH 171
Query: 177 ------YVAPEVI-NRRGYDGSKADIWSCGVILYVLLAG--YLPFHDSNLMEMYRKIGKA 227
Y APE++ R Y D+W+ G IL LL +LP DS+L ++ +I +
Sbjct: 172 QVVTRWYRAPELLFGARMYGVG-VDMWAVGCILAELLLRVPFLP-GDSDLDQLT-RIFET 228
Query: 228 ----------------EFK-FPNWFAPEVRR-----------LLSKILDPNPNTRISMTK 259
++ F ++ + L+ + NP RI+ T+
Sbjct: 229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 288
Query: 260 IMENSWFR 267
++ +F
Sbjct: 289 ALKMKYFS 296
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 8e-51
Identities = 76/282 (26%), Positives = 137/282 (48%), Gaps = 17/282 (6%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ +++ LG+G++ V+ A + +TG VAIK + E + +I +EIS+M+
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDS 83
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFG--KVAKGKLKEDAARKYFQQLISAVDYCHS 127
P+VV+ Y T ++ VMEY G + ++ L ED Q + ++Y H
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPEVINRR 186
HRD+K N+LL+ G+ K++DFG++ L ++ + +T GTP ++APEVI
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR---NTVIGTPFWMAPEVIQEI 200
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLL 243
GY+ ADIWS G+ + G P+ D + M I F+ P ++ +
Sbjct: 201 GYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259
Query: 244 SKILDPNPNTRISMTKIMENSWFRKGLVKPSISE--TEEKEW 283
+ L +P R + T+++++ + R + + E +
Sbjct: 260 KQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDV 301
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 1e-50
Identities = 82/313 (26%), Positives = 136/313 (43%), Gaps = 72/313 (23%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRL 66
+++ LG GT+A V+ N TG+ VA+K + D E+ G REIS+M+
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE----GTPSTAIREISLMKE 59
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYV----KG--GELFGKVAKGKLKEDAARKYFQQLIS 120
++H N+V LY+V+ ++ K+ V E++ K L+ + + + QL+
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA---- 176
+ +CH + HRDLKP+NLL+++ G LK+ DFGL A + G P
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL---ARAF----------GIPVNTFS 166
Query: 177 -------YVAPEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSN---LMEMYRKI 224
Y AP+V+ R Y + DIWSCG IL ++ G F ++ L ++ +
Sbjct: 167 SEVVTLWYRAPDVLMGSRTY-STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225
Query: 225 G--------------KAEFKFPNWFAPEVRR----------------LLSKILDPNPNTR 254
G K ++R+ L +L NP+ R
Sbjct: 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285
Query: 255 ISMTKIMENSWFR 267
+S + + + WF
Sbjct: 286 LSAKQALHHPWFA 298
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-50
Identities = 41/136 (30%), Positives = 76/136 (55%), Gaps = 4/136 (2%)
Query: 309 AKPCNLNAFDIISFSAGFDLSGLFEEREK--RKEVRFTSNKPVSTIISKLEGIAKLLRLK 366
P +NAF++I+ S G +LS LF+ R+ +++ RF S + S II+ +E +A + K
Sbjct: 2 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61
Query: 367 VKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKVMNQEIRP 426
++ ++EG + G L + EI+E+ P +V+V+K++G+TLEY K ++
Sbjct: 62 SHTRNFKT-RLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYK-KLCS 119
Query: 427 ALKDIVWTWQGEQRQQ 442
L++I+W +
Sbjct: 120 KLENIIWRATEGIPKS 135
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-50
Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 14/227 (6%)
Query: 12 YELGRLLGQG--TFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
YEL ++G+G V+ AR TG V ++ I+ E M+ ++ E+ V +L H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNH 85
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGG---ELFGKVAKGKLKEDAARKYFQQLISAVDYCH 126
PN+V + +++ V ++ G +L + E A Q ++ A+DY H
Sbjct: 86 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTC----GTPAYVAPE 181
G HR +K ++L+ G + +S + + + ++H +++PE
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 182 VI--NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK 226
V+ N +GYD +K+DI+S G+ L G++PF D +M +
Sbjct: 206 VLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-50
Identities = 89/306 (29%), Positives = 147/306 (48%), Gaps = 68/306 (22%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRL 66
M++Y +G+GT+ V+ A+N G + A+K I +KE G+ REIS+++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE---GIPSTTIREISILKE 56
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYV----KGGELFGKVAKGKLKEDAARKYFQQLISAV 122
++H N+V+LY+V+ +K ++ V E++ K V +G L+ A+ + QL++ +
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA------ 176
YCH R V HRDLKP+NLL++ G LK++DFGL+ G P
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLA-------------RAFGIPVRKYTHE 160
Query: 177 -----YVAPEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSN---LMEMYRKIG- 225
Y AP+V+ + Y + DIWS G I ++ G F S LM ++R +G
Sbjct: 161 IVTLWYRAPDVLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219
Query: 226 -------------KAEFKFPNWFAPEVRR-----------LLSKILDPNPNTRISMTKIM 261
K + F + LLSK+L +PN RI+ + +
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
Query: 262 ENSWFR 267
E+++F+
Sbjct: 280 EHAYFK 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-50
Identities = 48/262 (18%), Positives = 100/262 (38%), Gaps = 23/262 (8%)
Query: 13 ELGRLLGQGTFAKVHYAR-NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
L + ++ R G + +K++ E +R+ HPN
Sbjct: 13 NFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPN 68
Query: 72 VVELYEVMAS--KTKIYFVMEYVKGGELFG---KVAKGKLKEDAARKYFQQLISAVDYCH 126
V+ + S + ++ G L+ + + + A K+ + + + H
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128
Query: 127 SRG--VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVIN 184
+ + L ++++DE ++S + +S PA+VAPE +
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQ 181
Query: 185 RRGYDGS--KADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF--KFPNWFAPEVR 240
++ D + AD+WS V+L+ L+ +PF D + ME+ K+ P +P V
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS 241
Query: 241 RLLSKILDPNPNTRISMTKIME 262
+L+ ++ +P R I+
Sbjct: 242 KLMKICMNEDPAKRPKFDMIVP 263
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-50
Identities = 83/307 (27%), Positives = 131/307 (42%), Gaps = 69/307 (22%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRL 66
M++Y+ +G+GT+ V+ A++ G VA+K I D E G+ REIS+++
Sbjct: 20 MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDE---GIPSTAIREISLLKE 75
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYV----KGGELFGKVAKGKLKEDAARKYFQQLISAV 122
+ HPN+V L +V+ S+ + V E++ K K L++ + Y QL+ V
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKK---VLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA------ 176
+CH + HRDLKP+NLL++ G LK++DFGL A + G P
Sbjct: 133 AHCHQHRILHRDLKPQNLLINSDGALKLADFGL---ARAF----------GIPVRSYTHE 179
Query: 177 -----YVAPEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--- 227
Y AP+V+ + Y + DIWS G I ++ G F + KI
Sbjct: 180 VVTLWYRAPDVLMGSKKY-STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT 238
Query: 228 ----------------EFKFPNWFAPEVRR-----------LLSKILDPNPNTRISMTKI 260
+ F + LLS +L +PN RIS
Sbjct: 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298
Query: 261 MENSWFR 267
M + +F+
Sbjct: 299 MNHPYFK 305
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 6e-50
Identities = 77/296 (26%), Positives = 133/296 (44%), Gaps = 47/296 (15%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRL 66
M+ Y LG+GT+A V+ ++ T VA+K I + E+ G RE+S+++
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE----GAPCTAIREVSLLKD 56
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYV----KGGELFGKVAKGKLKEDAARKYFQQLISAV 122
++H N+V L++++ ++ + V EY+ K + + + + QL+ +
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQ---YLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV 182
YCH + V HRDLKP+NLL++E G LK++DFGL A A+S + T Y P++
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGL-ARAKSIPTKTYDNEVV-TLWYRPPDI 171
Query: 183 I-NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------- 227
+ Y ++ D+W G I Y + G F S + E I +
Sbjct: 172 LLGSTDY-STQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 228 -----EFKFPNWFAPEVRR-----------LLSKILDPNPNTRISMTKIMENSWFR 267
+ +P + A + LL+K+L RIS M++ +F
Sbjct: 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-49
Identities = 72/271 (26%), Positives = 119/271 (43%), Gaps = 29/271 (10%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDK--EKVLKVGMIDQIKREISVMRLVRHP 70
G +LG+G F + + +TG + +K + + E+ + +E+ VMR + HP
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR-----TFLKEVKVMRCLEHP 67
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFG--KVAKGKLKEDAARKYFQQLISAVDYCHSR 128
NV++ V+ ++ F+ EY+KGG L G K + + + + S + Y HS
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAES------------KHQDGLLHTTCGTPA 176
+ HRDL N L+ E+ N+ V+DFGL+ L K +T G P
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF----- 231
++APE+IN R YD K D++S G++L ++ D + G F
Sbjct: 188 WMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPD--YLPRTMDFGLNVRGFLDRYC 244
Query: 232 PNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
P P + + D +P R S K+
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-49
Identities = 42/125 (33%), Positives = 61/125 (48%), Gaps = 5/125 (4%)
Query: 310 KPCNLNAFDIISFSAGFDLSGLFEEREKRK-EVRFTSNKPVSTIISKLEGIAKLLRLKVK 368
+NAFDIIS S GF+LSGLF + K RF S ++ +LE I L V
Sbjct: 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVA 61
Query: 369 KKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEYQKVMNQEIRPAL 428
KK+ +KIEG +KG M EI ++T ++EV+K + + +RP
Sbjct: 62 KKETWGMKIEG----QKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFF 117
Query: 429 KDIVW 433
++V
Sbjct: 118 VELVH 122
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 3e-49
Identities = 69/284 (24%), Positives = 122/284 (42%), Gaps = 17/284 (5%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ + R +G G+F V++AR+++ VAIK + I +E+ ++ +RH
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGEL-FGKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
PN ++ + + VMEY G +V K L+E + + Y HS
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI---NR 185
+ HRD+K N+LL E G +K+ DFG +++ ++ GTP ++APEVI +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDE 227
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRL 242
YD K D+WS G+ L P + N M I + + +W + R
Sbjct: 228 GQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNF 285
Query: 243 LSKILDPNPNTRISMTKIMENSWFRKGLVKPSISE--TEEKEWA 284
+ L P R + ++++ + + I + K+
Sbjct: 286 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 329
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-48
Identities = 71/279 (25%), Positives = 126/279 (45%), Gaps = 18/279 (6%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
+ + E +G GT +V R KTG +A+K + + + +I ++
Sbjct: 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDL 74
Query: 62 SV-MRLVRHPNVVELYEVMASKTKIYFVMEYVKGG-ELFGKVAKGKLKEDAARKYFQQLI 119
V ++ P +V+ + + T ++ ME + E K +G + E K ++
Sbjct: 75 DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIV 134
Query: 120 SAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAY 177
A+ Y GV HRD+KP N+LLDE G +K+ DFG+S L + K +D + G AY
Sbjct: 135 KALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD----RSAGCAAY 190
Query: 178 VAPEVINRRGYDGS----KADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAE---F 229
+APE I+ +AD+WS G+ L L G P+ + E+ K+ + E
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250
Query: 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
F+ + + + L + R K++E+S+ ++
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-48
Identities = 78/320 (24%), Positives = 127/320 (39%), Gaps = 67/320 (20%)
Query: 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREIS 62
GS+ RYE +G G + V+ AR+ +G VA+K + G+ RE++
Sbjct: 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVA 63
Query: 63 VMR---LVRHPNVVELYEVMASK-----TKIYFVMEYV----KGGELFGKVAKGKLKEDA 110
++R HPNVV L +V A+ K+ V E+V + K L +
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT--YLDKAPPPGLPAET 121
Query: 111 ARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170
+ +Q + +D+ H+ + HRDLKPEN+L+ G +K++DFGL+
Sbjct: 122 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA-------------R 168
Query: 171 TCGTPA----------YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM 220
Y APEV+ + Y + D+WS G I + F ++ +
Sbjct: 169 IYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227
Query: 221 YRKIGKA----------------EFKFPNWFAPEVRR-----------LLSKILDPNPNT 253
KI FP V+ LL ++L NP+
Sbjct: 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 287
Query: 254 RISMTKIMENSWFRKGLVKP 273
RIS + +++S+ K P
Sbjct: 288 RISAFRALQHSYLHKDEGNP 307
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-48
Identities = 84/298 (28%), Positives = 133/298 (44%), Gaps = 46/298 (15%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIKREISVMRL 66
+ RY LG+GT+ +V+ A + T +VAIK I + E+ G+ RE+S+++
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE---GVPGTAIREVSLLKE 89
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYC 125
++H N++EL V+ +++ + EY + +L + + + + QLI+ V++C
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 126 HSRGVCHRDLKPENLLLD-----EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
HSR HRDLKP+NLLL E LK+ DFGL A A H T Y P
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL-ARAFGIPIRQFTHEII-TLWYRPP 206
Query: 181 EVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSN---LMEMYRKIG---------- 225
E++ R Y + DIWS I +L F DS L +++ +G
Sbjct: 207 EILLGSRHY-STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265
Query: 226 ------KAEF----------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267
K F E LL+ +L+ +P RIS +E+ +F
Sbjct: 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 6e-48
Identities = 69/261 (26%), Positives = 124/261 (47%), Gaps = 18/261 (6%)
Query: 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI-SV 63
G I+ +RY++ LG G + V+ A + + VAIK I K + + +RE+ +
Sbjct: 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGK---VAKGKLKEDAARKYFQQLIS 120
+L H N+V + +V Y VMEY++G L + G L D A + Q++
Sbjct: 66 SQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTL--SEYIESHGPLSVDTAINFTNQILD 122
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS-ALAESKH-QDGLLHTTCGTPAYV 178
+ + H + HRD+KP+N+L+D + LK+ DFG++ AL+E+ Q GT Y
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN---HVLGTVQYF 179
Query: 179 APEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSNLMEMYRKIGKAEFKFPNWFAP 237
+PE + DI+S G++LY +L G PF+ ++ + + I +
Sbjct: 180 SPEQA-KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRK 238
Query: 238 EV----RRLLSKILDPNPNTR 254
++ ++ + + + R
Sbjct: 239 DIPQSLSNVILRATEKDKANR 259
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 8e-48
Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 26/277 (9%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR-LVR 68
+EL L+G GT+ +V+ R++KTG AIK++D + ++IK+EI++++
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 69 HPNVVELYE------VMASKTKIYFVMEYVKGG---ELFGKVAKGKLKEDAARKYFQQLI 119
H N+ Y +++ VME+ G +L LKE+ ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
+ + H V HRD+K +N+LL E+ +K+ DFG+S A+ G +T GTP ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMA 197
Query: 180 PEVI-----NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKF 231
PEVI YD K+D+WS G+ + G P D + M I + K
Sbjct: 198 PEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 256
Query: 232 PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
W + + + + L N + R + ++M++ + R
Sbjct: 257 KKW-SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-46
Identities = 69/264 (26%), Positives = 116/264 (43%), Gaps = 13/264 (4%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
+ G + +E LG G V + +G+ +A K+I E +K + +QI RE
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRE 81
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQL 118
+ V+ P +V Y S +I ME++ GG L K A G++ E K +
Sbjct: 82 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAV 140
Query: 119 ISAVDYCHSRG-VCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPA 176
I + Y + + HRD+KP N+L++ G +K+ DFG+S L +S + ++ GT +
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRS 195
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFA 236
Y++PE + Y ++DIWS G+ L + G P + E+ G
Sbjct: 196 YMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254
Query: 237 PEVRRLLSKILDPNPNTRISMTKI 260
P R + ++R M
Sbjct: 255 PRPRTPGRPLNKFGMDSRPPMAIF 278
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 84/306 (27%), Positives = 139/306 (45%), Gaps = 67/306 (21%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
Y +++G G+F V A+ +++ VAIK + ++K K RE+ +MR+V+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN-------RELQIMRIVK 90
Query: 69 HPNVVELYEVMAS------KTKIYFVMEYV-----KGGELFGKVAKGKLKEDAARKYFQQ 117
HPNVV+L S + + V+EYV + + K K + + Y Q
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK-LKQTMPMLLIKLYMYQ 149
Query: 118 LISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
L+ ++ Y HS G+CHRD+KP+NLLLD G LK+ DFG +K +
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS-----AKILIAGEPNV----S 200
Query: 177 YV------APEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSN---LMEMYRKIG 225
Y+ APE+I Y + DIWS G ++ L+ G F +S L+E+ + +G
Sbjct: 201 YICSRYYRAPELIFGATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259
Query: 226 -------------KAEFKFPNWFA------------PEVRRLLSKILDPNPNTRISMTKI 260
E KFP P+ L+S++L+ P+ R++ +
Sbjct: 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA 319
Query: 261 MENSWF 266
+ + +F
Sbjct: 320 LCHPFF 325
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-46
Identities = 64/285 (22%), Positives = 123/285 (43%), Gaps = 25/285 (8%)
Query: 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
E + + +G+G + V+ + +G +A+K I + Q+ ++
Sbjct: 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDL 71
Query: 62 SV-MRLVRHPNVVELYEVMASKTKIYFVMEYVKGG-----ELFGKVAKGKLKEDAARKYF 115
V MR P +V+ Y + + + ME + + V + E+ K
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 116 QQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCG 173
+ A+++ + HRD+KP N+LLD GN+K+ DFG+S L +S + G
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAG 187
Query: 174 TPAYVAPEVI----NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGKAE 228
Y+APE I +R+GYD ++D+WS G+ LY L G P+ N + + ++ K +
Sbjct: 188 CRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246
Query: 229 -----FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
F+P ++ L + + R +++++ +
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 9e-46
Identities = 85/320 (26%), Positives = 130/320 (40%), Gaps = 72/320 (22%)
Query: 1 MENKGSI-LMQRYELGRLLGQGTFAKVHYARNLK-TGMSVAIKII--DKEKVLKVGMIDQ 56
ME G Q+YE +G+G + KV AR+LK G VA+K + + GM
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE---GMPLS 57
Query: 57 IKREISVMR---LVRHPNVVELYEV-----MASKTKIYFVMEYV----KGGELFGKVAKG 104
RE++V+R HPNVV L++V +TK+ V E+V KV +
Sbjct: 58 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEP 115
Query: 105 KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164
+ + + QL+ +D+ HS V HRDLKP+N+L+ G +K++DFGL+
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA-------- 167
Query: 165 DGLLHTTCGTPA----------YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD 214
Y APEV+ + Y + D+WS G I + F
Sbjct: 168 -----RIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRG 221
Query: 215 SNLMEMYRKIGKA----------------EFKFPNWFAPEVRR-----------LLSKIL 247
S+ ++ KI F + A + + LL K L
Sbjct: 222 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 281
Query: 248 DPNPNTRISMTKIMENSWFR 267
NP RIS + + +F+
Sbjct: 282 TFNPAKRISAYSALSHPYFQ 301
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-45
Identities = 90/306 (29%), Positives = 135/306 (44%), Gaps = 70/306 (22%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
Y +++G G+F V+ A+ +G VAIK + ++K K RE+ +MR + H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHC 107
Query: 71 NVVELYEVMASKT------KIYFVMEYV-----KGGELFGKVAKGKLKEDAARKYFQQLI 119
N+V L S + V++YV + + + AK L + Y QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR-AKQTLPVIYVKLYMYQLF 166
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALAESKHQDGLLHTTCGTP--A 176
++ Y HS G+CHRD+KP+NLLLD LK+ DFG A + G P +
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS-AKQLVR----------GEPNVS 215
Query: 177 YV------APEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSN---LMEMYRKIG 225
Y+ APE+I Y S D+WS G +L LL G F DS L+E+ + +G
Sbjct: 216 YICSRYYRAPELIFGATDYT-SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 274
Query: 226 -------------KAEFKFPNWFA------------PEVRRLLSKILDPNPNTRISMTKI 260
EFKFP A PE L S++L+ P R++ +
Sbjct: 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 334
Query: 261 MENSWF 266
+S+F
Sbjct: 335 CAHSFF 340
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 17/263 (6%)
Query: 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE-ISV 63
S L RYELG +LG G ++VH AR+L+ VA+K++ + + +RE +
Sbjct: 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 64 MRLVRHPNVVELY---EVMASKTKIYF-VMEYVKGGELFGKVAK-GKLKEDAARKYFQQL 118
L HP +V +Y E + + VMEYV G L V G + A +
Sbjct: 67 AALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC--GTPA 176
A+++ H G+ HRD+KP N+++ +KV DFG+ A A + + + T GT
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI-ARAIADSGNSVTQTAAVIGTAQ 184
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSNLMEMYRKIGKAEFKFPNWF 235
Y++PE R +++D++S G +LY +L G PF DS + Y+ + + + P+
Sbjct: 185 YLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSAR 242
Query: 236 AP----EVRRLLSKILDPNPNTR 254
++ ++ K L NP R
Sbjct: 243 HEGLSADLDAVVLKALAKNPENR 265
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 67/271 (24%), Positives = 125/271 (46%), Gaps = 21/271 (7%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV-MRLVRHP 70
E LG+G + V R++ +G +A+K I + ++ ++ + MR V P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66
Query: 71 NVVELYEVMASKTKIYFVMEYVKGG--ELFGKVAK--GKLKEDAARKYFQQLISAVDYCH 126
V Y + + ++ ME + + + +V + ED K ++ A+++ H
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 127 S-RGVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVAPEVI- 183
S V HRD+KP N+L++ G +K+ DFG+S L + +D G Y+APE I
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD----IDAGCKPYMAPERIN 182
Query: 184 ---NRRGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAE-FKFP-NWFAP 237
N++GY K+DIWS G+ + L P+ + +++ + + P + F+
Sbjct: 183 PELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA 241
Query: 238 EVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
E S+ L N R + ++M++ +F
Sbjct: 242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-44
Identities = 74/313 (23%), Positives = 127/313 (40%), Gaps = 66/313 (21%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII--DKEKVLKVGMIDQIK----REIS 62
+ +YE +GQGTF +V AR+ KTG VA+K + + EK + REI
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-------EGFPITALREIK 68
Query: 63 VMRLVRHPNVVELYEVMASK--------TKIYFVMEYV----KGGELFGKVAKGKLKEDA 110
+++L++H NVV L E+ +K IY V ++ G K
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSE 125
Query: 111 ARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS-ALAESKHQDGLLH 169
++ Q L++ + Y H + HRD+K N+L+ G LK++DFGL+ A + +K+ +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 170 TTC-GTPAYVAPEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSNLMEMYRKI-- 224
T T Y PE++ R Y G D+W G I+ + ++ ++ I
Sbjct: 186 TNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA-LISQ 243
Query: 225 -----------------GKAEFKFPNWFAPEVR-------------RLLSKILDPNPNTR 254
+ + +V+ L+ K+L +P R
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 303
Query: 255 ISMTKIMENSWFR 267
I + + +F
Sbjct: 304 IDSDDALNHDFFW 316
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 8e-44
Identities = 68/262 (25%), Positives = 105/262 (40%), Gaps = 32/262 (12%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLK-TGMSVAIKII----DKEKVLKVGMIDQI 57
N G I+ +YE+ + G ++ A + G V +K + D E
Sbjct: 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE------AQAMA 126
Query: 58 KREISVMRLVRHPNVVELYEV-----MASKTKIYFVMEYVKGGELFGKVAKGKLKEDAAR 112
E + V HP++V+++ Y VMEYV G L + KL A
Sbjct: 127 MAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-KRSKGQKLPVAEAI 185
Query: 113 KYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC 172
Y +++ A+ Y HS G+ + DLKPEN++L E LK+ D G + G L
Sbjct: 186 AYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLG---AVSRINSFGYL---Y 238
Query: 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP 232
GTP + APE++ R DI++ G L L + + + K
Sbjct: 239 GTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD--PVLKTY 294
Query: 233 NWFAPEVRRLLSKILDPNPNTR 254
RLL + +DP+P R
Sbjct: 295 ----DSYGRLLRRAIDPDPRQR 312
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-44
Identities = 61/300 (20%), Positives = 121/300 (40%), Gaps = 52/300 (17%)
Query: 9 MQRY-----ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV 63
MQR L +G+G + +V + G +VA+KI + E+
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGS-WQ-GENVAVKIFSSRDEKS----WFRETELYN 55
Query: 64 MRLVRHPNVVELY----EVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLI 119
++RH N++ S T+++ + Y + G L+ + L + + +
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIA 115
Query: 120 SAVDYCHSR--------GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL--H 169
S + + H + HRDLK +N+L+ ++G ++D GL+ + + +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 170 TTCGTPAYVAPEVINRRGYDGS-----KADIWSCGVILYVLLAGY----------LPFHD 214
GT Y+APEV++ + DIW+ G++L+ + PF+D
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235
Query: 215 SN-----LMEMYRKIGKAEF--KFPN-WFAPEVRRLLSKIL----DPNPNTRISMTKIME 262
+M + + + PN WF+ L+K++ NP+ R++ +I +
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-43
Identities = 80/308 (25%), Positives = 136/308 (44%), Gaps = 56/308 (18%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR-LV 67
Y+L R LG+G +++V A N+ V +KI+ K K IKREI ++ L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLR 88
Query: 68 RHPNVVELYEVM--ASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYC 125
PN++ L +++ V E+V + K L + R Y +++ A+DYC
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMYEILKALDYC 146
Query: 126 HSRGVCHRDLKPENLLLD-EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI- 183
HS G+ HRD+KP N+++D EH L++ D+G LAE H + + + PE++
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWG---LAEFYHPGQEYNVRVASRYFKGPELLV 203
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLP-FH-DSN---LMEMYRKIGKAEFK-------- 230
+ + YD S D+WS G +L ++ P FH N L+ + + +G +
Sbjct: 204 DYQMYDYS-LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 231 ---------FPNW----------------FAPEVRRLLSKILDPNPNTRISMTKIMENSW 265
+PE L K+L + +R++ + ME+ +
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 266 FRKGLVKP 273
F +VK
Sbjct: 323 F-YTVVKD 329
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 9/216 (4%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE-ISVMRLVRH 69
Y L RL+G+G V+ A + VA+K++ + +++RE + RL +
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QE 93
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR 128
P+VV +++ ++Y M + G +L + + G L A +Q+ SA+D H+
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT--TCGTPAYVAPEVINRR 186
G HRD+KPEN+L+ + DFG +A + + L T GT Y+APE
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFG---IASATTDEKLTQLGNTVGTLYYMAPERF-SE 209
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR 222
+ +ADI++ +LY L G P+ L M
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA 245
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-41
Identities = 63/291 (21%), Positives = 128/291 (43%), Gaps = 47/291 (16%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV 72
++ + +G+G + +V + + G VA+K+ + + EI L+RH N+
Sbjct: 40 QMVKQIGKGRYGEVWMGK-WR-GEKVAVKVFFTTEEAS----WFRETEIYQTVLMRHENI 93
Query: 73 VELY----EVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
+ + S T++Y + +Y + G L+ + L + K +S + + H+
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 129 --------GVCHRDLKPENLLLDEHGNLKVSDFGLSAL--AESKHQDGLLHTTCGTPAYV 178
+ HRDLK +N+L+ ++G ++D GL+ +++ D +T GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 179 APEVINRRGYDGS-----KADIWSCGVILYVLLAGY----------LPFH-----DSNLM 218
PEV++ AD++S G+IL+ + LP+H D +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 219 EMYRKIGKAEF--KFPN-WFAPEVRRLLSKIL----DPNPNTRISMTKIME 262
+M + + FPN W + E R + K++ NP +R++ ++ +
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 83/310 (26%), Positives = 131/310 (42%), Gaps = 65/310 (20%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL-- 66
M R+++ R+ GQGTF V + TGMSVAIK + ++ + RE+ +M+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-------NRELQIMQDLA 74
Query: 67 -VRHPNVVELYEVMASKTK-------IYFVMEYVKGGELFGKVAKGKLKE-----DAARK 113
+ HPN+V+L + + + VMEYV + + + + K
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV--PDTLHRCCRNYYRRQVAPPPILIK 132
Query: 114 YFQ-QLISAVDYCH--SRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALAESKHQDGLLH 169
F QLI ++ H S VCHRD+KP N+L++E G LK+ DFG + + +
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP--SEPNVA 190
Query: 170 TTCGTPAYVAPEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN----LMEMYRKI 224
C + Y APE+I + Y + DIWS G I ++ G F N L E+ R +
Sbjct: 191 YIC-SRYYRAPELIFGNQHYT-TAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248
Query: 225 G-------------KAEFKFPNW--------FA-------PEVRRLLSKILDPNPNTRIS 256
G + N F+ E LLS +L P R+
Sbjct: 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK 308
Query: 257 MTKIMENSWF 266
+ + + +F
Sbjct: 309 PYEALCHPYF 318
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-40
Identities = 72/325 (22%), Positives = 122/325 (37%), Gaps = 75/325 (23%)
Query: 11 RYE-LGRLLGQGTFAKVHYARNL--KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
+E G +G+GT+ V+ A+ K A+K I+ G+ REI+++R +
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-----GISMSACREIALLREL 75
Query: 68 RHPNVVELYEVMASKT--KIYFVMEYV---------KGGELFGKVAKGKLKEDAARKYFQ 116
+HPNV+ L +V S K++ + +Y +L +
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLL----DEHGNLKVSDFGLSALAESKHQDGLLHTTC 172
Q++ + Y H+ V HRDLKP N+L+ E G +K++D G A + L
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNSPLKPLADLDP 194
Query: 173 G--TPAYVAPEVI-NRRGYDGSKADIWSCGVILYVLLAG-------------YLPFHDSN 216
T Y APE++ R Y DIW+ G I LL P+H
Sbjct: 195 VVVTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253
Query: 217 LMEMYRKIG--------------KAEFKFPNWFA--------------------PEVRRL 242
L ++ +G + ++ + L
Sbjct: 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313
Query: 243 LSKILDPNPNTRISMTKIMENSWFR 267
L K+L +P RI+ + M++ +F
Sbjct: 314 LQKLLTMDPIKRITSEQAMQDPYFL 338
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-40
Identities = 62/291 (21%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV 72
L +G+G F +V + + G VA+KI + + EI ++RH N+
Sbjct: 45 VLQESIGKGRFGEVWRGK-WR-GEEVAVKIFSSREERS----WFREAEIYQTVMLRHENI 98
Query: 73 VELY----EVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
+ + + T+++ V +Y + G LF + + + + K S + + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 129 --------GVCHRDLKPENLLLDEHGNLKVSDFGLSAL--AESKHQDGLLHTTCGTPAYV 178
+ HRDLK +N+L+ ++G ++D GL+ + + D + GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 179 APEVINRRGYDGS-----KADIWSCGVILYVLLAGY----------LPFH-----DSNLM 218
APEV++ +ADI++ G++ + + LP++ D ++
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 219 EMYRKIGKAEF--KFPN-WFAPEVRRLLSKIL----DPNPNTRISMTKIME 262
EM + + + + PN W + E R+++KI+ N R++ +I +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 7e-40
Identities = 43/257 (16%), Positives = 82/257 (31%), Gaps = 38/257 (14%)
Query: 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM 64
I RY L G + A + VA+ +D + VL ++ + +
Sbjct: 26 ARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDY 124
+ P V + +V+ ++ V E+++GG L +VA A + Q L +A D
Sbjct: 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSL-QEVADTSPSPVGAIRAMQSLAAAADA 144
Query: 125 CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVIN 184
H GV P + + G++ + PA +
Sbjct: 145 AHRAGVALSIDHPSRVRVSIDGDVVL----------------------AYPATMPDA--- 179
Query: 185 RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN-------WFAP 237
+ DI G LY LL P ++ + + P
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234
Query: 238 EVRRLLSKILDPNPNTR 254
++ + ++ + + R
Sbjct: 235 QISAVAARSVQGDGGIR 251
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-38
Identities = 74/332 (22%), Positives = 131/332 (39%), Gaps = 86/332 (25%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
++Y LG+ LG G+F V ++++G A+K + ++ K RE+ +M+++
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVLD 58
Query: 69 HPNVVELYEVMASKTK--------------------------------------IYFVME 90
H N+++L + + + +ME
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 91 YV-----KGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD-E 144
YV K + F + + + + Y QL AV + HS G+CHRD+KP+NLL++ +
Sbjct: 119 YVPDTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177
Query: 145 HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI-NRRGYDGSKADIWSCGVILY 203
LK+ DFG + + + C + Y APE++ Y D+WS G +
Sbjct: 178 DNTLKLCDFGSAKKLIP--SEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLWSIGCVFG 233
Query: 204 VLLAGYLPF----HDSNLMEMYRKIG-------------KAEFKFPNWFA---------- 236
L+ G F L+ + + +G E +FP A
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEG 293
Query: 237 --PEVRRLLSKILDPNPNTRISMTKIMENSWF 266
LL +IL P+ RI+ + M + +F
Sbjct: 294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-38
Identities = 56/291 (19%), Positives = 112/291 (38%), Gaps = 47/291 (16%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV 72
+L + +G F V A+ VA+KI + Q + E+ + ++H N+
Sbjct: 27 QLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSW----QNEYEVYSLPGMKHENI 80
Query: 73 VELY----EVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
++ + ++ + + + G L + + + + + + Y H
Sbjct: 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHED 140
Query: 129 ----------GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
+ HRD+K +N+LL + ++DFGL+ E+ G H GT Y+
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 179 APEV----INRRGYDGSKADIWSCGVILYVLLAG-----------YLPFHDS-----NLM 218
APEV IN + + D+++ G++L+ L + LPF + +L
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260
Query: 219 EMYRKIG--KAEFKFPN-WFAPEVRRLLSKIL----DPNPNTRISMTKIME 262
+M + K + W +L + + D + R+S + E
Sbjct: 261 DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 57/290 (19%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV--GMID--QIKREISVMR 65
+ Y +G G + V A + ++G VAIK K+ + I + RE+ +++
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-----KLSRPFQSEIFAKRAYRELLLLK 78
Query: 66 LVRHPNVVELYEVMASKTK------IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLI 119
++H NV+ L +V + Y VM ++ +L K+ K E+ + Q++
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGLKFSEEKIQYLVYQML 136
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
+ Y HS GV HRDLKP NL ++E LK+ DFGL ++H D + T Y A
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL-----ARHADAEMTGYVVTRWYRA 191
Query: 180 PEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI----GK--AEF--- 229
PEVI + Y+ + DIWS G I+ +L G F + ++ +I G EF
Sbjct: 192 PEVILSWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250
Query: 230 -----------------------KFPNWFAPEVRRLLSKILDPNPNTRIS 256
FP +P+ LL K+L+ + + R++
Sbjct: 251 LNDKAAKSYIQSLPQTPRKDFTQLFPR-ASPQAADLLEKMLELDVDKRLT 299
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 75/291 (25%), Positives = 123/291 (42%), Gaps = 58/291 (19%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII----DKEKVLKVGMIDQIKREISVMR 65
+RY+ +G G + V A + KTG+ VA+K + K + RE+ +++
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-----RTYRELRLLK 83
Query: 66 LVRHPNVVELYEVMASKTK------IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ-QL 118
++H NV+ L +V +Y V + G +L + K + D ++ Q+
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQI 141
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
+ + Y HS + HRDLKP NL ++E LK+ DFGL ++H + T Y
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL-----ARHTADEMTGYVATRWYR 196
Query: 179 APEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI----GK--AEF-- 229
APE++ N Y+ + DIWS G I+ LL G F ++ ++ + I G AE
Sbjct: 197 APEIMLNWMHYNQT-VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 230 ------------------------KFPNWFAPEVRRLLSKILDPNPNTRIS 256
F P LL K+L + + RI+
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRIT 305
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 81/295 (27%), Positives = 126/295 (42%), Gaps = 62/295 (21%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII---DKEKVLKVGMIDQIKREISVMRL 66
RY +G+G + V A + + VAIK I + + + + REI ++
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-----RTLREIKILLR 81
Query: 67 VRHPNVVELYEVMASKTK-----IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ-QLIS 120
RH N++ + +++ + T +Y V + + +L K+ K + + YF Q++
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQILR 139
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV-- 178
+ Y HS V HRDLKP NLLL+ +LK+ DFGL+ +A+ H T YV
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE-----YVAT 194
Query: 179 ----APEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI----GK--A 227
APE++ N +GY S DIWS G IL +L+ F + ++ I G
Sbjct: 195 RWYRAPEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 228 EF--------------------------KFPNWFAPEVRRLLSKILDPNPNTRIS 256
E FPN + LL K+L NP+ RI
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIE 307
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-36
Identities = 57/304 (18%), Positives = 104/304 (34%), Gaps = 62/304 (20%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL--VRHP 70
+L L+G+G + V+ L VA+K+ E ++ R+ + H
Sbjct: 16 KLLELIGRGRYGAVYKGS-LD-ERPVAVKV------FSFANRQNFINEKNIYRVPLMEHD 67
Query: 71 NVVELY-----EVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYC 125
N+ + + VMEY G L ++ ++ + + + Y
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 126 HS---------RGVCHRDLKPENLLLDEHGNLKVSDFGLS------ALAESKHQDGLLHT 170
H+ + HRDL N+L+ G +SDFGLS L +D +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 171 TCGTPAYVAPEVINRR------GYDGSKADIWSCGVILYVLLAGY-------------LP 211
GT Y+APEV+ + D+++ G+I + + +
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
Query: 212 FHDS-----NLMEMYRKIGKAEF--KFPN-WFA-PEVRRLLSKIL----DPNPNTRISMT 258
F +M + + + KFP W R L + + D + R++
Sbjct: 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ 307
Query: 259 KIME 262
E
Sbjct: 308 XAEE 311
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 77/301 (25%), Positives = 128/301 (42%), Gaps = 63/301 (20%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV--GMID--QIKREISV 63
+++RY+ + +G G V A + +VAIK K+ + + RE+ +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELVL 77
Query: 64 MRLVRHPNVVELYEVMASKTK------IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQ 117
M+ V H N++ L V + +Y VME + L +V + +L + Q
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQ 135
Query: 118 LISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAY 177
++ + + HS G+ HRDLKP N+++ LK+ DFG LA + ++ T Y
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYY 192
Query: 178 VAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI----GK--AEF-- 229
APEVI GY + DIWS G I+ ++ G + F ++ ++ + K+ G EF
Sbjct: 193 RAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251
Query: 230 -----------------------KFPNWF-----------APEVRRLLSKILDPNPNTRI 255
FP+ A + R LLSK+L + + RI
Sbjct: 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311
Query: 256 S 256
S
Sbjct: 312 S 312
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 79/299 (26%), Positives = 126/299 (42%), Gaps = 62/299 (20%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIID---KEKVLKVGMIDQIKREISVMRL 66
++L LLG+G + V A + TG VAIK I+ K + REI +++
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL-----RTLREIKILKH 65
Query: 67 VRHPNVVELYEVMASKTK-----IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ-QLIS 120
+H N++ ++ + + +Y + E + +L +V ++ D +YF Q +
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLR 123
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP--AYV 178
AV H V HRDLKP NLL++ + +LKV DFGL+ + + D T + +V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 179 ------APEVI-NRRGYDGSKA-DIWSCGVILYVLLAG--------YL------------ 210
APEV+ Y S+A D+WSCG IL L Y
Sbjct: 184 ATRWYRAPEVMLTSAKY--SRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 211 PFHDS-----------NLMEMYRKIGKAEFK--FPNWFAPEVRRLLSKILDPNPNTRIS 256
P D+ ++ A + FP P+ LL ++L +P RI+
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRIT 299
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 77/299 (25%), Positives = 124/299 (41%), Gaps = 63/299 (21%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV--GMID--QIKREISVMR 65
+RY+ + +G G V A + +VAIK K+ + + RE+ +M+
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAKRAYRELVLMK 116
Query: 66 LVRHPNVVELYEVMASKTK------IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLI 119
V H N++ L V + +Y VME + L +V + +L + Q++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQML 174
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
+ + HS G+ HRDLKP N+++ LK+ DFG LA + ++ T Y A
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRA 231
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI----GK--AEF---- 229
PEVI GY + DIWS G I+ ++ + F + ++ + K+ G EF
Sbjct: 232 PEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 230 ---------------------KFPNWF-----------APEVRRLLSKILDPNPNTRIS 256
FP+ A + R LLSK+L +P RIS
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-35
Identities = 78/291 (26%), Positives = 127/291 (43%), Gaps = 58/291 (19%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV--GMID--QIKREISVMR 65
Y + +G G + V A + +TG VAIK K+ + + + RE+ +++
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLK 79
Query: 66 LVRHPNVVELYEVMASKTK------IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ-QL 118
+RH NV+ L +V Y VM ++ G +L GK+ K + + ++ Q+
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQM 137
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
+ + Y H+ G+ HRDLKP NL ++E LK+ DFGL ++ D + T Y
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL-----ARQADSEMTGYVVTRWYR 192
Query: 179 APEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI----GK--AEF-- 229
APEVI N Y + DIWS G I+ ++ G F S+ ++ ++I G AEF
Sbjct: 193 APEVILNWMRYTQT-VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 230 ------------------------KFPNWFAPEVRRLLSKILDPNPNTRIS 256
N +P LL K+L + R++
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVT 301
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 70/262 (26%), Positives = 113/262 (43%), Gaps = 23/262 (8%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVMRLVR 68
LG +G+G F +V R VA+K + + +K +E +++
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVK------SCRETLPPDLKAKFLQEARILKQYS 170
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCH 126
HPN+V L V K IY VME V+GG+ F + +L+ + + ++Y
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAY----VAPEV 182
S+ HRDL N L+ E LK+SDFG+S DG+ + G APE
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA----DGVYAASGGLRQVPVKWTAPEA 286
Query: 183 INRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVR 240
+N Y S++D+WS G++L+ G P+ + + + + K P V
Sbjct: 287 LNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF 345
Query: 241 RLLSKILDPNPNTRISMTKIME 262
RL+ + P R S + I +
Sbjct: 346 RLMEQCWAYEPGQRPSFSTIYQ 367
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 69/305 (22%), Positives = 117/305 (38%), Gaps = 74/305 (24%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK-----REISVM 64
RY + LG G V A + VAIK K+ + D REI ++
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK--------KIVLTDPQSVKHALREIKII 62
Query: 65 RLVRHPNVVELYEVMASKTK--------------IYFVMEYVKGGELFGKVAKGKLKEDA 110
R + H N+V+++E++ +Y V EY+ +L + +G L E+
Sbjct: 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEH 121
Query: 111 ARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAESKHQDGLLH 169
AR + QL+ + Y HS V HRDLKP NL ++ LK+ DFGL+ + + +
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 170 TTCGTPAYV------APEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR 222
+ + +P ++ + Y D+W+ G I +L G F ++ +E +
Sbjct: 182 SE-----GLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235
Query: 223 KI-----------------GKAEF--------------KFPNWFAPEVRRLLSKILDPNP 251
I + P + E L +IL +P
Sbjct: 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSP 294
Query: 252 NTRIS 256
R++
Sbjct: 295 MDRLT 299
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 47/233 (20%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII----DKEKVLKVGMIDQIKREISV 63
+ RYE+ L+G G++ V A + VAIK I + K +I REI++
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK-----RILREIAI 105
Query: 64 MRLVRHPNVVELYEVMASKT-----KIYFVMEYVKGGELFGKV--AKGKLKEDAARKYFQ 116
+ + H +VV++ +++ K ++Y V+E + K+ L E +
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHIKTLLY 163
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
L+ V Y HS G+ HRDLKP N L+++ ++KV DFGL+ +
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 177 -------------------YV------APEVI-NRRGYDGSKA-DIWSCGVIL 202
+V APE+I + Y ++A D+WS G I
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDVWSIGCIF 274
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 62/296 (20%), Positives = 107/296 (36%), Gaps = 56/296 (18%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIK-IIDKEKVLKVGMIDQ-------IKREI 61
Y + R + G++ V + G+ VAIK + + + I + REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 62 SVMRLVRHPNVVELYEVMASKTK-----IYFVMEYVKGGELFG--KVAKGKLKEDAARKY 114
++ HPN++ L ++ + +Y V E + +L + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 115 FQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT 174
++ + H GV HRDL P N+LL ++ ++ + DF LA D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN---LAREDTADANKTHYVTH 196
Query: 175 PAYVAPEVI-NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI----GK--A 227
Y APE++ +G+ D+WS G ++ + F S KI G
Sbjct: 197 RWYRAPELVMQFKGFTKL-VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 228 EF---------------------------KFPNWFAPEVRRLLSKILDPNPNTRIS 256
E P P L++K+L+ NP RIS
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRIS 310
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 64/254 (25%), Positives = 101/254 (39%), Gaps = 32/254 (12%)
Query: 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV 63
+ RYE+ +++G+G+F +V A + K VA+K++ EK Q EI +
Sbjct: 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR----FHRQAAEEIRI 146
Query: 64 MRLVRH------PNVVELYEVMASKTKIYFVME--------YVKGGELFGKVAKGKLKED 109
+ +R NV+ + E + I E +K + G
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG------FSLP 200
Query: 110 AARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG--NLKVSDFGLSALAESKHQDGL 167
RK+ ++ +D H + H DLKPEN+LL + G +KV DFG S +
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---- 256
Query: 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA 227
+T + Y APEVI Y D+WS G IL LL GY + + + +
Sbjct: 257 -YTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314
Query: 228 EFKFPNWFAPEVRR 241
+R
Sbjct: 315 LGMPSQKLLDASKR 328
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 40/231 (17%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV--GMID--QIKREISVMR 65
Y + L+G+G++ V+ A + T +VAIK KV ++ +ID +I REI+++
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-----KVNRMFEDLIDCKRILREITILN 80
Query: 66 LVRHPNVVELYEVMASKTK-----IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ-QLI 119
++ ++ LY+++ +Y V+E +L + K L+
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLL 139
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA--- 176
++ H G+ HRDLKP N LL++ ++KV DFGL+ S+ +++
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 177 -----------YV------APEVI-NRRGYDGSKA-DIWSCGVILYVLLAG 208
+V APE+I + Y +K+ DIWS G I LL
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENY--TKSIDIWSTGCIFAELLNM 248
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 38/228 (16%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV--GMID--QIKREISVMR 65
++YEL + LG+G + V + + +TG VA+K K+ D + REI ++
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQRTFREIMILT 63
Query: 66 -LVRHPNVVELYEVMASKTK--IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ-QLISA 121
L H N+V L V+ + +Y V +Y+ +L V + + E ++Y QLI
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKV 121
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA----- 176
+ Y HS G+ HRD+KP N+LL+ ++KV+DFGLS + +
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 177 --------YV------APEVI-NRRGYDGSKA-DIWSCGVILYVLLAG 208
YV APE++ Y +K D+WS G IL +L G
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKY--TKGIDMWSLGCILGEILCG 227
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 24/222 (10%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK--REISVMRLVRHP 70
+ +G G F VH VAIK ++ G + + E VM + HP
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIK------TIREGAMSEEDFIEEAEVMMKLSHP 63
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
+V+LY V + I V E+++ G L + + +G + + + Y
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAES----KHQDGLLHTTCGTPA-YVAPEVI 183
V HRDL N L+ E+ +KVSDFG++ P + +PEV
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF------PVKWASPEVF 177
Query: 184 NRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
+ Y SK+D+WS GV+++ V G +P+ + + E+ I
Sbjct: 178 SFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 72/282 (25%), Positives = 128/282 (45%), Gaps = 27/282 (9%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK--REISVMRLVRHP 70
+ LG G + +V+ K ++VA+K LK ++ + +E +VM+ ++HP
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVK------TLKEDTMEVEEFLKEAAVMKEIKHP 276
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFG---KVAKGKLKEDAARKYFQQLISAVDYCHS 127
N+V+L V + Y + E++ G L + + ++ Q+ SA++Y
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES----KHQDGLLHTTCGTPA-YVAPEV 182
+ HR+L N L+ E+ +KV+DFGLS L H P + APE
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF------PIKWTAPES 390
Query: 183 INRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVR 240
+ + K+D+W+ GV+L+ + G P+ +L ++Y + K + P +V
Sbjct: 391 LAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 449
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKE 282
L+ NP+ R S +I + F + SIS+ EKE
Sbjct: 450 ELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVEKE 489
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 24/221 (10%)
Query: 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK--REISVMRLVRHPN 71
L + LG G F V + K VA+K ++K G + + + +E M + HP
Sbjct: 12 LLKELGSGQFGVVKLGK-WKGQYDVAVK------MIKEGSMSEDEFFQEAQTMMKLSHPK 64
Query: 72 VVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
+V+ Y V + + IY V EY+ G L + + L+ + + + + S
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAES----KHQDGLLHTTCGTPA-YVAPEVIN 184
HRDL N L+D +KVSDFG++ P + APEV +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF------PVKWSAPEVFH 178
Query: 185 RRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
Y SK+D+W+ G++++ V G +P+ E+ K+
Sbjct: 179 YFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 67/272 (24%), Positives = 111/272 (40%), Gaps = 34/272 (12%)
Query: 13 ELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIK---REISVMR 65
+ + LG+G F V R TG VA+K L+ + ++ REI +++
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK------KLQHSTEEHLRDFEREIEILK 66
Query: 66 LVRHPNVVELYEVMASKTK--IYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISA 121
++H N+V+ V S + + +MEY+ G L + + K ++ +Y Q+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS-ALAESKHQDGLLHTTCGTPAYV-- 178
++Y ++ HRDL N+L++ +K+ DFGL+ L + K P
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-----FFKVKEPGESPI 181
Query: 179 ---APEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWF 235
APE + + +D+WS GV+LY L Y+ S E R IG K
Sbjct: 182 FWYAPESLTESKFS-VASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMIGND--KQGQMI 237
Query: 236 APEVRRLLSK--ILDPNPNTRISMTKIMENSW 265
+ LL L + IM W
Sbjct: 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECW 269
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 24/223 (10%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK--REISVMRLVRHP 70
+ LG G + +V+ K ++VA+K LK ++ + +E +VM+ ++HP
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVK------TLKEDTMEVEEFLKEAAVMKEIKHP 69
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFG---KVAKGKLKEDAARKYFQQLISAVDYCHS 127
N+V+L V + Y + E++ G L + + ++ Q+ SA++Y
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES----KHQDGLLHTTCGTPA-YVAPEV 182
+ HRDL N L+ E+ +KV+DFGLS L H P + APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF------PIKWTAPES 183
Query: 183 INRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
+ + K+D+W+ GV+L+ + G P+ +L ++Y +
Sbjct: 184 LAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 34/272 (12%)
Query: 13 ELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIK---REISVMR 65
+ + LG+G F V R TG VA+K L+ + ++ REI +++
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK------KLQHSTEEHLRDFEREIEILK 97
Query: 66 LVRHPNVVELYEVMASKTK--IYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISA 121
++H N+V+ V S + + +MEY+ G L + + K ++ +Y Q+
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS-ALAESKHQDGLLHTTCGTPAYV-- 178
++Y ++ HRDL N+L++ +K+ DFGL+ L + K + P
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-----YYKVKEPGESPI 212
Query: 179 ---APEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWF 235
APE + + +D+WS GV+LY L Y+ S E R IG K
Sbjct: 213 FWYAPESLTESKFS-VASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMIGND--KQGQMI 268
Query: 236 APEVRRLLSK--ILDPNPNTRISMTKIMENSW 265
+ LL L + IM W
Sbjct: 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECW 300
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 13/223 (5%)
Query: 13 ELGRLLGQGTFAKVHYAR-NLKTG--MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
L LG G+F V + +G +SVA+K + + + + +D RE++ M + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHS 127
N++ LY V + V E G L + +G +Y Q+ + Y S
Sbjct: 81 RNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP---AYVAPEVIN 184
+ HRDL NLLL +K+ DFGL D A+ APE +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKVPFAWCAPESLK 197
Query: 185 RRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGK 226
R + +D W GV L+ + G P+ N ++ KI K
Sbjct: 198 TRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK--REISVMRLVRHP 70
+ LG G F V Y + + VAIK ++K G + + + E VM + H
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIK------MIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
+V+LY V + I+ + EY+ G L + + + + + + + + A++Y S+
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAES----KHQDGLLHTTCGTPA-YVAPEVI 183
HRDL N L+++ G +KVSDFGLS P + PEV+
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF------PVRWSPPEVL 193
Query: 184 NRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
+ SK+DIW+ GV+++ + G +P+ E I
Sbjct: 194 MYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 71/283 (25%), Positives = 121/283 (42%), Gaps = 35/283 (12%)
Query: 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII-DKEKVLKVGMIDQIKREIS 62
G M RYE+ L+G+G+F +V A + VAIKII +K+ ++Q + E+
Sbjct: 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA-----FLNQAQIEVR 102
Query: 63 VMRLVRHP------NVVELYEVMASKTKIYFVME------YVKGGELFGKVAKGKLKEDA 110
++ L+ +V L + + V E Y +L + +
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLY----DLLRNTNFRGVSLNL 158
Query: 111 ARKYFQQLISAVDYCHSR--GVCHRDLKPENLLL--DEHGNLKVSDFGLSALAESKHQDG 166
RK+ QQ+ +A+ + + + H DLKPEN+LL + +K+ DFG S+ +
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQR--- 214
Query: 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK 226
++ + Y +PEV+ YD D+WS G IL + G F +N ++ KI +
Sbjct: 215 -IYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272
Query: 227 AEFKFPNWF---APEVRRLLSKILDPNPNTRISMTKIMENSWF 266
P AP+ R+ K+ D N + + E
Sbjct: 273 VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 315
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 14 LGRLLGQGTFAKVHYAR---NLKTGMSVAIKIIDKEKVLKVGMIDQIKR----EISVMRL 66
+ +++G G F +V R K +SVAIK LKVG ++ +R E S+M
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIK------TLKVGYTEKQRRDFLGEASIMGQ 102
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDY 124
HPN++ L V+ + V EY++ G L F + + + + S + Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 125 CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV---APE 181
G HRDL N+L++ + KVSDFGL + E + +TT G + +PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA--AYTTRGGKIPIRWTSPE 220
Query: 182 VINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
I R + S +D+WS G++L+ V+ G P+ + + ++ + +
Sbjct: 221 AIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 22/225 (9%)
Query: 13 ELGRLLGQGTFAKVHYAR---NLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVMR 65
+ +++G G +V Y R + + VAIK LK G ++ + E S+M
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK------ALKAGYTERQRRDFLSEASIMG 105
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVD 123
HPN++ L V+ V EY++ G L F + G+ + + + +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV---AP 180
Y G HRDL N+L+D + KVSDFGLS + E +TT G + AP
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKIPIRWTAP 223
Query: 181 EVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
E I R + S +D+WS GV+++ VL G P+ + ++ +
Sbjct: 224 EAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 14 LGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVMR 65
+++G G F +V+ + K + VAIK LK G ++ + E +M
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK------TLKAGYTEKQRVDFLGEAGIMG 101
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVD 123
H N++ L V++ + + EY++ G L F + G+ + + + +
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV---AP 180
Y + HRDL N+L++ + KVSDFGLS + E + +TT G + AP
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA--TYTTSGGKIPIRWTAP 219
Query: 181 EVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
E I+ R + S +D+WS G++++ V+ G P+ + + E+ + I
Sbjct: 220 EAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG-MIDQIKREISVMRLVRHPN 71
+L + +G+G F V G VA+K +K E SVM +RH N
Sbjct: 24 KLLQTIGKGEFGDVMLGD--YRGNKVAVK------CIKNDATAQAFLAEASVMTQLRHSN 75
Query: 72 VVELYEV-MASKTKIYFVMEYVKGGELFG---KVAKGKLKEDAARKYFQQLISAVDYCHS 127
+V+L V + K +Y V EY+ G L + L D K+ + A++Y
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV---APEVIN 184
HRDL N+L+ E KVSDFGL+ A S G L P V APE +
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAPEALR 187
Query: 185 RRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
+ + +K+D+WS G++L+ + G +P+ L ++ ++
Sbjct: 188 EKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 52/225 (23%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 13 ELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVM 64
+ ++LG G F V+ K + VAIK L+ + E VM
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK------ELREATSPKANKEILDEAYVM 71
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAV 122
V +P+V L + + + + + + G L + + K + + Q+ +
Sbjct: 72 ASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG-TP-AYVAP 180
+Y R + HRDL N+L+ ++K++DFGL+ L + ++ H G P ++A
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMAL 188
Query: 181 EVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
E I R Y ++D+WS GV ++ ++ G P+ E+ +
Sbjct: 189 ESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 69/274 (25%), Positives = 108/274 (39%), Gaps = 38/274 (13%)
Query: 13 ELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVM 64
+ R LG+G F KV R TG VA+K LK +EI ++
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK------SLKPESGGNHIADLKKEIEIL 77
Query: 65 RLVRHPNVVELYEVMASKTK--IYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLIS 120
R + H N+V+ + I +ME++ G L + K K+ KY Q+
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES------KHQDGLLHTTCGT 174
+DY SR HRDL N+L++ +K+ DFGL+ E+ D
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS------ 191
Query: 175 P-AYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN 233
P + APE + + + +D+WS GV L+ LL + DS+ M +
Sbjct: 192 PVFWYAPECLMQSKFY-IASDVWSFGVTLHELLT----YCDSDSSPMALFLKMIGPTHGQ 246
Query: 234 WFAPEVRRLLSK--ILDPNPNTRISMTKIMENSW 265
+ L + L PN + ++M W
Sbjct: 247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCW 280
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 36/227 (15%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-- 68
RY L R LG G F+ V A+++ VA+KI+ +KV + + EI +++ V
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDA 75
Query: 69 ---------HPNVVELYEV----MASKTKIYFVMEYVKGGELFGKVAK---GKLKEDAAR 112
++++L + + + V E V G L + K + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134
Query: 113 KYFQQLISAVDYCHSR-GVCHRDLKPENLLLDE------HGNLKVSDFGLSALAESKHQD 165
+ +QL+ +DY H R G+ H D+KPEN+L++ +K++D G + + + +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194
Query: 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPF 212
+ T Y +PEV+ + ADIWS +++ L+ G F
Sbjct: 195 SI-----QTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLF 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 80/355 (22%), Positives = 129/355 (36%), Gaps = 106/355 (29%)
Query: 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTG-MSVAIKII-DKEKVLKVGMIDQIKREI 61
G +L RYE+ LG+G F KV + K G VA+KI+ + ++ + + EI
Sbjct: 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR-----YCEAARSEI 62
Query: 62 SVMRLVRHP------NVVELYEVMASKTKIYFVME------YVKGGELFGKVAKGKLKED 109
V+ + V++ E I V E Y + + + D
Sbjct: 63 QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY----DFIKENGFLPFRLD 118
Query: 110 AARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN-------------------LKV 150
RK Q+ +V++ HS + H DLKPEN+L + +KV
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 151 SDFGLSALAESKHQDGLLHTTCGTPAYV------APEVINRRGYDGSKADIWSCGVILYV 204
DFG SA + +H H+T V APEVI G+ D+WS G IL
Sbjct: 179 VDFG-SATYDDEH-----HST-----LVSTRHYRAPEVILALGWS-QPCDVWSIGCILIE 226
Query: 205 LLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRR----------------------- 241
G+ F + E + + P + R+
Sbjct: 227 YYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSR 286
Query: 242 ---------------------LLSKILDPNPNTRISMTKIMENSWFRKGLVKPSI 275
L+ K+L+ +P RI++ + +++ +F L+K SI
Sbjct: 287 ACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFD--LLKKSI 339
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 71/227 (31%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 13 ELGRLLGQGTFAKVH---YARNLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVMR 65
ELGR +G+G F VH Y ++VAIK K D ++ +E MR
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIK------TCKNCTSDSVREKFLQEALTMR 71
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVD 123
HP++V+L V ++ ++ +ME GEL F +V K L + Y QL +A+
Sbjct: 72 QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES----KHQDGLLHTTCGTPA-YV 178
Y S+ HRD+ N+L+ + +K+ DFGLS E K G L P ++
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL------PIKWM 184
Query: 179 APEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
APE IN R + S +D+W GV ++ +L+ G PF ++ +I
Sbjct: 185 APESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK--REISVMRLVRHP 70
+L LG G F +V VA+K LK G + E ++M+ ++H
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVK------SLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKG-KLKEDAARKYFQQLISAVDYCHS 127
+V LY V ++ IY + EY++ G L F K G KL + Q+ + +
Sbjct: 69 RLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE----SKHQDGLLHTTCGTPA-YVAPEV 182
R HRDL+ N+L+ + + K++DFGL+ L E + + P + APE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF------PIKWTAPEA 181
Query: 183 INRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
IN + K+D+WS G++L ++ G +P+ E+ + +
Sbjct: 182 INYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 67/221 (30%), Positives = 98/221 (44%), Gaps = 18/221 (8%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK--REISVMRLVRHP 70
L LGQG F +V VAIK LK G + +E VM+ +RH
Sbjct: 187 RLEVKLGQGCFGEVWMGT-WNGTTRVAIK------TLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGK-LKEDAARKYFQQLISAVDYCHS 127
+V+LY V S+ IY V EY+ G L F K GK L+ Q+ S + Y
Sbjct: 240 KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPEVINRR 186
HRDL+ N+L+ E+ KV+DFGL+ L E P + APE
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA--RQGAKFPIKWTAPEAALYG 356
Query: 187 GYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGK 226
+ K+D+WS G++L + G +P+ E+ ++ +
Sbjct: 357 RFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 64/274 (23%), Positives = 109/274 (39%), Gaps = 39/274 (14%)
Query: 13 ELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIK---REISVMR 65
+ LG+G F V R TG VA+K L+ DQ + REI +++
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK------QLQHSGPDQQRDFQREIQILK 79
Query: 66 LVRHPNVVELYEVMASKTK--IYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISA 121
+ +V+ V + + VMEY+ G L F + + +L Y Q+
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES------KHQDGLLHTTCGTP 175
++Y SR HRDL N+L++ ++K++DFGL+ L + G P
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------P 193
Query: 176 -AYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEFKFPN 233
+ APE ++ + ++D+WS GV+LY L S + +
Sbjct: 194 IFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSA-----EFLRMMGCERDV 247
Query: 234 WFAPEVRRLLSK--ILDPNPNTRISMTKIMENSW 265
+ LL + L P + ++M+ W
Sbjct: 248 PALSRLLELLEEGQRLPAPPACPAEVHELMKLCW 281
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-28
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 12/218 (5%)
Query: 14 LGRLLGQGTFAKVHYA--RNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+ LG G F V + K +VA+KI+ K + + D++ E +VM+ + +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDYCHSRGV 130
+V + + VME + G L + + + +K+ + Q+ + Y
Sbjct: 80 IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 131 CHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT--P-AYVAPEVINRRG 187
HRDL N+LL K+SDFGLS + + P + APE IN
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 188 YDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
+ SK+D+WS GV+++ G P+ E+ +
Sbjct: 197 FS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK--REISVMRLVRHP 70
L LGQG F +V VAIK LK G + +E VM+ +RH
Sbjct: 270 RLEVKLGQGCFGEVWMGT-WNGTTRVAIK------TLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKY-FQQLI-------SAV 122
+V+LY V S+ IY V EY+ G L LK + + QL+ S +
Sbjct: 323 KLVQLYAV-VSEEPIYIVTEYMSKGSL-----LDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTP-AYVAPE 181
Y HRDL+ N+L+ E+ KV+DFGL+ L E P + APE
Sbjct: 377 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA--RQGAKFPIKWTAPE 434
Query: 182 VINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGK 226
+ K+D+WS G++L + G +P+ E+ ++ +
Sbjct: 435 AALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 13 ELGRLLGQGTFAKVH---YARNLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVMR 65
L R+LG+G F +V+ Y + ++VA+K K K E +M+
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVK------TCKKDCTLDNKEKFMSEAVIMK 68
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVD 123
+ HP++V+L ++ + + +ME GEL + + K LK Y Q+ A+
Sbjct: 69 NLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS-ALAES---KHQDGLLHTTCGTP-AYV 178
Y S HRD+ N+L+ +K+ DFGLS + + K L P ++
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL------PIKWM 181
Query: 179 APEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
+PE IN R + + +D+W V ++ +L G PF ++ +
Sbjct: 182 SPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG-MIDQIKREISVMRLVRHPN 71
+L + +G+G F V + G VA+K +K E SVM +RH N
Sbjct: 196 KLLQTIGKGEFGDVMLGD-YR-GNKVAVK------CIKNDATAQAFLAEASVMTQLRHSN 247
Query: 72 VVELYEV-MASKTKIYFVMEYVKGGELFG---KVAKGKLKEDAARKYFQQLISAVDYCHS 127
+V+L V + K +Y V EY+ G L + L D K+ + A++Y
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA-YVAPEVINRR 186
HRDL N+L+ E KVSDFGL+ A S G L P + APE + +
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREK 361
Query: 187 GYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
+ +K+D+WS G++L+ + G +P+ L ++ ++
Sbjct: 362 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 60/276 (21%), Positives = 107/276 (38%), Gaps = 52/276 (18%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKII-DKEKVLKVGMIDQIKREI 61
KG +L + + R +G GTF +V +++ A+K++ + +K K E
Sbjct: 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK-----YTRSAKIEA 82
Query: 62 SVMRLVRH-----PNVVELYEVMASKTKIYFVME------YVKGGELFGKVAKGKLKEDA 110
+++ +++ N+V+ + + + E Y E+ + +
Sbjct: 83 DILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY----EIITRNNYNGFHIED 138
Query: 111 ARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG------------------------ 146
+ Y +++ A++Y + H DLKPEN+LLD+
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 147 -NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVL 205
+K+ DFG A +S + + T Y APEVI G+D +D+WS G +L L
Sbjct: 199 TGIKLIDFG-CATFKSDY----HGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAEL 252
Query: 206 LAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRR 241
G L F ME + P E +
Sbjct: 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATK 288
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 69/272 (25%), Positives = 109/272 (40%), Gaps = 36/272 (13%)
Query: 13 ELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVM 64
+ R LG+G F KV N TG VA+K LK Q + +EI ++
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK------ALKADAGPQHRSGWKQEIDIL 87
Query: 65 RLVRHPNVVELYEVMASKTK--IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAV 122
R + H ++++ + VMEYV G L + + + + QQ+ +
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 147
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS-ALAES-----KHQDGLLHTTCGTP- 175
Y H++ HRDL N+LLD +K+ DFGL+ A+ E +DG P
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------PV 201
Query: 176 AYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWF 235
+ APE + + +D+WS GV LY LL DS+ + +
Sbjct: 202 FWYAPECLKEYKFY-YASDVWSFGVTLYELLT----HCDSSQSPPTKFLELIGIAQGQMT 256
Query: 236 APEVRRLLSK--ILDPNPNTRISMTKIMENSW 265
+ LL + L + +M+N W
Sbjct: 257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCW 288
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 72/360 (20%), Positives = 121/360 (33%), Gaps = 108/360 (30%)
Query: 4 KGSILMQRYELGRLLGQGTFAKVHYAR-NLKTGMSVAIKII-DKEKVLKVGMIDQIKREI 61
G L +RYE+ LG+GTF KV + + VA+KII + K + + EI
Sbjct: 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK-----YREAARLEI 67
Query: 62 SVMRLVRHP------NVVELYEVMASKTKIYFVME--------YVKGGELFGKVAKGKLK 107
+V++ ++ V + + + E ++K
Sbjct: 68 NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP------YP 121
Query: 108 EDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-------------------HGNL 148
R QL A+ + H + H DLKPEN+L + ++
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 149 KVSDFGLSALAESKHQDGLLHTTCGTPAYV------APEVINRRGYDGSKADIWSCGVIL 202
+V+DFG SA + +H HTT V PEVI G+ D+WS G IL
Sbjct: 182 RVADFG-SATFDHEH-----HTT-----IVATRHYRPPEVILELGWA-QPCDVWSIGCIL 229
Query: 203 YVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRR--------------------- 241
+ G+ F E + K P+ R+
Sbjct: 230 FEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYV 289
Query: 242 -----------------------LLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISET 278
L+ ++L+ +P RI++ + + + +F + T
Sbjct: 290 KENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT 349
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 52/225 (23%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 13 ELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVM 64
+ ++LG G F V+ K + VAIK L+ + E VM
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK------ELREATSPKANKEILDEAYVM 71
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAV 122
V +P+V L + + + + + + G L + + K + + Q+ +
Sbjct: 72 ASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG-TP-AYVAP 180
+Y R + HRDL N+L+ ++K++DFGL+ L + ++ H G P ++A
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMAL 188
Query: 181 EVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
E I R Y ++D+WS GV ++ ++ G P+ E+ +
Sbjct: 189 ESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 67/270 (24%), Positives = 106/270 (39%), Gaps = 55/270 (20%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIK--REISVMRLVRHP 70
+L + LG G F +V A VA+K +K G + E +VM+ ++H
Sbjct: 191 KLEKKLGAGQFGEVWMAT-YNKHTKVAVK------TMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKY-FQQLI-------SAV 122
+V+L+ V +K IY + E++ G L LK D K +LI +
Sbjct: 244 KLVKLHAV-VTKEPIYIITEFMAKGSL-----LDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES----KHQDGLLHTTCGTPA-Y 177
+ R HRDL+ N+L+ K++DFGL+ + E + P +
Sbjct: 298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF------PIKW 351
Query: 178 VAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAP 237
APE IN + K+D+WS G++L E+ +P P
Sbjct: 352 TAPEAINFGSFT-IKSDVWSFGILLM---------------EIVT---YGRIPYPGMSNP 392
Query: 238 EVRRLLSK--ILDPNPNTRISMTKIMENSW 265
EV R L + + N + IM W
Sbjct: 393 EVIRALERGYRMPRPENCPEELYNIMMRCW 422
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 66/231 (28%), Positives = 96/231 (41%), Gaps = 26/231 (11%)
Query: 6 SILMQRYELGRLLGQGTFAKVHYA--RNLKTGMSVAIKIIDKEKVLKVGMIDQIK----R 59
++L+ ELG G F V R K + VAIK VLK G R
Sbjct: 10 NLLIADIELG----CGNFGSVRQGVYRMRKKQIDVAIK------VLKQGTEKADTEEMMR 59
Query: 60 EISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQ 117
E +M + +P +V L V ++ + VME GG L F + ++ + Q
Sbjct: 60 EAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 118 LISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT--P 175
+ + Y + HRDL N+LL K+SDFGLS + D P
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWP 176
Query: 176 -AYVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
+ APE IN R + S++D+WS GV ++ L G P+ E+ I
Sbjct: 177 LKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 48/229 (20%), Positives = 92/229 (40%), Gaps = 31/229 (13%)
Query: 13 ELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVM 64
++LG G F VH + V IK V++ Q + +
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK------VIEDKSGRQSFQAVTDHMLAI 69
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAV 122
+ H ++V L + + + V +Y+ G L + +G L + Q+ +
Sbjct: 70 GSLDHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL-----AESKHQDGLLHTTCGTP-A 176
Y G+ HR+L N+LL ++V+DFG++ L + + + P
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT------PIK 182
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
++A E I+ Y ++D+WS GV ++ ++ G P+ L E+ +
Sbjct: 183 WMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 72/227 (31%), Positives = 109/227 (48%), Gaps = 29/227 (12%)
Query: 13 ELGRLLGQGTFAKVH---YARNLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVMR 65
ELGR +G+G F VH Y M+VAIK K D ++ +E MR
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK------TCKNCTSDSVREKFLQEALTMR 446
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVD 123
HP++V+L V ++ ++ +ME GEL F +V K L + Y QL +A+
Sbjct: 447 QFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES----KHQDGLLHTTCGTPA-YV 178
Y S+ HRD+ N+L+ + +K+ DFGLS E K G L P ++
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL------PIKWM 559
Query: 179 APEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
APE IN R + S +D+W GV ++ +L+ G PF ++ +I
Sbjct: 560 APESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 63/219 (28%), Positives = 91/219 (41%), Gaps = 22/219 (10%)
Query: 18 LGQGTFAKVHYA--RNLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVMRLVRHPN 71
LG G F V R K + VAIK VLK G RE +M + +P
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIK------VLKQGTEKADTEEMMREAQIMHQLDNPY 397
Query: 72 VVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
+V L V ++ + VME GG L F + ++ + Q+ + Y +
Sbjct: 398 IVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGT--P-AYVAPEVINRR 186
HR+L N+LL K+SDFGLS + D P + APE IN R
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFR 514
Query: 187 GYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
+ S++D+WS GV ++ L G P+ E+ I
Sbjct: 515 KFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 54/234 (23%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 13 ELGRLLGQGTFAKVHYAR---NLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVMR 65
++G+G F V++ N + A+K L E +M+
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------SLNRITDIGEVSQFLTEGIIMK 81
Query: 66 LVRHPNVVELYEVMA-SKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS-AVD 123
HPNV+ L + S+ V+ Y+K G+L + ++ + + LI +
Sbjct: 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLIGFGLQ 136
Query: 124 ------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG---- 173
Y S+ HRDL N +LDE +KV+DFGL+ K + + T
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 174 --TPAYVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
A E + + + +K+D+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 197 KWM----ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 35/237 (14%)
Query: 13 ELGRLLGQGTFAKVHYAR---NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
LGR+LG+G F V A+ + + VA+K++ K ++ I++ RE + M+ H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDH 84
Query: 70 PNVVELYEV------MASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS-AV 122
P+V +L V ++ ++K G+L + ++ E+ Q L+ V
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 123 D------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES-----KHQDGLLHTT 171
D Y SR HRDL N +L E + V+DFGLS S + L
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL--- 201
Query: 172 CGTPAYV---APEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
P V A E + Y +D+W+ GV ++ ++ G P+ E+Y +
Sbjct: 202 ---P--VKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 49/240 (20%), Positives = 80/240 (33%), Gaps = 47/240 (19%)
Query: 13 ELGRLLGQGTFAKVHYAR-------NLKTGMSVAIKIIDKEKVLKVGMIDQIK---REIS 62
LGQGTF K+ V +K VL + + S
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK------VLDKAHRNYSESFFEAAS 64
Query: 63 VMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLIS 120
+M + H ++V Y V + V E+VK G L + K K + + +QL +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNL--------KVSDFGLSALAESKHQDGLLHTTC 172
A+ + + H ++ +N+LL + K+SD G+S
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP----------- 173
Query: 173 GTPAY------VAPEVI-NRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
V PE I N + + D WS G L+ + G P + +
Sbjct: 174 -KDILQERIPWVPPECIENPKNLN-LATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 54/234 (23%), Positives = 97/234 (41%), Gaps = 38/234 (16%)
Query: 13 ELGRLLGQGTFAKVHYAR---NLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVMR 65
++G+G F V++ N + A+K L E +M+
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------SLNRITDIGEVSQFLTEGIIMK 145
Query: 66 LVRHPNVVELYEVMA-SKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS-AVD 123
HPNV+ L + S+ V+ Y+K G+L + ++ + + LI +
Sbjct: 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLIGFGLQ 200
Query: 124 ------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCG---- 173
+ S+ HRDL N +LDE +KV+DFGL+ K D + + T
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 174 --TPAYVAPEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
A E + + + +K+D+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 261 KWM----ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 55/224 (24%), Positives = 86/224 (38%), Gaps = 44/224 (19%)
Query: 13 ELGRLLGQGTFAKVH--YARNLKTG---MSVAIKIIDKEKVLKVGMIDQIKREISVM-RL 66
G+ LG G F KV A L M+VA+K++ K + E+ V+ L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREA-LMSELKVLSYL 83
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGEL------------FGKVAKGKLKEDAARKY 114
H N+V L + EY G+L K + +++D
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 115 FQQLIS-------AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES-----K 162
+ L+S + + S+ HRDL N+LL K+ DFGL+ ++
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 163 HQDGLLHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY 203
+ L P V APE I Y ++D+WS G+ L+
Sbjct: 204 KGNARL------P--VKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 56/238 (23%), Positives = 99/238 (41%), Gaps = 46/238 (19%)
Query: 13 ELGRLLGQGTFAKVHYAR---NLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISVMR 65
R++G+G F V++ + + AIK L Q RE +MR
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK------SLSRITEMQQVEAFLREGLLMR 77
Query: 66 LVRHPNVVELYEV-MASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS-AVD 123
+ HPNV+ L + + + + ++ Y+ G+L ++ + LIS +
Sbjct: 78 GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL-----LQFIRSPQRNPTVKDLISFGLQ 132
Query: 124 ------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL-------AESKHQDGLLHT 170
Y + HRDL N +LDE +KV+DFGL+ + +H+ L
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL-- 190
Query: 171 TCGTPAYV---APEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
P V A E + + +K+D+WS GV+L+ +L G P+ + ++ +
Sbjct: 191 ----P--VKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 53/241 (21%), Positives = 98/241 (40%), Gaps = 44/241 (18%)
Query: 13 ELGRLLGQGTFAKVH--YARNLKTG---MSVAIKIIDKEKVLKVGMIDQIK----REISV 63
+ R LGQG+F V+ A+ + VAIK + + + E SV
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK------TVNEAASMRERIEFLNEASV 81
Query: 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKY--FQQLI 119
M+ +VV L V++ +ME + G+L + + + + + ++I
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 120 S-AVD------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES-----KHQDGL 167
A + Y ++ HRDL N ++ E +K+ DFG++ K GL
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 168 LHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRK 223
L P V +PE + + + +D+WS GV+L+ + P+ + ++ R
Sbjct: 202 L------P--VRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252
Query: 224 I 224
+
Sbjct: 253 V 253
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 62/236 (26%), Positives = 99/236 (41%), Gaps = 34/236 (14%)
Query: 13 ELGRLLGQGTFAKVHYAR---NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
LG++LG+G F V T + VA+K + K I++ E + M+ H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 70 PNVVELYEV-----MASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS-AVD 123
PNV+ L V K ++ ++K G+L + +L+ Q L+ VD
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 124 ------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES-----KHQDGLLHTTC 172
Y +R HRDL N +L + + V+DFGLS S + + +
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM---- 211
Query: 173 GTPAYV---APEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKI 224
P V A E + R Y SK+D+W+ GV ++ + G P+ EMY +
Sbjct: 212 --P--VKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 62/219 (28%), Positives = 89/219 (40%), Gaps = 44/219 (20%)
Query: 14 LGRLLGQGTFAKVHYARNLKTG--MSVAIKIIDKEKVLKVGMIDQIK----REISVM-RL 66
++G+G F +V AR K G M AIK +K E+ V+ +L
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKR------MKEYASKDDHRDFAGELEVLCKL 82
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGEL----------FGKVAKGKLKEDAARKYFQ 116
HPN++ L + +Y +EY G L A A+ Q
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 117 QLIS-AVD------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE--SKHQDGL 167
QL+ A D Y + HRDL N+L+ E+ K++DFGLS E K G
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 202
Query: 168 LHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY 203
L P V A E +N Y + +D+WS GV+L+
Sbjct: 203 L------P--VRWMAIESLNYSVYT-TNSDVWSYGVLLW 232
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 54/247 (21%), Positives = 88/247 (35%), Gaps = 50/247 (20%)
Query: 13 ELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISV 63
LG+ F KV+ + +VAIK LK ++ E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK------TLKDKAEGPLREEFRHEAML 65
Query: 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL----------FGKVAKGKLKEDAARK 113
++HPNVV L V+ + + Y G+L + + +
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 114 YFQQLIS-AVD------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES----- 161
+ Y S V H+DL N+L+ + N+K+SD GL +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 162 KHQDGLLHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNL 217
+ LL P + APE I + +DIWS GV+L+ V G P+ +
Sbjct: 186 LLGNSLL------P--IRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
Query: 218 MEMYRKI 224
++ I
Sbjct: 237 QDVVEMI 243
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 70/262 (26%), Positives = 107/262 (40%), Gaps = 61/262 (23%)
Query: 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKR----EISVMRLVRHPN 71
L+G G F KV+ L+ G VA+K E Q EI + RHP+
Sbjct: 45 FLIGHGVFGKVYKGV-LRDGAKVALKRRTPESS-------QGIEEFETEIETLSFCRHPH 96
Query: 72 VVELYEVMASKTKIYFVMEYVKGGE----LFGKVAKGK-------LK--EDAARKYFQQL 118
+V L + ++ + +Y++ G L+G L+ AAR
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR------ 150
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT---CGTP 175
+ Y H+R + HRD+K N+LLDE+ K++DFG+S + H + GT
Sbjct: 151 --GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG---TELDQTHLSTVVKGTL 205
Query: 176 AYVAPEVINRRGYDGSKADIWSCGVILYVLLAG------YLPFHDSNLMEMYRKIGKAEF 229
Y+ PE +G K+D++S GV+L+ +L LP NL E
Sbjct: 206 GYIDPEYF-IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE---------- 254
Query: 230 KFPNWFAPEV-RRLLSKILDPN 250
W L +I+DPN
Sbjct: 255 ----WAVESHNNGQLEQIVDPN 272
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 13 ELGRLLGQGTFAKVHYAR-------NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM- 64
LG+ LG+G F +V A K ++VA+K++ K+ + + D + E+ +M
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 95
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL----------FGKVAKGKLKEDAARKY 114
+ +H N++ L +Y ++EY G L + + + +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 115 FQQLIS-AVD------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES-----K 162
F+ L+S Y S+ HRDL N+L+ E+ +K++DFGL+ + K
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 163 HQDGLLHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY 203
+G L P V APE + R Y ++D+WS GV+++
Sbjct: 216 TTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 13 ELGRLLGQGTFAKVHYAR-------NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM- 64
LG+ LG+G F +V A K ++VA+K++ K+ + + D + E+ +M
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 141
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL----------FGKVAKGKLKEDAARKY 114
+ +H N++ L +Y ++EY G L + + + +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 115 FQQLIS-AVD------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES-----K 162
F+ L+S Y S+ HRDL N+L+ E+ +K++DFGL+ + K
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 163 HQDGLLHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY 203
+G L P V APE + R Y ++D+WS GV+++
Sbjct: 262 TTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 8e-22
Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 13 ELGRLLGQGTFAKVH--YARNLKTG---MSVAIKIIDKEKVLKVG-MIDQIK--REISVM 64
L R LG+G F KV NL M VA+K LK + + RE ++
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA------LKDPTLAARKDFQREAELL 71
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL----------FGKVAKGKLKEDAARKY 114
++H ++V+ Y V + V EY+K G+L + G+ ++
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 115 FQQLIS-AVD------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES-----K 162
Q++ A Y S+ HRDL N L+ + +K+ DFG+S S
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 163 HQDGLLHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY 203
+L P + PE I R + +++D+WS GVIL+
Sbjct: 192 GGHTML------P--IRWMPPESIMYRKFT-TESDVWSFGVILW 226
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 44/224 (19%)
Query: 13 ELGRLLGQGTFAKVHYAR-------NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM- 64
LG+ LG+G F +V A VA+K++ K + + D I E+ +M
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI-SEMEMMK 129
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL----------FGKVAKGKLKEDAARKY 114
+ +H N++ L +Y ++EY G L + + +
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 115 FQQLIS-AVD------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES-----K 162
+ L+S A Y S+ HRDL N+L+ E +K++DFGL+ K
Sbjct: 190 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 163 HQDGLLHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY 203
+G L P V APE + R Y ++D+WS GV+L+
Sbjct: 250 TTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 59/245 (24%), Positives = 95/245 (38%), Gaps = 48/245 (19%)
Query: 13 ELGRLLGQGTFAKVH--YARNLKTG---MSVAIKIIDKEKVLKVGMIDQIK---REISVM 64
L LG+G F KV NL M VA+K LK + RE ++
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKA------LKEASESARQDFQREAELL 97
Query: 65 RLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL---------FGKVAKGKLKEDAARKYF 115
+++H ++V + V + V EY++ G+L K+ G
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 116 QQLIS-AVD------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES-----KH 163
QL++ A Y HRDL N L+ + +K+ DFG+S S
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 164 QDGLLHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLME 219
+L P + PE I R + +++D+WS GV+L+ + G P++ + E
Sbjct: 218 GRTML------P--IRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268
Query: 220 MYRKI 224
I
Sbjct: 269 AIDCI 273
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 57/241 (23%), Positives = 92/241 (38%), Gaps = 44/241 (18%)
Query: 13 ELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISV 63
L R LG G F +V+ + N + + VA+K L +Q + E +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK------TLPEVCSEQDELDFLMEALI 86
Query: 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISA 121
+ H N+V V + +ME + GG+L F + + + + ++ L A
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 122 VD------YCHSRGVCHRDLKPENLLLDEHGN---LKVSDFGLSALAES-----KHQDGL 167
D Y HRD+ N LL G K+ DFG++ K +
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 168 LHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRK 223
L P V PE + SK D WS GV+L+ + GY+P+ + E+
Sbjct: 207 L------P--VKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257
Query: 224 I 224
+
Sbjct: 258 V 258
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 4e-21
Identities = 68/291 (23%), Positives = 111/291 (38%), Gaps = 70/291 (24%)
Query: 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKR----EISVMRLVRHP 70
G +G+G F V+ + +VA+K + + ++K+ EI VM +H
Sbjct: 36 GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTE---ELKQQFDQEIKVMAKCQHE 90
Query: 71 NVVEL-------------YEVMASKTKIYFVMEYVKGGELFGKVAKGKLK--------ED 109
N+VEL Y M + + + L L +
Sbjct: 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDR---------LSCLDGTPPLSWHMRCKIAQG 141
Query: 110 AARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169
AA +++ H HRD+K N+LLDE K+SDFGL+ +E
Sbjct: 142 AAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK---FAQTV 190
Query: 170 TT---CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPF----HDSNLMEMYR 222
T GT AY+APE + RG K+DI+S GV+L ++ G L+++
Sbjct: 191 MTSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248
Query: 223 KIGKAEFKFP--------NWFAPEVRRLL---SKILDPNPNTRISMTKIME 262
+I E + + V + S+ L N R + K+ +
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 57/223 (25%), Positives = 88/223 (39%), Gaps = 43/223 (19%)
Query: 13 ELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RL 66
+LG+ LG+G F +V A T +VA+K++ KE + E+ ++ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA-LMSELKILIHI 87
Query: 67 VRHPNVVELYEV-MASKTKIYFVMEYVKGGEL----------FGKVAKGKLKEDAARKYF 115
H NVV L + ++E+ K G L F
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 116 QQLIS-AVD------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES-----KH 163
+ LI + + SR HRDL N+LL E +K+ DFGL+ +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 164 QDGLLHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY 203
D L P + APE I R Y ++D+WS GV+L+
Sbjct: 208 GDARL------P--LKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 55/220 (25%), Positives = 84/220 (38%), Gaps = 40/220 (18%)
Query: 13 ELGRLLGQGTFAKVHYA-----RNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RL 66
+ G+ LG G F KV A + VA+K++ K + E+ +M L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM-SELKIMSHL 106
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDY 124
+H N+V L + + EY G+L F + L+ D A S D
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 125 CH-------------SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES-----KHQDG 166
H S+ HRD+ N+LL K+ DFGL+ + +
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 167 LLHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY 203
L P V APE I Y ++D+WS G++L+
Sbjct: 227 RL------P--VKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 8e-21
Identities = 61/229 (26%), Positives = 94/229 (41%), Gaps = 49/229 (21%)
Query: 13 ELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
LG+ LG+G F KV A +VA+K++ KE + D + E +V++ V
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRD-LLSEFNVLKQV 83
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGEL------------------FGKVAKGKLKED 109
HP+V++LY + + ++EY K G L + + D
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 110 AARKYFQQLIS-AVD------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES- 161
LIS A Y + HRDL N+L+ E +K+SDFGLS
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 162 ----KHQDGLLHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY 203
K G + P V A E + Y +++D+WS GV+L+
Sbjct: 204 DSYVKRSQGRI------P--VKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 49/229 (21%)
Query: 13 ELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RL 66
E G++LG G F KV A + VA+K++ KEK + E+ +M +L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREA-LMSELKMMTQL 105
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGEL-----------------FGKVAKGKLKED 109
H N+V L IY + EY G+L + + + +ED
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 110 AARKYFQQLIS-AVD------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS-ALAES 161
F+ L+ A + + HRDL N+L+ +K+ DFGL+ +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 162 ----KHQDGLLHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY 203
+ L P V APE + Y K+D+WS G++L+
Sbjct: 226 SNYVVRGNARL------P--VKWMAPESLFEGIYT-IKSDVWSYGILLW 265
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 65/255 (25%), Positives = 111/255 (43%), Gaps = 44/255 (17%)
Query: 17 LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELY 76
+LG+G F KV+ R L G VA+K + +E+ G Q + E+ ++ + H N++ L
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 77 EVMASKTKIYFVMEYVKGG----ELFGKVAKGKLKED----------AAR--KYFQQLIS 120
+ T+ V Y+ G L + + + D +AR Y
Sbjct: 94 GFCMTPTERLLVYPYMANGSVASCLRER-PESQPPLDWPKRQRIALGSARGLAYLH---- 148
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT---CGTPAY 177
D+C + + HRD+K N+LLDE V DFGL+ L + H T GT +
Sbjct: 149 --DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMD----YKDTHVTTAVRGTIGH 201
Query: 178 VAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAP 237
+APE ++ G K D++ GV+L L+ G F ++ R + +W
Sbjct: 202 IAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAF------DLARLANDDDVMLLDWVKG 254
Query: 238 --EVRRLLSKILDPN 250
+ ++L ++D +
Sbjct: 255 LLKEKKLE-ALVDVD 268
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 52/233 (22%), Positives = 87/233 (37%), Gaps = 57/233 (24%)
Query: 13 ELGRLLGQGTFAKVH--YARNLKTG---MSVAIKIIDKEKVLKVGMIDQIK----REISV 63
E R +G+G F +V A L VA+K+ LK ++ RE ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM------LKEEASADMQADFQREAAL 103
Query: 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL------------------FGKVAKGK 105
M +PN+V+L V A + + EY+ G+L
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 106 LKEDAARKYFQQLIS-AVD------YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS-A 157
+ + A Y R HRDL N L+ E+ +K++DFGLS
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 158 LAES----KHQDGLLHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY 203
+ + + + P + PE I Y +++D+W+ GV+L+
Sbjct: 224 IYSADYYKADGNDAI------P--IRWMPPESIFYNRYT-TESDVWAYGVVLW 267
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 56/241 (23%), Positives = 94/241 (39%), Gaps = 44/241 (18%)
Query: 13 ELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIK----REISV 63
L R LG G F +V+ + N + + VA+K L +Q + E +
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK------TLPEVCSEQDELDFLMEALI 127
Query: 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISA 121
+ H N+V V + ++E + GG+L F + + + + ++ L A
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 122 VD------YCHSRGVCHRDLKPENLLLDEHGN---LKVSDFGLS-ALAES----KHQDGL 167
D Y HRD+ N LL G K+ DFG++ + + K +
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 168 LHTTCGTPAYV---APEVINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRK 223
L P V PE + SK D WS GV+L+ + GY+P+ + E+
Sbjct: 248 L------P--VKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 298
Query: 224 I 224
+
Sbjct: 299 V 299
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 60/244 (24%), Positives = 97/244 (39%), Gaps = 47/244 (19%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH- 69
+ +G+ +G G F ++ +NL T VAIK+ E + Q+ E + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAP--QLHLEYRFYKQLGSG 64
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYF--------QQLISA 121
+ ++Y V+E L G + L + R + QLIS
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLE------LLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISR 117
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVS-----DFGLSALAESKHQDGLLHT------ 170
++Y HS+ + +RD+KPEN L+ GN DF L+ ++ D
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA----KEYIDPETKKHIPYRE 173
Query: 171 ---TCGTPAYVAPEVINR-RGYDGS-KADIWSCGVILYVLLAGYLP---FHDSNLMEMYR 222
GT Y++ IN G + S + D+ + G + L G LP L E Y+
Sbjct: 174 HKSLTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230
Query: 223 KIGK 226
KIG
Sbjct: 231 KIGD 234
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-20
Identities = 55/254 (21%), Positives = 104/254 (40%), Gaps = 47/254 (18%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
M + +++ Y++GR +G+G+F + NL VAIK E Q++ E
Sbjct: 1 MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAP--QLRDE 55
Query: 61 ISVMRLVRH-PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYF---- 115
+L+ + +Y V++ L G + L + RK+
Sbjct: 56 YRTYKLLAGCTGIPNVYYFGQEGLHNVLVID------LLGP-SLEDLLDLCGRKFSVKTV 108
Query: 116 ----QQLISAVDYCHSRGVCHRDLKPENLLL----DEHGN-LKVSDFGLSALAESKHQDG 166
+Q+++ V H + + +RD+KP+N L+ ++ N + V DFG+ ++D
Sbjct: 109 AMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV----KFYRDP 164
Query: 167 LLHT---------TCGTPAYVAPEVINR-RGYDGS-KADIWSCGVILYVLLAGYLP---F 212
+ GT Y++ IN G + S + D+ + G + L G LP
Sbjct: 165 VTKQHIPYREKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
Query: 213 HDSNLMEMYRKIGK 226
+ + Y +IG+
Sbjct: 222 KAATNKQKYERIGE 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 75/386 (19%), Positives = 121/386 (31%), Gaps = 140/386 (36%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
G + RY + R LG G F+ V + +++ VA+K++ + EI
Sbjct: 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV----KSAEHYTETALDEIR 85
Query: 63 VMRLVR-----HPN---VVELYEVMASKTKIYF------------VMEYVKGGELFGKVA 102
+++ VR PN VV+L + F V E V G L +
Sbjct: 86 LLKSVRNSDPNDPNREMVVQLLD--------DFKISGVNGTHICMVFE-VLGHHLLKWII 136
Query: 103 K---GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLL---------------- 142
K L +K QQ++ +DY H++ + H D+KPEN+LL
Sbjct: 137 KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 143 ---------------------------------DEHGNLKVSDFGLSALAESKHQDGLLH 169
E +K++D G + +
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE---- 252
Query: 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPF--HDSN--------LME 219
T Y + EV+ GY+ + ADIWS + + L G F H +
Sbjct: 253 -DIQTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL 310
Query: 220 MYRKIGK------------AEF-----------KFPNWFAPEVR---------------R 241
+ +GK EF K W EV
Sbjct: 311 IIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTD 370
Query: 242 LLSKILDPNPNTRISMTKIMENSWFR 267
L +L+ P R + + + + W
Sbjct: 371 FLLPMLELIPEKRATAAECLRHPWLN 396
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 31/235 (13%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH- 69
RY LGR +G G+F ++ ++ G VAIK+ E V Q+ E + ++++
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHP--QLHIESKIYKMMQGG 64
Query: 70 PNVVELYEVMASKTKIYFVMEYVKG---GELFGKVAKGKLKEDAARKYFQQLISAVDYCH 126
+ + A VME + G +LF ++ K Q+IS ++Y H
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIH 122
Query: 127 SRGVCHRDLKPENLLLDEHGN---LKVSDFGLSALAESKHQDGLLHTT-------CGTPA 176
S+ HRD+KP+N L+ + + DFGL+ + + H GT
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA--KKYRDARTHQHIPYRENKNLTGTAR 180
Query: 177 YVAPEVINR-RGYDGS-KADIWSCGVILYVLLAGYLP---FHDSNLMEMYRKIGK 226
Y + IN G + S + D+ S G +L G LP + + Y +I +
Sbjct: 181 YAS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 31/235 (13%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-H 69
++ LGR +G G+F +++ N++T VAIK+ E V Q+ E + R+++
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHP--QLLYESKIYRILQGG 62
Query: 70 PNVVELYEVMASKTKIYFVMEYVKG---GELFGKVAKGKLKEDAARKYFQQLISAVDYCH 126
+ + VM+ + G +LF KL Q+I+ V++ H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 127 SRGVCHRDLKPENLLLDEHGN---LKVSDFGLSALAESKHQDGLLHTT-------CGTPA 176
S+ HRD+KP+N L+ + + DFGL+ + H GT
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY--RDTSTHQHIPYRENKNLTGTAR 178
Query: 177 YVAPEVINR-RGYDGS-KADIWSCGVILYVLLAGYLPFHD---SNLMEMYRKIGK 226
Y + +N G + S + D+ S G +L L G LP+ + Y KI +
Sbjct: 179 YAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 43/264 (16%), Positives = 87/264 (32%), Gaps = 49/264 (18%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
++ LG+ +G G F ++ A A ++ K + + G + E+ + V
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV-KVEYQENG---PLFSELKFYQRVAK 92
Query: 70 PNVVELYEVMASKTK------IYFVMEYVKGG-------ELFGK------VAKGKLKEDA 110
+ ++ + + KG E G G K+
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST 152
Query: 111 ARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV--SDFGLSALAESKHQDGLL 168
+ +++ ++Y H H D+K NLLL +V +D+GLS ++
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS----YRYCPNGN 208
Query: 169 HTT---------CGTPAYVAPEVINR-RGYDGS-KADIWSCGVILYVLLAGYLPFHD--- 214
H GT + + ++ +G S ++D+ G + L G LP+
Sbjct: 209 HKQYQENPRKGHNGTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265
Query: 215 ---SNLMEMYRKIGKAEFKFPNWF 235
+ + + W
Sbjct: 266 DPVAVQTAKTNLLDELPQSVLKWA 289
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.8 bits (188), Expect = 1e-15
Identities = 33/192 (17%), Positives = 60/192 (31%), Gaps = 47/192 (24%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGM-----IDQIKREISVM 64
++ + +G+G F +V VAIKII E V ++I EI +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 65 RLV---------RHPNVVELYEV------------------------------MASKTKI 85
+ + R + L V ++
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 86 YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDE 144
+ V+E+ GG ++ A+ QL +++ + HRDL N+LL +
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 145 HGNLKVSDFGLS 156
K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 35/257 (13%), Positives = 88/257 (34%), Gaps = 49/257 (19%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID-QIKREISV-M 64
++++L + ++ A T + ++ LK+ D ++ E +
Sbjct: 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQ-KQKFSLKLDAKDGRLFNEQNFFQ 97
Query: 65 RLVRHPNVVELYEVMASKT----KIYF-----------VMEYVKGGELFGKVAKGKLKED 109
R + V + ++ ++ V+ G+ + +
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP------SLGR-SLQSALDV 150
Query: 110 AARKYF---------QQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV--SDFGLSA- 157
+ + +L+ A+++ H H ++ EN+ +D +V + +G +
Sbjct: 151 SPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
Query: 158 -LAESKH---QDGLLHTTCGTPAYVAPEVINR-RGYDGS-KADIWSCGVILYVLLAGYLP 211
KH +G G +++ ++ +G S ++D+ S G + L G+LP
Sbjct: 211 YCPSGKHVAYVEGSRSPHEGDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
Query: 212 ---FHDSNLMEMYRKIG 225
+ M +K
Sbjct: 268 WTNCLPNTEDIMKQKQK 284
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 48/255 (18%), Positives = 92/255 (36%), Gaps = 51/255 (20%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID--QIKREISVMRLV 67
+++G +GQG F + Y ++ + SV V+KV D + E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCI-YLADMNSSESVGSDA---PCVVKVEPSDNGPLFTELKFYQRA 90
Query: 68 RHPNVVELYEVMASKTKI------YFVMEYVKGG-------ELFGKVAKGKLKEDAARKY 114
P ++ + + + G + FG K+ E A+++
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRF 149
Query: 115 FQ--------QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV--SDFGLSALAESKHQ 164
+ +++ ++Y H H D+K NLLL+ +V D+GL+ ++
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA----YRYC 205
Query: 165 DGLLHTT---------CGTPAYVAPEVINR-RGYDGS-KADIWSCGVILYVLLAGYLPFH 213
+H GT + + I+ G S + D+ G + L G+LP+
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262
Query: 214 D---SNLMEMYRKIG 225
D KI
Sbjct: 263 DNLKDPKYVRDSKIR 277
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 13/93 (13%)
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES-----KHQDGLLHTT 171
Q+ +++ SR HRDL N+LL E +K+ DFGL+ + D L
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--- 257
Query: 172 CGTPA-YVAPEVINRRGYDGSKADIWSCGVILY 203
P ++APE I R Y ++D+WS GV+L+
Sbjct: 258 ---PLKWMAPETIFDRVYT-IQSDVWSFGVLLW 286
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 23/91 (25%), Positives = 37/91 (40%), Gaps = 7/91 (7%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGM----IDQIKREISVM-RLV 67
+LG+ LG+G F +V A A K+LK G + E+ ++ +
Sbjct: 25 KLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 83
Query: 68 RHPNVVELYEVM-ASKTKIYFVMEYVKGGEL 97
H NVV L + ++E+ K G L
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 114
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 38/179 (21%), Positives = 61/179 (34%), Gaps = 31/179 (17%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKT--GMSVAIKI-------IDKEKVLKV 51
+ KG I +G ++ G A V YA + +++A+KI DK
Sbjct: 42 LSAKGYI----TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLY 97
Query: 52 GMIDQIKREISVMRLVR------HPNVVELYEVMASKTKIYF------VMEYVKGGELFG 99
G R IS V N+ E S + Y +ME++ EL
Sbjct: 98 GDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPA 157
Query: 100 ---KVAKGKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFG 154
+LKE F ++ V + + H DL N++ + + D G
Sbjct: 158 PTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK--VYFIDMG 214
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 1e-05
Identities = 51/323 (15%), Positives = 95/323 (29%), Gaps = 99/323 (30%)
Query: 49 LKVGMI-DQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLK 107
++ +I + I+ ++ +H N +L ++ S L+
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN--------------------VLE 367
Query: 108 EDAARKYFQQL--------ISA------------------VDYCHSRGVCHRDLKPENL- 140
RK F +L I V+ H + + K +
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427
Query: 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKA-DIWSCG 199
+ + LKV AL H+ +++ Y+ K D
Sbjct: 428 IPSIYLELKVKLENEYAL----HR----------------SIVDH--YNIPKTFDSDDLI 465
Query: 200 VIL---YVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI--LDPNPNTR 254
Y ++ H N +E ++ F F + R L KI N
Sbjct: 466 PPYLDQYF--YSHIGHHLKN-IEHPERMT----LFRMVFL-DFRFLEQKIRHDSTAWNAS 517
Query: 255 ISMTKIMENSWFRKGLVKPSISETEEKEWAPVDADAVFSPSGSTSTVAESKNELAKPCNL 314
S+ ++ + KP I + + K V+A F P + + SK
Sbjct: 518 GSILNTLQQ--LKF--YKPYICDNDPKYERLVNAILDFLPKIEENLI-CSKYT------- 565
Query: 315 NAFDIISFSAGFDLSGLFEEREK 337
D++ + + +FEE K
Sbjct: 566 ---DLLRIALMAEDEAIFEEAHK 585
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 23/154 (14%), Positives = 56/154 (36%), Gaps = 19/154 (12%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID-QIKREISVMRLVR-- 68
+G+L+G+G + V + + +K + + + ++ L
Sbjct: 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 69 ----HPNVVELYEVMASKTKIYF----VMEYVKGGELFGKVAKGKLKEDAARKYFQQLIS 120
+ +L + K + +ME + EL+ +++ + + ++
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELY------RVRVENPDEVLDMILE 204
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFG 154
V + RG+ H DL N+L+ + + DF
Sbjct: 205 EVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 472 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 100.0 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.45 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.34 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.25 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.94 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.91 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.88 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.83 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.68 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.59 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 98.58 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 98.55 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.55 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.43 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 98.4 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.34 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.23 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.93 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.79 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.65 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.63 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.59 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.51 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.45 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.45 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.4 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.37 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.34 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.14 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.99 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.32 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.11 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.67 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.4 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.77 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.77 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-67 Score=519.27 Aligned_cols=260 Identities=34% Similarity=0.657 Sum_probs=242.4
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+|+.++|||||++++++++++.+|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34679999999999999999999999999999999988766555667889999999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||||+||+|++++.+ +.++|.+++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.........
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999999976 789999999999999999999999999999999999999999999999999998775544445
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~ 246 (472)
...+.|||+.|||||++.+.+|+ .++|||||||++|+|++|+.||.+.+..+++.+|.+..+.+|..+++++++||.+|
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~l 268 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL 268 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHH
Confidence 56788999999999999988875 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCcCChhh------hhcCccccc
Q 012053 247 LDPNPNTRISMTK------IMENSWFRK 268 (472)
Q Consensus 247 L~~dP~~Rpt~~e------il~hp~f~~ 268 (472)
|+.||++|||++| |++||||+.
T Consensus 269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 269 LVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 9999999999998 588999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-66 Score=507.83 Aligned_cols=261 Identities=46% Similarity=0.883 Sum_probs=222.5
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
.|.. .++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+|+.++|||||++++++.+++
T Consensus 8 ~G~~-ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 8 DGAH-IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD 86 (275)
T ss_dssp -------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCE-eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 3554 378999999999999999999999999999999998877665566788999999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|+||||+ +|+|.+++.+ +++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999999999 6799988864 78999999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~l 242 (472)
....+.+||+.|||||++.+..|++.++|||||||++|+|+||+.||.+.+...++..+..+.+.+|.++|+++++|
T Consensus 166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (275)
T 3hyh_A 166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGL 242 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 23457899999999999999888888999999999999999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCcCChhhhhcCcccccC
Q 012053 243 LSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
|.+||+.||++|||++|+++||||+..
T Consensus 243 i~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHHcCcccccC
Confidence 999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-64 Score=506.98 Aligned_cols=256 Identities=27% Similarity=0.466 Sum_probs=231.5
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
..+|++++.||+|+||+||+|+++.+|+.||||++++.... ..+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35799999999999999999999999999999999866433 235678999999999999999999999999999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||||+||+|++++.++++++.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+...... ...
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCB
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Ccc
Confidence 999999999999998999999999999999999999999999999999999999999999999999998664322 235
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---CCCCCCCHHHHHHHhc
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF---KFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~l~~li~~ 245 (472)
.+.|||+.|||||++.+.+|+ .++|||||||++|+|++|+.||.+.+..+.+..+..... ..+..+|+++++||.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 678999999999999888885 899999999999999999999999998888888866532 2334589999999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
||+.||++|||++|+++||||++..
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HcCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999998743
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-65 Score=509.76 Aligned_cols=259 Identities=29% Similarity=0.568 Sum_probs=229.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++++.||+|+||+||+|+++.+|+.||||++++..... ...+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 579999999999999999999999999999999998776433 4567899999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 89 MEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
||||+||+|++++.. ..++|.+++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+......
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-- 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--
Confidence 999999999999953 357999999999999999999999999999999999999999999999999998664322
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCCCHHHHHHHh
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPEVRRLLS 244 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~l~~li~ 244 (472)
....+.|||+.|||||++.+.+|+ .++|||||||++|+|+||+.||.+.+..+++.++..+.+ ..+..+|+++++||.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 123567899999999999988886 899999999999999999999999999999988887765 466779999999999
Q ss_pred cccCCCCCCcCChhhhhcCcccccCCC
Q 012053 245 KILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
+||+.||++|||++|+++||||++...
T Consensus 259 ~~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 259 QLFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp HHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred HHccCChhHCcCHHHHhcCHHhhcCCC
Confidence 999999999999999999999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-63 Score=517.38 Aligned_cols=411 Identities=35% Similarity=0.617 Sum_probs=317.3
Q ss_pred CcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
..|.+..++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 35788999999999999999999999999999999999999876544445567899999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999999999975 6899999999999999999999999999999999999999999999999999886543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRR 241 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~ 241 (472)
. ....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+....+.++..+.+..|..+++++.+
T Consensus 169 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 245 (476)
T 2y94_A 169 G---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS 245 (476)
T ss_dssp T---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred c---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHH
Confidence 2 2346779999999999998887777899999999999999999999999988899999999988999999999999
Q ss_pred HHhcccCCCCCCcCChhhhhcCcccccCCCCCCCCcc--------cc---cccC-C--CCCCcccCC----C-CCCccc-
Q 012053 242 LLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISET--------EE---KEWA-P--VDADAVFSP----S-GSTSTV- 301 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~f~~~~~~~~~~~~--------~~---~~~~-~--~~~~~~~~~----~-~~~~~~- 301 (472)
||.+||..||.+|||+.+|++||||++.......+.. +. .+.. . .+.+.+... . ....+.
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 325 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVA 325 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC------------------------
T ss_pred HHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHH
Confidence 9999999999999999999999999875432111000 00 0000 0 000000000 0 000000
Q ss_pred --------------------c-ccc-----cc--cCCCCCCCchhhhccCCCCCCCCch-------hhhhhcccceeecc
Q 012053 302 --------------------A-ESK-----NE--LAKPCNLNAFDIISFSAGFDLSGLF-------EEREKRKEVRFTSN 346 (472)
Q Consensus 302 --------------------~-~~~-----~~--~~~~~~~~~f~~~~~s~~~~ls~l~-------~~~~~~~~~rf~s~ 346 (472)
. ... .. ...|.........+-+....++++. ..+..++++++.|+
T Consensus 326 y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~s~ 405 (476)
T 2y94_A 326 YHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQ 405 (476)
T ss_dssp -------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEEEC
T ss_pred HHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecCccC
Confidence 0 000 00 0000000000000000000111110 02345788999999
Q ss_pred CCHHHHHHHHHHHHhHcCcEEEEecCceEEEEeecCCcCceEEEEEEEEEEcCceEEEEEEccCCCcHHH
Q 012053 347 KPVSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEY 416 (472)
Q Consensus 347 ~~~~~i~~~l~~~~~~l~~~v~~~~~~~~~~~~~~~~~~g~l~~~~ev~e~~~~~~lVe~~~~~Gd~lef 416 (472)
.+|.+||.+|..+++.|||.||+.+.+.|++..........+.|.+++|++++..+|||||+..|+.++|
T Consensus 406 ~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 406 SRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp SCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred CCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 9999999999999999999999999999999864333345677999999999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-64 Score=496.73 Aligned_cols=256 Identities=35% Similarity=0.646 Sum_probs=226.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
-++|++++.||+|+||+||+|++. .+++.||||++++..... .....+.+|+.+|+.++|||||++++++.+++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 367999999999999999999985 468899999998765432 2234678999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+|||||+||+|++++.+ +.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-- 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC--
Confidence 999999999999999976 78999999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~ 244 (472)
.....+.|||+.|||||++.+.+|+ .++|||||||++|+|+||+.||.+.+..+++.++.+..+.+|..+|+++++||.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 2234678999999999999988886 899999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCcCC-----hhhhhcCccccc
Q 012053 245 KILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 245 ~~L~~dP~~Rpt-----~~eil~hp~f~~ 268 (472)
+||+.||++||| ++|+++||||+.
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 999999999998 479999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-63 Score=507.98 Aligned_cols=255 Identities=27% Similarity=0.481 Sum_probs=231.9
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 35799999999999999999999999999999999866433 235688999999999999999999999999999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
||||+||+|++++..+++++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+...... ...
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR 304 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCB
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccc
Confidence 999999999999998999999999999999999999999999999999999999999999999999998664322 234
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---CCCCCCCCHHHHHHHhc
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~l~~li~~ 245 (472)
.+.|||+.|||||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+..+.... ...+..+|+++++||.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 678999999999999888875 89999999999999999999999999888888886653 33445689999999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
||+.||++|||++|+|+||||++.
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HcCCChhHCcCHHHHhcCHHhcCC
Confidence 999999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-62 Score=480.34 Aligned_cols=257 Identities=25% Similarity=0.510 Sum_probs=223.5
Q ss_pred CCcccCCE-EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--
Q 012053 5 GSILMQRY-ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-- 81 (472)
Q Consensus 5 g~~l~~~y-~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 81 (472)
|....+|| ++.+.||+|+||+||+|.++.++..||+|++.+..... ...+.+.+|+.+|+.++|||||++++++.+
T Consensus 20 ~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred CcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 34456787 78889999999999999999999999999998765433 446789999999999999999999999865
Q ss_pred --CCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcC-CCCeEEecCcc
Q 012053 82 --KTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRG--VCHRDLKPENLLLDE-HGNLKVSDFGL 155 (472)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~g--iiHrDIKp~NILld~-~g~vkl~DFGl 155 (472)
+..+|+|||||+||+|.+++.+ +.+++..++.|+.||+.||.|||++| |+||||||+||||+. +|.+||+|||+
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 3568999999999999999976 78999999999999999999999999 999999999999984 89999999999
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC-cHHHHHHHHhccCC--CCC
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-NLMEMYRKIGKAEF--KFP 232 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~~~~~--~~~ 232 (472)
|+.... ....+.+|||.|||||++.+ .|+ .++|||||||++|+|+||+.||.+. +...++..+..+.. .++
T Consensus 179 a~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 179 ATLKRA----SFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp GGGCCT----TSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred CEeCCC----CccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC
Confidence 985432 33567899999999999865 464 8999999999999999999999764 45566666665543 355
Q ss_pred CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 233 NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 ~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..+++++++||.+||+.||++|||++|+++||||++
T Consensus 253 ~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 668999999999999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-61 Score=484.93 Aligned_cols=252 Identities=26% Similarity=0.410 Sum_probs=221.2
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.+.|++.++||+|+||+||+|+++.+|+.||||+++++... .+|+.+|+.++|||||++++++.+++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35699999999999999999999999999999999876432 3799999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-~vkl~DFGla~~~~~~~~~~ 166 (472)
||||+||+|++++.+ +.+++.+++.|+.||+.||.|||++||+||||||+||||+.+| .+||+|||+|+.........
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999999999975 7899999999999999999999999999999999999999998 59999999998765432211
Q ss_pred ---cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---CCCCCCCHHHH
Q 012053 167 ---LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF---KFPNWFAPEVR 240 (472)
Q Consensus 167 ---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~l~ 240 (472)
...+.|||+.|||||++.+..|+ .++|||||||++|+|+||+.||.+.+...++.++..... .+|+.+++++.
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred ceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 12346899999999999988876 799999999999999999999998777777777776654 46788999999
Q ss_pred HHHhcccCCCCCCcCChhhh-------------hcCcccccC
Q 012053 241 RLLSKILDPNPNTRISMTKI-------------MENSWFRKG 269 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~ei-------------l~hp~f~~~ 269 (472)
+||.+||+.||.+|||+.|+ ++|||+.+.
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 99999999999999999998 568888653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=482.26 Aligned_cols=260 Identities=26% Similarity=0.392 Sum_probs=224.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe------
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS------ 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (472)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.+|+.++|||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 346899999999999999999999999999999999765432 2445678899999999999999999999754
Q ss_pred CCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
.+.+|+||||+. |+|++++.+ +++++..++.|++||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 367999999996 679888865 789999999999999999999999999999999999999999999999999998654
Q ss_pred cc--cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC-------
Q 012053 161 SK--HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF------- 231 (472)
Q Consensus 161 ~~--~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~------- 231 (472)
.. .......+.|||+.|||||++.+..+.+.++||||+||++|+|++|++||.+.+..+.+..|.......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 32 122345678999999999999887777799999999999999999999999998888777765321111
Q ss_pred ------------------------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 232 ------------------------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 232 ------------------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+.+++++.+||.+||..||++|||++|+|+||||++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 12368999999999999999999999999999999863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-59 Score=499.04 Aligned_cols=259 Identities=31% Similarity=0.526 Sum_probs=228.9
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHH---HHHHHhcCCCCeeeEEEEEEeC
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE---ISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~E---i~il~~l~hpnIv~l~~~~~~~ 82 (472)
.+-+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+| +.+++.++|||||+++++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 4567899999999999999999999999999999999987665433333444444 5666677899999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+.+|+||||++||+|++++.+ +.++|..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999999999975 7899999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC---cHHHHHHHHhccCCCCCCCCCHH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS---NLMEMYRKIGKAEFKFPNWFAPE 238 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~ 238 (472)
. ...+.||||.|||||++.+...++.++|||||||++|+|++|.+||.+. +...++..+......+|..+|++
T Consensus 345 ~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 345 K----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420 (689)
T ss_dssp C----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred C----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence 2 3467899999999999975433358999999999999999999999763 44567778888889999999999
Q ss_pred HHHHHhcccCCCCCCcCC-----hhhhhcCccccc
Q 012053 239 VRRLLSKILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt-----~~eil~hp~f~~ 268 (472)
+++||.+||+.||.+|++ ++||++||||+.
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 999999999999999998 699999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=455.73 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=223.7
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
+-.++|.+.+.||+|+||+||+|++. .++..||||+++... ....+.+.+|+.+|++++|||||++++++.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 44578999999999999999999875 357899999997543 3446789999999999999999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK--------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN 147 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~ 147 (472)
++.+|+|||||+||+|.+++.. ..+++.++..++.||+.||.|||+++|+||||||+||||+.+++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 9999999999999999999854 36999999999999999999999999999999999999999999
Q ss_pred eEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhc
Q 012053 148 LKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGK 226 (472)
Q Consensus 148 vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~ 226 (472)
+||+|||+|+..............+||+.|||||++.+..|+ .++|||||||++|||+| |+.||.+.+..++...+..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999876544332223345799999999999888876 89999999999999998 9999999988888888877
Q ss_pred cC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 227 AE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 227 ~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+. ...|..+++++.+||.+||+.||++|||+.+| ++|+++
T Consensus 246 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 246 GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 65 56788899999999999999999999999999 567764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-58 Score=464.02 Aligned_cols=254 Identities=25% Similarity=0.433 Sum_probs=210.3
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKT 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (472)
+.++|++++.||+|+||+||+|+++ .+++.||+|.+.+.. ...++.+|+.+|+.+ +||||+++++++.+++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 5689999999999999999999885 467899999986543 235688999999988 6999999999999999
Q ss_pred EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~-g~vkl~DFGla~~~~~~ 162 (472)
++|+||||++||+|.+++. .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 94 ~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 9999999999999999884 69999999999999999999999999999999999999877 79999999999754321
Q ss_pred c--------------------------CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC-
Q 012053 163 H--------------------------QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS- 215 (472)
Q Consensus 163 ~--------------------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~- 215 (472)
. ......+.|||+.|+|||++.+..+++.++||||+||++|+|++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 1 1122355689999999999988766668999999999999999999999653
Q ss_pred cHHHHHHHHhc--------------------------------------cCC----------------CCCCCCCHHHHH
Q 012053 216 NLMEMYRKIGK--------------------------------------AEF----------------KFPNWFAPEVRR 241 (472)
Q Consensus 216 ~~~~~~~~i~~--------------------------------------~~~----------------~~~~~~s~~l~~ 241 (472)
+..+....|.. ... .....+|+++++
T Consensus 252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D 331 (361)
T 4f9c_A 252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD 331 (361)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence 33333332211 000 111237899999
Q ss_pred HHhcccCCCCCCcCChhhhhcCccccc
Q 012053 242 LLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
||++||+.||++|+|++|+|+||||++
T Consensus 332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 332 LLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-58 Score=454.44 Aligned_cols=254 Identities=27% Similarity=0.453 Sum_probs=201.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT----- 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 83 (472)
.++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 346999999999999999999999999999999997654 2344578899999999999999999999986544
Q ss_pred -------EEEEEEEecCCCcccchhccC-C---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEec
Q 012053 84 -------KIYFVMEYVKGGELFGKVAKG-K---LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSD 152 (472)
Q Consensus 84 -------~~~lV~E~~~gg~L~~~i~~~-~---l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~D 152 (472)
.+|+|||||+||+|.+++... . .++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 479999999999999999753 3 45677899999999999999999999999999999999999999999
Q ss_pred CcchhhhhcccCC----------CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH-HHHH
Q 012053 153 FGLSALAESKHQD----------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL-MEMY 221 (472)
Q Consensus 153 FGla~~~~~~~~~----------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~-~~~~ 221 (472)
||+|+........ ....+.|||+.|||||++.+..|+ .++|||||||++|+|++ ||..... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 9999876543221 122456899999999999988876 89999999999999996 8865432 2333
Q ss_pred HHHhccCCC-CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 222 RKIGKAEFK-FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 222 ~~i~~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..+....++ .+...++.+.+||.+||++||++|||+.|+++||||+.
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 333333221 11225677899999999999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-57 Score=483.62 Aligned_cols=259 Identities=31% Similarity=0.588 Sum_probs=234.7
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
..++++|++++.||+|+||+||+|+++.+|+.||+|++.+... ...+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 3456899999999999999999999999999999999976542 3346789999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC--CCeEEecCcchhhhhc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH--GNLKVSDFGLSALAES 161 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~--g~vkl~DFGla~~~~~ 161 (472)
|+|||||+||+|++++.. +.+++.+++.|++||+.||.|||++||+||||||+|||++.+ |.+||+|||+|+....
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999999999853 689999999999999999999999999999999999999854 8999999999987643
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCCCH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWFAP 237 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 237 (472)
. ....+.|||+.|||||++.+.+|. .++|||||||++|+|++|..||.+.+..+.+..+....+.++ ..+|+
T Consensus 310 ~---~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 310 K---QSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp T---SEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred C---CceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2 335678999999999999988875 899999999999999999999999999999999988876655 45899
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
++++||++||+.||.+|||+.|+|+||||+....
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 9999999999999999999999999999987544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-57 Score=452.09 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=214.3
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
-..+|.+.+.||+|+||+||+|++. .+++.||||+++... ....+.+.+|+.+|+.++|||||++++++.++
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3457899999999999999999875 368899999997543 34567899999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 012053 83 TKIYFVMEYVKGGELFGKVAK----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG 146 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g 146 (472)
+.+|+|||||++|+|.+++.. +++++.++..++.||+.||.|||+++|+||||||+||||+.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 999999999999999998753 3589999999999999999999999999999999999999999
Q ss_pred CeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHh
Q 012053 147 NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIG 225 (472)
Q Consensus 147 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~ 225 (472)
++||+|||+|+..............+||+.|||||++.+..|+ .++|||||||++|||+| |+.||.+.+..+....+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876544333334567899999999999888775 89999999999999999 999999988888888887
Q ss_pred cc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 226 KA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 226 ~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+ ....|..+++++.+||.+||+.||++|||+.||+++
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 65 467888899999999999999999999999999865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-57 Score=447.27 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=224.6
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
.+-.+.+++++.||+|+||+||+|+.. .+++.||||.++... .....+.+.+|+.+|++++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 456678999999999999999999864 467899999996543 2244578999999999999999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD 143 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld 143 (472)
+++.+|+|||||++|+|.+++.. +.+++.++.+++.||+.||.|||+++|+||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 99999999999999999998842 3589999999999999999999999999999999999999
Q ss_pred CCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHH
Q 012053 144 EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYR 222 (472)
Q Consensus 144 ~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~ 222 (472)
+++++||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+..+...
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999876554444445667899999999999888775 89999999999999998 899999998888888
Q ss_pred HHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 223 KIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 223 ~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+..+. .+.|..+++++.+|+.+||+.||++|||+.||+++
T Consensus 259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 887654 56788899999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-57 Score=445.76 Aligned_cols=253 Identities=23% Similarity=0.394 Sum_probs=206.8
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
++-.+++++++.||+|+||+||+|++. ..||||+++.... .....+.+.+|+.+|+.++|||||++++++.. +.+
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 455678899999999999999999863 3599999875443 23456789999999999999999999998854 568
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+|||||+||+|.+++.. +++++.++..++.||+.||.|||++||+||||||+||||++++++||+|||+|+......
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999999999999854 679999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccCCCCcccChhhhcccC--CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHH-HHhccC-----CCCCCCC
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRG--YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR-KIGKAE-----FKFPNWF 235 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~--~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~-~i~~~~-----~~~~~~~ 235 (472)
......+.+||+.|||||++.+.. ..+.++|||||||+||||+||+.||.+.+...... .+..+. ...+..+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 266 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence 334456779999999999996432 23589999999999999999999998865544333 333322 1345568
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++++.+||.+||+.||++|||+.||+++
T Consensus 267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 267 PKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999998765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-55 Score=438.13 Aligned_cols=261 Identities=41% Similarity=0.801 Sum_probs=241.2
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
....++|++++.||+|+||.||+|++..+|+.||||++.+.... ....+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 45678999999999999999999999999999999999876543 34567788999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||||++|++|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 167 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-- 167 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence 999999999999999865 78999999999999999999999999999999999999999999999999999765432
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~ 244 (472)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+..+.+..|..+++++.+||+
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 246 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 246 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 2356779999999999999888887899999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCcCChhhhhcCcccccCC
Q 012053 245 KILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+||..||.+|||++|+++||||+...
T Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 247 RFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999998643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-55 Score=442.87 Aligned_cols=255 Identities=24% Similarity=0.410 Sum_probs=217.9
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC-CCeeeEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKT-----GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH-PNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~ 79 (472)
++-.++|++++.||+|+||+||+|.+..+ ++.||||.+..... ....+.+.+|+.+|+.++| ||||++++++
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 45567999999999999999999998754 36899999976542 2345678999999999975 9999999998
Q ss_pred Ee-CCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 012053 80 AS-KTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLL 141 (472)
Q Consensus 80 ~~-~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NIL 141 (472)
.. ++.+|+|||||++|+|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 65 4679999999999999999853 34899999999999999999999999999999999999
Q ss_pred EcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcH-HH
Q 012053 142 LDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNL-ME 219 (472)
Q Consensus 142 ld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~-~~ 219 (472)
+++++.+||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+. ..
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999866443322223456899999999999888775 89999999999999998 9999988654 34
Q ss_pred HHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 220 MYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....+..+ .+..|..+++++.+||.+||+.||++|||+.+|++|
T Consensus 297 ~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 297 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 44455443 467888899999999999999999999999999988
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=436.93 Aligned_cols=261 Identities=32% Similarity=0.635 Sum_probs=231.9
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKT 83 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (472)
..+..++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 346678999999999999999999999999999999999876555555667888999999988 7999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999999865 78999999999999999999999999999999999999999999999999998753322
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~l 242 (472)
.....+.|||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+++.++......+|.++++++.+|
T Consensus 178 --~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 178 --GVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI 254 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred --CccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 1234567999999999999887775 8999999999999999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCcCCh------hhhhcCccccc
Q 012053 243 LSKILDPNPNTRISM------TKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~------~eil~hp~f~~ 268 (472)
|++||..||.+||++ .+|++||||+.
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 999999999999999 89999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-54 Score=430.74 Aligned_cols=259 Identities=36% Similarity=0.671 Sum_probs=236.9
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45789999999999999999999999999999999998765444455678899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--G 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--T
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC--C
Confidence 99999999999998865 68999999999999999999999999999999999999999999999999998753322 2
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
....+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......+|..+++++.+||.+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 234567899999999999887764 8999999999999999999999999999999999988999999999999999999
Q ss_pred ccCCCCCCcC-----ChhhhhcCccccc
Q 012053 246 ILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 246 ~L~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
||+.||.+|| ++++|++||||+.
T Consensus 239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 9999999999 8999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=434.83 Aligned_cols=260 Identities=41% Similarity=0.851 Sum_probs=234.2
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
...++|++++.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 46789999999999999999999999999999999998665443344567899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||+ +|+|.+++.. +++++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 999999 7788888754 789999999999999999999999999999999999999999999999999998654322
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
...+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+......+.++......+|..+++++.+||++
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 241 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRR 241 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 2456789999999999988877778999999999999999999999987766666666777778899999999999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
||..||.+|||++|+++||||+...
T Consensus 242 ~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 242 MIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp TSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HcCCChhHCcCHHHHHhChhhccCC
Confidence 9999999999999999999998643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=428.89 Aligned_cols=260 Identities=33% Similarity=0.630 Sum_probs=235.5
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTK 84 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (472)
.+..++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999999999999999999876544344567788999999876 89999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG- 171 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC-
Confidence 9999999999999999976 78999999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLL 243 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li 243 (472)
.....+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+...++..+......+|.++++++.+||
T Consensus 172 -~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (345)
T 1xjd_A 172 -DAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249 (345)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred -CCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHH
Confidence 1234567999999999999887765 89999999999999999999999999999999999999999999999999999
Q ss_pred hcccCCCCCCcCChh-hhhcCccccc
Q 012053 244 SKILDPNPNTRISMT-KIMENSWFRK 268 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~-eil~hp~f~~ 268 (472)
.+||..||.+||++. +|++||||+.
T Consensus 250 ~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHhcCCHhHcCCChHHHHcCccccC
Confidence 999999999999998 9999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=422.91 Aligned_cols=256 Identities=35% Similarity=0.754 Sum_probs=236.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45678999999999999999999999999999999998765444455678889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 99999999999999975 6899999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
...+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+.++......+|..+++++.+||.+
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred -ccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 23467899999999999887765 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCcC-----ChhhhhcCccccc
Q 012053 246 ILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 246 ~L~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
||..||.+|| ++++|++||||+.
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999 8999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=424.86 Aligned_cols=261 Identities=33% Similarity=0.601 Sum_probs=234.4
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV---GMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
+...+.++|++++.||+|+||+||+|++..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 345678899999999999999999999999999999999987653221 13577899999999999999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----CeEEecCcc
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG----NLKVSDFGL 155 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g----~vkl~DFGl 155 (472)
+.+.+|+||||++||+|++++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999999999975 6899999999999999999999999999999999999998877 799999999
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC---
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP--- 232 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~--- 232 (472)
+...... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+.+..+....+.++
T Consensus 166 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (361)
T 2yab_A 166 AHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241 (361)
T ss_dssp CEECCTT---CCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred ceEcCCC---CccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence 9865432 224567899999999999877764 899999999999999999999999999999999988877665
Q ss_pred -CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 233 -NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 -~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..+++++++||.+||..||.+|||+.|+++||||+.
T Consensus 242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 468999999999999999999999999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-53 Score=425.41 Aligned_cols=257 Identities=34% Similarity=0.701 Sum_probs=237.9
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
....++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45678999999999999999999999999999999999876654445567889999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 999999999999999976 78999999999999999999999999999999999999999999999999998865332
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~ 244 (472)
..+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+.++..+...+|..+++++.+||.
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred ---cccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 2456899999999999887765 899999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCcCC-----hhhhhcCccccc
Q 012053 245 KILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 245 ~~L~~dP~~Rpt-----~~eil~hp~f~~ 268 (472)
+||+.||.+||+ +++|++||||+.
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 999999999998 999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=419.43 Aligned_cols=262 Identities=37% Similarity=0.689 Sum_probs=225.7
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+.++|++++.||+|+||+||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 678999999999999999999999999999999999765432 234668899999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 9999999999999976 479999999999999999999999999999999999999999999999999998665444334
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhccCCCCC--CCCCHHHHHHH
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGKAEFKFP--NWFAPEVRRLL 243 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~l~~li 243 (472)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+ ..+++++.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 4556789999999999988877678899999999999999999999875543 33344433333333 44899999999
Q ss_pred hcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 244 SKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
.+||..||.+|||+.|+++||||++...
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHccCChhhCcCHHHHhhChhhccccc
Confidence 9999999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=426.09 Aligned_cols=261 Identities=30% Similarity=0.564 Sum_probs=235.3
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKT 83 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (472)
..+..++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|..+++.+ +||||+++++++.+.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 346678999999999999999999999999999999999876554445567888999999887 7999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999999876 78999999999999999999999999999999999999999999999999998753321
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~l 242 (472)
.....+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+++.++......+|..+++++.+|
T Consensus 175 --~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 175 --GVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 251 (353)
T ss_dssp --TCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred --CcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 1234567999999999999887774 8999999999999999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCcCC-----hhhhhcCccccc
Q 012053 243 LSKILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 243 i~~~L~~dP~~Rpt-----~~eil~hp~f~~ 268 (472)
|.+||..||.+||+ +++|++||||+.
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 99999999999995 599999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=420.88 Aligned_cols=260 Identities=32% Similarity=0.593 Sum_probs=233.1
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTK 84 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (472)
.+..++|++++.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 35578999999999999999999999999999999999887665556677889999999987 89999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~- 163 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 163 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC-
Confidence 9999999999999998875 78999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC---------CcHHHHHHHHhccCCCCCCC
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD---------SNLMEMYRKIGKAEFKFPNW 234 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~---------~~~~~~~~~i~~~~~~~~~~ 234 (472)
.....+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.. .....++..+......+|..
T Consensus 164 -~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 241 (345)
T 3a8x_A 164 -GDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241 (345)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred -CCcccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence 1234567999999999999887774 899999999999999999999975 33445677788888889999
Q ss_pred CCHHHHHHHhcccCCCCCCcCCh------hhhhcCccccc
Q 012053 235 FAPEVRRLLSKILDPNPNTRISM------TKIMENSWFRK 268 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~------~eil~hp~f~~ 268 (472)
+++++.+||.+||+.||.+||++ ++|++||||+.
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 99999999999999999999996 79999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=431.16 Aligned_cols=260 Identities=32% Similarity=0.592 Sum_probs=229.8
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTK 84 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (472)
.+-.++|++++.||+|+||+||+|++..+++.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 34567999999999999999999999999999999999887655545556788999999876 89999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+|+||||++||+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~- 206 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 206 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-
Confidence 9999999999999998875 78999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC---------cHHHHHHHHhccCCCCCCC
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS---------NLMEMYRKIGKAEFKFPNW 234 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~ 234 (472)
.....+.|||+.|+|||++.+..+. .++|||||||++|+|++|..||... ....++..+......+|..
T Consensus 207 -~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 207 -GDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp -TCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred -CCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 2235678999999999999888775 8999999999999999999999632 3345677888888999999
Q ss_pred CCHHHHHHHhcccCCCCCCcCCh------hhhhcCccccc
Q 012053 235 FAPEVRRLLSKILDPNPNTRISM------TKIMENSWFRK 268 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~------~eil~hp~f~~ 268 (472)
+++++++||++||+.||.+||++ ++|++||||+.
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 99999999999999999999995 79999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=409.45 Aligned_cols=262 Identities=35% Similarity=0.681 Sum_probs=224.4
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc-----------------------hhhHHHHHHHH
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK-----------------------VGMIDQIKREI 61 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----------------------~~~~~~~~~Ei 61 (472)
..+..++|++.+.||+|+||.||+|++..+|+.||||++.+..... ....+.+.+|+
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 3467899999999999999999999999999999999997654321 11235688999
Q ss_pred HHHHhcCCCCeeeEEEEEEe--CCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 012053 62 SVMRLVRHPNVVELYEVMAS--KTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPEN 139 (472)
Q Consensus 62 ~il~~l~hpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~N 139 (472)
.+|+.++||||+++++++.+ ...+|+||||+++++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999999999986 6789999999999999998888899999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCC--CCCcccchhhhHHHHHHhcCCCCCCCCcH
Q 012053 140 LLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY--DGSKADIWSCGVILYVLLAGYLPFHDSNL 217 (472)
Q Consensus 140 ILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~--~~~~~DiwSlGvil~~lltG~~Pf~~~~~ 217 (472)
||++.++.+||+|||++...... .......+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.+.
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999998765432 222345689999999999876542 35789999999999999999999999888
Q ss_pred HHHHHHHhccCCCCC--CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 218 MEMYRKIGKAEFKFP--NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 218 ~~~~~~i~~~~~~~~--~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
......+......+| ..+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 877777776665554 458999999999999999999999999999999963
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=422.16 Aligned_cols=261 Identities=35% Similarity=0.708 Sum_probs=232.1
Q ss_pred CcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
+.+..+.++|++++.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 22 NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEE 100 (362)
T ss_dssp --CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 44556778999999999999999999999999999999999876543 24457789999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---CeEEecCcchhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NLKVSDFGLSAL 158 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g---~vkl~DFGla~~ 158 (472)
+..|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999999999998865 6799999999999999999999999999999999999998654 599999999876
Q ss_pred hhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC----C
Q 012053 159 AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN----W 234 (472)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~----~ 234 (472)
.... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..+.+.+|. .
T Consensus 181 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (362)
T 2bdw_A 181 VNDS---EAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 256 (362)
T ss_dssp CTTC---CSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGG
T ss_pred ecCC---cccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 5432 223567899999999999877765 8999999999999999999999999988888888887766653 3
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+++++.+||.+||..||.+|||+.++++||||..
T Consensus 257 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 257 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 7999999999999999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=410.38 Aligned_cols=256 Identities=29% Similarity=0.501 Sum_probs=227.9
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..++|++++.||+|+||+||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 467899999999999999999999999999999999765432 34678899999999999999999999999999999
Q ss_pred EEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 88 VMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||||+.|++|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK 172 (297)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred EEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--cc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---CCCCCCCCCHHHHHHHh
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~l~~li~ 244 (472)
....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+... ....|..+++.+.+||.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence 3556899999999999887775 8999999999999999999999988776655544332 34456678999999999
Q ss_pred cccCCCCCCcCChhhhhcCcccccC
Q 012053 245 KILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+||+.||.+|||+.++++||||+..
T Consensus 252 ~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHccCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=424.58 Aligned_cols=263 Identities=28% Similarity=0.572 Sum_probs=235.8
Q ss_pred CcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
..+.+..++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 35678889999999999999999999999999999999999876655555667899999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+.+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999999999876 5899999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCcccccCCCCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCC---CcHHHHHHHHhccCCCCCCCCC
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHD---SNLMEMYRKIGKAEFKFPNWFA 236 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~---~~~~~~~~~i~~~~~~~~~~~s 236 (472)
.....+.+||+.|+|||++... ...+.++|||||||++|+|++|..||.. ......+..+......+|..++
T Consensus 168 ---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s 244 (384)
T 4fr4_A 168 ---ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244 (384)
T ss_dssp ---TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC
T ss_pred ---CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC
Confidence 2234677999999999998642 2234799999999999999999999974 3455677777788888999999
Q ss_pred HHHHHHHhcccCCCCCCcCC-hhhhhcCccccc
Q 012053 237 PEVRRLLSKILDPNPNTRIS-MTKIMENSWFRK 268 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt-~~eil~hp~f~~ 268 (472)
+++.+||.+||..||.+||+ ++++++||||+.
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 99999999999999999998 899999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=413.23 Aligned_cols=254 Identities=24% Similarity=0.497 Sum_probs=229.3
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+.++|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 5789999999999999999999999999999999987543 234678899999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCCeEEecCcchhhhhccc
Q 012053 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE--HGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~--~g~vkl~DFGla~~~~~~~ 163 (472)
||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999999975 36999999999999999999999999999999999999987 789999999998865432
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCCCHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWFAPEV 239 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~l 239 (472)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......++ ..+++++
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 158 --DNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred --CccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 22456689999999999977655 4899999999999999999999999998888888888777665 3689999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+||.+||..||.+|||+.|+++||||++.
T Consensus 235 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=431.51 Aligned_cols=262 Identities=32% Similarity=0.576 Sum_probs=230.9
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++++.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 34678999999999999999999999999999999997754333333456889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 87 FVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
+||||++||+|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|........ .
T Consensus 146 lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~ 224 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-V 224 (410)
T ss_dssp EEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-E
T ss_pred EEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-c
Confidence 999999999999999888999999999999999999999999999999999999999999999999999976543211 1
Q ss_pred cccccCCCCcccChhhhcccC---CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCC--CCCCHHH
Q 012053 167 LLHTTCGTPAYVAPEVINRRG---YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFP--NWFAPEV 239 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~---~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~l 239 (472)
...+.+||+.|+|||++.+.+ +.+.++|||||||++|+|++|..||.+.+....+.++.... ..+| ..+++++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence 234678999999999997655 13479999999999999999999999999999888887642 4444 4689999
Q ss_pred HHHHhcccCCCCCC--cCChhhhhcCcccccC
Q 012053 240 RRLLSKILDPNPNT--RISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~--Rpt~~eil~hp~f~~~ 269 (472)
++||.+||..+|.+ |++++||++||||+..
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999998 9999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=422.40 Aligned_cols=260 Identities=33% Similarity=0.590 Sum_probs=226.9
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV-MRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~ 84 (472)
.+..++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3566799999999999999999999999999999999988766554555667778777 577899999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+|+||||+.||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~- 192 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 192 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence 9999999999999998875 78999999999999999999999999999999999999999999999999998864322
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLL 243 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li 243 (472)
.....+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+++.++......++..+++++++||
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 193 -NSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp -CCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred -CCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 2234677999999999999887775 89999999999999999999999999999999999988899999999999999
Q ss_pred hcccCCCCCCcCCh----hhhhcCccccc
Q 012053 244 SKILDPNPNTRISM----TKIMENSWFRK 268 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~----~eil~hp~f~~ 268 (472)
.+||+.||.+||++ .+|++||||+.
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 99999999999997 58999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=431.65 Aligned_cols=261 Identities=35% Similarity=0.685 Sum_probs=231.1
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
.++.+.++|++++.||+|+||+||+|.+..+|+.||+|++.+.... ....+.+.+|+.+|+.++||||+++++++.+++
T Consensus 5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp --CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred ccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 3556788999999999999999999999999999999999876543 234567899999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCCeEEecCcchhhh
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD---EHGNLKVSDFGLSALA 159 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld---~~g~vkl~DFGla~~~ 159 (472)
..|+||||+.||+|++.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999999998865 6899999999999999999999999999999999999998 4678999999999765
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC----CC
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN----WF 235 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~----~~ 235 (472)
.... ......+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+....+..+..+.+.++. .+
T Consensus 164 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 164 EGEQ--QAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp CTTC--CBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred cCCC--ceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC
Confidence 4322 223567899999999999877765 8999999999999999999999999999999999888766553 47
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 241 s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 999999999999999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=402.65 Aligned_cols=262 Identities=36% Similarity=0.722 Sum_probs=234.7
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+.....++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp -CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 44567899999999999999999999999999999999997765444445678999999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
..|+||||+++++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999999998865 78999999999999999999999999999999999999999999999999998654332
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~l 242 (472)
. ....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+....+..+......+|..+++++.+|
T Consensus 163 ~----~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (279)
T 3fdn_A 163 R----RTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 237 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred c----ccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 2 245689999999999977665 48999999999999999999999999998999999888999999999999999
Q ss_pred HhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 243 LSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
|.+||+.||.+|||+.++++||||+...
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCc
Confidence 9999999999999999999999998743
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=414.03 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=196.4
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----E
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT----K 84 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 84 (472)
..+|.+.+.||+|+||+||+|++ +|+.||||+++.... .......|+..+..++|||||++++++..++ .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 45799999999999999999987 789999999975431 1122345666677899999999999997653 6
Q ss_pred EEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 85 IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR--------GVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~--------giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
+|+||||++||+|.+++..+++++..+.+++.|++.||.|||++ ||+||||||+|||||.++++||+|||+|
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 89999999999999999989999999999999999999999987 9999999999999999999999999999
Q ss_pred hhhhcccC--CCcccccCCCCcccChhhhcccCC-----CCCcccchhhhHHHHHHhcCCCCCCCC--------------
Q 012053 157 ALAESKHQ--DGLLHTTCGTPAYVAPEVINRRGY-----DGSKADIWSCGVILYVLLAGYLPFHDS-------------- 215 (472)
Q Consensus 157 ~~~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~-----~~~~~DiwSlGvil~~lltG~~Pf~~~-------------- 215 (472)
+....... .......+||+.|||||++.+... .+.++|||||||+||||+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 86544322 112345689999999999965421 236899999999999999997765321
Q ss_pred -cHHHHHHHHhccC--CCCCCC-----CCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 216 -NLMEMYRKIGKAE--FKFPNW-----FAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 216 -~~~~~~~~i~~~~--~~~~~~-----~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....+...+.... +.+|.. .+..+.+|+.+||+.||++|||+.||++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2233333333322 233432 22468899999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=418.45 Aligned_cols=264 Identities=31% Similarity=0.642 Sum_probs=225.2
Q ss_pred CCCcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch--hhHHHHHHHHHHHHhcCCCCeeeEEEE
Q 012053 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV--GMIDQIKREISVMRLVRHPNVVELYEV 78 (472)
Q Consensus 1 m~~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~ 78 (472)
|...+.++.++|++++.||+|+||+||+|.+..+|+.||||++........ ...+.+.+|+.+++.++||||++++++
T Consensus 15 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 94 (351)
T 3c0i_A 15 MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94 (351)
T ss_dssp -----CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCCCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 345566778899999999999999999999999999999999976442211 135778999999999999999999999
Q ss_pred EEeCCEEEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC---eEE
Q 012053 79 MASKTKIYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN---LKV 150 (472)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~---vkl 150 (472)
+.+++.+|+||||++|++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEE
Confidence 9999999999999999999887743 25899999999999999999999999999999999999987665 999
Q ss_pred ecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC
Q 012053 151 SDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK 230 (472)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~ 230 (472)
+|||++....... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.. ...+..+..+...
T Consensus 175 ~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 175 GGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYK 250 (351)
T ss_dssp CCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCC
T ss_pred ecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCC
Confidence 9999987654322 123456899999999999877764 89999999999999999999998754 4556666666655
Q ss_pred CC----CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 231 FP----NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 231 ~~----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.+ ..+++++.+||.+||..||++|||+.++++||||+.
T Consensus 251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 54 458999999999999999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=400.80 Aligned_cols=265 Identities=46% Similarity=0.877 Sum_probs=231.0
Q ss_pred CcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
..|.+..++|++++.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 46889999999999999999999999999999999999999766544445567899999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+..|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999999999865 6899999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRR 241 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~ 241 (472)
.. .....+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+....+..+.......|..+++++.+
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence 22 234567999999999998777666899999999999999999999999888888888888888889999999999
Q ss_pred HHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 242 LLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+|.+||+.||.+|||+.++++||||++..
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 99999999999999999999999998743
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=411.00 Aligned_cols=261 Identities=34% Similarity=0.632 Sum_probs=223.7
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVLK-VGMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
..+..++|++++.||+|+||+||+|++. .+|+.||+|++.+..... ......+.+|+.+|+.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 4567889999999999999999999986 689999999998764322 233456789999999999999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
+.+.+|+||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999875 78999999999999999999999999999999999999999999999999998754
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHH
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEV 239 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l 239 (472)
.... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+.++......+|..+++++
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 248 (327)
T 3a62_A 172 IHDG--TVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA 248 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred ccCC--ccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 3222 223567899999999999877764 8999999999999999999999999988888999888899999999999
Q ss_pred HHHHhcccCCCCCCcC-----ChhhhhcCccccc
Q 012053 240 RRLLSKILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
.+||.+||..||.+|| ++.++++||||+.
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 9999999999999999 7889999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=416.36 Aligned_cols=258 Identities=42% Similarity=0.754 Sum_probs=217.2
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
....++|++++.||+|+||+||+|++..+++.||||++...... .+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 34568999999999999999999999999999999999765433 25688999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC--eEEecCcchhhhhcc
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN--LKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~--vkl~DFGla~~~~~~ 162 (472)
|+||||+.||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999999998865 78999999999999999999999999999999999999988776 999999998743322
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc----HHHHHHHHhccCCCCCC--CCC
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN----LMEMYRKIGKAEFKFPN--WFA 236 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~----~~~~~~~i~~~~~~~~~--~~s 236 (472)
. .....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.. .......+......+|. .++
T Consensus 172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence 2 23456899999999999888887666999999999999999999998743 34555566666666665 479
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+++.+||.+||..||.+|||+.++++||||.+..
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 9999999999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=409.08 Aligned_cols=259 Identities=32% Similarity=0.612 Sum_probs=230.3
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV---GMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
..+.++|++++.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3466789999999999999999999999999999999977543221 1357799999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----CeEEecCcchh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG----NLKVSDFGLSA 157 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g----~vkl~DFGla~ 157 (472)
+..|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999999999865 6799999999999999999999999999999999999999888 79999999988
Q ss_pred hhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----C
Q 012053 158 LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----N 233 (472)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~ 233 (472)
...... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+....+......++ .
T Consensus 167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 167 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp ECCTTS---CCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred ECCCCC---ccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 654322 23556899999999999777664 899999999999999999999999888888877777666554 4
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 234 WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 58999999999999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=431.77 Aligned_cols=260 Identities=37% Similarity=0.664 Sum_probs=226.2
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999876544444556778999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|.......
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 999999999999998865 689999999999999999999998 999999999999999999999999999987543222
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLL 243 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li 243 (472)
......+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+....+..+......+|..+++++.+||
T Consensus 304 --~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 304 --ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred --cccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 234567899999999999887775 89999999999999999999999999999999999999999999999999999
Q ss_pred hcccCCCCCCcC-----ChhhhhcCccccc
Q 012053 244 SKILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 244 ~~~L~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
.+||+.||.+|| |++++++||||+.
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 999999999999 9999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=399.82 Aligned_cols=257 Identities=29% Similarity=0.466 Sum_probs=217.2
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++++.||+|+||+||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 4689999999999999999999999999999999986653 234557788999999999999999999999999999999
Q ss_pred EEecCCCcccchhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 89 MEYVKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|||+.++.+..+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 157 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--cc
Confidence 99998644443333 3689999999999999999999999999999999999999999999999999997654322 22
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCC-CCCCcHHHHHHHHhccC------------------
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLP-FHDSNLMEMYRKIGKAE------------------ 228 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~P-f~~~~~~~~~~~i~~~~------------------ 228 (472)
....+||+.|+|||++.+....+.++|||||||++|+|++|..| |...+.......+....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 35568999999999998776556899999999999999988887 45555555555543210
Q ss_pred -----------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 229 -----------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 229 -----------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
....+.+++++++||.+||+.||++|||++|+++||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 0122347899999999999999999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=427.90 Aligned_cols=261 Identities=27% Similarity=0.520 Sum_probs=228.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 45679999999999999999999999999999999998754433333445889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 87 FVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999999999999975 6899999999999999999999999999999999999999999999999999875533221
Q ss_pred CCcccccCCCCcccChhhhcc----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CCCCCC---CC
Q 012053 165 DGLLHTTCGTPAYVAPEVINR----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EFKFPN---WF 235 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~~~~~---~~ 235 (472)
......+||+.|+|||++.. .+..+.++|||||||++|+|++|+.||.+.+..+.+.++... .+.+|. .+
T Consensus 231 -~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 231 -VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp -EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred -cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 12234689999999999862 233458999999999999999999999999998888888653 345554 38
Q ss_pred CHHHHHHHhcccCCCCCC--cCChhhhhcCccccc
Q 012053 236 APEVRRLLSKILDPNPNT--RISMTKIMENSWFRK 268 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~--Rpt~~eil~hp~f~~ 268 (472)
++++++||++||..+|++ |++++|+++||||+.
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 999999999999998888 999999999999985
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=404.91 Aligned_cols=259 Identities=31% Similarity=0.463 Sum_probs=215.6
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
+..+.++|++++.||+|+||+||+|++. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+++.
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 4568899999999999999999999985 689999999976542 23445778899999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
+|+||||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999999975 77776654 46999999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc----C----------
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA----E---------- 228 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~----~---------- 228 (472)
. ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+... .
T Consensus 173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 2 22345689999999999977555568999999999999999999999876554444443220 0
Q ss_pred -------C---------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 229 -------F---------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 229 -------~---------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+ ...+.+++++.+||.+||+.||++|||++|+++||||++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 0 012346789999999999999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=397.08 Aligned_cols=261 Identities=35% Similarity=0.724 Sum_probs=235.7
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
++.+..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 45567889999999999999999999999999999999997665444444578899999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999999998865 68999999999999999999999999999999999999999999999999998654332
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRL 242 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~l 242 (472)
. ....+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+......+|..+++++.++
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred c----cccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHH
Confidence 2 2456899999999999877664 8999999999999999999999998888888888888888999999999999
Q ss_pred HhcccCCCCCCcCChhhhhcCcccccC
Q 012053 243 LSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
|.+||..||.+|||+.++++||||+..
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=397.77 Aligned_cols=255 Identities=32% Similarity=0.524 Sum_probs=215.0
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++++.||+|+||+||+|++ .+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999998 68999999999765432 23346788999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence 999976 88887764 679999999999999999999999999999999999999999999999999998764322 1
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--C----------------
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--E---------------- 228 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~---------------- 228 (472)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 2345689999999999976655568999999999999999999999988776655554321 0
Q ss_pred --C---------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 229 --F---------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 229 --~---------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+ .+...+++++.+||.+||+.||++|||++|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0 112347899999999999999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=418.01 Aligned_cols=262 Identities=29% Similarity=0.424 Sum_probs=212.9
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKT 83 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 83 (472)
+..+.++|++++.||+|+||.||+|.+..+|+.||||++.+... .......+.+|+.+|+.+. ||||+++++++...+
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 44678899999999999999999999999999999999865432 2344567889999999997 999999999997554
Q ss_pred --EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 --KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.+|+||||+. ++|...+..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred CCEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 7999999997 5899998888999999999999999999999999999999999999999999999999999976432
Q ss_pred c-------------------cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHH
Q 012053 162 K-------------------HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR 222 (472)
Q Consensus 162 ~-------------------~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~ 222 (472)
. .........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 111224556899999999999875555689999999999999999999999988777666
Q ss_pred HHhccCC-----------------------------------------------CCCCCCCHHHHHHHhcccCCCCCCcC
Q 012053 223 KIGKAEF-----------------------------------------------KFPNWFAPEVRRLLSKILDPNPNTRI 255 (472)
Q Consensus 223 ~i~~~~~-----------------------------------------------~~~~~~s~~l~~li~~~L~~dP~~Rp 255 (472)
.+..... ..+..+++++.+||.+||+.||++||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 6532100 01125789999999999999999999
Q ss_pred ChhhhhcCccccc
Q 012053 256 SMTKIMENSWFRK 268 (472)
Q Consensus 256 t~~eil~hp~f~~ 268 (472)
|++|+++||||+.
T Consensus 322 t~~e~l~Hp~~~~ 334 (388)
T 3oz6_A 322 SANDALKHPFVSI 334 (388)
T ss_dssp CHHHHTTSTTTTT
T ss_pred CHHHHhCCHHHHH
Confidence 9999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=402.49 Aligned_cols=262 Identities=34% Similarity=0.592 Sum_probs=238.5
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 45689999999999999999999999999999999987765555667889999999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||||+.+++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-- 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-- 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--
Confidence 9999999999998865 6899999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~ 246 (472)
.....+||+.|+|||++.+..+. .++||||||+++|+|++|..||......+.+..+......+|..+++++.+||.+|
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 275 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 23456799999999999877664 89999999999999999999999988888888888888889999999999999999
Q ss_pred cCCCCCCcCChhhhhcCcccccCCCC
Q 012053 247 LDPNPNTRISMTKIMENSWFRKGLVK 272 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~f~~~~~~ 272 (472)
|+.||++|||+.++++||||.....+
T Consensus 276 l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 276 LQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ccCChhHCcCHHHHhcCccccCCCcc
Confidence 99999999999999999999987653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=394.18 Aligned_cols=262 Identities=34% Similarity=0.590 Sum_probs=237.9
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
...++|++++.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45679999999999999999999999999999999998776555566778999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||+.+++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 99999999999998865 6899999999999999999999999999999999999999999999999999876543221
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
.....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+.+..+.......|..+++++.++|.+
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 171 -RKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp -CBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred -ccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 2345679999999999977665 48999999999999999999999999888888888888888999999999999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCCC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
||+.||++|||++++++||||.....
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HcccChhhCcCHHHHhhChheecCCc
Confidence 99999999999999999999987654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=392.58 Aligned_cols=260 Identities=35% Similarity=0.709 Sum_probs=231.5
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
++.+.++|++++.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 s~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (284)
T 3kk8_A 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 79 (284)
T ss_dssp CCTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CchhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE
Confidence 356789999999999999999999999999999999999876543 3445778899999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC---eEEecCcchhhhh
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN---LKVSDFGLSALAE 160 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~---vkl~DFGla~~~~ 160 (472)
.|+||||+.|++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999999888765 67999999999999999999999999999999999999987665 9999999987654
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCCC
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWFA 236 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s 236 (472)
... ......||+.|+|||++.+..+. .++||||||+++|+|++|..||.+.+.......+.......| ..++
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T 3kk8_A 160 DSE---AWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235 (284)
T ss_dssp SSC---BCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred cCc---cccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccC
Confidence 322 23456899999999999877664 899999999999999999999999988888888877766554 3579
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+++.+||.+||+.||.+|||+.++++||||++.
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 999999999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=428.82 Aligned_cols=261 Identities=35% Similarity=0.666 Sum_probs=234.3
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
.+.++.++|++++.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+.+
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45678889999999999999999999999999999999998776554455688999999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCCeEEecCcchhhh
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALA 159 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl---d~~g~vkl~DFGla~~~ 159 (472)
.+|+||||+.|++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999998865 689999999999999999999999999999999999999 56789999999999866
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCC
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWF 235 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~ 235 (472)
... ......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..+....+..+.+.++ ..+
T Consensus 180 ~~~---~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 180 EAS---KKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp CCC---CSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred ccc---cccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence 432 23456789999999999875 44 4899999999999999999999999999888888887765543 348
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
++++++||++||+.||.+|||+.++++||||+..
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=421.18 Aligned_cols=260 Identities=28% Similarity=0.524 Sum_probs=226.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 45679999999999999999999999999999999998754433344556889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 87 FVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||++||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++........
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 99999999999999975 4799999999999999999999999999999999999999999999999999876543221
Q ss_pred CCcccccCCCCcccChhhhcc------cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCC---C
Q 012053 165 DGLLHTTCGTPAYVAPEVINR------RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFP---N 233 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~------~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~---~ 233 (472)
......+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+..+.+.++.... ..+| .
T Consensus 218 -~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 218 -VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp -EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred -cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 11235689999999999873 2223589999999999999999999999999888888886532 3344 5
Q ss_pred CCCHHHHHHHhcccCCCCCCc---CChhhhhcCccccc
Q 012053 234 WFAPEVRRLLSKILDPNPNTR---ISMTKIMENSWFRK 268 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~R---pt~~eil~hp~f~~ 268 (472)
.+++++++||++||. +|.+| +++++|++||||+.
T Consensus 297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 699999999999999 99998 59999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=411.51 Aligned_cols=255 Identities=35% Similarity=0.666 Sum_probs=221.8
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASK 82 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 82 (472)
++..+.++|++++.||+|+||+||+|.+..+|+.||||++.+.... ..+|+.++.++ +||||+++++++.+.
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp ---CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 4556778999999999999999999999999999999999776432 34788888887 799999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-C---CeEEecCcchh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-G---NLKVSDFGLSA 157 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~-g---~vkl~DFGla~ 157 (472)
+.+|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+..+ + .+||+|||++.
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 999999999999999998865 679999999999999999999999999999999999998443 3 49999999988
Q ss_pred hhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC---CcHHHHHHHHhccCCCCC--
Q 012053 158 LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD---SNLMEMYRKIGKAEFKFP-- 232 (472)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~---~~~~~~~~~i~~~~~~~~-- 232 (472)
..... .....+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.. ....++...+..+.+.++
T Consensus 169 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 169 QLRAE--NGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245 (342)
T ss_dssp ECBCT--TCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST
T ss_pred cCcCC--CCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc
Confidence 65432 2334577999999999999877665 799999999999999999999985 456677788877776654
Q ss_pred --CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 233 --NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 --~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..+++++++||++||..||.+|||+.++++||||..
T Consensus 246 ~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 458999999999999999999999999999999965
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=412.59 Aligned_cols=260 Identities=24% Similarity=0.425 Sum_probs=218.0
Q ss_pred cCCEEEEeeEccc--CCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 9 MQRYELGRLLGQG--TFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 9 ~~~y~i~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
.++|++++.||+| +||+||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 5689999999999 9999999999999999999999876543 355678899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 87 FVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 99999999999999864 579999999999999999999999999999999999999999999999999876443211
Q ss_pred -----CCCcccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--------
Q 012053 164 -----QDGLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-------- 228 (472)
Q Consensus 164 -----~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-------- 228 (472)
........+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+.......+....
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 1122234589999999999976 344 489999999999999999999998755443333222111
Q ss_pred --------------------------------------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 229 --------------------------------------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 229 --------------------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
...+..+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 123455789999999999999999999999999999998743
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=432.33 Aligned_cols=260 Identities=28% Similarity=0.478 Sum_probs=233.0
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
+.+..++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 44667899999999999999999999999999999999987655444556778899999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 85 IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999998865 2499999999999999999999999999999999999999999999999999976543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC----cHHHHHHHHhccCCCCCCCCCH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS----NLMEMYRKIGKAEFKFPNWFAP 237 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~ 237 (472)
. ......+||+.|+|||++.+..|. .++|||||||++|+|++|..||... ....+...+......+|..+++
T Consensus 339 ~---~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~ 414 (576)
T 2acx_A 339 G---QTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414 (576)
T ss_dssp T---CCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred C---ccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCH
Confidence 2 224567999999999999877765 8999999999999999999999875 3456677777778888899999
Q ss_pred HHHHHHhcccCCCCCCcC-----ChhhhhcCccccc
Q 012053 238 EVRRLLSKILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
++++||.+||..||.+|| +++||++||||+.
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 999999999999999999 7899999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=398.59 Aligned_cols=261 Identities=30% Similarity=0.436 Sum_probs=213.2
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhcC---CCCeeeEEEE
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--KVGMIDQIKREISVMRLVR---HPNVVELYEV 78 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~ 78 (472)
-|+++.++|++++.||+|+||+||+|++..+|+.||+|++...... .......+.+|+.+++.++ ||||++++++
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 3778899999999999999999999999999999999999754321 1122345678888877765 9999999999
Q ss_pred EEeCC-----EEEEEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEE
Q 012053 79 MASKT-----KIYFVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 79 ~~~~~-----~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl 150 (472)
+.... .+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEE
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEE
Confidence 97765 6899999997 5898888653 3999999999999999999999999999999999999999999999
Q ss_pred ecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-
Q 012053 151 SDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF- 229 (472)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~- 229 (472)
+|||++...... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+......++.....
T Consensus 162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred eeCccccccCCC---cccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999865432 223567899999999999877765 899999999999999999999999887776666543110
Q ss_pred ----C----------------------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 230 ----K----------------------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 230 ----~----------------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
. ..+.+++++.+||.+||+.||++|||+.|+++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 0 113478899999999999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=442.72 Aligned_cols=259 Identities=30% Similarity=0.569 Sum_probs=236.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (472)
+..++|++++.||+|+||+||+|++..+++.||||++.+.........+.+.+|..+|..+ +||||+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4567899999999999999999999999999999999876544445567788999999887 799999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
|+||||++||+|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-- 495 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-- 495 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT--
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC--
Confidence 999999999999999976 78999999999999999999999999999999999999999999999999998753322
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLS 244 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~ 244 (472)
.....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+++..|......+|..+++++.+||+
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 2234677999999999999888775 899999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCcCCh-----hhhhcCccccc
Q 012053 245 KILDPNPNTRISM-----TKIMENSWFRK 268 (472)
Q Consensus 245 ~~L~~dP~~Rpt~-----~eil~hp~f~~ 268 (472)
+||+.||.+||++ ++|++||||+.
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 9999999999998 99999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=403.88 Aligned_cols=257 Identities=29% Similarity=0.479 Sum_probs=206.4
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 4689999999999999999999999999999999976542 22346788999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 89 MEYVKGGELFGKVAK-------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
|||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99998 488887753 3599999999999999999999999999999999999999999999999999886543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------- 228 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------- 228 (472)
.. ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 161 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 161 PV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp CC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred Cc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 22 223456899999999999775545689999999999999999999999888776665553210
Q ss_pred ---------------------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 229 ---------------------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 229 ---------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
...+..+++++.+||.+||+.||++|||+.|+++||||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 011224788999999999999999999999999999998744
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=396.51 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=215.7
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
++++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 46899999999999999999999999999999999866542 23445678899999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 157 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--D 157 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--c
Confidence 9999999999888765 679999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------------
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------- 227 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------- 227 (472)
.....+||+.|+|||++.+....+.++||||||+++|+|++|..||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 2345689999999999977555568999999999999999999999988766554443221
Q ss_pred --CCCCC----------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 --EFKFP----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 --~~~~~----------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
....+ +.+++++.+||.+||+.||.+|||++++++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 00001 3478899999999999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=394.76 Aligned_cols=258 Identities=33% Similarity=0.705 Sum_probs=206.8
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999999999999999999766544444567899999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-- 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence 999999999999875 5799999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~ 246 (472)
.....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+.......|..+++++.++|.+|
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHH
Confidence 1235679999999999877665 489999999999999999999998877666666666667778888999999999999
Q ss_pred cCCCCCCcCChhhhhcCcccccC
Q 012053 247 LDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
|+.||++|||++++++||||...
T Consensus 247 l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp SCSSGGGSCCHHHHTTSTTTC--
T ss_pred cccCHhhCCCHHHHhcCccccCC
Confidence 99999999999999999999763
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=406.13 Aligned_cols=254 Identities=25% Similarity=0.438 Sum_probs=220.7
Q ss_pred CcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-----CCCeeeEEE
Q 012053 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-----HPNVVELYE 77 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~ 77 (472)
.+|.++.++|++++.||+|+||+||+|++..+++.||||++.... .......+|+.+++.+. ||||+++++
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 468899999999999999999999999999999999999996532 33466788999999996 999999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC----------
Q 012053 78 VMASKTKIYFVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE---------- 144 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~---------- 144 (472)
++...+..|+||||+ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 999999999999999 99999998753 5999999999999999999999999999999999999975
Q ss_pred ---------------CCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCC
Q 012053 145 ---------------HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGY 209 (472)
Q Consensus 145 ---------------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~ 209 (472)
++.+||+|||+|...... ....+||+.|+|||++.+..+. .++|||||||++|+|++|.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSS
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCC
Confidence 788999999998754322 2456899999999999887765 8999999999999999999
Q ss_pred CCCCCCcHHHHHHHHhccCCCCCC----------------------------------------------CCCHHHHHHH
Q 012053 210 LPFHDSNLMEMYRKIGKAEFKFPN----------------------------------------------WFAPEVRRLL 243 (472)
Q Consensus 210 ~Pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~s~~l~~li 243 (472)
.||...+..+....+.......|. ..++.+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 999988777666555433222221 1237788999
Q ss_pred hcccCCCCCCcCChhhhhcCcccc
Q 012053 244 SKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
.+||+.||.+|||++|+|+||||+
T Consensus 337 ~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999995
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=423.73 Aligned_cols=261 Identities=34% Similarity=0.640 Sum_probs=228.9
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch----------hhHHHHHHHHHHHHhcCCCCeee
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV----------GMIDQIKREISVMRLVRHPNVVE 74 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~hpnIv~ 74 (472)
+..+.++|++++.||+|+||+||+|.+..+++.||+|++.+...... ...+.+.+|+.+|+.++||||++
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 44578899999999999999999999999999999999987643321 34577899999999999999999
Q ss_pred EEEEEEeCCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---CeEE
Q 012053 75 LYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NLKV 150 (472)
Q Consensus 75 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g---~vkl 150 (472)
+++++.+...+|+||||++||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999999998865 7899999999999999999999999999999999999999876 6999
Q ss_pred ecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC
Q 012053 151 SDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK 230 (472)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~ 230 (472)
+|||++...... ......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..+....+..+.+.
T Consensus 191 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 191 VDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp CCCTTCEECCTT---SCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EECCCCEEcCCC---CccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999865432 22456789999999999864 34 58999999999999999999999999999999999888776
Q ss_pred CC----CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 231 FP----NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 231 ~~----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
++ ..+++++++||++||+.||.+|||+.|+++||||++..
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 65 46899999999999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=388.76 Aligned_cols=262 Identities=37% Similarity=0.684 Sum_probs=227.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+.++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 567999999999999999999999999999999999765432 345788999999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999999999976 579999999999999999999999999999999999999999999999999988654433333
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhccCCCC--CCCCCHHHHHHH
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGKAEFKF--PNWFAPEVRRLL 243 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~--~~~~s~~l~~li 243 (472)
.....+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...... ..+..+....... ...+++++.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 3456789999999999987777667899999999999999999999875442 3334443333222 235899999999
Q ss_pred hcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 244 SKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
.+||+.||.+|||++++++||||++...
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChhh
Confidence 9999999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=407.89 Aligned_cols=256 Identities=27% Similarity=0.565 Sum_probs=227.2
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+.++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.+...+|+
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 45799999999999999999999999999999999976542 234578899999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCCeEEecCcchhhhhccc
Q 012053 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE--HGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~--~g~vkl~DFGla~~~~~~~ 163 (472)
||||+.|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 9999999999999865 37999999999999999999999999999999999999974 467999999998865432
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCCCHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWFAPEV 239 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~l 239 (472)
......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+......++ ..+++++
T Consensus 205 --~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 281 (387)
T 1kob_A 205 --EIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 281 (387)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred --cceeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 224556899999999999877664 899999999999999999999999888888888877655443 3579999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
.+||.+||..||.+|||+.++++||||+...
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 9999999999999999999999999998643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=389.15 Aligned_cols=256 Identities=39% Similarity=0.704 Sum_probs=230.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
-+.++|++.+.||+|+||.||+|.+..++..||+|.+.+... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 367789999999999999999999999999999999976543 23577899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCCeEEecCcchhhhhcc
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl---d~~g~vkl~DFGla~~~~~~ 162 (472)
+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999999988865 679999999999999999999999999999999999999 78889999999998765432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC----CCCHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN----WFAPE 238 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~ 238 (472)
......+||+.|+|||++.+. .+.++||||||+++|+|++|..||...+.......+.......|. .++++
T Consensus 163 ---~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 163 ---KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp ---SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred ---cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 223566899999999998654 458999999999999999999999999888888888888777764 58999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+.+||.+||+.||.+|||+.++++||||++..
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999999999998743
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=397.86 Aligned_cols=261 Identities=33% Similarity=0.595 Sum_probs=231.8
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV---GMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
++..+.++|++++.||+|+||.||+|++..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 85 (321)
T 2a2a_A 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85 (321)
T ss_dssp BCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 345678899999999999999999999999999999999976543221 13577899999999999999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----CeEEecCcc
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG----NLKVSDFGL 155 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g----~vkl~DFGl 155 (472)
+.+..|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999999999875 5799999999999999999999999999999999999999888 799999999
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC---
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP--- 232 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~--- 232 (472)
+....... .....+||+.|+|||++.+..+. .++||||||+++|+|++|..||.+.+..+....+......++
T Consensus 166 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (321)
T 2a2a_A 166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241 (321)
T ss_dssp CEECCTTC---CCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred ceecCccc---cccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh
Confidence 87654322 23456799999999999876664 899999999999999999999999888888888877666554
Q ss_pred -CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 233 -NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 -~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus 242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 468999999999999999999999999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=402.36 Aligned_cols=261 Identities=30% Similarity=0.433 Sum_probs=211.5
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
+....++|++++.||+|+||+||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 456788999999999999999999999999999999999765432 2345667899999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-----CCCCeEEecCcchhh
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD-----EHGNLKVSDFGLSAL 158 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld-----~~g~vkl~DFGla~~ 158 (472)
+|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999975 89888865 5799999999999999999999999999999999999994 445599999999987
Q ss_pred hhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--C-------
Q 012053 159 AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--F------- 229 (472)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~------- 229 (472)
..... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+......++.... .
T Consensus 187 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 187 FGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 64332 223456789999999999876655689999999999999999999999887776665553210 0
Q ss_pred --CCCC-------------------CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 230 --KFPN-------------------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 230 --~~~~-------------------~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
..+. .+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 0011 167899999999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=426.53 Aligned_cols=259 Identities=27% Similarity=0.449 Sum_probs=232.2
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 55679999999999999999999999999999999998766544455678899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 87 FVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+||||++||+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999988754 3699999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC----cHHHHHHHHhccCCCCCCCCCH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS----NLMEMYRKIGKAEFKFPNWFAP 237 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~ 237 (472)
.. ......+||+.|+|||++.+.+|. .++|||||||++|+|++|..||... ....++..+......+|..+++
T Consensus 342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 418 (543)
T 3c4z_A 342 GQ--TKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418 (543)
T ss_dssp TC--CCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred CC--cccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence 22 123456999999999999887775 8999999999999999999999875 4467777888888889999999
Q ss_pred HHHHHHhcccCCCCCCcCC-----hhhhhcCccccc
Q 012053 238 EVRRLLSKILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt-----~~eil~hp~f~~ 268 (472)
++.+||.+||..||.+||+ +++|++||||+.
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 9999999999999999996 488999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=397.69 Aligned_cols=262 Identities=29% Similarity=0.521 Sum_probs=226.3
Q ss_pred CcCCcccCCEEEE-eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q 012053 3 NKGSILMQRYELG-RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMA 80 (472)
Q Consensus 3 ~~g~~l~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 80 (472)
+.+..+.++|.+. +.||+|+||.||+|.+..+|+.||+|++.+..... .....+.+|+.+++.+. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 3455678899998 89999999999999999999999999998654332 34577889999999985 699999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCCeEEecCc
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE---HGNLKVSDFG 154 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~---~g~vkl~DFG 154 (472)
..+..|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 99999999999999999999854 57999999999999999999999999999999999999998 7899999999
Q ss_pred chhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC--
Q 012053 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP-- 232 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~-- 232 (472)
++....... .....+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+....+..+.......+
T Consensus 180 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 180 MSRKIGHAC---ELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cccccCCcc---ccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence 998654322 23456899999999999877665 899999999999999999999999888887777766554433
Q ss_pred --CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 233 --NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 233 --~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
..+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 3588999999999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=401.86 Aligned_cols=255 Identities=38% Similarity=0.721 Sum_probs=205.0
Q ss_pred CcccCCEEEE---eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEe
Q 012053 6 SILMQRYELG---RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMAS 81 (472)
Q Consensus 6 ~~l~~~y~i~---~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 81 (472)
+.+.++|++. +.||+|+||+||+|.+..+|+.||||++.+. ....+.+|+.+++.+. ||||+++++++.+
T Consensus 4 ~~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp CHHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CcchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 3456789986 8899999999999999999999999999654 2356789999999997 9999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---CeEEecCcchh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NLKVSDFGLSA 157 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g---~vkl~DFGla~ 157 (472)
+...|+||||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 9999999999999999999875 5799999999999999999999999999999999999998766 79999999987
Q ss_pred hhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc-------HHHHHHHHhccCCC
Q 012053 158 LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN-------LMEMYRKIGKAEFK 230 (472)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-------~~~~~~~i~~~~~~ 230 (472)
...... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+ ..+....+..+.+.
T Consensus 158 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 158 LKPPDN--QPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234 (325)
T ss_dssp ECCC------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC
T ss_pred ecCCCC--CcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC
Confidence 654322 234567899999999999887775 89999999999999999999997643 35667777777766
Q ss_pred CCC----CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 231 FPN----WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 231 ~~~----~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
++. .+++++++||.+||+.||.+|||+.++++||||+..
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 653 489999999999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=401.39 Aligned_cols=256 Identities=34% Similarity=0.638 Sum_probs=209.0
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
...+.++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 122 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE 122 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence 3456788999999999999999999999999999999997653 23567899999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCCeEEecCcchhhhh
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE---HGNLKVSDFGLSALAE 160 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~---~g~vkl~DFGla~~~~ 160 (472)
.|+||||+.|++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999999998865 57999999999999999999999999999999999999975 8899999999998654
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhccCCCCC----CCC
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGKAEFKFP----NWF 235 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~ 235 (472)
... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.... ..+..+.......+ ..+
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 278 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhC
Confidence 322 23466899999999999877664 8999999999999999999999876544 46666666554433 357
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
++++.+||.+||..||++|||+.++++||||...
T Consensus 279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 8999999999999999999999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=421.82 Aligned_cols=257 Identities=37% Similarity=0.676 Sum_probs=223.1
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
..+.++|++++.||+|+||+||+|++..++..||+|++.+..... .....+.+|+.+++.++||||+++++++.+...+
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 345668999999999999999999999999999999998765332 2346788999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CCeEEecCcchhhhhc
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH---GNLKVSDFGLSALAES 161 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~---g~vkl~DFGla~~~~~ 161 (472)
|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999999988865 789999999999999999999999999999999999999764 4599999999986643
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCCCH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWFAP 237 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 237 (472)
.. .....+||+.|+|||++.+ .| +.++|||||||++|+|++|..||.+.+..+....+..+.+.++ ..+++
T Consensus 192 ~~---~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 192 QK---KMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp TB---CBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred Cc---cccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence 22 2456789999999999864 44 4899999999999999999999999999998888888766554 34899
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
++++||.+||+.||.+|||+.++++||||++
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 9999999999999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=420.97 Aligned_cols=256 Identities=28% Similarity=0.454 Sum_probs=212.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK---- 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (472)
.+.++|++++.||+|+||+||+|++..+|+.||||++.+... .......+.+|+.+|+.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 457899999999999999999999999999999999976532 334567888999999999999999999999544
Q ss_pred --CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 --TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
..+|+||||+.++ |.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 138 ~~~~~~lv~E~~~~~-l~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 138 EFQDVYLVMELMDAN-LCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp TCCEEEEEEECCSEE-HHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred cCCeEEEEEeCCCCC-HHHHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 5789999999765 555554 359999999999999999999999999999999999999999999999999998664
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-----------
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF----------- 229 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~----------- 229 (472)
.. ......+||+.|+|||++.+..|. .++|||||||++|+|++|+.||.+.+..+.+.++.....
T Consensus 216 ~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 TS---FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp -C---CCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred CC---cccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 32 234567899999999999888776 899999999999999999999999887766666543110
Q ss_pred ----------------CC----CCC-----------CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 230 ----------------KF----PNW-----------FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 230 ----------------~~----~~~-----------~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+ |.. .++++++||.+||+.||++|||++|+|+||||+..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 00 100 15679999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=394.04 Aligned_cols=253 Identities=28% Similarity=0.519 Sum_probs=224.5
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
.|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 48899999999999999999999999999999976542 335678899999999999999999999999999999999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccc
Q 012053 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~ 170 (472)
|++|++|.+++...++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 200 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKS 200 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--cccc
Confidence 99999999999888999999999999999999999999999999999999999999999999999876543221 2345
Q ss_pred cCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---CCCCCCCHHHHHHHhccc
Q 012053 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF---KFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 171 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~l~~li~~~L 247 (472)
.+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..... ..+..+++++.++|.+||
T Consensus 201 ~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred ccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 6899999999999776664 899999999999999999999998887777766655432 223457899999999999
Q ss_pred CCCCCCcCChhhhhcCcccccC
Q 012053 248 DPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 248 ~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+.||++|||+.++++||||.+.
T Consensus 280 ~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 280 VRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp CSSTTTSCCHHHHHTSGGGGGC
T ss_pred cCChhhCcCHHHHhcChhhccC
Confidence 9999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=388.35 Aligned_cols=255 Identities=35% Similarity=0.666 Sum_probs=219.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
.+.++|++.+.||+|+||+||+|.+..++..||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 3667899999999999999999999999999999999776422 33578899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCCeEEecCcchhh
Q 012053 87 FVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSAL 158 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl---d~~g~vkl~DFGla~~ 158 (472)
+||||+++++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999999988742 579999999999999999999999999999999999999 4567899999999976
Q ss_pred hhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC---CCC
Q 012053 159 AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP---NWF 235 (472)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~~ 235 (472)
..... .....+||+.|+|||++.+ .+ +.++||||||+++|+|++|..||.+.+.......+.......+ ..+
T Consensus 177 ~~~~~---~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (285)
T 3is5_A 177 FKSDE---HSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL 251 (285)
T ss_dssp -------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCC
T ss_pred cCCcc---cCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcC
Confidence 54322 2345689999999999853 34 5899999999999999999999999888777766655544333 337
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
++++.+||.+||+.||++|||+.|+++||||++
T Consensus 252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 899999999999999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=401.45 Aligned_cols=262 Identities=35% Similarity=0.600 Sum_probs=221.7
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--KVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
+.++|++++.||+|+||+||+|.+..+++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 357999999999999999999999999999999999765432 234567899999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc-----------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q 012053 86 YFVMEYVKGGELFGKVAK-----------------------------------------GKLKEDAARKYFQQLISAVDY 124 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----------------------------------------~~l~e~~~~~i~~ql~~al~y 124 (472)
|+||||++||+|.+++.. ..+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999999999888741 124678899999999999999
Q ss_pred HHhCCceecCCCCCcEEEcCCC--CeEEecCcchhhhhcccCCC--cccccCCCCcccChhhhccc-CCCCCcccchhhh
Q 012053 125 CHSRGVCHRDLKPENLLLDEHG--NLKVSDFGLSALAESKHQDG--LLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCG 199 (472)
Q Consensus 125 LH~~giiHrDIKp~NILld~~g--~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlG 199 (472)
||++||+||||||+|||++.++ .+||+|||++.......... .....+||+.|+|||++.+. ...+.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 9999999999999999998777 89999999998654322211 23466899999999998652 3345899999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC----CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 200 VILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN----WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 200 vil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
|++|+|++|..||...+..+....+......++. .+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 9999999999999998888777777666544432 378999999999999999999999999999999863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=389.86 Aligned_cols=262 Identities=25% Similarity=0.413 Sum_probs=222.4
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
-|.++.++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 47889999999999999999999999999999999999997766555566788999999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.+|+||||++|++|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999999999875 68999999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-----CCCCCCCH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-----KFPNWFAP 237 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~s~ 237 (472)
.. ......+||+.|+|||++.+..++ .++||||||+++|+|++|..||.+.+......+...... ..+..+++
T Consensus 165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 165 SL-TQTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred cc-cccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 21 123456799999999999877664 889999999999999999999998877665544443332 23456899
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
.+.++|.+||..||.+||+..+.+.+.|..
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 999999999999999999666666666653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=420.49 Aligned_cols=259 Identities=33% Similarity=0.654 Sum_probs=227.5
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
.+.++|++++.||+|+||+||+|++..+|+.||||++.+..... .....+.+|+.+|+.++||||+++++++.+...+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 36779999999999999999999999999999999997654322 34577899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCCeEEecCcchhhhhcc
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD---EHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld---~~g~vkl~DFGla~~~~~~ 162 (472)
+||||+.|++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999999999988864 7899999999999999999999999999999999999995 4567999999999865432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCCCHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWFAPE 238 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~ 238 (472)
......+||+.|+|||++.+. | +.++|||||||++|+|++|..||.+.+..+....+..+.+.++ ..++++
T Consensus 178 ---~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 178 ---TKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp -------CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred ---CccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence 224567899999999998753 4 4899999999999999999999999999888888887765443 248999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
+++||.+||..||.+|||+.++++||||++...
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 999999999999999999999999999987543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=406.59 Aligned_cols=254 Identities=32% Similarity=0.547 Sum_probs=222.9
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV-----GMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
+.++|++++.||+|+||+||+|++..+++.||||++.+...... .....+.+|+.+|+.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 56789999999999999999999999999999999987653221 1234567899999999999999999999999
Q ss_pred CEEEEEEEecCCC-cccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGG-ELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg-~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
+.+|+||||+.+| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999998766 99998876 579999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVR 240 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~ 240 (472)
.. ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... ........|..+++++.
T Consensus 182 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~l~ 252 (335)
T 3dls_A 182 RG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKELM 252 (335)
T ss_dssp TT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHHHH
T ss_pred CC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHHHH
Confidence 32 2245678999999999998888767899999999999999999999976332 23444566777999999
Q ss_pred HHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 241 RLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+||.+||++||.+|||+.++++||||++..
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 999999999999999999999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=408.74 Aligned_cols=252 Identities=33% Similarity=0.642 Sum_probs=208.9
Q ss_pred cccCCEEEE-eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhcCCCCeeeEEEEEEe---
Q 012053 7 ILMQRYELG-RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVVELYEVMAS--- 81 (472)
Q Consensus 7 ~l~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~--- 81 (472)
.+.++|.+. +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 345678776 7999999999999999999999999998643 3567888887 55689999999999876
Q ss_pred -CCEEEEEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCCeEEecCc
Q 012053 82 -KTKIYFVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE---HGNLKVSDFG 154 (472)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~---~g~vkl~DFG 154 (472)
...+|+||||+.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 67899999999999999999752 5999999999999999999999999999999999999998 7889999999
Q ss_pred chhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH----HHHHHHhccCCC
Q 012053 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM----EMYRKIGKAEFK 230 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~----~~~~~i~~~~~~ 230 (472)
++...... ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||...+.. .....+..+.+.
T Consensus 210 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 210 FAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred cccccCCC---CccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence 98855432 224567899999999999877765 8999999999999999999999765432 234455555555
Q ss_pred CC----CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 231 FP----NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 231 ~~----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
++ ..+++++.+||++||..||.+|||+.++++||||....
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 44 34899999999999999999999999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=385.58 Aligned_cols=259 Identities=34% Similarity=0.646 Sum_probs=226.5
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV---GMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
++.++|++++.||+|+||.||+|++..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 567899999999999999999999999999999999976643321 13578999999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----CeEEecCcchhh
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG----NLKVSDFGLSAL 158 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g----~vkl~DFGla~~ 158 (472)
..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999999999865 6899999999999999999999999999999999999998877 799999999876
Q ss_pred hhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CC
Q 012053 159 AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NW 234 (472)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~ 234 (472)
..... ......||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.......+ ..
T Consensus 162 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 162 IEAGN---EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp CC-----------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ccCCC---cccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 54322 23456799999999999776664 899999999999999999999999888888777776665544 46
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 88999999999999999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=398.93 Aligned_cols=267 Identities=27% Similarity=0.458 Sum_probs=223.4
Q ss_pred CCcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012053 2 ENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 2 ~~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
......+.++|++++.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp CCCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred CCCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 34556789999999999999999999999999999999999987665555667789999999999999999999999865
Q ss_pred CC----EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 82 KT----KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 82 ~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
.. ..|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 43 45999999999999999865 78999999999999999999999999999999999999999999999999999
Q ss_pred hhhhcccCC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC----
Q 012053 157 ALAESKHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF---- 231 (472)
Q Consensus 157 ~~~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~---- 231 (472)
......... ......+||+.|+|||++.+..++ .++||||||+++|+|++|..||...+.......+.......
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence 865433221 123345799999999999877665 89999999999999999999999988776665555444332
Q ss_pred CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 232 PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 232 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+..+++++.++|.+||+.||.+||+..+++.|+|++..
T Consensus 243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 24589999999999999999999999999999999853
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=393.45 Aligned_cols=263 Identities=36% Similarity=0.665 Sum_probs=226.7
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhcCCCCeeeEEEEE--EeCC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK-VGMIDQIKREISVMRLVRHPNVVELYEVM--ASKT 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~ 83 (472)
.+.++|++++.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++ .+..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 36789999999999999999999999999999999997654322 23457789999999999999999999998 4556
Q ss_pred EEEEEEEecCCCcccchhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 84 KIYFVMEYVKGGELFGKVA---KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~---~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
..|+||||+.++ |.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 899999999887 555553 3679999999999999999999999999999999999999999999999999988654
Q ss_pred cccCCCcccccCCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEV 239 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l 239 (472)
............||+.|+|||++.+.. +.+.++||||||+++|+|++|..||...+.......+......++..+++++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 333333345667999999999987543 3357899999999999999999999999988888899888888999999999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
.+||.+||+.||.+|||+.++++||||++..
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999999999999998744
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=395.39 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=209.7
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhcCCCCeeeEEEEEEeC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVVELYEVMASK 82 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~ 82 (472)
.|.++.++|++++.||+|+||+||+|++..+|+.||||++.......... .....|+..+ +..+||||+++++++.++
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 46677789999999999999999999999999999999987654333223 3344455544 445999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
+.+|+||||+ +++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999999999 6688887754 569999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCCCCCCHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~ 238 (472)
... .....+||+.|+|||++.+ .+ +.++|||||||++|+|++|..|+...... ..+.... ..++..++++
T Consensus 209 ~~~---~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 280 (311)
T 3p1a_A 209 TAG---AGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTAGLSSE 280 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTTCCCHHHHTTSCHH
T ss_pred cCC---CCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhccCCCcccccCCCHH
Confidence 322 2345679999999999875 44 58999999999999999997776554332 2333222 2345568999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+.+||.+||++||++|||++++++||||++
T Consensus 281 l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=398.42 Aligned_cols=261 Identities=27% Similarity=0.408 Sum_probs=219.1
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe------
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS------ 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (472)
..++|++++.||+|+||+||+|++..+|+.||+|++....... .....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 4579999999999999999999999999999999987654322 334567799999999999999999999977
Q ss_pred --CCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 82 --KTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
.+.+|+||||+.+ +|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4579999999976 66666644 579999999999999999999999999999999999999999999999999998
Q ss_pred hhhccc--CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCC-
Q 012053 158 LAESKH--QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNW- 234 (472)
Q Consensus 158 ~~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~- 234 (472)
...... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......+..
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 654322 12234556899999999999776555689999999999999999999999988777666654422221111
Q ss_pred -------------------------------CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 235 -------------------------------FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 235 -------------------------------~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
.++++.+||.+||+.||++|||++|+++||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 267899999999999999999999999999998643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=392.78 Aligned_cols=258 Identities=33% Similarity=0.622 Sum_probs=216.3
Q ss_pred cccCCEEEE-eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCE
Q 012053 7 ILMQRYELG-RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTK 84 (472)
Q Consensus 7 ~l~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (472)
.+.++|++. +.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+++++ +||||+++++++.+++.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 466789995 789999999999999999999999999976532 3456788999999884 79999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC---eEEecCcchhhhh
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN---LKVSDFGLSALAE 160 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~---vkl~DFGla~~~~ 160 (472)
+|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999999999865 68999999999999999999999999999999999999998876 9999999987654
Q ss_pred cccC-----CCcccccCCCCcccChhhhcc-----cCCCCCcccchhhhHHHHHHhcCCCCCCCCc--------------
Q 012053 161 SKHQ-----DGLLHTTCGTPAYVAPEVINR-----RGYDGSKADIWSCGVILYVLLAGYLPFHDSN-------------- 216 (472)
Q Consensus 161 ~~~~-----~~~~~~~~gt~~Y~aPE~l~~-----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-------------- 216 (472)
.... .......+||+.|+|||++.. ..+ +.++|||||||++|+|++|..||....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 2211 112345679999999999864 233 478999999999999999999997653
Q ss_pred -HHHHHHHHhccCCCCC----CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 217 -LMEMYRKIGKAEFKFP----NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 217 -~~~~~~~i~~~~~~~~----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
....+..+......+| ..+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 2345666666766666 358999999999999999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=404.41 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=215.7
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC----
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK---- 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 82 (472)
.+.++|++++.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 356799999999999999999999999999999999965432 334567889999999999999999999999765
Q ss_pred --CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 --TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
..+|+||||+ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3569999999 8899999988899999999999999999999999999999999999999999999999999988643
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC------------
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------ 228 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------ 228 (472)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 180 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 180 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred c-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 23456899999999999874445689999999999999999999999887766655543210
Q ss_pred -------------------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 229 -------------------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 229 -------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.......++++.+||.+||..||.+|||++++++||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 01234578999999999999999999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=400.45 Aligned_cols=263 Identities=27% Similarity=0.446 Sum_probs=222.3
Q ss_pred cCCccc--CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012053 4 KGSILM--QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 4 ~g~~l~--~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
.|.++. ++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 19 ~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp C-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred ccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 355554 79999999999999999999999999999999997543 23445778899999999999999999999965
Q ss_pred C-----CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 82 K-----TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 82 ~-----~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
. ...|+||||+. ++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CCccccceEEEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 5 47999999997 48999998889999999999999999999999999999999999999999999999999999
Q ss_pred hhhhcccC-CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC------
Q 012053 157 ALAESKHQ-DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF------ 229 (472)
Q Consensus 157 ~~~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~------ 229 (472)
........ .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 86644322 22245568999999999976665456899999999999999999999988766555544431100
Q ss_pred -------------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 230 -------------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 230 -------------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
...+.+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0124478999999999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=398.68 Aligned_cols=256 Identities=28% Similarity=0.428 Sum_probs=210.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++++.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 47899999999999999999999999999999999654321 1112345799999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.| +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence 999975 88887764 469999999999999999999999999999999999999999999999999987554322 2
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-----------------
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF----------------- 229 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~----------------- 229 (472)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 234568899999999997755556899999999999999999999999887766665543100
Q ss_pred --C-----------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 230 --K-----------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 230 --~-----------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
. .++.+++++.+||.+||+.||.+|||++|+++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 0 112468899999999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=403.21 Aligned_cols=254 Identities=33% Similarity=0.578 Sum_probs=219.1
Q ss_pred ccCCEEE--EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 8 LMQRYEL--GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 8 l~~~y~i--~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
+.+.|++ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 3455666 6789999999999999999999999999976542 3356789999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE--cCCCCeEEecCcchhhhhc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL--DEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl--d~~g~vkl~DFGla~~~~~ 161 (472)
|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 999999999999988854 469999999999999999999999999999999999999 5677899999999986543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCCCH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWFAP 237 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~ 237 (472)
.. .....+||+.|+|||++....+ +.++|||||||++|+|++|..||.+.+..+.+..+....+.++ ..+++
T Consensus 242 ~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 242 RE---KLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp TC---BCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred cc---ccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 22 2345689999999999976655 4899999999999999999999999988888888877665544 45899
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
++.+||.+||+.||.+|||+.++++||||+.
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 9999999999999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=414.49 Aligned_cols=261 Identities=27% Similarity=0.372 Sum_probs=198.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS----- 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 81 (472)
.+.++|++++.||+|+||+||+|++..+|+.||||++.+.. ......+.+.+|+.+|+.++||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 35689999999999999999999999999999999996543 233456788999999999999999999999843
Q ss_pred CCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
...+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 35799999998 5688888876 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCC-------------------------CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc--------
Q 012053 161 SKHQD-------------------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-------- 207 (472)
Q Consensus 161 ~~~~~-------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-------- 207 (472)
..... ......+||+.|+|||++......+.++|||||||++|+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 32111 124556899999999987555444589999999999999999
Q ss_pred ---CCCCCCCCcH--------------------HHHHHHHhc-----------------------cC--------CCCCC
Q 012053 208 ---GYLPFHDSNL--------------------MEMYRKIGK-----------------------AE--------FKFPN 233 (472)
Q Consensus 208 ---G~~Pf~~~~~--------------------~~~~~~i~~-----------------------~~--------~~~~~ 233 (472)
|.++|.+.+. ......+.. .. ....+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 6777765431 111111110 00 01123
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 234 WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
..++++.+||.+||..||++|||++|+|+||||+..
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 468999999999999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=389.66 Aligned_cols=265 Identities=28% Similarity=0.416 Sum_probs=217.1
Q ss_pred CCCcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012053 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 1 m~~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
|.-+|..+.++|++++.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 2 m~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 78 (320)
T 2i6l_A 2 MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILG 78 (320)
T ss_dssp ----CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CccccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecc
Confidence 66788899999999999999999999999999999999999987543 345677899999999999999999999873
Q ss_pred --------------eCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CC
Q 012053 81 --------------SKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD-EH 145 (472)
Q Consensus 81 --------------~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld-~~ 145 (472)
.....|+||||+. |+|.+++..+++++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 79 PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157 (320)
T ss_dssp TTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred ccccccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 4578999999997 5999999889999999999999999999999999999999999999997 56
Q ss_pred CCeEEecCcchhhhhccc-CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHH
Q 012053 146 GNLKVSDFGLSALAESKH-QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI 224 (472)
Q Consensus 146 g~vkl~DFGla~~~~~~~-~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i 224 (472)
+.+||+|||++....... .........||+.|+|||++......+.++||||||+++|+|++|..||...+.......+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 789999999988654321 1122345678999999999876555568999999999999999999999988776665555
Q ss_pred hccCC------------------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 225 GKAEF------------------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 225 ~~~~~------------------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
..... ..++.+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 43211 1124589999999999999999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=394.50 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=217.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 46799999999999999999999999999999999976543 23445678899999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--E 179 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--c
Confidence 9999999999887654 689999999999999999999999999999999999999999999999999997654322 2
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-------------------
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------- 227 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~------------------- 227 (472)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 2345689999999999977655568999999999999999999999987766554443211
Q ss_pred CCCC------------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 228 EFKF------------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 228 ~~~~------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.... .+.+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0111 1246899999999999999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=389.89 Aligned_cols=258 Identities=35% Similarity=0.702 Sum_probs=225.3
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
++..+.++|++++.||+|+||+||+|++..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (304)
T 2jam_A 3 QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTT 79 (304)
T ss_dssp ---CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence 3456788999999999999999999999999999999999765422 2356889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCCeEEecCcchhhh
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALA 159 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl---d~~g~vkl~DFGla~~~ 159 (472)
..|+||||++|++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999999999998864 789999999999999999999999999999999999999 78889999999998754
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCC
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWF 235 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~ 235 (472)
.. ......+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..+...++ ..+
T Consensus 160 ~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (304)
T 2jam_A 160 QN----GIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDI 234 (304)
T ss_dssp CC----BTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTS
T ss_pred CC----CccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccC
Confidence 32 123456799999999999776664 899999999999999999999999888888888877654433 458
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
++++.+||.+||..||.+|||+.++++||||+..
T Consensus 235 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 235 SESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 8999999999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=405.49 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=210.5
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC---
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK--- 82 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--- 82 (472)
-.+.++|++++.||+|+||.||+|++..+|+.||||++.+.. ......+.+.+|+.+|+.++||||+++++++...
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 346789999999999999999999999999999999997543 2334567889999999999999999999999766
Q ss_pred --CEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 83 --TKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 83 --~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
..+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 67999999986 599998876 56999999999999999999999999999999999999999999999999999865
Q ss_pred hcccCC--------------------CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCC--------
Q 012053 160 ESKHQD--------------------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLP-------- 211 (472)
Q Consensus 160 ~~~~~~--------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~P-------- 211 (472)
...... ......+||+.|+|||++......+.++|||||||++|+|++|..|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 433211 1246678999999999975555456899999999999999985444
Q ss_pred ---CCCCc-----------------HHHHHHH------------------------HhccCCCCC-------CCCCHHHH
Q 012053 212 ---FHDSN-----------------LMEMYRK------------------------IGKAEFKFP-------NWFAPEVR 240 (472)
Q Consensus 212 ---f~~~~-----------------~~~~~~~------------------------i~~~~~~~~-------~~~s~~l~ 240 (472)
|.+.+ ....... +.......+ +.+++++.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 43322 0111111 111111111 34799999
Q ss_pred HHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 241 RLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+||.+||..||.+|||++|+|+||||+...
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 999999999999999999999999998743
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=398.45 Aligned_cols=258 Identities=31% Similarity=0.628 Sum_probs=226.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-----KVGMIDQIKREISVMRLV-RHPNVVELYEVMAS 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (472)
+.++|++.+.||+|+||.||+|++..+|+.||||++...... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 457899999999999999999999999999999999765321 112356788999999999 79999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
.+..|+||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999999875 689999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCCcccccCCCCcccChhhhccc-----CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC---
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRR-----GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP--- 232 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~-----~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~--- 232 (472)
.. ......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+..+...++
T Consensus 252 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 252 PG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp TT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 32 224567899999999998642 2235789999999999999999999999888888877777665543
Q ss_pred -CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 233 -NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 -~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..+++++.+||.+||..||++|||+.++++||||++
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 357899999999999999999999999999999973
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=397.98 Aligned_cols=266 Identities=28% Similarity=0.402 Sum_probs=213.8
Q ss_pred CCCcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhcCCCCeeeEEEE
Q 012053 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK--VGMIDQIKREISVMRLVRHPNVVELYEV 78 (472)
Q Consensus 1 m~~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 78 (472)
|...-....++|++++.||+|+||.||+|.+..+|+.||||++....... ......+.+|+.+++.++||||++++++
T Consensus 1 m~l~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (346)
T 1ua2_A 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80 (346)
T ss_dssp ------------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CchhhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 44444456789999999999999999999999999999999997543221 1123467899999999999999999999
Q ss_pred EEeCCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 79 MASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
+.+.+..|+||||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 81 FGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp ECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred EeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999999999986 78777765 46999999999999999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--C---CC
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--F---KF 231 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~---~~ 231 (472)
....... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+.++.... . .+
T Consensus 160 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 160 KSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp STTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 8764322 224567899999999999766555689999999999999999999999988777666654310 0 00
Q ss_pred -----------------------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 232 -----------------------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 232 -----------------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
...+++++.+||.+||..||.+|||+.|+++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13457899999999999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=384.22 Aligned_cols=259 Identities=30% Similarity=0.510 Sum_probs=230.1
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
-..++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++......|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 4567899999999999999999999999999999999766432 34678999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 87 FVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
+||||+.|++|.+++..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 174 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 174 (303)
T ss_dssp EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--
T ss_pred EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc--
Confidence 999999999999999989999999999999999999999999999999999999999999999999999876543221
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhc
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~ 245 (472)
......||+.|+|||++.+..+. .++||||||+++|+|++|..||...........+.... ..++..+++++.+||.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence 23456799999999999877665 79999999999999999999999887776666655443 45566789999999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccCC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
||..||.+|||+.++++||||....
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HcCCChhhCcCHHHHhhChhhhcCC
Confidence 9999999999999999999998643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=382.93 Aligned_cols=262 Identities=32% Similarity=0.563 Sum_probs=227.1
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc------chhhHHHHHHHHHHHHhcC-CCCeeeEEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL------KVGMIDQIKREISVMRLVR-HPNVVELYE 77 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~------~~~~~~~~~~Ei~il~~l~-hpnIv~l~~ 77 (472)
...+.++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+.+.+|+.+++.+. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 345788999999999999999999999999999999999765321 1133567889999999995 999999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 78 VMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
++..++..|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999999875 68999999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhcc-----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINR-----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF 231 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~ 231 (472)
...... ......+||+.|+|||++.. ....+.++||||||+++|+|++|..||...+.......+......+
T Consensus 172 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 172 CQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp EECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred hhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 765432 22345689999999999852 2233579999999999999999999999988888877777766554
Q ss_pred C----CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 232 P----NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 232 ~----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+ ..+++++.+||.+||..||.+|||+.++++||||++.
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 3 2478999999999999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=380.65 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=215.5
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 85 (472)
.+.++|++++.||+|+||+||+|.+..+++.||+|++....... .....+.+|+.++..+ +||||+++++++.+++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 35679999999999999999999999999999999998654332 3456778999999998 899999999999999999
Q ss_pred EEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC--------------
Q 012053 86 YFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-------------- 146 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-------------- 146 (472)
|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999999864 5699999999999999999999999999999999999998544
Q ss_pred -----CeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHH
Q 012053 147 -----NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMY 221 (472)
Q Consensus 147 -----~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~ 221 (472)
.+||+|||++...... ....||+.|+|||++.+....+.++|||||||++|+|++|..|+......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--- 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--- 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---
T ss_pred cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---
Confidence 7999999998765432 23469999999999977655557999999999999999999887665433
Q ss_pred HHHhcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 222 RKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 222 ~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
..+... ...+|..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 233333 345677899999999999999999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=396.00 Aligned_cols=259 Identities=27% Similarity=0.460 Sum_probs=222.7
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
.|.+..++|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+++
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 104 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 104 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence 46788899999999999999999999999999999999997653 2345678899999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999999999875 6899999999999999999999996 999999999999999999999999999876543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHH-----------------
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI----------------- 224 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i----------------- 224 (472)
.. ....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+
T Consensus 185 ~~----~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 185 SM----ANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HC--------CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred cc----ccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 32 2456899999999999877665 8999999999999999999999876654432221
Q ss_pred -------------------------hccC-CCCC-CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 225 -------------------------GKAE-FKFP-NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 225 -------------------------~~~~-~~~~-~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.... ...+ ..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 1111 1122 2378899999999999999999999999999999863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=393.71 Aligned_cols=259 Identities=26% Similarity=0.458 Sum_probs=213.6
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCCE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH--PNVVELYEVMASKTK 84 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~ 84 (472)
+..++|++++.||+|+||+||+|.+ .+++.||||++...... ....+.+.+|+.+|+.++| |||+++++++.++..
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 4567899999999999999999998 57899999999766532 3456788999999999986 999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+|+|||+ .+++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 9999994 57899999875 6799999999999999999999999999999999999997 6789999999998765433
Q ss_pred CCCcccccCCCCcccChhhhcc----------cCCCCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHhc--cCCC
Q 012053 164 QDGLLHTTCGTPAYVAPEVINR----------RGYDGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIGK--AEFK 230 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~----------~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~--~~~~ 230 (472)
........+||+.|+|||++.+ ....+.++|||||||++|+|++|..||.... .......+.. ....
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 3323446689999999999864 1334589999999999999999999998743 3333333332 3456
Q ss_pred CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 231 FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 231 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+|...++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 777788999999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=387.22 Aligned_cols=258 Identities=28% Similarity=0.486 Sum_probs=216.1
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
..+..++|++.+.||+|+||+||+|++ +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 346678999999999999999999987 7889999999766533 3445778999999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhccCC----CCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCCeEEecCcchhh
Q 012053 85 IYFVMEYVKGGELFGKVAKGK----LKEDAARKYFQQLISAVDYCHSRG--VCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~----l~e~~~~~i~~ql~~al~yLH~~g--iiHrDIKp~NILld~~g~vkl~DFGla~~ 158 (472)
.|+||||+.+++|.+++.... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999999997643 999999999999999999999999 99999999999999999999999999976
Q ss_pred hhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHH--hccCCCCCCCCC
Q 012053 159 AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI--GKAEFKFPNWFA 236 (472)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i--~~~~~~~~~~~s 236 (472)
...... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+ ......+|..++
T Consensus 189 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (309)
T 3p86_A 189 KASTFL--SSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred cccccc--ccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence 543221 23456899999999999877664 8999999999999999999999998877766665 344567788899
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhc--Cccccc
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIME--NSWFRK 268 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~--hp~f~~ 268 (472)
+++.+||.+||..||.+|||+.++++ .+|++.
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999987 455543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=399.61 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=202.2
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
+.++|++++.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 46799999999999999999999999999999999975432 234457788999999999999999999998654
Q ss_pred -CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 83 -TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..+|+|||++ +++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5689999999 78999999888999999999999999999999999999999999999999999999999999986542
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------- 228 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------- 228 (472)
. ....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.+..
T Consensus 185 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 185 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred c-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2 3456899999999999875555689999999999999999999999887766655543210
Q ss_pred ----------CCC--------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 229 ----------FKF--------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 229 ----------~~~--------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
... ....++++.+||.+||..||.+|||+.++++||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 001 12468899999999999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=395.83 Aligned_cols=258 Identities=26% Similarity=0.457 Sum_probs=210.4
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-- 83 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 83 (472)
+.+.++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 2 s~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp CHHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred chhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence 346789999999999999999999999999999999997654 2245678999999999999999999999985543
Q ss_pred -------------------------------------------------------EEEEEEEecCCCcccchhccC----
Q 012053 84 -------------------------------------------------------KIYFVMEYVKGGELFGKVAKG---- 104 (472)
Q Consensus 84 -------------------------------------------------------~~~lV~E~~~gg~L~~~i~~~---- 104 (472)
..|+||||++|++|.+++...
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 489999999999999998763
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC----------CcccccCCC
Q 012053 105 KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD----------GLLHTTCGT 174 (472)
Q Consensus 105 ~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~----------~~~~~~~gt 174 (472)
..++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ......+||
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 3566779999999999999999999999999999999999999999999998866543211 122446799
Q ss_pred CcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC-CCCCCCHHHHHHHhcccCCCCCC
Q 012053 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-FPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 175 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
+.|+|||++.+..+. .++|||||||++|+|++|..|+... ......+.....+ .+...++++.+||.+||+.||.+
T Consensus 240 ~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp GGGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred cCccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCc
Confidence 999999999887764 8999999999999999998775321 2222233322221 11235688999999999999999
Q ss_pred cCChhhhhcCccccc
Q 012053 254 RISMTKIMENSWFRK 268 (472)
Q Consensus 254 Rpt~~eil~hp~f~~ 268 (472)
|||+.++++||||++
T Consensus 317 Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 317 RPEATDIIENAIFEN 331 (332)
T ss_dssp SCCHHHHHHSTTCCC
T ss_pred CCCHHHHhhchhhhc
Confidence 999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=392.99 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=220.9
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999999999999999999876544445567889999999999999999999999999999999
Q ss_pred EEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+. |+|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 99997 57777764 36899999999999999999999999999999999999999999999999999876532
Q ss_pred cccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC--CCCCCCHHHHHH
Q 012053 167 LLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK--FPNWFAPEVRRL 242 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~l~~l 242 (472)
....+||+.|+|||++.. .+..+.++|||||||++|+|++|..||...+.......+...... .+..+++.+.+|
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 234689999999999852 233357999999999999999999999988776666555544322 345689999999
Q ss_pred HhcccCCCCCCcCChhhhhcCcccccC
Q 012053 243 LSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
|.+||+.||++|||++++++||||...
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHcccChhhCcCHHHHhhChhhhcc
Confidence 999999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=395.28 Aligned_cols=259 Identities=25% Similarity=0.532 Sum_probs=228.1
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchh--------------hHHHHHHHHHHHHhcCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG--------------MIDQIKREISVMRLVRH 69 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~h 69 (472)
.+.+..++|++++.||+|+||.||+|.+ +|+.||+|++......... ..+.+.+|+.+++.++|
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 4667789999999999999999999999 9999999999765432211 12788999999999999
Q ss_pred CCeeeEEEEEEeCCEEEEEEEecCCCcccch------hcc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCc
Q 012053 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGK------VAK---GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPEN 139 (472)
Q Consensus 70 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~------i~~---~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~N 139 (472)
|||+++++++.+.+..|+||||+++++|.++ +.. +.+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999999999999999999999999999998 653 579999999999999999999999 999999999999
Q ss_pred EEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhccc-CCCCCcccchhhhHHHHHHhcCCCCCCCCcH-
Q 012053 140 LLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCGVILYVLLAGYLPFHDSNL- 217 (472)
Q Consensus 140 ILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~- 217 (472)
||++.++.+||+|||++...... ......||+.|+|||++.+. .+.+.++||||||+++|+|++|..||.....
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999998765332 23456899999999999876 4443489999999999999999999988766
Q ss_pred HHHHHHHhccCCCCC-------------------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 218 MEMYRKIGKAEFKFP-------------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 218 ~~~~~~i~~~~~~~~-------------------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
......+......+| ..+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 777788877777766 568999999999999999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=405.78 Aligned_cols=258 Identities=34% Similarity=0.631 Sum_probs=209.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc-----hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK-----VGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.+..... ......+.+|+.+|+.++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45689999999999999999999999999999999998764321 112235789999999999999999999985
Q ss_pred CCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---CeEEecCcchh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NLKVSDFGLSA 157 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g---~vkl~DFGla~ 157 (472)
....|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 4568999999999999998865 6899999999999999999999999999999999999997654 49999999998
Q ss_pred hhhcccCCCcccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcH-HHHHHHHhccCCCCC--
Q 012053 158 LAESKHQDGLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNL-MEMYRKIGKAEFKFP-- 232 (472)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~-~~~~~~i~~~~~~~~-- 232 (472)
..... ....+.+||+.|+|||++.+ ....+.++|||||||++|+|++|..||..... ......+..+...++
T Consensus 291 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~ 367 (419)
T 3i6u_A 291 ILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE 367 (419)
T ss_dssp SCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH
T ss_pred ecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch
Confidence 75432 23456789999999999853 22234799999999999999999999986543 234445555554443
Q ss_pred --CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 233 --NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 233 --~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..+++++.+||.+||+.||.+|||++++++||||+.
T Consensus 368 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 358999999999999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=406.14 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=216.2
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc------CCCCeeeEEEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV------RHPNVVELYEV 78 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~ 78 (472)
+..+.++|++++.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.+ +|+||++++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 4567789999999999999999999999999999999997643 3346778899998877 57899999999
Q ss_pred EEeCCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC--eEEecC
Q 012053 79 MASKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN--LKVSDF 153 (472)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~--vkl~DF 153 (472)
+...+.+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999999999996 588888865 35999999999999999999999999999999999999999987 999999
Q ss_pred cchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC----
Q 012053 154 GLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF---- 229 (472)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---- 229 (472)
|+|..... ...+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 247 G~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 247 GSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp TTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccceecCC-----cccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 99865432 23467899999999999887775 899999999999999999999998877665554432100
Q ss_pred ----------------C---------------------------------------CCCCCCHHHHHHHhcccCCCCCCc
Q 012053 230 ----------------K---------------------------------------FPNWFAPEVRRLLSKILDPNPNTR 254 (472)
Q Consensus 230 ----------------~---------------------------------------~~~~~s~~l~~li~~~L~~dP~~R 254 (472)
. ++...++++.+||.+||+.||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 0 111237889999999999999999
Q ss_pred CChhhhhcCcccccCCC
Q 012053 255 ISMTKIMENSWFRKGLV 271 (472)
Q Consensus 255 pt~~eil~hp~f~~~~~ 271 (472)
||++|+|+||||++...
T Consensus 401 pta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 401 MTPGQALRHPWLRRRLP 417 (429)
T ss_dssp CCHHHHHTSTTTC----
T ss_pred CCHHHHhCChhhccCCC
Confidence 99999999999987543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=401.06 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=211.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS----- 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 81 (472)
+..++|++++.||+|+||+||+|.+..+|+.||||++...... ..+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 4567999999999999999999999999999999998765322 2379999999999999999999843
Q ss_pred ---------------------------------CCEEEEEEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHH
Q 012053 82 ---------------------------------KTKIYFVMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVD 123 (472)
Q Consensus 82 ---------------------------------~~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~al~ 123 (472)
...+|+||||+.| +|.+.+. .+.+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999985 6665553 267999999999999999999
Q ss_pred HHHhCCceecCCCCCcEEEc-CCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHH
Q 012053 124 YCHSRGVCHRDLKPENLLLD-EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVIL 202 (472)
Q Consensus 124 yLH~~giiHrDIKp~NILld-~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil 202 (472)
|||++||+||||||+|||++ .++.+||+|||+|....... .....+||+.|+|||++.+....+.++|||||||++
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999999998 68899999999998654322 234568899999999988766456899999999999
Q ss_pred HHHhcCCCCCCCCcHHHHHHHHhcc-----------------CC------------CCCCCCCHHHHHHHhcccCCCCCC
Q 012053 203 YVLLAGYLPFHDSNLMEMYRKIGKA-----------------EF------------KFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 203 ~~lltG~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
|+|++|..||.+.+..+....+... .. .+|..+++++.+||.+||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999988777666555321 01 135568899999999999999999
Q ss_pred cCChhhhhcCccccc
Q 012053 254 RISMTKIMENSWFRK 268 (472)
Q Consensus 254 Rpt~~eil~hp~f~~ 268 (472)
|||+.|+++||||+.
T Consensus 313 R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 313 RINPYEAMAHPFFDH 327 (383)
T ss_dssp SCCHHHHHTSGGGHH
T ss_pred CCCHHHHhcCHHHHH
Confidence 999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=396.86 Aligned_cols=255 Identities=28% Similarity=0.457 Sum_probs=208.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC---
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT--- 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 83 (472)
.+.++|++++.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 457899999999999999999999999999999999976532 2345577889999999999999999999997655
Q ss_pred ---EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 84 ---KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 84 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
.+|+||||+.+ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 89999999975 6777664 569999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC----------
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK---------- 230 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~---------- 230 (472)
... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+......
T Consensus 179 ~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 TSF---MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccc---ccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 321 23456899999999999887765 8999999999999999999999998877666665432110
Q ss_pred ------------C--------------CCC------CCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 231 ------------F--------------PNW------FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 231 ------------~--------------~~~------~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+ |.. .++++++||.+||..||.+|||++|+++||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0 000 1567899999999999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=378.38 Aligned_cols=252 Identities=24% Similarity=0.503 Sum_probs=217.6
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS----KTKI 85 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~ 85 (472)
..|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3589999999999999999999999999999999866543 3456788999999999999999999999865 4679
Q ss_pred EEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEc-CCCCeEEecCcchhhhhc
Q 012053 86 YFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRG--VCHRDLKPENLLLD-EHGNLKVSDFGLSALAES 161 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~g--iiHrDIKp~NILld-~~g~vkl~DFGla~~~~~ 161 (472)
|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999999999999976 78999999999999999999999999 99999999999997 789999999999875432
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC-cHHHHHHHHhccC--CCCCCCCCHH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-NLMEMYRKIGKAE--FKFPNWFAPE 238 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~~~~--~~~~~~~s~~ 238 (472)
. .....+||+.|+|||++.+. + +.++||||||+++|+|++|..||... +....+..+.... ..++...+++
T Consensus 185 ~----~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (290)
T 1t4h_A 185 S----FAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred c----ccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence 2 23456899999999988643 4 58999999999999999999999874 4445555554432 2345567899
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+.+||.+||+.||.+|||+.++++||||++
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 999999999999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=398.88 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=214.6
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC--CCCeeeEEEEEEeCCEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR--HPNVVELYEVMASKTKIY 86 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~ 86 (472)
..+|++++.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.+|+.++ ||||+++++++..++.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3469999999999999999999864 89999999987653 2345678999999999996 599999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||| +.+++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.........
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9999 568899998875 6799999999999999999999999999999999999995 589999999999876543332
Q ss_pred CcccccCCCCcccChhhhccc----------CCCCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHhcc--CCCCC
Q 012053 166 GLLHTTCGTPAYVAPEVINRR----------GYDGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIGKA--EFKFP 232 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~----------~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~--~~~~~ 232 (472)
......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+... ...+|
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence 234567899999999998652 234589999999999999999999998743 33444444433 34677
Q ss_pred CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 233 NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 233 ~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+.++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 291 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 8889999999999999999999999999999999854
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=381.44 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=202.9
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++++.||+|+||+||+|++..+|+.||+|++...... ......+.++...++.++||||+++++++.+++..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 35678999999999999999999999999999999999765322 23334455566668889999999999999999999
Q ss_pred EEEEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 86 YFVMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
|+||||+.| +|.+.+. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 7766553 25799999999999999999999998 9999999999999999999999999999866
Q ss_pred hcccCCCcccccCCCCcccChhhhc---ccCCCCCcccchhhhHHHHHHhcCCCCCCCC-cHH-HHHHHHhccCCCCC-C
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVIN---RRGYDGSKADIWSCGVILYVLLAGYLPFHDS-NLM-EMYRKIGKAEFKFP-N 233 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~-~~~-~~~~~i~~~~~~~~-~ 233 (472)
..... ....+||+.|+|||++. .....+.++||||||+++|+|++|..||... ... .....+.......+ .
T Consensus 161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 44322 23457999999999972 2333458999999999999999999999863 333 33333333333333 4
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 234 WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.+++++.++|.+||+.||++|||+.++++||||+.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 68999999999999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=394.82 Aligned_cols=261 Identities=30% Similarity=0.570 Sum_probs=223.5
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVL-KVGMIDQIKREISVMRLV-RHPNVVELYEVMAS 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 81 (472)
+-.++|++++.||+|+||+||+|++. .+|+.||||++.+.... .....+.+.+|+.+|+.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34579999999999999999999985 48999999999765431 112335577899999999 69999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
.+.+|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999999875 689999999999999999999999999999999999999999999999999987653
Q ss_pred cccCCCcccccCCCCcccChhhhccc-CCCCCcccchhhhHHHHHHhcCCCCCCCC----cHHHHHHHHhccCCCCCCCC
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCGVILYVLLAGYLPFHDS----NLMEMYRKIGKAEFKFPNWF 235 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~lltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~ 235 (472)
.... ......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ........+......+|..+
T Consensus 211 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 211 ADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp GGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 3221 123456899999999999753 23457899999999999999999999743 34556666667777888889
Q ss_pred CHHHHHHHhcccCCCCCCcC-----ChhhhhcCccccc
Q 012053 236 APEVRRLLSKILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
++.+.+||.+||..||.+|| |++++++||||++
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 99999999999999999999 9999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=388.41 Aligned_cols=256 Identities=27% Similarity=0.455 Sum_probs=217.6
Q ss_pred CCcCCcccCCEEEEeeEcccCCeEEEEEEE-cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCC------Ceee
Q 012053 2 ENKGSILMQRYELGRLLGQGTFAKVHYARN-LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP------NVVE 74 (472)
Q Consensus 2 ~~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~-~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~ 74 (472)
.+.|.++.++|++++.||+|+||+||+|.+ ..+++.||+|++.... ...+.+.+|+.+++.++|+ +|++
T Consensus 6 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 81 (339)
T 1z57_A 6 CQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81 (339)
T ss_dssp CSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred eecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence 467999999999999999999999999999 5688999999996542 3456788999999988765 4999
Q ss_pred EEEEEEeCCEEEEEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-------
Q 012053 75 LYEVMASKTKIYFVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE------- 144 (472)
Q Consensus 75 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~------- 144 (472)
+++++...+..|+||||+ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 88999888653 6899999999999999999999999999999999999987
Q ss_pred ------------CCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCC
Q 012053 145 ------------HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPF 212 (472)
Q Consensus 145 ------------~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf 212 (472)
++.+||+|||++...... ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSC
T ss_pred CCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCC
Confidence 678999999998754321 2456899999999999877765 8999999999999999999999
Q ss_pred CCCcHHHHHHHHhccCCCC--------------------------------------------CCCCCHHHHHHHhcccC
Q 012053 213 HDSNLMEMYRKIGKAEFKF--------------------------------------------PNWFAPEVRRLLSKILD 248 (472)
Q Consensus 213 ~~~~~~~~~~~i~~~~~~~--------------------------------------------~~~~s~~l~~li~~~L~ 248 (472)
...+..+....+....... +...++++.+||.+||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 9877665544432211111 11124678999999999
Q ss_pred CCCCCcCChhhhhcCccccc
Q 012053 249 PNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 249 ~dP~~Rpt~~eil~hp~f~~ 268 (472)
.||.+|||+.|+++||||+.
T Consensus 315 ~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 315 YDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp SSTTTSCCHHHHTTSGGGGG
T ss_pred cCcccccCHHHHhcCHHHHH
Confidence 99999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=389.43 Aligned_cols=264 Identities=34% Similarity=0.624 Sum_probs=217.0
Q ss_pred CCCcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhcCCCCeeeE
Q 012053 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-----KVGMIDQIKREISVMRLVRHPNVVEL 75 (472)
Q Consensus 1 m~~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l 75 (472)
|.-.+..+.++|++++.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+|+.++||||+++
T Consensus 1 M~~~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 80 (322)
T 2ycf_A 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80 (322)
T ss_dssp -CCCCHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred CccchhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence 5666677889999999999999999999999999999999999765431 11223457899999999999999999
Q ss_pred EEEEEeCCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC---eEEe
Q 012053 76 YEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN---LKVS 151 (472)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~---vkl~ 151 (472)
++++..+. .|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence 99997766 8999999999999998865 68999999999999999999999999999999999999987765 9999
Q ss_pred cCcchhhhhcccCCCcccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhccC
Q 012053 152 DFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGKAE 228 (472)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~ 228 (472)
|||++...... ......+||+.|+|||++.. ....+.++|||||||++|+|++|..||...... .....+..+.
T Consensus 160 Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 160 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236 (322)
T ss_dssp CCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred cCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence 99998765322 12345679999999999742 233358999999999999999999999764332 3334444444
Q ss_pred CCCC----CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 229 FKFP----NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 229 ~~~~----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.... ..+++++.+||.+||..||.+|||+.++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 237 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 4332 457899999999999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=384.70 Aligned_cols=250 Identities=26% Similarity=0.493 Sum_probs=211.5
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEe--CCEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMAS--KTKI 85 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~~ 85 (472)
.++|++++.||+|+||+||+|++..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 568999999999999999999999999999999986443 367889999999997 9999999999987 6789
Q ss_pred EEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-~vkl~DFGla~~~~~~~~ 164 (472)
++||||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 109 ~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp EEEEECCCCCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred EEEEeccCchhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 99999999999988875 499999999999999999999999999999999999999777 89999999997654322
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC-cHHHHHHH-------------HhccCCC
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-NLMEMYRK-------------IGKAEFK 230 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~-~~~~~~~~-------------i~~~~~~ 230 (472)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||... +....... +......
T Consensus 186 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 186 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2356689999999999987555568999999999999999999999543 22222111 1111111
Q ss_pred C------------------------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 231 F------------------------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 231 ~------------------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
. +..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 1 12278999999999999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=388.62 Aligned_cols=263 Identities=27% Similarity=0.407 Sum_probs=219.4
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK- 82 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~- 82 (472)
.+..+.++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence 34567889999999999999999999999999999999996543 234456788999999999999999999998654
Q ss_pred ----CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhh
Q 012053 83 ----TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 83 ----~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~ 158 (472)
...|+||||+. ++|.+.+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cCccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67999999997 5899988888999999999999999999999999999999999999999999999999999876
Q ss_pred hhcccCC--------CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---
Q 012053 159 AESKHQD--------GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--- 227 (472)
Q Consensus 159 ~~~~~~~--------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--- 227 (472)
....... ......+||+.|+|||++......+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 5432111 11234579999999999876555568999999999999999999999987765544333210
Q ss_pred ---------------------CCC--------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 ---------------------EFK--------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---------------------~~~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
... .++.+++++.+||.+||..||++|||+.++++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000 123578999999999999999999999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=380.40 Aligned_cols=260 Identities=30% Similarity=0.465 Sum_probs=219.9
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
+....++|++++.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++..++.
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 44567899999999999999999999999999999999875532 345778899999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999988764 67999999999999999999999999999999999999999999999999998654332
Q ss_pred cCCCcccccCCCCcccChhhhc----ccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---CCCCCC
Q 012053 163 HQDGLLHTTCGTPAYVAPEVIN----RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF---KFPNWF 235 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~----~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~ 235 (472)
... ....+||+.|+|||++. .....+.++||||||+++|+|++|..||...+.......+..... ..+..+
T Consensus 171 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 2j7t_A 171 LQK--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 248 (302)
T ss_dssp HHC-------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred ccc--cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCcccc
Confidence 211 23457999999999984 223335899999999999999999999999887776666655433 234568
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
++++.++|.+||..||.+|||+.++++||||+..
T Consensus 249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 9999999999999999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=399.37 Aligned_cols=255 Identities=31% Similarity=0.483 Sum_probs=211.1
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
.|....++|++++.||+|+||+||+|++..+++ ||+|.+...... ..+|+.+|+.++||||+++++++...+
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 466778899999999999999999999987766 888887654322 237999999999999999999985433
Q ss_pred ------EEEEEEEecCCCcccchhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCCeEEec
Q 012053 84 ------KIYFVMEYVKGGELFGKVA----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD-EHGNLKVSD 152 (472)
Q Consensus 84 ------~~~lV~E~~~gg~L~~~i~----~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld-~~g~vkl~D 152 (472)
.+|+||||+.++.+..... .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 4889999998754433221 46799999999999999999999999999999999999999 799999999
Q ss_pred CcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc-----
Q 012053 153 FGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA----- 227 (472)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~----- 227 (472)
||+|+....... ....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 186 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 186 FGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp CTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999986543222 345688999999999977655568999999999999999999999998776655554321
Q ss_pred ------------CCC------------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 ------------EFK------------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ------------~~~------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
... ++..+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 011 234578999999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=378.11 Aligned_cols=258 Identities=32% Similarity=0.584 Sum_probs=224.6
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA--SKTKI 85 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~ 85 (472)
..++|++++.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 357999999999999999999999999999999999876533 245678999999999999999999999874 46789
Q ss_pred EEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEcCCCCeEEecCcc
Q 012053 86 YFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRG-----VCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~g-----iiHrDIKp~NILld~~g~vkl~DFGl 155 (472)
|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999998864 24999999999999999999999999 99999999999999999999999999
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCC
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNW 234 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 234 (472)
+....... ......+||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..+.. .+|..
T Consensus 163 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 163 ARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp HHHC---C--HHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred heeecccc--ccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 88654321 112345799999999999877664 899999999999999999999999888777777776654 56778
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+++++.++|.+||+.||.+|||+.++++|+|+...
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 99999999999999999999999999999999763
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=378.22 Aligned_cols=256 Identities=33% Similarity=0.668 Sum_probs=225.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
.+.++|++++.||+|+||+||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 4567999999999999999999999999999999999765432 234578899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---CeEEecCcchhhhhcc
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NLKVSDFGLSALAESK 162 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g---~vkl~DFGla~~~~~~ 162 (472)
+||||+.+++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999999888754 7899999999999999999999999999999999999997644 6999999998865432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCCCHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWFAPE 238 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~ 238 (472)
. ......||+.|+|||++.+. + +.++||||||+++|+|++|..||...+.......+..+...++ ..++++
T Consensus 178 ~---~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T 2wei_A 178 T---KMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD 252 (287)
T ss_dssp S---SCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred C---ccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence 2 22345689999999998654 4 5899999999999999999999999888888777776655433 458999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+.++|.+||..||.+|||+.++++||||++
T Consensus 253 ~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 253 AKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 999999999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=379.35 Aligned_cols=256 Identities=29% Similarity=0.497 Sum_probs=217.4
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
....++|++++.||+|+||.||+|.+..+|+.||+|.+..... .+.+.+|+.+++.++||||+++++++...+.+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 3456799999999999999999999999999999999976532 35688999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||+.+++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999986 4689999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC---CCCCCCCCHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVR 240 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~l~ 240 (472)
. ......||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.... +..+..+++++.
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 256 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT 256 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred c--ccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence 1 23456799999999999877665 78999999999999999999999877665554444332 334556899999
Q ss_pred HHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 241 RLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+||.+||..||.+|||+.++++||||+..
T Consensus 257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 257 DFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 99999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=393.99 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=224.8
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEE-----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVM 79 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 79 (472)
..+..++|++++.||+|+||+||+|. +..+++.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34567899999999999999999999 45578899999986543 223445788999999999999999999999
Q ss_pred EeCCEEEEEEEecCCCcccchhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---Ce
Q 012053 80 ASKTKIYFVMEYVKGGELFGKVAK--------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---NL 148 (472)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~--------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g---~v 148 (472)
......|+||||+.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+| .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999998864 2499999999999999999999999999999999999999665 49
Q ss_pred EEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc
Q 012053 149 KVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA 227 (472)
Q Consensus 149 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~ 227 (472)
||+|||+++...............||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876544333334556789999999999877765 89999999999999998 99999999888888777665
Q ss_pred C-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 228 E-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 228 ~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
. ...+..+++++.+||.+||+.||.+|||+.+|+++.|+..
T Consensus 303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 4 5567779999999999999999999999999999987754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=394.99 Aligned_cols=254 Identities=25% Similarity=0.442 Sum_probs=209.9
Q ss_pred CcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC--------CCCeee
Q 012053 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR--------HPNVVE 74 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~ 74 (472)
..|.++.++|++++.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.++ ||||++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 347788999999999999999999999999999999999997542 34567889999999885 788999
Q ss_pred EEEEEE----eCCEEEEEEEecCCCcccchhc-c--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCC
Q 012053 75 LYEVMA----SKTKIYFVMEYVKGGELFGKVA-K--GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHG 146 (472)
Q Consensus 75 l~~~~~----~~~~~~lV~E~~~gg~L~~~i~-~--~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~g 146 (472)
+++++. ....+|+||||+ +++|.+.+. . +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 999987 566899999999 555655553 3 4699999999999999999999999 999999999999999776
Q ss_pred -------------------------------------------------CeEEecCcchhhhhcccCCCcccccCCCCcc
Q 012053 147 -------------------------------------------------NLKVSDFGLSALAESKHQDGLLHTTCGTPAY 177 (472)
Q Consensus 147 -------------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y 177 (472)
.+||+|||++...... ....+||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence 7999999998865432 3456899999
Q ss_pred cChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc------HHHHHHHHhcc------------------------
Q 012053 178 VAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN------LMEMYRKIGKA------------------------ 227 (472)
Q Consensus 178 ~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~------~~~~~~~i~~~------------------------ 227 (472)
+|||++.+..+. .++|||||||++|+|++|..||...+ .......+...
T Consensus 260 ~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 260 RSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp CCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred cCChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 999999887765 79999999999999999999997543 12222222110
Q ss_pred ------------------CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012053 228 ------------------EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 228 ------------------~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
....+...++++.+||.+||+.||++|||++|+++||||+
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0011222346788999999999999999999999999996
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=391.94 Aligned_cols=255 Identities=22% Similarity=0.430 Sum_probs=220.9
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLK-------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYE 77 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 77 (472)
.+..++|++++.||+|+||+||+|++.. ++..||||++.... .....+.+.+|+.+|+.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3456799999999999999999999753 45679999997653 234567899999999999 8999999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhccC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012053 78 VMASKTKIYFVMEYVKGGELFGKVAKG-----------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NI 140 (472)
++.+.+.+|+||||+.||+|.+++... .+++.+++.++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 999999999999999999999988642 478999999999999999999999999999999999
Q ss_pred EEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH
Q 012053 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~ 219 (472)
|++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999999865543322223445678899999999877665 89999999999999999 999999888777
Q ss_pred HHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 220 MYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+..+..+. ...|..+++++.++|.+||+.||.+|||+.+++++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777666553 56677899999999999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=386.84 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=212.7
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
.++++.++|++++.||+|+||+||+|++..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp EEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred cccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 4667889999999999999999999999999999999999765432 33567789999999999999999999997765
Q ss_pred --EEEEEEEecCCCcccchhccC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCCeEEecC
Q 012053 84 --KIYFVMEYVKGGELFGKVAKG----KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL----DEHGNLKVSDF 153 (472)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl----d~~g~vkl~DF 153 (472)
..|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 889999999999999998652 39999999999999999999999999999999999999 77888999999
Q ss_pred cchhhhhcccCCCcccccCCCCcccChhhhcc-------cCCCCCcccchhhhHHHHHHhcCCCCCCCC----cHHHHHH
Q 012053 154 GLSALAESKHQDGLLHTTCGTPAYVAPEVINR-------RGYDGSKADIWSCGVILYVLLAGYLPFHDS----NLMEMYR 222 (472)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-------~~~~~~~~DiwSlGvil~~lltG~~Pf~~~----~~~~~~~ 222 (472)
|++....... .....+||+.|+|||++.. ....+.++|||||||++|+|++|..||... ...+...
T Consensus 161 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 161 GAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred CCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 9997654322 2345679999999999863 233458999999999999999999999642 2233444
Q ss_pred HHhccCC-------------------CC------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCc
Q 012053 223 KIGKAEF-------------------KF------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENS 264 (472)
Q Consensus 223 ~i~~~~~-------------------~~------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp 264 (472)
++....+ .+ +..+++.+.+||++||+.||++|||++|+++||
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 4433221 11 112346788999999999999999999999995
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=384.22 Aligned_cols=265 Identities=29% Similarity=0.513 Sum_probs=197.7
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+..+..++|++++.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 3456788999999999999999999999999999999998765322 33567889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCc
Q 012053 84 KIYFVMEYVKGGELFGKVA---------KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~---------~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFG 154 (472)
..|+||||++|++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 9999999999999999885 2469999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccC---CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC--
Q 012053 155 LSALAESKHQ---DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-- 229 (472)
Q Consensus 155 la~~~~~~~~---~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-- 229 (472)
++........ .......+||+.|+|||++.+....+.++||||||+++|+|++|..||.................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 9876543211 11224567999999999987633345899999999999999999999988665544333322211
Q ss_pred --------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 230 --------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 230 --------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
.....+++++.++|.+||+.||.+|||+.++++||||++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 12345789999999999999999999999999999998643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=380.09 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=214.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEe----
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMAS---- 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~---- 81 (472)
...++|++++.||+|+||.||+|++..+|+.||||++..... ..+.+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 456899999999999999999999999999999999976532 236788999999998 79999999999976
Q ss_pred --CCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 82 --KTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
.+..|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 5689999999999999999864 47999999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhcc----cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC--
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINR----RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK-- 230 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~-- 230 (472)
....... ......+||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+.......+......
T Consensus 177 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 254 (326)
T 2x7f_A 177 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 254 (326)
T ss_dssp C---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred eecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC
Confidence 7654322 12345679999999999862 223358899999999999999999999988776666555544322
Q ss_pred CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 231 FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 231 ~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+..+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 255 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 255 KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 245589999999999999999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=404.56 Aligned_cols=248 Identities=19% Similarity=0.257 Sum_probs=205.2
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHH---HHhcCCCCeeeEE-------EE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV---MRLVRHPNVVELY-------EV 78 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~i---l~~l~hpnIv~l~-------~~ 78 (472)
.++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+ ++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4789999999999999999999999999999999987655555567889999955 4555799999998 77
Q ss_pred EEeCCE-----------------EEEEEEecCCCcccchhcc-CCCCH-------HHHHHHHHHHHHHHHHHHhCCceec
Q 012053 79 MASKTK-----------------IYFVMEYVKGGELFGKVAK-GKLKE-------DAARKYFQQLISAVDYCHSRGVCHR 133 (472)
Q Consensus 79 ~~~~~~-----------------~~lV~E~~~gg~L~~~i~~-~~l~e-------~~~~~i~~ql~~al~yLH~~giiHr 133 (472)
+.+.+. .|+||||+ +|+|.+++.. +.+++ ..++.++.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 766542 89999999 6799999875 44555 7888899999999999999999999
Q ss_pred CCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhccc-----------CCCCCcccchhhhHHH
Q 012053 134 DLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR-----------GYDGSKADIWSCGVIL 202 (472)
Q Consensus 134 DIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-----------~~~~~~~DiwSlGvil 202 (472)
||||+|||++.++.+||+|||+|..... .....+| +.|+|||++.+. .+ +.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence 9999999999999999999999885332 2356678 999999999876 55 4899999999999
Q ss_pred HHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 203 YVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 203 ~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
|+|++|..||.+.+.......+ ...+..+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGGG----GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchhhh----hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 9999999999876544333222 2334568999999999999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=390.35 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=213.6
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE--
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI-- 85 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-- 85 (472)
+.++|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 56799999999999999999999999999999999976542 234567888999999999999999999999877654
Q ss_pred ----EEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 86 ----YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 86 ----~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
|+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG-MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred ceeEEEEEcccc-ccHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999997 57777664 4599999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC------------
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF------------ 229 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~------------ 229 (472)
. ....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 197 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 197 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred C-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 2 24568999999999998744456899999999999999999999998877666555432100
Q ss_pred -------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 230 -------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 230 -------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..++.+++++.+||.+||+.||.+|||+.|+++||||+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 112346899999999999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=399.92 Aligned_cols=251 Identities=31% Similarity=0.447 Sum_probs=207.9
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK----- 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 82 (472)
...+|++++.||+|+||.||+|++..+|+.||||++..... ...+|+.+|+.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999976532 234799999999999999999998431
Q ss_pred -CEEEEEEEecCCCcccchhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CCeEEecCcc
Q 012053 83 -TKIYFVMEYVKGGELFGKVA-----KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGL 155 (472)
Q Consensus 83 -~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~-g~vkl~DFGl 155 (472)
..+++||||+.+ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 247799999976 4554442 3679999999999999999999999999999999999999965 5689999999
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--------
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------- 227 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------- 227 (472)
++...... .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+.++.+.
T Consensus 204 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 98654322 2345689999999999976644458999999999999999999999988766555444321
Q ss_pred ---------CCC------------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 ---------EFK------------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ---------~~~------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+. ++..+++++.+||.+||..||.+|||+.|+++||||+..
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 112 234568999999999999999999999999999999764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=384.63 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=202.4
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGM---SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
..+..++|++++.||+|+||+||+|.+..++. .||||++....... ...+.+.+|+.+++.++||||+++++++..
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 45667899999999999999999999887765 89999997654332 446788999999999999999999999987
Q ss_pred CCEE------EEEEEecCCCcccchhccC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCe
Q 012053 82 KTKI------YFVMEYVKGGELFGKVAKG-------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNL 148 (472)
Q Consensus 82 ~~~~------~lV~E~~~gg~L~~~i~~~-------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~v 148 (472)
.... |+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7665 9999999999999988531 59999999999999999999999999999999999999999999
Q ss_pred EEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc
Q 012053 149 KVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA 227 (472)
Q Consensus 149 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~ 227 (472)
||+|||++................+|+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 99999999876543332223345678899999999877665 89999999999999999 99999988777777766554
Q ss_pred -CCCCCCCCCHHHHHHHhcccCCCCCCcCC-------hhhhhcCcccccC
Q 012053 228 -EFKFPNWFAPEVRRLLSKILDPNPNTRIS-------MTKIMENSWFRKG 269 (472)
Q Consensus 228 -~~~~~~~~s~~l~~li~~~L~~dP~~Rpt-------~~eil~hp~f~~~ 269 (472)
....+..+++++.+||.+||+.||.+||| +++++.|||+...
T Consensus 256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 35677789999999999999999999999 7778889999753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=377.74 Aligned_cols=256 Identities=19% Similarity=0.312 Sum_probs=215.4
Q ss_pred CCCcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 012053 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVM 79 (472)
Q Consensus 1 m~~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (472)
|...|.++.++|++++.||+|+||.||+|.+..+|+.||+|++...... +.+.+|+.+++.+ +|+|++++++++
T Consensus 1 Ms~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 1 MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp -----CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred CCCcCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 8899999999999999999999999999999999999999998655322 3578899999999 799999999999
Q ss_pred EeCCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC-----eEEec
Q 012053 80 ASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN-----LKVSD 152 (472)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~-----vkl~D 152 (472)
......|+||||+ +++|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 76 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 76 QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred CCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 9999999999999 9999999974 46999999999999999999999999999999999999988776 99999
Q ss_pred CcchhhhhcccCC-----CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC---cHHHHHHHH
Q 012053 153 FGLSALAESKHQD-----GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS---NLMEMYRKI 224 (472)
Q Consensus 153 FGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~---~~~~~~~~i 224 (472)
||++......... ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||... .....+..+
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 9999866543221 12345679999999999987766 48999999999999999999999873 334444444
Q ss_pred hccCC-----CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 225 GKAEF-----KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 225 ~~~~~-----~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..... ..+..+++++.++|.+||+.||.+|||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 234 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 33221 2234689999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=379.79 Aligned_cols=263 Identities=33% Similarity=0.478 Sum_probs=216.6
Q ss_pred CCCcCCcc-cCCEEEEeeEcccCCeEEEEEEEc-CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc---CCCCeeeE
Q 012053 1 MENKGSIL-MQRYELGRLLGQGTFAKVHYARNL-KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV---RHPNVVEL 75 (472)
Q Consensus 1 m~~~g~~l-~~~y~i~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l 75 (472)
|++.|... .++|++++.||+|+||.||+|++. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++
T Consensus 1 m~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~ 79 (326)
T 1blx_A 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRL 79 (326)
T ss_dssp ----CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCE
T ss_pred CCCccccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEee
Confidence 66677544 489999999999999999999995 678999999997554221 1223456788877766 89999999
Q ss_pred EEEEE-----eCCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC
Q 012053 76 YEVMA-----SKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN 147 (472)
Q Consensus 76 ~~~~~-----~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~ 147 (472)
++++. .....|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 80 FDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp EEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC
Confidence 99987 5678999999997 589888864 35999999999999999999999999999999999999999999
Q ss_pred eEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc
Q 012053 148 LKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA 227 (472)
Q Consensus 148 vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~ 227 (472)
+||+|||++....... .....+||+.|+|||++.+..+. .++||||||+++|+|++|..||.+.+.......+...
T Consensus 159 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 159 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEEecCcccccccCCC---CccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 9999999987654322 23456899999999999877664 8999999999999999999999988777666555321
Q ss_pred C---------------------------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 E---------------------------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 ~---------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
. ..++..+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0 01234578999999999999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=385.72 Aligned_cols=257 Identities=30% Similarity=0.560 Sum_probs=222.2
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhcC--CCCeeeEEEE
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV---GMIDQIKREISVMRLVR--HPNVVELYEV 78 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--hpnIv~l~~~ 78 (472)
.+..+.++|++++.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++.++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 456788999999999999999999999999999999999976643221 11245678999999996 5999999999
Q ss_pred EEeCCEEEEEEEecCC-Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCCeEEecCcc
Q 012053 79 MASKTKIYFVMEYVKG-GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD-EHGNLKVSDFGL 155 (472)
Q Consensus 79 ~~~~~~~~lV~E~~~g-g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld-~~g~vkl~DFGl 155 (472)
+...+..|+|||++.+ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999999986 899998865 7899999999999999999999999999999999999999 788999999999
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCC
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWF 235 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 235 (472)
+...... ......||+.|+|||++.+..+.+.++||||||+++|+|++|..||.... .+......++..+
T Consensus 197 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~ 266 (320)
T 3a99_A 197 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRV 266 (320)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCC
T ss_pred ccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccC
Confidence 8765432 23456799999999999887776788999999999999999999997643 2334556677889
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
++++.+||.+||+.||.+|||+.+|++||||+...
T Consensus 267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 99999999999999999999999999999998744
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=383.75 Aligned_cols=253 Identities=28% Similarity=0.456 Sum_probs=213.4
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE---
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK--- 84 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--- 84 (472)
+.++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 56799999999999999999999999999999999976542 33456778899999999999999999999977653
Q ss_pred ---EEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 85 ---IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 85 ---~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+|+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMG-LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred ceeEEEEecccc-CCHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 599999997 58887765 3599999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--------------
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------- 227 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------- 227 (472)
. ....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.+.
T Consensus 179 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 179 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred C-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 2 245689999999999977444568999999999999999999999987766555444221
Q ss_pred -----------------CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 228 -----------------EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 228 -----------------~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
....+..+++++.+||.+||+.||.+|||++++++||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 01123457899999999999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=382.88 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=222.7
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
.+..++|++++.||+|+||.||+|++. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 456689999999999999999999997 355899999997653 2345678999999999999999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAK-------------------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDL 135 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDI 135 (472)
+.+..|+||||+.+++|.+++.. +.+++.+++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99999999999999999998864 56999999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCC
Q 012053 136 KPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHD 214 (472)
Q Consensus 136 Kp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~ 214 (472)
||+|||++.++.+||+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999876543322233456789999999999877765 89999999999999999 9999999
Q ss_pred CcHHHHHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 215 SNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 215 ~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+..+....+..+. ...|..+++++.++|.+||+.||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 88888777776655 35677899999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=381.60 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=220.2
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGM---SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
+.+..++|++.+.||+|+||+||+|.+..+++ .||||++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 45677899999999999999999999986655 49999997543 23445778999999999999999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
.+..|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999999999854 58999999999999999999999999999999999999999999999999999866
Q ss_pred hcccCCC-cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCC
Q 012053 160 ESKHQDG-LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFA 236 (472)
Q Consensus 160 ~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 236 (472)
....... ......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...........+... ....+..++
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence 4432211 12234567889999999877665 79999999999999999 99999998888877777655 456677899
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+++.+||.+||..||.+|||+.+|++.
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=368.42 Aligned_cols=250 Identities=25% Similarity=0.416 Sum_probs=219.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-.++|++++.||+|+||+||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 44579999999999999999999986 5778999999765432 357889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 87 FVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 99999999999999865 4699999999999999999999999999999999999999999999999999986543221
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRL 242 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~l 242 (472)
. ......||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... ....|..+++++.++
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (269)
T 4hcu_A 162 T-SSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 239 (269)
T ss_dssp H-STTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred c-cccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHH
Confidence 1 12345678899999999877765 89999999999999999 99999998888888777665 455667789999999
Q ss_pred HhcccCCCCCCcCChhhhhcC
Q 012053 243 LSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h 263 (472)
|.+||+.||.+|||+.+++++
T Consensus 240 i~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 240 MNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=383.05 Aligned_cols=255 Identities=26% Similarity=0.431 Sum_probs=213.9
Q ss_pred CcCCcccCCEEEEeeEcccCCeEEEEEEEcCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC------eeeE
Q 012053 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTG-MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN------VVEL 75 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l 75 (472)
..|.++.++|++++.||+|+||+||+|.+..++ +.||+|++.... ...+.+.+|+.+++.++|++ ++.+
T Consensus 12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 457889999999999999999999999998777 689999996542 34567889999999997665 9999
Q ss_pred EEEEEeCCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----------
Q 012053 76 YEVMASKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL---------- 142 (472)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl---------- 142 (472)
++++...+..|+||||+ +++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence 99999999999999999 5566666543 369999999999999999999999999999999999999
Q ss_pred ---------cCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCC
Q 012053 143 ---------DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH 213 (472)
Q Consensus 143 ---------d~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~ 213 (472)
+.++.+||+|||++...... ....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCC
Confidence 66789999999998754322 2456899999999999877765 89999999999999999999999
Q ss_pred CCcHHHHHHHHhccCCCCC--------------------------------------------CCCCHHHHHHHhcccCC
Q 012053 214 DSNLMEMYRKIGKAEFKFP--------------------------------------------NWFAPEVRRLLSKILDP 249 (472)
Q Consensus 214 ~~~~~~~~~~i~~~~~~~~--------------------------------------------~~~s~~l~~li~~~L~~ 249 (472)
..+.......+.......| ...++++.+||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 8776554444332211111 11245788999999999
Q ss_pred CCCCcCChhhhhcCccccc
Q 012053 250 NPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 250 dP~~Rpt~~eil~hp~f~~ 268 (472)
||.+|||+.++++||||+.
T Consensus 321 dP~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAG 339 (355)
T ss_dssp STTTSCCHHHHTTSGGGGG
T ss_pred ChhhCcCHHHHhcChhhcC
Confidence 9999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=385.63 Aligned_cols=260 Identities=22% Similarity=0.372 Sum_probs=209.2
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc--------chhhHHHHHHHHHHHHhcCCCCeeeEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL--------KVGMIDQIKREISVMRLVRHPNVVELYE 77 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 77 (472)
..+.++|++++.||+|+||.||+|.+. +|+.||||++...... .....+.+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 356789999999999999999999985 4999999998654321 2233578999999999999999999999
Q ss_pred EEEe-----CCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEE
Q 012053 78 VMAS-----KTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 78 ~~~~-----~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl 150 (472)
++.. ...+|+||||+. |+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 9843 347999999997 577777754 37999999999999999999999999999999999999999999999
Q ss_pred ecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---
Q 012053 151 SDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--- 227 (472)
Q Consensus 151 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--- 227 (472)
+|||++....... .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 176 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 176 CDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9999997544322 2345689999999999977455568999999999999999999999988776665555321
Q ss_pred ---------------------CC--------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 228 ---------------------EF--------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 228 ---------------------~~--------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
.. ..++..++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 00 11234688999999999999999999999999999998743
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=387.53 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=215.3
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEE-----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (472)
.+..++|++++.||+|+||.||+|+ +..+++.||||++..... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 4567899999999999999999999 455779999999976532 23456789999999999 799999999999
Q ss_pred EeCC-EEEEEEEecCCCcccchhccCC-----------------------------------------------------
Q 012053 80 ASKT-KIYFVMEYVKGGELFGKVAKGK----------------------------------------------------- 105 (472)
Q Consensus 80 ~~~~-~~~lV~E~~~gg~L~~~i~~~~----------------------------------------------------- 105 (472)
...+ .+|+||||+.||+|.+++....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 7754 5999999999999999886521
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccccc
Q 012053 106 --------------LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT 171 (472)
Q Consensus 106 --------------l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~ 171 (472)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 899999999999999999999999999999999999999999999999999865443322233456
Q ss_pred CCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH-HHHHHHhc-cCCCCCCCCCHHHHHHHhcccC
Q 012053 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM-EMYRKIGK-AEFKFPNWFAPEVRRLLSKILD 248 (472)
Q Consensus 172 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~-~~~~~i~~-~~~~~~~~~s~~l~~li~~~L~ 248 (472)
.||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.... .....+.. .....|..+++++.++|.+||.
T Consensus 256 ~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 334 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334 (359)
T ss_dssp EECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 789999999999877765 89999999999999998 99999886543 33333333 3456778899999999999999
Q ss_pred CCCCCcCChhhhhcC
Q 012053 249 PNPNTRISMTKIMEN 263 (472)
Q Consensus 249 ~dP~~Rpt~~eil~h 263 (472)
.||.+|||+.++++|
T Consensus 335 ~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 335 GEPSQRPTFSELVEH 349 (359)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCCCHHHHHHH
Confidence 999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=395.77 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=196.2
Q ss_pred CcccCCEEE-EeeEcccCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-
Q 012053 6 SILMQRYEL-GRLLGQGTFAKVHYARNL--KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS- 81 (472)
Q Consensus 6 ~~l~~~y~i-~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 81 (472)
..+.+.|++ +++||+|+||+||+|++. .+++.||||++...... ..+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 345677888 568999999999999976 57899999999765432 467899999999999999999999954
Q ss_pred -CCEEEEEEEecCCCcccchhcc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCC
Q 012053 82 -KTKIYFVMEYVKGGELFGKVAK----------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL----DEHG 146 (472)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl----d~~g 146 (472)
...+|+||||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 7799999999965 77766642 249999999999999999999999999999999999999 7788
Q ss_pred CeEEecCcchhhhhcccC-CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-------
Q 012053 147 NLKVSDFGLSALAESKHQ-DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM------- 218 (472)
Q Consensus 147 ~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~------- 218 (472)
.+||+|||+|........ .......+||+.|+|||++.+....+.++|||||||++|+|++|..||......
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 999999999987654221 123456789999999999987665568999999999999999999999764431
Q ss_pred --HHHHHHhcc-C-CC------------------------------------CCCCCCHHHHHHHhcccCCCCCCcCChh
Q 012053 219 --EMYRKIGKA-E-FK------------------------------------FPNWFAPEVRRLLSKILDPNPNTRISMT 258 (472)
Q Consensus 219 --~~~~~i~~~-~-~~------------------------------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~ 258 (472)
+....+... . .. .....++++.+||.+||..||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 222222110 0 00 0011267899999999999999999999
Q ss_pred hhhcCcccccCC
Q 012053 259 KIMENSWFRKGL 270 (472)
Q Consensus 259 eil~hp~f~~~~ 270 (472)
|+|+||||....
T Consensus 330 e~L~hp~f~~~~ 341 (405)
T 3rgf_A 330 QAMQDPYFLEDP 341 (405)
T ss_dssp HHHTSGGGTSSS
T ss_pred HHhcChhhccCC
Confidence 999999998754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=383.62 Aligned_cols=257 Identities=28% Similarity=0.383 Sum_probs=202.1
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC---
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT--- 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 83 (472)
...++|++.+.||+|+||+||+|.+..+|+.||||++...... .....+|+..++.++||||+++++++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3467999999999999999999999999999999998665422 234567888889999999999999986533
Q ss_pred ----EEEEEEEecCCCccc---chhc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEcC-CCCeEEec
Q 012053 84 ----KIYFVMEYVKGGELF---GKVA-KGKLKEDAARKYFQQLISAVDYCH--SRGVCHRDLKPENLLLDE-HGNLKVSD 152 (472)
Q Consensus 84 ----~~~lV~E~~~gg~L~---~~i~-~~~l~e~~~~~i~~ql~~al~yLH--~~giiHrDIKp~NILld~-~g~vkl~D 152 (472)
.+|+||||+.++.+. .... ...+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 388999999875332 2222 357999999999999999999999 999999999999999997 89999999
Q ss_pred CcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC----
Q 012053 153 FGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---- 228 (472)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~---- 228 (472)
||++........ ....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+..+.+..
T Consensus 176 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 176 FGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 999986543322 3456799999999999776655689999999999999999999999988776666554310
Q ss_pred ----------------------------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 229 ----------------------------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 229 ----------------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
...+...++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 011222567899999999999999999999999999998743
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=388.13 Aligned_cols=255 Identities=29% Similarity=0.439 Sum_probs=215.1
Q ss_pred CcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CC-----CeeeEE
Q 012053 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HP-----NVVELY 76 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~ 76 (472)
..|..+.++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++ |+ +|++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 356778899999999999999999999999999999999997543 34567788999998885 55 499999
Q ss_pred EEEEeCCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEc--CCCCeE
Q 012053 77 EVMASKTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCH--SRGVCHRDLKPENLLLD--EHGNLK 149 (472)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH--~~giiHrDIKp~NILld--~~g~vk 149 (472)
+++...+..|+||||+.+ +|.+++.. +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+|
T Consensus 123 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 999999999999999964 89888865 46999999999999999999999 47999999999999994 477899
Q ss_pred EecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC
Q 012053 150 VSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF 229 (472)
Q Consensus 150 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~ 229 (472)
|+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 202 L~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 202 IVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp ECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeccCceeccc-----ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999976532 23457899999999999887765 899999999999999999999998887766655543110
Q ss_pred CC-------------------------------------CCC---------------------------CCHHHHHHHhc
Q 012053 230 KF-------------------------------------PNW---------------------------FAPEVRRLLSK 245 (472)
Q Consensus 230 ~~-------------------------------------~~~---------------------------~s~~l~~li~~ 245 (472)
.. |.. .++++.+||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 00 000 01378999999
Q ss_pred ccCCCCCCcCChhhhhcCccccc
Q 012053 246 ILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
||+.||++|||++|+|+||||++
T Consensus 356 mL~~dP~~Rpta~e~L~hp~f~~ 378 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQHSFFKK 378 (382)
T ss_dssp HTCSCTTTSCCHHHHTTSGGGCC
T ss_pred hcCCChhhCCCHHHHhcCccccc
Confidence 99999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=373.03 Aligned_cols=254 Identities=29% Similarity=0.538 Sum_probs=208.9
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe------
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS------ 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (472)
+.++|++++.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 4578999999999999999999999999999999996432 445778999999999999999999998854
Q ss_pred -------CCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEec
Q 012053 82 -------KTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSD 152 (472)
Q Consensus 82 -------~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~D 152 (472)
.+..|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 4678999999999999999964 3588999999999999999999999999999999999999999999999
Q ss_pred Ccchhhhhccc------------CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC-cHHH
Q 012053 153 FGLSALAESKH------------QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-NLME 219 (472)
Q Consensus 153 FGla~~~~~~~------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~-~~~~ 219 (472)
||++....... ........+||+.|+|||++.+.+..+.++|||||||++|+|++ ||... +...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99987654211 01223456799999999999876555689999999999999998 66543 3345
Q ss_pred HHHHHhccCCCCC----CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 220 MYRKIGKAEFKFP----NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 220 ~~~~i~~~~~~~~----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
....+......+| ...++.+.++|.+||+.||.+|||+.++++||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 5555555544444 345678999999999999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=386.08 Aligned_cols=256 Identities=22% Similarity=0.422 Sum_probs=223.7
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKT-------GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELY 76 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 76 (472)
..+..++|++++.||+|+||+||+|++..+ +..||+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 356678999999999999999999998643 3579999997653 234457889999999999 899999999
Q ss_pred EEEEeCCEEEEEEEecCCCcccchhccC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 012053 77 EVMASKTKIYFVMEYVKGGELFGKVAKG-----------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPEN 139 (472)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~N 139 (472)
+++.+++..|+||||+.+|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 9999999999999999999999998642 49999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH
Q 012053 140 LLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM 218 (472)
Q Consensus 140 ILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~ 218 (472)
||++.++.+||+|||++................||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+..
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999866543332334455688999999999876664 89999999999999999 99999998888
Q ss_pred HHHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 219 EMYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 219 ~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+....+... ....+..+++++.+||.+||+.||++|||+.+++++
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 301 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 887777665 456677899999999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=365.23 Aligned_cols=250 Identities=27% Similarity=0.504 Sum_probs=207.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK-VGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
+-.++|++.+.||+|+||.||+|.+ +|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 4467999999999999999999998 58999999987654322 23457789999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEcC--------CCCeEEecCc
Q 012053 86 YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG---VCHRDLKPENLLLDE--------HGNLKVSDFG 154 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~g---iiHrDIKp~NILld~--------~g~vkl~DFG 154 (472)
|+||||++|++|.+++..+++++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999999998889999999999999999999999999 999999999999986 7789999999
Q ss_pred chhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC--CCCC
Q 012053 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE--FKFP 232 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~--~~~~ 232 (472)
++....... .....||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+.... ...+
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 998654322 2345799999999999877664 89999999999999999999999887776665554443 4567
Q ss_pred CCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 233 NWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 233 ~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..+++++.++|.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 7799999999999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=392.60 Aligned_cols=251 Identities=16% Similarity=0.222 Sum_probs=195.7
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc--CCCCeeeEE-------EEEEe
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV--RHPNVVELY-------EVMAS 81 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~~~~~ 81 (472)
.|++++.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 599999999999999999999999999999999887654445667888896655555 699988755 55543
Q ss_pred C-----------------CEEEEEEEecCCCcccchhcc--CCCCHHHH------HHHHHHHHHHHHHHHhCCceecCCC
Q 012053 82 K-----------------TKIYFVMEYVKGGELFGKVAK--GKLKEDAA------RKYFQQLISAVDYCHSRGVCHRDLK 136 (472)
Q Consensus 82 ~-----------------~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~------~~i~~ql~~al~yLH~~giiHrDIK 136 (472)
. ..+|+||||+. ++|.+++.. ..+++... ..++.||+.||.|||++||+|||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 3 34899999998 899999875 34555555 5777999999999999999999999
Q ss_pred CCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCC
Q 012053 137 PENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHD 214 (472)
Q Consensus 137 p~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~ 214 (472)
|+|||++.+|.+||+|||+|...... .....||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||..
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999865422 224567799999999976 445 4899999999999999999999987
Q ss_pred CcHHH--HHHH-----HhccCCCCC--CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 215 SNLME--MYRK-----IGKAEFKFP--NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 215 ~~~~~--~~~~-----i~~~~~~~~--~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..... .+.. .......++ ..+++++.+||.+||+.||++|||+.++++||||++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 63321 1110 011122233 468999999999999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=381.65 Aligned_cols=255 Identities=31% Similarity=0.604 Sum_probs=187.0
Q ss_pred cCCcccCCEEEEe-eEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-
Q 012053 4 KGSILMQRYELGR-LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS- 81 (472)
Q Consensus 4 ~g~~l~~~y~i~~-~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~- 81 (472)
++..+.++|++.+ .||+|+||+||+|.+..+|+.||||++.... ....+....++.++||||+++++++..
T Consensus 22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 4557889999965 6999999999999999999999999986542 112223334677899999999999876
Q ss_pred ---CCEEEEEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CCeEEec
Q 012053 82 ---KTKIYFVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH---GNLKVSD 152 (472)
Q Consensus 82 ---~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~---g~vkl~D 152 (472)
+..+|+||||++||+|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 55689999999999999999753 69999999999999999999999999999999999999864 4599999
Q ss_pred CcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHH----HHHHhccC
Q 012053 153 FGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM----YRKIGKAE 228 (472)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~----~~~i~~~~ 228 (472)
||++...... .....+||+.|+|||++.+..+. .++||||||+++|+|++|..||........ ...+....
T Consensus 175 fg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 175 FGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249 (336)
T ss_dssp CTTCEEC--------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred cccceecccc----ccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence 9998755432 23466899999999998766654 789999999999999999999977654332 22222233
Q ss_pred CCCC----CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 229 FKFP----NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 229 ~~~~----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
..++ ..+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 3332 35899999999999999999999999999999998643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=380.67 Aligned_cols=256 Identities=34% Similarity=0.630 Sum_probs=211.6
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhc----CCCCeeeEE
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV---GMIDQIKREISVMRLV----RHPNVVELY 76 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~hpnIv~l~ 76 (472)
.+..+.++|++++.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++.+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 456788999999999999999999999999999999999976543221 1223456799999998 899999999
Q ss_pred EEEEeCCEEEEEEEe-cCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCCeEEecC
Q 012053 77 EVMASKTKIYFVMEY-VKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD-EHGNLKVSDF 153 (472)
Q Consensus 77 ~~~~~~~~~~lV~E~-~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld-~~g~vkl~DF 153 (472)
+++...+..|+|||+ +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999999999 789999999875 6799999999999999999999999999999999999999 8899999999
Q ss_pred cchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC
Q 012053 154 GLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN 233 (472)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 233 (472)
|++...... ......||+.|+|||++.+..+.+.++||||||+++|+|++|..||.... .+......++.
T Consensus 185 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~ 254 (312)
T 2iwi_A 185 GSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPA 254 (312)
T ss_dssp SSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCT
T ss_pred chhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcc
Confidence 998865432 23456799999999999887776668999999999999999999997642 23445667788
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 234 WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+++++.++|.+||+.||++|||+.++++||||+..
T Consensus 255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 899999999999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=382.56 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=212.2
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTK 84 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 84 (472)
.++.++|++++.||+|+||+||+|.+..+|+.||||++...... +.+.+|+.+++.+ +||||+++++++...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 35667899999999999999999999999999999998765422 3578999999999 89999999999999999
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC-----eEEecCcchh
Q 012053 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN-----LKVSDFGLSA 157 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~-----vkl~DFGla~ 157 (472)
.|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 9999999874 68999999999999999999999999999999999999999887 9999999998
Q ss_pred hhhcccCCC-----cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC---CcHHHHHHHHhccCC
Q 012053 158 LAESKHQDG-----LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD---SNLMEMYRKIGKAEF 229 (472)
Q Consensus 158 ~~~~~~~~~-----~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~---~~~~~~~~~i~~~~~ 229 (472)
......... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+ ....+.+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 654332211 12467899999999999887764 899999999999999999999987 444555666544333
Q ss_pred CCC-----CCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 230 KFP-----NWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 230 ~~~-----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
..+ ..++ ++.++|.+||+.||.+||++++|++
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 322 2244 9999999999999999999999876
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=375.61 Aligned_cols=256 Identities=24% Similarity=0.399 Sum_probs=220.6
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVM 79 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 79 (472)
..+..++|++++.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 3456779999999999999999999984 456899999997543 234567889999999999999999999999
Q ss_pred EeCCEEEEEEEecCCCcccchhccC-------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 012053 80 ASKTKIYFVMEYVKGGELFGKVAKG-------------------------KLKEDAARKYFQQLISAVDYCHSRGVCHRD 134 (472)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~-------------------------~l~e~~~~~i~~ql~~al~yLH~~giiHrD 134 (472)
.+.+..|+||||+.|++|.+++... .+++..++.++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 9999999999999999999988642 389999999999999999999999999999
Q ss_pred CCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCC
Q 012053 135 LKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFH 213 (472)
Q Consensus 135 IKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~ 213 (472)
|||+|||++.++.+||+|||++................+|+.|+|||++.+..+. .++||||||+++|+|++ |..||.
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998765433222222345678899999999876654 89999999999999999 999999
Q ss_pred CCcHHHHHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 214 DSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 214 ~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.+.......+.... ...+..+++++.++|.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 887777766665543 55677899999999999999999999999999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=366.75 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=217.2
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++++.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 355679999999999999999999875 6778999999765432 36688999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999999865 679999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~ 241 (472)
.. ......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+.... ...|...++.+.+
T Consensus 175 ~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (283)
T 3gen_A 175 YT-SSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 252 (283)
T ss_dssp HH-STTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cc-cccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHH
Confidence 11 12334578889999999877764 89999999999999998 999999988887777776653 4556778999999
Q ss_pred HHhcccCCCCCCcCChhhhhcC
Q 012053 242 LLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~h 263 (472)
+|.+||+.||.+|||+.++++|
T Consensus 253 li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 253 IMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=363.78 Aligned_cols=250 Identities=23% Similarity=0.389 Sum_probs=217.9
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++++.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 55679999999999999999999875 6778999999765432 366889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 87 FVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999999999999865 3599999999999999999999999999999999999999999999999999876543221
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRL 242 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~l 242 (472)
.......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+.... ...|...++++.++
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (268)
T 3sxs_A 160 -VSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI 237 (268)
T ss_dssp -EECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred -hcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence 112334567789999999876665 79999999999999999 999999988877777776554 44566789999999
Q ss_pred HhcccCCCCCCcCChhhhhcC
Q 012053 243 LSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h 263 (472)
|.+||+.||.+|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 238 MYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=364.83 Aligned_cols=253 Identities=20% Similarity=0.348 Sum_probs=218.6
Q ss_pred CCCcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012053 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 1 m~~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
|.+...+..++|++.+.||+|+||+||+|.+ +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus 1 m~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp ---CCCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred CCCcCCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 6777888999999999999999999999998 5899999999766432 244567899999999999999999999998
Q ss_pred eC--CEEEEEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCCeEEecC
Q 012053 81 SK--TKIYFVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRG--VCHRDLKPENLLLDEHGNLKVSDF 153 (472)
Q Consensus 81 ~~--~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~g--iiHrDIKp~NILld~~g~vkl~DF 153 (472)
+. ...|+||||+++|+|.+++... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec
Confidence 77 7899999999999999999763 4899999999999999999999999 999999999999999999999999
Q ss_pred cchhhhhcccCCCcccccCCCCcccChhhhcccCCCC--CcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--CC
Q 012053 154 GLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDG--SKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--EF 229 (472)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~--~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--~~ 229 (472)
|++.... .....||+.|+|||++.+..+.. .++||||||+++|+|++|..||.+.+.......+... ..
T Consensus 158 ~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 158 DVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230 (271)
T ss_dssp GSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred cceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC
Confidence 8765422 23457899999999997655442 3799999999999999999999988877766555443 45
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..|..+++++.++|.+||+.||++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 231 TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6777899999999999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=382.39 Aligned_cols=253 Identities=26% Similarity=0.468 Sum_probs=208.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-----------CCCeeeE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-----------HPNVVEL 75 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l 75 (472)
+..++|++++.||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.+++.++ ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 44679999999999999999999999999999999997543 23467889999998886 8999999
Q ss_pred EEEEEeCC----EEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcC---
Q 012053 76 YEVMASKT----KIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDE--- 144 (472)
Q Consensus 76 ~~~~~~~~----~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~--- 144 (472)
++++...+ .+++||||+ +++|.+++.. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99987654 899999999 8899998864 4699999999999999999999998 9999999999999953
Q ss_pred ---CCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH----
Q 012053 145 ---HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL---- 217 (472)
Q Consensus 145 ---~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~---- 217 (472)
++.+||+|||++...... ....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 347999999998765432 2455899999999999887764 899999999999999999999986431
Q ss_pred --HHHHHHHh------------------------------------------ccCCCCCCCCCHHHHHHHhcccCCCCCC
Q 012053 218 --MEMYRKIG------------------------------------------KAEFKFPNWFAPEVRRLLSKILDPNPNT 253 (472)
Q Consensus 218 --~~~~~~i~------------------------------------------~~~~~~~~~~s~~l~~li~~~L~~dP~~ 253 (472)
......+. .....++..+++++.+||.+||+.||.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 11111111 1112233345678999999999999999
Q ss_pred cCChhhhhcCcccccCC
Q 012053 254 RISMTKIMENSWFRKGL 270 (472)
Q Consensus 254 Rpt~~eil~hp~f~~~~ 270 (472)
|||++|+++||||++..
T Consensus 325 Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDTL 341 (373)
T ss_dssp CBCHHHHHTCGGGTTCT
T ss_pred cCCHHHHhhChhhhccc
Confidence 99999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=374.28 Aligned_cols=250 Identities=27% Similarity=0.429 Sum_probs=211.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++++.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4467999999999999999999999999999999998543 2345678999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 87 FVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||+.|++|.+++.. +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999975 6799999999999999999999999999999999999999999999999999976543221
Q ss_pred CC------------cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH-----HHHHHhcc
Q 012053 165 DG------------LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME-----MYRKIGKA 227 (472)
Q Consensus 165 ~~------------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~-----~~~~i~~~ 227 (472)
.. .....+||+.|+|||++.+..+. .++||||||+++|+|++|..||....... ..... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~--~ 240 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF--L 240 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH--H
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc--c
Confidence 10 11256899999999999887665 89999999999999999999986532110 00000 1
Q ss_pred CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 228 EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 228 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
....|..+++++.++|.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12346678899999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=376.50 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=209.5
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEE----EEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSV----AIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~v----AiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
+..++|++++.||+|+||+||+|++..+++.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 44678999999999999999999998888765 666664332 223457789999999999999999999999876
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
. .++|+||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999998865 579999999999999999999999999999999999999999999999999998775
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ....+..++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 54433333445678899999999877765 89999999999999999 99999987776666666544 35667779999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.+++.+||+.||.+|||+.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=367.90 Aligned_cols=250 Identities=28% Similarity=0.478 Sum_probs=209.8
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecCC
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKG 94 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 94 (472)
...||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 3499999999999999999999999999976532 3457789999999999999999999999999999999999999
Q ss_pred CcccchhccC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCCeEEecCcchhhhhcccCCCccc
Q 012053 95 GELFGKVAKG----KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-HGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 95 g~L~~~i~~~----~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~-~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....... ....
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 181 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTE 181 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--Cccc
Confidence 9999988642 4679999999999999999999999999999999999987 8999999999987654322 1234
Q ss_pred ccCCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCCcHH-H-HHH-HHhccCCCCCCCCCHHHHHHHhc
Q 012053 170 TTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDSNLM-E-MYR-KIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~-~~~-~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
...||+.|+|||++.+.. ..+.++||||||+++|+|++|..||...... . ... ........+|..+++++.++|.+
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILK 261 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHH
Confidence 567999999999986543 2358999999999999999999999754322 2 211 22334556778899999999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
||+.||++|||+.++++||||+..
T Consensus 262 ~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 262 CFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp TTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HccCChhhCCCHHHHhcChhhhhc
Confidence 999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=378.58 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=214.2
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMS----VAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
+..++|++++.||+|+||+||+|.+..+++. ||+|.+..... ......+.+|+.+++.++||||+++++++. +
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 4467999999999999999999999988876 66776643321 122345678999999999999999999986 4
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
...|+||||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 568999999999999998865 579999999999999999999999999999999999999999999999999998765
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.........+... ....|..++++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 245 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTT
T ss_pred cccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHH
Confidence 54443344556788899999999877765 89999999999999999 99999987776666666655 45667778999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.++|.+||..||.+|||+.+++++
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=375.44 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=219.4
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEE-----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEE
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEV 78 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 78 (472)
-+.+..++|++++.||+|+||.||+|. +..+++.||||.+.... .......+.+|+.+++.++||||++++++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGV 101 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 356778899999999999999999999 55688899999996443 22345678899999999999999999999
Q ss_pred EEeCCEEEEEEEecCCCcccchhccC--------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---C
Q 012053 79 MASKTKIYFVMEYVKGGELFGKVAKG--------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG---N 147 (472)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g---~ 147 (472)
+......|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 99999999999999999999998652 389999999999999999999999999999999999999544 5
Q ss_pred eEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhc
Q 012053 148 LKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGK 226 (472)
Q Consensus 148 vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~ 226 (472)
+||+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 999999999866543332233455789999999999877664 89999999999999998 9999998888777776665
Q ss_pred c-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 227 A-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 227 ~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
. ....+..+++.+.++|.+||..||.+|||+.+++++.|+..
T Consensus 261 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 4 34567779999999999999999999999999999988754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=373.32 Aligned_cols=256 Identities=20% Similarity=0.287 Sum_probs=222.3
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVM 79 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 79 (472)
..+..++|++.+.||+|+||.||+|.+. .+++.||+|.+..... ......+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 4567789999999999999999999987 4678999999975532 23456788999999999999999999999
Q ss_pred EeCCEEEEEEEecCCCcccchhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCe
Q 012053 80 ASKTKIYFVMEYVKGGELFGKVAK-----------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNL 148 (472)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~v 148 (472)
.+.+..|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 999999999999999999998864 457999999999999999999999999999999999999999999
Q ss_pred EEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc
Q 012053 149 KVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA 227 (472)
Q Consensus 149 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~ 227 (472)
||+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence 99999998865443322223345678999999999877664 89999999999999999 89999998887777776655
Q ss_pred C-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 228 E-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 228 ~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
. ...+..+++++.++|.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 4 45677899999999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=368.56 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=210.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
...++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++..++..|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 45689999999999999999999999999999999998765544455688999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 189 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL- 189 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-
Confidence 99999999999999876 6899999999999999999999999999999999999999999999999999876543221
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---CCCCCCCHHHHHH
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF---KFPNWFAPEVRRL 242 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~l~~l 242 (472)
.......||+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..... ..+..+++++.++
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 123456799999999999776654 799999999999999999999998877655555443322 3456789999999
Q ss_pred HhcccCCCCCCcC-ChhhhhcC
Q 012053 243 LSKILDPNPNTRI-SMTKIMEN 263 (472)
Q Consensus 243 i~~~L~~dP~~Rp-t~~eil~h 263 (472)
|.+||+.||.+|| |++++++.
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~~ 290 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSAA 290 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHH
T ss_pred HHHhccCCHHHHHHhHHHHHHH
Confidence 9999999999999 78887753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=366.98 Aligned_cols=254 Identities=28% Similarity=0.436 Sum_probs=207.7
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
-.+..++|++++.||+|+||+||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 456788999999999999999999998754 4579999986543 2345677899999999999999999999984
Q ss_pred CCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
++..|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 5678999999999999999865 36999999999999999999999999999999999999999999999999999876
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCH
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAP 237 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 237 (472)
..... .......+|+.|+|||++....+. .++||||||+++|+|++ |..||.+....+....+... ....+..+++
T Consensus 167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (281)
T 1mp8_A 167 EDSTY-YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 244 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred Ccccc-cccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 43221 112344678899999999877665 89999999999999996 99999987777666666554 3567778999
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++.++|.+||+.||.+|||+.+++++
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=377.75 Aligned_cols=255 Identities=22% Similarity=0.369 Sum_probs=214.5
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (472)
.+..++|++++.||+|+||.||+|.+. .++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455679999999999999999999973 4567899999975432 23347789999999999 899999999999
Q ss_pred EeCCEEEEEEEecCCCcccchhccC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 012053 80 ASKTKIYFVMEYVKGGELFGKVAKG------------------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDL 135 (472)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~------------------------~l~e~~~~~i~~ql~~al~yLH~~giiHrDI 135 (472)
...+..|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 9999999999999999999988652 2799999999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCC
Q 012053 136 KPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHD 214 (472)
Q Consensus 136 Kp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~ 214 (472)
||+|||++.++.+||+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||.+
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999866543332223445678899999999877664 89999999999999998 9999988
Q ss_pred CcHHHHHHHHhcc--CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 215 SNLMEMYRKIGKA--EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 215 ~~~~~~~~~i~~~--~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.........+... ....|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 6544333333322 345677799999999999999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=386.50 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=217.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-.++|++++.||+|+||+||+|.+..+++.||||++.... .....+.+.+|+.+|+.++||||+++++++..++.+|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 44578999999999999999999999999999999987542 2234456889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 87 FVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 99999999999999865 4699999999999999999999999999999999999999999999999999875432211
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRL 242 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~l 242 (472)
........+++.|+|||++....+. .++|||||||++|+|++ |..||...+.......+..+ ....|..+++++.+|
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1111122356789999999876654 89999999999999998 99999998877766666554 456778899999999
Q ss_pred HhcccCCCCCCcCChhhhhcC
Q 012053 243 LSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h 263 (472)
|.+||+.||.+|||+.+|++.
T Consensus 348 i~~cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 348 MEQCWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHHH
Confidence 999999999999999999763
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=368.88 Aligned_cols=248 Identities=24% Similarity=0.315 Sum_probs=213.0
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCC-------cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTG-------MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEV 78 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 78 (472)
.+..++|++.+.||+|+||+||+|++..++ ..||+|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456789999999999999999999998877 479999996543 2445788999999999999999999999
Q ss_pred EEeCCEEEEEEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC--------e
Q 012053 79 MASKTKIYFVMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN--------L 148 (472)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~--------v 148 (472)
+.+++..|+||||+.|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999999763 4999999999999999999999999999999999999999887 9
Q ss_pred EEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCC-CCCCCCcHHHHHHHHhcc
Q 012053 149 KVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGY-LPFHDSNLMEMYRKIGKA 227 (472)
Q Consensus 149 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~-~Pf~~~~~~~~~~~i~~~ 227 (472)
||+|||++...... ....||+.|+|||++.+....+.++||||||+++|+|++|. +||...+... ...+...
T Consensus 161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~ 233 (289)
T 4fvq_A 161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYED 233 (289)
T ss_dssp EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHT
T ss_pred eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhc
Confidence 99999998654321 23468999999999987444568999999999999999954 5555544443 3344445
Q ss_pred CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 228 EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 228 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....|...++++.+||.+||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 666777788999999999999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=368.80 Aligned_cols=257 Identities=22% Similarity=0.384 Sum_probs=209.9
Q ss_pred CcCCcccCCEEEEeeEcccCCeEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEE
Q 012053 3 NKGSILMQRYELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEV 78 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 78 (472)
..+.+..++|++++.||+|+||+||+|+ +..+++.||||++.... ....+.+.+|+.+++.++||||++++++
T Consensus 3 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 79 (295)
T 3ugc_A 3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGV 79 (295)
T ss_dssp ---CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4567888999999999999999999998 56789999999997543 3445778999999999999999999999
Q ss_pred EEe--CCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCc
Q 012053 79 MAS--KTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFG 154 (472)
Q Consensus 79 ~~~--~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFG 154 (472)
+.. ...+|+||||+++++|.+++.. .++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp ECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred EecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 854 4568999999999999999965 359999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccCC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH---------------
Q 012053 155 LSALAESKHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM--------------- 218 (472)
Q Consensus 155 la~~~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~--------------- 218 (472)
++......... .......||+.|+|||++.+..+. .++||||||+++|+|++|..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 99876443221 122334577889999999887765 8999999999999999999998654321
Q ss_pred -HHHHHHh-ccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 219 -EMYRKIG-KAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 219 -~~~~~i~-~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.....+. ......|..+++++.++|.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1122222 23456677899999999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=369.76 Aligned_cols=260 Identities=26% Similarity=0.448 Sum_probs=212.3
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC--CCCeeeEEEEEEeCC
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR--HPNVVELYEVMASKT 83 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~ 83 (472)
.+..++|++++.||+|+||.||+|.+. +++.||+|++...... ....+.+.+|+.+++.++ ||||+++++++.+++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 455678999999999999999999985 5899999999765432 345678899999999997 599999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
..|+||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 9999999 558899999865 6799999999999999999999999999999999999996 489999999999866543
Q ss_pred cCCCcccccCCCCcccChhhhccc----------CCCCCcccchhhhHHHHHHhcCCCCCCCCc-HHHHHHHHhcc--CC
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRR----------GYDGSKADIWSCGVILYVLLAGYLPFHDSN-LMEMYRKIGKA--EF 229 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~----------~~~~~~~DiwSlGvil~~lltG~~Pf~~~~-~~~~~~~i~~~--~~ 229 (472)
.........+||+.|+|||++.+. ...+.++||||||+++|+|++|..||.... .......+... ..
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 259 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence 332233456799999999998652 234579999999999999999999998753 33333333332 34
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.+|...++++.++|.+||+.||.+|||+.++++||||+..
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 5677789999999999999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=372.11 Aligned_cols=255 Identities=23% Similarity=0.375 Sum_probs=216.6
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARN-----LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (472)
.+..++|++++.||+|+||+||+|.+ ..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 45568999999999999999999985 45788999999976542 23457889999999999 899999999999
Q ss_pred EeCCEEEEEEEecCCCcccchhccC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012053 80 ASKTKIYFVMEYVKGGELFGKVAKG-------------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~~-------------------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NI 140 (472)
...+..|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 9999999999999999999988653 389999999999999999999999999999999999
Q ss_pred EEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH
Q 012053 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~ 219 (472)
|++.++.+||+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||.......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999876543332223345678899999999877664 89999999999999999 999998765443
Q ss_pred HHHHHhc-c-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 220 MYRKIGK-A-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~-~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....... . ....+..+++++.++|.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 3333322 2 334466789999999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=373.62 Aligned_cols=255 Identities=22% Similarity=0.437 Sum_probs=219.2
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEc-------CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNL-------KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYE 77 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 77 (472)
.+..++|++++.||+|+||+||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 455689999999999999999999986 467789999997653 234467789999999999 8999999999
Q ss_pred EEEeCCEEEEEEEecCCCcccchhccC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012053 78 VMASKTKIYFVMEYVKGGELFGKVAKG-----------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 78 ~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NI 140 (472)
++...+..|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 999999999999999999999998653 389999999999999999999999999999999999
Q ss_pred EEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHH
Q 012053 141 LLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLME 219 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~ 219 (472)
|++.++.+||+|||++................+|+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+..+
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 9999999999999998765433221122344678899999999776654 89999999999999999 999999988887
Q ss_pred HHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 220 MYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....+.... ...+..+++++.++|.+||..||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 777766553 55677799999999999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=366.04 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=223.0
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
...+..++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.++.
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 45677889999999999999999999999999999999997543 33577889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 84 KIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
..|+||||+.|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999999864 459999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
.... .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... ....|..++++
T Consensus 163 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T 3kfa_A 163 GDTY-TAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240 (288)
T ss_dssp SSSS-EEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred CCcc-ccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHH
Confidence 3221 112334578899999999877764 89999999999999999 99999988777666666554 45667789999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.+||.+||..||.+|||+.++++.
T Consensus 241 l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 241 VYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhCCChhhCcCHHHHHHH
Confidence 9999999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=373.99 Aligned_cols=253 Identities=22% Similarity=0.352 Sum_probs=209.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEE----EEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSV----AIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~v----AiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
+..++|++++.||+|+||+||+|++..+++.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 44679999999999999999999999888876 555554322 223467889999999999999999999999876
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
. .++|+||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 7899999999999999864 579999999999999999999999999999999999999999999999999998765
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
............||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ....+..++++
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 247 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 44333333445678899999999887765 89999999999999999 99999988777666666554 35667789999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.++|.+||..||.+|||+.++++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=366.53 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=198.2
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..++|++++.||+|+||.||+|.+..+|+.||||++...... ....+.+.++..+++.++||||+++++++.+.+.+|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 467899999999999999999999999999999999766432 2233445556667888999999999999999999999
Q ss_pred EEEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 88 VMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 88 V~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
||||+ ++.+..+.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK- 179 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence 99999 555544443 36899999999999999999999995 99999999999999999999999999987654322
Q ss_pred CCcccccCCCCcccChhhhcc----cCCCCCcccchhhhHHHHHHhcCCCCCCC-CcHHHHHHHHhccCC-CCC--CCCC
Q 012053 165 DGLLHTTCGTPAYVAPEVINR----RGYDGSKADIWSCGVILYVLLAGYLPFHD-SNLMEMYRKIGKAEF-KFP--NWFA 236 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~lltG~~Pf~~-~~~~~~~~~i~~~~~-~~~--~~~s 236 (472)
.....+||+.|+|||++.. ....+.++||||||+++|+|++|..||.. .........+..... ..+ ..++
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCC
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCC
Confidence 1245679999999999852 22335799999999999999999999987 344455555544432 233 3479
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+++.+||.+||..||.+|||++++++||||+.
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 99999999999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=363.06 Aligned_cols=256 Identities=31% Similarity=0.577 Sum_probs=208.1
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
|....++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 44567899999999999999999999999999999999987555455567788999999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 85 IYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
.|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999999988853 56999999999999999999999999999999999999999999999999998865
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC--cHHHHHHHHhccCCCC--CCCC
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS--NLMEMYRKIGKAEFKF--PNWF 235 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~--~~~~~~~~i~~~~~~~--~~~~ 235 (472)
..... ......||+.|+|||++.+..+. .++||||||+++|+|++|..||.+. +.......+....... +..+
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTS
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccccc
Confidence 43221 23456799999999999877664 8999999999999999999999764 3344555555444322 2558
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++++.++|.+||+.||.+|||+.+++++
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=357.93 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=218.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-.++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 44578999999999999999999986 6789999999766532 367889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 87 FVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 99999999999999865 5699999999999999999999999999999999999999999999999999886533211
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHH
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRL 242 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~l 242 (472)
.......||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+.... ...|..+++++.++
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 160 -TSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 237 (267)
T ss_dssp -HSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred -cccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHH
Confidence 112345678899999999877664 89999999999999999 999999988888777776653 45566789999999
Q ss_pred HhcccCCCCCCcCChhhhhcC
Q 012053 243 LSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h 263 (472)
|.+||+.||.+|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=365.07 Aligned_cols=255 Identities=24% Similarity=0.438 Sum_probs=200.8
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
.+++..++|++++.||+|+||+||+|.+. ..||+|++..... .....+.+.+|+.+++.++||||++++++. ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 57889999999999999999999999863 3599999976543 234567889999999999999999999965 556
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..++||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 68999999999999998854 5799999999999999999999999999999999999999999999999999986554
Q ss_pred ccCCCcccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhccCC-----CCCC
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGKAEF-----KFPN 233 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~-----~~~~ 233 (472)
...........||+.|+|||++.. ....+.++||||||+++|+|++|..||...... .....+..... ..+.
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence 333333455689999999999862 222347899999999999999999999875544 33334433322 2234
Q ss_pred CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 234 WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 234 ~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+++++.+||.+||..||.+|||+.++++.
T Consensus 253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 253 NCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 678999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=372.62 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=204.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT---- 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (472)
-.++|++++.||+|+||+||+|++ .++.||||++.... .......+|+.+++.++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred chhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 356899999999999999999987 48999999996543 22345667999999999999999999997743
Q ss_pred EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCcEEEcCCCCeEEecC
Q 012053 84 KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR----------GVCHRDLKPENLLLDEHGNLKVSDF 153 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~----------giiHrDIKp~NILld~~g~vkl~DF 153 (472)
.+|+||||+++|+|.+++..+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred eEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 589999999999999999988999999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhcccCCCcccccCCCCcccChhhhcccCC----CCCcccchhhhHHHHHHhcCCCCCCCCc-------------
Q 012053 154 GLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY----DGSKADIWSCGVILYVLLAGYLPFHDSN------------- 216 (472)
Q Consensus 154 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~----~~~~~DiwSlGvil~~lltG~~Pf~~~~------------- 216 (472)
|++...............+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+..
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 99987654443333455689999999999876322 2357899999999999999999996532
Q ss_pred ---HHHHHHHHhccCC--CCCCC-----CCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 217 ---LMEMYRKIGKAEF--KFPNW-----FAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 217 ---~~~~~~~i~~~~~--~~~~~-----~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.......+..... ..+.. .++++.+||.+||+.||++|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222222222211 11111 23569999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=371.73 Aligned_cols=255 Identities=21% Similarity=0.369 Sum_probs=216.3
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGM-----SVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (472)
.+..++|++++.||+|+||+||+|.+..+++ .||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4556799999999999999999999987664 79999997654 223457789999999999 899999999999
Q ss_pred EeCCEEEEEEEecCCCcccchhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC
Q 012053 80 ASKTKIYFVMEYVKGGELFGKVAK---------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE 144 (472)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~ 144 (472)
...+..|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 999999999999999999998753 35899999999999999999999999999999999999999
Q ss_pred CCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHH
Q 012053 145 HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRK 223 (472)
Q Consensus 145 ~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~ 223 (472)
++.+||+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.........
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 999999999999866543322223345678899999999877665 89999999999999998 9999987654443333
Q ss_pred Hhcc--CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 224 IGKA--EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 224 i~~~--~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+... ....|...++++.++|.+||+.||.+|||+.+++++
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 3332 344567789999999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=359.24 Aligned_cols=252 Identities=26% Similarity=0.435 Sum_probs=211.7
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhh----HHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGM----IDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
+.+..++|++.+.||+|+||+||+|++..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 4567789999999999999999999999999999999997654332211 267899999999999999999999997
Q ss_pred eCCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCC-----eEEe
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRG--VCHRDLKPENLLLDEHGN-----LKVS 151 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~g--iiHrDIKp~NILld~~g~-----vkl~ 151 (472)
+.. ++||||+++++|.+.+.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 766 799999999999888854 57999999999999999999999999 999999999999998886 9999
Q ss_pred cCcchhhhhcccCCCcccccCCCCcccChhhhccc-CCCCCcccchhhhHHHHHHhcCCCCCCCCcHH--HHHHHHhc--
Q 012053 152 DFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR-GYDGSKADIWSCGVILYVLLAGYLPFHDSNLM--EMYRKIGK-- 226 (472)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~--~~~~~i~~-- 226 (472)
|||++..... ......||+.|+|||++... ...+.++|||||||++|+|++|..||...+.. .....+..
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 9999874332 23456899999999998432 22357899999999999999999999865432 22333332
Q ss_pred cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 227 AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 227 ~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.....+..+++++.++|.+||+.||.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 3446677899999999999999999999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=369.35 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=215.1
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (472)
.+..++|++++.||+|+||+||+|.+. .+++.||+|++..... ......+.+|+.+++.+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 355679999999999999999999853 5678999999976532 23456789999999999 699999999998
Q ss_pred EeCC-EEEEEEEecCCCcccchhccCC-----------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 012053 80 ASKT-KIYFVMEYVKGGELFGKVAKGK-----------------LKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLL 141 (472)
Q Consensus 80 ~~~~-~~~lV~E~~~gg~L~~~i~~~~-----------------l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NIL 141 (472)
...+ .+|+||||+++++|.+++.... +++..++.++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7654 5999999999999999987532 899999999999999999999999999999999999
Q ss_pred EcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH-H
Q 012053 142 LDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM-E 219 (472)
Q Consensus 142 ld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~-~ 219 (472)
++.++.+||+|||++................||+.|+|||++.+..+. .++||||||+++|+|++ |..||...... .
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 999999999999999865443222223345688999999999877765 89999999999999998 99999876533 3
Q ss_pred HHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 220 MYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....+... ....+..+++++.++|.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33333333 356677899999999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=369.53 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=215.6
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEE--EEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSV--AIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKT 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~v--AiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (472)
+-.++|++.+.||+|+||.||+|++..+|..+ |+|.+.... .....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 44679999999999999999999999898865 999986532 223446788999999999 8999999999999999
Q ss_pred EEEEEEEecCCCcccchhccC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 012053 84 KIYFVMEYVKGGELFGKVAKG-----------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG 146 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g 146 (472)
..|+||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999999999998653 599999999999999999999999999999999999999999
Q ss_pred CeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHh
Q 012053 147 NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIG 225 (472)
Q Consensus 147 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~ 225 (472)
.+||+|||++........ .....+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+....+..+.
T Consensus 180 ~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 999999999874332221 2344678899999999776654 89999999999999998 999999998888887776
Q ss_pred cc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 226 KA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 226 ~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.. ....+..+++++.+||.+||..||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 65 345667789999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=359.84 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=217.4
Q ss_pred cccCCEEEEe-eEcccCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 7 ILMQRYELGR-LLGQGTFAKVHYARNL--KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 7 ~l~~~y~i~~-~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+..++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 4567898887 9999999999999864 467889999997653 234567899999999999999999999999 455
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
..|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 68999999999999999854 5699999999999999999999999999999999999999999999999999886543
Q ss_pred ccCC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHH
Q 012053 162 KHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPE 238 (472)
Q Consensus 162 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 238 (472)
.... .......||+.|+|||++.+..+. .++||||||+++|+|++ |..||...+..+....+..+. ..+|..++++
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 241 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence 2211 112334578999999999776654 89999999999999998 999999887777777766553 5677889999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENS 264 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp 264 (472)
+.++|.+||..||.+|||+.+++++.
T Consensus 242 l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 242 LYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999999999999873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=365.47 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=206.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLK---TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+..++|++++.||+|+||.||+|.+.. ++..||+|++...... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 445789999999999999999998875 4568999999765432 244577899999999999999999999997655
Q ss_pred -----EEEEEEEecCCCcccchhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEe
Q 012053 84 -----KIYFVMEYVKGGELFGKVA-------KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVS 151 (472)
Q Consensus 84 -----~~~lV~E~~~gg~L~~~i~-------~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~ 151 (472)
..|+||||+.+++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 3599999999999998873 2469999999999999999999999999999999999999999999999
Q ss_pred cCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CC
Q 012053 152 DFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EF 229 (472)
Q Consensus 152 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~ 229 (472)
|||++................+++.|+|||++.+..+. .++||||||+++|+|++ |..||...........+... ..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 268 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL 268 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence 99999866443322223345678899999999877664 89999999999999999 99999988777766666554 45
Q ss_pred CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 230 KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 230 ~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..+..+++++.++|.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6677799999999999999999999999999876
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=370.67 Aligned_cols=257 Identities=23% Similarity=0.402 Sum_probs=192.2
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS-VMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~ 84 (472)
.+..++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+. +++.++||||+++++++...+.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 4566899999999999999999999999999999999976532 223345555655 6778899999999999999999
Q ss_pred EEEEEEecCCCcccchhc------cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 85 IYFVMEYVKGGELFGKVA------KGKLKEDAARKYFQQLISAVDYCHSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~------~~~l~e~~~~~i~~ql~~al~yLH~~-giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
.|+||||+.+ +|.+++. .+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999986 6766654 46799999999999999999999999 99999999999999999999999999987
Q ss_pred hhhcccCCCcccccCCCCcccChhhhc----ccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhccC-CCC
Q 012053 158 LAESKHQDGLLHTTCGTPAYVAPEVIN----RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGKAE-FKF 231 (472)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~----~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~-~~~ 231 (472)
....... .....||+.|+|||++. +..+ +.++||||||+++|+|++|..||...+.. .....+..+. ..+
T Consensus 175 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 175 QLVDSIA---KTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp C---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred ecccccc---cccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 6543221 23457999999999983 3344 48999999999999999999999875432 2222222222 122
Q ss_pred C----CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 232 P----NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 232 ~----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
+ ..+++++.+||.+||..||.+|||+.++++||||...
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 2 3588999999999999999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=362.66 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=208.1
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEE-EEeCCEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEV-MASKTKI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~ 85 (472)
.+.++|++++.||+|+||+||+|++..+|+.||+|++...... +.+.+|+.+++.++|++++..+.. .......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 4678999999999999999999999999999999998765432 358899999999998876655554 4778899
Q ss_pred EEEEEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCCeEEecCcchhhhh
Q 012053 86 YFVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl---d~~g~vkl~DFGla~~~~ 160 (472)
|+||||+ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 999999986 4679999999999999999999999999999999999999 588899999999988655
Q ss_pred cccCC-----CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---HHHHHHHHhccCCCC-
Q 012053 161 SKHQD-----GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKIGKAEFKF- 231 (472)
Q Consensus 161 ~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~~~- 231 (472)
..... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+ ....+..+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 43221 112456899999999999877664 89999999999999999999998632 222333333322222
Q ss_pred ----CCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 232 ----PNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 232 ----~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+..+++++.++|.+||+.||.+|||+.++++.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 36689999999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=360.41 Aligned_cols=249 Identities=25% Similarity=0.421 Sum_probs=214.3
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--- 81 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 81 (472)
+..+.++|++++.||+|+||.||+|.+..+|+.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 4567789999999999999999999999999999999997653 346789999999999999999999864
Q ss_pred -------------CCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 012053 82 -------------KTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH 145 (472)
Q Consensus 82 -------------~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~ 145 (472)
...+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 4568999999999999999853 579999999999999999999999999999999999999999
Q ss_pred CCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHh
Q 012053 146 GNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIG 225 (472)
Q Consensus 146 g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~ 225 (472)
+.+||+|||++....... ......||+.|+|||++.+..+. .++||||||+++|+|++|..||... ......+.
T Consensus 159 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~ 232 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET--SKFFTDLR 232 (284)
T ss_dssp TEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH
T ss_pred CCEEECcchhheeccccc---cccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh
Confidence 999999999987654322 23456799999999999877664 8999999999999999999987532 22333333
Q ss_pred ccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 226 KAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 226 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
. ..++..+++++.++|.+||+.||.+|||+.+++++.|.-+
T Consensus 233 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 233 D--GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp T--TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred c--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 3 2356678999999999999999999999999999987754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=362.90 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=211.6
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVM 79 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 79 (472)
.+.+..++|++++.||+|+||.||+|+ +..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 355667789999999999999999999 567899999999976542 23457889999999999999999999999
Q ss_pred EeC--CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcc
Q 012053 80 ASK--TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 80 ~~~--~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGl 155 (472)
... ..+|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 876 678999999999999999843 5799999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---------------HHH
Q 012053 156 SALAESKHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---------------LME 219 (472)
Q Consensus 156 a~~~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---------------~~~ 219 (472)
+......... .......||+.|+|||++.+..+. .++||||||+++|+|++|..|+.... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 8865433211 123345788899999999877665 78999999999999999999864321 112
Q ss_pred HHHHHhc-cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 220 MYRKIGK-AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 220 ~~~~i~~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
....+.. .....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2222222 345567789999999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=376.73 Aligned_cols=255 Identities=23% Similarity=0.381 Sum_probs=207.5
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
.+..++|++.+.||+|+||+||+|++. .++..||||++.... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 455678999999999999999999987 467789999997543 234457789999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
+..|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999999999975 379999999999999999999999999999999999999999999999999998765
Q ss_pred cccCCC-cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCH
Q 012053 161 SKHQDG-LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAP 237 (472)
Q Consensus 161 ~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 237 (472)
...... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+... ....+..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA 277 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 432211 11223457889999999877765 89999999999999998 99999988887777766554 3455667899
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++.++|.+||+.||.+|||+.+|++.
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHHH
Confidence 99999999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=354.38 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=216.2
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
...+..++|++++.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.. +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 45577789999999999999999999974 667899999976542 24678999999999999999999999864 4
Q ss_pred EEEEEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 84 KIYFVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
..|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 589999999999999999752 79999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
.... .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||.+.+..+....+... ....+..++++
T Consensus 161 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 161 DNEY-TAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238 (279)
T ss_dssp SSCE-ECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred Cccc-ccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHH
Confidence 3221 112334578899999999766654 89999999999999999 99999998887777776654 34566778999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+.++|.+||..||++|||+.++++
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=364.92 Aligned_cols=255 Identities=21% Similarity=0.332 Sum_probs=212.3
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTG----MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
.+..++|++.+.||+|+||+||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 355679999999999999999999987653 359999997543 22345678899999999999999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
.+..|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999999999864 57999999999999999999999999999999999999999999999999999876
Q ss_pred hcccCCC-cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCC
Q 012053 160 ESKHQDG-LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFA 236 (472)
Q Consensus 160 ~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s 236 (472)
....... ......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+..+....+... ....+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 276 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred ccccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCC
Confidence 4432211 12233568899999999877665 89999999999999999 99999988887777777655 455667789
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+++.++|.+||+.||.+|||+.+++++
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=372.79 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=208.5
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..++|++.+.||+|+||+||+|.+ .+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 467999999999999999999996 4789999999866532 345778999999999999999999999999999999
Q ss_pred EEEecCCCcccchhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 88 VMEYVKGGELFGKVAKG-----KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~-----~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999998652 4899999999999999999999999999999999999999999999999998765433
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHH-------HHHHhccC------C
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM-------YRKIGKAE------F 229 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~-------~~~i~~~~------~ 229 (472)
.........+||+.|+|||++.+..+. .++||||||+++|+|++|..||........ ........ .
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 332233455689999999999777664 899999999999999999999976432111 01111111 1
Q ss_pred CC----CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCc
Q 012053 230 KF----PNWFAPEVRRLLSKILDPNPNTRISMTKIMENS 264 (472)
Q Consensus 230 ~~----~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp 264 (472)
.. +...+..+.+++.+||+.||++|||+.+++++-
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11 122346788999999999999999999999873
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=358.99 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=212.8
Q ss_pred ccCCEEEEe-eEcccCCeEEEEEEE--cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 8 LMQRYELGR-LLGQGTFAKVHYARN--LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 8 l~~~y~i~~-~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
-.++|++.+ .||+|+||+||+|.+ ..+++.||||++..... .....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 356899998 999999999999954 45688999999976542 224467899999999999999999999999 5667
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
.|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 8999999999999999976 569999999999999999999999999999999999999999999999999987654322
Q ss_pred CC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHH
Q 012053 164 QD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVR 240 (472)
Q Consensus 164 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~ 240 (472)
.. .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+.... ...|..+++++.
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 250 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11 112234577899999999776654 79999999999999999 999999988877777766553 566778999999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012053 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++|.+||+.||.+|||+.++++
T Consensus 251 ~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 251 DLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=381.09 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=210.4
Q ss_pred CcCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 3 ~~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
..++++.++|++++.||+|+||+||+|++..+|+.||||++...... ...+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (396)
T ss_dssp CEEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CCCCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence 35677889999999999999999999999999999999999765432 3356778999999999999999999999876
Q ss_pred C--EEEEEEEecCCCcccchhccC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCCeEEec
Q 012053 83 T--KIYFVMEYVKGGELFGKVAKG----KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL----DEHGNLKVSD 152 (472)
Q Consensus 83 ~--~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl----d~~g~vkl~D 152 (472)
+ ..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence 5 789999999999999998752 39999999999999999999999999999999999999 7778899999
Q ss_pred CcchhhhhcccCCCcccccCCCCcccChhhhccc-------CCCCCcccchhhhHHHHHHhcCCCCCCC----CcHHHHH
Q 012053 153 FGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR-------GYDGSKADIWSCGVILYVLLAGYLPFHD----SNLMEMY 221 (472)
Q Consensus 153 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-------~~~~~~~DiwSlGvil~~lltG~~Pf~~----~~~~~~~ 221 (472)
||++....... .....+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.. ....+..
T Consensus 160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp GGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred CCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 99998654332 23456899999999998652 2224789999999999999999999964 2223444
Q ss_pred HHHhccCCC-------------------CC------CCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 222 RKIGKAEFK-------------------FP------NWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 222 ~~i~~~~~~-------------------~~------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.++..+... +| ..+++.+.++|.+||+.||++|||+++++++
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 444333211 11 1234578899999999999999999998654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=369.21 Aligned_cols=253 Identities=16% Similarity=0.210 Sum_probs=200.9
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcC---CCcEEEEEEeecccccchh--------hHHHHHHHHHHHHhcCCCCeeeEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLK---TGMSVAIKIIDKEKVLKVG--------MIDQIKREISVMRLVRHPNVVELYE 77 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l~~ 77 (472)
.++|++++.||+|+||+||+|.+.. ++..||+|++......... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 7899999999765321100 1133567889999999999999999
Q ss_pred EEEe----CCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC--CeEE
Q 012053 78 VMAS----KTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG--NLKV 150 (472)
Q Consensus 78 ~~~~----~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g--~vkl 150 (472)
++.. ....|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9987 78999999999 9999999975 5899999999999999999999999999999999999999887 9999
Q ss_pred ecCcchhhhhcccCC-----CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCC--CcHHHHHHH
Q 012053 151 SDFGLSALAESKHQD-----GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHD--SNLMEMYRK 223 (472)
Q Consensus 151 ~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~--~~~~~~~~~ 223 (472)
+|||+++........ ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.. .+.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 999999765433211 112456899999999999877654 899999999999999999999965 222222222
Q ss_pred HhccCCCCC---------CCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 224 IGKAEFKFP---------NWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 224 i~~~~~~~~---------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
........| ..+++++.++|.+||..||++|||+.+|++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 211111222 2688999999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=358.87 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=202.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEE-EEeCCEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEV-MASKTKI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~ 85 (472)
.+.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.++|++++..+.. +...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 4568999999999999999999999999999999997655432 347889999999998776665555 4778899
Q ss_pred EEEEEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCCeEEecCcchhhhh
Q 012053 86 YFVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl---d~~g~vkl~DFGla~~~~ 160 (472)
|+||||+ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999999 999999987 4679999999999999999999999999999999999999 789999999999998665
Q ss_pred cccCC-----CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH---HHHHHHHhccCCCCC
Q 012053 161 SKHQD-----GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL---MEMYRKIGKAEFKFP 232 (472)
Q Consensus 161 ~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~---~~~~~~i~~~~~~~~ 232 (472)
..... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+. ...+..+.......|
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 43221 122356899999999999877764 899999999999999999999976322 122333333222222
Q ss_pred -----CCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 233 -----NWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 233 -----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
..+++++.++|.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 568999999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=354.93 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=212.4
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
.+..++|++.+.||+|+||+||+|.+... +..||+|++.... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 45678999999999999999999997643 4469999997653 223457889999999999999999999998654
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
..|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 56899999999999999865 469999999999999999999999999999999999999999999999999988654
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
.... .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...........+... ....+..+++.
T Consensus 165 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (281)
T 3cc6_A 165 DEDY-YKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV 242 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred cccc-cccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence 3221 112345678899999999777664 89999999999999998 99999876665555555443 45567779999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.++|.+||..||.+|||+.+++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=376.24 Aligned_cols=257 Identities=15% Similarity=0.201 Sum_probs=201.7
Q ss_pred cCCccc----CCEEEEeeEcccCCeEEEEEEEcCC-----CcEEEEEEeecccccchhh--------HHHHHHHHHHHHh
Q 012053 4 KGSILM----QRYELGRLLGQGTFAKVHYARNLKT-----GMSVAIKIIDKEKVLKVGM--------IDQIKREISVMRL 66 (472)
Q Consensus 4 ~g~~l~----~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~--------~~~~~~Ei~il~~ 66 (472)
.|.++. ++|++++.||+|+||.||+|.+..+ ++.||||++.......... ...+.+|+..++.
T Consensus 25 ~g~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~ 104 (364)
T 3op5_A 25 VGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRK 104 (364)
T ss_dssp TTCEEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCcEeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhh
Confidence 355554 4999999999999999999998764 5889999987654211000 1223345666777
Q ss_pred cCCCCeeeEEEEEEeC----CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 012053 67 VRHPNVVELYEVMASK----TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENL 140 (472)
Q Consensus 67 l~hpnIv~l~~~~~~~----~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NI 140 (472)
++||||+++++++... ...|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 105 l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Ni 183 (364)
T 3op5_A 105 LKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNL 183 (364)
T ss_dssp CSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred ccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHE
Confidence 8899999999998664 5689999999 9999999865 5799999999999999999999999999999999999
Q ss_pred EEc--CCCCeEEecCcchhhhhcccCCC-----cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCC
Q 012053 141 LLD--EHGNLKVSDFGLSALAESKHQDG-----LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH 213 (472)
Q Consensus 141 Lld--~~g~vkl~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~ 213 (472)
|++ .++.+||+|||+++......... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCcc
Confidence 999 88999999999997654432211 12345699999999999877764 89999999999999999999998
Q ss_pred CCcHHHHHHHHhc----cC-------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 214 DSNLMEMYRKIGK----AE-------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 214 ~~~~~~~~~~i~~----~~-------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+......+..... .. .-.+..+++++.++|.+||..||.+|||+.+|++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 263 DNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp GGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 5322111111100 00 0012557899999999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=378.92 Aligned_cols=244 Identities=28% Similarity=0.497 Sum_probs=212.0
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-E
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-K 84 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~ 84 (472)
.+..++|++++.||+|+||+||+|.+ +|+.||||++.... ..+.+.+|+.+|+.++||||+++++++.... .
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 35567899999999999999999988 57899999997653 2367889999999999999999999986655 7
Q ss_pred EEEEEEecCCCcccchhcc-C--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 85 IYFVMEYVKGGELFGKVAK-G--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+|+||||+++|+|.+++.. + .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999999975 3 379999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEV 239 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l 239 (472)
. .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+..+ ....|..+++++
T Consensus 342 ~-----~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 342 T-----QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 415 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHH
T ss_pred c-----ccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 1 1234678999999999877765 89999999999999998 99999987776666666554 456788899999
Q ss_pred HHHHhcccCCCCCCcCChhhhhc
Q 012053 240 RRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.+||.+||+.||.+|||+.+|++
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=364.10 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=211.8
Q ss_pred CcccCCE-EEEeeEcccCCeEEEEEEE----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012053 6 SILMQRY-ELGRLLGQGTFAKVHYARN----LKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 6 ~~l~~~y-~i~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
.++.+|| ++++.||+|+||+||++.. ..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 4577777 9999999999999988754 4578999999997653 2344677899999999999999999999998
Q ss_pred e--CCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhh
Q 012053 81 S--KTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 81 ~--~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~ 158 (472)
+ ...+|+||||+++++|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred cCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 7 47899999999999999999988899999999999999999999999999999999999999999999999999986
Q ss_pred hhcccCC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH---------------HHHH
Q 012053 159 AESKHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM---------------EMYR 222 (472)
Q Consensus 159 ~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~---------------~~~~ 222 (472)
....... .......||+.|+|||++.+..+. .++||||||+++|+|++|..||...... ....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 5432211 112345688899999999877665 8999999999999999999999764321 1112
Q ss_pred HHhc-cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 223 KIGK-AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 223 ~i~~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.+.. .....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2222 244567779999999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=380.26 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=216.1
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++.+.||+|+||+||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++. ...+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 455678999999999999999999985 578899999976542 3577899999999999999999999986 5678
Q ss_pred EEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 86 YFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999999999975 37999999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
... ......+|+.|+|||++....+. .++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++++.
T Consensus 338 ~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 415 (454)
T 1qcf_A 338 EYT-AREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 415 (454)
T ss_dssp HHH-TTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred cee-ccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 111 11234567889999999877665 89999999999999999 99999998887777776654 3556778999999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012053 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+||.+||..||.+|||+.+|++.
T Consensus 416 ~li~~cl~~dp~~RPt~~~i~~~ 438 (454)
T 1qcf_A 416 NIMMRCWKNRPEERPTFEYIQSV 438 (454)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999999999999763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=356.76 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=202.1
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--cCCCCeeeEEEEEEe-
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL--VRHPNVVELYEVMAS- 81 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~- 81 (472)
+.++.++|++++.||+|+||+||+|++ +|+.||||++.... ...+.+|.+++.. ++||||+++++++..
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 457889999999999999999999988 79999999986542 2455667777776 799999999998643
Q ss_pred ---CCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEcCCCCeEE
Q 012053 82 ---KTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCH--------SRGVCHRDLKPENLLLDEHGNLKV 150 (472)
Q Consensus 82 ---~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH--------~~giiHrDIKp~NILld~~g~vkl 150 (472)
...+|+||||+++|+|.+++..+.+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred cCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 356899999999999999998889999999999999999999999 999999999999999999999999
Q ss_pred ecCcchhhhhcccCC--CcccccCCCCcccChhhhcccCCC-----CCcccchhhhHHHHHHhcC----------CCCCC
Q 012053 151 SDFGLSALAESKHQD--GLLHTTCGTPAYVAPEVINRRGYD-----GSKADIWSCGVILYVLLAG----------YLPFH 213 (472)
Q Consensus 151 ~DFGla~~~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~-----~~~~DiwSlGvil~~lltG----------~~Pf~ 213 (472)
+|||++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999998754432211 112345899999999999765332 2589999999999999999 88886
Q ss_pred CC----cHHHHHHHHhcc---CCCCCC-----CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 214 DS----NLMEMYRKIGKA---EFKFPN-----WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 214 ~~----~~~~~~~~i~~~---~~~~~~-----~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.. ............ ....|. ..++++.+||.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 52 122222232221 122222 144789999999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=387.51 Aligned_cols=252 Identities=24% Similarity=0.420 Sum_probs=219.4
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++.+.||+|+||+||+|.+..++..||||++..... ..+.+.+|+.+|+.++||||+++++++.....+
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 3455689999999999999999999998999999999976542 246789999999999999999999999999999
Q ss_pred EEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 86 YFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999999999864 46999999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
.. .......+|+.|+|||++....+. .++|||||||++|+|++ |..||.+.+....+..+... ....|..+++++.
T Consensus 372 ~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 449 (495)
T 1opk_A 372 TY-TAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 449 (495)
T ss_dssp CE-ECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ce-eecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11 112234567889999999877664 89999999999999999 99999988777666666544 3566778999999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012053 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+||.+||+.||.+|||+.+|++.
T Consensus 450 ~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 450 ELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCcChhHCcCHHHHHHH
Confidence 99999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=355.21 Aligned_cols=245 Identities=28% Similarity=0.488 Sum_probs=206.3
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-KTK 84 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~ 84 (472)
.+..++|++++.||+|+||+||+|.+ +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.. .+.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 35678999999999999999999987 58999999987543 34678899999999999999999999754 457
Q ss_pred EEEEEEecCCCcccchhccC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 85 IYFVMEYVKGGELFGKVAKG---KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.|+||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 89999999999999998753 389999999999999999999999999999999999999999999999999875543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEV 239 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l 239 (472)
.. ....+++.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+... ....+..+++++
T Consensus 170 ~~-----~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 170 TQ-----DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred cc-----cCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence 22 344688999999999877664 89999999999999998 99999988777666666554 456677899999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.++|.+||..||.+|||+.++++.
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~~ 267 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLREQ 267 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHHH
Confidence 999999999999999999999863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=354.87 Aligned_cols=250 Identities=21% Similarity=0.380 Sum_probs=210.7
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE-E
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGM---SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI-Y 86 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-~ 86 (472)
+|++.+.||+|+||+||+|.+..+++ .||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57778999999999999999876655 79999986533 334567889999999999999999999999766654 9
Q ss_pred EEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc-
Q 012053 87 FVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH- 163 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~- 163 (472)
+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999975 579999999999999999999999999999999999999999999999999997553322
Q ss_pred -CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012053 164 -QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 164 -~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
.........+|+.|+|||.+.+..+. .++||||||+++|+|++ |.+||...+.......+... ....+..+++++.
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 258 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence 11223455788999999999877665 89999999999999999 55556666665655555544 3556777999999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012053 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++|.+||+.||.+|||+.++++.
T Consensus 259 ~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 259 QVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=356.66 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=209.0
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEE-EeCCE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTG---MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVM-ASKTK 84 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~ 84 (472)
..+|++.+.||+|+||+||+|.+..++ ..||+|.+.... .....+.+.+|+.+++.++||||+++++++ ..++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 347999999999999999999976443 368999987533 334567889999999999999999999985 55678
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
.|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 8999999999999999965 56899999999999999999999999999999999999999999999999999765432
Q ss_pred cC--CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHH
Q 012053 163 HQ--DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPE 238 (472)
Q Consensus 163 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 238 (472)
.. ........||+.|+|||++.+..+. .++||||||+++|+|++ |.+||...+.......+.... ...|..++++
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred chhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 21 1122345678899999999877665 89999999999999999 677787766665555555444 4456778999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.++|.+||+.||.+|||+.++++.
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=358.47 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=207.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcC-CCc--EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLK-TGM--SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+..++|++++.||+|+||+||+|.+.. +++ .||+|++...........+.+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 446799999999999999999998653 333 69999997765444456788999999999999999999999998766
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.++||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 8999999999999998865 5799999999999999999999999999999999999999999999999999876543
Q ss_pred ccCC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC--CCCCCCCCH
Q 012053 162 KHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE--FKFPNWFAP 237 (472)
Q Consensus 162 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~ 237 (472)
.... .......+|+.|+|||++.+..+. .++||||||+++|+|++ |..||...+.......+.... ...+..+++
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 252 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence 2211 112345678899999999776654 89999999999999999 999999988888777776553 445567899
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++.++|.+||..||.+|||+.+++++
T Consensus 253 ~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 253 DIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=362.37 Aligned_cols=252 Identities=23% Similarity=0.386 Sum_probs=204.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE----eCCE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA----SKTK 84 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~ 84 (472)
.++|++++.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 468999999999999999999999999999999986542 244577899999999999999999999986 3458
Q ss_pred EEEEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhh
Q 012053 85 IYFVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~ 159 (472)
.|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 8999999999999988854 57999999999999999999999999999999999999999999999999987654
Q ss_pred hcccCC-------CcccccCCCCcccChhhhcccCC--CCCcccchhhhHHHHHHhcCCCCCCCCcH--HHHHHHHh-cc
Q 012053 160 ESKHQD-------GLLHTTCGTPAYVAPEVINRRGY--DGSKADIWSCGVILYVLLAGYLPFHDSNL--MEMYRKIG-KA 227 (472)
Q Consensus 160 ~~~~~~-------~~~~~~~gt~~Y~aPE~l~~~~~--~~~~~DiwSlGvil~~lltG~~Pf~~~~~--~~~~~~i~-~~ 227 (472)
...... .......||+.|+|||++..... .+.++||||||+++|+|++|..||..... ......+. ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 321111 00123468999999999865432 24799999999999999999999953111 01111111 22
Q ss_pred CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 228 EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 228 ~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....+..+++++.++|.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 234445689999999999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=369.12 Aligned_cols=250 Identities=14% Similarity=0.237 Sum_probs=206.0
Q ss_pred cCCcc----cCCEEEEeeEcccCCeEEEEEEEcCC--------CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC
Q 012053 4 KGSIL----MQRYELGRLLGQGTFAKVHYARNLKT--------GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71 (472)
Q Consensus 4 ~g~~l----~~~y~i~~~LG~G~fg~Vy~a~~~~~--------g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 71 (472)
.|+++ .++|++++.||+|+||.||+|++..+ ++.||+|++... +.+.+|+.+++.++|||
T Consensus 32 ~g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~n 103 (352)
T 2jii_A 32 TGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPL 103 (352)
T ss_dssp TTCEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHH
T ss_pred CCceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccc
Confidence 46666 47999999999999999999999874 889999998754 34779999999999999
Q ss_pred eee---------------EEEEEEe-CCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 012053 72 VVE---------------LYEVMAS-KTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCH 132 (472)
Q Consensus 72 Iv~---------------l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiH 132 (472)
|++ +++++.. +...|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+|
T Consensus 104 iv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH 182 (352)
T 2jii_A 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVH 182 (352)
T ss_dssp HHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred hhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 987 6777766 78999999999 9999999975 57999999999999999999999999999
Q ss_pred cCCCCCcEEEcCCC--CeEEecCcchhhhhcccCC-----CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHH
Q 012053 133 RDLKPENLLLDEHG--NLKVSDFGLSALAESKHQD-----GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVL 205 (472)
Q Consensus 133 rDIKp~NILld~~g--~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~l 205 (472)
|||||+|||++.++ .+||+|||++......... .......||+.|+|||++.+..+. .++|||||||++|+|
T Consensus 183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el 261 (352)
T 2jii_A 183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKW 261 (352)
T ss_dssp SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHH
Confidence 99999999999998 8999999999765443221 122345899999999999877664 899999999999999
Q ss_pred hcCCCCCCCCc--HHHHHHHH---hccCCCCC------CCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 206 LAGYLPFHDSN--LMEMYRKI---GKAEFKFP------NWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 206 ltG~~Pf~~~~--~~~~~~~i---~~~~~~~~------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++|..||.... ........ ......++ ..+++++.+||.+||+.||.+|||+.++++.
T Consensus 262 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 262 LYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp HHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 99999998753 22222222 22222222 2468999999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=362.12 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=213.4
Q ss_pred CCcc-cCCEEEEeeEcccCCeEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 012053 5 GSIL-MQRYELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVM 79 (472)
Q Consensus 5 g~~l-~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 79 (472)
++++ .++|++++.||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence 3444 4699999999999999999999 56789999999997653 23456789999999999999999999998
Q ss_pred E--eCCEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcc
Q 012053 80 A--SKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 80 ~--~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGl 155 (472)
. .....|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence 6 56789999999999999999865 5699999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcccCC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH---------------H
Q 012053 156 SALAESKHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM---------------E 219 (472)
Q Consensus 156 a~~~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~---------------~ 219 (472)
+......... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... .
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 9865432211 11234568889999999977665 48999999999999999999998654322 2
Q ss_pred HHHHHhc-cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 220 MYRKIGK-AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....+.. .....+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222222 2345677899999999999999999999999999876
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=376.40 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=211.4
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++.+.||+|+||+||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.. +..
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 3556789999999999999999999864 46799999976542 23678999999999999999999999866 678
Q ss_pred EEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 86 YFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999999964 46999999999999999999999999999999999999999999999999999865432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
.. .......+|+.|+|||++....+. .++|||||||++|+|++ |..||.+....+....+..+ ....|..+++++.
T Consensus 334 ~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 411 (452)
T 1fmk_A 334 EY-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 411 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred ce-ecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 21 112234578899999999877665 89999999999999999 99999998887777777655 3566778999999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012053 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+||.+||+.||++|||+++|++.
T Consensus 412 ~li~~cl~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 412 DLMCQCWRKEPEERPTFEYLQAF 434 (452)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=373.18 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=198.4
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKT 83 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (472)
...+.+.|.+.+.||+|+||+||.+. ..+|+.||||.+.... .+.+.+|+.+|+.+ +||||+++++++.+++
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 44567788899999999999998754 5689999999986542 35678999999876 8999999999999999
Q ss_pred EEEEEEEecCCCcccchhccCCC--------CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC----------
Q 012053 84 KIYFVMEYVKGGELFGKVAKGKL--------KEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH---------- 145 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l--------~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~---------- 145 (472)
.+|+||||+. |+|.+++..... ++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 9999999996 599999876432 233457899999999999999999999999999999754
Q ss_pred ---CCeEEecCcchhhhhcccCC--CcccccCCCCcccChhhhcc------cCCCCCcccchhhhHHHHHHhc-CCCCCC
Q 012053 146 ---GNLKVSDFGLSALAESKHQD--GLLHTTCGTPAYVAPEVINR------RGYDGSKADIWSCGVILYVLLA-GYLPFH 213 (472)
Q Consensus 146 ---g~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~Y~aPE~l~~------~~~~~~~~DiwSlGvil~~llt-G~~Pf~ 213 (472)
+.+||+|||++......... ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 47999999999866443211 12345689999999999965 2334589999999999999999 999997
Q ss_pred CCcHHHHHHHHhccCCCCCC-------CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 214 DSNLMEMYRKIGKAEFKFPN-------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 214 ~~~~~~~~~~i~~~~~~~~~-------~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+..... ..+.......+. .+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 242 DKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp STTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 754433 223333333221 23578999999999999999999999999999964
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=361.37 Aligned_cols=250 Identities=24% Similarity=0.432 Sum_probs=200.4
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc--CCCCeeeEEEEEEeC-
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV--RHPNVVELYEVMASK- 82 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~~~~~~~- 82 (472)
..+.++|++++.||+|+||.||+|.+ +|+.||||++.... .....+|..++..+ +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 45678999999999999999999988 48999999986442 23445566666554 899999999999887
Q ss_pred ---CEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEcCCCCeEEe
Q 012053 83 ---TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR--------GVCHRDLKPENLLLDEHGNLKVS 151 (472)
Q Consensus 83 ---~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~--------giiHrDIKp~NILld~~g~vkl~ 151 (472)
...|+||||+++|+|.+++....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7999999999999999999888999999999999999999999999 99999999999999999999999
Q ss_pred cCcchhhhhcccCCC--cccccCCCCcccChhhhcccCCCCC-----cccchhhhHHHHHHhcC----------CCCCCC
Q 012053 152 DFGLSALAESKHQDG--LLHTTCGTPAYVAPEVINRRGYDGS-----KADIWSCGVILYVLLAG----------YLPFHD 214 (472)
Q Consensus 152 DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~-----~~DiwSlGvil~~lltG----------~~Pf~~ 214 (472)
|||++.......... .....+||+.|+|||++.+..+... ++|||||||++|+|++| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999987554322211 1235689999999999977655432 38999999999999999 777754
Q ss_pred C-----cHHHHHHHHh--ccCCCCCC-----CCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 215 S-----NLMEMYRKIG--KAEFKFPN-----WFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 215 ~-----~~~~~~~~i~--~~~~~~~~-----~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
. ........+. .....+|. .+++++.+||.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2 1122222222 12223332 245679999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=375.18 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=196.9
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+|++.+.||+|+||+|+. ....+|+.||||++...... .+.+|+.+|+.+ +||||+++++++.+....|+||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 599999999999999764 44568999999999765432 246899999999 7999999999999999999999
Q ss_pred EecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CC--CeEEecCcchhhhhcc
Q 012053 90 EYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE---HG--NLKVSDFGLSALAESK 162 (472)
Q Consensus 90 E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~---~g--~vkl~DFGla~~~~~~ 162 (472)
||+. |+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++ .+||+|||+|......
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9996 5899988753 4666678899999999999999999999999999999953 23 5789999999865432
Q ss_pred cC-CCcccccCCCCcccChhhhccc--CCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccCCCC---CCCC
Q 012053 163 HQ-DGLLHTTCGTPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEFKF---PNWF 235 (472)
Q Consensus 163 ~~-~~~~~~~~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~ 235 (472)
.. .......+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||...........+....... +...
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence 21 1223456899999999998742 233478999999999999999 999997665544433333222221 1224
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
++.+.+||.+||+.||.+|||+.++++||||..
T Consensus 257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 566899999999999999999999999999964
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=353.14 Aligned_cols=231 Identities=30% Similarity=0.610 Sum_probs=191.8
Q ss_pred cccCCEEEE-eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhcCCCCeeeEEEEEEe---
Q 012053 7 ILMQRYELG-RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLVRHPNVVELYEVMAS--- 81 (472)
Q Consensus 7 ~l~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~--- 81 (472)
.+.++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 355677777 8899999999999999999999999998643 3567888888 66799999999999987
Q ss_pred -CCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCCeEEecCc
Q 012053 82 -KTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE---HGNLKVSDFG 154 (472)
Q Consensus 82 -~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~---~g~vkl~DFG 154 (472)
...+|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 7789999999999999999865 26999999999999999999999999999999999999998 7889999999
Q ss_pred chhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHH----HhccCCC
Q 012053 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRK----IGKAEFK 230 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~----i~~~~~~ 230 (472)
++..... ..+ +.++|||||||++|+|++|..||...+....... +......
T Consensus 166 ~a~~~~~------------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 166 FAKETTG------------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220 (299)
T ss_dssp TCEECTT------------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred ccccccc------------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence 8764321 122 3689999999999999999999987655433221 1222333
Q ss_pred CC----CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 231 FP----NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 231 ~~----~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
++ ..+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 33 45899999999999999999999999999999998643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=366.45 Aligned_cols=246 Identities=15% Similarity=0.224 Sum_probs=201.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEE-----EEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC---CCCeeeEEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYA-----RNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR---HPNVVELYEV 78 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a-----~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~ 78 (472)
+..++|++.+.||+|+||+||+| .+..+++.||+|++.... ...+.+|+.+++.++ |+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 34568999999999999999999 467789999999996543 356778888888887 9999999999
Q ss_pred EEeCCEEEEEEEecCCCcccchhc------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--------
Q 012053 79 MASKTKIYFVMEYVKGGELFGKVA------KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-------- 144 (472)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~------~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~-------- 144 (472)
+...+..|+||||++||+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999999985 357999999999999999999999999999999999999998
Q ss_pred ---CCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHH
Q 012053 145 ---HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMY 221 (472)
Q Consensus 145 ---~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~ 221 (472)
++.+||+|||+|...............+||+.|+|||++.+..++ .++|||||||++|+|++|..||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 899999999999765433333345667899999999999887765 89999999999999999999996543211
Q ss_pred HHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 222 RKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 222 ~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
..........+.++.+.+++.+||..+|.+|++..+.+.+
T Consensus 293 --~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 293 --CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp --EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred --eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 0000111112357789999999999999999765554443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=353.24 Aligned_cols=242 Identities=29% Similarity=0.501 Sum_probs=199.5
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-.++|++.+.||+|+||+||+|.+ .++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 3456899999999999999999988 5789999998643 234678899999999999999999998864 479
Q ss_pred EEEEecCCCcccchhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCcEEEcCCCC-eEEecCcchhh
Q 012053 87 FVMEYVKGGELFGKVAKG----KLKEDAARKYFQQLISAVDYCHS---RGVCHRDLKPENLLLDEHGN-LKVSDFGLSAL 158 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~al~yLH~---~giiHrDIKp~NILld~~g~-vkl~DFGla~~ 158 (472)
+||||++|++|.+++... .+++..++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 999999999999999753 37899999999999999999999 89999999999999999887 79999999875
Q ss_pred hhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc--HHHHHHHHh-ccCCCCCCCC
Q 012053 159 AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN--LMEMYRKIG-KAEFKFPNWF 235 (472)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~--~~~~~~~i~-~~~~~~~~~~ 235 (472)
.... .....||+.|+|||++.+..+. .++||||||+++|+|++|..||.... .......+. ......+..+
T Consensus 156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 156 IQTH-----MTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred cccc-----cccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence 5432 2345799999999999877664 89999999999999999999997542 223333332 2344566778
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++.+.++|.+||+.||.+|||+++++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=367.09 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=201.5
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCCEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTG---MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA-SKTKIY 86 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~ 86 (472)
+|++.+.||+|+||+||+|.+..++ ..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 5899999999999999999986543 468999986532 2345678999999999999999999999864 556889
Q ss_pred EEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 87 FVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 99999999999999975 4689999999999999999999999999999999999999999999999999986543221
Q ss_pred CC--cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHH
Q 012053 165 DG--LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVR 240 (472)
Q Consensus 165 ~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~ 240 (472)
.. ......+|+.|+|||++.+..+. .++|||||||++|+|++ |.+||...+..+....+..+. ...|..+++++.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~ 326 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11 12334678899999999877665 89999999999999999 788888766555555554443 455677999999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012053 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
++|.+||..||.+|||+.+++++
T Consensus 327 ~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 327 EVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=357.95 Aligned_cols=250 Identities=29% Similarity=0.436 Sum_probs=187.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEE-------
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMA------- 80 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~------- 80 (472)
..+|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+++.+. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 458999999999999999999999999999999985543 234567889999999996 999999999983
Q ss_pred -eCCEEEEEEEecCCCcccchhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCCeEEecC
Q 012053 81 -SKTKIYFVMEYVKGGELFGKVAK----GKLKEDAARKYFQQLISAVDYCHSRG--VCHRDLKPENLLLDEHGNLKVSDF 153 (472)
Q Consensus 81 -~~~~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~al~yLH~~g--iiHrDIKp~NILld~~g~vkl~DF 153 (472)
....+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 4456899999996 688777643 57999999999999999999999999 999999999999999999999999
Q ss_pred cchhhhhcccCC----------CcccccCCCCcccChhhhc---ccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHH
Q 012053 154 GLSALAESKHQD----------GLLHTTCGTPAYVAPEVIN---RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM 220 (472)
Q Consensus 154 Gla~~~~~~~~~----------~~~~~~~gt~~Y~aPE~l~---~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~ 220 (472)
|++......... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 998765432111 0112457999999999983 3333 5799999999999999999999987655433
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcc
Q 012053 221 YRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSW 265 (472)
Q Consensus 221 ~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~ 265 (472)
.... .....+...++.+.+||.+||+.||.+|||+.+++++-+
T Consensus 262 ~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 262 VNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 3221 223344557788999999999999999999999998843
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=379.18 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=215.8
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.+..++|++.+.||+|+||+||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.. ..+
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 4567789999999999999999999864 46799999976542 23678999999999999999999999866 678
Q ss_pred EEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 86 YFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
|+||||+.+|+|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999999999964 46999999999999999999999999999999999999999999999999999865422
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVR 240 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~ 240 (472)
... ......++..|+|||++....+. .++|||||||++|+|++ |..||.+....+....+..+ ....|..+++++.
T Consensus 417 ~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 494 (535)
T 2h8h_A 417 EYT-ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 494 (535)
T ss_dssp HHH-TTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cee-cccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 110 11234567899999999877665 89999999999999999 99999998887777777655 3556778999999
Q ss_pred HHHhcccCCCCCCcCChhhhhcC
Q 012053 241 RLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+||.+||+.||++|||+++|++.
T Consensus 495 ~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 495 DLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=383.62 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=209.6
Q ss_pred EEEE-eeEcccCCeEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 12 YELG-RLLGQGTFAKVHYARNL--KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 12 y~i~-~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+.+. +.||+|+||+||+|.+. .+++.||||++..... .....+.+.+|+.+|+.++|||||++++++..+ ..|+|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEE
Confidence 4443 48999999999999654 5678999999976532 234567899999999999999999999999754 58899
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC-C
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD-G 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~-~ 166 (472)
|||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999999999975 57999999999999999999999999999999999999999999999999999876543221 1
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHHHHh
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLS 244 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~li~ 244 (472)
......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+. ...|..+++++.+||.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp -------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 12334578899999999877765 89999999999999998 999999988888877776654 5677889999999999
Q ss_pred cccCCCCCCcCChhhhhcC
Q 012053 245 KILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 245 ~~L~~dP~~Rpt~~eil~h 263 (472)
+||+.||++|||+.+|++.
T Consensus 607 ~cl~~dP~~RPs~~~l~~~ 625 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVELR 625 (635)
T ss_dssp HHTCSSTTTSCCHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=360.47 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=204.3
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++.+.||+|+||+||+|.+ .+|+.||||++....... ....+.+|+.+++.++||||+++++++.+.+..|
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 4567999999999999999999985 478999999997654321 1236889999999999999999999999999999
Q ss_pred EEEEecCCCcccchhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEcCCCCeEEecCcchhh
Q 012053 87 FVMEYVKGGELFGKVAKG-----KLKEDAARKYFQQLISAVDYCHSR---GVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~~-----~l~e~~~~~i~~ql~~al~yLH~~---giiHrDIKp~NILld~~g~vkl~DFGla~~ 158 (472)
+||||+.+|+|.+++... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 999999999999988652 499999999999999999999999 999999999999999999999999999986
Q ss_pred hhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc--------HHHHHHHHhcc-C-
Q 012053 159 AESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN--------LMEMYRKIGKA-E- 228 (472)
Q Consensus 159 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~--------~~~~~~~i~~~-~- 228 (472)
...... ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.... ........... .
T Consensus 184 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 3uim_A 184 MDYKDT-HVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261 (326)
T ss_dssp CCSSSS-CEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred cCcccc-cccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence 543222 22344569999999999977665 489999999999999999999995211 11111111000 0
Q ss_pred ---------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCc
Q 012053 229 ---------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENS 264 (472)
Q Consensus 229 ---------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp 264 (472)
..++...++++.+++.+||+.||.+|||+.++++|-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 011111236799999999999999999999999883
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=354.86 Aligned_cols=248 Identities=26% Similarity=0.358 Sum_probs=203.4
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccc-cchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV-LKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
|..++.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44568999999999999986 789999999975432 223456789999999999999999999999999999999999
Q ss_pred ecCCCcccchhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 91 YVKGGELFGKVAK----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 91 ~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999998853 469999999999999999999999999999999999999999999999999987654432222
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH----HHHHHHhccCC-----------CC
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM----EMYRKIGKAEF-----------KF 231 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~----~~~~~i~~~~~-----------~~ 231 (472)
.....+||+.|+|||++.+. + +.++||||||+++|+|++|..||...... .....+..... ..
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 23446799999999998653 3 57999999999999999999999865432 22222221111 11
Q ss_pred CCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 232 PNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 232 ~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+...++.+.++|.+||+.||.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22245678999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=381.83 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=209.7
Q ss_pred cCCEEEEe-eEcccCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 9 MQRYELGR-LLGQGTFAKVHYARNLK--TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~-~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.++|.+.+ .||+|+||+||+|.+.. ++..||||++.... .....+.+.+|+.+|+.++||||+++++++.. +.+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 44667776 89999999999998763 56679999997653 22346789999999999999999999999976 458
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 999999999999998864 569999999999999999999999999999999999999999999999999998654322
Q ss_pred CC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHH
Q 012053 164 QD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVR 240 (472)
Q Consensus 164 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~ 240 (472)
.. .......+|+.|+|||++....+. .++|||||||++|+|++ |..||.+.+..+....+..+. ...|..+++++.
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 569 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 569 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 11 111233467899999999877765 89999999999999998 999999988888777776654 567788999999
Q ss_pred HHHhcccCCCCCCcCChhhhhc
Q 012053 241 RLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+||.+||..||.+|||+.+|++
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999854
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=357.40 Aligned_cols=250 Identities=21% Similarity=0.354 Sum_probs=193.8
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHH--HHhcCCCCeeeEEEEEEe-
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV--MRLVRHPNVVELYEVMAS- 81 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~i--l~~l~hpnIv~l~~~~~~- 81 (472)
..+..++|++++.||+|+||.||+|++ +++.||||++.... ...+..|..+ ++.++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 346788999999999999999999977 78999999996543 1333344444 456899999999986532
Q ss_pred ----CCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEEcCCCCe
Q 012053 82 ----KTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR---------GVCHRDLKPENLLLDEHGNL 148 (472)
Q Consensus 82 ----~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~---------giiHrDIKp~NILld~~g~v 148 (472)
...+|+||||+++|+|.+++.....++..++.++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 33689999999999999999888889999999999999999999999 99999999999999999999
Q ss_pred EEecCcchhhhhccc------CCCcccccCCCCcccChhhhccc------CCCCCcccchhhhHHHHHHhcCCCCCCCCc
Q 012053 149 KVSDFGLSALAESKH------QDGLLHTTCGTPAYVAPEVINRR------GYDGSKADIWSCGVILYVLLAGYLPFHDSN 216 (472)
Q Consensus 149 kl~DFGla~~~~~~~------~~~~~~~~~gt~~Y~aPE~l~~~------~~~~~~~DiwSlGvil~~lltG~~Pf~~~~ 216 (472)
||+|||++....... ........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999997654321 11223355799999999998752 122368999999999999999977764321
Q ss_pred ------------------HHHHHHHHh--ccCCCCCCC------CCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 217 ------------------LMEMYRKIG--KAEFKFPNW------FAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 217 ------------------~~~~~~~i~--~~~~~~~~~------~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.......+. .....+|.. +++++.+||.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 111111111 112333333 3357999999999999999999999955
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=369.04 Aligned_cols=245 Identities=20% Similarity=0.274 Sum_probs=199.9
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhcC---------CCCe
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-----KVGMIDQIKREISVMRLVR---------HPNV 72 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------hpnI 72 (472)
+..++|++++.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+|+.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457899999999999999999998 7899999999876431 2234577899999999886 8888
Q ss_pred eeEEEEEE------------------------------eCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHH
Q 012053 73 VELYEVMA------------------------------SKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAV 122 (472)
Q Consensus 73 v~l~~~~~------------------------------~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al 122 (472)
+++++++. ..+.+|+||||+.+|++.+.+.++.+++..++.++.||+.||
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 88877753 268899999999999888888778899999999999999999
Q ss_pred HHHH-hCCceecCCCCCcEEEcCCC--------------------CeEEecCcchhhhhcccCCCcccccCCCCcccChh
Q 012053 123 DYCH-SRGVCHRDLKPENLLLDEHG--------------------NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181 (472)
Q Consensus 123 ~yLH-~~giiHrDIKp~NILld~~g--------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE 181 (472)
.||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 9999 99999999999999999987 899999999986542 2458999999999
Q ss_pred hhcccCCCCCcccchhhhHH-HHHHhcCCCCCCCCcH-HHHHHHHhcc-CCC--C----CCCCCHHHHHHHhcccCCCCC
Q 012053 182 VINRRGYDGSKADIWSCGVI-LYVLLAGYLPFHDSNL-MEMYRKIGKA-EFK--F----PNWFAPEVRRLLSKILDPNPN 252 (472)
Q Consensus 182 ~l~~~~~~~~~~DiwSlGvi-l~~lltG~~Pf~~~~~-~~~~~~i~~~-~~~--~----~~~~s~~l~~li~~~L~~dP~ 252 (472)
++.+.. +.++||||||++ .+++++|..||..... ......+... ... . +..+++++++||++||+.|
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 998665 589999998777 7789999999854321 1122222211 111 1 1236789999999999977
Q ss_pred CcCChhhhh-cCcccc
Q 012053 253 TRISMTKIM-ENSWFR 267 (472)
Q Consensus 253 ~Rpt~~eil-~hp~f~ 267 (472)
|++|++ +||||+
T Consensus 324 ---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHCGGGC
T ss_pred ---CHHHHHhcCCCcC
Confidence 999999 999995
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=354.29 Aligned_cols=255 Identities=22% Similarity=0.381 Sum_probs=210.0
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYAR----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
..+..++|++++.||+|+||.||+|+ +..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 44567789999999999999999998 45689999999997643 244578899999999999999999999986
Q ss_pred eCC--EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 81 SKT--KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 81 ~~~--~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
..+ .+|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 544 78999999999999999875 46999999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccCC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH----------------H
Q 012053 157 ALAESKHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM----------------E 219 (472)
Q Consensus 157 ~~~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~----------------~ 219 (472)
......... .......+|+.|+|||++.+..+. .++||||||+++|+|++|..||...... .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 865432211 112234678889999999876654 8999999999999999999998643211 1
Q ss_pred HHHHHhc-cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 220 MYRKIGK-AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+...+.. .....+..+++++.++|.+||..||++|||+.++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~ 316 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1122222 2345677799999999999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=353.94 Aligned_cols=250 Identities=22% Similarity=0.389 Sum_probs=206.3
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--cCCCCeeeEEEEEEeCC
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL--VRHPNVVELYEVMASKT 83 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~ 83 (472)
..+.++|++.+.||+|+||.||+|.+ +|+.||||++.... ...+.+|+.+++. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 34567999999999999999999998 68999999986442 3567789999987 78999999999998776
Q ss_pred ----EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEcCCCCeEEe
Q 012053 84 ----KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCH--------SRGVCHRDLKPENLLLDEHGNLKVS 151 (472)
Q Consensus 84 ----~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH--------~~giiHrDIKp~NILld~~g~vkl~ 151 (472)
..|+||||+.+|+|.+++.++++++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 8999999999999999998889999999999999999999999 8999999999999999999999999
Q ss_pred cCcchhhhhcccCC--CcccccCCCCcccChhhhcccCCCC-----CcccchhhhHHHHHHhcC----------CCCCCC
Q 012053 152 DFGLSALAESKHQD--GLLHTTCGTPAYVAPEVINRRGYDG-----SKADIWSCGVILYVLLAG----------YLPFHD 214 (472)
Q Consensus 152 DFGla~~~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~-----~~~DiwSlGvil~~lltG----------~~Pf~~ 214 (472)
|||++......... ......+||+.|+|||++.+..... .++|||||||++|+|++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 99998765432211 0124557999999999987653221 579999999999999999 889876
Q ss_pred C-----cHHHHHHHHhccC--CCCCCC-----CCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 215 S-----NLMEMYRKIGKAE--FKFPNW-----FAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 215 ~-----~~~~~~~~i~~~~--~~~~~~-----~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
. ........+.... ..+|.. .++.+.+||.+||+.||++|||+.+++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 4 2334444443322 223321 23578999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=369.91 Aligned_cols=249 Identities=21% Similarity=0.319 Sum_probs=209.6
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCCEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH-PNVVELYEVMASKTKI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 85 (472)
.+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|..+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 5678999999999999999999999999999999998765432 347789999999986 6666777777888999
Q ss_pred EEEEEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCCeEEecCcchhhhh
Q 012053 86 YFVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILl---d~~g~vkl~DFGla~~~~ 160 (472)
|+||||+ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++....
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 999999997 4689999999999999999999999999999999999999 688999999999998665
Q ss_pred cccCC-----CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---HHHHHHHHhccCC---
Q 012053 161 SKHQD-----GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKIGKAEF--- 229 (472)
Q Consensus 161 ~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~--- 229 (472)
..... ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.. ....+.++.....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 43221 112356899999999999887765 89999999999999999999998743 3344444432221
Q ss_pred --CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 230 --KFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 230 --~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.++..+++++.+||.+||..||.+||++.+|++
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 233568999999999999999999999998865
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=356.22 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=209.9
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
..+..++|++++.||+|+||.||+|.+.. .||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 45677899999999999999999999843 4999999765322 1233557789999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 85 IYFVMEYVKGGELFGKVAKG--KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
+|+||||+.|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999999999763 699999999999999999999999999999999999998 689999999998754321
Q ss_pred ---cCCCcccccCCCCcccChhhhccc--------CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC
Q 012053 163 ---HQDGLLHTTCGTPAYVAPEVINRR--------GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF 231 (472)
Q Consensus 163 ---~~~~~~~~~~gt~~Y~aPE~l~~~--------~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~ 231 (472)
..........||+.|+|||++... ...+.++||||||+++|+|++|..||...........+.......
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 112233455799999999998642 223578999999999999999999999988877777766554322
Q ss_pred --CCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 232 --PNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 232 --~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+..+++++.++|.+||..||.+|||+.++++.
T Consensus 263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 23478899999999999999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=369.91 Aligned_cols=246 Identities=21% Similarity=0.267 Sum_probs=194.7
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC-CCe---------e-------
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH-PNV---------V------- 73 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnI---------v------- 73 (472)
.|.+++.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.++| +|. +
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 48899999999999999999999999999999975544333446789999999999987 211 1
Q ss_pred -----eEEEEEEe-----CCEEEEEEEecCCCcccchhc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 012053 74 -----ELYEVMAS-----KTKIYFVMEYVKGGELFGKVA--------KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDL 135 (472)
Q Consensus 74 -----~l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~--------~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDI 135 (472)
.+..++.. ...++++|+++ +++|.+++. .+.+++..+..++.||+.||.|||++||+||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11111111 12367777766 678888874 245788899999999999999999999999999
Q ss_pred CCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhc----------ccCCCCCcccchhhhHHHHHH
Q 012053 136 KPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVIN----------RRGYDGSKADIWSCGVILYVL 205 (472)
Q Consensus 136 Kp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~----------~~~~~~~~~DiwSlGvil~~l 205 (472)
||+|||++.++.+||+|||+++..... ....+| +.|+|||++. ...+ +.++|||||||++|+|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHH
Confidence 999999999999999999998765433 355688 9999999983 3333 4799999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 206 LAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 206 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
++|+.||...+.......+ +.....+++++.+||.+||+.||++|||+.++++||||+.
T Consensus 311 ltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHSSCCCCTTGGGSCSGGG----GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHCCCCCCCcchhhhHHHH----HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 9999999887654433333 2223457899999999999999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=345.81 Aligned_cols=229 Identities=17% Similarity=0.237 Sum_probs=195.6
Q ss_pred CcCC-cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 012053 3 NKGS-ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS 81 (472)
Q Consensus 3 ~~g~-~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 81 (472)
..|. ++.++|++.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++..
T Consensus 23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 4677 888999999999999999999999999999999999987765555566889999999999999999999999999
Q ss_pred CCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 82 KTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
++..|+||||++|++|.+++..+. ...++.+++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTSP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTCC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred CCcEEEEEEecCCCCHHHHHhcCC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999999999997664 566788999999999999999999999999999999999999998554
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHH---HHhccCC----CCCCC
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR---KIGKAEF----KFPNW 234 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~---~i~~~~~----~~~~~ 234 (472)
|++| .+.++|||||||++|+|++|..||.+.+...... +...... ..+..
T Consensus 175 ---------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T 3uqc_A 175 ---------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231 (286)
T ss_dssp ---------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred ---------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence 3332 3589999999999999999999998765432110 1111111 12356
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+++++.++|.+||+.||.+| |+.++++.
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 89999999999999999999 99999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=379.50 Aligned_cols=253 Identities=28% Similarity=0.447 Sum_probs=214.3
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
.+..++|++++.||+|+||+||+|.+..+ +..||+|.+.... .....+.+.+|+.+|+.++||||+++++++. +
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 35567899999999999999999998654 4579999986543 2344578899999999999999999999985 4
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
+..|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 568999999999999999875 369999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 238 (472)
.... .......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+....+..+. ...|..++++
T Consensus 543 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 543 DSTY-YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHH
T ss_pred CCcc-eeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence 3221 112345678899999999877665 89999999999999997 999999988887777776553 5678889999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.++|.+||..||.+|||+.++++.
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=387.69 Aligned_cols=255 Identities=28% Similarity=0.409 Sum_probs=206.9
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe------
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS------ 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (472)
..++|++++.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 4589999999999999999999999999999999987643 23456778999999999999999999999755
Q ss_pred CCEEEEEEEecCCCcccchhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC---eEEecCc
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK----GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN---LKVSDFG 154 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~---vkl~DFG 154 (472)
++..|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 6778999999999999999865 25999999999999999999999999999999999999998775 9999999
Q ss_pred chhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHH---------HH-
Q 012053 155 LSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR---------KI- 224 (472)
Q Consensus 155 la~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~---------~i- 224 (472)
++....... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.......... .+
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 998664332 23456899999999999877665 89999999999999999999997653322110 00
Q ss_pred ----hccCCC----------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 225 ----GKAEFK----------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 225 ----~~~~~~----------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
..+... ++..+++.+.+||.+||..||++|||+.++++||||+.
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 011111 11225678999999999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=378.61 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=204.7
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLK-TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
.|.++.++|++++.||+|+||+||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 577888999999999999999999999976 78999999986543 224456788999999999999999999999776
Q ss_pred CE-----EEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 83 TK-----IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 83 ~~-----~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
+. .|+||||++|++|.+.+.. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++.
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 54 7999999999999987765 89999999999999999999999999999999999999985 89999999987
Q ss_pred hhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCH
Q 012053 158 LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAP 237 (472)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 237 (472)
..... ...+||+.|+|||++.+. + +.++|||||||++|+|++|..||........ . ........++
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----~--~~~~~~~~~~ 295 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----P--EDDPVLKTYD 295 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----C--TTCHHHHHCH
T ss_pred hcccC------CccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccccc----c--ccccccccCH
Confidence 65432 456799999999998654 3 5899999999999999999999865321100 0 0000011357
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
.+.++|.+||+.||.+||+..+.+.|+|+.
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 899999999999999999999999999885
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=289.75 Aligned_cols=129 Identities=32% Similarity=0.617 Sum_probs=116.0
Q ss_pred CCCCCCchhhhccCCCCCCCCchhhhh--hcccceeeccCCHHHHHHHHHHHHhHcCcEEEEecCceEEEEeecCCcCce
Q 012053 310 KPCNLNAFDIISFSAGFDLSGLFEERE--KRKEVRFTSNKPVSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGV 387 (472)
Q Consensus 310 ~~~~~~~f~~~~~s~~~~ls~l~~~~~--~~~~~rf~s~~~~~~i~~~l~~~~~~l~~~v~~~~~~~~~~~~~~~~~~g~ 387 (472)
.|..+||||+||||+|||||+||+... .+++|||+|+.||++|+++||++|+++||+|+++++ .|++++..+|+||+
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~-~vkl~~~~~grkG~ 81 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNF-KTRLEGLSSIKAGQ 81 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSS-EEEEEECCSSGGGC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCc-EEEEEEecCCCcce
Confidence 466799999999999999999998654 478999999999999999999999999999998876 69999999999999
Q ss_pred EEEEEEEEEEcCceEEEEEEccCCCcHHHHHHHHHhhhhccccceeecccchh
Q 012053 388 LGMDAEIFEITPFFHLVEVKKSSGDTLEYQKVMNQEIRPALKDIVWTWQGEQR 440 (472)
Q Consensus 388 l~~~~ev~e~~~~~~lVe~~~~~Gd~lef~~~~~~~l~~~L~~~~~~~~~~~~ 440 (472)
|+|+||||||+|+++||||||++||++||+++|++ |||+|+||||+|+++..
T Consensus 82 l~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~-Lr~~L~diV~~~~~~~~ 133 (143)
T 2ehb_D 82 LAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKK-LCSKLENIIWRATEGIP 133 (143)
T ss_dssp CEEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHH-HHHHSTTTBCC------
T ss_pred EEEEEEEEEecCCEEEEEEEecCCChHHHHHHHHH-HHHHhhcceecCCCCCc
Confidence 99999999999999999999999999999998885 99999999999998664
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=271.34 Aligned_cols=121 Identities=32% Similarity=0.451 Sum_probs=107.5
Q ss_pred CCCCCCchhhhccCCCCCCCCchhhhh-hcccceeeccCCHHHHHHHHHHHHhHcCcEEEEecCceEEEEeecCCcCceE
Q 012053 310 KPCNLNAFDIISFSAGFDLSGLFEERE-KRKEVRFTSNKPVSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVL 388 (472)
Q Consensus 310 ~~~~~~~f~~~~~s~~~~ls~l~~~~~-~~~~~rf~s~~~~~~i~~~l~~~~~~l~~~v~~~~~~~~~~~~~~~~~~g~l 388 (472)
.|..+|||||||||+|||||+||+++. .+++|||+|+.||++|+++||++|+++||+|++++++ ++..+|+||+|
T Consensus 2 ~~~~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~----~~~~~g~kG~l 77 (123)
T 2zfd_B 2 GARRMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW----GMKIEGQKGNF 77 (123)
T ss_dssp --CCCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT----EEEEEEGGGTE
T ss_pred CcccccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc----cccccCCCccE
Confidence 356799999999999999999997643 3679999999999999999999999999999998875 66678999999
Q ss_pred EEEEEEEEEcCceEEEEEEccCCCcHHHHHHHHHhhhhccccceee
Q 012053 389 GMDAEIFEITPFFHLVEVKKSSGDTLEYQKVMNQEIRPALKDIVWT 434 (472)
Q Consensus 389 ~~~~ev~e~~~~~~lVe~~~~~Gd~lef~~~~~~~l~~~L~~~~~~ 434 (472)
+|+||||||+|+++||||||++||++||++||.++|||+|+||||+
T Consensus 78 ~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 78 AMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 9999999999999999999999999999999988899999999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=321.47 Aligned_cols=232 Identities=13% Similarity=0.102 Sum_probs=163.7
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-------chhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCEEEE
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-------KVGMIDQIKREISVMRLV-RHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l 87 (472)
..++.|++|.+..++....|+.||+|++.+.... .....+++.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 4567889999988888889999999999765322 122346799999999999 69999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||||++|++|.++|.. +++++. +|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...... .
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~ 394 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--S 394 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--c
Confidence 9999999999999976 577765 488999999999999999999999999999999999999999998664432 2
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~ 246 (472)
...+.+||+.|||||++.+.. ..++|+||+|++++.+.++..+| +..+... +.. ...+..+...+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~----~~~-~~~~~~l~~~l 459 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQE----PVE-RWNFVLLLALF 459 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHHH--------HHHHHTS----CGG-GCSHHHHHHHH
T ss_pred cccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchh--------HHHhhcC----CCC-CCcHHHHHHHH
Confidence 346779999999999997643 36799999999999888775543 1111111 110 11245667777
Q ss_pred cCCCCCCcCChhhhhcCcccc
Q 012053 247 LDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~f~ 267 (472)
+..+|..|+.......++|..
T Consensus 460 ~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 460 EKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HTGGGSCCGGGSSCCHHHHHH
T ss_pred hCCCCCCCCChhhhccchhHH
Confidence 888888888888887887765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-29 Score=270.41 Aligned_cols=188 Identities=20% Similarity=0.240 Sum_probs=145.8
Q ss_pred EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV-----GMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
...+.||+|+||+||+|. ..+..+|+|.......... ...+++.+|+.+|+.++||||+++..++...+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 346789999999999994 4788999998765433221 124568999999999999999965555557777899
Q ss_pred EEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC-
Q 012053 88 VMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG- 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~- 166 (472)
||||++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999999876 6789999999999999999999999999999998 99999999998764322111
Q ss_pred ----cccccCCCCcccChhhhcc--cCCCCCcccchhhhHHHHHHhcCCCCC
Q 012053 167 ----LLHTTCGTPAYVAPEVINR--RGYDGSKADIWSCGVILYVLLAGYLPF 212 (472)
Q Consensus 167 ----~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~lltG~~Pf 212 (472)
...+.+||+.|+|||++.. .+|. ..+|+||..+-..+-..++-+|
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhcccc
Confidence 1235689999999999976 5564 6789999998888877776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=224.30 Aligned_cols=147 Identities=18% Similarity=0.233 Sum_probs=117.7
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch---------------hhHHHHHHHHHHHHhcCCCCeeeE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV---------------GMIDQIKREISVMRLVRHPNVVEL 75 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~hpnIv~l 75 (472)
.|++++.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|+.+|+.++| +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 355669999999999999999 8899999999965432110 134678899999999984 555
Q ss_pred EEEEEeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcc
Q 012053 76 YEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGL 155 (472)
Q Consensus 76 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGl 155 (472)
++++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||++||+||||||+|||++ +|.+||+|||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 555544 44699999999999988 422 23557999999999999999999999999999999 99999999998
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhc
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVIN 184 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~ 184 (472)
|.. +..|.|||.+.
T Consensus 239 a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 239 SVE---------------VGEEGWREILE 252 (282)
T ss_dssp CEE---------------TTSTTHHHHHH
T ss_pred CeE---------------CCCCCHHHHHH
Confidence 752 34678999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=194.98 Aligned_cols=140 Identities=21% Similarity=0.273 Sum_probs=109.3
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcE--EEEEEeecccccc---------------------hhhHHHHHHHHHHHHhcC
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMS--VAIKIIDKEKVLK---------------------VGMIDQIKREISVMRLVR 68 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~ 68 (472)
|++.+.||+|+||.||+|.+..+|+. ||||++......- ......+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999888999 9999975432110 011246889999999998
Q ss_pred CCCe--eeEEEEEEeCCEEEEEEEecCC-C----cccchhccCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcE
Q 012053 69 HPNV--VELYEVMASKTKIYFVMEYVKG-G----ELFGKVAKGKLKEDAARKYFQQLISAVDYCH-SRGVCHRDLKPENL 140 (472)
Q Consensus 69 hpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH-~~giiHrDIKp~NI 140 (472)
|+++ +.+++. +..|+||||+.+ | +|.+.... .++..+..++.||+.||.||| ++||+||||||+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 8754 445543 246899999942 4 44443322 345678899999999999999 99999999999999
Q ss_pred EEcCCCCeEEecCcchhhh
Q 012053 141 LLDEHGNLKVSDFGLSALA 159 (472)
Q Consensus 141 Lld~~g~vkl~DFGla~~~ 159 (472)
|++. .++|+|||+|...
T Consensus 203 Ll~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 203 MYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EESS--SEEECCCTTCEET
T ss_pred EEcC--cEEEEECcccccC
Confidence 9998 8999999998643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.5e-19 Score=178.79 Aligned_cols=138 Identities=16% Similarity=0.208 Sum_probs=102.7
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-----------c----hhh----HHHHHHHHHHHHhcCCCCe
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-----------K----VGM----IDQIKREISVMRLVRHPNV 72 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----------~----~~~----~~~~~~Ei~il~~l~hpnI 72 (472)
|++++.||.|+||.||+|.+ .+|+.||||+++..... . ... .-...+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999998 47999999998543210 0 000 1123467888888865554
Q ss_pred eeEEEEEEeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC-----
Q 012053 73 VELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN----- 147 (472)
Q Consensus 73 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~----- 147 (472)
.-..-+.... .++||||+.|++|..+.. ...+..++.||+.+|.|||++||+||||||.|||++++|.
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccc
Confidence 3222222222 279999999988876543 2245678899999999999999999999999999988773
Q ss_pred -----eEEecCcchh
Q 012053 148 -----LKVSDFGLSA 157 (472)
Q Consensus 148 -----vkl~DFGla~ 157 (472)
+.|+||+-+.
T Consensus 249 ~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 249 SITLTPIIIXFPQMV 263 (397)
T ss_dssp SEEEEEEECCCTTCE
T ss_pred ccccceEEEEeCCcc
Confidence 8999999654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=3e-13 Score=129.62 Aligned_cols=140 Identities=16% Similarity=0.140 Sum_probs=112.9
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 87 (472)
.+.|++...+|.|+++.||++.. .+..+++|+....... ....+.+|+.+++.+. +..+.+++++....+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 35799999999999999999975 4789999998653211 1235889999999985 6778899999999999999
Q ss_pred EEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 012053 88 VMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHS---------------------------------------- 127 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~---------------------------------------- 127 (472)
||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999998876532 122344788899999999998
Q ss_pred -------------------CCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 128 -------------------RGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 128 -------------------~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
.+++|+|++|.|||+++++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799998654
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.34 E-value=6.7e-12 Score=105.57 Aligned_cols=86 Identities=15% Similarity=0.235 Sum_probs=77.2
Q ss_pred eeccCCHHHHHHHHHHHHhHcCcEEEEecCceEEEEeecCCcCceEEEEEEEEEEc-CceEEEEEEccCCCcHHHHHHHH
Q 012053 343 FTSNKPVSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEIT-PFFHLVEVKKSSGDTLEYQKVMN 421 (472)
Q Consensus 343 f~s~~~~~~i~~~l~~~~~~l~~~v~~~~~~~~~~~~~~~~~~g~l~~~~ev~e~~-~~~~lVe~~~~~Gd~lef~~~~~ 421 (472)
-||+.+|++|+.+|+.+++.+|+.|++++.+.+++.....+.++.+.|.+||+++. +++++|+||+.+||++.|+++|.
T Consensus 33 tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc~ 112 (120)
T 3ose_A 33 TTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (120)
T ss_dssp CEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHHH
Confidence 47899999999999999999999999988888999875445567899999999995 89999999999999999999999
Q ss_pred Hhhhhccc
Q 012053 422 QEIRPALK 429 (472)
Q Consensus 422 ~~l~~~L~ 429 (472)
+ |.+.|+
T Consensus 113 ~-il~~L~ 119 (120)
T 3ose_A 113 K-IANELK 119 (120)
T ss_dssp H-HHHHCC
T ss_pred H-HHHHhc
Confidence 7 766664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=1e-11 Score=117.93 Aligned_cols=135 Identities=13% Similarity=0.166 Sum_probs=102.2
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEEEEEEeCCEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELYEVMASKTKIY 86 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~ 86 (472)
...|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++++....+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 34577755555677799999964 567889999975431 135778999999886544 567899888888899
Q ss_pred EEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 012053 87 FVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG------------------------------------- 129 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~g------------------------------------- 129 (472)
+||||++|.+|. .. ..+ ...++.+++..|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 999999998884 21 122 2356778888888888643
Q ss_pred ---------------------ceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 130 ---------------------VCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 130 ---------------------iiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.25 E-value=2.2e-11 Score=122.28 Aligned_cols=141 Identities=20% Similarity=0.342 Sum_probs=108.0
Q ss_pred EEEeeEcccCCeEEEEEEEcCCCcEEEEEEee--cccccchhhHHHHHHHHHHHHhcC--CCCeeeEEEEEEeC---CEE
Q 012053 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIID--KEKVLKVGMIDQIKREISVMRLVR--HPNVVELYEVMASK---TKI 85 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~ 85 (472)
.-++.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 3467899999999999875 35688899875 33211 12356889999999997 45678999988776 458
Q ss_pred EEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 012053 86 YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHS-------------------------------------- 127 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~-------------------------------------- 127 (472)
|+||||++|..+.+... ..+++.+...++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~~~-~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQSL-PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEEECCCCBCCCCTTC-TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEEecCCeecCCCcc-ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999988755322 347888889999999999999997
Q ss_pred --------------------CCceecCCCCCcEEEcCCCC--eEEecCcchhh
Q 012053 128 --------------------RGVCHRDLKPENLLLDEHGN--LKVSDFGLSAL 158 (472)
Q Consensus 128 --------------------~giiHrDIKp~NILld~~g~--vkl~DFGla~~ 158 (472)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999998764 68999998763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=2.8e-11 Score=118.75 Aligned_cols=182 Identities=16% Similarity=0.203 Sum_probs=123.3
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCC--eeeEEEEEEeCC---EEEEE
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPN--VVELYEVMASKT---KIYFV 88 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpn--Iv~l~~~~~~~~---~~~lV 88 (472)
++.++.|....||++. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999763 46889985432 33567899999998883 333 445555543333 45899
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 012053 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHS----------------------------------------- 127 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~----------------------------------------- 127 (472)
||+++|..|..... ..++..+...++.+++..+..||+
T Consensus 95 m~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred EcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99999988865322 457888888899999999999996
Q ss_pred -----------------CCceecCCCCCcEEEcC--CCCeEEecCcchhhhhcccCCCcccccCCCCcc---cChhhh--
Q 012053 128 -----------------RGVCHRDLKPENLLLDE--HGNLKVSDFGLSALAESKHQDGLLHTTCGTPAY---VAPEVI-- 183 (472)
Q Consensus 128 -----------------~giiHrDIKp~NILld~--~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y---~aPE~l-- 183 (472)
..++|+|++|.||+++. ++.+.|+||+.+....... .......+ ..|+..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccccCHHHHHH
Confidence 13699999999999998 4567899999876421100 00000111 233321
Q ss_pred --cccCCCC---------CcccchhhhHHHHHHhcCCCCCC
Q 012053 184 --NRRGYDG---------SKADIWSCGVILYVLLAGYLPFH 213 (472)
Q Consensus 184 --~~~~~~~---------~~~DiwSlGvil~~lltG~~Pf~ 213 (472)
...+... ...+.|++|.+++.+.+|..+|.
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1111110 12589999999999999988763
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.94 E-value=1.4e-09 Score=91.40 Aligned_cols=86 Identities=13% Similarity=0.208 Sum_probs=75.4
Q ss_pred eeccCCHHHHHHHHHHHHhHcCcEEEEecCceEEEEeecCCcCceEEEEEEEEEEc-CceEEEEEEccCCCcHHHHHHHH
Q 012053 343 FTSNKPVSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEIT-PFFHLVEVKKSSGDTLEYQKVMN 421 (472)
Q Consensus 343 f~s~~~~~~i~~~l~~~~~~l~~~v~~~~~~~~~~~~~~~~~~g~l~~~~ev~e~~-~~~~lVe~~~~~Gd~lef~~~~~ 421 (472)
-||+.+|++|+.+|..+++.+|+.|++++++.+++.......++.+.|.+||+.+. .+++.|+||+.+||+..|+++|.
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~ 112 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHH
Confidence 36788999999999999999999999988898999764444456899999999994 78999999999999999999999
Q ss_pred Hhhhhccc
Q 012053 422 QEIRPALK 429 (472)
Q Consensus 422 ~~l~~~L~ 429 (472)
+ |-..|+
T Consensus 113 ~-IL~eLk 119 (126)
T 1v5s_A 113 K-IANELK 119 (126)
T ss_dssp H-HHHHTT
T ss_pred H-HHHHHh
Confidence 8 656665
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=1.1e-08 Score=82.94 Aligned_cols=91 Identities=12% Similarity=0.174 Sum_probs=78.6
Q ss_pred hcccceeeccCCHHHHHHHHHHHHhHcCcEEEEecCceEEEEeecCCcCceEEEEEEEEEEcCceEEEEEEccCCC----
Q 012053 337 KRKEVRFTSNKPVSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGD---- 412 (472)
Q Consensus 337 ~~~~~rf~s~~~~~~i~~~l~~~~~~l~~~v~~~~~~~~~~~~~~~~~~g~l~~~~ev~e~~~~~~lVe~~~~~Gd---- 412 (472)
.++.....|...|.+||.+|..+.+.+|+.|++.+.+.|++..........+.|.+++|.+.+..+|+||++..||
T Consensus 6 ~kW~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~ 85 (106)
T 4eai_A 6 AKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGG 85 (106)
T ss_dssp CEEEESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCS
T ss_pred ccceEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCC
Confidence 3566778999999999999999999999999999999999986443333569999999999999999999999994
Q ss_pred ----cHHHHHHHHHhhhhcc
Q 012053 413 ----TLEYQKVMNQEIRPAL 428 (472)
Q Consensus 413 ----~lef~~~~~~~l~~~L 428 (472)
+++|-++|.+ +-.+|
T Consensus 86 ~~~~~~~F~d~ca~-li~~l 104 (106)
T 4eai_A 86 GGSHTIEFFEMCAN-LIKIL 104 (106)
T ss_dssp SSCHHHHHHHHHHH-HHHHC
T ss_pred CCcCcEeHHHHHHH-HHHHH
Confidence 9999999998 54444
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=3.1e-08 Score=86.11 Aligned_cols=87 Identities=14% Similarity=0.164 Sum_probs=68.7
Q ss_pred CCchhhhhhcccceeeccCCHHHHHHHHHHHHhHcCcEEEEecCceEEEEeecCCcCceEEEEEEEEEEcCceEEEEEEc
Q 012053 329 SGLFEEREKRKEVRFTSNKPVSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKK 408 (472)
Q Consensus 329 s~l~~~~~~~~~~rf~s~~~~~~i~~~l~~~~~~l~~~v~~~~~~~~~~~~~~~~~~g~l~~~~ev~e~~~~~~lVe~~~ 408 (472)
|||-..+..|+..+..|+..|.+||..|..+.+.||+.||+.+.+.|++.....-....+.|.+++|+|.+..|||||++
T Consensus 9 ~~~~~~k~~kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~ 88 (173)
T 2y8l_A 9 SGLVPRGSMAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRS 88 (173)
T ss_dssp -------CCEEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEE
T ss_pred cCCcccccceeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEe
Confidence 45555556678889999999999999999999999999999999999998743322236899999999999999999999
Q ss_pred cCCCcHH
Q 012053 409 SSGDTLE 415 (472)
Q Consensus 409 ~~Gd~le 415 (472)
..||+-|
T Consensus 89 l~Gd~~e 95 (173)
T 2y8l_A 89 IDDEITE 95 (173)
T ss_dssp ECCC---
T ss_pred cCCCccc
Confidence 9999866
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.77 E-value=6.5e-08 Score=83.04 Aligned_cols=79 Identities=11% Similarity=0.130 Sum_probs=66.9
Q ss_pred hcccceeeccCCHHHHHHHHHHHHhHcCcEEEEecCceEEEEeecCCcCceEEEEEEEEEEcCceEEEEEEccCCCcHH
Q 012053 337 KRKEVRFTSNKPVSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLE 415 (472)
Q Consensus 337 ~~~~~rf~s~~~~~~i~~~l~~~~~~l~~~v~~~~~~~~~~~~~~~~~~g~l~~~~ev~e~~~~~~lVe~~~~~Gd~le 415 (472)
.|+..+..|+..|.+||.+|..+.+.||+.||+.+.+.|++..........+.|.+++|+|.+..|||||++..||+-|
T Consensus 3 ~kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 3 MAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp CEEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred ccceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 3577788899999999999999999999999999999999987543222368999999999999999999999999855
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=2.2e-07 Score=91.03 Aligned_cols=133 Identities=20% Similarity=0.218 Sum_probs=97.1
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCC---CeeeEEEEEE-eCCEEEEEEE
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP---NVVELYEVMA-SKTKIYFVME 90 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lV~E 90 (472)
++.++.|....||+. |..+++|+-.. ......+.+|..+|+.+.+. .+.+++.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456888999999987 56788898422 13456789999999999752 3567777764 4566789999
Q ss_pred ecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 012053 91 YVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR------------------------------------------ 128 (472)
Q Consensus 91 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~------------------------------------------ 128 (472)
+++|..+.... -..++..+...++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~-~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 94 KVQGQILGEDG-MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCCSEECHHHH-HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ccCCeECchhh-hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99998876532 13356666666666676666666642
Q ss_pred ------------------CceecCCCCCcEEEcC---CCCe-EEecCcchhh
Q 012053 129 ------------------GVCHRDLKPENLLLDE---HGNL-KVSDFGLSAL 158 (472)
Q Consensus 129 ------------------giiHrDIKp~NILld~---~g~v-kl~DFGla~~ 158 (472)
.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999987 4554 8999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=3.9e-07 Score=87.07 Aligned_cols=131 Identities=14% Similarity=0.170 Sum_probs=96.4
Q ss_pred EcccCCe-EEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEEEEEecCCC
Q 012053 18 LGQGTFA-KVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 18 LG~G~fg-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~~gg 95 (472)
+..|..| .||.......+..+.+|+-... ....+.+|..+|+.+. +--+.+++.++.+.+..|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 3445444 7898887777788999986432 3456889999999885 333678899999999999999999998
Q ss_pred cccchhccCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------------
Q 012053 96 ELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR----------------------------------------------- 128 (472)
Q Consensus 96 ~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~----------------------------------------------- 128 (472)
++.+..... ......+..++...|..||+.
T Consensus 106 ~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 106 TAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp EHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 776544321 122334566677777777741
Q ss_pred -----------CceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 129 -----------GVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 129 -----------giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 16899999999999987777899998755
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=98.58 E-value=4.7e-07 Score=75.28 Aligned_cols=81 Identities=12% Similarity=0.130 Sum_probs=65.0
Q ss_pred hcccceeeccCCHHHHHHHHHHHHhHcCcEEEEecCceEEEEeecCCcCceEEEEEEEEEEcCceEEEEEEccCCCcHHH
Q 012053 337 KRKEVRFTSNKPVSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEY 416 (472)
Q Consensus 337 ~~~~~rf~s~~~~~~i~~~l~~~~~~l~~~v~~~~~~~~~~~~~~~~~~g~l~~~~ev~e~~~~~~lVe~~~~~Gd~lef 416 (472)
.++.....|+..|.+||..|..+.+.+|+.||+.+.+.|++..........+.|.+++|++.+..+|+|||...||..|+
T Consensus 6 ~kW~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~ 85 (130)
T 4eag_A 6 AKWHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQ 85 (130)
T ss_dssp CCEEESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC------
T ss_pred cceeeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhc
Confidence 35667778888999999999999999999999999999999865544445688999999999999999999999997654
Q ss_pred H
Q 012053 417 Q 417 (472)
Q Consensus 417 ~ 417 (472)
.
T Consensus 86 ~ 86 (130)
T 4eag_A 86 G 86 (130)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=1.2e-07 Score=80.69 Aligned_cols=91 Identities=9% Similarity=0.066 Sum_probs=76.6
Q ss_pred hcccceeeccCCHHHHHHHHHHHHhHcCcEEEEe---------cCceEEEEeecCCc-----CceEEEEEEEEEEcCceE
Q 012053 337 KRKEVRFTSNKPVSTIISKLEGIAKLLRLKVKKK---------DGGLLKIEGSKEGR-----KGVLGMDAEIFEITPFFH 402 (472)
Q Consensus 337 ~~~~~rf~s~~~~~~i~~~l~~~~~~l~~~v~~~---------~~~~~~~~~~~~~~-----~g~l~~~~ev~e~~~~~~ 402 (472)
.|+..+.-|+..|.+||..|..+.+.||+.|++. +.+.|++....+.. ...+.|.+++|+|.+..+
T Consensus 11 ~kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~Y 90 (137)
T 2qrd_A 11 NKWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCF 90 (137)
T ss_dssp CCCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEE
T ss_pred CccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcE
Confidence 4677888999999999999999999999999988 88889998744321 236899999999999999
Q ss_pred EEEEEccCCC---------------c----HHHHHHHHHhhhhcc
Q 012053 403 LVEVKKSSGD---------------T----LEYQKVMNQEIRPAL 428 (472)
Q Consensus 403 lVe~~~~~Gd---------------~----lef~~~~~~~l~~~L 428 (472)
|||||...|+ . ++|-.+|.. |-.+|
T Consensus 91 LlDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~-Li~eL 134 (137)
T 2qrd_A 91 MLDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAM-LVCKL 134 (137)
T ss_dssp EEEEEEEEEEESCC-------------CCCTTHHHHHHH-HHHHH
T ss_pred EEEEEecCCccccccCccccccCCccccccccHHHHHHH-HHHHH
Confidence 9999999999 5 889999987 54444
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=3.6e-07 Score=91.17 Aligned_cols=87 Identities=14% Similarity=0.150 Sum_probs=58.7
Q ss_pred EEEeeE-cccCCeEEEEEEEc--C----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-C--CCeeeEEEEEEeC
Q 012053 13 ELGRLL-GQGTFAKVHYARNL--K----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-H--PNVVELYEVMASK 82 (472)
Q Consensus 13 ~i~~~L-G~G~fg~Vy~a~~~--~----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~ 82 (472)
...+.| +.|....+|+.... . ++..+++|+..............+.+|+.+|+.+. + -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 445778 88999999988653 1 26789999865432000000135678999998884 2 3577888887655
Q ss_pred ---CEEEEEEEecCCCcccc
Q 012053 83 ---TKIYFVMEYVKGGELFG 99 (472)
Q Consensus 83 ---~~~~lV~E~~~gg~L~~ 99 (472)
+..|+||||++|..+.+
T Consensus 103 ~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTTSSCEEEEECCCCBCCCB
T ss_pred CccCCceEEEEecCCCChhh
Confidence 35789999999977654
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=98.40 E-value=1.3e-06 Score=76.65 Aligned_cols=91 Identities=15% Similarity=0.125 Sum_probs=74.8
Q ss_pred hcccceeeccCCHHHHHHHHHHHHhHcCcEEEEec---CceEEEEeecC---------CcCceEEEEEEEEEEcCceEEE
Q 012053 337 KRKEVRFTSNKPVSTIISKLEGIAKLLRLKVKKKD---GGLLKIEGSKE---------GRKGVLGMDAEIFEITPFFHLV 404 (472)
Q Consensus 337 ~~~~~rf~s~~~~~~i~~~l~~~~~~l~~~v~~~~---~~~~~~~~~~~---------~~~g~l~~~~ev~e~~~~~~lV 404 (472)
.++.....|+..+.+||..|..+++.||+.||+.+ .+.|+|..... +....+.|.+++|+|.++.|||
T Consensus 49 ~kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLL 128 (179)
T 3t4n_A 49 TRWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLV 128 (179)
T ss_dssp CCCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEE
T ss_pred ceeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEE
Confidence 35777788999999999999999999999999876 88899985321 1123589999999999999999
Q ss_pred EEEccCC----------------------CcHHHHHHHHHhhhhccc
Q 012053 405 EVKKSSG----------------------DTLEYQKVMNQEIRPALK 429 (472)
Q Consensus 405 e~~~~~G----------------------d~lef~~~~~~~l~~~L~ 429 (472)
||| +.| ....|-.+|.. |--+|.
T Consensus 129 Dfk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~-LI~eLa 173 (179)
T 3t4n_A 129 DFK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTK-LIMELA 173 (179)
T ss_dssp EEE-EEEEECC----------------CCCCHHHHHHHHH-HHHHHH
T ss_pred EEE-eccccccccccccccccccccccccCCccHHHHHHH-HHHHHH
Confidence 999 888 67899999997 554453
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=8.1e-07 Score=90.07 Aligned_cols=80 Identities=18% Similarity=0.095 Sum_probs=51.7
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccc-cch---hhHHHHHHHHHHHHhcCC--C-CeeeEEEEEEeCCEEE
Q 012053 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV-LKV---GMIDQIKREISVMRLVRH--P-NVVELYEVMASKTKIY 86 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~h--p-nIv~l~~~~~~~~~~~ 86 (472)
-.+.||.|..+.||++....+++.+++|....... ... ...+++..|..+|+.+.. | .+.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35789999999999997655678999998653221 000 123456789999988742 3 34466654 344468
Q ss_pred EEEEecCCC
Q 012053 87 FVMEYVKGG 95 (472)
Q Consensus 87 lV~E~~~gg 95 (472)
+|||++.|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.23 E-value=6.5e-06 Score=80.95 Aligned_cols=134 Identities=16% Similarity=0.186 Sum_probs=78.6
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC--CCCeeeEEE------EEEeCCEEE
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR--HPNVVELYE------VMASKTKIY 86 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~------~~~~~~~~~ 86 (472)
++.|+.|..+.||++.. .+..+++|+..... ..+..|..+++.+. .-.+++++. +....+..|
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 45567678899999875 33459999986521 33445666665553 112333332 123567899
Q ss_pred EEEEecCCCccc--------------chhcc--CCC--C-----------HH--------H-------------------
Q 012053 87 FVMEYVKGGELF--------------GKVAK--GKL--K-----------ED--------A------------------- 110 (472)
Q Consensus 87 lV~E~~~gg~L~--------------~~i~~--~~l--~-----------e~--------~------------------- 110 (472)
++|+|++|..+. ..+.. ..+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 00110 001 0 00 0
Q ss_pred ----HHHHHHHHHHHHHHHH-------------hCCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 111 ----ARKYFQQLISAVDYCH-------------SRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 111 ----~~~i~~ql~~al~yLH-------------~~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
...+..++..++.+|+ ..+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111222334566665 2579999999999999888899999998653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.93 E-value=0.00014 Score=71.33 Aligned_cols=76 Identities=16% Similarity=0.228 Sum_probs=61.6
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCEEEEEEE
Q 012053 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR---HPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lV~E 90 (472)
-.+.|+.|....+|+... ++..+++|+.... ....+.+|...|+.|. ...+++++.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 457899999999999875 5678899987543 2466889999998884 3668899999888899999999
Q ss_pred ecCCCcc
Q 012053 91 YVKGGEL 97 (472)
Q Consensus 91 ~~~gg~L 97 (472)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9999754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.79 E-value=4.8e-05 Score=77.67 Aligned_cols=77 Identities=16% Similarity=0.096 Sum_probs=46.8
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccc-cchh-----hHHHHHHHHHHHH-hcCCCCeeeEEEEEEeCCEEE
Q 012053 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV-LKVG-----MIDQIKREISVMR-LVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~-----~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~ 86 (472)
-++.||.|..+.||++.. ++..++||....... .... ....+..|+..+. ......+++++.+. ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 457899999999999964 577899995322111 0000 1223333333322 22334567777765 56679
Q ss_pred EEEEec-CC
Q 012053 87 FVMEYV-KG 94 (472)
Q Consensus 87 lV~E~~-~g 94 (472)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00016 Score=70.49 Aligned_cols=138 Identities=14% Similarity=0.151 Sum_probs=79.0
Q ss_pred EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC--eeeEEEE------EEeCCE
Q 012053 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN--VVELYEV------MASKTK 84 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~ 84 (472)
.-++.|+.|....+|+... .+ ..+++|+..... ..+.+..|+.+++.+...+ +.+++.. ....+.
T Consensus 25 ~~~~~i~~G~~n~~~~v~~-~~-g~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHT-TK-DPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEECC---EEEEEEEE-SS-CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred eEeeccCCCcccceEEEEe-CC-ccEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 3456788888899999875 23 368899986531 1134667888887764212 2333321 223567
Q ss_pred EEEEEEecCCCcccch--------------hc---cC---C----CCHHHHHHH---------------HHHHHHHHHHH
Q 012053 85 IYFVMEYVKGGELFGK--------------VA---KG---K----LKEDAARKY---------------FQQLISAVDYC 125 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~--------------i~---~~---~----l~e~~~~~i---------------~~ql~~al~yL 125 (472)
.+++|+|++|..+... +. .+ . ......... -..+...++.+
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 8999999998654210 11 00 0 111100000 01133445555
Q ss_pred Hh-------CCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 126 HS-------RGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 126 H~-------~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
+. .+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 42 369999999999999887666899998654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.63 E-value=9.3e-05 Score=71.82 Aligned_cols=71 Identities=17% Similarity=0.055 Sum_probs=45.7
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEEEEEec-
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIYFVMEYV- 92 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~- 92 (472)
++.|+.|....+|++ ..+++|+....... .-...+|+.+++.+...++ .+++.+. .+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 688999999999998 56889987643211 0123568888877753233 4666543 33347899999
Q ss_pred CCCcc
Q 012053 93 KGGEL 97 (472)
Q Consensus 93 ~gg~L 97 (472)
+|.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00012 Score=72.02 Aligned_cols=134 Identities=15% Similarity=0.200 Sum_probs=71.1
Q ss_pred EeeEcccCCeE-EEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCCEEEEEEEe
Q 012053 15 GRLLGQGTFAK-VHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH--PNVVELYEVMASKTKIYFVMEY 91 (472)
Q Consensus 15 ~~~LG~G~fg~-Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 91 (472)
.+.|+.|+... +|+... .+|..+++|....... ..+..|+.+++.+.. -.+.+++.+....+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 45666665554 556542 2367788876543320 234567787777742 23566777644444 789999
Q ss_pred cCCCcccchhccC---------------------------CCCHHHHH-------H-HH------------HHHHHHHHH
Q 012053 92 VKGGELFGKVAKG---------------------------KLKEDAAR-------K-YF------------QQLISAVDY 124 (472)
Q Consensus 92 ~~gg~L~~~i~~~---------------------------~l~e~~~~-------~-i~------------~ql~~al~y 124 (472)
+.+..+.+.+... .++..... . +. ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9765543222110 12221110 0 00 011122222
Q ss_pred H------HhCCceecCCCCCcEEEcCC----CCeEEecCcchh
Q 012053 125 C------HSRGVCHRDLKPENLLLDEH----GNLKVSDFGLSA 157 (472)
Q Consensus 125 L------H~~giiHrDIKp~NILld~~----g~vkl~DFGla~ 157 (472)
+ +...++|+|+.|.|||++.+ +.+.|+||+.+.
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 2 23479999999999999875 679999999765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.51 E-value=0.0003 Score=64.73 Aligned_cols=120 Identities=18% Similarity=0.150 Sum_probs=79.3
Q ss_pred cccchhcc--CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcccccC
Q 012053 96 ELFGKVAK--GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTC 172 (472)
Q Consensus 96 ~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~ 172 (472)
+|.+++.. .+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|+|.+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 67777753 799999999999999999887722 1222344567999999999988764 2111 1
Q ss_pred CCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcccCC
Q 012053 173 GTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 173 gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L~~ 249 (472)
....+.|||... ...+.+.=|||||+++|.-+-=.+| ..-+..+|+.+.+||..|...
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhc
Confidence 233567888753 2234678899999999987753333 122344899999999999866
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00048 Score=70.56 Aligned_cols=75 Identities=13% Similarity=0.169 Sum_probs=51.3
Q ss_pred EEeeEcccCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEE
Q 012053 14 LGRLLGQGTFAKVHYARNLK-------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKI 85 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~ 85 (472)
-++.|+.|....||++.... .+..+++|+..... ..+.+.+|..+++.+...++ +++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678889899999998642 25789999974321 11345579999988853333 577776542
Q ss_pred EEEEEecCCCcc
Q 012053 86 YFVMEYVKGGEL 97 (472)
Q Consensus 86 ~lV~E~~~gg~L 97 (472)
.+|+||++|..|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 289999987544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0012 Score=63.41 Aligned_cols=81 Identities=10% Similarity=0.026 Sum_probs=57.4
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC---CCeeeEEEEEEeCCEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH---PNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~~~~~ 85 (472)
..+..-++.+|.|..+.||+.+. .+|+.|.+|+-..... .....+.+|+..|+.+.. --+++.+.+. . -
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--R 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--T
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--c
Confidence 34567788999999999999985 6889999998654332 122457889999998852 2345555542 2 3
Q ss_pred EEEEEecCCCcc
Q 012053 86 YFVMEYVKGGEL 97 (472)
Q Consensus 86 ~lV~E~~~gg~L 97 (472)
++||||+.++..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 789999987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00053 Score=69.02 Aligned_cols=134 Identities=16% Similarity=0.207 Sum_probs=81.9
Q ss_pred eeEcccCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEEE
Q 012053 16 RLLGQGTFAKVHYARNLK-------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 87 (472)
+.|..|-...+|++.... +++.+.+|+..... .....+.+|..+++.+. +.-..++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 567668888899987632 35789999853311 22355669999998885 3333567766643 29
Q ss_pred EEEecCCCcccch-----------------hcc-----C-CCC--HHHHHHHHHHHHH-------------------HHH
Q 012053 88 VMEYVKGGELFGK-----------------VAK-----G-KLK--EDAARKYFQQLIS-------------------AVD 123 (472)
Q Consensus 88 V~E~~~gg~L~~~-----------------i~~-----~-~l~--e~~~~~i~~ql~~-------------------al~ 123 (472)
||||++|..|... +.. + ... ..++.+|..++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998655311 111 1 111 3456666655422 233
Q ss_pred HHH----h----CCceecCCCCCcEEEcCC----CCeEEecCcchh
Q 012053 124 YCH----S----RGVCHRDLKPENLLLDEH----GNLKVSDFGLSA 157 (472)
Q Consensus 124 yLH----~----~giiHrDIKp~NILld~~----g~vkl~DFGla~ 157 (472)
.|. . ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 332 2 258999999999999876 789999998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0011 Score=64.69 Aligned_cols=134 Identities=16% Similarity=0.112 Sum_probs=79.3
Q ss_pred eeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCC--CeeeEEEE-----EEeCCEEEEE
Q 012053 16 RLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP--NVVELYEV-----MASKTKIYFV 88 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~-----~~~~~~~~lV 88 (472)
+.|+ |....||++.. .+|+.+++|+...... ....+..|..+++.+... .+++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998754 4567899999864321 135677788888777421 23444432 2335678899
Q ss_pred EEecCCCcccc-----------h---hc---c-C------CCCHHHH----------------------HHHHHHHHHHH
Q 012053 89 MEYVKGGELFG-----------K---VA---K-G------KLKEDAA----------------------RKYFQQLISAV 122 (472)
Q Consensus 89 ~E~~~gg~L~~-----------~---i~---~-~------~l~e~~~----------------------~~i~~ql~~al 122 (472)
|++++|..+.. . +. . . ..+.... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 99998854421 0 10 0 0 1111110 11112222222
Q ss_pred HHH----HhCCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 123 DYC----HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 123 ~yL----H~~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
.-+ ....++|+|++|.|||++ + .+.|+||+.+.
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 222 234689999999999999 4 89999998654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00062 Score=67.96 Aligned_cols=75 Identities=13% Similarity=0.106 Sum_probs=45.9
Q ss_pred EeeEcccCCeEEEEEEEcC--------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCEE
Q 012053 15 GRLLGQGTFAKVHYARNLK--------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN-VVELYEVMASKTKI 85 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~--------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 85 (472)
++.|+.|....+|++.... .+..+++|+...... .......|..+++.+...+ ..++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4677888888999988643 136899998754321 1112367888888875333 44676554 22
Q ss_pred EEEEEecCCCcc
Q 012053 86 YFVMEYVKGGEL 97 (472)
Q Consensus 86 ~lV~E~~~gg~L 97 (472)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999998544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0035 Score=64.65 Aligned_cols=76 Identities=13% Similarity=0.235 Sum_probs=50.0
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEEEEEEec
Q 012053 14 LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIYFVMEYV 92 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lV~E~~ 92 (472)
-++.|+.|-...+|++.....+..+++|+...... ...+ ..+|..+++.+...++ .++++++. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 34678889899999998744357899998754321 1111 2589999999875555 57777763 2 2599999
Q ss_pred CCCcc
Q 012053 93 KGGEL 97 (472)
Q Consensus 93 ~gg~L 97 (472)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 98544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0038 Score=61.57 Aligned_cols=72 Identities=14% Similarity=0.091 Sum_probs=45.7
Q ss_pred EeeEcc--cCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC---CCCeeeEEEE------EEeCC
Q 012053 15 GRLLGQ--GTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR---HPNVVELYEV------MASKT 83 (472)
Q Consensus 15 ~~~LG~--G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~------~~~~~ 83 (472)
++.|.. |....||+... .+| .+++|+...... .+|+.+++.|. -|++++++.. ....+
T Consensus 26 ~~~l~~G~g~~N~vy~v~~-~~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g 94 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADS-ESK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKH 94 (339)
T ss_dssp EEEETTTSCSSCEEEEEEC-SSC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSS
T ss_pred eEEeeccCccccceEEEEe-CCC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECC
Confidence 344533 33678999874 345 899998765431 35666666553 2334554432 23467
Q ss_pred EEEEEEEecCCCcc
Q 012053 84 KIYFVMEYVKGGEL 97 (472)
Q Consensus 84 ~~~lV~E~~~gg~L 97 (472)
..|++|+|++|..+
T Consensus 95 ~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 95 FKIIAYPFIHAPNG 108 (339)
T ss_dssp EEEEEEECCCCCBT
T ss_pred EEEEEEeccCCCcC
Confidence 89999999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.11 E-value=0.015 Score=59.30 Aligned_cols=75 Identities=13% Similarity=0.134 Sum_probs=48.9
Q ss_pred EeeEcccCCeEEEEEEEcCC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEE
Q 012053 15 GRLLGQGTFAKVHYARNLKT-------GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIY 86 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 86 (472)
++.|..|-...+|++..... +..+++|+...... .. -...+|..+++.+. +.-..++++.+. + +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~---~~-idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG---KF-YDSKVELDVFRYLSNINIAPNIIADFP--E--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CC-CCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc---hh-cCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence 46677788889999886421 67899998644321 11 12357888888885 333456665432 2 7
Q ss_pred EEEEecCCCcc
Q 012053 87 FVMEYVKGGEL 97 (472)
Q Consensus 87 lV~E~~~gg~L 97 (472)
+||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999999654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.67 E-value=0.16 Score=51.07 Aligned_cols=28 Identities=39% Similarity=0.681 Sum_probs=24.1
Q ss_pred ceecCCCCCcEEE------cCCCCeEEecCcchh
Q 012053 130 VCHRDLKPENLLL------DEHGNLKVSDFGLSA 157 (472)
Q Consensus 130 iiHrDIKp~NILl------d~~g~vkl~DFGla~ 157 (472)
++|+|+.+.|||+ ++++.+.++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 456679999998765
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.40 E-value=1 Score=41.23 Aligned_cols=82 Identities=16% Similarity=0.116 Sum_probs=62.5
Q ss_pred CCCCeeeEEEEEEeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHH-HHHhCCceecCCCCCcEEEcCCC
Q 012053 68 RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVD-YCHSRGVCHRDLKPENLLLDEHG 146 (472)
Q Consensus 68 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~-yLH~~giiHrDIKp~NILld~~g 146 (472)
.||++ -..+-.+++.+.+.++.-+++.=+..+ ..++..+.++++.+|+.... ++ ..-+|--|+|+||++|.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCC
Confidence 58888 555667888888877766554334434 46888999999999888666 44 4457778999999999999
Q ss_pred CeEEecCcc
Q 012053 147 NLKVSDFGL 155 (472)
Q Consensus 147 ~vkl~DFGl 155 (472)
.++|.-.|+
T Consensus 122 ~p~i~hRGi 130 (219)
T 4ano_A 122 EPFFLHVGV 130 (219)
T ss_dssp CEEESCCEE
T ss_pred cEEEEEcCC
Confidence 999988875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.77 E-value=1.8 Score=39.43 Aligned_cols=83 Identities=12% Similarity=0.157 Sum_probs=62.0
Q ss_pred CCCCeeeEEEEEEeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCC
Q 012053 68 RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGN 147 (472)
Q Consensus 68 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~ 147 (472)
.||+++.. .+-++++.+.+.++.-..+ ..+-.-..++..+.++++.+|+....++ ..-+|--|+|+||+++.++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f~~ik~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~~ 117 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNH--TPFDNIKSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDGL 117 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTS--EEGGGGGGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTSC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCccc--CCHHHHHhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCCC
Confidence 58999977 5777777777766654433 2222224578899999999999887444 34577889999999999999
Q ss_pred eEEecCcc
Q 012053 148 LKVSDFGL 155 (472)
Q Consensus 148 vkl~DFGl 155 (472)
+++.-.|+
T Consensus 118 p~i~~RGi 125 (215)
T 4ann_A 118 PIAKTRGL 125 (215)
T ss_dssp EEESCCEE
T ss_pred EEEEEccC
Confidence 99988775
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.77 E-value=0.071 Score=54.87 Aligned_cols=63 Identities=11% Similarity=0.162 Sum_probs=17.9
Q ss_pred EEeeEcccCCeEEEEEEEcCCCcEEEE------EEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE
Q 012053 14 LGRLLGQGTFAKVHYARNLKTGMSVAI------KIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA 80 (472)
Q Consensus 14 i~~~LG~G~fg~Vy~a~~~~~g~~vAi------K~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 80 (472)
+.+.|| ||+||.+........||+ |....... ..+....+.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence 445676 999999988665568888 65433222 1233445778899999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 472 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-93 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-88 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-87 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-86 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-84 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-83 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-82 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-82 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-80 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-80 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-78 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-78 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-78 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-78 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-76 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-76 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-75 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-75 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-74 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-74 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-74 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-73 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-72 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-71 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-69 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-68 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-66 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-66 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-65 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-65 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-65 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-65 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-65 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-65 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-64 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-64 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-64 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-63 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-63 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-63 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-62 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-62 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-60 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-60 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-59 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-58 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-55 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-53 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-43 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-26 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 7e-13 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 281 bits (721), Expect = 2e-93
Identities = 96/261 (36%), Positives = 153/261 (58%), Gaps = 6/261 (2%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
++ +E+GR LG+G F V+ AR ++ +A+K++ K ++ K G+ Q++RE+ + +R
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS 127
HPN++ LY T++Y ++EY G ++ ++ K K E Y +L +A+ YCHS
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
+ V HRD+KPENLLL G LK++DFG S A S T CGT Y+ PE+I R
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRM 180
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247
+D K D+WS GV+ Y L G PF + E Y++I + EF FP++ R L+S++L
Sbjct: 181 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239
Query: 248 DPNPNTRISMTKIMENSWFRK 268
NP+ R + +++E+ W
Sbjct: 240 KHNPSQRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 269 bits (688), Expect = 2e-88
Identities = 99/267 (37%), Positives = 155/267 (58%), Gaps = 6/267 (2%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ ++L + LG+G + +V A N T +VA+KI+D ++ + + IK+EI + +++ H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 62
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCHSR 128
NVV+ Y Y +EY GGELF ++ + E A+++F QL++ V Y H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY 188
G+ HRD+KPENLLLDE NLK+SDFGL+ + +++ LL+ CGT YVAPE++ RR +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 189 DGSKADIWSCGVILYVLLAGYLPFH-DSNLMEMYRKIGKAEFKFPNW--FAPEVRRLLSK 245
D+WSCG++L +LAG LP+ S+ + Y + + W LL K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 246 ILDPNPNTRISMTKIMENSWFRKGLVK 272
IL NP+ RI++ I ++ W+ K L K
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 267 bits (684), Expect = 1e-87
Identities = 87/259 (33%), Positives = 146/259 (56%), Gaps = 2/259 (0%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
++ G++LG+G+F+ V AR L T AIKI++K ++K + + RE VM + HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRG 129
V+LY K+YF + Y K GEL + K G E R Y +++SA++Y H +G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD 189
+ HRDLKPEN+LL+E +++++DFG + + + + ++ GT YV+PE++ +
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 190 GSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKILDP 249
+D+W+ G I+Y L+AG PF N +++KI K E+ FP F P+ R L+ K+L
Sbjct: 189 -KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 250 NPNTRISMTKIMENSWFRK 268
+ R+ ++ +
Sbjct: 248 DATKRLGCEEMEGYGPLKA 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 264 bits (675), Expect = 4e-86
Identities = 79/278 (28%), Positives = 141/278 (50%), Gaps = 13/278 (4%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
++Y +GQG V+ A ++ TG VAI+ ++ ++ K + I EI VMR ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
PN+V + +++ VMEY+ GG L V + + E ++ + A+++ HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD 189
V HRD+K +N+LL G++K++DFG A + T GTP ++APEV+ R+ Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 190 GSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI---GKAEFKFPNWFAPEVRRLLSKI 246
K DIWS G++ ++ G P+ + N + I G E + P + R L++
Sbjct: 195 -PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 247 LDPNPNTRISMTKIMENSWFRKGL----VKPSISETEE 280
LD + R S +++++ + + + P I+ +E
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (661), Expect = 4e-84
Identities = 75/272 (27%), Positives = 137/272 (50%), Gaps = 14/272 (5%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
+E+ LG G F KV+ A+N +T + A K+ID + ++ EI ++ HP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHP 69
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSR 128
N+V+L + + ++ ++E+ GG + + + L E + +Q + A++Y H
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI----N 184
+ HRDLK N+L G++K++DFG+SA Q + GTP ++APEV+ +
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETS 187
Query: 185 RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE---FKFPNWFAPEVRR 241
+ KAD+WS G+ L + P H+ N M + KI K+E P+ ++ +
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247
Query: 242 LLSKILDPNPNTRISMTKIMENSWFRKGLVKP 273
L K L+ N + R + ++++++ + KP
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 258 bits (661), Expect = 3e-83
Identities = 89/318 (27%), Positives = 149/318 (46%), Gaps = 21/318 (6%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKRE 60
+E K ++ Y++ LG G F VH TG + A K + + +++E
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKE 73
Query: 61 ISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQL 118
I M ++RHP +V L++ ++ + E++ GGELF KVA K+ ED A +Y +Q+
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 119 ISAVDYCHSRGVCHRDLKPENLLL--DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
+ + H H DLKPEN++ LK+ DFGL+A + K + T GT
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAE 190
Query: 177 YVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN--- 233
+ APEV + G D+WS GV+ Y+LL+G PF N E R + ++ +
Sbjct: 191 FAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249
Query: 234 -WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVK------PSISETEEKEWAPV 286
+ + + + K+L +PNTR+++ + +E+ W G PS T+ ++
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKT 309
Query: 287 DADAVFSPSGSTSTVAES 304
DA P ++
Sbjct: 310 KYDAWPEPLPPLGRISNY 327
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 254 bits (649), Expect = 5e-82
Identities = 67/277 (24%), Positives = 119/277 (42%), Gaps = 11/277 (3%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
+ + R +G G+F V++AR+++ VAIK + I +E+ ++ +RH
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELF-GKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
PN ++ + + VMEY G +V K L+E + + Y HS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI--NRR 186
+ HRD+K N+LL E G +K+ DFG +++ ++ GTP ++APEVI
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDE 188
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNW--FAPEVRRLLS 244
G K D+WS G+ L P + N M I + E ++ R +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248
Query: 245 KILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEK 281
L P R + ++++ + + I + ++
Sbjct: 249 SCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQR 285
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 254 bits (651), Expect = 9e-82
Identities = 74/274 (27%), Positives = 137/274 (50%), Gaps = 16/274 (5%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
+GS+ Y++ LG G F VH TG K I+ L +K EIS
Sbjct: 23 KQGSVY-DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEIS 78
Query: 63 VMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLIS 120
+M + HP ++ L++ K ++ ++E++ GGELF ++A K+ E Y +Q
Sbjct: 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 138
Query: 121 AVDYCHSRGVCHRDLKPENLLLD--EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
+ + H + H D+KPEN++ + + ++K+ DFG LA + D ++ T T +
Sbjct: 139 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG---LATKLNPDEIVKVTTATAEFA 195
Query: 179 APEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NW 234
APE+++R D+W+ GV+ YVLL+G PF + +E + + + +++F +
Sbjct: 196 APEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 235 FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
+PE + + +L P R+++ +E+ W +
Sbjct: 255 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (635), Expect = 1e-80
Identities = 83/267 (31%), Positives = 138/267 (51%), Gaps = 17/267 (6%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
YE+ +G G++ + R G + K +D + + + E++++R ++HPN
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPN 64
Query: 72 VVELYEVMASKT--KIYFVMEYVKGGELF-----GKVAKGKLKEDAARKYFQQLISAVDY 124
+V Y+ + +T +Y VMEY +GG+L G + L E+ + QL A+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 125 CHSRG-----VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
CH R V HRDLKP N+ LD N+K+ DFGL+ + H GTP Y++
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWFAPE 238
PE +NR Y+ K+DIWS G +LY L A PF + E+ KI + +F + P ++ E
Sbjct: 183 PEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 241
Query: 239 VRRLLSKILDPNPNTRISMTKIMENSW 265
+ +++++L+ R S+ +I+EN
Sbjct: 242 LNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 247 bits (632), Expect = 5e-80
Identities = 89/276 (32%), Positives = 141/276 (51%), Gaps = 20/276 (7%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV------GMIDQIKREISV 63
+ YE +LG+G + V + T A+KIID + + +E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 64 MRLVR-HPNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISA 121
+R V HPN+++L + + T + V + +K GELF + K L E RK + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+ H + HRDLKPEN+LLD+ N+K++DFG S + + L CGTP+Y+APE
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPE 179
Query: 182 VI-----NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI--GKAEFKFPNW 234
+I + G + D+WS GVI+Y LLAG PF M M R I G +F P W
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 235 --FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
++ V+ L+S+ L P R + + + + +F++
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 245 bits (626), Expect = 1e-78
Identities = 96/273 (35%), Positives = 153/273 (56%), Gaps = 14/273 (5%)
Query: 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISV 63
+ + Y+ +LG G F++V A + +T VAIK I K+ + G ++ EI+V
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAV 60
Query: 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAV 122
+ ++HPN+V L ++ S +Y +M+ V GGELF ++ KG E A + Q++ AV
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120
Query: 123 DYCHSRGVCHRDLKPENLLL---DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
Y H G+ HRDLKPENLL DE + +SDFGLS + + +L T CGTP YVA
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVA 177
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWF 235
PEV+ ++ Y D WS GVI Y+LL GY PF+D N +++ +I KAE++F +
Sbjct: 178 PEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
+ + + +++ +P R + + +++ W
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (627), Expect = 1e-78
Identities = 87/263 (33%), Positives = 144/263 (54%), Gaps = 6/263 (2%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV- 67
++ + L ++LG+G+F KV A KT AIK + K+ VL ++ E V+ L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKV-AKGKLKEDAARKYFQQLISAVDYCH 126
HP + ++ +K ++FVMEY+ GG+L + + K A Y ++I + + H
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR 186
S+G+ +RDLK +N+LLD+ G++K++DFG+ E+ D +T CGTP Y+APE++ +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246
Y+ D WS GV+LY +L G PFH + E++ I +P W E + LL K+
Sbjct: 179 KYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237
Query: 247 LDPNPNTRISMTK-IMENSWFRK 268
P R+ + I ++ FR+
Sbjct: 238 FVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (625), Expect = 3e-78
Identities = 64/275 (23%), Positives = 128/275 (46%), Gaps = 16/275 (5%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
L ++Y + LG+G F VH + + K + + +V +K+EIS++ +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKEISILNIA 58
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYC 125
RH N++ L+E S ++ + E++ G ++F ++ +L E Y Q+ A+ +
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 126 HSRGVCHRDLKPENLLLD--EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
HS + H D++PEN++ +K+ +FG + + P Y APEV
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVH 175
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWFAPEV 239
+ D+WS G ++YVLL+G PF ++ I AE+ F + E
Sbjct: 176 QHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 240 RRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPS 274
+ ++L +R++ ++ +++ W ++ + + S
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 243 bits (621), Expect = 7e-78
Identities = 90/266 (33%), Positives = 163/266 (61%), Gaps = 12/266 (4%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+Q +++ R LG G+F +VH R+ G A+K++ KE V+++ ++ E ++ +V
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFG-KVAKGKLKEDAARKYFQQLISAVDYCHS 127
HP ++ ++ +I+ +M+Y++GGELF + A+ Y ++ A++Y HS
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
+ + +RDLKPEN+LLD++G++K++DFG +K+ + +T CGTP Y+APEV++ +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFG-----FAKYVPDVTYTLCGTPDYIAPEVVSTKP 177
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247
Y+ D WS G+++Y +LAGY PF+DSN M+ Y KI AE +FP +F +V+ LLS+++
Sbjct: 178 YN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236
Query: 248 DPNPNTRI-----SMTKIMENSWFRK 268
+ + R+ + + WF++
Sbjct: 237 TRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (607), Expect = 3e-76
Identities = 63/267 (23%), Positives = 129/267 (48%), Gaps = 18/267 (6%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+ +G+G+F V+ + +T + VA + K+ K + K E +++ ++HPN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 69
Query: 72 VVELYEVMASKTK----IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCH 126
+V Y+ S K I V E + G L + + +K R + +Q++ + + H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 127 SRG--VCHRDLKPENLLL-DEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
+R + HRDLK +N+ + G++K+ D GL+ L + GTP ++APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMY 185
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-NLMEMYRKI--GKAEFKFPNWFAPEVR 240
+ YD D+++ G+ + + P+ + N ++YR++ G F PEV+
Sbjct: 186 EEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243
Query: 241 RLLSKILDPNPNTRISMTKIMENSWFR 267
++ + N + R S+ ++ +++F+
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 8e-76
Identities = 70/308 (22%), Positives = 125/308 (40%), Gaps = 53/308 (17%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL 66
+ +E LG G V + +G+ +A K+I E +K + +QI RE+ V+
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHE 60
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYC 125
P +V Y S +I ME++ GG L + K G++ E K +I + Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 126 HSR-GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVIN 184
+ + HRD+KP N+L++ G +K+ DFG+S D + ++ GT +Y++PE +
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176
Query: 185 RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEM------------------------ 220
Y ++DIWS G+ L + G P + E+
Sbjct: 177 GTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 221 --------------------YRKIGKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKI 260
Y F+ E + ++K L NP R + ++
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 261 MENSWFRK 268
M +++ ++
Sbjct: 296 MVHAFIKR 303
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (604), Expect = 6e-75
Identities = 93/267 (34%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL 66
+ M ++ +LLG+GTF KV R TG A+KI+ KE ++ + E V++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKG-KLKEDAARKYFQQLISAVDYC 125
RHP + L + ++ FVMEY GGELF +++ E+ AR Y +++SA++Y
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
HSR V +RD+K ENL+LD+ G++K++DFGL E + T CGTP Y+APEV+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245
Y D W GV++Y ++ G LPF++ + ++ I E +FP +PE + LL+
Sbjct: 180 NDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238
Query: 246 ILDPNPNTRISMTK-----IMENSWFR 267
+L +P R+ +ME+ +F
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 9e-75
Identities = 77/278 (27%), Positives = 134/278 (48%), Gaps = 18/278 (6%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMID---QIKREISVM 64
L +Y++G LLG G F V+ + + VAIK ++K+++ G + ++ E+ ++
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 65 RLVR--HPNVVELYEVMASKTKIYFVMEYVKGGELFGKV--AKGKLKEDAARKYFQQLIS 120
+ V V+ L + ++E + + +G L+E+ AR +F Q++
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
AV +CH+ GV HRD+K EN+L+D + G LK+ DFG AL + GT Y
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP 177
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEV 239
PE I Y G A +WS G++LY ++ G +PF +I + + F + E
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231
Query: 240 RRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISE 277
+ L+ L P+ R + +I + W + L+ +E
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 2e-74
Identities = 57/262 (21%), Positives = 120/262 (45%), Gaps = 15/262 (5%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
+ +G+ +G G+F V+ + VA+K+++ + K E+ V+R RH
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHV 64
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGELFG--KVAKGKLKEDAARKYFQQLISAVDYCHSR 128
N++ + ++ V ++ +G L+ + + K + +Q +DY H++
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY 188
+ HRDLK N+ L E +K+ DFGL+ + G+ ++APEVI +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 189 D--GSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNW------FAPEVR 240
+ ++D+++ G++LY L+ G LP+ + N + + + P+ ++
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 241 RLLSKILDPNPNTRISMTKIME 262
RL+++ L + R +I+
Sbjct: 244 RLMAECLKKKRDERPLFPQILA 265
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 3e-74
Identities = 84/270 (31%), Positives = 144/270 (53%), Gaps = 16/270 (5%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL---KVGMIDQIKREISVMRLV 67
Y+ G LG G FA V R TG+ A K I K + + + I+RE+S+++ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 68 RHPNVVELYEVMASKTKIYFVMEYVKGGELF-GKVAKGKLKEDAARKYFQQLISAVDYCH 126
+HPNV+ L+EV +KT + ++E V GGELF K L E+ A ++ +Q+++ V Y H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 127 SRGVCHRDLKPENLLLDEHG----NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV 182
S + H DLKPEN++L + +K+ DFGL+ + ++ GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 187
Query: 183 INRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWF----APE 238
+N +AD+WS GVI Y+LL+G PF E + ++F + + +
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 239 VRRLLSKILDPNPNTRISMTKIMENSWFRK 268
+ + ++L +P R+++ +++ W +
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 233 bits (594), Expect = 3e-74
Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 11/272 (4%)
Query: 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR 65
S L RYELG +LG G ++VH AR+L+ VA+K++ + + +RE
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 66 LVRHPNVVELYEVMASKTK----IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLIS 120
+ HP +V +Y+ ++T Y VMEYV G L V G + A +
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA-LAESKHQDGLLHTTCGTPAYVA 179
A+++ H G+ HRD+KP N+++ +KV DFG++ +A+S + GT Y++
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN----WF 235
PE D +++D++S G +LY +L G PF + + + + + + P+
Sbjct: 183 PEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFR 267
+ ++ ++ K L NP R M R
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 234 bits (597), Expect = 1e-73
Identities = 81/271 (29%), Positives = 139/271 (51%), Gaps = 16/271 (5%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
M + + R++G+G F +V+ R TG A+K +DK+++ E ++ LV
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 69 ---HPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDY 124
P +V + + K+ F+++ + GG+L +++ G E R Y ++I +++
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 125 CHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVIN 184
H+R V +RDLKP N+LLDEHG++++SD GL+ H + GT Y+APEV+
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACD----FSKKKPHASVGTHGYMAPEVLQ 178
Query: 185 RRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKIGKAEFKFPNWFAPEVRR 241
+ S AD +S G +L+ LL G+ PF E+ R + P+ F+PE+R
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 242 LLSKILDPNPNTRISMTK-----IMENSWFR 267
LL +L + N R+ + E+ +FR
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 5e-72
Identities = 83/293 (28%), Positives = 139/293 (47%), Gaps = 26/293 (8%)
Query: 1 MENKGSILMQRYE-LGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKR 59
++ K + ++ Y+ ++LG G KV N +T A+K++ + +R
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARR 53
Query: 60 EISVM-RLVRHPNVVELYEV----MASKTKIYFVMEYVKGGELFGKVAK---GKLKEDAA 111
E+ + R + P++V + +V A + + VME + GGELF ++ E A
Sbjct: 54 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 113
Query: 112 RKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT 171
+ + + A+ Y HS + HRD+KPENLL + A+ L T
Sbjct: 114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173
Query: 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME----MYRKIGKA 227
C TP YVAPEV+ YD D+WS GVI+Y+LL GY PF+ ++ + M +I
Sbjct: 174 CYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232
Query: 228 EFKFPNW----FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSIS 276
+++FPN + EV+ L+ +L P R+++T+ M + W + P
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 226 bits (578), Expect = 6e-71
Identities = 90/272 (33%), Positives = 154/272 (56%), Gaps = 12/272 (4%)
Query: 3 NKGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREIS 62
++ + + +++ + LG G+F +V ++ ++G A+KI+DK+KV+K+ I+ E
Sbjct: 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 63 VMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISA 121
+++ V P +V+L + +Y VMEYV GGE+F + + G+ E AR Y Q++
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+Y HS + +RDLKPENLL+D+ G ++V+DFG +K G T CGTP +APE
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-----AKRVKGRTWTLCGTPEALAPE 208
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRR 241
+I +GY+ D W+ GV++Y + AGY PF +++Y KI + +FP+ F+ +++
Sbjct: 209 IILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD 267
Query: 242 LLSKILDPNPNTRI-----SMTKIMENSWFRK 268
LL +L + R + I + WF
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 3e-69
Identities = 69/262 (26%), Positives = 115/262 (43%), Gaps = 19/262 (7%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL 66
+ M+ +L + +G+G F V G VA+K I + E SVM
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQ 56
Query: 67 VRHPNVVELYEVMA-SKTKIYFVMEYVKGGELFG---KVAKGKLKEDAARKYFQQLISAV 122
+RH N+V+L V+ K +Y V EY+ G L + L D K+ + A+
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 123 DYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEV 182
+Y HRDL N+L+ E KVSDFGL+ A S T + APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEA 171
Query: 183 INRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVR 240
+ + + +K+D+WS G++L+ + + G +P+ L ++ ++ K P+ P V
Sbjct: 172 LREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230
Query: 241 RLLSKILDPNPNTRISMTKIME 262
++ + R S ++ E
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 2e-68
Identities = 58/264 (21%), Positives = 101/264 (38%), Gaps = 9/264 (3%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISV 63
I + L LG G+F V +SVA+K + + + + +D RE++
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISA 121
M + H N++ LY V+ + + V E G L ++ K G +Y Q+
Sbjct: 65 MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+ Y S+ HRDL NLLL +K+ DFGL ++ P
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 182 VINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEFKF--PNWFAPE 238
+ +D W GV L+ + G P+ N ++ KI K + P +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 239 VRRLLSKILDPNPNTRISMTKIME 262
+ ++ + P R + + +
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 2e-68
Identities = 71/294 (24%), Positives = 122/294 (41%), Gaps = 38/294 (12%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
RY +G+G + V A + + VAIK I + + REI ++ RH
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 66
Query: 71 NVVELYEVMASKT----KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCH 126
N++ + +++ + T K +++ ++ G +L+ + L D + Q++ + Y H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT-CGTPAYVAPEVINR 185
S V HRDLKP NLLL+ +LK+ DFGL+ +A+ H T T Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------ 227
DIWS G IL +L+ F + ++ I
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 228 --EFKFPNW-----------FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
P+ + LL K+L NP+ RI + + + + + +
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 3e-66
Identities = 61/256 (23%), Positives = 114/256 (44%), Gaps = 11/256 (4%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN 71
+ LG G F V Y + + VAIK+I + + + D+ E VM + H
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 72 VVELYEVMASKTKIYFVMEYVKGGELFG--KVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
+V+LY V + I+ + EY+ G L + + + + + + + A++Y S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD 189
HRDL N L+++ G +KVSDFGLS + + + PEV+ +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 190 GSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKIL 247
SK+DIW+ GV+++ + + G +P+ E I + P+ + +V ++
Sbjct: 180 -SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 248 DPNPNTRISMTKIMEN 263
+ R + ++ N
Sbjct: 239 HEKADERPTFKILLSN 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 5e-66
Identities = 59/295 (20%), Positives = 112/295 (37%), Gaps = 36/295 (12%)
Query: 1 MENKGSILMQRYELGRLLGQGTFAKVHYARNLKTG-----MSVAIKIIDKEKVLKVGMID 55
+ K + E G++LG G F KV A + VA+K++ ++ +
Sbjct: 28 YDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSERE 85
Query: 56 QIKREISVM-RLVRHPNVVELYEVMASKTKIYFVMEYVKGGELF---------------- 98
+ E+ +M +L H N+V L IY + EY G+L
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 99 --------GKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKV 150
+ L + + Q+ +++ + HRDL N+L+ +K+
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI 205
Query: 151 SDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GY 209
DFGL+ S + ++APE + Y K+D+WS G++L+ + + G
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGV 264
Query: 210 LPFHDSNLMEMYRKIGKAEFKF--PNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
P+ + + K+ + FK P + E+ ++ + R S +
Sbjct: 265 NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (538), Expect = 7e-66
Identities = 69/281 (24%), Positives = 129/281 (45%), Gaps = 13/281 (4%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL 66
+ + LG G + +V+ K ++VA+K + ++ + +++ +E +VM+
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKE 69
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELF---GKVAKGKLKEDAARKYFQQLISAVD 123
++HPN+V+L V + Y + E++ G L + + ++ Q+ SA++
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
Y + HRDL N L+ E+ +KV+DFGLS L + APE +
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESL 188
Query: 184 NRRGYDGSKADIWSCGVILYVLL-AGYLPFHDSNLMEMYRKIGK-AEFKFPNWFAPEVRR 241
+ K+D+W+ GV+L+ + G P+ +L ++Y + K + P +V
Sbjct: 189 AYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 242 LLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKE 282
L+ NP+ R S +I + F + SIS+ EKE
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQ--AFETMFQESSISDEVEKE 286
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 1e-65
Identities = 65/252 (25%), Positives = 104/252 (41%), Gaps = 11/252 (4%)
Query: 18 LGQGTFAKVHYA--RNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVEL 75
LG G F V R K + VAIK++ + + +++ RE +M + +P +V L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 76 YEVMASKTKIYFVMEYVKGGELFG--KVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHR 133
V + VME GG L + ++ + Q+ + Y + HR
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 134 DLKPENLLLDEHGNLKVSDFGLS-ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSK 192
DL N+LL K+SDFGLS AL + APE IN R + S+
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 192
Query: 193 ADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDPN 250
+D+WS GV ++ L+ G P+ E+ I + + + P PE+ L+S
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 251 PNTRISMTKIME 262
R + +
Sbjct: 253 WEDRPDFLTVEQ 264
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-65
Identities = 73/286 (25%), Positives = 119/286 (41%), Gaps = 33/286 (11%)
Query: 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV--LKVGMIDQIKREISVMRLVRHP 70
E LG+G FA V+ AR+ T VAIK I K G+ REI +++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGEL-FGKVAKGKLKEDAARKYFQQLISAVDYCHSRG 129
N++ L + K+ I V ++++ K L + Y + ++Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 130 VCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYD 189
+ HRDLKP NLLLDE+G LK++DFGL+ S ++ T Y APE++
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMY 178
Query: 190 GSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----------------- 232
G D+W+ G IL LL + ++ +I +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 233 -----------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267
+ ++ L+ + NP RI+ T+ ++ +F
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 210 bits (534), Expect = 3e-65
Identities = 81/290 (27%), Positives = 138/290 (47%), Gaps = 34/290 (11%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
M++Y +G+GT+ V+ A+N G + A+K I EK G+ REIS+++ ++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELK 58
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGELFG-KVAKGKLKEDAARKYFQQLISAVDYCHS 127
H N+V+LY+V+ +K ++ V E++ V +G L+ A+ + QL++ + YCH
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
R V HRDLKP+NLL++ G LK++DFGL+ + T Y AP+V+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSK 176
Query: 188 YDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF------------------ 229
+ DIWS G I ++ G F + + +I +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 230 -----------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
F LLSK+L +PN RI+ + +E+++F++
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 4e-65
Identities = 59/261 (22%), Positives = 113/261 (43%), Gaps = 13/261 (4%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL 66
+ + +L LG G F +V VA+K + + + D E ++M+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQ 64
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELFG---KVAKGKLKEDAARKYFQQLISAVD 123
++H +V LY V+ ++ IY + EY++ G L + KL + Q+ +
Sbjct: 65 LQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
+ R HRDL+ N+L+ + + K++DFGL+ L E ++ + APE I
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAI 182
Query: 184 NRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241
G K+D+WS G++L ++ G +P+ E+ + + + P+ E+ +
Sbjct: 183 -NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241
Query: 242 LLSKILDPNPNTRISMTKIME 262
L+ P R + +
Sbjct: 242 LMRLCWKERPEDRPTFDYLRS 262
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 4e-65
Identities = 70/303 (23%), Positives = 112/303 (36%), Gaps = 44/303 (14%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
+ +YE +GQGTF +V AR+ KTG VA+K + E K G REI +++L++
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLK 67
Query: 69 HPNVVELYEVMASKT--------KIYFVMEYVKGGEL-FGKVAKGKLKEDAARKYFQQLI 119
H NVV L E+ +K IY V ++ + K ++ Q L+
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 120 SAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL--AESKHQDGLLHTTCGTPAY 177
+ + Y H + HRD+K N+L+ G LK++DFGL+ Q T Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 178 VAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----- 232
PE++ G D+W G I+ + + I +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 233 ---------------------------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSW 265
P L+ K+L +P RI + + +
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307
Query: 266 FRK 268
F
Sbjct: 308 FWS 310
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 4e-65
Identities = 61/263 (23%), Positives = 109/263 (41%), Gaps = 11/263 (4%)
Query: 16 RLLGQGTFAKVHYA--RNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVV 73
+ LG G F V + K +VA+KI+ E + D++ E +VM+ + +P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIV 71
Query: 74 ELYEVMASKTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCH 132
+ + ++ VME + G L + + +K+ + Q+ + Y H
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 133 RDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT-CGTPAYVAPEVINRRGYDGS 191
RDL N+LL K+SDFGLS + T + APE IN + S
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 189
Query: 192 KADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDP 249
K+D+WS GV+++ + G P+ E+ + K E P E+ L++
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 250 NPNTRISMTKIME--NSWFRKGL 270
+ R + +++ +
Sbjct: 250 DVENRPGFAAVELRLRNYYYDVV 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 5e-65
Identities = 82/296 (27%), Positives = 139/296 (46%), Gaps = 35/296 (11%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
M+ ++ +G+GT+ V+ ARN TG VA+K I + G+ REIS+++ +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELN 59
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQLISAVDYCH 126
HPN+V+L +V+ ++ K+Y V E++ + A + + Y QL+ + +CH
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 127 SRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRR 186
S V HRDLKP+NLL++ G +K++DFGL+ + T Y APE++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGC 177
Query: 187 GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA------------------E 228
Y + DIWS G I ++ F + ++ +I + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 229 FKFPNW-----------FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKP 273
FP W + R LLS++L +PN RIS + + +F + + KP
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKP 292
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (533), Expect = 6e-65
Identities = 61/267 (22%), Positives = 110/267 (41%), Gaps = 13/267 (4%)
Query: 6 SILMQRYELGRLLGQGTFAKVHYARNLKTG---MSVAIKIIDKEKVLKVGMIDQIKREIS 62
I + ++ +++G G F +V G + VAIK + K E S
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK--QRRDFLSEAS 79
Query: 63 VMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLIS 120
+M HPNV+ L V+ T + + E+++ G L F + G+ + + +
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTT---CGTPAY 177
+ Y HRDL N+L++ + KVSDFGLS E D + +
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 178 VAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWF 235
APE I R + +D+WS G++++ +++ G P+ D ++ I + P
Sbjct: 200 TAPEAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC 258
Query: 236 APEVRRLLSKILDPNPNTRISMTKIME 262
+ +L+ + N R +I+
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 1e-64
Identities = 76/296 (25%), Positives = 123/296 (41%), Gaps = 44/296 (14%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH 69
Y + +G G + V A + +TG VAIK + + + RE+ +++ +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRH 76
Query: 70 PNVVELYEVMASK------TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVD 123
NV+ L +V T Y VM ++ G +L + KL ED + Q++ +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
Y H+ G+ HRDLKP NL ++E LK+ DFGL+ + D + T Y APEVI
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAPEVI 190
Query: 184 NRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFA------- 236
DIWS G I+ ++ G F S+ ++ ++I K P F
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 237 ------------------------PEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
P LL K+L + R++ + + + +F
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-64
Identities = 61/256 (23%), Positives = 110/256 (42%), Gaps = 11/256 (4%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
+ +G G F VH VAIK I + + + + E VM + HP
Sbjct: 6 ELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60
Query: 71 NVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
+V+LY V + I V E+++ G L + + +G + + + Y
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 129 GVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGY 188
V HRDL N L+ E+ +KVSDFG++ Q T + +PEV + Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 189 DGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKI 246
SK+D+WS GV+++ + + G +P+ + + E+ I P + V ++++
Sbjct: 180 S-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 247 LDPNPNTRISMTKIME 262
P R + ++++
Sbjct: 239 WKERPEDRPAFSRLLR 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-64
Identities = 64/306 (20%), Positives = 118/306 (38%), Gaps = 26/306 (8%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-R 65
+ + ++G+G F +V AR K G+ + I ++ E+ V+ +
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGGELF-----------------GKVAKGKLKE 108
L HPN++ L + +Y +EY G L L
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 109 DAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168
+ + +DY + HRDL N+L+ E+ K++DFG L+ +
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKK 183
Query: 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA 227
++A E +N Y +D+WS GV+L+ +++ G P+ E+Y K+ +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242
Query: 228 E-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME--NSWFRKGLVKPSISETEEKEWA 284
+ P EV L+ + P R S +I+ N + + + E+ +A
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 302
Query: 285 PVDADA 290
+D A
Sbjct: 303 GIDCSA 308
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 7e-64
Identities = 84/306 (27%), Positives = 131/306 (42%), Gaps = 51/306 (16%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
Y +++G G+F V+ A+ +G VAIK + ++K K RE+ +MR + H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDHC 73
Query: 71 NVVELYEVMAS------KTKIYFVMEYVKGGEL----FGKVAKGKLKEDAARKYFQQLIS 120
N+V L S + + V++YV AK L + Y QL
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNL-KVSDFGLSALAESKHQDGLLHTTCGTPAYVA 179
++ Y HS G+CHRD+KP+NLLLD + K+ DFG A+ + + + Y A
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS---AKQLVRGEPNVSYICSRYYRA 190
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK------------- 226
PE+I S D+WS G +L LL G F + ++ +I K
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 227 ----AEFKFPNW------------FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270
EFKFP PE L S++L+ P R++ + +S+F L
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DEL 309
Query: 271 VKPSIS 276
P++
Sbjct: 310 RDPNVK 315
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-63
Identities = 83/296 (28%), Positives = 131/296 (44%), Gaps = 43/296 (14%)
Query: 10 QRYELGRLLGQGTFAKVHYARNLKT-GMSVAIKIIDKEKVLKVGMIDQIKREISVMRL-- 66
Q+YE +G+G + KV AR+LK G VA+K + + + GM RE++V+R
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLE 65
Query: 67 -VRHPNVVELYEVMAS-----KTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQL 118
HPNVV L++V +TK+ V E+V KV + + + + QL
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 119 ISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYV 178
+ +D+ HS V HRDLKP+N+L+ G +K++DFGL+ + + + T Y
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYR 182
Query: 179 APEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKI-------------- 224
APEV+ + Y + D+WS G I + F S+ ++ KI
Sbjct: 183 APEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 225 -------------GKAEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267
+ KF + LL K L NP RIS + + +F+
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-63
Identities = 63/291 (21%), Positives = 125/291 (42%), Gaps = 9/291 (3%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKE--KVLKVGMIDQIKREISVMRLVRH 69
++ ++LG G F V+ + G V I + KE + +I E VM V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 70 PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLK--EDAARKYFQQLISAVDYCHS 127
P+V L + + T + + + + G L V + K + Q+ ++Y
Sbjct: 71 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
R + HRDL N+L+ ++K++DFGL+ L ++ ++ ++A E I R
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 188 YDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRRLLSK 245
Y ++D+WS GV ++ L+ G P+ E+ + K E P +V ++ K
Sbjct: 190 YT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248
Query: 246 ILDPNPNTRISMTKIMEN-SWFRKGLVKPSISETEEKEWAPVDADAVFSPS 295
+ ++R +++ S + + + + +E+ P D+ F +
Sbjct: 249 CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRA 299
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 6e-63
Identities = 73/263 (27%), Positives = 122/263 (46%), Gaps = 12/263 (4%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKT---GMSVAIKIIDKEKVLKVGMIDQIKREISV 63
I +R ELGR +G+G F VH + ++VAIK + ++ +E
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALT 61
Query: 64 MRLVRHPNVVELYEVMASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDAARKYFQQLISA 121
MR HP++V+L V+ ++ ++ +ME GEL F +V K L + Y QL +A
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+ Y S+ HRD+ N+L+ + +K+ DFGLS E ++APE
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE 179
Query: 182 VINRRGYDGSKADIWSCGVILY-VLLAGYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEV 239
IN R + +D+W GV ++ +L+ G PF ++ +I E P P +
Sbjct: 180 SINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238
Query: 240 RRLLSKILDPNPNTRISMTKIME 262
L++K +P+ R T++
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-62
Identities = 73/277 (26%), Positives = 138/277 (49%), Gaps = 15/277 (5%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVL-KVGMIDQIKREIS 62
+ ++ +EL ++LG G + KV R + TG A+K++ K ++ K + + E
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 63 VMRLVRH-PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKG-KLKEDAARKYFQQLIS 120
V+ +R P +V L+ ++TK++ +++Y+ GGELF +++ + E + Y +++
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAP 180
A+++ H G+ +RD+K EN+LLD +G++ ++DFGLS + +
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN----LMEMYRKIGKAEFKFPNWFA 236
V D WS GV++Y LL G PF E+ R+I K+E +P +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 237 PEVRRLLSKILDPNPNTRISMTK-----IMENSWFRK 268
+ L+ ++L +P R+ I E+ +F+K
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-62
Identities = 65/261 (24%), Positives = 105/261 (40%), Gaps = 13/261 (4%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL 66
I + L LGQG F +V VAIK + + + +E VM+
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKK 68
Query: 67 VRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLK---EDAARKYFQQLISAVD 123
+RH +V+LY V+ S+ IY V EY+ G L + K Q+ S +
Sbjct: 69 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 124 YCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVI 183
Y HRDL+ N+L+ E+ KV+DFGL+ L E + + APE
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAA 186
Query: 184 NRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRR 241
+ K+D+WS G++L L G +P+ E+ ++ + P +
Sbjct: 187 LYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245
Query: 242 LLSKILDPNPNTRISMTKIME 262
L+ + P R + +
Sbjct: 246 LMCQCWRKEPEERPTFEYLQA 266
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (513), Expect = 4e-62
Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 34/291 (11%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR 68
MQ+YE +G+GT+ V A+N +T VA+K + + G+ REI +++ ++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELK 59
Query: 69 HPNVVELYEVMASKTKIYFVMEYVKGGEL-FGKVAKGKLKEDAARKYFQQLISAVDYCHS 127
H N+V L++V+ S K+ V E+ + G L + + + QL+ + +CHS
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 128 RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRG 187
R V HRDLKP+NLL++ +G LK+++FGL+ + T Y P+V+
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAK 177
Query: 188 YDGSKADIWSCGVILYVLLAGYLP-FHDSNLMEMYRKIGKAEFKFPN------------- 233
+ D+WS G I L P F +++ + ++I +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 234 ----------------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
R LL +L NP RIS + +++ +F
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 8e-62
Identities = 70/294 (23%), Positives = 127/294 (43%), Gaps = 42/294 (14%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
RY+ +G G + V A + KTG+ VA+K + + + + RE+ +++ ++H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 71 NVVELYEVMASKTKI-----YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYC 125
NV+ L +V + +++ ++ G +L V KL +D + Q++ + Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 126 HSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINR 185
HS + HRDLKP NL ++E LK+ DFGL ++H D + T Y APE++
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGL-----ARHTDDEMTGYVATRWYRAPEIMLN 192
Query: 186 RGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFA--------- 236
+ DIWS G I+ LL G F ++ ++ + I +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 237 ----------------------PEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268
P LL K+L + + RI+ + + +++F +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 2e-61
Identities = 63/284 (22%), Positives = 107/284 (37%), Gaps = 35/284 (12%)
Query: 11 RYELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR 65
E R +G+G F +V AR + VA+K++ +E M +RE ++M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 66 LVRHPNVVELYEVMASKTKIYFVMEYVKGGELF-------------------------GK 100
+PN+V+L V A + + EY+ G+L
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 101 VAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160
L +Q+ + + Y R HRDL N L+ E+ +K++DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYL-PFHDSNLME 219
S ++ PE I Y +++D+W+ GV+L+ + + L P++ E
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 220 MYRKIGKAEF-KFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
+ + P E+ L+ P R S I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-60
Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 31/284 (10%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYAR-----NLKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
R G+ LG G F KV A M+VA+K++ + + + E+
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSEL 77
Query: 62 SVM-RLVRHPNVVELYEVMASKTKIYFVMEYVKGGELF-------------------GKV 101
V+ L H N+V L + EY G+L +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 102 AKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161
+ L + + Q+ + + S+ HRDL N+LL K+ DFGL+ ++
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEM 220
+ ++APE I ++D+WS G+ L+ L + G P+ +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 221 YRKIGKAEFK--FPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
+ K+ K F+ P E+ ++ D +P R + +I++
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 196 bits (500), Expect = 8e-60
Identities = 70/301 (23%), Positives = 125/301 (41%), Gaps = 53/301 (17%)
Query: 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVM-RLV 67
Y+L R LG+G +++V A N+ V +KI+ K +IKREI ++ L
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLR 87
Query: 68 RHPNVVELYEVMASKTK--IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYC 125
PN++ L +++ V E+V + L + R Y +++ A+DYC
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYC 145
Query: 126 HSRGVCHRDLKPENLLLD-EHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVIN 184
HS G+ HRD+KP N+++D EH L++ D+GL+ + + + + PE++
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLV 202
Query: 185 RRGYDGSKADIWSCGVILYVLLAGYLPFHDSN--------------LMEMYRKIGKAEFK 230
D+WS G +L ++ PF + ++Y I K +
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 231 FPNWF------------------------APEVRRLLSKILDPNPNTRISMTKIMENSWF 266
F +PE L K+L + +R++ + ME+ +F
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322
Query: 267 R 267
Sbjct: 323 Y 323
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 194 bits (493), Expect = 3e-59
Identities = 53/297 (17%), Positives = 106/297 (35%), Gaps = 28/297 (9%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRL 66
++ Y++GR +G+G+F + NL VAIK + Q++ E +L
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKL 56
Query: 67 VRH-PNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGK-LKEDAARKYFQQLISAVDY 124
+ + +Y V++ + G+ +Q+++ V
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 125 CHSRGVCHRDLKPENLLLDE-----HGNLKVSDFGLSALAESKHQDGLLH-----TTCGT 174
H + + +RD+KP+N L+ + V DFG+ + GT
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 175 PAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPF---HDSNLMEMYRKIGKAEFKF 231
Y++ R + D+ + G + L G LP+ + + Y +IG+ +
Sbjct: 177 ARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 232 PNW-----FAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEW 283
P F E + + + + + F K L + + +E E +W
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKVLERLNTTEDENFDW 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 7e-59
Identities = 58/283 (20%), Positives = 115/283 (40%), Gaps = 30/283 (10%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKT-------GMSVAIKIIDKEKVLKVGMIDQIKR 59
+ R LG+ LG+G F +V A + VA+K++ + K + +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLIS 67
Query: 60 EISVM-RLVRHPNVVELYEVMASKTKIYFVMEYVKGGELF-----------------GKV 101
E+ +M + +H N++ L +Y ++EY G L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 102 AKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161
+ +L Q+ ++Y S+ HRDL N+L+ E +K++DFGL+
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEM 220
++APE + R Y ++D+WS GV+L+ + G P+ + E+
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246
Query: 221 YRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
++ + + P+ E+ ++ P+ R + +++E
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 9e-59
Identities = 62/276 (22%), Positives = 123/276 (44%), Gaps = 17/276 (6%)
Query: 1 MENKGSILMQRYEL----GRLLGQGTFAKVHYARNLK---TGMSVAIKIIDKEKVLKVGM 53
++ +++ L ++G+G F V++ L + A+K +++ +G
Sbjct: 14 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGE 71
Query: 54 IDQIKREISVMRLVRHPNVVELYEV-MASKTKIYFVMEYVKGGEL--FGKVAKGKLKEDA 110
+ Q E +M+ HPNV+ L + + S+ V+ Y+K G+L F +
Sbjct: 72 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 131
Query: 111 ARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170
+ Q+ + + S+ HRDL N +LDE +KV+DFGL+ K D + +
Sbjct: 132 LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 171 T--CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA 227
T ++A E + + +K+D+WS GV+L+ L+ G P+ D N ++ + +
Sbjct: 192 TGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250
Query: 228 E-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
P + + ++ K P R S ++++
Sbjct: 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-58
Identities = 54/265 (20%), Positives = 105/265 (39%), Gaps = 12/265 (4%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLKTG----MSVAIKIIDKEKVLKVGMIDQIKREIS 62
I +++G G F +V+ + + VAIK + K E
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAG 61
Query: 63 VMRLVRHPNVVELYEVMASKTKIYFVMEYVKGG--ELFGKVAKGKLKEDAARKYFQQLIS 120
+M H N++ L V++ + + EY++ G + F + G+ + + +
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 121 AVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT-TCGTPAYVA 179
+ Y + HRDL N+L++ + KVSDFGLS + E + + + A
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 180 PEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAP 237
PE I S +D+WS G++++ ++ G P+ + + E+ + I P
Sbjct: 182 PEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240
Query: 238 EVRRLLSKILDPNPNTRISMTKIME 262
+ +L+ + R I+
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (486), Expect = 4e-58
Identities = 57/291 (19%), Positives = 103/291 (35%), Gaps = 26/291 (8%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
RY LGR +G G+F ++ ++ G VAIK+ + Q+ E + ++++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGG 62
Query: 71 N-VVELYEVMASKTKIYFVMEYVKGGELF-GKVAKGKLKEDAARKYFQQLISAVDYCHSR 128
+ + A VME + K Q+IS ++Y HS+
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 129 GVCHRDLKPENLL---LDEHGNLKVSDFGLS-----ALAESKHQDGLLHTTCGTPAYVAP 180
HRD+KP+N L + + + DFGL+ A GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 181 EVINRRGYDGSKADIWSCGVILYVLLAGYLPF---HDSNLMEMYRKIGKAEFKFP----- 232
+ D+ S G +L G LP+ + + Y +I + + P
Sbjct: 183 NTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 233 NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGLVKPSISETEEKEW 283
+ E L+ + + + + + FR + S +W
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRNLFHRQGFSYDYVFDW 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 8e-55
Identities = 55/294 (18%), Positives = 110/294 (37%), Gaps = 23/294 (7%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARN-----LKTGMSVAIKIIDKEKVLKVGMIDQIKREI 61
+ ++ + R LGQG+F V+ + VAIK +++ ++ + E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEA 74
Query: 62 SVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELF-----------GKVAKGKLKEDA 110
SVM+ +VV L V++ +ME + G+L
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 111 ARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHT 170
+ ++ + Y ++ HRDL N ++ E +K+ DFG++
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 171 TCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAG-YLPFHDSNLMEMYRKIGKAE- 228
+++PE + + +D+WS GV+L+ + P+ + ++ R + +
Sbjct: 195 GLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253
Query: 229 FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME--NSWFRKGLVKPSISETEE 280
P+ + L+ NP R S +I+ G + S +EE
Sbjct: 254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 307
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-54
Identities = 74/309 (23%), Positives = 127/309 (41%), Gaps = 55/309 (17%)
Query: 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV 67
+++RY+ + +G G V A + +VAIK + + + RE+ +M+ V
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV 73
Query: 68 RHPNVVELYEVMASK------TKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISA 121
H N++ L V + +Y VME + +V + +L + Q++
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC--QVIQMELDHERMSYLLYQMLCG 131
Query: 122 VDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPE 181
+ + HS G+ HRDLKP N+++ LK+ DFGL A + ++ T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAPE 188
Query: 182 VINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGK--------------- 226
VI GY DIWS G I+ ++ + F + ++ + K+ +
Sbjct: 189 VILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 227 ------------AEFKFPNWF---------------APEVRRLLSKILDPNPNTRISMTK 259
A FP F A + R LLSK+L +P RIS+
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 260 IMENSWFRK 268
+++ +
Sbjct: 308 ALQHPYINV 316
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 7e-54
Identities = 62/282 (21%), Positives = 114/282 (40%), Gaps = 28/282 (9%)
Query: 7 ILMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREI 61
R +LG+ LG+G F +V A T +VA+K++ + +
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELK 68
Query: 62 SVMRLVRHPNVVELYEVMASK-TKIYFVMEYVKGGELF-----------------GKVAK 103
++ + H NVV L + ++E+ K G L + K
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 104 GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163
L + Y Q+ +++ SR HRDL N+LL E +K+ DFGL+
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGY-LPFHDSNLMEMYR 222
++APE I R Y ++D+WS GV+L+ + + P+ + E +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 223 KIGKA--EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262
+ K + P++ PE+ + + P+ R + ++++E
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-53
Identities = 57/293 (19%), Positives = 116/293 (39%), Gaps = 47/293 (16%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
L +G+G F +V + G VA+KI + + EI ++RH
Sbjct: 4 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSW----FREAEIYQTVMLRHE 57
Query: 71 NVVELYEVM----ASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCH 126
N++ + T+++ V +Y + G LF + + + + K S + + H
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 127 S--------RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES--KHQDGLLHTTCGTPA 176
+ HRDLK +N+L+ ++G ++D GL+ +S D + GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 177 YVAPEVIN-----RRGYDGSKADIWSCGVILYVLLAGYLPFH---------------DSN 216
Y+APEV++ + +ADI++ G++ + + D +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 217 LMEMYRKI--GKAEFKFPNWFAP-----EVRRLLSKILDPNPNTRISMTKIME 262
+ EM + + K PN + + +++ + N R++ +I +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (387), Expect = 5e-43
Identities = 65/333 (19%), Positives = 121/333 (36%), Gaps = 72/333 (21%)
Query: 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHP 70
RY L R LG G F+ V A+++ VA+KI+ +KV + + EI +++ V
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 69
Query: 71 NVVEL-------------YEVMASKTKIYFVMEYVKGG----ELFGKVAKGKLKEDAARK 113
+ + + ++ VM + G L K + ++
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 114 YFQQLISAVDYC-HSRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAESKHQDGLLHTT 171
+QL+ +DY G+ H D+KPEN+L++ + ++ L + D +
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPF----------HDSNLMEMY 221
T Y +PEV+ + ADIWS +++ L+ G F D ++ ++
Sbjct: 190 IQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 222 RKIGK--------------------------------------AEFKFPNWFAPEVRRLL 243
+G+ ++KF A E+ L
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 244 SKILDPNPNTRISMTKIMENSWFRKGLVKPSIS 276
S +L +P R ++ + W + L I
Sbjct: 309 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (256), Expect = 3e-26
Identities = 37/212 (17%), Positives = 71/212 (33%), Gaps = 41/212 (19%)
Query: 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKV---------------LKVGMIDQ 56
+G+L+G+G + V + + +K V I
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 57 IKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQ 116
+ E ++ ++ V ++Y +ME + EL+ + + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYRV------RVENPDEVLD 110
Query: 117 QLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPA 176
++ V + RG+ H DL N+L+ E G + + DF S + +L
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV---- 165
Query: 177 YVAPEVIN---RRGYDGSKADIWSCGVILYVL 205
I R Y ++ DI S I +L
Sbjct: 166 ----RNIITYFSRTY-RTEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 62.5 bits (152), Expect = 7e-13
Identities = 10/80 (12%), Positives = 36/80 (45%), Gaps = 1/80 (1%)
Query: 341 VRFTSNKPVSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEI-TP 399
++ TS+ S ++ ++ + ++++ LL + ++ + E+ ++
Sbjct: 13 MKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRL 72
Query: 400 FFHLVEVKKSSGDTLEYQKV 419
+ V K+ SG ++ ++ +
Sbjct: 73 SLNGVRFKRISGTSIAFKNI 92
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 472 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.59 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.65 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 98.6 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.2 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 98.19 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.04 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.32 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.77 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-64 Score=483.61 Aligned_cols=256 Identities=38% Similarity=0.746 Sum_probs=238.3
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
..++|++++.||+|+||+||+|+++.+|+.||+|++.+....+....+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 35789999999999999999999999999999999987665555667889999999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..... .
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~----~ 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----S 159 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----C
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC----C
Confidence 9999999999999875 7899999999999999999999999999999999999999999999999999976543 2
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~ 246 (472)
.....+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+|..+|+++++||.+|
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 238 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 24567899999999999988775 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCcCChhhhhcCccccc
Q 012053 247 LDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 247 L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
|++||++|||++|+++||||+.
T Consensus 239 L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 239 LKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TCSSGGGSCCHHHHHTCHHHHH
T ss_pred ccCCHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-63 Score=483.35 Aligned_cols=262 Identities=37% Similarity=0.689 Sum_probs=226.7
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+.++|++++.||+|+||+||+|+++.+|+.||||++++.... ...+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 457899999999999999999999999999999999876432 234678999999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||||++||+|++++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999999976 679999999999999999999999999999999999999999999999999998765544444
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhccCCCCC--CCCCHHHHHHH
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGKAEFKFP--NWFAPEVRRLL 243 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~l~~li 243 (472)
...+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||...+.. ..+..+.......+ ..+++++.+||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 4567899999999999998888778899999999999999999999775433 33334433333222 45899999999
Q ss_pred hcccCCCCCCcCChhhhhcCcccccCCC
Q 012053 244 SKILDPNPNTRISMTKIMENSWFRKGLV 271 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~eil~hp~f~~~~~ 271 (472)
.+||+.||++|||++|+++||||++...
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 9999999999999999999999987543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-63 Score=485.12 Aligned_cols=263 Identities=33% Similarity=0.652 Sum_probs=235.8
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
....-++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+|++++||||+++++++.+++.
T Consensus 3 ~~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 82 (288)
T d1uu3a_ 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82 (288)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE
T ss_pred CCCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE
Confidence 33445689999999999999999999999999999999987765555567889999999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++++|.+||+|||+|+......
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999999998865 789999999999999999999999999999999999999999999999999998765544
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLL 243 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li 243 (472)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+++.++.+..+.+|..+++++++||
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred cccccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 44445667899999999999888775 89999999999999999999999999999999999999999999999999999
Q ss_pred hcccCCCCCCcCChhh------hhcCccccc
Q 012053 244 SKILDPNPNTRISMTK------IMENSWFRK 268 (472)
Q Consensus 244 ~~~L~~dP~~Rpt~~e------il~hp~f~~ 268 (472)
.+||+.||++|||++| |++||||+.
T Consensus 242 ~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp HTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 9999999999999998 477888864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-62 Score=477.11 Aligned_cols=254 Identities=29% Similarity=0.510 Sum_probs=228.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 45899999999999999999999999999999999765432 346789999999999999999999999999999999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCcc
Q 012053 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLL 168 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~ 168 (472)
|||++||+|.+++.++++++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...... ...
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 173 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCB
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--ccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999998654322 234
Q ss_pred cccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---CCCCCCCCCHHHHHHHhc
Q 012053 169 HTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---EFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 169 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~l~~li~~ 245 (472)
...+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+.......+... .+..|..+++++++||.+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 567899999999999887775 7999999999999999999999988776665555433 344567799999999999
Q ss_pred ccCCCCCCcCChhhhhcCccccc
Q 012053 246 ILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
||++||.+|||++|+++||||+.
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-61 Score=483.14 Aligned_cols=259 Identities=36% Similarity=0.669 Sum_probs=240.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+-+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++||||+++++++.+++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45788999999999999999999999999999999998876555556788999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||++||+|++++.+ +.++|..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-- 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC--
Confidence 99999999999999876 789999999999999999999999999999999999999999999999999998654322
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
....+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+..+++.++....+.+|..+|+++++||++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 234678999999999999988885 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCcCC-----hhhhhcCccccc
Q 012053 246 ILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 246 ~L~~dP~~Rpt-----~~eil~hp~f~~ 268 (472)
||++||.+|++ +++|++||||+.
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hccCCchhhcccccccHHHHHcCccccc
Confidence 99999999994 899999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-61 Score=472.61 Aligned_cols=259 Identities=36% Similarity=0.697 Sum_probs=215.9
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+++-+.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++|||||++++++.+++
T Consensus 3 ~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp ECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 44557789999999999999999999999999999999998765432 2356889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCCeEEecCcchhhh
Q 012053 84 KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD---EHGNLKVSDFGLSALA 159 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld---~~g~vkl~DFGla~~~ 159 (472)
.+|+||||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||+. +++.+||+|||+|+..
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999999999865 6899999999999999999999999999999999999994 5789999999999866
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCC
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWF 235 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~ 235 (472)
... ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+..+.+....++ +.+
T Consensus 161 ~~~---~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 161 DPG---SVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred cCC---CeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCC
Confidence 432 234567899999999999888775 899999999999999999999999998888888887765543 458
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
|+++++||.+||+.||++|||++|+++||||+.
T Consensus 237 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-60 Score=472.08 Aligned_cols=254 Identities=35% Similarity=0.759 Sum_probs=236.5
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46799999999999999999999999999999999876655555678899999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|||+.||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-----
Confidence 999999999988875 67999999999999999999999999999999999999999999999999999865432
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhccc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKIL 247 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~L 247 (472)
..+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..+.+.++..+...+|+.++++++++|.+||
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 3467999999999999888776 799999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcC-----ChhhhhcCccccc
Q 012053 248 DPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 248 ~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
.+||.+|+ |+++|++||||+.
T Consensus 237 ~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred hhCHHhccccchhhHHHHHcCccccc
Confidence 99999996 9999999999976
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-60 Score=462.08 Aligned_cols=254 Identities=32% Similarity=0.595 Sum_probs=216.8
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS--KTKIY 86 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 86 (472)
.++|++++.||+|+||+||+|+++.+|+.||+|++++.... ....+.+.+|+.+|++++|||||++++++.+ ++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 36799999999999999999999999999999999877543 3446778999999999999999999999854 45689
Q ss_pred EEEEecCCCcccchhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 87 FVMEYVKGGELFGKVAK-----GKLKEDAARKYFQQLISAVDYCHSRG-----VCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~al~yLH~~g-----iiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
+||||++||+|.+++.+ +.+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999998853 57999999999999999999999976 999999999999999999999999999
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC-CCCCCC
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-KFPNWF 235 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~ 235 (472)
+...... ....+.+||+.|+|||++.+..|+ .++|||||||++|+|+||..||.+.+..+++.++..+.+ .+|..+
T Consensus 162 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 162 RILNHDT--SFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eecccCC--CccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 8765422 224567899999999999887775 899999999999999999999999998888888877765 467789
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCccc
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWF 266 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f 266 (472)
|+++.+||++||+.||++|||++||++|||+
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-60 Score=466.91 Aligned_cols=254 Identities=30% Similarity=0.501 Sum_probs=224.5
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
.+.|++++.||+|+||+||+|+++.+|+.||||++++... ...+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 3579999999999999999999999999999999976542 3346788999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||++||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-- 165 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 165 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc--
Confidence 999999999998753 5799999999999999999999999999999999999999999999999999875443211
Q ss_pred cccccCCCCcccChhhhc-----ccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC---CCCCCCCHH
Q 012053 167 LLHTTCGTPAYVAPEVIN-----RRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF---KFPNWFAPE 238 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~-----~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~ 238 (472)
...+.+||+.|+|||++. ...| +.++|||||||++|+|++|+.||.+.+..+.+.++.+... ..|..+|++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred cccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHH
Confidence 234678999999999984 2334 4899999999999999999999999888777777776643 345668999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
+++||.+||++||++|||++|+++||||+.
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-59 Score=460.32 Aligned_cols=257 Identities=33% Similarity=0.628 Sum_probs=232.4
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKV---GMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
+.++|++++.||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+.+|+.++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 57899999999999999999999999999999999987654321 236789999999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----CeEEecCcchhhh
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG----NLKVSDFGLSALA 159 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g----~vkl~DFGla~~~ 159 (472)
+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999999865 7899999999999999999999999999999999999998877 4999999999866
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCC
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWF 235 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~ 235 (472)
.... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+......++ ..+
T Consensus 168 ~~~~---~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 168 DFGN---EFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp TTSC---BCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred CCCc---cccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence 4332 2456789999999999987766 4899999999999999999999999999998888888776654 568
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
|+++++||++||+.||++|||++|+++||||+.
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-59 Score=455.81 Aligned_cols=256 Identities=25% Similarity=0.504 Sum_probs=222.5
Q ss_pred CCcccCCE-EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe--
Q 012053 5 GSILMQRY-ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-- 81 (472)
Q Consensus 5 g~~l~~~y-~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 81 (472)
|....+|| ++.+.||+|+||+||+|++..+++.||+|.+....... ...+.+.+|+++|+.++|||||++++++.+
T Consensus 3 g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp EECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred CcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 55667788 68889999999999999999999999999998765433 446789999999999999999999999865
Q ss_pred --CCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEc-CCCCeEEecCcc
Q 012053 82 --KTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRG--VCHRDLKPENLLLD-EHGNLKVSDFGL 155 (472)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~g--iiHrDIKp~NILld-~~g~vkl~DFGl 155 (472)
+..+|+||||++||+|.+++.+ +.+++.+++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 4578999999999999999876 78999999999999999999999998 99999999999996 588999999999
Q ss_pred hhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC-cHHHHHHHHhccCC--CCC
Q 012053 156 SALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-NLMEMYRKIGKAEF--KFP 232 (472)
Q Consensus 156 a~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~~~~~--~~~ 232 (472)
|+.... ....+.+||+.|+|||++.+ .| +.++|||||||++|+|++|+.||.+. +...++..+..+.. .++
T Consensus 162 a~~~~~----~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 162 ATLKRA----SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235 (270)
T ss_dssp GGGCCT----TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred ceeccC----CccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccC
Confidence 986432 22456789999999999865 45 48999999999999999999999765 45566666665432 345
Q ss_pred CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012053 233 NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 233 ~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
...++++++||.+||++||++|||++|+++||||+
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 56899999999999999999999999999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-60 Score=473.96 Aligned_cols=256 Identities=34% Similarity=0.702 Sum_probs=238.1
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
.-+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 44689999999999999999999999999999999998776555566788999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD 165 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~ 165 (472)
+||||+.||+|...+.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 99999999999998865 78999999999999999999999999999999999999999999999999999865432
Q ss_pred CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 012053 166 GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 166 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~ 245 (472)
..+.+||+.|+|||++.+.+|+ .++|||||||++|+|+||+.||.+.+....+.++....+.+|..+++++.+||++
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred --cccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 3467899999999999988775 8999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCcC-----ChhhhhcCccccc
Q 012053 246 ILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 246 ~L~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
||+.||.+|+ |+++|++||||+.
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HhhhCHHhccccccccHHHHHcCccccC
Confidence 9999999995 9999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-59 Score=471.39 Aligned_cols=257 Identities=31% Similarity=0.591 Sum_probs=231.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
-++++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356899999999999999999999999999999999976542 33567899999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CCCCeEEecCcchhhhhcc
Q 012053 87 FVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD--EHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld--~~g~vkl~DFGla~~~~~~ 162 (472)
+||||++||+|.+++.. +++++.+++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999999998843 5799999999999999999999999999999999999995 4678999999999865432
Q ss_pred cCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCCCHH
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWFAPE 238 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~ 238 (472)
....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+..+......++ ..+|++
T Consensus 180 ---~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 180 ---QSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp ---SCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred ---cccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 234567999999999999888775 899999999999999999999999999999998888776654 358999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
+++||.+||..||++|||++|+++||||+...
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999998653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-59 Score=469.88 Aligned_cols=259 Identities=28% Similarity=0.578 Sum_probs=232.4
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+|. +.++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+|+.+|+.++|||||++++++.+++
T Consensus 24 ~~~-~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 24 QGS-VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp CSC-GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred CCC-cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 354 45789999999999999999999999999999999977543 23467889999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CCCCeEEecCcchhhh
Q 012053 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLD--EHGNLKVSDFGLSALA 159 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld--~~g~vkl~DFGla~~~ 159 (472)
.+|+|||||+||+|++.+.. .++++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|...
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 99999999999999987754 4699999999999999999999999999999999999998 6789999999999876
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCC----CCC
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFP----NWF 235 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~~ 235 (472)
.. +....+.+||+.|+|||++.+..|+ .++|||||||++|+|+||..||.+.+..+.+.++....+.++ ..+
T Consensus 180 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 255 (352)
T d1koba_ 180 NP---DEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255 (352)
T ss_dssp CT---TSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTS
T ss_pred CC---CCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence 43 2335677999999999999887775 899999999999999999999999999998888888776554 458
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
++++++||.+||+.||.+|||++|+++||||+...
T Consensus 256 s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 99999999999999999999999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-59 Score=463.26 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=225.4
Q ss_pred CEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 11 RYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 11 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999988766555667789999999999999999999999999999999999
Q ss_pred ecCCCcccchhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 91 YVKGGELFGKVA-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 91 ~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
||.||+|..++. .+++++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 999999876654 46899999999999999999999999999999999999999999999999999975432 24
Q ss_pred ccCCCCcccChhhhccc--CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCC--CCCCCCHHHHHHHhc
Q 012053 170 TTCGTPAYVAPEVINRR--GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFK--FPNWFAPEVRRLLSK 245 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~l~~li~~ 245 (472)
..+||+.|+|||++.+. +..+.++|||||||++|+|++|..||.+.+......++...... .+..+|+++++||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 56899999999998643 22347999999999999999999999998887777777655433 234589999999999
Q ss_pred ccCCCCCCcCChhhhhcCcccccC
Q 012053 246 ILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
||+.||.+|||++|+++||||.+.
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-60 Score=470.25 Aligned_cols=255 Identities=28% Similarity=0.460 Sum_probs=218.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIY 86 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 86 (472)
+..++|++++.||+|+||+||+|+++.+|+.||+|++++.. .....+.+.+|+.+|+.++|||||++++++.+++++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56789999999999999999999999999999999997653 2345678999999999999999999999999999999
Q ss_pred EEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 87 FVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
+||||++||+|.+++.+ +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 99999999999999865 789999999999999999999997 499999999999999999999999999998765432
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHH----------------------
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYR---------------------- 222 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~---------------------- 222 (472)
..+.+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+......
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ---cccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2467999999999999988775 89999999999999999999997654321110
Q ss_pred --------------------HHhcc-CCCCC-CCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 223 --------------------KIGKA-EFKFP-NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 223 --------------------~i~~~-~~~~~-~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.+... ....| ..+|+++.+||.+||+.||.+|||++|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00000 11112 126889999999999999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-59 Score=463.78 Aligned_cols=257 Identities=33% Similarity=0.621 Sum_probs=233.7
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH-hcCCCCeeeEEEEEEeCCEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR-LVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++. .++|||||++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 368999999999999999999999999999999998765544455566677777664 7899999999999999999999
Q ss_pred EEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 88 VMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
||||++||+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...... .
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--A 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--C
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc--c
Confidence 9999999999999965 789999999999999999999999999999999999999999999999999998654322 2
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHHHHHHhcc
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEVRRLLSKI 246 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l~~li~~~ 246 (472)
.....+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+...++.++....+.+|..+|+++.+||.+|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 34567899999999999988876 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCcCChh-hhhcCccccc
Q 012053 247 LDPNPNTRISMT-KIMENSWFRK 268 (472)
Q Consensus 247 L~~dP~~Rpt~~-eil~hp~f~~ 268 (472)
|+.||.+|||+. ++++||||++
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999995 8999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.4e-58 Score=449.02 Aligned_cols=257 Identities=33% Similarity=0.585 Sum_probs=228.9
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc------hhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEe
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK------VGMIDQIKREISVMRLVR-HPNVVELYEVMAS 81 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~ 81 (472)
.++|++++.||+|+||+||+|++..+|+.||||++++..... ....+.+.+|+.+|+.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 579999999999999999999999999999999998765332 123456889999999997 9999999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
++.+|+||||++||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 9999999999999999999964 789999999999999999999999999999999999999999999999999998764
Q ss_pred cccCCCcccccCCCCcccChhhhccc-----CCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC--
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRR-----GYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN-- 233 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~-----~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~-- 233 (472)
... .....+||+.|+|||++.+. ...+.++||||+||++|+|++|+.||.+.+.......+..+....+.
T Consensus 162 ~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 162 PGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred CCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 322 23567899999999998642 22357899999999999999999999999988888888877655433
Q ss_pred --CCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 234 --WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 234 --~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.+|+++++||.+||++||.+|||++||++||||++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-59 Score=461.22 Aligned_cols=254 Identities=24% Similarity=0.500 Sum_probs=230.3
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYF 87 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 87 (472)
+.+||++++.||+|+||+||+|+++.+|+.||||++++... ....+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 67899999999999999999999999999999999977642 23567899999999999999999999999999999
Q ss_pred EEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC--CCeEEecCcchhhhhccc
Q 012053 88 VMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH--GNLKVSDFGLSALAESKH 163 (472)
Q Consensus 88 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~--g~vkl~DFGla~~~~~~~ 163 (472)
|||||+||+|++++.. +++++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999999999999965 379999999999999999999999999999999999999854 47999999998765432
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC----CCCHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN----WFAPEV 239 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~l 239 (472)
....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..+.+.++.+..+.++. .+|+++
T Consensus 158 --~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 158 --DNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred --CcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 234567899999999999877765 8999999999999999999999999999999999888877663 689999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
++||.+||+.||++|||++|+++||||++.
T Consensus 235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-58 Score=467.07 Aligned_cols=257 Identities=31% Similarity=0.518 Sum_probs=223.7
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHH---HHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKR---EISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~---Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+ |+.+++.++|||||++++++.+++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 4678999999999999999999999999999999998765433333333444 4666777789999999999999999
Q ss_pred EEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 85 IYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+|+||||++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 9999999999999999865 78999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCc---HHHHHHHHhccCCCCCCCCCHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSN---LMEMYRKIGKAEFKFPNWFAPEVR 240 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~s~~l~ 240 (472)
.....+||+.|+|||++......+.++|||||||++|+|+||+.||.+.+ .......+......+|..++++++
T Consensus 161 ---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred ---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 23567899999999999755444589999999999999999999998643 334555556667788888999999
Q ss_pred HHHhcccCCCCCCcCC-----hhhhhcCccccc
Q 012053 241 RLLSKILDPNPNTRIS-----MTKIMENSWFRK 268 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt-----~~eil~hp~f~~ 268 (472)
+||.+||+.||++||| ++||++||||+.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999999 699999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=448.49 Aligned_cols=252 Identities=31% Similarity=0.574 Sum_probs=221.9
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchh---hHHHHHHHHHHHHhcC--CCCeeeEEEEEEeC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVG---MIDQIKREISVMRLVR--HPNVVELYEVMASK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~---~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~ 82 (472)
+.++|++++.||+|+||+||+|++..+|+.||||++.+....... ...++.+|+.+|+.++ |||||++++++.++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 568999999999999999999999999999999999876543211 1234678999999997 89999999999999
Q ss_pred CEEEEEEEecCC-Ccccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CCeEEecCcchhhh
Q 012053 83 TKIYFVMEYVKG-GELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEH-GNLKVSDFGLSALA 159 (472)
Q Consensus 83 ~~~~lV~E~~~g-g~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~-g~vkl~DFGla~~~ 159 (472)
+..|+||||+.+ +++.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|...
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999986 577777754 789999999999999999999999999999999999999855 78999999999764
Q ss_pred hcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCCCCCHHH
Q 012053 160 ESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPNWFAPEV 239 (472)
Q Consensus 160 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~l 239 (472)
.. ....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||...+ .+.++...++..+|+++
T Consensus 162 ~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~ 231 (273)
T d1xwsa_ 162 KD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231 (273)
T ss_dssp CS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHH
T ss_pred cc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHH
Confidence 33 234567899999999999888887788999999999999999999997642 35567788889999999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
++||++||+.||++|||++|+++||||++.
T Consensus 232 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=454.60 Aligned_cols=258 Identities=33% Similarity=0.629 Sum_probs=219.6
Q ss_pred CCCcCCcccCCEEEEe-eEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH-hcCCCCeeeEEEE
Q 012053 1 MENKGSILMQRYELGR-LLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMR-LVRHPNVVELYEV 78 (472)
Q Consensus 1 m~~~g~~l~~~y~i~~-~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~ 78 (472)
|+-+...+.++|+++. .||+|+||+||+|++..+|+.||||++++. ..+.+|+.++. .++|||||+++++
T Consensus 2 ~~~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~ 73 (335)
T d2ozaa1 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDV 73 (335)
T ss_dssp CCCBCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred ccCCCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 5556667788999875 699999999999999999999999999653 45678999865 5589999999999
Q ss_pred EEe----CCEEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCCe
Q 012053 79 MAS----KTKIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE---HGNL 148 (472)
Q Consensus 79 ~~~----~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~---~g~v 148 (472)
+.+ +..+|+|||||+||+|++++.. .++++.+++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 74 ~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~ 153 (335)
T d2ozaa1 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 153 (335)
T ss_dssp EEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCE
T ss_pred EeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccc
Confidence 876 4679999999999999999965 36999999999999999999999999999999999999985 4579
Q ss_pred EEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHH----HHHHH
Q 012053 149 KVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLME----MYRKI 224 (472)
Q Consensus 149 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~----~~~~i 224 (472)
||+|||+|+...... .....+||+.|+|||++.+..|+ .++|||||||++|+|+||+.||.+.+... +...+
T Consensus 154 Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i 229 (335)
T d2ozaa1 154 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229 (335)
T ss_dssp EECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC
T ss_pred cccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH
Confidence 999999998654422 34567899999999999888776 89999999999999999999998765433 33444
Q ss_pred hccCCCCCC----CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 225 GKAEFKFPN----WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 225 ~~~~~~~~~----~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
....+.+|. .+|+++.+||++||+.||++|||+.|+++||||++..
T Consensus 230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 555556654 3799999999999999999999999999999998644
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-57 Score=442.22 Aligned_cols=258 Identities=30% Similarity=0.464 Sum_probs=218.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
+++|++++.||+|+||+||+|+++.+|+.||||++..... .....+++.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 4689999999999999999999999999999999976543 223457889999999999999999999999999999999
Q ss_pred EEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCC
Q 012053 89 MEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDG 166 (472)
Q Consensus 89 ~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~ 166 (472)
|||+.++.+..... .+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|....... .
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--R 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--B
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc--c
Confidence 99997764443332 3579999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC------------------
Q 012053 167 LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------------ 228 (472)
Q Consensus 167 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------------ 228 (472)
.....+||+.|+|||++....+.+.++|||||||++|+|++|+.||.+.+..+...++.+..
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 34566899999999999888888899999999999999999999999887766555543210
Q ss_pred CCC-----------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 229 FKF-----------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 229 ~~~-----------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
... ...+++++.+||++||++||++|||++|+++||||++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 001 12357899999999999999999999999999999863
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-57 Score=444.95 Aligned_cols=255 Identities=28% Similarity=0.384 Sum_probs=215.1
Q ss_pred EEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEE
Q 012053 13 ELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLK--VGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVME 90 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E 90 (472)
+.++.||+|+||+||+|+++.+|+.||||+++...... ....+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 35789999999999999999999999999997654322 1223568899999999999999999999999999999999
Q ss_pred ecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCccc
Q 012053 91 YVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGLLH 169 (472)
Q Consensus 91 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~~~ 169 (472)
|+.|+.+..+... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... ....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~~ 158 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYT 158 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc--cccc
Confidence 9999888777664 579999999999999999999999999999999999999999999999999998654432 2245
Q ss_pred ccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCC--------------------
Q 012053 170 TTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEF-------------------- 229 (472)
Q Consensus 170 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~-------------------- 229 (472)
+.+||+.|+|||++......+.++|||||||++|+|++|..||.+.+..+...++.+...
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 678999999999997666666899999999999999999999999888777766643100
Q ss_pred C--------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 230 K--------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 230 ~--------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
. ....+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 012367899999999999999999999999999999853
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.4e-56 Score=433.72 Aligned_cols=261 Identities=28% Similarity=0.469 Sum_probs=219.4
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT-- 83 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 83 (472)
+.+.+||++++.||+|+||+||+|++..+|+.||||++.+....+......+.+|+.+|+.++||||+++++++...+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 567899999999999999999999999999999999998877666666788999999999999999999999987654
Q ss_pred --EEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 84 --KIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
.+|+||||++|++|.+++.. +++++.+++.++.||+.||.|||++||+||||||+|||++.++..+|+|||++....
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 48999999999999988865 789999999999999999999999999999999999999999999999999886543
Q ss_pred ccc-CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC----CCCC
Q 012053 161 SKH-QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF----PNWF 235 (472)
Q Consensus 161 ~~~-~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~----~~~~ 235 (472)
... ........+||+.|+|||++.+..|+ .++|||||||++|+|+||.+||.+.+..+...++....... .+.+
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp ----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred cccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 322 22234567899999999999887775 89999999999999999999999988887777766654433 3568
Q ss_pred CHHHHHHHhcccCCCCCCcCChhhhhcCcccc
Q 012053 236 APEVRRLLSKILDPNPNTRISMTKIMENSWFR 267 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~ 267 (472)
|+++.+||.+||++||++||+..+.+.|+|.+
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 99999999999999999999555555677765
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.5e-56 Score=433.97 Aligned_cols=256 Identities=31% Similarity=0.476 Sum_probs=219.3
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
++||++++.||+|+||+||+|++. +|+.||||++...... ....+.+.+|+.+|+.++||||+++++++.+++..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 479999999999999999999985 8899999999776532 34457899999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
|||+.++.+..+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|........ .
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--K 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--c
Confidence 999988887777664 7899999999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------------
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------------- 228 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------------- 228 (472)
.....||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+..+...++....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 3455799999999999887777899999999999999999999999887766655543210
Q ss_pred ----------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 229 ----------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 229 ----------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
...+..+++++.+||++||++||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0123446889999999999999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-55 Score=432.19 Aligned_cols=255 Identities=32% Similarity=0.464 Sum_probs=214.0
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCC-CcEEEEEEeecccccchhhHHHHHHHHHHHHhc---CCCCeeeEEEEEEe---
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKT-GMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV---RHPNVVELYEVMAS--- 81 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~--- 81 (472)
.++|++++.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 57999999999999999999999765 6789999997654322 2223456788887766 79999999999853
Q ss_pred --CCEEEEEEEecCCCcccchh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 82 --KTKIYFVMEYVKGGELFGKV--AKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i--~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
...+|++|||+.++.+.... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 35789999999998765443 33679999999999999999999999999999999999999999999999999987
Q ss_pred hhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc----------
Q 012053 158 LAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---------- 227 (472)
Q Consensus 158 ~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---------- 227 (472)
...... .....+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+...++...
T Consensus 165 ~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 165 IYSFQM---ALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCGGG---GGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhcccc---cCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 654332 24567899999999999888875 8999999999999999999999998877776665321
Q ss_pred -----------------CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 228 -----------------EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 228 -----------------~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
...++..+++++++||++||+.||++|||++|+|+||||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 01123457899999999999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=437.44 Aligned_cols=254 Identities=22% Similarity=0.367 Sum_probs=216.0
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGM-----SVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMA 80 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 80 (472)
+-.++|++++.||+|+||+||+|++..+++ .||+|.+..... ......+.+|+.+|+.+ +|||||++++++.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 445789999999999999999999976654 699999865432 23346788999999988 8999999999999
Q ss_pred eCCEEEEEEEecCCCcccchhcc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 012053 81 SKTKIYFVMEYVKGGELFGKVAK------------------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLK 136 (472)
Q Consensus 81 ~~~~~~lV~E~~~gg~L~~~i~~------------------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIK 136 (472)
+.+.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+|||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 99999999999999999998854 248999999999999999999999999999999
Q ss_pred CCcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCC
Q 012053 137 PENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDS 215 (472)
Q Consensus 137 p~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~ 215 (472)
|+|||++.++++||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||++|||+| |..||.+.
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999876654433334466789999999999887775 89999999999999998 89999886
Q ss_pred cHHHHHHHHhcc--CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 216 NLMEMYRKIGKA--EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 216 ~~~~~~~~i~~~--~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+....+.++... .+..|..+++++++||.+||+.||++|||++||++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 655444444443 356678899999999999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-55 Score=438.88 Aligned_cols=254 Identities=29% Similarity=0.442 Sum_probs=216.2
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT---- 83 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 83 (472)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 67899999999999999999999999999999999976543 3355678899999999999999999999997654
Q ss_pred --EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 --KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 --~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.+|+||||+ |.+|...+..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred cceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 67788888888999999999999999999999999999999999999999999999999999976533
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccC-------------
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAE------------- 228 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~------------- 228 (472)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 174 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 174 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 23567899999999999877777799999999999999999999999877665544432210
Q ss_pred ------------------CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 229 ------------------FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 229 ------------------~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
......+++++.+||++||+.||++|||++|||+||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 1123457899999999999999999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=429.86 Aligned_cols=261 Identities=26% Similarity=0.369 Sum_probs=215.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe------
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS------ 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (472)
-.+||++++.||+|+||+||+|++..+|+.||||++.+.... ......+.+|+.+|+.++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 368999999999999999999999999999999999766543 2445678899999999999999999999854
Q ss_pred --CCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhh
Q 012053 82 --KTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSAL 158 (472)
Q Consensus 82 --~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~ 158 (472)
++.+|+||||+.++.+...... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 4468999999988776655543 6899999999999999999999999999999999999999999999999999975
Q ss_pred hhccc--CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCCCC---
Q 012053 159 AESKH--QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKFPN--- 233 (472)
Q Consensus 159 ~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~~~--- 233 (472)
..... ......+.+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.......+.
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 54322 2223455689999999999977655568999999999999999999999988777666655432211110
Q ss_pred -----------------------------CCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 234 -----------------------------WFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 234 -----------------------------~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
..++++.+||.+||++||++|||++|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 026788999999999999999999999999999863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=427.87 Aligned_cols=254 Identities=23% Similarity=0.409 Sum_probs=208.6
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
.++-.++|++++.||+|+||+||+|+. +..||||+++..... ....+.+.+|+.+|++++|||||++++++. .+.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 456678999999999999999999975 336999999765433 345678999999999999999999999875 456
Q ss_pred EEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcc
Q 012053 85 IYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESK 162 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~ 162 (472)
+|+||||++||+|.+++.. +++++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 8999999999999999853 57999999999999999999999999999999999999999999999999999876544
Q ss_pred cCCCcccccCCCCcccChhhhcccC--CCCCcccchhhhHHHHHHhcCCCCCCCCcHHH-HHHHHhccC-----CCCCCC
Q 012053 163 HQDGLLHTTCGTPAYVAPEVINRRG--YDGSKADIWSCGVILYVLLAGYLPFHDSNLME-MYRKIGKAE-----FKFPNW 234 (472)
Q Consensus 163 ~~~~~~~~~~gt~~Y~aPE~l~~~~--~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~-~~~~i~~~~-----~~~~~~ 234 (472)
.......+.+||+.|||||++.+.. ..+.++|||||||++|||+||+.||.+.+... ....+.++. ...+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 4434456678999999999986432 23579999999999999999999998865543 333333332 134566
Q ss_pred CCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 235 FAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 235 ~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+++++.+||.+||+.||++|||+++|+++
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-55 Score=427.99 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=218.9
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTK 84 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 84 (472)
.++-.++|++++.||+|+||+||+|++..+|+.||||+++.+.. ..+++.+|+.+|+.++|||||++++++.+++.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 35667799999999999999999999999999999999976542 34678999999999999999999999999999
Q ss_pred EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 85 IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 9999999999999998854 4799999999999999999999999999999999999999999999999999987644
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCC-CCCCcHHHHHHHHhcc-CCCCCCCCCHHH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLP-FHDSNLMEMYRKIGKA-EFKFPNWFAPEV 239 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~P-f~~~~~~~~~~~i~~~-~~~~~~~~s~~l 239 (472)
... .......||+.|+|||++.+..|+ .++|||||||++|+|++|..| |...+....+..+..+ ....|..+++++
T Consensus 168 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 245 (287)
T d1opja_ 168 DTY-TAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245 (287)
T ss_dssp SSS-EEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCc-eeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHH
Confidence 221 112334589999999999888775 899999999999999996655 4555666666665544 456778899999
Q ss_pred HHHHhcccCCCCCCcCChhhhhc
Q 012053 240 RRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.+||.+||+.||++|||+++|++
T Consensus 246 ~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 246 YELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999999965
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=422.20 Aligned_cols=257 Identities=23% Similarity=0.391 Sum_probs=220.8
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
..++-.++|++++.||+|+||+||+|++. ++..||||+++..... .+.+.+|+.+|++++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 34567789999999999999999999974 6788999999765432 3678999999999999999999998754 5
Q ss_pred EEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 84 KIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
.+|+||||+++|+|.+++.. .++++..+..++.||+.||.|||++||+||||||+||||++++.+||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 67999999999999987754 369999999999999999999999999999999999999999999999999998764
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcC-CCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAG-YLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
.... .......||+.|+|||++....++ .++|||||||++|||+|| .+||...+..+....+..+ ....|..++++
T Consensus 161 ~~~~-~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~ 238 (272)
T d1qpca_ 161 DNEY-TAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238 (272)
T ss_dssp SSCE-ECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCcc-ccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHH
Confidence 3221 123456799999999999877665 899999999999999995 5666677777777777665 45677889999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhc--Cccccc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIME--NSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~--hp~f~~ 268 (472)
+.+||.+||+.||++|||+++|++ ++||..
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999999999998 788853
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=433.98 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=216.1
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----E
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT----K 84 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 84 (472)
..||++++.||+|+||+||+|++..+|+.||||++++.. .....+.+.+|+.+|+.++||||+++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 379999999999999999999999999999999997654 2345678889999999999999999999996653 2
Q ss_pred EEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccC
Q 012053 85 IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~ 164 (472)
.+++++++.||+|++++..+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|........
T Consensus 85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 34445566799999999888999999999999999999999999999999999999999999999999999976544322
Q ss_pred -CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc----------------
Q 012053 165 -DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA---------------- 227 (472)
Q Consensus 165 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~---------------- 227 (472)
.......+||+.|+|||++.....++.++||||+||++|+|++|..||.+.+...........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 233466789999999999876666678999999999999999999999887765444433210
Q ss_pred --------CC-------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccCC
Q 012053 228 --------EF-------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKGL 270 (472)
Q Consensus 228 --------~~-------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~~ 270 (472)
.. ...+.+++++++||.+||+.||.+|||++|+|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 00 01234788999999999999999999999999999998643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=419.10 Aligned_cols=247 Identities=25% Similarity=0.426 Sum_probs=208.4
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
++|++++.||+|+||+||+|++. +++.||||++++.... .+.+.+|+.+++.++|||||++++++..++.+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 58999999999999999999985 6788999999765432 367899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+|.++++||+|||+|+........ .
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-S 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce-e
Confidence 99999999998865 56899999999999999999999999999999999999999999999999999876543221 2
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~ 245 (472)
.....||+.|+|||++.+..|+ .++|||||||++|||+| |.+||...+..+.+..+..+ ....|..+++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3346799999999999888775 89999999999999999 57777777777788777665 345677789999999999
Q ss_pred ccCCCCCCcCChhhhhcC
Q 012053 246 ILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h 263 (472)
||+.||++|||+++|++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-54 Score=425.67 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=209.6
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGM---SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
+-.++|++.+.||+|+||+||+|+++.+|+ .||||.+..... ....+.+.+|+.+|+.++|||||++++++.+++
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 446789999999999999999999987765 588998865432 244567899999999999999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 84 KIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.+|+||||++||+|.+++.. +.+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999998765 5799999999999999999999999999999999999999999999999999987654
Q ss_pred ccCCCc---ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCC
Q 012053 162 KHQDGL---LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFA 236 (472)
Q Consensus 162 ~~~~~~---~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s 236 (472)
...... .....||+.|+|||++.+..|+ .++|||||||++|||+| |..||.+.+..+....+..+. .+.|..++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 322211 1224579999999999877765 89999999999999998 899999988888888776653 56677799
Q ss_pred HHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 237 PEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 237 ~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+++.+||.+||+.||++|||+.||+++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=421.51 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=219.3
Q ss_pred cCCEEEEee-EcccCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 9 MQRYELGRL-LGQGTFAKVHYARNLK--TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~-LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.++|.+.+. ||+|+||+||+|.++. ++..||||+++... .....+.+.+|+.+|+.++|||||++++++.++ .+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-AL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eE
Confidence 357888885 9999999999998764 45579999997653 234567899999999999999999999998754 58
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999999998753 579999999999999999999999999999999999999999999999999998765432
Q ss_pred CC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHH
Q 012053 164 QD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVR 240 (472)
Q Consensus 164 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~ 240 (472)
.. ......+||+.|+|||++....++ .++|||||||++|||+| |..||.+.+..+....+..+. ...|+.+++++.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 242 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 21 223456799999999999877665 89999999999999998 999999988888888877654 577888999999
Q ss_pred HHHhcccCCCCCCcCChhhh---hcCcccc
Q 012053 241 RLLSKILDPNPNTRISMTKI---MENSWFR 267 (472)
Q Consensus 241 ~li~~~L~~dP~~Rpt~~ei---l~hp~f~ 267 (472)
+||.+||+.||++|||+.+| |+|+|+.
T Consensus 243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999988 5677775
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=423.22 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=209.9
Q ss_pred eeEcccCCeEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEEEecC
Q 012053 16 RLLGQGTFAKVHYARNLK--TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVMEYVK 93 (472)
Q Consensus 16 ~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 93 (472)
+.||+|+||+||+|.+.. +++.||||++..... .....+.+.+|+.+|++++|||||++++++.++ ..|+||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 479999999999998653 567899999976543 334567899999999999999999999999655 5789999999
Q ss_pred CCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC-Cccccc
Q 012053 94 GGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD-GLLHTT 171 (472)
Q Consensus 94 gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~-~~~~~~ 171 (472)
+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........ ......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999876 67999999999999999999999999999999999999999999999999999865432221 112345
Q ss_pred CCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhcccCC
Q 012053 172 CGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 172 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~ 249 (472)
.||+.|+|||++.+..++ .++|||||||++|||+| |..||.+.+..+....+.++ ....|..+++++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 799999999999877665 89999999999999998 89999998888888877765 4677888999999999999999
Q ss_pred CCCCcCChhhhh---cCccc
Q 012053 250 NPNTRISMTKIM---ENSWF 266 (472)
Q Consensus 250 dP~~Rpt~~eil---~hp~f 266 (472)
||++|||+++|+ +|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 999999999984 55554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=416.61 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=222.1
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV 88 (472)
++||++++.||+|+||+||+|++..+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4799999999999999999999999999999999977653 345678899999999999999999999999999999999
Q ss_pred EEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 89 MEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
+|++.|++|..++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||.|........ .
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--C 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--C
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc--c
Confidence 999999999887765 6899999999999999999999999999999999999999999999999999986544322 2
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCC-CCcHHHHHHHHhcc-------------------
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFH-DSNLMEMYRKIGKA------------------- 227 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~-~~~~~~~~~~i~~~------------------- 227 (472)
.....+++.|+|||++....+.+.++|||||||++|+|++|..||. +.+..+...++...
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 3445678899999999887777789999999999999999999964 44555555544211
Q ss_pred ----------CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 228 ----------EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 228 ----------~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
....+..+++++.+||++||++||++|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 11123346889999999999999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=413.16 Aligned_cols=247 Identities=25% Similarity=0.427 Sum_probs=221.0
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEEEEEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKIYFVM 89 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lV~ 89 (472)
+.|++++.||+|+||+||+|+++ +++.||||++++.... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 57999999999999999999984 7889999999876533 367899999999999999999999999999999999
Q ss_pred EecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCCCc
Q 012053 90 EYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQDGL 167 (472)
Q Consensus 90 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~~~ 167 (472)
||+.+|+|.+++.. ..+++..+++++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-ee
Confidence 99999999888643 6799999999999999999999999999999999999999999999999999976544322 22
Q ss_pred ccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHHHHHHhc
Q 012053 168 LHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEVRRLLSK 245 (472)
Q Consensus 168 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l~~li~~ 245 (472)
....+||+.|+|||++....++ .++|||||||++|||+| |+.||.+.+..+...++..+ ....|...++++.+||++
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 3346799999999999888776 79999999999999998 89999999988888888775 456777899999999999
Q ss_pred ccCCCCCCcCChhhhhcC
Q 012053 246 ILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 246 ~L~~dP~~Rpt~~eil~h 263 (472)
||+.||++|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=431.69 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=217.7
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----C
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK-----T 83 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 83 (472)
.+||++++.||+|+||+||+|+++.+|+.||||++.+... .....+++.+|+.+|+.++|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 4799999999999999999999999999999999986543 234456788999999999999999999998532 3
Q ss_pred EEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 84 KIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
..+++|+|+.||+|.+++..+++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|......
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~- 174 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE- 174 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG-
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc-
Confidence 4466677788999999998889999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhccCCCC------------
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKAEFKF------------ 231 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~~~~~------------ 231 (472)
..+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 175 ----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 175 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 3456899999999998887777799999999999999999999999887776666554321111
Q ss_pred -------------------CCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 232 -------------------PNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 232 -------------------~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
...+++++++||++||+.||++|||++|+|+||||++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 12478999999999999999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-54 Score=430.64 Aligned_cols=252 Identities=31% Similarity=0.429 Sum_probs=211.0
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe------
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS------ 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 81 (472)
..-+|+.++.||+|+||+||+|++..+|+.||||++.+.... ..+|+.+|+.++||||+++++++..
T Consensus 18 ~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred ccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 344799999999999999999999999999999999766422 2479999999999999999999843
Q ss_pred CCEEEEEEEecCCCcccchh---c-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CeEEecCcch
Q 012053 82 KTKIYFVMEYVKGGELFGKV---A-KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDFGLS 156 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i---~-~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-~vkl~DFGla 156 (472)
..++|+||||+.++.+.... . ...+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence 34689999999876433322 2 35799999999999999999999999999999999999999876 8999999998
Q ss_pred hhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc---------
Q 012053 157 ALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA--------- 227 (472)
Q Consensus 157 ~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~--------- 227 (472)
....... ...+.+||+.|+|||++.+....+.++|||||||++|+|++|..||...+..+.+..+.+.
T Consensus 171 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 171 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp EECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 7654322 2456789999999999877655568999999999999999999999988776665554321
Q ss_pred --------CCC------------CCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 --------EFK------------FPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 --------~~~------------~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
... ....+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 111 123478999999999999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=423.14 Aligned_cols=261 Identities=30% Similarity=0.574 Sum_probs=223.9
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEe
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNL---KTGMSVAIKIIDKEKVL-KVGMIDQIKREISVMRLVRH-PNVVELYEVMAS 81 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~ 81 (472)
+-.++|++++.||+|+||+||+|++. .+|+.||||++++.... +....+.+.+|+.+|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 44578999999999999999999984 46899999999765432 22334668899999999976 899999999999
Q ss_pred CCEEEEEEEecCCCcccchhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 82 KTKIYFVMEYVKGGELFGKVAK-GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
...+|++|||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999999999999875 689999999999999999999999999999999999999999999999999997654
Q ss_pred cccCCCcccccCCCCcccChhhhcccC-CCCCcccchhhhHHHHHHhcCCCCCCCCcH----HHHHHHHhccCCCCCCCC
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRG-YDGSKADIWSCGVILYVLLAGYLPFHDSNL----MEMYRKIGKAEFKFPNWF 235 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~lltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~ 235 (472)
.... ....+.+||+.|+|||.+.+.. +.+.++|||||||+||+|++|..||.+.+. ..+..........+|..+
T Consensus 181 ~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 181 ADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp GGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 3322 2245678999999999997654 345789999999999999999999977543 344444556677788889
Q ss_pred CHHHHHHHhcccCCCCCCcC-----ChhhhhcCccccc
Q 012053 236 APEVRRLLSKILDPNPNTRI-----SMTKIMENSWFRK 268 (472)
Q Consensus 236 s~~l~~li~~~L~~dP~~Rp-----t~~eil~hp~f~~ 268 (472)
++++.+||++||++||.+|| |++|+++||||+.
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 99999999999999999999 5899999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=413.76 Aligned_cols=253 Identities=28% Similarity=0.445 Sum_probs=209.1
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTG---MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
++..++|++++.||+|+||+||+|++..++ ..||||.++... .....+.+.+|+.+|+.++|||||++++++. +
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 456689999999999999999999987653 468888875433 3345678999999999999999999999995 5
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
+.+|+||||+++|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 678999999999999887653 579999999999999999999999999999999999999999999999999998654
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~ 238 (472)
.... ......+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+..+.+.++..+. .++|+.+|++
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 237 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred CCcc-eeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 3222 223456789999999999887775 89999999999999998 899999988888888877664 5778889999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhcC
Q 012053 239 VRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
+.+||.+||+.||++|||+.||+++
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.4e-53 Score=419.64 Aligned_cols=249 Identities=27% Similarity=0.487 Sum_probs=209.4
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEe--CCEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMAS--KTKI 85 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~~ 85 (472)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .+++.+|+.+|+.++ ||||+++++++.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 468999999999999999999999999999999996543 367889999999995 9999999999974 4569
Q ss_pred EEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-CeEEecCcchhhhhcccC
Q 012053 86 YFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG-NLKVSDFGLSALAESKHQ 164 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g-~vkl~DFGla~~~~~~~~ 164 (472)
|+||||+.+++|.... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.......
T Consensus 108 ~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp EEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred eEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 9999999999997764 5699999999999999999999999999999999999998765 59999999998654332
Q ss_pred CCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHH-HHHHHHhc-------------cCC-
Q 012053 165 DGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLM-EMYRKIGK-------------AEF- 229 (472)
Q Consensus 165 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~-~~~~~i~~-------------~~~- 229 (472)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||...... .....+.. ...
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 2456789999999999887765568999999999999999999999764322 21111110 000
Q ss_pred -----------------------CCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcCccccc
Q 012053 230 -----------------------KFPNWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRK 268 (472)
Q Consensus 230 -----------------------~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~ 268 (472)
.....+++++.+||++||..||++|||++|+|+||||+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 011226899999999999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-53 Score=411.38 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=214.5
Q ss_pred cCCcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 012053 4 KGSILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT 83 (472)
Q Consensus 4 ~g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 83 (472)
++++-.++|++++.||+|+||+||+|++..+ +.||||++...... .+.+.+|+.+|++++|||||++++++.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 3467778999999999999999999998654 67999999765432 3678999999999999999999999854 5
Q ss_pred EEEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 84 KIYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
.+|+||||+++|+|..++.. +.+++.+++.++.||+.||+|||++||+||||||+|||||.++.+||+|||+|+...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 57999999999999888753 579999999999999999999999999999999999999999999999999998764
Q ss_pred cccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcC-CCCCCCCcHHHHHHHHhcc-CCCCCCCCCHH
Q 012053 161 SKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAG-YLPFHDSNLMEMYRKIGKA-EFKFPNWFAPE 238 (472)
Q Consensus 161 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 238 (472)
.... ......+||+.|+|||++....++ .++|||||||++|+|++| .+||......+.+..+.++ ....+..++++
T Consensus 165 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (285)
T d1fmka3 165 DNEY-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 242 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred CCCc-eeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHH
Confidence 3322 223446799999999999887775 899999999999999995 5556667777777777654 45678889999
Q ss_pred HHHHHhcccCCCCCCcCChhhhhc--Cccccc
Q 012053 239 VRRLLSKILDPNPNTRISMTKIME--NSWFRK 268 (472)
Q Consensus 239 l~~li~~~L~~dP~~Rpt~~eil~--hp~f~~ 268 (472)
+++||.+||+.||++|||+++|++ ++||..
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 999999999999999999999987 778754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=417.04 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=210.6
Q ss_pred CCEEEEeeEcccCCeEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 10 QRYELGRLLGQGTFAKVHYARNLKTGM----SVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 10 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
..|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.+|+.++|||||++++++.+++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-e
Confidence 469999999999999999999988887 47777775432 2244678999999999999999999999998654 6
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
+++|||+.+|+|.+.+.. ..+++..+++++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 788899999999887754 579999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccC-CCCCCCCCHHHHH
Q 012053 164 QDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAE-FKFPNWFAPEVRR 241 (472)
Q Consensus 164 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~l~~ 241 (472)
.........||+.|+|||++.+..|+ .++|||||||++|||+| |..||.+.+..++...+..+. ...|..+++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 43334455789999999999887765 89999999999999998 899999887777777776654 5677889999999
Q ss_pred HHhcccCCCCCCcCChhhhhcCc
Q 012053 242 LLSKILDPNPNTRISMTKIMENS 264 (472)
Q Consensus 242 li~~~L~~dP~~Rpt~~eil~hp 264 (472)
||.+||..||.+|||+.+|++|.
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999883
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=406.14 Aligned_cols=253 Identities=21% Similarity=0.320 Sum_probs=208.4
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTG----MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
+-.+.|++.+.||+|+||+||+|.+..++ ..||||.+..... ......+.+|+.+|+.++|||||++++++.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 44568999999999999999999987655 4799999975542 23456788999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhh
Q 012053 83 TKIYFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAE 160 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~ 160 (472)
...|+||||+.++++.+.+.. +.+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999999887754 579999999999999999999999999999999999999999999999999998765
Q ss_pred cccCC-CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcC-CCCCCCCcHHHHHHHHhcc-CCCCCCCCCH
Q 012053 161 SKHQD-GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAG-YLPFHDSNLMEMYRKIGKA-EFKFPNWFAP 237 (472)
Q Consensus 161 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG-~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~ 237 (472)
..... .......||+.|+|||++.+..++ .++|||||||++|||++| .+||...+..+.+..+..+ ....|..+++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence 43221 122345789999999999887765 899999999999999995 5556666666777776554 3566777999
Q ss_pred HHHHHHhcccCCCCCCcCChhhhhc
Q 012053 238 EVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 238 ~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
++.+||.+||+.||++|||+.+|++
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=422.32 Aligned_cols=255 Identities=28% Similarity=0.454 Sum_probs=205.2
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE------e
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA------S 81 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------~ 81 (472)
+.+||++++.||+|+||+||+|+++.+|+.||||++.+... ......++.+|+.+|+.++||||+++++++. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 45899999999999999999999999999999999987653 3345678899999999999999999999995 3
Q ss_pred CCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 82 KTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 82 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
.+++|+||||+.++.+.. + .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++....
T Consensus 94 ~~~~~iv~Ey~~~~l~~~-~-~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQV-I-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CCEEEEEEECCSEEHHHH-H-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CceeEEEEeccchHHHHh-h-hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 478999999997765543 3 35799999999999999999999999999999999999999999999999999886554
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHHHhcc--------------
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRKIGKA-------------- 227 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~i~~~-------------- 227 (472)
.. .....+||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+......++...
T Consensus 172 ~~---~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 172 SF---MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cc---ccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 32 23566899999999999887765 7999999999999999999999987766555444211
Q ss_pred --------CCCC--------------C------CCCCHHHHHHHhcccCCCCCCcCChhhhhcCcccccC
Q 012053 228 --------EFKF--------------P------NWFAPEVRRLLSKILDPNPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 228 --------~~~~--------------~------~~~s~~l~~li~~~L~~dP~~Rpt~~eil~hp~f~~~ 269 (472)
.... + ...++++.+||++||..||++|||++|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0000 0 0135688999999999999999999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-52 Score=409.12 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=220.2
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASK 82 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 82 (472)
-.++|++++.||+|+||+||+|+++. +++.||||+++.... ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence 35689999999999999999999753 567899999976542 34467899999999999999999999999999
Q ss_pred CEEEEEEEecCCCcccchhcc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 012053 83 TKIYFVMEYVKGGELFGKVAK-------------------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKP 137 (472)
Q Consensus 83 ~~~~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp 137 (472)
+..+++|||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 999999999999999988743 1388999999999999999999999999999999
Q ss_pred CcEEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCC-CCCCCCc
Q 012053 138 ENLLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGY-LPFHDSN 216 (472)
Q Consensus 138 ~NILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~-~Pf~~~~ 216 (472)
+|||+|.++++||+|||+|+............+.+||+.|+|||.+.+..|+ .++|||||||++|||++|. +||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999877655444445567899999999999888776 8999999999999999985 6898888
Q ss_pred HHHHHHHHhccC-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 217 LMEMYRKIGKAE-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 217 ~~~~~~~i~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
..+....+..+. ...|..+++++.+||.+||+.||++|||+.||++
T Consensus 248 ~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888887765 3567789999999999999999999999999965
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=408.09 Aligned_cols=255 Identities=22% Similarity=0.425 Sum_probs=219.9
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcCCC-------cEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLKTG-------MSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELY 76 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 76 (472)
..+..++|++++.||+|+||.||+|++..++ ..||||++++... ......+.+|...+.++ +|||||+++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 4566789999999999999999999987654 4799999976542 23456788888888887 799999999
Q ss_pred EEEEeCCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 012053 77 EVMASKTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPEN 139 (472)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~N 139 (472)
+++.+++.+|+||||+++|+|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 999999999999999999999999853 248999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH
Q 012053 140 LLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM 218 (472)
Q Consensus 140 ILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~ 218 (472)
||++.++.+||+|||+++..............+||+.|+|||.+.+..|+ .++|||||||++|+|++ |.+||.+.+..
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999977665554445667899999999999887775 89999999999999998 79999998888
Q ss_pred HHHHHHhcc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 219 EMYRKIGKA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 219 ~~~~~i~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
..+..+..+ .+..|.++++++.+||.+||+.||++|||+.||++
T Consensus 245 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 888877654 46778889999999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=408.45 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=204.6
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVM 79 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 79 (472)
++..++|++++.||+|+||+||+|++.. +++.||||++..... ....+.+.+|..++.++ +||||+.+++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 3556899999999999999999999864 457899999875432 23345677787777666 689999999997
Q ss_pred Ee-CCEEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 012053 80 AS-KTKIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLL 141 (472)
Q Consensus 80 ~~-~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NIL 141 (472)
.. +..+|+||||+++|+|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 65 4578999999999999998853 24899999999999999999999999999999999999
Q ss_pred EcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcC-CCCCCCCcHHH-
Q 012053 142 LDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAG-YLPFHDSNLME- 219 (472)
Q Consensus 142 ld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG-~~Pf~~~~~~~- 219 (472)
|+.++++||+|||+|+..............+||+.|+|||++.+..++ .++|||||||++|+|+|| ..||.+.+...
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999876544443344567899999999999887765 899999999999999986 56787755433
Q ss_pred HHHHHhc-cCCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 220 MYRKIGK-AEFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 220 ~~~~i~~-~~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
....+.. ..+..|..+++++.+||.+||+.||++|||++||++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3333333 3466778899999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=408.10 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=215.5
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcE--EEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMS--VAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEVMASKT 83 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 83 (472)
+-.++|++.+.||+|+||+||+|+++.+|.. ||||.+.... .....+.+.+|+.+|+++ +|||||++++++.+++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4457999999999999999999999988875 6677765432 223456789999999998 7999999999999999
Q ss_pred EEEEEEEecCCCcccchhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 012053 84 KIYFVMEYVKGGELFGKVAK-----------------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHG 146 (472)
Q Consensus 84 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g 146 (472)
.+|+||||++||+|.+++.. ..+++..+++++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 99999999999999998743 4699999999999999999999999999999999999999999
Q ss_pred CeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCC-CCCCCCcHHHHHHHHh
Q 012053 147 NLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGY-LPFHDSNLMEMYRKIG 225 (472)
Q Consensus 147 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~-~Pf~~~~~~~~~~~i~ 225 (472)
.+||+|||+|+....... ....+||+.|+|||.+....|+ .++|||||||++|+|++|. +||.+.+..+++..+.
T Consensus 165 ~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp CEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred ceEEcccccccccccccc---ccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999976544332 2456799999999999887775 8999999999999999965 6788888888888887
Q ss_pred cc-CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 226 KA-EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 226 ~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+ .+..|..+++++.+||.+||+.||++|||+.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 65 466778899999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=404.78 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=206.0
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCC-C--cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCEE
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKT-G--MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKTKI 85 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-g--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 85 (472)
.++|++++.||+|+||+||+|++..+ + ..||||++.+.........+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 45799999999999999999987543 3 3689999987766555667889999999999999999999999965 467
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhccc
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKH 163 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~ 163 (472)
|+||||+++|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999887754 579999999999999999999999999999999999999999999999999998764432
Q ss_pred CCC-cccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhccCC--CCCCCCCHHH
Q 012053 164 QDG-LLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKAEF--KFPNWFAPEV 239 (472)
Q Consensus 164 ~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~~l 239 (472)
... .....+||+.|+|||++.+..++ .++|||||||++|||+| |..||.+.+..+....+.+... +.+..+++++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 221 22345678899999999876654 88999999999999998 8999999999988888876643 5567799999
Q ss_pred HHHHhcccCCCCCCcCChhhhhc
Q 012053 240 RRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
.+||.+||+.||++|||+.+|++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999964
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-52 Score=399.82 Aligned_cols=245 Identities=28% Similarity=0.486 Sum_probs=209.3
Q ss_pred CcccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCCE
Q 012053 6 SILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMA-SKTK 84 (472)
Q Consensus 6 ~~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~ 84 (472)
.+-.++|++++.||+|+||.||+|++ +|+.||||+++++. ..+.+.+|+.+|++++||||+++++++. .++.
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence 46678999999999999999999998 57899999997653 3367899999999999999999999984 4567
Q ss_pred EEEEEEecCCCcccchhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhc
Q 012053 85 IYFVMEYVKGGELFGKVAK---GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAES 161 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~ 161 (472)
+|+||||+++|+|.+++.. ..+++..+++++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 8999999999999999865 2599999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHHHHHHHHhcc-CCCCCCCCCHHH
Q 012053 162 KHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLMEMYRKIGKA-EFKFPNWFAPEV 239 (472)
Q Consensus 162 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~l 239 (472)
. ..+.++|+.|+|||++.+..++ .++|||||||++|||+| |.+||...+..+.+..+..+ .+.+|..+++++
T Consensus 156 ~-----~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (262)
T d1byga_ 156 T-----QDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 229 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred C-----CccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 2 2455789999999999887764 89999999999999998 79999988888888887654 467888899999
Q ss_pred HHHHhcccCCCCCCcCChhhhhcC
Q 012053 240 RRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 240 ~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
.+||.+||+.||++|||+.+|+++
T Consensus 230 ~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 230 YEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=404.44 Aligned_cols=255 Identities=20% Similarity=0.277 Sum_probs=222.5
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNLK-----TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVM 79 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 79 (472)
.++..++|++++.||+|+||+||+|.+.. +++.||||++++... ......+.+|+.++++++||||+++++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC--hHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 34666899999999999999999998853 357899999975542 23456789999999999999999999999
Q ss_pred EeCCEEEEEEEecCCCcccchhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCe
Q 012053 80 ASKTKIYFVMEYVKGGELFGKVAK-----------GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNL 148 (472)
Q Consensus 80 ~~~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~v 148 (472)
..++..++||||+.+|+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+|||+|.++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 999999999999999999988742 247899999999999999999999999999999999999999999
Q ss_pred EEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcC-CCCCCCCcHHHHHHHHhcc
Q 012053 149 KVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAG-YLPFHDSNLMEMYRKIGKA 227 (472)
Q Consensus 149 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG-~~Pf~~~~~~~~~~~i~~~ 227 (472)
||+|||+|+..............+||+.|+|||.+.+..+. .++||||||+++|+|+|| ..||.+.+..+.+..+.++
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence 99999999876554433334455789999999999887765 799999999999999998 5889988888888887765
Q ss_pred C-CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 228 E-FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 228 ~-~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
. ...|..+++.+.++|.+||+.||++|||+.+|++
T Consensus 252 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 4 4567889999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=400.60 Aligned_cols=255 Identities=23% Similarity=0.374 Sum_probs=216.4
Q ss_pred CCcccCCEEEEeeEcccCCeEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhc-CCCCeeeEEEE
Q 012053 5 GSILMQRYELGRLLGQGTFAKVHYARNL-----KTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLV-RHPNVVELYEV 78 (472)
Q Consensus 5 g~~l~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 78 (472)
..+..++|++++.||+|+||+||+|++. .+++.||||++.+... ......+.+|+.+++.+ +|||||+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4456689999999999999999999864 4677999999976542 23456788999999998 69999999999
Q ss_pred EEeCCEEEEEEEecCCCcccchhccC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 012053 79 MASKTKIYFVMEYVKGGELFGKVAKG-------------------KLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPEN 139 (472)
Q Consensus 79 ~~~~~~~~lV~E~~~gg~L~~~i~~~-------------------~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~N 139 (472)
+.++..+|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 99999999999999999999887532 58999999999999999999999999999999999
Q ss_pred EEEcCCCCeEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhc-CCCCCCCCcHH
Q 012053 140 LLLDEHGNLKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLA-GYLPFHDSNLM 218 (472)
Q Consensus 140 ILld~~g~vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~llt-G~~Pf~~~~~~ 218 (472)
||++.++++||+|||+++..............+||+.|+|||++....+ +.++|||||||++|+|+| |.+||...+..
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999987654433333345689999999999987665 489999999999999998 66667666554
Q ss_pred HHHHHHhcc--CCCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 219 EMYRKIGKA--EFKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 219 ~~~~~i~~~--~~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
+.+.++... ....|..+++++.+||.+||+.||.+|||+++|++
T Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 444444332 34556778999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=386.23 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=205.5
Q ss_pred EEEeeEcccCCeEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCEEEEE
Q 012053 13 ELGRLLGQGTFAKVHYARNLKTG---MSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMAS-KTKIYFV 88 (472)
Q Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lV 88 (472)
.+.++||+|+||+||+|++..++ ..||||.+++.. .....+.+.+|+.+|++++||||+++++++.. +...|+|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34688999999999999987653 369999986532 34556889999999999999999999999765 5689999
Q ss_pred EEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcchhhhhcccCC-
Q 012053 89 MEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLSALAESKHQD- 165 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla~~~~~~~~~- 165 (472)
|||+++|+|.+++.. ..+++..+.+++.|++.||.|||++||+||||||+|||+++++.+||+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999998865 46888999999999999999999999999999999999999999999999999876443221
Q ss_pred -CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC-cHHHHHHHHhcc-CCCCCCCCCHHHHHH
Q 012053 166 -GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS-NLMEMYRKIGKA-EFKFPNWFAPEVRRL 242 (472)
Q Consensus 166 -~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~-~~~~~~~~i~~~-~~~~~~~~s~~l~~l 242 (472)
.......||+.|+|||++....++ .++||||||+++|||+||..||... +..+....+..+ .+..|..+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 122345789999999999877664 8999999999999999977777653 344445555444 456778899999999
Q ss_pred HhcccCCCCCCcCChhhhhcC
Q 012053 243 LSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 243 i~~~L~~dP~~Rpt~~eil~h 263 (472)
|.+||+.||++|||+.||++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-49 Score=387.09 Aligned_cols=257 Identities=21% Similarity=0.293 Sum_probs=204.7
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPN-VVELYEVMASKTKIY 86 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~ 86 (472)
+.+||++++.||+|+||+||+|++..+|+.||||++..+... +.+.+|+.+++.++|+| |+.+++++.+.+..|
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 346899999999999999999999999999999998765422 34788999999998766 555666778889999
Q ss_pred EEEEecCCCcccchhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCCeEEecCcchhhhhc
Q 012053 87 FVMEYVKGGELFGKVA--KGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE---HGNLKVSDFGLSALAES 161 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~---~g~vkl~DFGla~~~~~ 161 (472)
+||||+. ++|.+.+. .+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+....
T Consensus 80 ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9999995 45555543 368999999999999999999999999999999999999864 45799999999987654
Q ss_pred ccCC-----CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcHHHHHHH---HhccC-----
Q 012053 162 KHQD-----GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNLMEMYRK---IGKAE----- 228 (472)
Q Consensus 162 ~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~~~~~~~---i~~~~----- 228 (472)
.... ....+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||........... .....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 3221 123456899999999999888775 899999999999999999999987554332222 11111
Q ss_pred CCCCCCCCHHHHHHHhcccCCCCCCcCChhh---hhcCcccccCCC
Q 012053 229 FKFPNWFAPEVRRLLSKILDPNPNTRISMTK---IMENSWFRKGLV 271 (472)
Q Consensus 229 ~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~e---il~hp~f~~~~~ 271 (472)
...+..+|+++.++|.+||..||.+||++++ +++|+|.+.+..
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 1234568999999999999999999999874 567887766543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.4e-49 Score=384.82 Aligned_cols=249 Identities=19% Similarity=0.311 Sum_probs=208.8
Q ss_pred cccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCCEE
Q 012053 7 ILMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH-PNVVELYEVMASKTKI 85 (472)
Q Consensus 7 ~l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 85 (472)
|+.++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.++| +|++.+++++..+...
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 6788999999999999999999999999999999998665322 346789999999975 8999999999999999
Q ss_pred EEEEEecCCCcccchhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-----CCCeEEecCcchhh
Q 012053 86 YFVMEYVKGGELFGKVAK--GKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDE-----HGNLKVSDFGLSAL 158 (472)
Q Consensus 86 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~-----~g~vkl~DFGla~~ 158 (472)
|+||||+ |++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 7788888754 57999999999999999999999999999999999999974 56899999999987
Q ss_pred hhcccCC-----CcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCC---cHHHHHHHHhccC--
Q 012053 159 AESKHQD-----GLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDS---NLMEMYRKIGKAE-- 228 (472)
Q Consensus 159 ~~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~---~~~~~~~~i~~~~-- 228 (472)
....... ....+.+||+.|||||++.+..++ .++|||||||++|+|++|..||.+. +....+.++....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 5432211 223456899999999999887765 8999999999999999999999753 2333333333221
Q ss_pred ---CCCCCCCCHHHHHHHhcccCCCCCCcCChhhhhc
Q 012053 229 ---FKFPNWFAPEVRRLLSKILDPNPNTRISMTKIME 262 (472)
Q Consensus 229 ---~~~~~~~s~~l~~li~~~L~~dP~~Rpt~~eil~ 262 (472)
...+..+|+++.+++..|+..+|++||+++.+.+
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1234568899999999999999999999887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=378.37 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=194.6
Q ss_pred cCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----E
Q 012053 9 MQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNVVELYEVMASKT----K 84 (472)
Q Consensus 9 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 84 (472)
..+|.+.+.||+|+||+||+|++ +|+.||||+++.+.. .......|+..++.++||||+++++++.+++ .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 45799999999999999999986 789999999865431 1122334555556789999999999987654 7
Q ss_pred EEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 85 IYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHS--------RGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 85 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~--------~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
+|+||||+++|+|.+++.+.++++.....++.|++.||.|||+ +||+||||||+||||+.++++||+|||++
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 8999999999999999998899999999999999999999996 59999999999999999999999999999
Q ss_pred hhhhcccC--CCcccccCCCCcccChhhhcccCC-----CCCcccchhhhHHHHHHhcCCCCCCCC--------------
Q 012053 157 ALAESKHQ--DGLLHTTCGTPAYVAPEVINRRGY-----DGSKADIWSCGVILYVLLAGYLPFHDS-------------- 215 (472)
Q Consensus 157 ~~~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~-----~~~~~DiwSlGvil~~lltG~~Pf~~~-------------- 215 (472)
+....... .......+||+.|+|||++.+... .+.++|||||||++|||+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 86643221 122345689999999999865432 235799999999999999998876321
Q ss_pred -cHHHHHHHHhccC--CCCCCC-----CCHHHHHHHhcccCCCCCCcCChhhhhcC
Q 012053 216 -NLMEMYRKIGKAE--FKFPNW-----FAPEVRRLLSKILDPNPNTRISMTKIMEN 263 (472)
Q Consensus 216 -~~~~~~~~i~~~~--~~~~~~-----~s~~l~~li~~~L~~dP~~Rpt~~eil~h 263 (472)
........+.... ..+|.. ....+.+|+.+||+.||++|||+.||+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2222333332222 222222 12458899999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-46 Score=378.29 Aligned_cols=257 Identities=26% Similarity=0.453 Sum_probs=201.9
Q ss_pred CcCCccc-CCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-----------CC
Q 012053 3 NKGSILM-QRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-----------HP 70 (472)
Q Consensus 3 ~~g~~l~-~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hp 70 (472)
..|.++. +||++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+++.++ |+
T Consensus 5 ~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 5 FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp CTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence 3588775 68999999999999999999999999999999997654 23466788999988775 57
Q ss_pred CeeeEEEEEE--eCCEEEEEEEecCCCcccchh----ccCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEc
Q 012053 71 NVVELYEVMA--SKTKIYFVMEYVKGGELFGKV----AKGKLKEDAARKYFQQLISAVDYCHS-RGVCHRDLKPENLLLD 143 (472)
Q Consensus 71 nIv~l~~~~~--~~~~~~lV~E~~~gg~L~~~i----~~~~l~e~~~~~i~~ql~~al~yLH~-~giiHrDIKp~NILld 143 (472)
||+++++++. .....+++|+++..+...... ....+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeee
Confidence 8999998875 446777888877665433222 23579999999999999999999998 8999999999999998
Q ss_pred CCCC------eEEecCcchhhhhcccCCCcccccCCCCcccChhhhcccCCCCCcccchhhhHHHHHHhcCCCCCCCCcH
Q 012053 144 EHGN------LKVSDFGLSALAESKHQDGLLHTTCGTPAYVAPEVINRRGYDGSKADIWSCGVILYVLLAGYLPFHDSNL 217 (472)
Q Consensus 144 ~~g~------vkl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~lltG~~Pf~~~~~ 217 (472)
.++. ++++|||.|...... ....+||+.|+|||++....|+ .++||||+||++++|++|+.||...+.
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCcc
Confidence 7664 999999998754332 2467899999999999888875 799999999999999999999975432
Q ss_pred H------HHHHHH----hc--------------------------------------cCCCCCCCCCHHHHHHHhcccCC
Q 012053 218 M------EMYRKI----GK--------------------------------------AEFKFPNWFAPEVRRLLSKILDP 249 (472)
Q Consensus 218 ~------~~~~~i----~~--------------------------------------~~~~~~~~~s~~l~~li~~~L~~ 249 (472)
. .....+ .. .....+...++++.+||.+||+.
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence 1 111110 00 00111122357899999999999
Q ss_pred CCCCcCChhhhhcCcccccC
Q 012053 250 NPNTRISMTKIMENSWFRKG 269 (472)
Q Consensus 250 dP~~Rpt~~eil~hp~f~~~ 269 (472)
||.+|||++|+|+||||++.
T Consensus 315 dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 315 DPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp STTTCBCHHHHHTCGGGTTC
T ss_pred ChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999853
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=2.7e-26 Score=209.26 Aligned_cols=137 Identities=20% Similarity=0.314 Sum_probs=109.2
Q ss_pred EEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc---------------chhhHHHHHHHHHHHHhcCCCCeeeEE
Q 012053 12 YELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL---------------KVGMIDQIKREISVMRLVRHPNVVELY 76 (472)
Q Consensus 12 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv~l~ 76 (472)
|.+++.||+|+||+||+|++ .+|+.||||+++..... .........+|..++..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 46899999999999999998 47999999987532110 011123456789999999999999988
Q ss_pred EEEEeCCEEEEEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCCeEEecCcch
Q 012053 77 EVMASKTKIYFVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSRGVCHRDLKPENLLLDEHGNLKVSDFGLS 156 (472)
Q Consensus 77 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~giiHrDIKp~NILld~~g~vkl~DFGla 156 (472)
++.. .+++|||+++..+.+ +++..+..++.||+.+|.|||++||+||||||+|||+++++ ++|+|||+|
T Consensus 81 ~~~~----~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a 149 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS 149 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTC
T ss_pred EecC----CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCc
Confidence 7642 279999998866533 45566778999999999999999999999999999999665 899999998
Q ss_pred hhhh
Q 012053 157 ALAE 160 (472)
Q Consensus 157 ~~~~ 160 (472)
....
T Consensus 150 ~~~~ 153 (191)
T d1zara2 150 VEVG 153 (191)
T ss_dssp EETT
T ss_pred ccCC
Confidence 6543
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.59 E-value=2.9e-15 Score=120.12 Aligned_cols=88 Identities=15% Similarity=0.233 Sum_probs=80.6
Q ss_pred ceeeccCCHHHHHHHHHHHHhHcCcEEEEecCceEEEEeecCCcCceEEEEEEEEEEc-CceEEEEEEccCCCcHHHHHH
Q 012053 341 VRFTSNKPVSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEIT-PFFHLVEVKKSSGDTLEYQKV 419 (472)
Q Consensus 341 ~rf~s~~~~~~i~~~l~~~~~~l~~~v~~~~~~~~~~~~~~~~~~g~l~~~~ev~e~~-~~~~lVe~~~~~Gd~lef~~~ 419 (472)
..-||+.+|++||.+|+++++.+|+.|++++++.+++++..+++++.+.|.+||+++. +++++|+|||.+||+++|+++
T Consensus 13 v~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l 92 (102)
T d1ul7a_ 13 MKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNI 92 (102)
T ss_dssp CCCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHH
T ss_pred eecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHH
Confidence 4458999999999999999999999999888888999998889999999999999995 799999999999999999999
Q ss_pred HHHhhhhccc
Q 012053 420 MNQEIRPALK 429 (472)
Q Consensus 420 ~~~~l~~~L~ 429 (472)
|.+ |-..|+
T Consensus 93 ~~~-il~~l~ 101 (102)
T d1ul7a_ 93 ASK-IANELK 101 (102)
T ss_dssp HHH-HHHHCC
T ss_pred HHH-HHHhcc
Confidence 998 655553
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.65 E-value=4.8e-08 Score=90.66 Aligned_cols=141 Identities=16% Similarity=0.136 Sum_probs=99.6
Q ss_pred ccCCEEEEeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCEEE
Q 012053 8 LMQRYELGRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVR-HPNVVELYEVMASKTKIY 86 (472)
Q Consensus 8 l~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 86 (472)
+.+.|++.+..+-++.+.||+.. .++..+.+|+....... ....+.+|..+++.+. +--+.+++.+...++..|
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 45688888877666678999875 36677888987654322 2235678999888774 434678888888999999
Q ss_pred EEEEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 012053 87 FVMEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHSR-------------------------------------- 128 (472)
Q Consensus 87 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~~-------------------------------------- 128 (472)
+||++++|..+........ ....++.++...+..||+.
T Consensus 87 lv~~~l~G~~~~~~~~~~~----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEEecccccccccccccc----cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 9999999987755432221 1223444555555555531
Q ss_pred ---------------------CceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 129 ---------------------GVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 129 ---------------------giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 26899999999999987666799998654
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.60 E-value=1.2e-07 Score=78.68 Aligned_cols=76 Identities=12% Similarity=0.148 Sum_probs=64.9
Q ss_pred ceeeccCCHHHHHHHHHHHHhHcCcEEEEecCceEEEEeecCCcCceEEEEEEEEEEcCceEEEEEEccCCCcHHH
Q 012053 341 VRFTSNKPVSTIISKLEGIAKLLRLKVKKKDGGLLKIEGSKEGRKGVLGMDAEIFEITPFFHLVEVKKSSGDTLEY 416 (472)
Q Consensus 341 ~rf~s~~~~~~i~~~l~~~~~~l~~~v~~~~~~~~~~~~~~~~~~g~l~~~~ev~e~~~~~~lVe~~~~~Gd~lef 416 (472)
..+.|+..+.+||..|..+.++||+.||+.+.+.|+++.........+.|.+++|+|.+..||||||...|+..|=
T Consensus 3 lGIrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e~ 78 (153)
T d2v8qa1 3 LGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITEA 78 (153)
T ss_dssp ESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred cccccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhcc
Confidence 3567889999999999999999999999999999999985554456789999999999999999999999997663
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.20 E-value=5e-06 Score=76.14 Aligned_cols=131 Identities=15% Similarity=0.180 Sum_probs=86.0
Q ss_pred EEEEeeEcccC-CeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCCEEEEE
Q 012053 12 YELGRLLGQGT-FAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRH--PNVVELYEVMASKTKIYFV 88 (472)
Q Consensus 12 y~i~~~LG~G~-fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lV 88 (472)
++.. .+..|. -+.||+... ..+..+.+|....... ..+.+|...|+.+.. -.+.+++.+..+++..|+|
T Consensus 13 ~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 13 YDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 4443 334444 468898874 5677788998654432 346788888887743 3367788888888899999
Q ss_pred EEecCCCcccchhccCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 012053 89 MEYVKGGELFGKVAKGKLKEDAARKYFQQLISAVDYCHS----------------------------------------- 127 (472)
Q Consensus 89 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~al~yLH~----------------------------------------- 127 (472)
|++++|.++.... .+... .+.++...|.-||+
T Consensus 85 ~~~i~G~~~~~~~----~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
T d1nd4a_ 85 LGEVPGQDLLSSH----LAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 157 (255)
T ss_dssp EECCSSEETTTSC----CCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred EEeeecccccccc----ccHHH---HHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhH
Confidence 9999987653321 11111 12233333333332
Q ss_pred ----------C-------CceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 128 ----------R-------GVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 128 ----------~-------giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
. .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 158 ~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 158 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 27999999999999987667899998654
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=98.19 E-value=2.8e-06 Score=68.94 Aligned_cols=70 Identities=11% Similarity=0.131 Sum_probs=58.5
Q ss_pred cccceeeccCCHHHHHHHHHHHHhHcCcEEEEecC---------ceEEEEeec-----CCcCceEEEEEEEEEEcCceEE
Q 012053 338 RKEVRFTSNKPVSTIISKLEGIAKLLRLKVKKKDG---------GLLKIEGSK-----EGRKGVLGMDAEIFEITPFFHL 403 (472)
Q Consensus 338 ~~~~rf~s~~~~~~i~~~l~~~~~~l~~~v~~~~~---------~~~~~~~~~-----~~~~g~l~~~~ev~e~~~~~~l 403 (472)
|+....-|+..|-+||..|..+.++||+.|++.+. +.|+++... .+....+.|.+++|+|.++.+|
T Consensus 2 KWhfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YL 81 (127)
T d2qrda1 2 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM 81 (127)
T ss_dssp CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred CceeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEE
Confidence 45567789999999999999999999999998775 679887432 2233468899999999999999
Q ss_pred EEEE
Q 012053 404 VEVK 407 (472)
Q Consensus 404 Ve~~ 407 (472)
||||
T Consensus 82 lDFK 85 (127)
T d2qrda1 82 LDVK 85 (127)
T ss_dssp EEEE
T ss_pred EEEc
Confidence 9998
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.04 E-value=5.9e-06 Score=81.42 Aligned_cols=81 Identities=17% Similarity=0.103 Sum_probs=52.1
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeeccccc-c---hhhHHHHHHHHHHHHhcC-C--CCeeeEEEEEEeCCEEEE
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVL-K---VGMIDQIKREISVMRLVR-H--PNVVELYEVMASKTKIYF 87 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~---~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l 87 (472)
.+.||.|....||++.+..+++.+++|.-...... . ....++...|..+|+.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56789999999999988777889999975432111 1 012355678998888763 2 345666655 3445578
Q ss_pred EEEecCCCcc
Q 012053 88 VMEYVKGGEL 97 (472)
Q Consensus 88 V~E~~~gg~L 97 (472)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.88 E-value=1.7e-05 Score=67.49 Aligned_cols=71 Identities=17% Similarity=0.079 Sum_probs=55.2
Q ss_pred cccceeeccCCHHHHHHHHHHHHhHcCcEEEEec---CceEEEEeecC---------CcCceEEEEEEEEEEcCceEEEE
Q 012053 338 RKEVRFTSNKPVSTIISKLEGIAKLLRLKVKKKD---GGLLKIEGSKE---------GRKGVLGMDAEIFEITPFFHLVE 405 (472)
Q Consensus 338 ~~~~rf~s~~~~~~i~~~l~~~~~~l~~~v~~~~---~~~~~~~~~~~---------~~~g~l~~~~ev~e~~~~~~lVe 405 (472)
|+....-|+..|-+||..|..+.++||+.|++.+ .+.|++....+ .....+.|.+++|+|.++.||||
T Consensus 45 kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlD 124 (171)
T d2qlva1 45 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 124 (171)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEE
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEE
Confidence 5778899999999999999999999999998765 47789875321 11134789999999999999999
Q ss_pred EEc
Q 012053 406 VKK 408 (472)
Q Consensus 406 ~~~ 408 (472)
||-
T Consensus 125 FK~ 127 (171)
T d2qlva1 125 FKF 127 (171)
T ss_dssp EEE
T ss_pred Eec
Confidence 984
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.32 E-value=0.00022 Score=67.84 Aligned_cols=70 Identities=16% Similarity=0.152 Sum_probs=47.5
Q ss_pred CeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe--eeEE-----EEEEeCCEEEEEEEecCCC
Q 012053 23 FAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV--VELY-----EVMASKTKIYFVMEYVKGG 95 (472)
Q Consensus 23 fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI--v~l~-----~~~~~~~~~~lV~E~~~gg 95 (472)
--.||.+.. .+|+.|++|+.+.... ..+++..|...+..|...+| +... ..+..++..+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 358999875 6889999999876542 24668889988887742222 1111 1235677899999999875
Q ss_pred cc
Q 012053 96 EL 97 (472)
Q Consensus 96 ~L 97 (472)
.+
T Consensus 110 ~~ 111 (325)
T d1zyla1 110 QF 111 (325)
T ss_dssp EC
T ss_pred CC
Confidence 43
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.07 E-value=0.0014 Score=63.75 Aligned_cols=74 Identities=14% Similarity=0.179 Sum_probs=51.4
Q ss_pred EeeEcccCCeEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCEEE
Q 012053 15 GRLLGQGTFAKVHYARNLK-------TGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV-VELYEVMASKTKIY 86 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 86 (472)
++.|+.|---.+|++.... .++.|.+++.-... . .-...+|..+++.+.-.++ .++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4678888889999988643 34678888865321 1 2345689999998863344 577777653 6
Q ss_pred EEEEecCCCcc
Q 012053 87 FVMEYVKGGEL 97 (472)
Q Consensus 87 lV~E~~~gg~L 97 (472)
+|+||++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999988654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.77 E-value=0.0019 Score=60.37 Aligned_cols=136 Identities=13% Similarity=0.114 Sum_probs=74.5
Q ss_pred EeeEcccCCeEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhcCCCCe--eeEEE------EEEeCCEEE
Q 012053 15 GRLLGQGTFAKVHYARNLKTGMSVAIKIIDKEKVLKVGMIDQIKREISVMRLVRHPNV--VELYE------VMASKTKIY 86 (472)
Q Consensus 15 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI--v~l~~------~~~~~~~~~ 86 (472)
.+.|..|---+.|+... ++..+++|++..... .+.+..|+.+|..|...++ ..... +...+....
T Consensus 23 ~~~i~~G~~N~ny~v~t--~~g~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHT--TKDPLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp EEEECC---EEEEEEEE--SSCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eecCCCCcccCeEEEEE--CCCcEEEEEcCCCCC-----HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence 44455676688898875 334589999865421 1356667777777643222 11111 123456677
Q ss_pred EEEEecCCCcccch--------------hc---c-------CCCCH------------------HHHHHHHHHHHHHHHH
Q 012053 87 FVMEYVKGGELFGK--------------VA---K-------GKLKE------------------DAARKYFQQLISAVDY 124 (472)
Q Consensus 87 lV~E~~~gg~L~~~--------------i~---~-------~~l~e------------------~~~~~i~~ql~~al~y 124 (472)
.++.++.|...... +. . ..... ......+..+...+.-
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence 77887777433210 00 0 00000 1122222233333333
Q ss_pred HHh----CCceecCCCCCcEEEcCCCCeEEecCcchh
Q 012053 125 CHS----RGVCHRDLKPENLLLDEHGNLKVSDFGLSA 157 (472)
Q Consensus 125 LH~----~giiHrDIKp~NILld~~g~vkl~DFGla~ 157 (472)
.+. .|++|+|+.++||+++.+...-|.||+.+.
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 332 379999999999999988877899999654
|